1	The	DT	O	the	det	4	SENT_1	[p1l385t81r431b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l449t83r534b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l553t83r742b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l761t83r940b109],
5	of	IN	O	of	_	0	SENT_1	[p1l960t81r988b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_1	[p1l1000t83r1199b102],

1	l	NN	O	l	_	0	SENT_2	[p1l92t184r95b303],
2	ORIGINAL	NNP	O	ORIGINAL	nn	3	SENT_2	[p1l581t234r805b260],
3	ARTICLE	NN	O	article	dep	1	SENT_2	[p1l817t234r1003b260],
4	I	PRP	O	I	dep	1	SENT_2	[p1l1490t184r1493b303],

1	Dolutegravir	NNP	MISC	Dolutegravir	_	0	SENT_3	[p1l186t364r566b434],
2	plus	CC	O	plus	_	0	SENT_3	[p1l592t364r717b434],
3	Abacavir	NNP	O	Abacavir	conj_plus	1	SENT_3	[p1l745t364r1398b419],
4	.	.	O	.	_	0	SENT_3	[p1l745t364r1398b419],

1	—	NN	O	—	_	0	SENT_4	[p1l745t364r1398b419],
2	.	.	O	.	_	0	SENT_4	[p1l745t364r1398b419],

1	Lamivudine	NN	O	lamivudine	_	0	SENT_5	[p1l745t364r1398b419],
2	for	IN	O	for	_	0	SENT_5	[p1l220t446r308b502],
3	the	DT	O	the	det	4	SENT_5	[p1l335t447r427b502],
4	Treatment	NN	O	treatment	prep_for	1	SENT_5	[p1l454t451r771b502],
5	of	IN	O	of	_	0	SENT_5	[p1l797t446r868b502],
6	HIV-1	NN	O	hiv-1	nn	7	SENT_5	[p1l884t451r1063b502],
7	Infection	NN	O	infection	prep_of	1	SENT_5	[p1l1092t446r1365b502],

1	Sharon	NNP	PERSON	Sharon	nn	3	SENT_6	[p1l107t558r225b589],
2	L.	NNP	PERSON	L.	nn	3	SENT_6	[p1l242t561r266b589],
3	Walmsley	NNP	PERSON	Walmsley	_	0	SENT_6	[p1l279t558r452b599],
4	,	,	O	,	_	0	SENT_6	[p1l279t558r452b599],
5	M.D.	NNP	O	M.D.	appos	3	SENT_6	[p1l469t561r559b595],
6	,	,	O	,	_	0	SENT_6	[p1l469t561r559b595],
7	Antonio	NNP	PERSON	Antonio	nn	15	SENT_6	[p1l573t560r708b589],
8	Antela	NNP	PERSON	Antela	nn	15	SENT_6	[p1l720t558r837b595],
9	,	,	O	,	_	0	SENT_6	[p1l720t558r837b595],
10	M.D.	NNP	O	M.D.	appos	15	SENT_6	[p1l854t561r944b595],
11	,	,	O	,	_	0	SENT_6	[p1l854t561r944b595],
12	Ph.D.	NNP	O	Ph.D.	appos	15	SENT_6	[p1l961t558r1060b595],
13	,	,	O	,	_	0	SENT_6	[p1l961t558r1060b595],
14	Nathan	NNP	PERSON	Nathan	appos	15	SENT_6	[p1l1078t558r1199b589],
15	Clumeck	NNP	PERSON	Clumeck	appos	3	SENT_6	[p1l1214t558r1369b595],
16	,	,	O	,	_	0	SENT_6	[p1l1214t558r1369b595],
17	M.D.	NNP	O	M.D.	appos	15	SENT_6	[p1l1387t561r1477b595],
18	,	,	O	,	_	0	SENT_6	[p1l1387t561r1477b595],

1	Dan	NNP	PERSON	Dan	nn	2	SENT_7	[p1l203t611r268b639],
2	Duiculescu	NNP	PERSON	Duiculescu	_	0	SENT_7	[p1l285t608r481b645],
3	,	,	O	,	_	0	SENT_7	[p1l285t608r481b645],
4	M.D.	NNP	O	M.D.	dep	2	SENT_7	[p1l498t611r588b645],
5	,	,	O	,	_	0	SENT_7	[p1l498t611r588b645],
6	Andrea	NNP	PERSON	Andrea	nn	7	SENT_7	[p1l602t608r722b639],
7	Eberhard	NNP	PERSON	Eberhard	appos	4	SENT_7	[p1l739t608r898b645],
8	,	,	O	,	_	0	SENT_7	[p1l739t608r898b645],
9	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l915t611r1005b645],
10	,	,	O	,	_	0	SENT_7	[p1l915t611r1005b645],
11	Felix	NNP	PERSON	Felix	nn	12	SENT_7	[p1l1023t608r1096b639],
12	Gutiérrez	NNP	PERSON	Gutiérrez	appos	4	SENT_7	[p1l1108t610r1275b645],
13	,	,	O	,	_	0	SENT_7	[p1l1108t610r1275b645],
14	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l1292t611r1382b645],
15	,	,	O	,	_	0	SENT_7	[p1l1292t611r1382b645],

1	Laurent	NNP	PERSON	Laurent	nn	2	SENT_8	[p1l142t661r269b689],
2	Hocqueloux	NNP	PERSON	Hocqueloux	_	0	SENT_8	[p1l284t658r495b699],
3	,	,	O	,	_	0	SENT_8	[p1l284t658r495b699],
4	M.D.	NNP	O	M.D.	appos	2	SENT_8	[p1l512t661r602b695],
5	,	,	O	,	_	0	SENT_8	[p1l512t661r602b695],
6	Franco	NNP	PERSON	Franco	nn	7	SENT_8	[p1l620t661r732b689],
7	Maggiolo	NNP	PERSON	Maggiolo	appos	4	SENT_8	[p1l748t658r915b699],
8	,	,	O	,	_	0	SENT_8	[p1l748t658r915b699],
9	M.D.	NNP	O	M.D.	appos	4	SENT_8	[p1l932t661r1022b695],
10	,	,	O	,	_	0	SENT_8	[p1l932t661r1022b695],
11	Uriel	NNP	PERSON	Uriel	nn	12	SENT_8	[p1l1039t658r1114b689],
12	Sandkovsky	NNP	PERSON	Sandkovsky	appos	4	SENT_8	[p1l1130t658r1336b699],
13	,	,	O	,	_	0	SENT_8	[p1l1130t658r1336b699],
14	M.D.	NNP	O	M.D.	appos	4	SENT_8	[p1l1354t661r1443b695],
15	,	,	O	,	_	0	SENT_8	[p1l1354t661r1443b695],
16	Catherine	NNP	PERSON	Catherine	nn	17	SENT_8	[p1l177t708r340b739],
17	Granier	NNP	PERSON	Granier	appos	4	SENT_8	[p1l353t710r489b745],
18	,	,	O	,	_	0	SENT_8	[p1l353t710r489b745],
19	D.E.S.S.	NNP	ORGANIZATION	D.E.S.S.	appos	4	SENT_8	[p1l506t710r647b745],
20	,	,	O	,	_	0	SENT_8	[p1l506t710r647b745],
21	Keith	NNP	PERSON	Keith	nn	22	SENT_8	[p1l665t708r746b739],
22	Pappa	NNP	PERSON	Pappa	appos	4	SENT_8	[p1l763t711r874b749],
23	,	,	O	,	_	0	SENT_8	[p1l763t711r874b749],
24	Pharm	NNP	O	Pharm	appos	4	SENT_8	[p1l891t708r1059b745],
25	.	.	O	.	_	0	SENT_8	[p1l891t708r1059b745],

1	D.	NNP	O	D.	dep	26	SENT_9	[p1l891t708r1059b745],
2	,	,	O	,	_	0	SENT_9	[p1l891t708r1059b745],
3	Brian	NNP	PERSON	Brian	nn	11	SENT_9	[p1l1077t711r1160b739],
4	Wynne	NNP	PERSON	Wynne	nn	11	SENT_9	[p1l1174t711r1299b749],
5	,	,	O	,	_	0	SENT_9	[p1l1174t711r1299b749],
6	M.D.	NNP	O	M.D.	appos	11	SENT_9	[p1l1316t711r1406b745],
7	,	,	O	,	_	0	SENT_9	[p1l1316t711r1406b745],
8	Sherene	NNP	O	Sherene	appos	11	SENT_9	[p1l130t757r266b788],
9	Min	NNP	DURATION	Min	nn	11	SENT_9	[p1l281t760r354b794],
10	,	,	O	,	_	0	SENT_9	[p1l281t760r354b794],
11	M.D.	NNP	O	M.D.	appos	1	SENT_9	[p1l371t760r461b794],
12	,	,	O	,	_	0	SENT_9	[p1l371t760r461b794],
13	and	CC	O	and	prep	11	SENT_9	[p1l476t757r536b788],
14	Garrett	NNP	PERSON	Garrett	nn	17	SENT_9	[p1l551t760r670b788],
15	Nichols	NNP	PERSON	Nichols	nn	17	SENT_9	[p1l685t757r822b794],
16	,	,	O	,	_	0	SENT_9	[p1l685t757r822b794],
17	M.D.	NNP	O	M.D.	dep	13	SENT_9	[p1l839t760r929b794],
18	,	,	O	,	_	0	SENT_9	[p1l839t760r929b794],
19	for	IN	O	for	_	0	SENT_9	[p1l943t757r990b788],
20	the	DT	O	the	det	21	SENT_9	[p1l1000t757r1053b788],
21	SINGLE	JJ	O	single	prep_for	17	SENT_9	[p1l1066t760r1201b788],
22	|	NN	O	|	prep	17	SENT_9	[p1l1217t760r1456b798],
23	nvestigators	NNS	O	nvestigator	dep	22	SENT_9	[p1l1217t760r1456b798],
24	"	``	O	"	punct	17	SENT_9	[p1l1217t760r1456b798],
25	'	''	O	'	_	0	SENT_9	[p1l1217t760r1456b798],
26	=	JJ	O	=	_	0	SENT_9	[p1l1217t760r1456b798],

1	ABSTRACT	NN	O	abstract	_	0	SENT_10	[p1l681t882r903b905],

1	BAC	NN	O	bac	nn	2	SENT_11	[p1l95t987r150b1006],
2	KG	NN	O	kg	nsubjpass	21	SENT_11	[p1l156t987r192b1006],
3	no	DT	O	no	det	10	SENT_11	[p1l199t987r238b1006],
4	u	NN	O	u	nn	10	SENT_11	[p1l244t987r260b1006],
5	N	NN	PERSON	n	nn	10	SENT_11	[p1l268t987r285b1006],
6	D	NN	PERSON	d	nn	10	SENT_11	[p1l292t987r310b1006],
7	Dolutegravir	NN	PERSON	dolutegravir	nn	10	SENT_11	[p1l93t1030r304b1069],
8	(	CD	NUMBER	(	num	10	SENT_11	[p1l319t1032r593b1067],
9	S/GSK1349572	NN	O	s/gsk1349572	nn	10	SENT_11	[p1l319t1032r593b1067],
10	)	NN	O	)	dep	2	SENT_11	[p1l319t1032r593b1067],
11	,	,	O	,	_	0	SENT_11	[p1l319t1032r593b1067],
12	a	DT	O	a	det	17	SENT_11	[p1l610t1040r628b1060],
13	once-daily	JJ	O	once-daily	amod	17	SENT_11	[p1l642t1030r821b1069],
14	,	,	O	,	_	0	SENT_11	[p1l642t1030r821b1069],
15	unboosted	JJ	O	unboosted	amod	17	SENT_11	[p1l838t1030r1014b1060],
16	integrase	NN	O	integrase	nn	17	SENT_11	[p1l1029t1030r1182b1069],
17	inhibitor	NN	O	inhibitor	appos	2	SENT_11	[p1l1197t1030r1352b1067],
18	,	,	O	,	_	0	SENT_11	[p1l1197t1030r1352b1067],
19	was	VBD	O	be	auxpass	21	SENT_11	[p1l1368t1040r1431b1061],
20	recently	RB	DATE	recently	advmod	21	SENT_11	[p1l1447t1040r1491b1060, p1l94t1079r190b1118],
21	approved	VBN	O	approve	_	0	SENT_11	[p1l203t1079r351b1118],
22	in	IN	O	in	_	0	SENT_11	[p1l365t1080r397b1109],
23	the	DT	O	the	det	25	SENT_11	[p1l411t1079r462b1110],
24	United	NNP	LOCATION	United	nn	25	SENT_11	[p1l476t1079r585b1110],
25	States	NNPS	LOCATION	States	prep_in	21	SENT_11	[p1l600t1082r695b1110],
26	for	IN	O	for	_	0	SENT_11	[p1l710t1079r757b1110],
27	the	DT	O	the	det	28	SENT_11	[p1l770t1079r821b1110],
28	treatment	NN	O	treatment	prep_for	21	SENT_11	[p1l835t1086r996b1110],
29	of	IN	O	of	_	0	SENT_11	[p1l1009t1079r1047b1110],
30	human	JJ	O	human	amod	33	SENT_11	[p1l1054t1079r1171b1110],
31	immunodeﬁciency	NN	O	immunodeﬁciency	nn	33	SENT_11	[p1l1185t1079r1493b1118],
32	virus	NN	O	virus	nn	33	SENT_11	[p1l92t1130r173b1160],
33	type	NN	O	type	nn	38	SENT_11	[p1l187t1136r256b1169],
34	1	CD	NUMBER	1	number	35	SENT_11	[p1l270t1132r288b1160],
35	(	CD	NUMBER	(	dep	36	SENT_11	[p1l303t1132r417b1165],
36	HIV-1	NN	O	hiv-1	dep	38	SENT_11	[p1l303t1132r417b1165],
37	)	NN	O	)	nn	38	SENT_11	[p1l303t1132r417b1165],
38	infection	NN	O	infection	prep_of	28	SENT_11	[p1l432t1129r578b1160],
39	in	IN	O	in	_	0	SENT_11	[p1l591t1130r623b1160],
40	combination	NN	O	combination	prep_in	21	SENT_11	[p1l637t1130r844b1160],
41	with	IN	O	with	_	0	SENT_11	[p1l856t1130r930b1160],
42	other	JJ	O	other	amod	44	SENT_11	[p1l944t1130r1030b1160],
43	antiretroviral	JJ	O	antiretroviral	amod	44	SENT_11	[p1l1042t1130r1259b1160],
44	agents	NNS	O	agent	prep_with	40	SENT_11	[p1l1272t1136r1386b1169],
45	.	.	O	.	_	0	SENT_11	[p1l1272t1136r1386b1169],

1	Dolutegravir	NNP	PERSON	Dolutegravir	nsubj	11	SENT_12	[p1l1401t1130r1491b1160, p1l94t1180r225b1219],
2	,	,	O	,	_	0	SENT_12	[p1l1401t1130r1491b1160, p1l94t1180r225b1219],
3	in	IN	O	in	_	0	SENT_12	[p1l238t1180r269b1210],
4	combination	NN	O	combination	prep_in	1	SENT_12	[p1l280t1179r486b1210],
5	with	IN	O	with	_	0	SENT_12	[p1l495t1179r569b1210],
6	abacavir	NN	O	abacavir	nn	8	SENT_12	[p1l579t1179r924b1217],
7	—	CD	NUMBER	—	num	8	SENT_12	[p1l579t1179r924b1217],
8	lamivudine	NN	O	lamivudine	prep_with	4	SENT_12	[p1l579t1179r924b1217],
9	,	,	O	,	_	0	SENT_12	[p1l579t1179r924b1217],
10	may	MD	O	may	aux	11	SENT_12	[p1l937t1189r1005b1219],
11	provide	VB	O	provide	_	0	SENT_12	[p1l1013t1179r1133b1219],
12	a	DT	O	a	det	14	SENT_12	[p1l1143t1190r1161b1210],
13	simpliﬁed	JJ	O	simpliﬁed	amod	14	SENT_12	[p1l1171t1179r1336b1219],
14	regimen	NN	O	regimen	dobj	11	SENT_12	[p1l1346t1180r1489b1219],
15	.	.	O	.	_	0	SENT_12	[p1l1346t1180r1489b1219],

1	METHODS	NNS	O	method	nsubj	3	SENT_13	[p1l96t1256r249b1275],
2	We	PRP	O	we	nsubj	3	SENT_13	[p1l92t1302r144b1330],
3	conducted	VBD	O	conduct	_	0	SENT_13	[p1l161t1299r332b1330],
4	a	DT	O	a	dobj	3	SENT_13	[p1l348t1309r365b1330],
5	randomized	VBN	O	randomize	dep	3	SENT_13	[p1l381t1299r592b1336],
6	,	,	O	,	_	0	SENT_13	[p1l381t1299r592b1336],
7	double-blind	JJ	O	double-blind	amod	11	SENT_13	[p1l611t1299r832b1336],
8	,	,	O	,	_	0	SENT_13	[p1l611t1299r832b1336],
9	phase	NN	O	phase	dep	11	SENT_13	[p1l850t1299r947b1338],
10	3	CD	NUMBER	3	num	11	SENT_13	[p1l964t1301r981b1330],
11	study	NN	O	study	nsubj	12	SENT_13	[p1l999t1299r1089b1338],
12	involving	VBG	O	involve	dep	5	SENT_13	[p1l1103t1299r1257b1338],
13	adult	NN	O	adult	nn	14	SENT_13	[p1l1272t1299r1356b1330],
14	participants	NNS	O	participant	dobj	12	SENT_13	[p1l1370t1300r1491b1338, p1l93t1356r184b1388],
15	who	WP	O	who	nsubj	18	SENT_13	[p1l199t1349r270b1380],
16	had	VBD	O	have	aux	18	SENT_13	[p1l286t1349r347b1380],
17	not	RB	O	not	neg	18	SENT_13	[p1l362t1356r417b1380],
18	received	VBN	O	receive	dep	12	SENT_13	[p1l431t1349r565b1380],
19	previous	JJ	O	previous	amod	20	SENT_13	[p1l580t1350r721b1388],
20	therapy	NN	O	therapy	dobj	18	SENT_13	[p1l737t1349r862b1388],
21	for	IN	O	for	_	0	SENT_13	[p1l876t1349r924b1380],
22	HIV-1	NN	MISC	hiv-1	nn	23	SENT_13	[p1l938t1351r1033b1379],
23	infection	NN	O	infection	prep_for	18	SENT_13	[p1l1048t1349r1198b1380],
24	and	CC	O	and	_	0	SENT_13	[p1l1213t1349r1275b1380],
25	who	WP	O	who	nsubj	26	SENT_13	[p1l1288t1349r1359b1380],
26	had	VBD	O	have	conj_and	18	SENT_13	[p1l1375t1349r1436b1380],
27	an	DT	O	a	det	30	SENT_13	[p1l1451t1359r1491b1380],
28	HIV-1	NN	MISC	hiv-1	nn	30	SENT_13	[p1l93t1401r188b1429],
29	RNA	NN	MISC	rna	nn	30	SENT_13	[p1l202t1402r283b1432],
30	level	NN	O	level	dobj	26	SENT_13	[p1l295t1399r369b1430],
31	of	IN	O	of	_	0	SENT_13	[p1l383t1399r422b1430],
32	1000	CD	DATE	1000	num	33	SENT_13	[p1l430t1401r509b1430],
33	copies	NNS	O	copy	prep_of	30	SENT_13	[p1l523t1400r626b1438],
34	per	IN	O	per	_	0	SENT_13	[p1l640t1409r695b1438],
35	milliliter	NN	O	milliliter	prep_per	33	SENT_13	[p1l708t1399r856b1430],
36	or	CC	O	or	_	0	SENT_13	[p1l870t1409r904b1430],
37	more	JJR	O	more	dep	3	SENT_13	[p1l917t1409r1011b1430],
38	.	.	O	.	_	0	SENT_13	[p1l917t1409r1011b1430],

1	Participants	NNS	O	participant	nsubjpass	4	SENT_14	[p1l1027t1400r1226b1438],
2	were	VBD	O	be	auxpass	4	SENT_14	[p1l1240t1409r1318b1430],
3	randomly	RB	O	randomly	advmod	4	SENT_14	[p1l1332t1399r1493b1438],
4	assigned	VBN	O	assign	_	0	SENT_14	[p1l93t1517r238b1556],
5	to	TO	O	to	_	0	SENT_14	[p1l255t1524r287b1548],
6	dolutegravir	NN	O	dolutegravir	prep_to	4	SENT_14	[p1l305t1517r507b1556],
7	at	IN	O	at	_	0	SENT_14	[p1l523t1524r554b1548],
8	a	DT	O	a	det	9	SENT_14	[p1l568t1527r586b1548],
9	dose	NN	O	dose	prep_at	4	SENT_14	[p1l602t1517r678b1548],
10	of	IN	O	of	_	0	SENT_14	[p1l695t1517r734b1548],
11	50	CD	NUMBER	50	num	12	SENT_14	[p1l745t1519r782b1548],
12	mg	NN	O	mg	prep_of	9	SENT_14	[p1l799t1527r853b1556],
13	plus	CC	O	plus	prep	12	SENT_14	[p1l868t1517r937b1556],
14	abacavir	NN	O	abacavir	dep	13	SENT_14	[p1l954t1517r1301b1548],
15	—	CD	NUMBER	—	num	16	SENT_14	[p1l954t1517r1301b1548],
16	lamivudine	NN	O	lamivudine	npadvmod	17	SENT_14	[p1l954t1517r1301b1548],
17	once	RB	DATE	once	advmod	12	SENT_14	[p1l1319t1527r1395b1548],
18	daily	JJ	SET	daily	amod	20	SENT_14	[p1l1412t1517r1493b1556],
19	(	NN	O	(	nn	20	SENT_14	[p1l95t1570r365b1603],
20	DTG	NN	O	dtg	dep	12	SENT_14	[p1l95t1570r365b1603],
21	.	.	O	.	_	0	SENT_14	[p1l95t1570r365b1603],

1	—	NN	O	—	_	0	SENT_15	[p1l95t1570r365b1603],
2	.	.	O	.	_	0	SENT_15	[p1l95t1570r365b1603],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_16	[p1l95t1570r365b1603],
2	.	.	O	.	_	0	SENT_16	[p1l95t1570r365b1603],

1	—	NN	O	—	_	0	SENT_17	[p1l95t1570r365b1603],
2	.	.	O	.	_	0	SENT_17	[p1l95t1570r365b1603],

1	3TC	NN	O	3tc	nn	2	SENT_18	[p1l95t1570r365b1603],
2	group	NN	O	group	_	0	SENT_18	[p1l380t1570r486b1607],
3	)	CD	NUMBER	)	dep	2	SENT_18	[p1l380t1570r486b1607],
4	or	CC	O	or	_	0	SENT_18	[p1l503t1577r537b1598],
5	combination	NN	O	combination	nn	6	SENT_18	[p1l550t1567r758b1598],
6	therapy	NN	O	therapy	dep	2	SENT_18	[p1l773t1567r895b1606],
7	with	IN	O	with	_	0	SENT_18	[p1l906t1567r980b1598],
8	efavirenz	NN	O	efavirenz	nn	11	SENT_18	[p1l995t1567r1313b1598],
9	—	CD	NUMBER	—	num	11	SENT_18	[p1l995t1567r1313b1598],
10	tenofovir	NN	O	tenofovir	nn	11	SENT_18	[p1l995t1567r1313b1598],
11	disoproxil	NN	O	disoproxil	prep_with	6	SENT_18	[p1l1327t1567r1492b1606],
12	fumarate	NN	O	fumarate	nn	15	SENT_18	[p1l94t1617r246b1648],
13	(	CD	NUMBER	(	num	15	SENT_18	[p1l265t1618r583b1653],
14	DF	NN	O	df	nn	15	SENT_18	[p1l265t1618r583b1653],
15	)	NN	O	)	dep	6	SENT_18	[p1l265t1618r583b1653],
16	.	.	O	.	_	0	SENT_18	[p1l265t1618r583b1653],

1	—	NN	O	—	_	0	SENT_19	[p1l265t1618r583b1653],
2	.	.	O	.	_	0	SENT_19	[p1l265t1618r583b1653],

1	emtricitabine	NN	O	emtricitabine	_	0	SENT_20	[p1l265t1618r583b1653],
2	once	RB	DATE	once	advmod	1	SENT_20	[p1l601t1627r677b1648],
3	daily	JJ	SET	daily	amod	5	SENT_20	[p1l695t1618r775b1656],
4	(	NN	O	(	nn	5	SENT_20	[p1l793t1620r1047b1653],
5	EFV	NN	O	efv	dep	1	SENT_20	[p1l793t1620r1047b1653],
6	.	.	O	.	_	0	SENT_20	[p1l793t1620r1047b1653],

1	—	NN	O	—	_	0	SENT_21	[p1l793t1620r1047b1653],
2	.	.	O	.	_	0	SENT_21	[p1l793t1620r1047b1653],

1	TDF	NNP	O	TDF	_	0	SENT_22	[p1l793t1620r1047b1653],
2	.	.	O	.	_	0	SENT_22	[p1l793t1620r1047b1653],

1	—	NN	O	—	_	0	SENT_23	[p1l793t1620r1047b1653],
2	.	.	O	.	_	0	SENT_23	[p1l793t1620r1047b1653],

1	FTC	NNP	ORGANIZATION	FTC	_	0	SENT_24	[p1l793t1620r1047b1653],
2	group	NN	O	group	dep	1	SENT_24	[p1l1065t1620r1182b1657],
3	)	CD	NUMBER	)	num	2	SENT_24	[p1l1065t1620r1182b1657],
4	.	.	O	.	_	0	SENT_24	[p1l1065t1620r1182b1657],

1	The	DT	O	the	det	4	SENT_25	[p1l1201t1618r1263b1648],
2	primary	JJ	O	primary	amod	4	SENT_25	[p1l1280t1618r1416b1657],
3	end	NN	O	end	nn	4	SENT_25	[p1l1432t1617r1492b1648],
4	point	NN	O	point	nsubj	7	SENT_25	[p1l93t1737r179b1775],
5	was	VBD	O	be	cop	7	SENT_25	[p1l186t1746r247b1767],
6	the	DT	O	the	det	7	SENT_25	[p1l259t1736r308b1767],
7	proportion	NN	O	proportion	_	0	SENT_25	[p1l318t1737r493b1775],
8	of	IN	O	of	_	0	SENT_25	[p1l504t1736r541b1767],
9	participants	NNS	O	participant	prep_of	7	SENT_25	[p1l544t1737r736b1775],
10	with	IN	O	with	_	0	SENT_25	[p1l745t1736r818b1767],
11	an	DT	O	a	det	14	SENT_25	[p1l829t1746r868b1767],
12	HIV-1	NN	O	hiv-1	nn	14	SENT_25	[p1l878t1738r969b1767],
13	RNA	NN	O	rna	nn	14	SENT_25	[p1l980t1739r1059b1769],
14	level	NN	O	level	prep_with	9	SENT_25	[p1l1068t1736r1138b1767],
15	of	IN	O	of	_	0	SENT_25	[p1l1149t1736r1187b1767],
16	less	JJR	O	less	mwe	17	SENT_25	[p1l1189t1736r1247b1767],
17	than	IN	O	than	quantmod	18	SENT_25	[p1l1259t1736r1333b1767],
18	50	CD	NUMBER	50	num	19	SENT_25	[p1l1344t1738r1381b1767],
19	copies	NNS	O	copy	prep_of	14	SENT_25	[p1l1392t1737r1491b1775],
20	per	IN	O	per	_	0	SENT_25	[p1l93t1796r147b1825],
21	milliliter	NN	O	milliliter	prep_per	19	SENT_25	[p1l160t1786r309b1817],
22	at	IN	O	at	_	0	SENT_25	[p1l322t1793r352b1817],
23	week	NN	DURATION	week	prep_at	21	SENT_25	[p1l363t1786r450b1817],
24	48	CD	NUMBER	48	num	23	SENT_25	[p1l461t1789r510b1817],
25	.	.	O	.	_	0	SENT_25	[p1l461t1789r510b1817],

1	Secondary	JJ	O	secondary	amod	3	SENT_26	[p1l528t1786r700b1825],
2	end	NN	O	end	nn	3	SENT_26	[p1l713t1786r772b1817],
3	points	NNS	O	point	nsubj	4	SENT_26	[p1l786t1787r891b1825],
4	included	VBD	O	include	_	0	SENT_26	[p1l905t1786r1047b1817],
5	the	DT	O	the	det	6	SENT_26	[p1l1062t1786r1113b1817],
6	time	NN	O	time	dobj	4	SENT_26	[p1l1128t1787r1203b1817],
7	to	TO	O	to	_	0	SENT_26	[p1l1217t1793r1249b1817],
8	viral	JJ	O	viral	amod	9	SENT_26	[p1l1262t1786r1336b1817],
9	suppression	NN	O	suppression	prep_to	4	SENT_26	[p1l1351t1796r1491b1825, p1l94t1837r171b1874],
10	,	,	O	,	_	0	SENT_26	[p1l1351t1796r1491b1825, p1l94t1837r171b1874],
11	the	DT	O	the	det	21	SENT_26	[p1l187t1837r238b1867],
12	change	NN	O	change	dep	21	SENT_26	[p1l252t1837r370b1876],
13	from	IN	O	from	_	0	SENT_26	[p1l384t1836r465b1867],
14	baseline	NN	O	baseline	prep_from	12	SENT_26	[p1l479t1837r615b1867],
15	in	IN	O	in	_	0	SENT_26	[p1l628t1837r661b1867],
16	CD4	NN	O	cd4	prep_in	14	SENT_26	[p1l674t1839r770b1867],
17	+	CC	O	+	_	0	SENT_26	[p1l674t1839r770b1867],
18	T	NN	O	t	nn	19	SENT_26	[p1l782t1837r873b1867],
19	—	NN	O	—	prep_in	14	SENT_26	[p1l782t1837r873b1867],
20	cell	NN	O	cell	nn	21	SENT_26	[p1l782t1837r873b1867],
21	count	NN	O	count	prep_to	4	SENT_26	[p1l887t1843r989b1874],
22	,	,	O	,	_	0	SENT_26	[p1l887t1843r989b1874],
23	safety	NN	O	safety	prep_to	4	SENT_26	[p1l1005t1836r1109b1876],
24	,	,	O	,	_	0	SENT_26	[p1l1005t1836r1109b1876],
25	and	CC	O	and	_	0	SENT_26	[p1l1124t1837r1185b1867],
26	viral	JJ	O	viral	amod	27	SENT_26	[p1l1197t1837r1271b1867],
27	resistance	NN	O	resistance	prep_to	4	SENT_26	[p1l1284t1837r1460b1867],
28	.	.	O	.	_	0	SENT_26	[p1l1284t1837r1460b1867],

1	RESULTS	NNS	O	result	nsubj	7	SENT_27	[p1l95t1916r223b1935],
2	A	DT	O	a	det	3	SENT_27	[p1l92t1962r118b1989],
3	total	NN	O	total	dep	1	SENT_27	[p1l130t1959r206b1990],
4	of	IN	O	of	_	0	SENT_27	[p1l219t1959r258b1990],
5	833	CD	NUMBER	833	num	6	SENT_27	[p1l264t1961r320b1990],
6	participants	NNS	O	participant	prep_of	1	SENT_27	[p1l334t1959r534b1998],
7	received	VBD	O	receive	_	0	SENT_27	[p1l548t1959r682b1990],
8	at	IN	O	at	quantmod	10	SENT_27	[p1l694t1966r725b1989],
9	least	JJS	O	least	mwe	8	SENT_27	[p1l736t1959r813b1989],
10	one	CD	NUMBER	one	num	11	SENT_27	[p1l824t1969r883b1990],
11	dose	NN	O	dose	dobj	7	SENT_27	[p1l896t1959r971b1990],
12	of	IN	O	of	_	0	SENT_27	[p1l985t1959r1023b1990],
13	study	NN	O	study	nn	14	SENT_27	[p1l1030t1959r1119b1998],
14	drug	NN	O	drug	prep_of	11	SENT_27	[p1l1130t1959r1217b1998],
15	.	.	O	.	_	0	SENT_27	[p1l1130t1959r1217b1998],

1	At	IN	O	at	_	0	SENT_28	[p1l1230t1962r1269b1989],
2	week	NN	DURATION	week	prep_at	23	SENT_28	[p1l1278t1959r1365b1990],
3	48	CD	NUMBER	48	num	2	SENT_28	[p1l1375t1961r1424b1996],
4	,	,	O	,	_	0	SENT_28	[p1l1375t1961r1424b1996],
5	the	DT	O	the	det	6	SENT_28	[p1l1440t1959r1491b1989],
6	proportion	NN	O	proportion	nsubj	23	SENT_28	[p1l93t2009r271b2048],
7	of	IN	O	of	_	0	SENT_28	[p1l283t2009r322b2040],
8	participants	NNS	O	participant	prep_of	6	SENT_28	[p1l326t2009r522b2048],
9	with	IN	O	with	_	0	SENT_28	[p1l533t2009r607b2040],
10	an	DT	O	a	det	13	SENT_28	[p1l619t2019r658b2039],
11	HIV-1	NN	O	hiv-1	nn	13	SENT_28	[p1l670t2011r763b2039],
12	RNA	NN	O	rna	nn	13	SENT_28	[p1l775t2012r855b2041],
13	level	NN	O	level	prep_with	8	SENT_28	[p1l865t2009r937b2040],
14	of	IN	O	of	_	0	SENT_28	[p1l949t2009r987b2040],
15	less	JJR	O	less	mwe	16	SENT_28	[p1l991t2009r1051b2039],
16	than	IN	O	than	quantmod	17	SENT_28	[p1l1063t2009r1139b2039],
17	50	CD	NUMBER	50	num	18	SENT_28	[p1l1151t2011r1188b2040],
18	copies	NNS	O	copy	prep_of	13	SENT_28	[p1l1201t2009r1302b2048],
19	per	IN	O	per	_	0	SENT_28	[p1l1314t2019r1367b2048],
20	milliliter	NN	O	milliliter	prep_per	18	SENT_28	[p1l1378t2009r1491b2039, p1l94t2065r138b2089],
21	was	VBD	O	be	cop	23	SENT_28	[p1l147t2069r210b2090],
22	significantly	RB	O	significantly	advmod	23	SENT_28	[p1l223t2059r434b2098],
23	higher	JJR	O	higher	_	0	SENT_28	[p1l443t2059r552b2098],
24	in	IN	O	in	_	0	SENT_28	[p1l562t2059r595b2089],
25	the	DT	O	the	det	27	SENT_28	[p1l606t2059r658b2089],
26	DTG-ABC-3TC	NN	O	dtg-abc-3tc	nn	27	SENT_28	[p1l669t2061r931b2090],
27	group	NN	O	group	prep_in	23	SENT_28	[p1l944t2069r1042b2098],
28	than	IN	O	than	prep	23	SENT_28	[p1l1054t2059r1130b2089],
29	in	IN	O	in	pcomp	28	SENT_28	[p1l1141t2059r1174b2089],
30	the	DT	O	the	det	31	SENT_28	[p1l1185t2059r1237b2089],
31	EFV	NN	O	efv	pobj	29	SENT_28	[p1l1248t2061r1490b2090],
32	.	.	O	.	_	0	SENT_28	[p1l1248t2061r1490b2090],

1	—	NN	O	—	_	0	SENT_29	[p1l1248t2061r1490b2090],
2	.	.	O	.	_	0	SENT_29	[p1l1248t2061r1490b2090],

1	TDF-FTC	NN	O	tdf-ftc	_	0	SENT_30	[p1l1248t2061r1490b2090],

1	group	NN	O	group	_	0	SENT_31	[p1l93t2183r191b2212],
2	(	CD	PERCENT	(	number	3	SENT_31	[p1l204t2175r288b2208],
3	88	CD	PERCENT	88	num	4	SENT_31	[p1l204t2175r288b2208],
4	%	NN	PERCENT	%	dep	1	SENT_31	[p1l204t2175r288b2208],
5	vs.	CC	O	vs.	_	0	SENT_31	[p1l296t2183r339b2204],
6	81	CD	NUMBER	81	number	7	SENT_31	[p1l352t2175r430b2210],
7	°	CD	NUMBER	°	conj_vs.	1	SENT_31	[p1l352t2175r430b2210],
8	/	:	O	/	punct	9	SENT_31	[p1l352t2175r430b2210],
9	o	NN	O	o	dep	7	SENT_31	[p1l352t2175r430b2210],
10	,	,	O	,	_	0	SENT_31	[p1l352t2175r430b2210],
11	P	NN	O	p	appos	9	SENT_31	[p1l443t2176r490b2203],
12	:	:	O	:	_	0	SENT_31	[p1l443t2176r490b2203],
13	0.003	CD	NUMBER	0.003	num	14	SENT_31	[p1l497t2175r605b2210],
14	)	NN	O	)	dep	1	SENT_31	[p1l497t2175r605b2210],
15	,	,	O	,	_	0	SENT_31	[p1l497t2175r605b2210],
16	thus	RB	O	thus	advmod	17	SENT_31	[p1l618t2173r689b2204],
17	meeting	VBG	O	meet	partmod	14	SENT_31	[p1l701t2173r838b2212],
18	the	DT	O	the	det	19	SENT_31	[p1l848t2173r900b2204],
19	criterion	NN	O	criterion	dobj	17	SENT_31	[p1l911t2173r1052b2204],
20	for	IN	O	for	_	0	SENT_31	[p1l1063t2173r1111b2204],
21	superiority	NN	O	superiority	prep_for	19	SENT_31	[p1l1121t2173r1306b2212],
22	.	.	O	.	_	0	SENT_31	[p1l1121t2173r1306b2212],

1	The	DT	O	the	det	6	SENT_32	[p1l1318t2173r1380b2204],
2	DTG	NN	O	dtg	nn	6	SENT_32	[p1l1391t2175r1493b2204],
3	—	CD	NUMBER	—	num	6	SENT_32	[p1l1391t2175r1493b2204],
4	ABC	NNP	ORGANIZATION	ABC	nn	6	SENT_32	[p1l92t2225r254b2254],
5	—	CD	NUMBER	—	num	6	SENT_32	[p1l92t2225r254b2254],
6	3TC	NN	O	3tc	nsubj	17	SENT_32	[p1l92t2225r254b2254],
7	group	NN	O	group	nsubj	8	SENT_32	[p1l268t2233r366b2263],
8	had	VBD	O	have	parataxis	17	SENT_32	[p1l380t2223r441b2254],
9	a	DT	O	a	det	12	SENT_32	[p1l454t2233r471b2254],
10	shorter	JJR	O	shorter	amod	12	SENT_32	[p1l485t2223r604b2254],
11	median	JJ	O	median	amod	12	SENT_32	[p1l616t2223r741b2254],
12	time	NN	O	time	dobj	8	SENT_32	[p1l755t2224r830b2254],
13	to	TO	O	to	_	0	SENT_32	[p1l843t2230r875b2254],
14	viral	JJ	O	viral	amod	15	SENT_32	[p1l887t2223r962b2254],
15	suppression	NN	O	suppression	prep_to	8	SENT_32	[p1l976t2224r1174b2262],
16	than	IN	O	than	prep	8	SENT_32	[p1l1187t2223r1263b2254],
17	did	VBD	O	do	_	0	SENT_32	[p1l1277t2223r1329b2254],
18	the	DT	O	the	det	19	SENT_32	[p1l1343t2223r1394b2254],
19	EFVTDF	NNP	O	EFVTDF	dobj	17	SENT_32	[p1l1407t2226r1493b2254, p1l92t2276r250b2304],
20	.	.	O	.	_	0	SENT_32	[p1l1407t2226r1493b2254, p1l92t2276r250b2304],

1	—	NN	O	—	_	0	SENT_33	[p1l1407t2226r1493b2254, p1l92t2276r250b2304],
2	.	.	O	.	_	0	SENT_33	[p1l1407t2226r1493b2254, p1l92t2276r250b2304],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_34	[p1l1407t2226r1493b2254, p1l92t2276r250b2304],
2	group	NN	O	group	_	0	SENT_34	[p1l263t2283r359b2313],
3	(	CD	NUMBER	(	number	4	SENT_34	[p1l374t2276r422b2309],
4	28	CD	NUMBER	28	dep	2	SENT_34	[p1l374t2276r422b2309],
5	vs.	IN	O	vs.	_	0	SENT_34	[p1l433t2284r475b2304],
6	84	CD	DURATION	84	num	7	SENT_34	[p1l489t2276r528b2304],
7	days	NNS	NUMBER	day	prep_vs.	4	SENT_34	[p1l541t2273r620b2312],
8	,	,	O	,	_	0	SENT_34	[p1l541t2273r620b2312],
9	P	NN	O	p	appos	7	SENT_34	[p1l634t2276r781b2311],
10	<	JJR	O	<	dep	2	SENT_34	[p1l634t2276r781b2311],
11	0.001	CD	NUMBER	0.001	num	12	SENT_34	[p1l634t2276r781b2311],
12	)	NN	O	)	dep	10	SENT_34	[p1l634t2276r781b2311],
13	,	,	O	,	_	0	SENT_34	[p1l634t2276r781b2311],
14	as	RB	O	as	_	0	SENT_34	[p1l795t2284r828b2304],
15	well	RB	O	well	_	0	SENT_34	[p1l839t2273r907b2304],
16	as	IN	O	as	_	0	SENT_34	[p1l918t2284r951b2304],
17	greater	JJR	O	greater	amod	18	SENT_34	[p1l964t2280r1080b2313],
18	increases	NNS	O	increase	conj_and	10	SENT_34	[p1l1091t2274r1240b2304],
19	in	IN	O	in	_	0	SENT_34	[p1l1253t2274r1285b2304],
20	CD4	NN	O	cd4	prep_in	18	SENT_34	[p1l1297t2276r1391b2304],
21	+	CC	O	+	_	0	SENT_34	[p1l1297t2276r1391b2304],
22	T-cell	NN	O	t-cell	nn	24	SENT_34	[p1l1402t2273r1491b2304],
23	count	NN	O	count	nn	24	SENT_34	[p1l94t2329r189b2354],
24	(	NN	O	(	prep_in	18	SENT_34	[p1l204t2325r273b2358],
25	267	CD	NUMBER	267	dep	2	SENT_34	[p1l204t2325r273b2358],
26	vs.	CC	O	vs.	prep	25	SENT_34	[p1l288t2333r331b2354],
27	208	CD	NUMBER	208	dep	26	SENT_34	[p1l349t2325r408b2354],
28	per	IN	O	per	_	0	SENT_34	[p1l424t2333r478b2362],
29	cubic	JJ	O	cubic	amod	30	SENT_34	[p1l494t2323r580b2354],
30	millimeter	NN	O	millimeter	prep_per	27	SENT_34	[p1l596t2323r781b2360],
31	,	,	O	,	_	0	SENT_34	[p1l596t2323r781b2360],
32	P	NN	O	p	dep	33	SENT_34	[p1l799t2325r950b2358],
33	<	JJR	O	<	appos	2	SENT_34	[p1l799t2325r950b2358],
34	0.001	CD	NUMBER	0.001	num	35	SENT_34	[p1l799t2325r950b2358],
35	)	NN	O	)	dep	33	SENT_34	[p1l799t2325r950b2358],
36	.	.	O	.	_	0	SENT_34	[p1l799t2325r950b2358],

1	The	DT	O	the	det	2	SENT_35	[p1l967t2323r1029b2353],
2	proportion	NN	O	proportion	nsubj	13	SENT_35	[p1l1045t2323r1227b2362],
3	of	IN	O	of	_	0	SENT_35	[p1l1243t2323r1282b2354],
4	participants	NNS	O	participant	prep_of	2	SENT_35	[p1l1290t2323r1491b2362],
5	who	WP	O	who	nsubj	6	SENT_35	[p1l92t2373r163b2404],
6	discontinued	VBD	O	discontinue	rcmod	4	SENT_35	[p1l175t2373r392b2404],
7	therapy	NN	O	therapy	dobj	6	SENT_35	[p1l403t2373r528b2412],
8	owing	VBG	O	owe	partmod	7	SENT_35	[p1l538t2373r643b2412],
9	to	TO	O	to	_	0	SENT_35	[p1l653t2380r685b2404],
10	adverse	JJ	O	adverse	amod	11	SENT_35	[p1l697t2373r819b2404],
11	events	NNS	O	event	prep_to	8	SENT_35	[p1l831t2379r933b2404],
12	was	VBD	O	be	cop	13	SENT_35	[p1l943t2383r1007b2404],
13	lower	JJR	O	lower	_	0	SENT_35	[p1l1019t2373r1111b2404],
14	in	IN	O	in	_	0	SENT_35	[p1l1121t2373r1153b2403],
15	the	DT	O	the	det	17	SENT_35	[p1l1165t2373r1217b2403],
16	DTG-ABC-3TC	NN	O	dtg-abc-3tc	nn	17	SENT_35	[p1l1228t2375r1490b2404],
17	group	NN	O	group	prep_in	13	SENT_35	[p1l93t2433r191b2462],
18	than	IN	O	than	prep	13	SENT_35	[p1l209t2423r285b2453],
19	in	IN	O	in	pcomp	18	SENT_35	[p1l302t2424r334b2453],
20	the	DT	O	the	det	21	SENT_35	[p1l352t2423r403b2453],
21	EFV	NN	O	efv	pobj	19	SENT_35	[p1l420t2425r662b2454],
22	.	.	O	.	_	0	SENT_35	[p1l420t2425r662b2454],

1	—	NN	O	—	_	0	SENT_36	[p1l420t2425r662b2454],
2	.	.	O	.	_	0	SENT_36	[p1l420t2425r662b2454],

1	TDF-FTC	NN	O	tdf-ftc	nn	2	SENT_37	[p1l420t2425r662b2454],
2	group	NN	O	group	nsubj	30	SENT_37	[p1l680t2433r778b2462],
3	(	CD	PERCENT	(	number	4	SENT_37	[p1l797t2425r861b2458],
4	2	CD	PERCENT	2	num	5	SENT_37	[p1l797t2425r861b2458],
5	%	NN	PERCENT	%	dep	2	SENT_37	[p1l797t2425r861b2458],
6	vs.	CC	O	vs.	_	0	SENT_37	[p1l876t2433r918b2454],
7	10	CD	PERCENT	10	num	8	SENT_37	[p1l938t2425r1028b2460],
8	%	NN	PERCENT	%	nsubj	30	SENT_37	[p1l938t2425r1028b2460],
9	)	CD	NUMBER	)	dep	8	SENT_37	[p1l938t2425r1028b2460],
10	;	:	O	;	_	0	SENT_37	[p1l938t2425r1028b2460],
11	rash	NN	O	rash	dep	8	SENT_37	[p1l1046t2423r1117b2453],
12	and	CC	O	and	_	0	SENT_37	[p1l1134t2423r1195b2454],
13	neuropsychiatric	JJ	O	neuropsychiatric	amod	14	SENT_37	[p1l1212t2423r1491b2462],
14	events	NNS	O	event	conj_and	11	SENT_37	[p1l94t2479r196b2504],
15	(	JJ	O	(	amod	2	SENT_37	[p1l212t2473r383b2512],
16	including	VBG	O	include	_	0	SENT_37	[p1l212t2473r383b2512],
17	abnormal	JJ	O	abnormal	amod	22	SENT_37	[p1l395t2473r556b2504],
18	dreams	NNS	O	dream	nn	22	SENT_37	[p1l570t2473r702b2510],
19	,	,	O	,	_	0	SENT_37	[p1l570t2473r702b2510],
20	anxiety	NN	O	anxiety	dep	22	SENT_37	[p1l718t2473r846b2512],
21	,	,	O	,	_	0	SENT_37	[p1l718t2473r846b2512],
22	dizziness	NN	O	dizziness	prep_including	2	SENT_37	[p1l862t2473r1026b2510],
23	,	,	O	,	_	0	SENT_37	[p1l862t2473r1026b2510],
24	and	CC	O	and	_	0	SENT_37	[p1l1042t2473r1103b2504],
25	somnolence	NN	O	somnolence	nn	26	SENT_37	[p1l1117t2473r1326b2508],
26	)	NN	O	)	conj_and	22	SENT_37	[p1l1117t2473r1326b2508],
27	were	VBD	O	be	cop	30	SENT_37	[p1l1340t2483r1418b2504],
28	significantly	RB	O	significantly	advmod	30	SENT_37	[p1l1433t2473r1491b2512, p1l93t2522r256b2561],
29	more	RBR	O	more	advmod	30	SENT_37	[p1l271t2532r356b2553],
30	common	JJ	O	common	_	0	SENT_37	[p1l373t2532r521b2553],
31	in	IN	O	in	_	0	SENT_37	[p1l538t2523r570b2552],
32	the	DT	O	the	det	33	SENT_37	[p1l587t2522r639b2552],
33	EFV	NN	O	efv	prep_in	30	SENT_37	[p1l655t2524r898b2553],
34	.	.	O	.	_	0	SENT_37	[p1l655t2524r898b2553],

1	—	NN	O	—	_	0	SENT_38	[p1l655t2524r898b2553],
2	.	.	O	.	_	0	SENT_38	[p1l655t2524r898b2553],

1	TDF-FTC	NN	O	tdf-ftc	nn	2	SENT_39	[p1l655t2524r898b2553],
2	group	NN	O	group	_	0	SENT_39	[p1l916t2532r1022b2561],
3	,	,	O	,	_	0	SENT_39	[p1l916t2532r1022b2561],
4	whereas	IN	O	whereas	mark	7	SENT_39	[p1l1039t2522r1176b2553],
5	insomnia	NN	O	insomnia	nsubjpass	7	SENT_39	[p1l1193t2522r1352b2553],
6	was	VBD	O	be	auxpass	7	SENT_39	[p1l1366t2532r1429b2553],
7	reported	VBN	O	report	dep	2	SENT_39	[p1l1447t2532r1491b2552, p1l93t2571r203b2610],
8	more	RBR	O	more	advmod	9	SENT_39	[p1l216t2581r301b2602],
9	frequently	RB	O	frequently	advmod	7	SENT_39	[p1l315t2571r485b2610],
10	in	IN	O	in	_	0	SENT_39	[p1l496t2571r529b2601],
11	the	DT	O	the	det	13	SENT_39	[p1l542t2571r594b2601],
12	DTG-ABC-3TC	NN	O	dtg-abc-3tc	nn	13	SENT_39	[p1l606t2573r869b2602],
13	group	NN	O	group	prep_in	7	SENT_39	[p1l883t2581r990b2610],
14	.	.	O	.	_	0	SENT_39	[p1l883t2581r990b2610],

1	No	DT	O	no	det	2	SENT_40	[p1l1004t2574r1053b2602],
2	participants	NNS	O	participant	nsubjpass	23	SENT_40	[p1l1066t2571r1267b2610],
3	in	IN	O	in	_	0	SENT_40	[p1l1280t2571r1313b2601],
4	the	DT	O	the	det	5	SENT_40	[p1l1326t2571r1378b2601],
5	DTG	NN	O	dtg	prep_in	2	SENT_40	[p1l1391t2573r1493b2602],
6	—	CD	NUMBER	—	num	8	SENT_40	[p1l1391t2573r1493b2602],
7	ABC-3TC	NN	O	abc-3tc	nn	8	SENT_40	[p1l92t2622r254b2651],
8	group	NN	O	group	nsubj	9	SENT_40	[p1l273t2630r371b2659],
9	had	VBD	O	have	rcmod	5	SENT_40	[p1l389t2620r450b2651],
10	detectable	JJ	O	detectable	amod	12	SENT_40	[p1l468t2620r636b2651],
11	antiviral	JJ	O	antiviral	amod	12	SENT_40	[p1l653t2620r793b2651],
12	resistance	NN	O	resistance	dobj	9	SENT_40	[p1l810t2620r986b2657],
13	;	:	O	;	_	0	SENT_40	[p1l810t2620r986b2657],
14	one	CD	NUMBER	one	num	15	SENT_40	[p1l1005t2630r1064b2651],
15	tenofovir	NN	O	tenofovir	dep	12	SENT_40	[p1l1082t2620r1233b2651],
16	DF-associated	JJ	MISC	df-associated	amod	17	SENT_40	[p1l1249t2620r1491b2651],
17	mutation	NN	O	mutation	dep	15	SENT_40	[p1l93t2669r246b2700],
18	and	CC	O	and	_	0	SENT_40	[p1l265t2669r327b2700],
19	four	CD	NUMBER	four	num	21	SENT_40	[p1l346t2669r416b2700],
20	efavirenz-associated	JJ	O	efavirenz-associated	amod	21	SENT_40	[p1l436t2669r774b2700],
21	mutations	NNS	O	mutation	dep	15	SENT_40	[p1l794t2669r962b2700],
22	were	VBD	O	be	auxpass	23	SENT_40	[p1l981t2679r1059b2700],
23	detected	VBN	O	detect	_	0	SENT_40	[p1l1080t2669r1219b2700],
24	in	IN	O	in	_	0	SENT_40	[p1l1238t2669r1271b2699],
25	participants	NNS	O	participant	prep_in	23	SENT_40	[p1l1290t2669r1491b2708],
26	with	IN	O	with	_	0	SENT_40	[p1l92t2718r168b2749],
27	virologic	JJ	O	virologic	amod	28	SENT_40	[p1l179t2718r326b2757],
28	failure	NN	O	failure	prep_with	25	SENT_40	[p1l339t2718r446b2749],
29	in	IN	O	in	_	0	SENT_40	[p1l459t2718r492b2748],
30	the	DT	O	the	det	31	SENT_40	[p1l505t2718r557b2748],
31	EFV	NN	O	efv	prep_in	28	SENT_40	[p1l570t2720r812b2749],
32	.	.	O	.	_	0	SENT_40	[p1l570t2720r812b2749],

1	—	NN	O	—	_	0	SENT_41	[p1l570t2720r812b2749],
2	.	.	O	.	_	0	SENT_41	[p1l570t2720r812b2749],

1	TDF-FTC	NN	O	tdf-ftc	_	0	SENT_42	[p1l570t2720r812b2749],
2	group	NN	O	group	dep	1	SENT_42	[p1l827t2728r933b2757],
3	.	.	O	.	_	0	SENT_42	[p1l827t2728r933b2757],

1	co	NN	O	co	nn	3	SENT_43	[p1l94t2797r135b2817],
2	N	NN	O	n	nn	3	SENT_43	[p1l141t2797r158b2817],
3	c	NN	O	c	dep	11	SENT_43	[p1l164t2797r181b2817],
4	L	NN	O	l	nn	6	SENT_43	[p1l186t2797r198b2817],
5	u	NN	O	u	nn	6	SENT_43	[p1l203t2797r220b2817],
6	s	NNS	O	s	dep	3	SENT_43	[p1l225t2797r239b2817],
7	I	PRP	O	I	dep	11	SENT_43	[p1l245t2797r250b2817],
8	o	NN	O	o	nn	11	SENT_43	[p1l256t2797r277b2817],
9	N	NN	O	n	nn	11	SENT_43	[p1l283t2797r300b2817],
10	s	NNS	O	s	nn	11	SENT_43	[p1l306t2797r320b2817],
11	Dolutegravir	NN	O	dolutegravir	dep	16	SENT_43	[p1l93t2838r297b2878],
12	plus	CC	O	plus	prep	11	SENT_43	[p1l307t2838r373b2878],
13	abacavir	NN	O	abacavir	nn	15	SENT_43	[p1l385t2838r722b2870],
14	—	CD	NUMBER	—	num	15	SENT_43	[p1l385t2838r722b2870],
15	lamivudine	NN	O	lamivudine	dep	12	SENT_43	[p1l385t2838r722b2870],
16	had	VBD	O	have	_	0	SENT_43	[p1l734t2838r793b2869],
17	a	DT	O	a	det	20	SENT_43	[p1l804t2849r822b2869],
18	better	JJR	O	better	amod	20	SENT_43	[p1l833t2838r928b2869],
19	safety	NN	O	safety	nn	20	SENT_43	[p1l939t2838r1034b2878],
20	profile	NN	O	profile	dobj	16	SENT_43	[p1l1043t2838r1151b2878],
21	and	CC	O	and	_	0	SENT_43	[p1l1162t2838r1223b2869],
22	was	VBD	O	be	cop	24	SENT_43	[p1l1232t2849r1294b2870],
23	more	RBR	O	more	advmod	24	SENT_43	[p1l1306t2848r1390b2869],
24	effective	JJ	O	effective	conj_and	16	SENT_43	[p1l1402t2838r1491b2869, p1l94t2891r149b2922],
25	through	IN	O	through	_	0	SENT_43	[p1l164t2891r296b2930],
26	48	CD	DURATION	48	num	27	SENT_43	[p1l310t2893r349b2921],
27	weeks	NNS	NUMBER	week	prep_through	24	SENT_43	[p1l362t2891r461b2922],
28	than	IN	O	than	_	0	SENT_43	[p1l477t2891r552b2921],
29	the	DT	O	the	det	30	SENT_43	[p1l567t2890r617b2921],
30	regimen	NN	O	regimen	prep_than	24	SENT_43	[p1l632t2891r766b2930],
31	with	IN	O	with	_	0	SENT_43	[p1l780t2891r853b2922],
32	efavirenz	NN	O	efavirenz	nn	35	SENT_43	[p1l869t2890r1184b2922],
33	—	CD	NUMBER	—	num	35	SENT_43	[p1l869t2890r1184b2922],
34	tenofovir	NN	O	tenofovir	nn	35	SENT_43	[p1l869t2890r1184b2922],
35	DF	NN	O	df	prep_with	30	SENT_43	[p1l1197t2891r1489b2921],
36	—	CD	NUMBER	—	num	37	SENT_43	[p1l1197t2891r1489b2921],
37	emtricitabine	NN	O	emtricitabine	dobj	16	SENT_43	[p1l1197t2891r1489b2921],
38	.	.	O	.	_	0	SENT_43	[p1l1197t2891r1489b2921],

1	(	NN	O	(	nsubj	2	SENT_44	[p1l95t2943r227b2978],
2	Funded	VBN	O	fund	_	0	SENT_44	[p1l95t2943r227b2978],
3	by	IN	O	by	_	0	SENT_44	[p1l240t2943r277b2982],
4	ViiV	NNP	O	ViiV	nn	5	SENT_44	[p1l286t2943r355b2973],
5	Healthcare	NNP	O	Healthcare	prep_by	2	SENT_44	[p1l365t2943r551b2980],
6	;	:	O	;	_	0	SENT_44	[p1l365t2943r551b2980],
7	SINGLE	NNP	O	SINGLE	nn	8	SENT_44	[p1l566t2945r693b2974],
8	ClinicalTrials	NNPS	O	ClinicalTrials	dep	5	SENT_44	[p1l706t2943r992b2982],
9	.	.	O	.	_	0	SENT_44	[p1l706t2943r992b2982],

1	gov	NN	O	gov	nn	2	SENT_45	[p1l706t2943r992b2982],
2	number	NN	O	number	_	0	SENT_45	[p1l1003t2943r1137b2980],
3	,	,	O	,	_	0	SENT_45	[p1l1003t2943r1137b2980],
4	NCTO1263015	NN	O	ncto1263015	appos	2	SENT_45	[p1l1150t2945r1401b2978],
5	.	.	O	.	_	0	SENT_45	[p1l1150t2945r1401b2978],
6	)	SYM	O	)	dep	2	SENT_45	[p1l1150t2945r1401b2978],

1	N	NN	O	n	nn	2	SENT_46	[p1l448t3067r461b3082],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_46	[p1l476t3067r554b3089],
3	MED	VBD	O	med	_	0	SENT_46	[p1l569t3067r620b3082],
4	ٜߺ	CD	NUMBER	ٜߺ	number	5	SENT_46	[p1l631t3061r712b3089],
5	*	CD	NUMBER	*	num	6	SENT_46	[p1l631t3061r712b3089],
6	NEJM.ORG	NN	O	nejm.org	dobj	3	SENT_46	[p1l747t3067r871b3089],
7	NOVEMBER	NNP	DATE	NOVEMBER	tmod	3	SENT_46	[p1l908t3067r1043b3083],
8	7	CD	DATE	7	num	7	SENT_46	[p1l1053t3067r1072b3088],
9	,	,	DATE	,	_	0	SENT_46	[p1l1053t3067r1072b3088],
10	2013	CD	DATE	2013	num	7	SENT_46	[p1l1084t3067r1139b3089],

1	The	DT	O	the	det	5	SENT_47	[p1l752t3124r803b3148],
2	New	NNP	O	New	nn	5	SENT_47	[p1l812t3125r874b3148],
3	England	NNP	O	England	nn	5	SENT_47	[p1l883t3124r994b3155],
4	J	NNP	O	J	nn	5	SENT_47	[p1l1002t3125r1015b3148],
5	oumal	NN	O	oumal	_	0	SENT_47	[p1l1016t3124r1100b3148],
6	of	IN	O	of	_	0	SENT_47	[p1l1109t3124r1138b3148],
7	Medicine	NN	O	medicine	prep_of	5	SENT_47	[p1l1145t3124r1270b3148],

1	From	IN	O	from	dep	74	SENT_48	[p1l1533t1038r1597b1060],
2	the	DT	O	the	det	5	SENT_48	[p1l1608t1036r1648b1060],
3	University	NNP	ORGANIZATION	University	nn	5	SENT_48	[p1l1660t1038r1790b1067],
4	Health	NNP	ORGANIZATION	Health	nn	5	SENT_48	[p1l1801t1036r1885b1060],
5	Network	NNP	ORGANIZATION	Network	pobj	1	SENT_48	[p1l1898t1036r2016b1064],
6	,	,	O	,	_	0	SENT_48	[p1l1898t1036r2016b1064],
7	Toronto	NNP	LOCATION	Toronto	appos	5	SENT_48	[p1l2026t1038r2066b1060, p1l1532t1078r1600b1097],
8	(	CD	NUMBER	(	num	7	SENT_48	[p1l1613t1075r1718b1104],
9	S.L.W.	NNP	O	S.L.W.	dep	7	SENT_48	[p1l1613t1075r1718b1104],
10	)	CD	NUMBER	)	num	9	SENT_48	[p1l1613t1075r1718b1104],
11	;	:	O	;	_	0	SENT_48	[p1l1613t1075r1718b1104],
12	Hospital	NNP	ORGANIZATION	Hospital	nn	14	SENT_48	[p1l1732t1073r1840b1104],
13	Clinico	NNP	ORGANIZATION	Clinico	nn	14	SENT_48	[p1l1851t1073r1939b1097],
14	Universitario	NNP	ORGANIZATION	Universitario	dep	7	SENT_48	[p1l1951t1075r2066b1097, p1l1530t1113r1597b1139],
15	,	,	O	,	_	0	SENT_48	[p1l1951t1075r2066b1097, p1l1530t1113r1597b1139],
16	Santiago	NNP	LOCATION	Santiago	nn	19	SENT_48	[p1l1619t1113r1732b1142],
17	de	IN	O	de	amod	19	SENT_48	[p1l1753t1111r1783b1134],
18	Compostela	NNP	ORGANIZATION	Compostela	nn	19	SENT_48	[p1l1804t1111r1960b1142],
19	(	NNP	O	(	appos	14	SENT_48	[p1l1985t1112r2065b1142],
20	A.A.	NNP	LOCATION	A.A.	nn	21	SENT_48	[p1l1985t1112r2065b1142],
21	)	NNP	O	)	dep	19	SENT_48	[p1l1985t1112r2065b1142],
22	,	,	O	,	_	0	SENT_48	[p1l1985t1112r2065b1142],
23	and	CC	O	and	_	0	SENT_48	[p1l1531t1148r1577b1172],
24	Hospital	NNP	ORGANIZATION	Hospital	nn	27	SENT_48	[p1l1593t1148r1701b1179],
25	General	NNP	ORGANIZATION	General	nn	27	SENT_48	[p1l1715t1148r1815b1172],
26	de	NNP	ORGANIZATION	de	nn	27	SENT_48	[p1l1829t1148r1859b1172],
27	Elche	NNP	ORGANIZATION	Elche	conj_and	14	SENT_48	[p1l1873t1148r1940b1172],
28	and	CC	O	and	_	0	SENT_48	[p1l1953t1148r1998b1172],
29	Universidad	NNP	PERSON	Universidad	nn	35	SENT_48	[p1l2014t1151r2066b1172, p1l1530t1186r1639b1210],
30	Miguel	NNP	PERSON	Miguel	nn	35	SENT_48	[p1l1669t1186r1755b1217],
31	Hernandez	NNP	PERSON	Hernandez	nn	35	SENT_48	[p1l1784t1186r1935b1214],
32	,	,	O	,	_	0	SENT_48	[p1l1784t1186r1935b1214],
33	Alicante	NNP	LOCATION	Alicante	appos	35	SENT_48	[p1l1961t1186r2066b1210],
34	(	CD	NUMBER	(	num	35	SENT_48	[p1l1534t1225r1599b1254],
35	F.G.	NNP	LOCATION	F.G.	conj_and	14	SENT_48	[p1l1534t1225r1599b1254],
36	)	CD	NUMBER	)	number	37	SENT_48	[p1l1534t1225r1599b1254],
37	—	CD	NUMBER	—	num	38	SENT_48	[p1l1609t1238r1640b1240],
38	both	DT	O	both	dep	27	SENT_48	[p1l1649t1223r1704b1247],
39	in	IN	O	in	_	0	SENT_48	[p1l1715t1225r1735b1246],
40	Spain	NNP	LOCATION	Spain	prep_in	38	SENT_48	[p1l1746t1225r1822b1254],
41	;	:	O	;	_	0	SENT_48	[p1l1746t1225r1822b1254],
42	Centre	NNP	ORGANIZATION	Centre	nn	45	SENT_48	[p1l1832t1225r1915b1247],
43	Hospitalier	NNP	ORGANIZATION	Hospitalier	nn	45	SENT_48	[p1l1926t1223r2067b1254],
44	Universitaire	NNP	ORGANIZATION	Universitaire	nn	45	SENT_48	[p1l1532t1260r1693b1282],
45	Saint-Pierre	NNP	ORGANIZATION	Saint-Pierre	dep	7	SENT_48	[p1l1702t1259r1856b1286],
46	,	,	O	,	_	0	SENT_48	[p1l1702t1259r1856b1286],
47	Brussels	NNP	LOCATION	Brussels	appos	45	SENT_48	[p1l1868t1258r1973b1282],
48	(	CD	NUMBER	(	num	47	SENT_48	[p1l1984t1259r2065b1289],
49	N.C.	NNP	LOCATION	N.C.	dep	47	SENT_48	[p1l1984t1259r2065b1289],
50	)	CD	NUMBER	)	num	49	SENT_48	[p1l1984t1259r2065b1289],
51	;	:	O	;	_	0	SENT_48	[p1l1984t1259r2065b1289],
52	Dr.	NNP	O	Dr.	nn	54	SENT_48	[p1l1533t1297r1568b1319],
53	Victor	NNP	PERSON	Victor	nn	54	SENT_48	[p1l1580t1297r1659b1319],
54	Babes	NNP	PERSON	Babes	dep	7	SENT_48	[p1l1672t1295r1748b1319],
55	Infectious	JJ	PERSON	infectious	amod	54	SENT_48	[p1l1763t1295r1891b1319],
56	and	CC	O	and	_	0	SENT_48	[p1l1904t1295r1949b1319],
57	Tropical	JJ	ORGANIZATION	tropical	amod	59	SENT_48	[p1l1962t1295r2065b1326],
58	Diseases	NNS	ORGANIZATION	disease	nn	59	SENT_48	[p1l1533t1335r1646b1356],
59	Hospital	NN	ORGANIZATION	hospital	dep	7	SENT_48	[p1l1664t1333r1780b1363],
60	,	,	O	,	_	0	SENT_48	[p1l1664t1333r1780b1363],
61	Bucharest	NNP	LOCATION	Bucharest	nn	66	SENT_48	[p1l1799t1333r1935b1360],
62	,	,	O	,	_	0	SENT_48	[p1l1799t1333r1935b1360],
63	Romania	NNP	LOCATION	Romania	appos	66	SENT_48	[p1l1953t1335r2066b1356],
64	(	NNP	O	(	nn	66	SENT_48	[p1l1534t1372r1617b1401],
65	D.D.	NNP	LOCATION	D.D.	nn	66	SENT_48	[p1l1534t1372r1617b1401],
66	)	NNP	O	)	appos	59	SENT_48	[p1l1534t1372r1617b1401],
67	;	:	O	;	_	0	SENT_48	[p1l1534t1372r1617b1401],
68	Medizinisches	NNP	O	Medizinisches	nn	69	SENT_48	[p1l1639t1370r1825b1394],
69	Versorgungszen	NNP	O	Versorgungszen	dep	7	SENT_48	[p1l1844t1372r2066b1401],
70	—	CD	NUMBER	—	num	71	SENT_48	[p1l1844t1372r2066b1401],
71	trum	NN	O	trum	dep	69	SENT_48	[p1l1530t1412r1592b1431],
72	Karlsplatz	NNP	LOCATION	Karlsplatz	nn	74	SENT_48	[p1l1608t1408r1735b1438],
73	HIV	NNP	O	HIV	nn	74	SENT_48	[p1l1750t1410r1798b1431],
74	Research	NNP	O	Research	_	0	SENT_48	[p1l1812t1408r1926b1431],
75	and	CC	O	and	_	0	SENT_48	[p1l1940t1408r1986b1431],
76	Clinical	JJ	O	clinical	conj_and	74	SENT_48	[p1l2000t1408r2066b1431, p1l1531t1513r1565b1537],

1	Care	NNP	O	Care	nn	9	SENT_49	[p1l1575t1515r1633b1537],
2	Center	NNP	O	Center	nn	9	SENT_49	[p1l1642t1515r1732b1541],
3	,	,	O	,	_	0	SENT_49	[p1l1642t1515r1732b1541],
4	Munich	NNP	LOCATION	Munich	appos	9	SENT_49	[p1l1745t1513r1848b1541],
5	,	,	O	,	_	0	SENT_49	[p1l1745t1513r1848b1541],
6	Germany	NNP	LOCATION	Germany	appos	9	SENT_49	[p1l1859t1515r1978b1544],
7	(	NNP	O	(	nn	9	SENT_49	[p1l1989t1515r2065b1544],
8	A.E.	NNP	LOCATION	A.E.	nn	9	SENT_49	[p1l1989t1515r2065b1544],
9	)	NNP	O	)	_	0	SENT_49	[p1l1989t1515r2065b1544],
10	;	:	O	;	_	0	SENT_49	[p1l1989t1515r2065b1544],
11	Centre	NNP	O	Centre	nn	14	SENT_49	[p1l1531t1553r1616b1574],
12	Hospitalier	NNP	O	Hospitalier	nn	14	SENT_49	[p1l1637t1551r1781b1582],
13	Régional	NNP	O	Régional	nn	14	SENT_49	[p1l1801t1551r1910b1582],
14	d’Orléans	NNP	O	d’Orléans	dep	21	SENT_49	[p1l1930t1551r2065b1579],
15	,	,	O	,	_	0	SENT_49	[p1l1930t1551r2065b1579],
16	Orléans	NNP	LOCATION	Orléans	appos	14	SENT_49	[p1l1531t1588r1641b1616],
17	,	,	O	,	_	0	SENT_49	[p1l1531t1588r1641b1616],
18	France	NNP	LOCATION	France	nn	21	SENT_49	[p1l1655t1590r1738b1612],
19	(	NNP	O	(	nn	21	SENT_49	[p1l1752t1590r1832b1619],
20	L.H.	NNP	LOCATION	L.H.	nn	21	SENT_49	[p1l1752t1590r1832b1619],
21	)	NNP	O	)	dep	9	SENT_49	[p1l1752t1590r1832b1619],
22	;	:	O	;	_	0	SENT_49	[p1l1752t1590r1832b1619],
23	Antiviral	JJ	O	antiviral	amod	25	SENT_49	[p1l1843t1588r1951b1612],
24	Therapy	NN	O	therapy	nn	25	SENT_49	[p1l1962t1588r2067b1619],
25	Unit	NN	O	unit	dep	32	SENT_49	[p1l1532t1628r1593b1654],
26	,	,	O	,	_	0	SENT_49	[p1l1532t1628r1593b1654],
27	Ospedali	NNP	PERSON	Ospedali	nn	28	SENT_49	[p1l1616t1626r1731b1657],
28	Riuniti	NNP	PERSON	Riuniti	appos	25	SENT_49	[p1l1755t1628r1844b1654],
29	,	,	O	,	_	0	SENT_49	[p1l1755t1628r1844b1654],
30	Bergamo	NNP	LOCATION	Bergamo	appos	28	SENT_49	[p1l1868t1628r1991b1657],
31	,	,	O	,	_	0	SENT_49	[p1l1868t1628r1991b1657],
32	Italy	NNP	LOCATION	Italy	parataxis	21	SENT_49	[p1l2015t1626r2067b1657],

1	(	RB	O	(	dep	3	SENT_50	[p1l1534t1734r1615b1763],
2	F.M.	NNP	LOCATION	F.M.	nn	3	SENT_50	[p1l1534t1734r1615b1763],
3	)	NNP	O	)	_	0	SENT_50	[p1l1534t1734r1615b1763],
4	;	:	O	;	_	0	SENT_50	[p1l1534t1734r1615b1763],
5	University	NNP	ORGANIZATION	University	dep	3	SENT_50	[p1l1635t1734r1765b1763],
6	of	IN	ORGANIZATION	of	_	0	SENT_50	[p1l1781t1732r1809b1756],
7	Nebraska	NNP	ORGANIZATION	Nebraska	nn	14	SENT_50	[p1l1824t1732r1945b1756],
8	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_50	[p1l1965t1732r2065b1756],
9	Center	NNP	ORGANIZATION	Center	nn	14	SENT_50	[p1l1531t1772r1622b1798],
10	,	,	O	,	_	0	SENT_50	[p1l1531t1772r1622b1798],
11	Omaha	NNP	LOCATION	Omaha	appos	14	SENT_50	[p1l1636t1770r1731b1793],
12	(	NNP	O	(	nn	14	SENT_50	[p1l1747t1772r1826b1801],
13	U.S.	NNP	LOCATION	U.S.	nn	14	SENT_50	[p1l1747t1772r1826b1801],
14	)	NN	O	)	prep_of	5	SENT_50	[p1l1747t1772r1826b1801],
15	;	:	O	;	_	0	SENT_50	[p1l1747t1772r1826b1801],
16	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	dep	5	SENT_50	[p1l1841t1770r2065b1798],
17	,	,	O	,	_	0	SENT_50	[p1l1841t1770r2065b1798],
18	Stockley	NNP	PERSON	Stockley	nn	19	SENT_50	[p1l1531t1807r1634b1838],
19	Park	NNP	PERSON	Park	conj_and	16	SENT_50	[p1l1644t1807r1703b1835],
20	,	,	O	,	_	0	SENT_50	[p1l1644t1807r1703b1835],
21	United	NNP	LOCATION	United	nn	25	SENT_50	[p1l1715t1807r1796b1831],
22	Kingdom	NNP	LOCATION	Kingdom	nn	25	SENT_50	[p1l1809t1807r1920b1839],
23	(	NNP	O	(	nn	25	SENT_50	[p1l1933t1809r2010b1838],
24	C.G.	NNP	LOCATION	C.G.	nn	25	SENT_50	[p1l1933t1809r2010b1838],
25	)	NNP	O	)	conj_and	16	SENT_50	[p1l1933t1809r2010b1838],
26	;	:	O	;	_	0	SENT_50	[p1l1933t1809r2010b1838],
27	and	CC	O	and	_	0	SENT_50	[p1l2021t1807r2065b1831],
28	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	nn	43	SENT_50	[p1l1531t1845r1751b1873],
29	,	,	O	,	_	0	SENT_50	[p1l1531t1845r1751b1873],
30	Research	NNP	O	Research	appos	43	SENT_50	[p1l1766t1845r1878b1869],
31	Triangle	NNP	O	Triangle	nn	43	SENT_50	[p1l1890t1845r1992b1876],
32	Park	NNP	O	Park	nn	43	SENT_50	[p1l2005t1845r2065b1873],
33	,	,	O	,	_	0	SENT_50	[p1l2005t1845r2065b1873],
34	NC	NNP	O	NC	appos	43	SENT_50	[p1l1533t1884r1572b1906],
35	(	NNP	O	(	nn	43	SENT_50	[p1l1587t1884r1651b1913],
36	K.P.	NNP	LOCATION	K.P.	nn	43	SENT_50	[p1l1587t1884r1651b1913],
37	,	,	O	,	_	0	SENT_50	[p1l1587t1884r1651b1913],
38	B.W.	NNP	LOCATION	B.W.	appos	43	SENT_50	[p1l1667t1884r1729b1910],
39	,	,	O	,	_	0	SENT_50	[p1l1667t1884r1729b1910],
40	S.M.	NNP	O	S.M.	appos	43	SENT_50	[p1l1744t1884r1809b1910],
41	,	,	O	,	_	0	SENT_50	[p1l1744t1884r1809b1910],
42	G.N.	NNP	O	G.N.	appos	43	SENT_50	[p1l1823t1884r1901b1913],
43	)	NNP	O	)	conj_and	16	SENT_50	[p1l1823t1884r1901b1913],
44	.	.	O	.	_	0	SENT_50	[p1l1823t1884r1901b1913],

1	Address	NN	O	address	nsubj	2	SENT_51	[p1l1914t1882r2019b1906],
2	reprint	VB	O	reprint	_	0	SENT_51	[p1l2034t1890r2066b1906, p1l1532t1922r1593b1951],
3	requests	NNS	O	request	dobj	2	SENT_51	[p1l1602t1924r1712b1951],
4	to	TO	O	to	_	0	SENT_51	[p1l1721t1924r1746b1944],
5	Dr.	NNP	O	Dr.	nn	6	SENT_51	[p1l1756t1922r1791b1944],
6	Walmsley	NNP	PERSON	Walmsley	prep_to	2	SENT_51	[p1l1800t1920r1925b1951],
7	at	IN	O	at	_	0	SENT_51	[p1l1934t1924r1956b1944],
8	Toronto	NNP	ORGANIZATION	Toronto	nn	10	SENT_51	[p1l1963t1922r2066b1944],
9	General	NNP	ORGANIZATION	General	nn	10	SENT_51	[p1l1531t1957r1630b1981],
10	Hospital	NNP	ORGANIZATION	Hospital	prep_at	6	SENT_51	[p1l1641t1957r1755b1988],
11	,	,	O	,	_	0	SENT_51	[p1l1641t1957r1755b1988],
12	Eaton	NNP	ORGANIZATION	Eaton	nn	14	SENT_51	[p1l1767t1959r1836b1981],
13	N.	NNP	ORGANIZATION	N.	nn	14	SENT_51	[p1l1848t1959r1956b1988],
14	Wing	NNP	ORGANIZATION	Wing	appos	10	SENT_51	[p1l1848t1959r1956b1988],
15	,	,	O	,	_	0	SENT_51	[p1l1848t1959r1956b1988],
16	13th	JJ	ORDINAL	13th	amod	17	SENT_51	[p1l1968t1957r2020b1981],
17	Fl.	NN	O	fl.	appos	10	SENT_51	[p1l2031t1957r2065b1985],
18	,	,	O	,	_	0	SENT_51	[p1l2031t1957r2065b1985],
19	Rm	NN	O	rm	appos	10	SENT_51	[p1l1533t1997r1581b2018],
20	.	.	O	.	_	0	SENT_51	[p1l1533t1997r1581b2018],

1	214	CD	NUMBER	214	_	0	SENT_52	[p1l1594t1997r1644b2022],
2	,	,	O	,	_	0	SENT_52	[p1l1594t1997r1644b2022],
3	200	CD	NUMBER	200	dep	1	SENT_52	[p1l1657t1996r1704b2018],
4	Elizabeth	NNP	PERSON	Elizabeth	nn	5	SENT_52	[p1l1717t1995r1834b2018],
5	St.	NNP	PERSON	St.	dep	3	SENT_52	[p1l1847t1996r1886b2022],
6	,	,	O	,	_	0	SENT_52	[p1l1847t1996r1886b2022],
7	Toronto	NNP	LOCATION	Toronto	dep	1	SENT_52	[p1l1898t1997r2008b2022],
8	,	,	O	,	_	0	SENT_52	[p1l1898t1997r2008b2022],
9	ON	NNP	O	ON	nn	11	SENT_52	[p1l2021t1996r2064b2018],
10	MSG	NNP	O	MSG	nn	11	SENT_52	[p1l1533t2034r1590b2056],
11	2C4	NN	O	2c4	appos	7	SENT_52	[p1l1600t2034r1652b2060],
12	,	,	O	,	_	0	SENT_52	[p1l1600t2034r1652b2060],
13	Canada	NNP	LOCATION	Canada	appos	7	SENT_52	[p1l1662t2032r1760b2060],
14	,	,	O	,	_	0	SENT_52	[p1l1662t2032r1760b2060],
15	or	CC	O	or	_	0	SENT_52	[p1l1770t2040r1795b2056],
16	at	IN	O	at	advmod	13	SENT_52	[p1l1803t2037r1825b2056],
17	sharon	NN	O	sharon	appos	7	SENT_52	[p1l1833t2032r2064b2063],
18	.	.	O	.	_	0	SENT_52	[p1l1833t2032r2064b2063],

1	wa	NN	O	wa	nn	3	SENT_53	[p1l1833t2032r2064b2063],
2	|	NN	O	|	nn	3	SENT_53	[p1l1833t2032r2064b2063],
3	msley	NN	O	msley	_	0	SENT_53	[p1l1833t2032r2064b2063],
4	@	IN	O	@	_	0	SENT_53	[p1l1833t2032r2064b2063],
5	uhn	NN	O	uhn	prep_@	3	SENT_53	[p1l1532t2070r1625b2093],
6	.	.	O	.	_	0	SENT_53	[p1l1532t2070r1625b2093],

1	ca	MD	O	can	_	0	SENT_54	[p1l1532t2070r1625b2093],
2	.	.	O	.	_	0	SENT_54	[p1l1532t2070r1625b2093],

1	*	NN	O	*	nn	5	SENT_55	[p1l1531t2210r1565b2232],
2	A	NN	O	a	nn	5	SENT_55	[p1l1531t2210r1565b2232],
3	list	NN	O	list	nn	5	SENT_55	[p1l1575t2209r1610b2232],
4	ofthe	NN	O	ofthe	nn	5	SENT_55	[p1l1619t2208r1690b2232],
5	investigators	NNS	O	investigator	nsubj	8	SENT_55	[p1l1700t2211r1859b2240],
6	and	CC	O	and	_	0	SENT_55	[p1l1869t2209r1914b2232],
7	institutions	NNS	O	institution	conj_and	5	SENT_55	[p1l1925t2211r2066b2232],
8	participating	VBG	O	participate	dep	18	SENT_55	[p1l1549t2249r1714b2278],
9	in	IN	O	in	_	0	SENT_55	[p1l1733t2249r1753b2270],
10	the	DT	O	the	det	13	SENT_55	[p1l1771t2246r1812b2270],
11	Study	NNP	O	Study	nn	13	SENT_55	[p1l1831t2246r1903b2277],
12	|	NN	O	|	nn	13	SENT_55	[p1l1923t2248r2066b2270],
13	NG114467	NN	O	ng114467	prep_in	8	SENT_55	[p1l1923t2248r2066b2270],
14	(	CD	NUMBER	(	num	16	SENT_55	[p1l1550t2286r1667b2315],
15	SINGLE	JJ	O	single	amod	16	SENT_55	[p1l1550t2286r1667b2315],
16	)	NN	O	)	nsubjpass	18	SENT_55	[p1l1550t2286r1667b2315],
17	is	VBZ	O	be	auxpass	18	SENT_55	[p1l1681t2286r1698b2308],
18	provided	VBN	O	provide	_	0	SENT_55	[p1l1711t2284r1819b2315],
19	in	IN	O	in	_	0	SENT_55	[p1l1832t2286r1852b2307],
20	the	DT	O	the	det	22	SENT_55	[p1l1863t2284r1903b2308],
21	Supplementary	NNP	MISC	Supplementary	nn	22	SENT_55	[p1l1914t2284r2066b2315, p1l1547t2326r1595b2352],
22	Appendix	NNP	MISC	Appendix	prep_in	18	SENT_55	[p1l1602t2321r1728b2352],
23	,	,	O	,	_	0	SENT_55	[p1l1602t2321r1728b2352],
24	available	JJ	O	available	acomp	18	SENT_55	[p1l1739t2321r1846b2345],
25	at	IN	O	at	_	0	SENT_55	[p1l1856t2326r1878b2345],
26	NEJM.org	NN	O	nejm.org	prep_at	24	SENT_55	[p1l1889t2323r2016b2352],
27	.	.	O	.	_	0	SENT_55	[p1l1889t2323r2016b2352],

1	N	NN	O	n	nn	3	SENT_56	[p1l1533t2398r1551b2419],
2	Engl	NNP	O	Engl	nn	3	SENT_56	[p1l1562t2396r1628b2427],
3	]	NNP	O	]	nsubj	4	SENT_56	[p1l1562t2396r1628b2427],
4	Med	VBD	O	med	_	0	SENT_56	[p1l1640t2396r1693b2419],
5	2013	CD	DATE	2013	dobj	4	SENT_56	[p1l1702t2398r1925b2424],
6	;	:	O	;	_	0	SENT_56	[p1l1702t2398r1925b2424],
7	369:1807	CD	NUMBER	369:1807	num	8	SENT_56	[p1l1702t2398r1925b2424],
8	-18	CD	NUMBER	-18	dep	5	SENT_56	[p1l1702t2398r1925b2424],
9	.	.	O	.	_	0	SENT_56	[p1l1702t2398r1925b2424],

1	DOI	NNP	O	DOI	_	0	SENT_57	[p1l1532t2437r1587b2457],
2	:	:	O	:	_	0	SENT_57	[p1l1532t2437r1587b2457],
3	10.1056	CD	NUMBER	10.1056	dep	1	SENT_57	[p1l1596t2437r1715b2464],
4	/	:	O	/	punct	7	SENT_57	[p1l1596t2437r1715b2464],
5	N	NN	O	n	nn	7	SENT_57	[p1l1596t2437r1715b2464],
6	EJMoa12l5541	NN	O	ejmoa12l5541	nn	7	SENT_57	[p1l1720t2437r1889b2463],
7	Copyright	NN	O	copyright	dep	3	SENT_57	[p1l1531t2476r1625b2501],
8	©	CD	NUMBER	©	num	12	SENT_57	[p1l1634t2478r1655b2498],
9	2013	CD	DATE	2013	num	12	SENT_57	[p1l1665t2477r1713b2495],
10	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	12	SENT_57	[p1l1723t2476r1863b2495],
11	Medical	NNP	ORGANIZATION	Medical	nn	12	SENT_57	[p1l1872t2476r1949b2495],
12	Society	NNP	ORGANIZATION	Society	dep	7	SENT_57	[p1l1957t2476r2025b2500],

1	The	DT	O	the	det	4	SENT_58	[p1l673t3312r719b3333],
2	NEW	NNP	O	NEW	nn	4	SENT_58	[p1l737t3314r822b3333],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_58	[p1l841t3314r1030b3333],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_58	[p1l1049t3314r1228b3340],
5	of	IN	O	of	_	0	SENT_58	[p1l1248t3312r1276b3339],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_58	[p1l1288t3314r1487b3333],

1	HE	PRP	O	he	_	0	SENT_59	[p2l300t126r426b181],
2	INITIAL	JJ	O	initial	amod	4	SENT_59	[p2l470t125r833b182],
3	ANTIRETROVIRAL	JJ	O	antiretroviral	amod	4	SENT_59	[p2l867t125r1692b182],
4	THERAPY	NN	O	therapy	dep	1	SENT_59	[p2l1726t125r2152b182],

1	(	NN	O	(	nn	2	SENT_60	[p2l302t239r546b325],
2	ART	NN	O	art	nsubj	29	SENT_60	[p2l302t239r546b325],
3	)	CD	NUMBER	)	nsubj	21	SENT_60	[p2l302t239r546b325],
4	recommended	VBN	O	recommend	amod	3	SENT_60	[p2l600t233r1221b312],
5	in	IN	O	in	_	0	SENT_60	[p2l1269t234r1353b311],
6	treatment	NN	O	treatment	nn	7	SENT_60	[p2l1402t249r1829b312],
7	guidelines	NNS	O	guideline	prep_in	3	SENT_60	[p2l1872t233r2147b334, p2l295t363r499b442],
8	for	IN	O	for	_	0	SENT_60	[p2l550t362r674b442],
9	human	JJ	O	human	amod	15	SENT_60	[p2l720t363r1026b442],
10	immunodeficiency	NN	O	immunodeficiency	nn	15	SENT_60	[p2l1075t362r1892b464],
11	virus	NN	O	virus	nn	15	SENT_60	[p2l1932t364r2146b442],
12	(	CD	NUMBER	(	num	15	SENT_60	[p2l17t500r251b585],
13	HIV	NN	MISC	hiv	nn	15	SENT_60	[p2l17t500r251b585],
14	)	NN	O	)	nn	15	SENT_60	[p2l17t500r251b585],
15	type	NN	O	type	nn	20	SENT_60	[p2l310t510r492b594],
16	1	CD	NUMBER	1	number	17	SENT_60	[p2l549t499r593b571],
17	(	CD	NUMBER	(	dep	18	SENT_60	[p2l652t499r952b585],
18	HIV-1	NN	O	hiv-1	dep	20	SENT_60	[p2l652t499r952b585],
19	)	NN	O	)	nn	20	SENT_60	[p2l652t499r952b585],
20	infection	NN	O	infection	prep_for	7	SENT_60	[p2l1010t493r1399b572],
21	consists	VBZ	O	consist	rcmod	2	SENT_60	[p2l1453t494r1797b572],
22	of	IN	O	of	_	0	SENT_60	[p2l1853t493r1953b572],
23	two	CD	NUMBER	two	num	28	SENT_60	[p2l1988t510r2147b572],
24	nucleoside	JJ	O	nucleoside	amod	28	SENT_60	[p2l12t621r452b700],
25	reverse	JJ	O	reverse	amod	28	SENT_60	[p2l478t622r1352b722],
26	—	NN	O	—	nn	28	SENT_60	[p2l478t622r1352b722],
27	transcriptase	NN	O	transcriptase	nn	28	SENT_60	[p2l478t622r1352b722],
28	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_60	[p2l1377t621r1787b700],
29	(	VBP	O	(	dep	57	SENT_60	[p2l1820t628r1923b713],
30	N	NN	O	n	nn	31	SENT_60	[p2l1820t628r1923b713],
31	RTIS	NNS	O	rti	dobj	29	SENT_60	[p2l1926t627r2143b713],
32	)	CD	NUMBER	)	dep	31	SENT_60	[p2l1926t627r2143b713],
33	and	CC	O	and	_	0	SENT_60	[p2l11t749r170b828],
34	a	DT	O	a	det	36	SENT_60	[p2l209t776r254b828],
35	third	JJ	ORDINAL	third	amod	36	SENT_60	[p2l294t749r507b828],
36	agent	NN	O	agent	dep	31	SENT_60	[p2l547t766r806b850],
37	:	:	O	:	_	0	SENT_60	[p2l547t766r806b850],
38	a	DT	O	a	det	42	SENT_60	[p2l849t776r894b828],
39	nonnucleoside	JJ	O	nonnucleoside	amod	42	SENT_60	[p2l933t749r1558b828],
40	reverse	JJ	O	reverse	amod	42	SENT_60	[p2l1599t766r2147b828],
41	—	NN	O	—	nn	42	SENT_60	[p2l1599t766r2147b828],
42	tran	NN	O	tran	dep	32	SENT_60	[p2l1599t766r2147b828],
43	—	NN	O	—	nn	47	SENT_60	[p2l1599t766r2147b828],
44	scriptase	NN	O	scriptase	nn	47	SENT_60	[p2l13t878r403b978],
45	inhibitor	NN	O	inhibitor	nn	47	SENT_60	[p2l461t877r854b956],
46	(	NN	O	(	nn	47	SENT_60	[p2l914t883r1286b973],
47	NNRTI	NN	ORGANIZATION	nnrtus	dep	42	SENT_60	[p2l914t883r1286b973],
48	;	:	O	;	_	0	SENT_60	[p2l914t883r1286b973],
49	e.g.	FW	O	e.g.	dep	32	SENT_60	[p2l1349t904r1524b978],
50	,	,	O	,	_	0	SENT_60	[p2l1349t904r1524b978],
51	efavirenz	NN	O	efavirenz	nn	52	SENT_60	[p2l1589t877r2042b973],
52	)	NN	O	)	appos	49	SENT_60	[p2l1589t877r2042b973],
53	,	,	O	,	_	0	SENT_60	[p2l1589t877r2042b973],
54	a	DT	O	a	det	56	SENT_60	[p2l2105t904r2149b956],
55	ritonavir	NN	O	ritonavir	nn	56	SENT_60	[p2l12t1005r780b1084],
56	—	NN	O	—	appos	49	SENT_60	[p2l12t1005r780b1084],
57	boosted	VBD	O	boost	_	0	SENT_60	[p2l12t1005r780b1084],
58	protease	NN	O	protease	nn	60	SENT_60	[p2l836t1022r1209b1106],
59	inhibitor	NN	O	inhibitor	nn	60	SENT_60	[p2l1267t1005r1661b1084],
60	(	NN	O	(	iobj	57	SENT_60	[p2l1722t1012r1922b1106],
61	e.g.	FW	O	e.g.	dobj	57	SENT_60	[p2l1722t1012r1922b1106],
62	,	,	O	,	_	0	SENT_60	[p2l1722t1012r1922b1106],
63	atazanavir	NN	O	atazanavir	nn	66	SENT_60	[p2l1985t1022r2147b1084, p2l12t1134r331b1212],
64	or	CC	O	or	_	0	SENT_60	[p2l377t1159r465b1212],
65	darunavir	NN	O	darunavir	nn	66	SENT_60	[p2l511t1133r982b1229],
66	)	NN	O	)	dobj	57	SENT_60	[p2l511t1133r982b1229],
67	,	,	O	,	_	0	SENT_60	[p2l511t1133r982b1229],
68	or	CC	O	or	_	0	SENT_60	[p2l1037t1159r1126b1212],
69	an	DT	O	a	det	72	SENT_60	[p2l1170t1159r1274b1212],
70	integrase	NN	O	integrase	nn	72	SENT_60	[p2l1321t1134r1719b1234],
71	inhibitor	NN	O	inhibitor	nn	72	SENT_60	[p2l1766t1133r2151b1212],
72	(	NN	O	(	dobj	57	SENT_60	[p2l17t1268r212b1362],
73	e.g.	FW	O	e.g.	nsubj	57	SENT_60	[p2l17t1268r212b1362],
74	,	,	O	,	_	0	SENT_60	[p2l17t1268r212b1362],
75	raltegravir	FW	O	raltegravir	nn	76	SENT_60	[p2l284t1261r785b1362],
76	)	FW	O	)	appos	73	SENT_60	[p2l284t1261r785b1362],
77	.	.	O	.	_	0	SENT_60	[p2l284t1261r785b1362],

1	Integrase	NN	O	integrase	nn	2	SENT_61	[p2l856t1269r1259b1362],
2	inhibitors	NNS	O	inhibitor	nsubj	8	SENT_61	[p2l1326t1261r1749b1340],
3	are	VBP	O	be	cop	8	SENT_61	[p2l1818t1287r1947b1340],
4	the	DT	O	the	det	8	SENT_61	[p2l2014t1261r2148b1340],
5	most	RBS	O	most	advmod	6	SENT_61	[p2l12t1406r229b1468],
6	recent	JJ	O	recent	amod	8	SENT_61	[p2l259t1406r525b1468],
7	drug	NN	O	drug	nn	8	SENT_61	[p2l555t1389r760b1490],
8	class	NN	O	class	_	0	SENT_61	[p2l791t1389r995b1468],
9	to	TO	O	to	aux	11	SENT_61	[p2l1032t1406r1114b1468],
10	be	VB	O	be	auxpass	11	SENT_61	[p2l1151t1389r1247b1468],
11	approved	VBN	O	approve	infmod	8	SENT_61	[p2l1281t1389r1673b1490],
12	on	IN	O	on	_	0	SENT_61	[p2l1708t1415r1814b1468],
13	the	DT	O	the	det	14	SENT_61	[p2l1849t1389r1982b1468],
14	basis	NN	O	basis	prep_on	11	SENT_61	[p2l2018t1389r2147b1468, p2l13t1518r120b1596],
15	of	IN	O	of	_	0	SENT_61	[p2l172t1517r273b1596],
16	their	PRP$	O	they	poss	17	SENT_61	[p2l304t1517r508b1596],
17	efficacy	NN	O	efficacy	prep_of	14	SENT_61	[p2l556t1517r894b1618],
18	and	CC	O	and	_	0	SENT_61	[p2l938t1517r1096b1596],
19	safety	NN	O	safety	nn	20	SENT_61	[p2l1147t1517r1401b1618],
20	prof1les	NNS	O	prof1le	prep_of	14	SENT_61	[p2l1445t1517r1899b1618],
21	.1	NN	NUMBER	.1	dobj	11	SENT_61	[p2l1445t1517r1899b1618],
22	'	''	O	'	_	0	SENT_61	[p2l1445t1517r1899b1618],
23	3	CD	NUMBER	3	dep	21	SENT_61	[p2l1445t1517r1899b1618],
24	Over	IN	O	over	_	0	SENT_61	[p2l1949t1523r2151b1596],
25	the	DT	DURATION	the	det	28	SENT_61	[p2l12t1645r146b1724],
26	past	JJ	DURATION	past	amod	28	SENT_61	[p2l204t1662r386b1746],
27	15	CD	DURATION	15	num	28	SENT_61	[p2l444t1651r539b1724],
28	years	NNS	NUMBER	year	prep_over	34	SENT_61	[p2l598t1671r843b1746],
29	,	,	O	,	_	0	SENT_61	[p2l598t1671r843b1746],
30	combination	NN	O	combination	nn	31	SENT_61	[p2l909t1645r1459b1724],
31	products	NNS	O	product	nsubjpass	34	SENT_61	[p2l1517t1645r1895b1746],
32	have	VBP	O	have	aux	34	SENT_61	[p2l1957t1645r2148b1725],
33	been	VBN	O	be	auxpass	34	SENT_61	[p2l12t1773r215b1852],
34	developed	VBN	O	develop	rcmod	23	SENT_61	[p2l281t1773r734b1874],
35	,	,	O	,	_	0	SENT_61	[p2l281t1773r734b1874],
36	consisting	VBG	O	consist	partmod	21	SENT_61	[p2l806t1774r1255b1874],
37	initially	RB	O	initially	advmod	36	SENT_61	[p2l1316t1773r1652b1874],
38	of	IN	O	of	_	0	SENT_61	[p2l1714t1773r1814b1852],
39	partial	JJ	O	partial	amod	40	SENT_61	[p2l1860t1773r2149b1874],
40	regimens	NNS	O	regimen	prep_of	36	SENT_61	[p2l12t1902r412b2002],
41	with	IN	O	with	_	0	SENT_61	[p2l455t1901r651b1980],
42	two	CD	NUMBER	two	num	43	SENT_61	[p2l695t1918r854b1980],
43	NRTIS	NNS	O	nrti	prep_with	40	SENT_61	[p2l897t1907r1173b1985],
44	and	CC	O	and	_	0	SENT_61	[p2l1219t1901r1378b1980],
45	now	RB	DATE	now	advmod	40	SENT_61	[p2l1422t1927r1607b1980],
46	available	JJ	O	available	amod	51	SENT_61	[p2l1647t1901r2021b1980],
47	in	IN	O	in	_	0	SENT_61	[p2l2064t1902r2148b1979],
48	triple	JJ	O	triple	amod	49	SENT_61	[p2l12t2029r238b2130],
49	combinations	NNS	O	combination	prep_in	46	SENT_61	[p2l268t2029r982b2108],
50	.4	CD	NUMBER	.4	tmod	46	SENT_61	[p2l268t2029r982b2108],
51	>	JJR	O	>	prep_of	36	SENT_61	[p2l268t2029r982b2108],
52	5	CD	NUMBER	5	dep	51	SENT_61	[p2l268t2029r982b2108],
53	All	PDT	O	all	predet	55	SENT_61	[p2l1010t2029r1136b2107],
54	the	DT	O	the	det	55	SENT_61	[p2l1165t2029r1298b2108],
55	regimens	NNS	O	regimen	tmod	36	SENT_61	[p2l1327t2030r1728b2130],
56	that	WDT	O	that	nsubjpass	59	SENT_61	[p2l1759t2029r1933b2108],
57	have	VBP	O	have	aux	59	SENT_61	[p2l1957t2029r2148b2109],
58	been	VBN	O	be	auxpass	59	SENT_61	[p2l12t2157r215b2236],
59	compared	VBN	O	compare	rcmod	55	SENT_61	[p2l279t2157r708b2258],
60	with	IN	O	with	_	0	SENT_61	[p2l766t2157r963b2237],
61	efavirenz	NN	O	efavirenz	nn	64	SENT_61	[p2l1026t2157r1871b2236],
62	—	CD	NUMBER	—	num	64	SENT_61	[p2l1026t2157r1871b2236],
63	tenofovir	NN	O	tenofovir	nn	64	SENT_61	[p2l1026t2157r1871b2236],
64	disoproxil	NN	O	disoproxil	prep_with	59	SENT_61	[p2l1932t2157r2147b2236, p2l11t2285r264b2386],
65	fumarate	NN	O	fumarate	nn	68	SENT_61	[p2l292t2285r688b2364],
66	(	CD	NUMBER	(	num	68	SENT_61	[p2l721t2285r1545b2377],
67	DF	NN	O	df	nn	68	SENT_61	[p2l721t2285r1545b2377],
68	)	NN	O	)	dep	55	SENT_61	[p2l721t2285r1545b2377],
69	.	.	O	.	_	0	SENT_61	[p2l721t2285r1545b2377],

1	—	NN	O	—	_	0	SENT_62	[p2l721t2285r1545b2377],
2	.	.	O	.	_	0	SENT_62	[p2l721t2285r1545b2377],

1	emtricitabine	NN	O	emtricitabine	nsubjpass	7	SENT_63	[p2l721t2285r1545b2377],
2	or	CC	O	or	_	0	SENT_63	[p2l1574t2311r1664b2364],
3	its	PRP$	O	its	poss	4	SENT_63	[p2l1688t2286r1787b2364],
4	components	NNS	O	component	nsubjpass	7	SENT_63	[p2l1819t2311r2147b2386, p2l12t2430r244b2492],
5	have	VBP	O	have	aux	7	SENT_63	[p2l281t2413r472b2492],
6	been	VBN	O	be	auxpass	7	SENT_63	[p2l508t2413r710b2492],
7	shown	VBN	O	show	_	0	SENT_63	[p2l747t2413r1030b2493],
8	to	TO	O	to	aux	10	SENT_63	[p2l1065t2430r1147b2492],
9	be	VB	O	be	cop	10	SENT_63	[p2l1184t2413r1281b2492],
10	noninferior	JJ	O	noninferior	xcomp	7	SENT_63	[p2l1317t2413r1834b2492],
11	.	.	O	.	_	0	SENT_63	[p2l1317t2413r1834b2492],

1	Dolutegravir	NNP	O	Dolutegravir	nsubj	6	SENT_64	[p2l140t2541r675b2642],
2	is	VBZ	O	be	cop	6	SENT_64	[p2l709t2542r773b2620],
3	an	DT	O	a	det	6	SENT_64	[p2l813t2567r915b2620],
4	unboosted	JJ	O	unboosted	amod	6	SENT_64	[p2l952t2541r1401b2620],
5	integrase	NN	O	integrase	nn	6	SENT_64	[p2l1438t2542r1827b2642],
6	inhibi	NN	O	inhibus	_	0	SENT_64	[p2l1864t2541r2147b2620],
7	—	CD	NUMBER	—	num	8	SENT_64	[p2l1864t2541r2147b2620],
8	tor	NN	O	tor	nsubj	20	SENT_64	[p2l12t2686r136b2748],
9	with	IN	O	with	_	0	SENT_64	[p2l178t2669r375b2749],
10	a	DT	O	a	det	16	SENT_64	[p2l425t2696r469b2748],
11	long	JJ	O	long	amod	16	SENT_64	[p2l516t2669r709b2770],
12	plasma	NN	O	plasma	nn	16	SENT_64	[p2l755t2669r1067b2770],
13	half	NN	O	half	nn	16	SENT_64	[p2l1115t2669r1452b2748],
14	—	CD	NUMBER	—	num	16	SENT_64	[p2l1115t2669r1452b2748],
15	life	NN	O	life	nn	16	SENT_64	[p2l1115t2669r1452b2748],
16	(	NN	O	(	prep_with	8	SENT_64	[p2l1508t2669r2153b2770],
17	approximately	RB	O	approximately	quantmod	18	SENT_64	[p2l1508t2669r2153b2770],
18	14	CD	DURATION	14	num	19	SENT_64	[p2l15t2803r108b2876],
19	hours	NNS	NUMBER	hour	tmod	16	SENT_64	[p2l151t2797r421b2888],
20	)	VBP	O	)	rcmod	6	SENT_64	[p2l151t2797r421b2888],
21	that	IN	O	that	complm	22	SENT_64	[p2l470t2797r643b2876],
22	supports	VBZ	O	support	ccomp	20	SENT_64	[p2l682t2814r1057b2898],
23	once	RB	DATE	once	advmod	45	SENT_64	[p2l1103t2797r1552b2898],
24	—	JJ	O	—	amod	26	SENT_64	[p2l1103t2797r1552b2898],
25	daily	JJ	SET	daily	amod	26	SENT_64	[p2l1103t2797r1552b2898],
26	dosing	NN	O	dosing	nsubjpass	45	SENT_64	[p2l1591t2797r1883b2898],
27	without	IN	O	without	_	0	SENT_64	[p2l1919t2797r2147b2877, p2l12t2942r155b3004],
28	the	DT	O	the	det	29	SENT_64	[p2l215t2925r351b3004],
29	need	NN	O	need	prep_without	26	SENT_64	[p2l416t2925r621b3004],
30	for	IN	O	for	_	0	SENT_64	[p2l686t2925r812b3004],
31	pharmacokinetic	JJ	O	pharmacokinetic	prep_for	29	SENT_64	[p2l873t2925r1627b3026],
32	boosting	VBG	O	boost	partmod	31	SENT_64	[p2l1692t2925r2148b3026],
33	.6	CD	NUMBER	.6	iobj	32	SENT_64	[p2l1692t2925r2148b3026],
34	Dolutegravir	NNP	O	Dolutegravir	dobj	32	SENT_64	[p2l11t3053r546b3154],
35	in	IN	O	in	_	0	SENT_64	[p2l584t3054r667b3131],
36	combination	NN	O	combination	prep_in	34	SENT_64	[p2l710t3053r1249b3132],
37	with	IN	O	with	_	0	SENT_64	[p2l1287t3053r1480b3132],
38	abacavir	NN	O	abacavir	nn	42	SENT_64	[p2l1522t3053r2147b3132],
39	—	CD	NUMBER	—	num	42	SENT_64	[p2l1522t3053r2147b3132],
40	lami	NN	O	lamus	nn	42	SENT_64	[p2l1522t3053r2147b3132],
41	—	NN	O	—	nn	42	SENT_64	[p2l1522t3053r2147b3132],
42	vudine	NN	O	vudine	prep_with	32	SENT_64	[p2l7t3181r299b3260],
43	is	VBZ	O	be	aux	45	SENT_64	[p2l373t3182r439b3260],
44	being	VBG	O	be	auxpass	45	SENT_64	[p2l517t3181r759b3282],
45	developed	VBN	O	develop	ccomp	22	SENT_64	[p2l831t3181r1261b3282],
46	as	IN	O	as	_	0	SENT_64	[p2l1335t3208r1421b3260],
47	a	DT	O	a	det	51	SENT_64	[p2l1497t3208r1542b3260],
48	single	JJ	O	single	amod	51	SENT_64	[p2l1617t3181r2153b3282],
49	—	NN	O	—	nn	51	SENT_64	[p2l1617t3181r2153b3282],
50	tablet	NN	O	tablet	nn	51	SENT_64	[p2l1617t3181r2153b3282],
51	regimen	NN	O	regimen	prep_as	45	SENT_64	[p2l12t3310r371b3410],
52	for	IN	O	for	_	0	SENT_64	[p2l403t3309r526b3388],
53	the	DT	O	the	det	54	SENT_64	[p2l556t3309r689b3388],
54	treatment	NN	O	treatment	prep_for	51	SENT_64	[p2l722t3326r1148b3388],
55	of	IN	O	of	_	0	SENT_64	[p2l1176t3309r1277b3388],
56	HIV	NN	MISC	hiv	nn	57	SENT_64	[p2l1289t3317r1465b3388],
57	infection	NN	O	infection	prep_of	54	SENT_64	[p2l1493t3309r1905b3388],
58	.	.	O	.	_	0	SENT_64	[p2l1493t3309r1905b3388],

1	Such	JJ	O	such	dep	152	SENT_65	[p2l1945t3309r2148b3388],
2	treatment	NN	O	treatment	dep	152	SENT_65	[p2l12t3454r438b3516],
3	could	MD	O	could	dep	152	SENT_65	[p2l481t3437r716b3516],
4	offer	VB	O	offer	dep	152	SENT_65	[p2l763t3437r970b3516],
5	advantages	NNS	O	advantage	dep	152	SENT_65	[p2l1013t3437r1489b3538],
6	over	IN	O	over	dep	152	SENT_65	[p2l1538t3463r1717b3517],
7	currently	RB	DATE	currently	dep	152	SENT_65	[p2l1761t3437r2153b3538],
8	available	JJ	O	available	dep	152	SENT_65	[p2l11t3565r385b3644],
9	single	JJ	O	single	dep	152	SENT_65	[p2l453t3565r990b3666],
10	—	NN	O	—	dep	152	SENT_65	[p2l453t3565r990b3666],
11	tablet	NN	O	tablet	dep	152	SENT_65	[p2l453t3565r990b3666],
12	regimens	NNS	O	regimen	dep	152	SENT_65	[p2l1052t3566r1452b3666],
13	and	CC	O	and	dep	152	SENT_65	[p2l1520t3565r1679b3644],
14	regimens	NNS	O	regimen	dep	152	SENT_65	[p2l1745t3566r2146b3666],
15	containing	VBG	O	contain	dep	152	SENT_65	[p2l12t3694r485b3794],
16	alternate	JJ	O	alternate	dep	152	SENT_65	[p2l526t3693r907b3772],
17	drug	NN	O	drug	dep	152	SENT_65	[p2l952t3693r1158b3794],
18	classes	NNS	O	class	dep	152	SENT_65	[p2l1200t3693r1521b3789],
19	,	,	O	,	_	0	SENT_65	[p2l1200t3693r1521b3789],
20	owing	VBG	O	owe	dep	152	SENT_65	[p2l1572t3694r1843b3794],
21	to	TO	O	to	dep	152	SENT_65	[p2l1885t3710r1967b3772],
22	the	DT	O	the	dep	152	SENT_65	[p2l2014t3693r2148b3772],
23	absence	NN	O	absence	dep	152	SENT_65	[p3l11t20r351b99],
24	of	IN	O	of	dep	152	SENT_65	[p3l420t20r520b99],
25	effects	NNS	O	effect	dep	152	SENT_65	[p3l570t20r853b99],
26	related	VBN	O	relate	dep	152	SENT_65	[p3l923t20r1217b99],
27	to	TO	O	to	dep	152	SENT_65	[p3l1284t37r1366b99],
28	the	DT	O	the	dep	152	SENT_65	[p3l1436t20r1570b99],
29	cytochrome	NN	O	cytochrome	dep	152	SENT_65	[p3l1639t20r2148b121],
30	P	NN	O	p	dep	152	SENT_65	[p3l11t154r250b227],
31	—	CD	NUMBER	—	dep	152	SENT_65	[p3l11t154r250b227],
32	450	CD	NUMBER	450	dep	152	SENT_65	[p3l11t154r250b227],
33	enzyme	NN	O	enzyme	dep	152	SENT_65	[p3l298t174r630b249],
34	CYP3A4	NN	O	cyp3a4	dep	152	SENT_65	[p3l677t154r1015b227],
35	(	NN	O	(	dep	152	SENT_65	[p3l1066t148r1250b239],
36	and	CC	O	and	dep	152	SENT_65	[p3l1066t148r1250b239],
37	thus	RB	O	thus	dep	152	SENT_65	[p3l1296t148r1480b227],
38	fewer	JJR	O	fewer	dep	152	SENT_65	[p3l1529t148r1767b228],
39	relevant	JJ	O	relevant	dep	152	SENT_65	[p3l1810t148r2153b228],
40	drug	NN	O	drug	dep	152	SENT_65	[p3l12t276r218b377],
41	interactions	NNS	O	interaction	dep	152	SENT_65	[p3l264t277r828b372],
42	)	VBP	O	)	dep	152	SENT_65	[p3l264t277r828b372],
43	,	,	O	,	_	0	SENT_65	[p3l264t277r828b372],
44	the	DT	O	the	dep	152	SENT_65	[p3l884t276r1017b355],
45	absence	NN	O	absence	dep	152	SENT_65	[p3l1067t276r1406b355],
46	of	IN	O	of	dep	152	SENT_65	[p3l1457t276r1558b355],
47	tenofovir	NN	O	tenofovir	dep	152	SENT_65	[p3l1589t276r1982b355],
48	DF	NN	O	df	dep	152	SENT_65	[p3l2027t283r2147b354],
49	(	NN	O	(	dep	152	SENT_65	[p3l17t404r399b505],
50	possibly	RB	O	possibly	dep	152	SENT_65	[p3l17t404r399b505],
51	resulting	VBG	O	result	dep	152	SENT_65	[p3l456t404r845b505],
52	in	IN	O	in	dep	152	SENT_65	[p3l901t405r985b482],
53	improved	VBN	O	improve	dep	152	SENT_65	[p3l1045t404r1452b505],
54	renal	JJ	O	renal	dep	152	SENT_65	[p3l1513t404r1731b483],
55	or	CC	O	or	dep	152	SENT_65	[p3l1792t430r1881b483],
56	bone	NN	O	bone	dep	152	SENT_65	[p3l1939t404r2148b483],
57	safety	NN	O	safety	dep	152	SENT_65	[p3l13t532r315b633],
58	)	NN	O	)	dep	152	SENT_65	[p3l13t532r315b633],
59	,	,	O	,	_	0	SENT_65	[p3l13t532r315b633],
60	and	CC	O	and	dep	152	SENT_65	[p3l368t532r526b611],
61	activity	NN	O	activity	dep	152	SENT_65	[p3l573t533r885b633],
62	against	IN	O	against	dep	152	SENT_65	[p3l927t533r1245b633],
63	transmitted	VBN	O	transmit	dep	152	SENT_65	[p3l1288t532r1798b611],
64	viruses	NNS	O	virus	dep	152	SENT_65	[p3l1841t533r2145b611],
65	that	WDT	O	that	dep	152	SENT_65	[p3l12t660r186b739],
66	are	VBP	O	be	dep	152	SENT_65	[p3l245t686r375b739],
67	resistant	JJ	O	resistant	dep	152	SENT_65	[p3l440t661r815b739],
68	to	TO	O	to	dep	152	SENT_65	[p3l875t677r957b739],
69	NNRTIs	NNS	O	nnrti	dep	152	SENT_65	[p3l1022t666r1502b744],
70	.7	CD	NUMBER	.7	dep	152	SENT_65	[p3l1022t666r1502b744],
71	'	''	O	'	_	0	SENT_65	[p3l1022t666r1502b744],
72	9	CD	NUMBER	9	dep	152	SENT_65	[p3l1022t666r1502b744],
73	We	PRP	O	we	dep	152	SENT_65	[p3l1564t668r1698b739],
74	designed	VBD	O	design	dep	152	SENT_65	[p3l1764t660r2148b761],
75	Study	NNP	O	Study	dep	152	SENT_65	[p3l14t788r253b889],
76	ING114467	NNP	O	ING114467	dep	152	SENT_65	[p3l291t794r782b867],
77	(	NNP	O	(	dep	152	SENT_65	[p3l833t794r1230b880],
78	SINGLE	NNP	O	SINGLE	dep	152	SENT_65	[p3l833t794r1230b880],
79	)	CD	NUMBER	)	dep	152	SENT_65	[p3l833t794r1230b880],
80	to	TO	O	to	dep	152	SENT_65	[p3l1279t805r1361b867],
81	assess	VB	O	assess	dep	152	SENT_65	[p3l1406t815r1672b867],
82	the	DT	O	the	dep	152	SENT_65	[p3l1719t788r1852b867],
83	safety	NN	O	safety	dep	152	SENT_65	[p3l1898t788r2152b889],
84	and	CC	O	and	dep	152	SENT_65	[p3l11t916r170b995],
85	efficacy	NN	O	efficacy	dep	152	SENT_65	[p3l216t916r554b1017],
86	of	IN	O	of	dep	152	SENT_65	[p3l595t916r696b995],
87	dolutegravir	NN	O	dolutegravir	dep	152	SENT_65	[p3l723t916r1250b1017],
88	at	IN	O	at	dep	152	SENT_65	[p3l1291t933r1370b995],
89	a	DT	O	a	dep	152	SENT_65	[p3l1409t943r1454b995],
90	dose	NN	O	dose	dep	152	SENT_65	[p3l1498t916r1694b995],
91	of	IN	O	of	dep	152	SENT_65	[p3l1740t916r1840b995],
92	50	CD	NUMBER	50	dep	152	SENT_65	[p3l1869t922r1966b995],
93	mg	NN	O	mg	dep	152	SENT_65	[p3l2012t942r2152b1017],
94	plus	CC	O	plus	dep	152	SENT_65	[p3l11t1044r187b1145],
95	a	DT	O	a	dep	152	SENT_65	[p3l227t1071r272b1123],
96	fiXed	JJ	O	fixed	dep	152	SENT_65	[p3l308t1044r760b1123],
97	—	NN	O	—	dep	152	SENT_65	[p3l308t1044r760b1123],
98	dose	NN	O	dose	dep	152	SENT_65	[p3l308t1044r760b1123],
99	combination	NN	O	combination	dep	152	SENT_65	[p3l800t1044r1349b1123],
100	of	IN	O	of	dep	152	SENT_65	[p3l1388t1044r1489b1123],
101	abacavir	NN	O	abacavir	dep	152	SENT_65	[p3l1508t1044r2147b1124],
102	—	CD	NUMBER	—	dep	152	SENT_65	[p3l1508t1044r2147b1124],
103	lami	NN	O	lamus	dep	152	SENT_65	[p3l1508t1044r2147b1124],
104	—	NN	O	—	dep	152	SENT_65	[p3l1508t1044r2147b1124],
105	vudine	NN	O	vudine	dep	152	SENT_65	[p3l7t1172r324b1268],
106	,	,	O	,	_	0	SENT_65	[p3l7t1172r324b1268],
107	as	IN	O	as	dep	152	SENT_65	[p3l370t1199r456b1251],
108	compared	VBN	O	compare	dep	152	SENT_65	[p3l501t1172r930b1273],
109	with	IN	O	with	dep	152	SENT_65	[p3l968t1172r1164b1252],
110	fiXed	JJ	O	fixed	dep	152	SENT_65	[p3l1205t1172r1658b1251],
111	—	NN	O	—	dep	152	SENT_65	[p3l1205t1172r1658b1251],
112	dose	NN	O	dose	dep	152	SENT_65	[p3l1205t1172r1658b1251],
113	efavirenz	NN	O	efavirenz	dep	152	SENT_65	[p3l1701t1172r2151b1251],
114	—	CD	NUMBER	—	dep	152	SENT_65	[p3l1701t1172r2151b1251],
115	tenofovir	NN	O	tenofovir	dep	152	SENT_65	[p3l12t1300r404b1379],
116	DF	NN	O	df	dep	152	SENT_65	[p3l464t1300r1246b1396],
117	—	CD	NUMBER	—	dep	152	SENT_65	[p3l464t1300r1246b1396],
118	emtricitabine	NN	O	emtricitabine	dep	152	SENT_65	[p3l464t1300r1246b1396],
119	,	,	O	,	_	0	SENT_65	[p3l464t1300r1246b1396],
120	which	WDT	O	which	dep	152	SENT_65	[p3l1310t1300r1575b1379],
121	is	VBZ	O	be	dep	152	SENT_65	[p3l1637t1301r1704b1379],
122	the	DT	O	the	dep	152	SENT_65	[p3l1770t1300r1903b1379],
123	only	JJ	O	only	dep	152	SENT_65	[p3l1967t1300r2153b1401],
124	single	JJ	O	single	dep	152	SENT_65	[p3l13t1428r550b1529],
125	—	NN	O	—	dep	152	SENT_65	[p3l13t1428r550b1529],
126	tablet	NN	O	tablet	dep	152	SENT_65	[p3l13t1428r550b1529],
127	regimen	NNS	O	regimen	dep	152	SENT_65	[p3l594t1429r952b1529],
128	currently	RB	DATE	currently	dep	152	SENT_65	[p3l1001t1428r1393b1529],
129	preferred	VBN	O	prefer	dep	152	SENT_65	[p3l1435t1428r1834b1529],
130	in	IN	O	in	dep	152	SENT_65	[p3l1882t1429r1966b1506],
131	the	DT	O	the	dep	152	SENT_65	[p3l2014t1428r2148b1507],
132	U.S.	NNP	LOCATION	U.S.	dep	152	SENT_65	[p3l11t1562r180b1635],
133	HIV	NN	O	hiv	dep	152	SENT_65	[p3l224t1564r399b1635],
134	treatment	NN	O	treatment	dep	152	SENT_65	[p3l435t1573r861b1635],
135	guidelines	NNS	O	guideline	dep	152	SENT_65	[p3l895t1556r1439b1657],
136	”	CD	NUMBER	”	dep	152	SENT_65	[p3l895t1556r1439b1657],
137	and	CC	O	and	dep	152	SENT_65	[p3l1477t1556r1636b1635],
138	one	CD	TIME	one	dep	152	SENT_65	[p3l1675t1582r1827b1635],
139	of	IN	TIME	of	dep	152	SENT_65	[p3l1867t1556r1968b1635],
140	two	CD	TIME	two	dep	152	SENT_65	[p3l1988t1573r2147b1635],
141	currently	RB	DATE	currently	dep	152	SENT_65	[p3l12t1684r404b1785],
142	recommended	VBN	O	recommend	dep	152	SENT_65	[p3l464t1684r1084b1763],
143	single	JJ	O	single	dep	152	SENT_65	[p3l1149t1684r1686b1785],
144	—	NN	O	—	dep	152	SENT_65	[p3l1149t1684r1686b1785],
145	tablet	NN	O	tablet	dep	152	SENT_65	[p3l1149t1684r1686b1785],
146	regimens	NNS	O	regimen	dep	152	SENT_65	[p3l1745t1685r2146b1785],
147	in	IN	O	in	dep	152	SENT_65	[p3l11t1813r95b1890],
148	the	DT	O	the	dep	152	SENT_65	[p3l135t1812r268b1891],
149	European	JJ	MISC	european	dep	152	SENT_65	[p3l307t1820r723b1913],
150	treatment	NN	O	treatment	dep	152	SENT_65	[p3l763t1829r1190b1891],
151	guidelines	NNS	O	guideline	dep	152	SENT_65	[p3l1223t1812r1735b1913],
152	.3	NN	NUMBER	.3	_	0	SENT_65	[p3l1223t1812r1735b1913],

1	METHODS	NNS	O	method	_	0	SENT_66	[p3l806t2110r1352b2170],

1	sruov	NN	O	sruov	nn	3	SENT_67	[p3l12t2346r269b2396],
2	OVERSIGHT	NNP	O	OVERSIGHT	nn	3	SENT_67	[p3l303t2345r766b2396],
3	SINGLE	NNP	O	SINGLE	nsubj	6	SENT_67	[p3l14t2451r354b2524],
4	is	VBZ	O	be	cop	6	SENT_67	[p3l415t2446r481b2524],
5	an	DT	O	a	det	6	SENT_67	[p3l543t2471r646b2524],
6	ongoing	JJ	O	ongoing	_	0	SENT_67	[p3l707t2446r1085b2546],
7	,	,	O	,	_	0	SENT_67	[p3l707t2446r1085b2546],
8	phase	NN	O	phase	appos	6	SENT_67	[p3l1149t2445r1399b2546],
9	3	CD	NUMBER	3	num	8	SENT_67	[p3l1461t2451r1530b2541],
10	,	,	O	,	_	0	SENT_67	[p3l1461t2451r1530b2541],
11	randomized	VBN	O	randomize	partmod	6	SENT_67	[p3l1595t2445r2143b2541],
12	,	,	O	,	_	0	SENT_67	[p3l1595t2445r2143b2541],
13	double	JJ	O	double	amod	16	SENT_67	[p3l12t2573r563b2652],
14	—	RB	O	—	advmod	15	SENT_67	[p3l12t2573r563b2652],
15	blind	JJ	O	blind	amod	16	SENT_67	[p3l12t2573r563b2652],
16	study	NN	O	study	dobj	11	SENT_67	[p3l626t2573r858b2674],
17	involving	VBG	O	involve	_	0	SENT_67	[p3l914t2573r1313b2674],
18	participants	NNS	O	participant	prep_involving	16	SENT_67	[p3l1371t2574r1891b2674],
19	with	IN	O	with	_	0	SENT_67	[p3l1952t2573r2148b2653],
20	HIV-1	NN	O	hiv-1	nn	21	SENT_67	[p3l11t2707r257b2780],
21	infection	NN	O	infection	prep_with	18	SENT_67	[p3l317t2701r706b2780],
22	who	WP	O	who	nsubj	25	SENT_67	[p3l761t2701r945b2781],
23	had	VBD	O	have	aux	25	SENT_67	[p3l1006t2701r1164b2780],
24	not	RB	O	not	neg	25	SENT_67	[p3l1223t2718r1366b2780],
25	received	VBN	O	receive	rcmod	6	SENT_67	[p3l1421t2701r1769b2780],
26	therapy	NN	O	therapy	dobj	25	SENT_67	[p3l1829t2701r2152b2802],
27	previously	RB	DATE	previously	advmod	25	SENT_67	[p3l11t2829r466b2930],
28	.	.	O	.	_	0	SENT_67	[p3l11t2829r466b2930],

1	We	PRP	O	we	nsubj	2	SENT_68	[p3l534t2837r667b2908],
2	enrolled	VBD	O	enrol	_	0	SENT_68	[p3l734t2829r1088b2908],
3	participants	NNS	O	participant	dobj	2	SENT_68	[p3l1152t2830r1673b2930],
4	in	IN	O	in	_	0	SENT_68	[p3l1740t2830r1824b2907],
5	North	NNP	LOCATION	North	nn	6	SENT_68	[p3l1888t2829r2148b2908],
6	America	NNP	LOCATION	America	prep_in	3	SENT_68	[p3l8t2958r380b3053],
7	,	,	O	,	_	0	SENT_68	[p3l8t2958r380b3053],
8	Europe	NNP	LOCATION	Europe	conj_and	3	SENT_68	[p3l409t2965r725b3058],
9	,	,	O	,	_	0	SENT_68	[p3l409t2965r725b3058],
10	and	CC	O	and	_	0	SENT_68	[p3l755t2957r909b3036],
11	Australia	NNP	LOCATION	Australia	dobj	2	SENT_68	[p3l930t2957r1309b3036],
12	between	IN	O	between	_	0	SENT_68	[p3l1334t2957r1681b3036],
13	February	NNP	DATE	February	prep_between	11	SENT_68	[p3l1704t2957r2077b3058],
14	1	CD	DATE	1	num	13	SENT_68	[p3l2103t2963r2148b3035],
15	and	CC	O	and	_	0	SENT_68	[p3l10t3085r170b3163],
16	June	NNP	DATE	June	prep_between	11	SENT_68	[p3l198t3092r394b3175],
17	13	CD	DATE	13	num	16	SENT_68	[p3l436t3091r558b3180],
18	,	,	DATE	,	_	0	SENT_68	[p3l436t3091r558b3180],
19	2011	CD	DATE	2011	num	16	SENT_68	[p3l601t3091r832b3180],
20	;	:	O	;	_	0	SENT_68	[p3l601t3091r832b3180],
21	the	DT	O	the	det	23	SENT_68	[p3l874t3085r1009b3163],
22	last	JJ	O	last	amod	23	SENT_68	[p3l1046t3085r1202b3163],
23	participant	NN	O	participant	dep	11	SENT_68	[p3l1234t3086r1722b3184],
24	completed	VBN	O	complete	partmod	23	SENT_68	[p3l1756t3085r2133b3184, p3l11t3212r108b3291],
25	48	CD	DURATION	48	num	26	SENT_68	[p3l141t3218r242b3291],
26	weeks	NNS	NUMBER	week	dobj	24	SENT_68	[p3l275t3212r536b3292],
27	of	IN	O	of	_	0	SENT_68	[p3l574t3211r673b3291],
28	treatment	NN	O	treatment	prep_of	26	SENT_68	[p3l691t3229r1114b3290],
29	on	IN	O	on	_	0	SENT_68	[p3l1144t3238r1250b3291],
30	May	NNP	DATE	May	prep_on	24	SENT_68	[p3l1282t3220r1463b3312],
31	14	CD	DATE	14	num	30	SENT_68	[p3l1496t3218r1610b3308],
32	,	,	DATE	,	_	0	SENT_68	[p3l1496t3218r1610b3308],
33	2012	CD	DATE	2012	num	30	SENT_68	[p3l1651t3218r1878b3291],
34	.	.	O	.	_	0	SENT_68	[p3l1651t3218r1878b3291],

1	The	DT	O	the	det	2	SENT_69	[p3l136t3341r298b3419],
2	sponsor	NN	O	sponsor	nsubj	7	SENT_69	[p3l339t3367r699b3440],
3	,	,	O	,	_	0	SENT_69	[p3l339t3367r699b3440],
4	ViiV	NNP	ORGANIZATION	ViiV	nn	5	SENT_69	[p3l740t3342r922b3419],
5	Healthcare	NNP	ORGANIZATION	Healthcare	appos	2	SENT_69	[p3l957t3341r1451b3436],
6	,	,	O	,	_	0	SENT_69	[p3l957t3341r1451b3436],
7	participated	VBD	O	participate	_	0	SENT_69	[p3l1494t3341r2012b3440],
8	in	IN	O	in	_	0	SENT_69	[p3l2051t3342r2134b3418],
9	the	DT	O	the	det	10	SENT_69	[p3l11t3469r144b3547],
10	design	NN	O	design	prep_in	7	SENT_69	[p3l201t3469r481b3570],
11	of	IN	O	of	_	0	SENT_69	[p3l537t3468r637b3548],
12	the	DT	O	the	det	13	SENT_69	[p3l675t3469r807b3547],
13	study	NN	O	study	prep_of	10	SENT_69	[p3l865t3469r1095b3569],
14	and	CC	O	and	_	0	SENT_69	[p3l1145t3469r1303b3548],
15	in	IN	O	in	_	0	SENT_69	[p3l1358t3470r1441b3547],
16	the	DT	O	the	det	17	SENT_69	[p3l1497t3469r1630b3547],
17	collection	NN	O	collection	prep_in	7	SENT_69	[p3l1687t3469r2129b3565],
18	,	,	O	,	_	0	SENT_69	[p3l1687t3469r2129b3565],
19	analysis	NN	O	analysis	conj_and	10	SENT_69	[p3l10t3596r375b3696],
20	,	,	O	,	_	0	SENT_69	[p3l10t3596r375b3696],
21	and	CC	O	and	_	0	SENT_69	[p3l425t3596r583b3675],
22	interpretation	NN	O	interpretation	conj_and	10	SENT_69	[p3l627t3597r1226b3696],
23	of	IN	O	of	_	0	SENT_69	[p3l1272t3595r1372b3675],
24	the	DT	O	the	det	25	SENT_69	[p3l1399t3596r1532b3674],
25	data	NNS	O	datum	prep_of	17	SENT_69	[p3l1579t3596r1783b3675],
26	.	.	O	.	_	0	SENT_69	[p3l1579t3596r1783b3675],

1	All	PDT	O	all	predet	3	SENT_70	[p3l1830t3596r1956b3674],
2	the	DT	O	the	det	3	SENT_70	[p3l2001t3596r2134b3674],
3	authors	NNS	O	author	nsubj	4	SENT_70	[p4l10t21r333b101],
4	had	VBD	O	have	_	0	SENT_70	[p4l374t21r530b100],
5	full	JJ	O	full	amod	6	SENT_70	[p4l568t20r717b100],
6	access	NN	O	access	dobj	4	SENT_70	[p4l754t47r1020b99],
7	to	TO	O	to	_	0	SENT_70	[p4l1061t38r1143b100],
8	all	PDT	O	all	predet	11	SENT_70	[p4l1183t21r1287b99],
9	the	DT	O	the	det	11	SENT_70	[p4l1326t21r1459b99],
10	study	NN	O	study	nn	11	SENT_70	[p4l1499t21r1729b121],
11	data	NNS	O	datum	prep_to	6	SENT_70	[p4l1763t21r1969b100],
12	.	.	O	.	_	0	SENT_70	[p4l1763t21r1969b100],

1	All	PDT	O	all	predet	3	SENT_71	[p4l2009t21r2134b99],
2	the	DT	O	the	det	3	SENT_71	[p4l11t149r144b227],
3	authors	NNS	O	author	nsubj	5	SENT_71	[p4l189t149r511b229],
4	are	VBP	O	be	cop	5	SENT_71	[p4l558t175r687b227],
5	responsible	JJ	O	responsible	_	0	SENT_71	[p4l732t149r1222b249],
6	for	IN	O	for	_	0	SENT_71	[p4l1267t148r1390b228],
7	the	DT	O	the	det	8	SENT_71	[p4l1433t149r1565b227],
8	veracity	NN	O	veracity	prep_for	5	SENT_71	[p4l1606t150r1936b249],
9	and	CC	O	and	_	0	SENT_71	[p4l1976t149r2134b228],
10	completeness	NN	O	completeness	prep_for	5	SENT_71	[p4l11t277r589b377],
11	of	IN	O	of	_	0	SENT_71	[p4l629t276r729b356],
12	the	DT	O	the	det	13	SENT_71	[p4l747t277r880b355],
13	data	NNS	O	datum	nsubj	14	SENT_71	[p4l917t277r1100b356],
14	reported	VBD	O	report	prep_of	8	SENT_71	[p4l1134t277r1500b377],
15	and	CC	O	and	_	0	SENT_71	[p4l1536t277r1694b356],
16	vouch	NN	O	vouch	prep_of	8	SENT_71	[p4l1726t277r1978b356],
17	for	IN	O	for	_	0	SENT_71	[p4l2014t276r2137b356],
18	the	DT	O	the	det	19	SENT_71	[p4l11t405r143b483],
19	ﬁdelity	NN	O	ﬁdelity	prep_for	16	SENT_71	[p4l174t404r473b505],
20	of	IN	O	of	_	0	SENT_71	[p4l500t404r599b484],
21	the	DT	O	the	det	22	SENT_71	[p4l612t405r743b483],
22	study	NN	O	study	prep_of	19	SENT_71	[p4l775t405r1000b505],
23	to	TO	O	to	_	0	SENT_71	[p4l1027t422r1107b484],
24	the	DT	O	the	det	25	SENT_71	[p4l1140t405r1270b483],
25	protocol	NN	O	protocol	prep_to	22	SENT_71	[p4l1299t405r1674b505],
26	.	.	O	.	_	0	SENT_71	[p4l1299t405r1674b505],

1	An	DT	O	a	det	2	SENT_72	[p4l1708t413r1829b483],
2	author	NN	O	author	nsubj	9	SENT_72	[p4l1860t405r2137b484],
3	who	WP	O	who	nsubj	6	SENT_72	[p4l6t533r189b613],
4	was	VBD	O	be	cop	6	SENT_72	[p4l221t559r384b613],
5	an	DT	O	a	det	6	SENT_72	[p4l420t559r523b611],
6	employee	NN	O	employee	rcmod	2	SENT_72	[p4l558t533r958b633],
7	of	IN	O	of	_	0	SENT_72	[p4l993t532r1094b612],
8	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_of	6	SENT_72	[p4l1109t533r1856b614],
9	Wrote	VBD	O	write	_	0	SENT_72	[p4l1887t550r2134b613],
10	the	DT	O	the	det	12	SENT_72	[p4l11t661r144b739],
11	first	JJ	ORDINAL	first	amod	12	SENT_72	[p4l183t660r366b739],
12	draft	NN	O	draft	dobj	9	SENT_72	[p4l401t660r614b740],
13	of	IN	O	of	_	0	SENT_72	[p4l648t660r748b740],
14	the	DT	O	the	det	15	SENT_72	[p4l768t661r901b739],
15	manuscript	NN	O	manuscript	prep_of	12	SENT_72	[p4l939t662r1453b761],
16	,	,	O	,	_	0	SENT_72	[p4l939t662r1453b761],
17	all	PDT	O	all	predet	19	SENT_72	[p4l1496t661r1601b739],
18	the	DT	O	the	det	19	SENT_72	[p4l1639t661r1771b739],
19	authors	NNS	O	author	appos	15	SENT_72	[p4l1810t661r2132b741],
20	reviewed	VBN	O	review	partmod	19	SENT_72	[p4l11t789r389b869],
21	drafts	NNS	O	draft	dobj	20	SENT_72	[p4l430t788r683b868],
22	of	IN	O	of	_	0	SENT_72	[p4l726t788r827b868],
23	the	DT	O	the	det	24	SENT_72	[p4l849t789r982b867],
24	manuscript	NN	O	manuscript	prep_of	21	SENT_72	[p4l1023t790r1536b889],
25	,	,	O	,	_	0	SENT_72	[p4l1023t790r1536b889],
26	and	CC	O	and	_	0	SENT_72	[p4l1582t789r1740b868],
27	the	DT	O	the	det	29	SENT_72	[p4l1781t789r1914b867],
28	first	JJ	ORDINAL	first	amod	29	SENT_72	[p4l1955t788r2139b867],
29	author	NN	O	author	nsubj	30	SENT_72	[p4l10t917r293b997],
30	had	VBD	O	have	conj_and	9	SENT_72	[p4l334t917r490b996],
31	the	DT	O	the	det	33	SENT_72	[p4l535t917r668b995],
32	ﬁnal	JJ	O	ﬁnal	amod	33	SENT_72	[p4l713t916r916b995],
33	responsibility	NN	O	responsibility	dobj	30	SENT_72	[p4l960t917r1549b1017],
34	for	IN	O	for	_	0	SENT_72	[p4l1589t916r1712b996],
35	the	DT	O	the	det	36	SENT_72	[p4l1754t917r1886b995],
36	decision	NN	O	decision	prep_for	33	SENT_72	[p4l1931t917r2133b996, p4l12t1046r188b1124],
37	to	TO	O	to	aux	38	SENT_72	[p4l228t1062r309b1124],
38	submit	VB	O	submit	infmod	36	SENT_72	[p4l352t1045r650b1125],
39	the	DT	O	the	det	40	SENT_72	[p4l686t1045r818b1123],
40	manuscript	NN	O	manuscript	dobj	38	SENT_72	[p4l858t1046r1351b1145],
41	for	IN	O	for	_	0	SENT_72	[p4l1385t1044r1508b1124],
42	publication	NN	O	publication	prep_for	40	SENT_72	[p4l1543t1045r2054b1145],
43	.	.	O	.	_	0	SENT_72	[p4l1543t1045r2054b1145],

1	Approval	NN	O	approval	nsubjpass	7	SENT_73	[p4l136t1174r524b1273],
2	by	IN	O	by	_	0	SENT_73	[p4l585t1174r682b1273],
3	the	DT	O	the	det	5	SENT_73	[p4l740t1174r872b1252],
4	ethics	NNS	O	ethic	nn	5	SENT_73	[p4l935t1174r1185b1252],
5	committee	NN	O	committee	prep_by	1	SENT_73	[p4l1250t1175r1711b1252],
6	was	VBD	O	be	auxpass	7	SENT_73	[p4l1768t1200r1930b1253],
7	obtained	VBN	O	obtain	_	0	SENT_73	[p4l1995t1174r2132b1252, p4l11t1302r281b1381],
8	at	IN	O	at	_	0	SENT_73	[p4l314t1319r393b1380],
9	each	DT	O	each	det	11	SENT_73	[p4l424t1302r615b1380],
10	participating	VBG	O	participate	amod	11	SENT_73	[p4l649t1303r1210b1403],
11	center	NN	O	center	prep_at	7	SENT_73	[p4l1242t1319r1505b1381],
12	in	IN	O	in	_	0	SENT_73	[p4l1536t1303r1619b1380],
13	accordance	NN	O	accordance	prep_in	11	SENT_73	[p4l1653t1302r2134b1381],
14	with	IN	O	with	_	0	SENT_73	[p4l6t1429r201b1509],
15	the	DT	O	the	det	16	SENT_73	[p4l255t1429r388b1507],
16	principles	NNS	O	principle	prep_with	11	SENT_73	[p4l439t1429r861b1529],
17	of	IN	O	of	_	0	SENT_73	[p4l917t1428r1016b1508],
18	the	DT	O	the	det	20	SENT_73	[p4l1051t1429r1184b1507],
19	2008	CD	DATE	2008	num	20	SENT_73	[p4l1237t1435r1444b1508],
20	Declaration	NN	O	declaration	prep_of	16	SENT_73	[p4l1497t1429r2000b1508],
21	of	IN	O	of	_	0	SENT_73	[p4l2053t1428r2153b1508],
22	Helsinki	NNP	LOCATION	Helsinki	prep_of	11	SENT_73	[p4l10t1558r374b1637],
23	and	CC	O	and	_	0	SENT_73	[p4l421t1558r579b1637],
24	the	DT	O	the	det	28	SENT_73	[p4l628t1558r761b1637],
25	Good	JJ	O	good	amod	28	SENT_73	[p4l809t1558r1046b1637],
26	Clinical	JJ	O	clinical	amod	28	SENT_73	[p4l1095t1558r1427b1637],
27	Practice	NN	O	practice	nn	28	SENT_73	[p4l1474t1559r1811b1636],
28	guidelines	NNS	O	guideline	prep_at	7	SENT_73	[p4l1860t1558r2132b1659, p4l10t1686r203b1764],
29	of	IN	O	of	_	0	SENT_73	[p4l238t1685r336b1765],
30	the	DT	O	the	det	32	SENT_73	[p4l350t1686r478b1764],
31	International	NNP	ORGANIZATION	International	nn	32	SENT_73	[p4l510t1686r1053b1765],
32	Conference	NNP	ORGANIZATION	Conference	prep_of	28	SENT_73	[p4l1084t1685r1551b1765],
33	on	IN	ORGANIZATION	on	_	0	SENT_73	[p4l1585t1712r1689b1765],
34	Harmonisation	NNP	ORGANIZATION	Harmonisation	prep_on	32	SENT_73	[p4l1720t1687r2133b1765, p4l12t1815r272b1893],
35	of	IN	ORGANIZATION	of	_	0	SENT_73	[p4l324t1813r424b1893],
36	Technical	NNP	ORGANIZATION	Technical	nn	37	SENT_73	[p4l453t1814r869b1892],
37	Requirements	NNS	ORGANIZATION	requirement	prep_of	34	SENT_73	[p4l919t1815r1520b1914],
38	for	IN	ORGANIZATION	for	_	0	SENT_73	[p4l1573t1813r1696b1893],
39	Registration	NN	ORGANIZATION	registration	prep_for	28	SENT_73	[p4l1743t1815r2133b1915, p4l11t1943r180b2021],
40	of	IN	ORGANIZATION	of	_	0	SENT_73	[p4l238t1941r338b2021],
41	Pharmaceuticals	NNS	ORGANIZATION	pharmaceutical	prep_of	39	SENT_73	[p4l375t1942r1086b2021],
42	for	IN	O	for	_	0	SENT_73	[p4l1145t1941r1268b2021],
43	Human	JJ	O	human	amod	44	SENT_73	[p4l1321t1950r1645b2021],
44	Use	NN	O	use	prep_for	41	SENT_73	[p4l1701t1947r1956b2021],
45	.1	CD	NUMBER	.1	number	46	SENT_73	[p4l1701t1947r1956b2021],
46	°	CD	NUMBER	°	num	44	SENT_73	[p4l1701t1947r1956b2021],
47	All	PDT	O	all	predet	49	SENT_73	[p4l2009t1942r2134b2020],
48	the	DT	O	the	det	49	SENT_73	[p4l11t2069r144b2147],
49	participants	NNS	O	participant	nsubj	50	SENT_73	[p4l183t2070r700b2169],
50	provided	VBD	O	provide	rcmod	28	SENT_73	[p4l741t2069r1116b2169],
51	written	VBN	O	write	amod	53	SENT_73	[p4l1153t2070r1467b2149],
52	informed	VBN	O	inform	amod	53	SENT_73	[p4l1507t2068r1908b2148],
53	consent	NN	O	consent	dobj	50	SENT_73	[p4l1949t2095r2133b2148, p4l12t2214r189b2275],
54	before	IN	O	before	_	0	SENT_73	[p4l238t2196r507b2276],
55	any	DT	O	any	det	57	SENT_73	[p4l559t2223r710b2297],
56	study	NN	O	study	nn	57	SENT_73	[p4l761t2196r1354b2297],
57	—	NN	O	—	prep_before	50	SENT_73	[p4l761t2196r1354b2297],
58	specific	JJ	O	specific	amod	59	SENT_73	[p4l761t2196r1354b2297],
59	procedures	NNS	O	procedure	nsubjpass	61	SENT_73	[p4l1406t2197r1881b2297],
60	were	VBD	O	be	auxpass	61	SENT_73	[p4l1932t2223r2134b2277],
61	performed	VBN	O	perform	rcmod	57	SENT_73	[p4l10t2324r489b2425],
62	.	.	O	.	_	0	SENT_73	[p4l10t2324r489b2425],

1	An	DT	O	a	det	3	SENT_74	[p4l571t2333r694b2403],
2	independent	JJ	O	independent	amod	3	SENT_74	[p4l773t2325r1312b2425],
3	data	NNS	O	datum	nsubj	8	SENT_74	[p4l1387t2325r1570b2404],
4	and	CC	O	and	_	0	SENT_74	[p4l1647t2325r1805b2404],
5	safety	NN	O	safety	nn	7	SENT_74	[p4l1886t2324r2139b2425],
6	monitoring	NN	O	monitoring	nn	7	SENT_74	[p4l11t2455r504b2555],
7	committee	NN	O	committee	conj_and	3	SENT_74	[p4l553t2455r1014b2533],
8	performed	VBD	O	perform	_	0	SENT_74	[p4l1065t2453r1521b2554],
9	five	CD	NUMBER	five	num	11	SENT_74	[p4l1572t2453r1725b2533],
10	separate	JJ	O	separate	amod	11	SENT_74	[p4l1779t2471r2134b2554],
11	reviews	NNS	O	review	dobj	8	SENT_74	[p4l11t2582r329b2661],
12	of	IN	O	of	_	0	SENT_74	[p4l392t2580r492b2660],
13	unblinded	JJ	O	unblinded	amod	14	SENT_74	[p4l534t2581r972b2661],
14	efficacy	NN	O	efficacy	prep_of	11	SENT_74	[p4l1033t2580r1369b2681],
15	and	CC	O	and	_	0	SENT_74	[p4l1424t2581r1582b2660],
16	safety	NN	O	safety	nn	17	SENT_74	[p4l1643t2580r1896b2681],
17	data	NNS	O	datum	prep_of	11	SENT_74	[p4l1953t2581r2135b2660],
18	during	IN	O	during	_	0	SENT_74	[p4l11t2710r300b2811],
19	the	DT	O	the	det	20	SENT_74	[p4l337t2710r470b2789],
20	course	NN	O	course	prep_during	8	SENT_74	[p4l510t2736r789b2789],
21	of	IN	O	of	_	0	SENT_74	[p4l830t2709r930b2789],
22	the	DT	O	the	det	23	SENT_74	[p4l952t2710r1084b2789],
23	study	NN	O	study	prep_of	20	SENT_74	[p4l1126t2710r1368b2810],
24	.	.	O	.	_	0	SENT_74	[p4l1126t2710r1368b2810],

1	sruov	NN	O	sruov	nn	2	SENT_75	[p4l11t2985r267b3035],
2	DESIGN	NN	O	design	nsubj	22	SENT_75	[p4l304t2985r599b3035],
3	AND	CC	O	and	_	0	SENT_75	[p4l638t2986r806b3034],
4	PARTICIPANTS	NNS	O	participant	conj_and	2	SENT_75	[p4l846t2985r1405b3035],
5	Eligible	JJ	O	eligible	amod	6	SENT_75	[p4l10t3084r325b3185],
6	participants	NNS	O	participant	nsubj	9	SENT_75	[p4l355t3085r860b3184],
7	were	VBD	O	be	cop	9	SENT_75	[p4l890t3110r1088b3163],
8	18	CD	DURATION	18	num	9	SENT_75	[p4l1124t3090r1217b3163],
9	years	NNS	NUMBER	year	parataxis	15	SENT_75	[p4l1246t3110r1462b3184],
10	of	IN	O	of	_	0	SENT_75	[p4l1496t3083r1596b3163],
11	age	NN	O	age	prep_of	9	SENT_75	[p4l1608t3110r1749b3185],
12	or	CC	O	or	_	0	SENT_75	[p4l1782t3110r1869b3163],
13	older	JJR	O	older	prep_of	9	SENT_75	[p4l1899t3084r2129b3180],
14	,	,	O	,	_	0	SENT_75	[p4l1899t3084r2129b3180],
15	had	VBD	O	have	_	0	SENT_75	[p4l11t3211r167b3290],
16	HIV-1	NN	MISC	hiv-1	nn	17	SENT_75	[p4l206t3217r450b3290],
17	infection	NN	O	infection	dobj	15	SENT_75	[p4l489t3210r899b3307],
18	,	,	O	,	_	0	SENT_75	[p4l489t3210r899b3307],
19	had	VBD	O	have	aux	22	SENT_75	[p4l944t3211r1100b3290],
20	not	RB	O	not	neg	22	SENT_75	[p4l1139t3228r1281b3290],
21	previously	RB	DATE	previously	advmod	22	SENT_75	[p4l1314t3211r1754b3311],
22	received	VBN	O	receive	conj_and	15	SENT_75	[p4l1789t3211r2134b3291],
23	ART	NN	O	art	dobj	22	SENT_75	[p4l7t3346r214b3435],
24	,	,	O	,	_	0	SENT_75	[p4l7t3346r214b3435],
25	had	VBD	O	have	conj_and	15	SENT_75	[p4l267t3339r423b3418],
26	a	DT	O	a	det	30	SENT_75	[p4l469t3365r513b3417],
27	plasma	NN	O	plasma	nn	30	SENT_75	[p4l558t3339r868b3439],
28	HIV-1	NN	O	hiv-1	nn	30	SENT_75	[p4l913t3345r1157b3417],
29	RNA	NN	O	rna	nn	30	SENT_75	[p4l1204t3346r1413b3423],
30	level	NN	O	level	dobj	25	SENT_75	[p4l1456t3339r1645b3419],
31	of	IN	O	of	_	0	SENT_75	[p4l1692t3338r1792b3418],
32	at	IN	O	at	quantmod	34	SENT_75	[p4l1820t3356r1899b3417],
33	least	JJS	O	least	mwe	32	SENT_75	[p4l1940t3339r2139b3417],
34	1000	CD	DATE	1000	num	35	SENT_75	[p4l14t3474r217b3547],
35	copies	NNS	O	copy	prep_of	30	SENT_75	[p4l257t3469r522b3568],
36	per	IN	O	per	_	0	SENT_75	[p4l562t3494r702b3568],
37	milliliter	NN	O	milliliter	prep_per	35	SENT_75	[p4l739t3468r1122b3546],
38	Without	IN	O	without	_	0	SENT_75	[p4l1153t3468r1493b3547],
39	genotypic	JJ	O	genotypic	amod	40	SENT_75	[p4l1526t3469r1946b3569],
40	evidence	NN	O	evidence	prep_without	25	SENT_75	[p4l1985t3469r2132b3547, p4l11t3596r256b3675],
41	of	IN	O	of	_	0	SENT_75	[p4l301t3595r401b3675],
42	viral	JJ	O	viral	amod	43	SENT_75	[p4l422t3596r614b3675],
43	resistance	NN	O	resistance	prep_of	40	SENT_75	[p4l658t3597r1086b3674],
44	at	IN	O	at	_	0	SENT_75	[p4l1130t3613r1209b3674],
45	screening	NN	O	screening	prep_at	43	SENT_75	[p4l1250t3597r1685b3697],
46	,	,	O	,	_	0	SENT_75	[p4l1250t3597r1685b3697],
47	and	CC	O	and	_	0	SENT_75	[p4l1735t3596r1892b3675],
48	were	VBD	O	be	cop	49	SENT_75	[p4l1932t3622r2134b3675],
49	negative	JJ	O	negative	conj_and	15	SENT_75	[p5l11t22r364b122],
50	for	IN	O	for	_	0	SENT_75	[p5l419t20r542b100],
51	the	DT	O	the	det	52	SENT_75	[p5l593t21r726b99],
52	HLA	NN	O	hlum	prep_for	49	SENT_75	[p5l780t21r1317b100],
53	.	.	O	.	_	0	SENT_75	[p5l780t21r1317b100],

1	—	NN	O	—	_	0	SENT_76	[p5l780t21r1317b100],
2	.	.	O	.	_	0	SENT_76	[p5l780t21r1317b100],

1	B	NN	O	b	_	0	SENT_77	[p5l780t21r1317b100],
2	*	CD	NUMBER	*	number	3	SENT_77	[p5l780t21r1317b100],
3	5701	CD	NUMBER	5701	dep	1	SENT_77	[p5l780t21r1317b100],
4	allele	NN	O	allele	dep	3	SENT_77	[p5l1371t21r1618b100],
5	.	.	O	.	_	0	SENT_77	[p5l1371t21r1618b100],

1	Resistance	NN	O	resistance	nn	2	SENT_78	[p5l1676t22r2134b104],
2	screening	NN	O	screening	nsubj	5	SENT_78	[p5l12t150r429b250],
3	at	IN	O	at	_	0	SENT_78	[p5l471t166r550b227],
4	baseline	NN	O	baseline	prep_at	2	SENT_78	[p5l591t149r943b228],
5	ensured	VBD	O	ensure	_	0	SENT_78	[p5l989t149r1328b228],
6	the	DT	O	the	det	7	SENT_78	[p5l1374t149r1507b227],
7	activity	NN	O	activity	dobj	5	SENT_78	[p5l1552t150r1862b249],
8	of	IN	O	of	_	0	SENT_78	[p5l1904t148r2003b228],
9	all	DT	O	all	det	10	SENT_78	[p5l2030t149r2134b227],
10	components	NNS	O	component	prep_of	7	SENT_78	[p5l11t293r538b376],
11	of	IN	O	of	_	0	SENT_78	[p5l586t275r686b355],
12	the	DT	O	the	det	14	SENT_78	[p5l714t276r847b354],
13	study	NN	O	study	nn	14	SENT_78	[p5l895t276r1124b376],
14	treatments	NNS	O	treatment	prep_of	10	SENT_78	[p5l1166t293r1654b372],
15	,	,	O	,	_	0	SENT_78	[p5l1166t293r1654b372],
16	and	CC	O	and	_	0	SENT_78	[p5l1704t276r1862b355],
17	HLA	NN	O	hlum	nn	19	SENT_78	[p5l1907t284r2133b354],
18	—	NN	O	—	nn	19	SENT_78	[p5l1907t284r2133b354],
19	B	NN	O	b	dobj	5	SENT_78	[p5l10t405r319b484],
20	*	CD	NUMBER	*	number	21	SENT_78	[p5l10t405r319b484],
21	5701	CD	NUMBER	5701	num	22	SENT_78	[p5l10t405r319b484],
22	screening	NN	O	screening	dep	19	SENT_78	[p5l352t406r788b506],
23	,	,	O	,	_	0	SENT_78	[p5l352t406r788b506],
24	as	IN	O	as	mark	31	SENT_78	[p5l824t431r909b483],
25	recommended	VBN	O	recommend	partmod	31	SENT_78	[p5l943t405r1560b484],
26	by	IN	O	by	_	0	SENT_78	[p5l1591t405r1688b505],
27	treatment	NN	O	treatment	nn	28	SENT_78	[p5l1715t422r2139b484],
28	guidelines	NNS	O	guideline	agent	25	SENT_78	[p5l11t533r558b634],
29	,	,	O	,	_	0	SENT_78	[p5l11t533r558b634],
30	“	NN	O	“	nsubj	31	SENT_78	[p5l11t533r558b634],
31	minimized	VBD	O	minimize	advcl	5	SENT_78	[p5l589t533r1064b612],
32	the	DT	O	the	det	33	SENT_78	[p5l1095t533r1228b611],
33	potential	NN	O	potential	dobj	31	SENT_78	[p5l1257t533r1645b633],
34	of	IN	O	of	_	0	SENT_78	[p5l1677t532r1776b612],
35	a	DT	O	a	det	37	SENT_78	[p5l1788t559r1832b611],
36	hypersensitivity	NN	O	hypersensitivity	nn	37	SENT_78	[p5l1861t533r2133b633, p5l12t662r445b760],
37	reaction	NN	O	reaction	prep_of	33	SENT_78	[p5l470t662r819b739],
38	to	TO	O	to	_	0	SENT_78	[p5l848t678r930b739],
39	abacavir	NN	O	abacavir	prep_to	31	SENT_78	[p5l960t661r1335b740],
40	.	.	O	.	_	0	SENT_78	[p5l960t661r1335b740],

1	Women	NNS	O	woman	nsubjpass	33	SENT_79	[p5l1366t668r1698b739],
2	who	WP	O	who	nsubj	4	SENT_79	[p5l1722t661r1905b740],
3	were	VBD	O	be	cop	4	SENT_79	[p5l1932t687r2134b740],
4	pregnant	JJ	O	pregnant	rcmod	1	SENT_79	[p5l10t806r389b890],
5	or	CC	O	or	_	0	SENT_79	[p5l417t815r504b868],
6	breast	NN	O	breast	nn	8	SENT_79	[p5l533t788r1136b890],
7	—	NN	O	—	nn	8	SENT_79	[p5l533t788r1136b890],
8	feeding	NN	O	feeding	conj_or	1	SENT_79	[p5l533t788r1136b890],
9	,	,	O	,	_	0	SENT_79	[p5l533t788r1136b890],
10	persons	NNS	O	person	conj_or	1	SENT_79	[p5l1172t815r1495b889],
11	with	IN	O	with	_	0	SENT_79	[p5l1524t789r1713b868],
12	moderate	JJ	O	moderate	amod	16	SENT_79	[p5l1745t789r2134b868],
13	or	CC	O	or	_	0	SENT_79	[p5l11t943r100b995],
14	severe	JJ	O	severe	conj_or	12	SENT_79	[p5l139t943r397b996],
15	hepatic	JJ	O	hepatic	amod	16	SENT_79	[p5l438t917r748b1016],
16	impairment	NN	O	impairment	prep_with	10	SENT_79	[p5l788t918r1322b1016],
17	,	,	O	,	_	0	SENT_79	[p5l788t918r1322b1016],
18	and	CC	O	and	_	0	SENT_79	[p5l1368t917r1526b995],
19	persons	NNS	O	person	conj_or	1	SENT_79	[p5l1564t943r1900b1016],
20	with	IN	O	with	_	0	SENT_79	[p5l1939t917r2134b996],
21	an	DT	O	a	det	24	SENT_79	[p5l10t1071r114b1123],
22	estimated	VBN	O	estimate	amod	24	SENT_79	[p5l164t1045r594b1124],
23	creatinine	NN	O	creatinine	nn	24	SENT_79	[p5l643t1046r1084b1124],
24	clearance	NN	O	clearance	prep_with	19	SENT_79	[p5l1133t1045r1544b1123],
25	of	IN	O	of	_	0	SENT_79	[p5l1594t1044r1695b1124],
26	less	JJR	O	less	mwe	27	SENT_79	[p5l1724t1045r1882b1123],
27	than	IN	O	than	quantmod	28	SENT_79	[p5l1935t1045r2134b1123],
28	50	CD	NUMBER	50	num	29	SENT_79	[p5l13t1178r111b1251],
29	ml	NN	O	ml	prep_of	24	SENT_79	[p5l166t1172r277b1250],
30	per	IN	O	per	_	0	SENT_79	[p5l322t1198r458b1272],
31	minute	NN	DURATION	minute	prep_per	29	SENT_79	[p5l503t1173r796b1252],
32	were	VBD	O	be	auxpass	33	SENT_79	[p5l839t1198r1035b1252],
33	excluded	VBN	O	exclude	_	0	SENT_79	[p5l1083t1172r1441b1252],
34	from	IN	O	from	_	0	SENT_79	[p5l1488t1171r1691b1251],
35	the	DT	O	the	det	39	SENT_79	[p5l1740t1172r1868b1250],
36	study	NN	O	study	nn	39	SENT_79	[p5l1918t1172r2139b1272],
37	(	CD	NUMBER	(	num	39	SENT_79	[p5l16t1301r273b1391],
38	Table	NNP	O	Table	nn	39	SENT_79	[p5l16t1301r273b1391],
39	S1	NN	O	s1	prep_from	33	SENT_79	[p5l315t1307r410b1379],
40	in	IN	O	in	_	0	SENT_79	[p5l450t1302r533b1378],
41	the	DT	O	the	det	43	SENT_79	[p5l572t1301r705b1379],
42	Supplementary	NNP	O	Supplementary	nn	43	SENT_79	[p5l746t1301r1393b1400],
43	Appendix	NNP	O	Appendix	prep_in	39	SENT_79	[p5l1424t1301r1863b1400],
44	,	,	O	,	_	0	SENT_79	[p5l1424t1301r1863b1400],
45	available	JJ	O	available	acomp	33	SENT_79	[p5l1906t1301r2133b1380, p5l10t1429r181b1508],
46	with	IN	O	with	_	0	SENT_79	[p5l206t1429r401b1508],
47	the	DT	O	the	det	49	SENT_79	[p5l430t1429r563b1507],
48	full	JJ	O	full	amod	49	SENT_79	[p5l592t1428r740b1508],
49	text	NN	O	text	prep_with	45	SENT_79	[p5l769t1446r930b1507],
50	of	IN	O	of	_	0	SENT_79	[p5l954t1428r1054b1508],
51	this	DT	O	this	det	52	SENT_79	[p5l1065t1429r1224b1507],
52	article	NN	O	article	prep_of	49	SENT_79	[p5l1255t1429r1522b1507],
53	at	IN	O	at	_	0	SENT_79	[p5l1551t1446r1630b1507],
54	N	NN	O	n	nn	56	SENT_79	[p5l1651t1437r1726b1508],
55	EJM.org	NN	O	ejm.org	nn	56	SENT_79	[p5l1730t1436r2128b1530],
56	)	NN	O	)	prep_at	52	SENT_79	[p5l1730t1436r2128b1530],
57	.	.	O	.	_	0	SENT_79	[p5l1730t1436r2128b1530],

1	Randomization	NN	O	randomization	nsubjpass	3	SENT_80	[p5l139t1557r798b1640],
2	was	VBD	O	be	auxpass	3	SENT_80	[p5l826t1583r987b1636],
3	stratified	VBN	O	stratify	_	0	SENT_80	[p5l1024t1556r1407b1636],
4	according	VBG	O	accord	_	0	SENT_80	[p5l1440t1557r1858b1658],
5	to	TO	O	to	prepc_according_to	3	SENT_80	[p5l1888t1574r1969b1636],
6	the	DT	O	the	det	10	SENT_80	[p5l2003t1557r2134b1635],
7	plasma	NN	O	plasma	nn	10	SENT_80	[p5l10t1685r320b1785],
8	HIV-1	NN	O	hiv-1	nn	10	SENT_80	[p5l353t1691r597b1764],
9	RNA	NN	O	rna	nn	10	SENT_80	[p5l632t1692r841b1768],
10	level	NN	O	level	pobj	3	SENT_80	[p5l872t1685r1060b1764],
11	at	IN	O	at	_	0	SENT_80	[p5l1095t1702r1174b1763],
12	the	DT	O	the	det	13	SENT_80	[p5l1204t1685r1337b1764],
13	time	NN	O	time	prep_at	10	SENT_80	[p5l1372t1686r1565b1764],
14	of	IN	O	of	_	0	SENT_80	[p5l1602t1684r1701b1764],
15	screening	NN	O	screening	prep_of	13	SENT_80	[p5l1719t1686r2137b1786],
16	(	CD	NUMBER	(	num	15	SENT_80	[p5l16t1819r437b1908],
17	$	$	MONEY	$	amod	19	SENT_80	[p5l16t1819r437b1908],
18	100,000	CD	MONEY	100,000	number	17	SENT_80	[p5l16t1819r437b1908],
19	copies	NNS	O	copy	dep	13	SENT_80	[p5l474t1814r739b1912],
20	per	IN	O	per	_	0	SENT_80	[p5l776t1839r916b1912],
21	milliliter	NN	O	milliliter	prep_per	19	SENT_80	[p5l949t1813r1332b1891],
22	vs.	CC	O	vs.	_	0	SENT_80	[p5l1360t1839r1469b1892],
23	>	JJR	O	>	dep	13	SENT_80	[p5l1517t1819r1906b1908],
24	100,000	CD	NUMBER	100,000	num	25	SENT_80	[p5l1517t1819r1906b1908],
25	copies	NNS	O	copy	dep	23	SENT_80	[p5l1945t1839r2133b1912, p5l10t1942r124b2019],
26	per	IN	O	per	_	0	SENT_80	[p5l186t1967r328b2040],
27	milliliter	NN	O	milliliter	nn	28	SENT_80	[p5l386t1941r803b2031],
28	)	NN	O	)	prep_per	25	SENT_80	[p5l386t1941r803b2031],
29	and	CC	O	and	_	0	SENT_80	[p5l869t1941r1029b2019],
30	the	DT	O	the	det	34	SENT_80	[p5l1090t1941r1225b2019],
31	CD4	NN	O	cd4	nn	34	SENT_80	[p5l1286t1947r1536b2019],
32	+	CC	O	+	_	0	SENT_80	[p5l1286t1947r1536b2019],
33	T-cell	NN	O	t-cell	nn	34	SENT_80	[p5l1593t1941r1835b2019],
34	count	NN	O	count	prep_at	10	SENT_80	[p5l1895t1958r2139b2020],
35	(	CD	NUMBER	(	number	36	SENT_80	[p5l16t2075r255b2159],
36	5200	CD	NUMBER	5200	dep	34	SENT_80	[p5l16t2075r255b2159],
37	per	IN	O	per	_	0	SENT_80	[p5l312t2095r451b2168],
38	cubic	JJ	O	cubic	amod	39	SENT_80	[p5l506t2069r729b2148],
39	millimeter	NN	O	millimeter	prep_per	36	SENT_80	[p5l784t2069r1244b2147],
40	vs.	CC	O	vs.	_	0	SENT_80	[p5l1292t2095r1402b2148],
41	>	JJR	O	>	conj_vs.	36	SENT_80	[p5l1470t2075r1670b2147],
42	200	CD	NUMBER	200	dep	41	SENT_80	[p5l1470t2075r1670b2147],
43	per	IN	O	per	_	0	SENT_80	[p5l1726t2095r1864b2168],
44	cubic	JJ	O	cubic	amod	46	SENT_80	[p5l1916t2069r2134b2148],
45	millimeter	NN	O	millimeter	nn	46	SENT_80	[p5l11t2197r506b2288],
46	)	NN	O	)	prep_per	42	SENT_80	[p5l11t2197r506b2288],
47	.	.	O	.	_	0	SENT_80	[p5l11t2197r506b2288],

1	Participants	NNS	O	participant	nsubjpass	4	SENT_81	[p5l539t2198r1042b2297],
2	were	VBD	O	be	auxpass	4	SENT_81	[p5l1069t2223r1268b2276],
3	randomly	RB	O	randomly	advmod	4	SENT_81	[p5l1297t2197r1705b2297],
4	assigned	VBN	O	assign	_	0	SENT_81	[p5l1731t2197r2129b2298],
5	,	,	O	,	_	0	SENT_81	[p5l1731t2197r2129b2298],
6	in	IN	O	in	_	0	SENT_81	[p5l10t2326r94b2403],
7	a	DT	O	a	det	9	SENT_81	[p5l141t2351r186b2403],
8	1:1	CD	NUMBER	1:1	num	9	SENT_81	[p5l237t2331r358b2404],
9	ratio	NN	O	ratio	prep_in	4	SENT_81	[p5l407t2326r627b2421],
10	,	,	O	,	_	0	SENT_81	[p5l407t2326r627b2421],
11	to	TO	O	to	_	0	SENT_81	[p5l682t2342r762b2404],
12	the	DT	O	the	det	13	SENT_81	[p5l813t2325r946b2404],
13	DTG	NN	O	dtg	prep_to	4	SENT_81	[p5l994t2331r1672b2404],
14	.	.	O	.	_	0	SENT_81	[p5l994t2331r1672b2404],

1	—	NN	O	—	_	0	SENT_82	[p5l994t2331r1672b2404],
2	.	.	O	.	_	0	SENT_82	[p5l994t2331r1672b2404],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_83	[p5l994t2331r1672b2404],
2	.	.	O	.	_	0	SENT_83	[p5l994t2331r1672b2404],

1	—	NN	O	—	_	0	SENT_84	[p5l994t2331r1672b2404],
2	.	.	O	.	_	0	SENT_84	[p5l994t2331r1672b2404],

1	3TC	NN	O	3tc	nn	2	SENT_85	[p5l994t2331r1672b2404],
2	group	NN	O	group	_	0	SENT_85	[p5l1722t2351r1997b2426],
3	,	,	O	,	_	0	SENT_85	[p5l1722t2351r1997b2426],
4	in	IN	O	in	dep	2	SENT_85	[p5l2051t2326r2134b2403],

1	1303	CD	DATE	1303	num	4	SENT_86	[p5l149t2484r224b2505],
2	N	NN	O	n	nn	4	SENT_86	[p5l933t2494r947b2509],
3	ENGLJ	NN	O	englj	nn	4	SENT_86	[p5l961t2494r1039b2516],
4	MED	NN	O	med	_	0	SENT_86	[p5l1054t2494r1106b2509],
5	369	CD	NUMBER	369	num	7	SENT_86	[p5l1116t2488r1197b2516],
6	;	:	O	;	_	0	SENT_86	[p5l1116t2488r1197b2516],
7	19	CD	NUMBER	19	dep	4	SENT_86	[p5l1116t2488r1197b2516],
8	NEjM	NNP	O	NEjM	dep	4	SENT_86	[p5l1233t2494r1357b2516],
9	,	,	O	,	_	0	SENT_86	[p5l1233t2494r1357b2516],
10	ORG	NNP	O	ORG	nn	11	SENT_86	[p5l1233t2494r1357b2516],
11	NOVEMBER	NNP	DATE	NOVEMBER	appos	8	SENT_86	[p5l1394t2494r1529b2510],
12	7	CD	DATE	7	num	11	SENT_86	[p5l1539t2494r1558b2515],
13	,	,	DATE	,	_	0	SENT_86	[p5l1539t2494r1558b2515],
14	2013	CD	DATE	2013	num	11	SENT_86	[p5l1569t2494r1624b2516],

1	The	DT	O	the	det	4	SENT_87	[p5l935t2527r986b2551],
2	New	NNP	O	New	nn	4	SENT_87	[p5l995t2528r1057b2551],
3	England	NNP	O	England	nn	4	SENT_87	[p5l1066t2527r1177b2558],
4	Joumal	NNP	O	Joumal	_	0	SENT_87	[p5l1186t2527r1283b2551],
5	of	IN	O	of	_	0	SENT_87	[p5l1293t2527r1322b2551],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_87	[p5l1329t2527r1454b2551],

1	DOLUTEGRAVIR	NN	O	dolutegravir	_	0	SENT_88	[p5l507t2715r769b2734],
2	AND	CC	O	and	cc	3	SENT_88	[p5l780t2715r852b2734],
3	ABACAVIR	NN	O	abacavir	dep	1	SENT_88	[p5l864t2715r1270b2734],
4	.	.	O	.	_	0	SENT_88	[p5l864t2715r1270b2734],

1	—	NN	O	—	_	0	SENT_89	[p5l864t2715r1270b2734],
2	.	.	O	.	_	0	SENT_89	[p5l864t2715r1270b2734],

1	LAMIVUDINE	NNP	O	LAMIVUDINE	_	0	SENT_90	[p5l864t2715r1270b2734],
2	FOR	IN	O	for	_	0	SENT_90	[p5l1284t2715r1348b2734],
3	HIV-1	NN	O	hiv-1	nn	4	SENT_90	[p5l1362t2715r1452b2734],
4	INFECTION	NN	O	infection	prep_for	1	SENT_90	[p5l1467t2715r1653b2734],

1	which	WDT	O	which	dep	3	SENT_91	[p5l6t2928r264b3007],
2	participants	NNS	O	participant	nsubj	3	SENT_91	[p5l298t2929r803b3028],
3	received	VBD	O	receive	_	0	SENT_91	[p5l841t2928r1179b3007],
4	dolutegravir	NN	O	dolutegravir	dobj	3	SENT_91	[p5l1215t2928r1727b3029],
5	at	IN	O	at	_	0	SENT_91	[p5l1759t2945r1837b3006],
6	a	DT	O	a	det	7	SENT_91	[p5l1866t2954r1910b3006],
7	dose	NN	O	dose	prep_at	3	SENT_91	[p5l1945t2928r2135b3007],
8	of	IN	O	of	_	0	SENT_91	[p5l11t3055r111b3135],
9	50	CD	NUMBER	50	num	10	SENT_91	[p5l130t3062r227b3135],
10	mg	NN	O	mg	prep_of	7	SENT_91	[p5l264t3082r404b3157],
11	as	IN	O	as	mark	14	SENT_91	[p5l436t3082r521b3134],
12	a	DT	O	a	det	14	SENT_91	[p5l559t3082r603b3134],
13	separate	JJ	O	separate	amod	14	SENT_91	[p5l639t3073r994b3156],
14	tablet	NN	O	tablet	advcl	3	SENT_91	[p5l1031t3056r1274b3135],
15	and	CC	O	and	_	0	SENT_91	[p5l1304t3056r1462b3135],
16	abacavir	NN	O	abacavir	nn	20	SENT_91	[p5l1498t3056r2134b3135],
17	—	CD	NUMBER	—	num	20	SENT_91	[p5l1498t3056r2134b3135],
18	lami	NN	O	lamus	nn	20	SENT_91	[p5l1498t3056r2134b3135],
19	—	NN	O	—	nn	20	SENT_91	[p5l1498t3056r2134b3135],
20	vudine	NN	O	vudine	advcl	3	SENT_91	[p5l6t3184r297b3263],
21	in	IN	O	in	dep	14	SENT_91	[p5l345t3185r429b3262],
22	a	DT	O	a	det	26	SENT_91	[p5l476t3210r521b3262],
23	fixed	VBN	O	fix	amod	26	SENT_91	[p5l568t3183r1018b3263],
24	—	NN	O	—	nn	26	SENT_91	[p5l568t3183r1018b3263],
25	dose	NN	O	dose	nn	26	SENT_91	[p5l568t3183r1018b3263],
26	combination	NN	O	combination	pobj	21	SENT_91	[p5l1068t3184r1615b3263],
27	of	IN	O	of	_	0	SENT_91	[p5l1665t3183r1764b3263],
28	600	CD	NUMBER	600	num	29	SENT_91	[p5l1795t3190r1950b3263],
29	mg	NN	O	mg	prep_of	26	SENT_91	[p5l2000t3210r2139b3285],
30	and	CC	O	and	_	0	SENT_91	[p5l10t3312r168b3391],
31	300	CD	NUMBER	300	num	32	SENT_91	[p5l203t3318r357b3391],
32	mg	NN	O	mg	prep_of	26	SENT_91	[p5l393t3338r551b3413],
33	,	,	O	,	_	0	SENT_91	[p5l393t3338r551b3413],
34	respectively	RB	O	respectively	advmod	26	SENT_91	[p5l592t3312r1074b3412],
35	(	CD	NUMBER	(	dep	26	SENT_91	[p5l1106t3313r1492b3412],
36	Epzicom	NNP	O	Epzicom	dep	35	SENT_91	[p5l1106t3313r1492b3412],
37	or	CC	O	or	_	0	SENT_91	[p5l1524t3338r1610b3391],
38	Kivexa	NNP	LOCATION	Kivexa	dep	35	SENT_91	[p5l1637t3313r1931b3408],
39	,	,	O	,	_	0	SENT_91	[p5l1637t3313r1931b3408],
40	ViiV	NNP	O	ViiV	nn	42	SENT_91	[p5l1963t3313r2139b3391],
41	Healthcare	NNP	O	Healthcare	nn	42	SENT_91	[p5l10t3440r506b3536],
42	)	NN	O	)	appos	36	SENT_91	[p5l10t3440r506b3536],
43	,	,	O	,	_	0	SENT_91	[p5l10t3440r506b3536],
44	or	CC	O	or	_	0	SENT_91	[p5l565t3466r654b3519],
45	to	TO	O	to	conj_or	21	SENT_91	[p5l707t3457r789b3519],
46	the	DT	O	the	det	47	SENT_91	[p5l845t3440r978b3519],
47	EFV	NN	O	efv	pobj	45	SENT_91	[p5l1033t3446r1659b3519],
48	.	.	O	.	_	0	SENT_91	[p5l1033t3446r1659b3519],

1	—	NN	O	—	_	0	SENT_92	[p5l1033t3446r1659b3519],
2	.	.	O	.	_	0	SENT_92	[p5l1033t3446r1659b3519],

1	TDF	NNP	O	TDF	_	0	SENT_93	[p5l1033t3446r1659b3519],
2	.	.	O	.	_	0	SENT_93	[p5l1033t3446r1659b3519],

1	—	NN	O	—	_	0	SENT_94	[p5l1033t3446r1659b3519],
2	.	.	O	.	_	0	SENT_94	[p5l1033t3446r1659b3519],

1	FTC	NNP	ORGANIZATION	FTC	nsubj	2	SENT_95	[p5l1033t3446r1659b3519],
2	group	NN	O	group	_	0	SENT_95	[p5l1716t3466r1992b3541],
3	,	,	O	,	_	0	SENT_95	[p5l1716t3466r1992b3541],
4	in	IN	O	in	_	0	SENT_95	[p5l2052t3441r2135b3518],
5	which	WDT	O	which	rel	7	SENT_95	[p5l6t3567r273b3647],
6	participants	NNS	O	participant	nsubj	7	SENT_95	[p5l318t3568r847b3667],
7	received	VBD	O	receive	rcmod	2	SENT_95	[p5l896t3567r1250b3646],
8	an	DT	O	a	det	13	SENT_95	[p5l1296t3593r1400b3645],
9	efavirenz	NN	O	efavirenz	nn	13	SENT_95	[p5l1448t3566r2134b3647],
10	—	CD	NUMBER	—	num	13	SENT_95	[p5l1448t3566r2134b3647],
11	teno	NN	O	teno	nn	13	SENT_95	[p5l1448t3566r2134b3647],
12	—	NN	O	—	nn	13	SENT_95	[p5l1448t3566r2134b3647],
13	fovir	NN	O	fovir	dobj	7	SENT_95	[p5l10t3694r214b3775],
14	DF	NN	O	df	nn	17	SENT_95	[p5l244t3695r1016b3774],
15	—	CD	NUMBER	—	num	17	SENT_95	[p5l244t3695r1016b3774],
16	emtricitabine	NN	O	emtricitabine	nn	17	SENT_95	[p5l244t3695r1016b3774],
17	tablet	NN	O	tablet	dep	13	SENT_95	[p5l1051t3695r1299b3774],
18	once	RB	DATE	once	advmod	13	SENT_95	[p5l1329t3721r1529b3774],
19	daily	RB	SET	daily	advmod	13	SENT_95	[p5l1564t3695r1777b3795],
20	at	IN	O	at	amod	13	SENT_95	[p5l1805t3712r1886b3773],
21	fixed	JJ	O	fixed	amod	22	SENT_95	[p5l1914t3694r2135b3774],
22	doses	NNS	O	dose	dep	13	SENT_95	[p6l11t22r252b101],
23	of	IN	O	of	_	0	SENT_95	[p6l300t21r399b101],
24	600	CD	NUMBER	600	num	25	SENT_95	[p6l424t28r577b101],
25	mg	NN	O	mg	prep_of	22	SENT_95	[p6l621t48r776b123],
26	,	,	O	,	_	0	SENT_95	[p6l621t48r776b123],
27	300	CD	NUMBER	300	num	28	SENT_95	[p6l826t28r978b101],
28	mg	NN	O	mg	conj_and	25	SENT_95	[p6l1021t48r1177b123],
29	,	,	O	,	_	0	SENT_95	[p6l1021t48r1177b123],
30	and	CC	O	and	_	0	SENT_95	[p6l1224t22r1381b101],
31	200	CD	NUMBER	200	num	32	SENT_95	[p6l1423t28r1576b101],
32	mg	NN	O	mg	conj_and	25	SENT_95	[p6l1619t48r1775b123],
33	,	,	O	,	_	0	SENT_95	[p6l1619t48r1775b123],
34	respectively	RB	O	respectively	dep	36	SENT_95	[p6l1823t48r2134b122, p6l11t150r240b249],
35	(	CD	NUMBER	(	num	36	SENT_95	[p6l284t150r636b249],
36	Atripla	NNP	O	Atripla	dep	2	SENT_95	[p6l284t150r636b249],
37	,	,	O	,	_	0	SENT_95	[p6l284t150r636b249],
38	Bristol-Myers	NNP	O	Bristol-Myers	nn	39	SENT_95	[p6l684t150r1264b249],
39	Squibb	NNP	O	Squibb	dep	2	SENT_95	[p6l1312t150r1611b249],
40	and	CC	O	and	_	0	SENT_95	[p6l1655t150r1815b228],
41	Gilead	NNP	ORGANIZATION	Gilead	nn	43	SENT_95	[p6l1858t150r2135b228],
42	Sciences	NNPS	ORGANIZATION	Sciences	nn	43	SENT_95	[p6l12t278r409b368],
43	)	NN	O	)	conj_and	36	SENT_95	[p6l12t278r409b368],
44	.	.	O	.	_	0	SENT_95	[p6l12t278r409b368],

1	Randomization	NN	O	randomization	nsubjpass	3	SENT_96	[p6l444t277r1104b361],
2	was	VBD	O	be	auxpass	3	SENT_96	[p6l1129t303r1289b357],
3	performed	VBN	O	perform	_	0	SENT_96	[p6l1320t276r1768b377],
4	in	IN	O	in	_	0	SENT_96	[p6l1797t278r1879b355],
5	block	NN	O	block	nn	6	SENT_96	[p6l1909t277r2140b357],
6	sizes	NNS	O	size	prep_in	3	SENT_96	[p6l11t406r216b483],
7	of	IN	O	of	_	0	SENT_96	[p6l257t404r357b484],
8	six	CD	NUMBER	six	prep_of	6	SENT_96	[p6l378t406r517b501],
9	,	,	O	,	_	0	SENT_96	[p6l378t406r517b501],
10	with	IN	O	with	_	0	SENT_96	[p6l556t405r752b485],
11	the	DT	O	the	det	12	SENT_96	[p6l790t405r923b483],
12	use	NN	O	use	prep_with	3	SENT_96	[p6l962t431r1102b485],
13	of	IN	O	of	_	0	SENT_96	[p6l1141t404r1241b484],
14	a	DT	O	a	det	16	SENT_96	[p6l1260t431r1304b483],
15	central	JJ	O	central	amod	16	SENT_96	[p6l1342t405r1638b483],
16	procedure	NN	O	procedure	prep_of	12	SENT_96	[p6l1674t405r2130b505],
17	.	.	O	.	_	0	SENT_96	[p6l1674t405r2130b505],

1	In	IN	O	in	dep	4	SENT_97	[p6l8t541r98b611],
2	addition	NN	O	addition	pobj	1	SENT_97	[p6l152t534r532b629],
3	,	,	O	,	_	0	SENT_97	[p6l152t534r532b629],
4	participants	NNS	O	participant	_	0	SENT_97	[p6l590t535r1095b633],
5	in	IN	O	in	_	0	SENT_97	[p6l1149t535r1232b611],
6	the	DT	O	the	det	7	SENT_97	[p6l1284t534r1414b612],
7	DTG	NN	O	dtg	prep_in	4	SENT_97	[p6l1466t540r2133b613],
8	.	.	O	.	_	0	SENT_97	[p6l1466t540r2133b613],

1	—	NN	O	—	_	0	SENT_98	[p6l1466t540r2133b613],
2	.	.	O	.	_	0	SENT_98	[p6l1466t540r2133b613],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_99	[p6l1466t540r2133b613],
2	.	.	O	.	_	0	SENT_99	[p6l1466t540r2133b613],

1	—	NN	O	—	_	0	SENT_100	[p6l1466t540r2133b613],
2	.	.	O	.	_	0	SENT_100	[p6l1466t540r2133b613],

1	3TC	NN	O	3tc	nn	2	SENT_101	[p6l1466t540r2133b613],
2	group	NN	O	group	nsubj	3	SENT_101	[p6l10t688r258b763],
3	received	VBD	O	receive	_	0	SENT_101	[p6l323t662r661b741],
4	a	DT	O	a	det	5	SENT_101	[p6l725t688r770b740],
5	placebo	NN	O	placebo	dobj	3	SENT_101	[p6l833t662r1162b762],
6	matching	VBG	O	match	partmod	5	SENT_101	[p6l1229t662r1643b763],
7	the	DT	O	the	det	13	SENT_101	[p6l1706t662r1839b740],
8	efavi	NN	O	efavus	nn	13	SENT_101	[p6l1906t661r2134b741],
9	—	NN	O	—	nn	13	SENT_101	[p6l1906t661r2134b741],
10	renz	NN	O	renz	nn	13	SENT_101	[p6l10t789r647b869],
11	—	CD	NUMBER	—	num	13	SENT_101	[p6l10t789r647b869],
12	tenofovir	NN	O	tenofovir	nn	13	SENT_101	[p6l10t789r647b869],
13	DF	NN	O	df	dobj	6	SENT_101	[p6l679t790r1422b869],
14	—	CD	NUMBER	—	num	16	SENT_101	[p6l679t790r1422b869],
15	emtricitabine	NN	O	emtricitabine	nn	16	SENT_101	[p6l679t790r1422b869],
16	tablet	NN	O	tablet	dep	13	SENT_101	[p6l1458t790r1693b869],
17	and	CC	O	and	_	0	SENT_101	[p6l1721t790r1876b869],
18	those	DT	O	those	conj_and	13	SENT_101	[p6l1910t790r2135b869],
19	in	IN	O	in	_	0	SENT_101	[p6l10t919r91b996],
20	the	DT	O	the	det	21	SENT_101	[p6l154t918r284b997],
21	EFV	NN	O	efv	prep_in	18	SENT_101	[p6l346t924r957b997],
22	.	.	O	.	_	0	SENT_101	[p6l346t924r957b997],

1	—	NN	O	—	_	0	SENT_102	[p6l346t924r957b997],
2	.	.	O	.	_	0	SENT_102	[p6l346t924r957b997],

1	TDF	NNP	O	TDF	_	0	SENT_103	[p6l346t924r957b997],
2	.	.	O	.	_	0	SENT_103	[p6l346t924r957b997],

1	—	NN	O	—	_	0	SENT_104	[p6l346t924r957b997],
2	.	.	O	.	_	0	SENT_104	[p6l346t924r957b997],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_105	[p6l346t924r957b997],
2	group	NN	O	group	nsubj	3	SENT_105	[p6l1022t944r1269b1019],
3	received	VBD	O	receive	ccomp	20	SENT_105	[p6l1335t918r1689b997],
4	placebos	NNS	O	placebo	dobj	3	SENT_105	[p6l1755t918r2134b1018],
5	matching	VBG	O	match	partmod	4	SENT_105	[p6l10t1046r423b1147],
6	the	DT	O	the	det	10	SENT_105	[p6l462t1046r594b1125],
7	dolutegravir	NN	O	dolutegravir	nn	10	SENT_105	[p6l636t1046r1160b1147],
8	and	CC	O	and	_	0	SENT_105	[p6l1197t1046r1355b1125],
9	abacavir	NN	O	abacavir	nn	10	SENT_105	[p6l1396t1046r2134b1125],
10	—	NN	O	—	dobj	5	SENT_105	[p6l1396t1046r2134b1125],
11	lamivu	NN	O	lamivu	nsubj	13	SENT_105	[p6l1396t1046r2134b1125],
12	—	CD	NUMBER	—	num	11	SENT_105	[p6l1396t1046r2134b1125],
13	dine	VBP	O	dine	rcmod	10	SENT_105	[p6l11t1174r196b1252],
14	tablets	NNS	O	tablet	dobj	13	SENT_105	[p6l243t1174r525b1252],
15	(	CD	NUMBER	(	tmod	5	SENT_105	[p6l579t1175r753b1269],
16	i.e.	FW	O	i.e.	dep	15	SENT_105	[p6l579t1175r753b1269],
17	,	,	O	,	_	0	SENT_105	[p6l579t1175r753b1269],
18	all	DT	O	all	det	19	SENT_105	[p6l805t1174r910b1252],
19	participants	NNS	O	participant	nsubj	20	SENT_105	[p6l955t1175r1472b1273],
20	received	VBD	O	receive	_	0	SENT_105	[p6l1522t1174r1868b1253],
21	three	CD	NUMBER	three	num	22	SENT_105	[p6l1915t1174r2135b1252],
22	tablets	NNS	O	tablet	dobj	20	SENT_105	[p6l11t1302r293b1380],
23	each	DT	SET	each	det	24	SENT_105	[p6l331t1302r523b1380],
24	day	NN	SET	day	dep	22	SENT_105	[p6l560t1302r728b1401],
25	)	CD	NUMBER	)	number	26	SENT_105	[p6l560t1302r728b1401],
26	(	CD	NUMBER	(	num	28	SENT_105	[p6l774t1302r1033b1392],
27	Table	NNP	O	Table	nn	28	SENT_105	[p6l774t1302r1033b1392],
28	S2	NN	O	s2	dep	20	SENT_105	[p6l1071t1308r1166b1380],
29	in	IN	O	in	_	0	SENT_105	[p6l1202t1303r1285b1379],
30	the	DT	O	the	det	33	SENT_105	[p6l1321t1302r1454b1380],
31	Supplementary	NNP	O	Supplementary	nn	33	SENT_105	[p6l1493t1302r2140b1401],
32	Appendix	NNP	O	Appendix	nn	33	SENT_105	[p6l6t1430r473b1529],
33	)	NN	O	)	prep_in	20	SENT_105	[p6l6t1430r473b1529],
34	.	.	O	.	_	0	SENT_105	[p6l6t1430r473b1529],

1	srunv	NN	O	srunv	dep	101	SENT_106	[p6l10t1704r267b1754],
2	END	NN	O	end	dep	101	SENT_106	[p6l303t1705r462b1753],
3	pomrs	NNS	O	pomr	dep	101	SENT_106	[p6l502t1704r793b1754],
4	The	DT	O	the	dep	101	SENT_106	[p6l6t1802r168b1880],
5	primary	JJ	O	primary	dep	101	SENT_106	[p6l208t1803r559b1902],
6	efficacy	NN	O	efficacy	dep	101	SENT_106	[p6l598t1801r934b1902],
7	end	NN	O	end	dep	101	SENT_106	[p6l973t1802r1126b1881],
8	point	NN	O	point	dep	101	SENT_106	[p6l1166t1803r1397b1902],
9	was	VBD	O	be	dep	101	SENT_106	[p6l1429t1828r1593b1882],
10	the	DT	O	the	dep	101	SENT_106	[p6l1637t1802r1770b1880],
11	proportion	NN	O	proportion	dep	101	SENT_106	[p6l1811t1828r2134b1902, p6l11t1931r180b2009],
12	of	IN	O	of	dep	101	SENT_106	[p6l233t1929r333b2009],
13	participants	NNS	O	participant	dep	101	SENT_106	[p6l365t1931r882b2030],
14	with	IN	O	with	dep	101	SENT_106	[p6l932t1930r1128b2010],
15	a	DT	O	a	dep	101	SENT_106	[p6l1179t1956r1224b2008],
16	plasma	NN	O	plasma	dep	101	SENT_106	[p6l1273t1930r1583b2030],
17	HIV-1	NN	O	hiv-1	dep	101	SENT_106	[p6l1634t1936r1878b2009],
18	RNA	NN	O	rna	dep	101	SENT_106	[p6l1929t1937r2139b2014],
19	level	NN	O	level	dep	101	SENT_106	[p6l9t2058r198b2137],
20	of	IN	O	of	dep	101	SENT_106	[p6l235t2057r335b2137],
21	less	JJR	O	less	dep	101	SENT_106	[p6l352t2058r507b2136],
22	than	IN	O	than	dep	101	SENT_106	[p6l547t2058r744b2136],
23	50	CD	NUMBER	50	dep	101	SENT_106	[p6l782t2064r879b2137],
24	copies	NNS	O	copy	dep	101	SENT_106	[p6l918t2059r1183b2158],
25	per	IN	O	per	dep	101	SENT_106	[p6l1220t2084r1360b2158],
26	milliliter	NN	O	milliliter	dep	101	SENT_106	[p6l1394t2058r1777b2136],
27	at	IN	O	at	dep	101	SENT_106	[p6l1811t2075r1890b2136],
28	week	NN	DURATION	week	dep	101	SENT_106	[p6l1916t2058r2140b2138],
29	48	CD	NUMBER	48	dep	101	SENT_106	[p6l8t2192r135b2282],
30	,	,	O	,	_	0	SENT_106	[p6l8t2192r135b2282],
31	as	IN	O	as	dep	101	SENT_106	[p6l183t2212r267b2264],
32	determined	VBN	O	determine	dep	101	SENT_106	[p6l313t2186r808b2265],
33	with	IN	O	with	dep	101	SENT_106	[p6l845t2186r1041b2266],
34	the	DT	O	the	dep	101	SENT_106	[p6l1083t2186r1217b2264],
35	use	NN	O	use	dep	101	SENT_106	[p6l1259t2212r1400b2266],
36	of	IN	O	of	dep	101	SENT_106	[p6l1442t2185r1542b2265],
37	the	DT	O	the	dep	101	SENT_106	[p6l1567t2186r1700b2264],
38	Snapshot	NNP	O	Snapshot	dep	101	SENT_106	[p6l1745t2186r2140b2286],
39	algorithm	NN	O	algorithm	dep	101	SENT_106	[p6l10t2315r439b2416],
40	from	IN	O	from	dep	101	SENT_106	[p6l480t2314r691b2394],
41	the	DT	O	the	dep	101	SENT_106	[p6l732t2315r864b2393],
42	Food	NNP	ORGANIZATION	Food	dep	101	SENT_106	[p6l904t2315r1118b2394],
43	and	CC	ORGANIZATION	and	dep	101	SENT_106	[p6l1158t2315r1316b2394],
44	Drug	NNP	ORGANIZATION	Drug	dep	101	SENT_106	[p6l1356t2322r1577b2416],
45	Administration	NNP	ORGANIZATION	Administration	dep	101	SENT_106	[p6l1610t2315r2134b2394, p6l11t2444r180b2521],
46	(	NN	O	(	dep	101	SENT_106	[p6l243t2443r680b2533],
47	described	VBN	O	describe	dep	101	SENT_106	[p6l243t2443r680b2533],
48	in	IN	O	in	dep	101	SENT_106	[p6l737t2444r820b2520],
49	the	DT	O	the	dep	101	SENT_106	[p6l879t2443r1012b2521],
50	Statistical	JJ	MISC	statistical	dep	101	SENT_106	[p6l1073t2443r1496b2521],
51	Analysis	NN	MISC	analysis	dep	101	SENT_106	[p6l1550t2443r1911b2542],
52	section	NN	O	section	dep	101	SENT_106	[p6l1972t2469r2134b2521, p6l11t2572r230b2666],
53	)	NN	O	)	dep	101	SENT_106	[p6l1972t2469r2134b2521, p6l11t2572r230b2666],
54	,	,	O	,	_	0	SENT_106	[p6l1972t2469r2134b2521, p6l11t2572r230b2666],
55	Which	WDT	O	which	dep	101	SENT_106	[p6l263t2571r526b2650],
56	is	VBZ	O	be	dep	101	SENT_106	[p6l556t2572r622b2648],
57	now	RB	DATE	now	dep	101	SENT_106	[p6l656t2597r840b2650],
58	widely	RB	O	widely	dep	101	SENT_106	[p6l863t2571r1143b2670],
59	used	VBN	O	use	dep	101	SENT_106	[p6l1170t2571r1368b2650],
60	in	IN	O	in	dep	101	SENT_106	[p6l1398t2572r1481b2648],
61	HIV	NN	MISC	hiv	dep	101	SENT_106	[p6l1512t2578r1687b2649],
62	trials	NNS	O	trial	dep	101	SENT_106	[p6l1715t2571r2133b2649],
63	.12	CD	NUMBER	.12	dep	101	SENT_106	[p6l1715t2571r2133b2649],
64	'15	CD	NUMBER	'15	dep	101	SENT_106	[p6l1715t2571r2133b2649],
65	Secondary	JJ	O	secondary	dep	101	SENT_106	[p6l12t2698r458b2798],
66	efficacy	NN	O	efficacy	dep	101	SENT_106	[p6l493t2697r830b2798],
67	end	NN	O	end	dep	101	SENT_106	[p6l865t2698r1018b2777],
68	points	NNS	O	point	dep	101	SENT_106	[p6l1055t2699r1325b2798],
69	included	VBD	O	include	dep	101	SENT_106	[p6l1365t2698r1732b2778],
70	the	DT	O	the	dep	101	SENT_106	[p6l1770t2698r1904b2776],
71	time	NN	O	time	dep	101	SENT_106	[p6l1942t2699r2135b2776],
72	to	TO	O	to	dep	101	SENT_106	[p6l11t2843r92b2905],
73	viral	JJ	O	viral	dep	101	SENT_106	[p6l131t2826r323b2906],
74	suppression	NN	O	suppression	dep	101	SENT_106	[p6l366t2827r878b2926],
75	(	CD	NUMBER	(	dep	101	SENT_106	[p6l925t2827r1098b2922],
76	i.e.	FW	O	i.e.	dep	101	SENT_106	[p6l925t2827r1098b2922],
77	,	,	O	,	_	0	SENT_106	[p6l925t2827r1098b2922],
78	an	DT	O	a	dep	101	SENT_106	[p6l1145t2852r1248b2904],
79	HIV-1	NN	O	hiv-1	dep	101	SENT_106	[p6l1290t2832r1534b2905],
80	RNA	NN	O	rna	dep	101	SENT_106	[p6l1575t2833r1784b2910],
81	level	NN	O	level	dep	101	SENT_106	[p6l1822t2826r2011b2906],
82	of	IN	O	of	dep	101	SENT_106	[p6l2054t2825r2153b2905],
83	<	JJR	O	<	dep	101	SENT_106	[p6l12t2961r166b3034],
84	50	CD	NUMBER	50	dep	101	SENT_106	[p6l12t2961r166b3034],
85	copies	NNS	O	copy	dep	101	SENT_106	[p6l217t2956r483b3055],
86	per	IN	O	per	dep	101	SENT_106	[p6l533t2981r673b3055],
87	milliliter	NN	O	milliliter	dep	101	SENT_106	[p6l719t2955r1125b3046],
88	)	NN	O	)	dep	101	SENT_106	[p6l719t2955r1125b3046],
89	and	CC	O	and	dep	101	SENT_106	[p6l1180t2955r1338b3034],
90	the	DT	O	the	dep	101	SENT_106	[p6l1387t2955r1520b3033],
91	change	NN	O	change	dep	101	SENT_106	[p6l1570t2955r1876b3056],
92	from	IN	O	from	dep	101	SENT_106	[p6l1925t2954r2136b3034],
93	baseline	NN	O	baseline	dep	101	SENT_106	[p6l11t3084r363b3163],
94	in	IN	O	in	dep	101	SENT_106	[p6l396t3085r479b3162],
95	the	DT	O	the	dep	101	SENT_106	[p6l512t3084r644b3162],
96	CD4	NN	O	cd4	dep	101	SENT_106	[p6l678t3090r924b3163],
97	+	CC	O	+	dep	101	SENT_106	[p6l678t3090r924b3163],
98	T	NN	O	t	dep	101	SENT_106	[p6l954t3084r1190b3163],
99	—	NN	O	—	dep	101	SENT_106	[p6l954t3084r1190b3163],
100	cell	NN	O	cell	dep	101	SENT_106	[p6l954t3084r1190b3163],
101	count	NN	O	count	_	0	SENT_106	[p6l1223t3101r1488b3163],
102	.	.	O	.	_	0	SENT_106	[p6l1223t3101r1488b3163],

1	Other	JJ	O	other	amod	4	SENT_107	[p6l1526t3084r1775b3163],
2	secondary	JJ	O	secondary	amod	4	SENT_107	[p6l1806t3084r2134b3163, p6l10t3237r145b3311],
3	end	NN	O	end	nn	4	SENT_107	[p6l175t3211r328b3290],
4	points	NNS	O	point	nsubj	5	SENT_107	[p6l360t3212r630b3311],
5	included	VBD	O	include	_	0	SENT_107	[p6l665t3211r1032b3291],
6	the	DT	O	the	det	8	SENT_107	[p6l1066t3211r1199b3289],
7	safety	NN	O	safety	nn	8	SENT_107	[p6l1234t3210r1487b3311],
8	profile	NN	O	profile	dobj	5	SENT_107	[p6l1515t3210r1826b3311],
9	,	,	O	,	_	0	SENT_107	[p6l1515t3210r1826b3311],
10	health	NN	O	health	nn	11	SENT_107	[p6l1865t3211r2136b3289],
11	outcomes	NNS	O	outcome	dobj	5	SENT_107	[p6l11t3356r447b3435],
12	,	,	O	,	_	0	SENT_107	[p6l11t3356r447b3435],
13	and	CC	O	and	_	0	SENT_107	[p6l489t3339r648b3418],
14	the	DT	O	the	det	15	SENT_107	[p6l685t3339r819b3417],
15	incidence	NN	O	incidence	dobj	5	SENT_107	[p6l856t3339r1262b3418],
16	of	IN	O	of	_	0	SENT_107	[p6l1300t3338r1400b3418],
17	the	DT	O	the	det	18	SENT_107	[p6l1419t3339r1552b3417],
18	development	NN	O	development	prep_of	15	SENT_107	[p6l1591t3339r2140b3439],
19	of	IN	O	of	_	0	SENT_107	[p6l11t3467r111b3547],
20	genotypic	JJ	O	genotypic	amod	23	SENT_107	[p6l135t3469r555b3569],
21	and	CC	O	and	_	0	SENT_107	[p6l597t3468r755b3547],
22	phenotypic	JJ	O	phenotypic	conj_and	20	SENT_107	[p6l797t3468r1276b3568],
23	resistance	NN	O	resistance	prep_of	18	SENT_107	[p6l1318t3469r1747b3546],
24	to	TO	O	to	_	0	SENT_107	[p6l1791t3485r1873b3547],
25	dolutegravir	NN	O	dolutegravir	prep_to	5	SENT_107	[p6l1918t3468r2134b3547, p6l11t3597r362b3697],
26	,	,	O	,	_	0	SENT_107	[p6l1918t3468r2134b3547, p6l11t3597r362b3697],
27	efavirenz	NN	O	efavirenz	conj_and	25	SENT_107	[p6l405t3595r820b3692],
28	,	,	O	,	_	0	SENT_107	[p6l405t3595r820b3692],
29	and	CC	O	and	_	0	SENT_107	[p6l862t3596r1020b3675],
30	the	DT	O	the	det	32	SENT_107	[p6l1057t3596r1190b3675],
31	respective	JJ	O	respective	amod	32	SENT_107	[p6l1227t3597r1652b3696],
32	backbonetherapy	JJ	O	backbonetherapy	conj_and	25	SENT_107	[p6l1690t3596r2134b3675, p7l11t20r339b119],

1	components	NNS	O	component	_	0	SENT_108	[p7l387t36r923b119],
2	(	CD	NUMBER	(	num	3	SENT_108	[p7l982t20r1925b110],
3	abacavir	NN	O	abacavir	dep	1	SENT_108	[p7l982t20r1925b110],
4	—	CD	NUMBER	—	num	5	SENT_108	[p7l982t20r1925b110],
5	lamivudine	NN	O	lamivudine	dep	3	SENT_108	[p7l982t20r1925b110],
6	and	CC	O	and	_	0	SENT_108	[p7l1976t20r2136b98],
7	tenofovir	NN	O	tenofovir	nn	8	SENT_108	[p7l11t147r400b227],
8	DF	NN	O	df	dep	3	SENT_108	[p7l424t148r1205b239],
9	—	CD	NUMBER	—	num	11	SENT_108	[p7l424t148r1205b239],
10	emtricitabine	NN	O	emtricitabine	nn	11	SENT_108	[p7l424t148r1205b239],
11	)	NN	O	)	dep	1	SENT_108	[p7l424t148r1205b239],
12	during	IN	O	during	_	0	SENT_108	[p7l1240t148r1529b249],
13	the	DT	O	the	det	15	SENT_108	[p7l1555t148r1687b226],
14	treatment	NN	O	treatment	nn	15	SENT_108	[p7l1716t165r2140b226],
15	period	NN	O	period	prep_during	11	SENT_108	[p7l9t276r310b376],
16	.	.	O	.	_	0	SENT_108	[p7l9t276r310b376],

1	(	NN	O	(	npadvmod	10	SENT_109	[p7l361t283r533b367],
2	For	IN	O	for	_	0	SENT_109	[p7l361t283r533b367],
3	full	JJ	O	full	amod	4	SENT_109	[p7l571t275r719b355],
4	details	NNS	O	detail	prep_for	10	SENT_109	[p7l761t276r1043b355],
5	of	IN	O	of	_	0	SENT_109	[p7l1087t275r1187b355],
6	the	DT	O	the	det	8	SENT_109	[p7l1210t276r1343b354],
7	study	NN	O	study	nn	8	SENT_109	[p7l1386t276r1616b376],
8	design	NN	O	design	prep_of	4	SENT_109	[p7l1653t276r1957b377],
9	,	,	O	,	_	0	SENT_109	[p7l1653t276r1957b377],
10	see	VB	O	see	_	0	SENT_109	[p7l2006t302r2135b354],
11	the	DT	O	the	det	12	SENT_109	[p7l11t404r143b482],
12	protocol	NN	O	protocol	dobj	10	SENT_109	[p7l203t404r564b503],
13	and	CC	O	and	_	0	SENT_109	[p7l625t404r783b482],
14	the	DT	O	the	det	17	SENT_109	[p7l844t404r977b482],
15	statistical	JJ	O	statistical	amod	17	SENT_109	[p7l1039t404r1456b482],
16	analysis	NN	O	analysis	nn	17	SENT_109	[p7l1516t404r1856b503],
17	plan	NN	O	plan	conj_and	12	SENT_109	[p7l1918t404r2130b503],
18	,	,	O	,	_	0	SENT_109	[p7l1918t404r2130b503],
19	available	JJ	O	available	rcmod	12	SENT_109	[p7l10t532r381b611],
20	at	IN	O	at	dep	19	SENT_109	[p7l415t549r495b610],
21	N	NN	O	n	nn	22	SENT_109	[p7l522t539r597b611],
22	EJM.org	NN	O	ejm.org	pobj	20	SENT_109	[p7l600t538r994b633],
23	.	.	O	.	_	0	SENT_109	[p7l600t538r994b633],
24	)	SYM	O	)	dep	12	SENT_109	[p7l600t538r994b633],

1	ASSESSMENTS	NNS	O	assessment	nsubjpass	5	SENT_110	[p7l8t807r575b857],
2	Study	NNP	O	Study	nn	3	SENT_110	[p7l12t906r250b1005],
3	visits	NNS	O	visit	dep	1	SENT_110	[p7l296t907r515b985],
4	were	VBD	O	be	auxpass	5	SENT_110	[p7l569t932r771b985],
5	scheduled	VBN	O	schedule	_	0	SENT_110	[p7l829t906r1256b985],
6	at	IN	O	at	_	0	SENT_110	[p7l1311t923r1390b983],
7	baseline	NN	O	baseline	prep_at	5	SENT_110	[p7l1441t906r1794b984],
8	and	CC	O	and	_	0	SENT_110	[p7l1849t906r2007b984],
9	at	IN	O	at	_	0	SENT_110	[p7l2061t922r2140b984],
10	Weeks	NNS	DURATION	week	xcomp	5	SENT_110	[p7l6t1033r267b1113],
11	2	CD	NUMBER	2	num	10	SENT_110	[p7l299t1039r371b1129],
12	,	,	O	,	_	0	SENT_110	[p7l299t1039r371b1129],
13	4	CD	NUMBER	4	num	10	SENT_110	[p7l405t1039r476b1129],
14	,	,	O	,	_	0	SENT_110	[p7l405t1039r476b1129],
15	8	CD	NUMBER	8	num	10	SENT_110	[p7l513t1039r583b1129],
16	,	,	O	,	_	0	SENT_110	[p7l513t1039r583b1129],
17	12	CD	NUMBER	12	num	10	SENT_110	[p7l622t1039r744b1129],
18	,	,	O	,	_	0	SENT_110	[p7l622t1039r744b1129],
19	16	CD	NUMBER	16	num	10	SENT_110	[p7l783t1039r900b1129],
20	,	,	O	,	_	0	SENT_110	[p7l783t1039r900b1129],
21	24	CD	NUMBER	24	num	10	SENT_110	[p7l936t1039r1055b1129],
22	,	,	O	,	_	0	SENT_110	[p7l936t1039r1055b1129],
23	32	CD	NUMBER	32	num	10	SENT_110	[p7l1092t1039r1212b1129],
24	,	,	O	,	_	0	SENT_110	[p7l1092t1039r1212b1129],
25	40	CD	NUMBER	40	num	10	SENT_110	[p7l1246t1039r1372b1129],
26	,	,	O	,	_	0	SENT_110	[p7l1246t1039r1372b1129],
27	and	CC	NUMBER	and	_	0	SENT_110	[p7l1406t1033r1565b1112],
28	48	CD	NUMBER	48	xcomp	5	SENT_110	[p7l1593t1039r1720b1112],
29	.	.	O	.	_	0	SENT_110	[p7l1593t1039r1720b1112],

1	After	IN	O	after	_	0	SENT_111	[p7l1752t1032r1975b1111],
2	the	DT	DATE	the	det	5	SENT_111	[p7l2003t1033r2135b1111],
3	Week	NN	DATE	week	nn	5	SENT_111	[p7l6t1162r229b1241],
4	48	CD	NUMBER	48	num	5	SENT_111	[p7l271t1168r372b1240],
5	visit	NN	O	visit	prep_after	8	SENT_111	[p7l418t1163r618b1257],
6	,	,	O	,	_	0	SENT_111	[p7l418t1163r618b1257],
7	participants	NNS	O	participant	nsubj	8	SENT_111	[p7l670t1163r1187b1261],
8	continued	VBD	O	continue	_	0	SENT_111	[p7l1238t1162r1667b1241],
9	to	TO	O	to	aux	10	SENT_111	[p7l1715t1178r1797b1240],
10	receive	VB	O	receive	xcomp	8	SENT_111	[p7l1846t1163r2135b1241],
11	blinded	JJ	O	blinded	amod	12	SENT_111	[p7l11t1290r328b1369],
12	treatment	NN	O	treatment	dobj	10	SENT_111	[p7l356t1307r771b1368],
13	until	IN	O	until	_	0	SENT_111	[p7l793t1290r992b1369],
14	Week	NN	DATE	week	prep_until	10	SENT_111	[p7l1014t1290r1235b1369],
15	96	CD	DATE	96	num	14	SENT_111	[p7l1257t1296r1379b1386],
16	,	,	O	,	_	0	SENT_111	[p7l1257t1296r1379b1386],
17	with	IN	O	with	_	0	SENT_111	[p7l1407t1290r1599b1369],
18	visits	NNS	O	visit	prep_with	8	SENT_111	[p7l1622t1291r1835b1369],
19	scheduled	VBN	O	schedule	partmod	18	SENT_111	[p7l1866t1290r2134b1369, p7l10t1418r192b1498],
20	every	DT	O	every	det	22	SENT_111	[p7l229t1444r451b1518],
21	12	CD	NUMBER	12	num	22	SENT_111	[p7l487t1424r585b1496],
22	vveeks	NNS	O	vveek	dobj	19	SENT_111	[p7l618t1418r904b1498],
23	.	.	O	.	_	0	SENT_111	[p7l618t1418r904b1498],

1	On	IN	O	on	_	0	SENT_112	[p7l946t1424r1073b1497],
2	completion	NN	O	completion	prep_on	13	SENT_112	[p7l1111t1418r1595b1518],
3	of	IN	O	of	_	0	SENT_112	[p7l1632t1417r1732b1497],
4	the	DT	DATE	the	det	7	SENT_112	[p7l1751t1418r1884b1496],
5	Week	NN	DATE	week	nn	7	SENT_112	[p7l1916t1418r2140b1498],
6	96	CD	NUMBER	96	num	7	SENT_112	[p7l10t1552r111b1625],
7	visit	NN	O	visit	prep_of	2	SENT_112	[p7l143t1547r343b1642],
8	,	,	O	,	_	0	SENT_112	[p7l143t1547r343b1642],
9	all	PDT	O	all	predet	11	SENT_112	[p7l384t1546r489b1624],
10	the	DT	O	the	det	11	SENT_112	[p7l525t1546r658b1624],
11	participants	NNS	O	participant	nsubjpass	13	SENT_112	[p7l693t1547r1210b1646],
12	were	VBD	O	be	auxpass	13	SENT_112	[p7l1244t1572r1446b1626],
13	offered	VBN	O	offer	_	0	SENT_112	[p7l1484t1545r1790b1625],
14	the	DT	O	the	det	15	SENT_112	[p7l1826t1546r1959b1624],
15	opportunity	NN	O	opportunity	dobj	13	SENT_112	[p7l1996t1572r2134b1646, p7l8t1676r421b1774],
16	to	TO	O	to	aux	17	SENT_112	[p7l464t1692r546b1753],
17	continue	VB	O	continue	infmod	15	SENT_112	[p7l596t1676r970b1754],
18	the	DT	O	the	det	19	SENT_112	[p7l1018t1675r1151b1753],
19	treatment	NN	O	treatment	dobj	17	SENT_112	[p7l1199t1691r1624b1753],
20	until	IN	O	until	_	0	SENT_112	[p7l1667t1675r1870b1754],
21	Week	NN	DURATION	week	prep_until	17	SENT_112	[p7l1913t1675r2140b1754],
22	144	CD	NUMBER	144	num	21	SENT_112	[p7l14t1808r164b1881],
23	in	IN	O	in	_	0	SENT_112	[p7l204t1803r288b1880],
24	an	DT	O	a	det	28	SENT_112	[p7l329t1828r433b1880],
25	open	JJ	O	open	amod	28	SENT_112	[p7l475t1802r934b1902],
26	—	NN	O	—	nn	28	SENT_112	[p7l475t1802r934b1902],
27	label	NN	O	label	nn	28	SENT_112	[p7l475t1802r934b1902],
28	fashion	NN	O	fashion	prep_in	21	SENT_112	[p7l975t1801r1325b1881],
29	.	.	O	.	_	0	SENT_112	[p7l975t1801r1325b1881],

1	The	DT	O	the	det	5	SENT_113	[p7l1368t1802r1531b1880],
2	Abbott	NNP	MISC	Abbott	nn	5	SENT_113	[p7l1569t1802r1875b1881],
3	RealTime	NNP	MISC	RealTime	nn	5	SENT_113	[p7l1910t1802r2134b1886, p7l7t1932r230b2009],
4	HIV-1	NN	MISC	hiv-1	nn	5	SENT_113	[p7l264t1937r514b2009],
5	assay	NN	O	assay	nsubjpass	7	SENT_113	[p7l548t1957r780b2030],
6	was	VBD	O	be	auxpass	7	SENT_113	[p7l807t1957r971b2010],
7	used	VBN	O	use	_	0	SENT_113	[p7l1008t1931r1209b2010],
8	to	TO	O	to	aux	9	SENT_113	[p7l1244t1948r1326b2009],
9	detect	VB	O	detect	xcomp	7	SENT_113	[p7l1363t1931r1628b2009],
10	the	DT	O	the	det	12	SENT_113	[p7l1658t1931r1793b2009],
11	plasma	NN	O	plasma	nn	12	SENT_113	[p7l1827t1931r2138b2030],
12	level	NN	O	level	dobj	9	SENT_113	[p7l9t2059r198b2139],
13	of	IN	O	of	_	0	SENT_113	[p7l239t2058r339b2138],
14	HIV-1	NN	O	hiv-1	nn	15	SENT_113	[p7l360t2065r604b2138],
15	RNA	NN	O	rna	prep_of	12	SENT_113	[p7l644t2066r854b2143],
16	(	CD	NUMBER	(	num	18	SENT_113	[p7l896t2059r1162b2150],
17	lower	JJR	O	lower	amod	18	SENT_113	[p7l896t2059r1162b2150],
18	limit	NN	O	limit	tmod	9	SENT_113	[p7l1198t2059r1408b2137],
19	of	IN	O	of	_	0	SENT_113	[p7l1444t2058r1544b2138],
20	detection	NN	O	detection	prep_of	18	SENT_113	[p7l1567t2059r1988b2154],
21	,	,	O	,	_	0	SENT_113	[p7l1567t2059r1988b2154],
22	40	CD	NUMBER	40	num	23	SENT_113	[p7l2032t2065r2135b2138],
23	copies	NNS	O	copy	appos	20	SENT_113	[p7l12t2189r277b2287],
24	per	IN	O	per	_	0	SENT_113	[p7l331t2214r470b2287],
25	milliliter	NN	O	milliliter	nn	26	SENT_113	[p7l521t2188r952b2278],
26	)	NN	O	)	prep_per	23	SENT_113	[p7l521t2188r952b2278],
27	.	.	O	.	_	0	SENT_113	[p7l521t2188r952b2278],

1	CD4	NN	O	cd4	nsubjpass	6	SENT_114	[p7l1011t2194r1257b2266],
2	+	CC	O	+	_	0	SENT_114	[p7l1011t2194r1257b2266],
3	T-cell	NN	O	t-cell	nn	4	SENT_114	[p7l1307t2188r1543b2266],
4	counts	NNS	O	count	conj_+	1	SENT_114	[p7l1597t2205r1880b2267],
5	were	VBD	O	be	auxpass	6	SENT_114	[p7l1931t2214r2133b2267],
6	assessed	VBN	O	assess	_	0	SENT_114	[p7l11t2315r379b2394],
7	by	IN	O	by	_	0	SENT_114	[p7l412t2315r509b2415],
8	means	NNS	O	means	_	0	SENT_114	[p7l537t2341r816b2393],
9	of	IN	O	of	_	0	SENT_114	[p7l851t2314r951b2394],
10	flow	NN	O	flow	nn	11	SENT_114	[p7l965t2314r1163b2395],
11	cytometry	NN	O	cytometry	prep_by_means_of	6	SENT_114	[p7l1192t2332r1627b2415],
12	in	IN	O	in	_	0	SENT_114	[p7l1654t2316r1737b2393],
13	a	DT	O	a	det	15	SENT_114	[p7l1769t2341r1813b2393],
14	central	JJ	O	central	amod	15	SENT_114	[p7l1845t2315r2134b2393],
15	laboratory	NN	O	laboratory	prep_in	6	SENT_114	[p7l10t2444r459b2543],
16	.	.	O	.	_	0	SENT_114	[p7l10t2444r459b2543],

1	Adverse	JJ	O	adverse	amod	2	SENT_115	[p7l492t2444r820b2523],
2	events	NNS	O	event	nsubj	11	SENT_115	[p7l852t2460r1133b2539],
3	,	,	O	,	_	0	SENT_115	[p7l852t2460r1133b2539],
4	serious	JJ	O	serious	amod	6	SENT_115	[p7l1172t2445r1466b2523],
5	adverse	JJ	O	adverse	amod	6	SENT_115	[p7l1499t2444r1807b2523],
6	events	NNS	O	event	conj_and	2	SENT_115	[p7l1840t2461r2128b2539],
7	,	,	O	,	_	0	SENT_115	[p7l1840t2461r2128b2539],
8	and	CC	O	and	_	0	SENT_115	[p7l11t2572r168b2651],
9	laboratory	NN	O	laboratory	nn	10	SENT_115	[p7l214t2572r661b2672],
10	measurements	NNS	O	measurement	conj_and	2	SENT_115	[p7l703t2589r1330b2651],
11	(	VBP	O	(	_	0	SENT_115	[p7l1384t2572r1823b2673],
12	including	VBG	O	include	_	0	SENT_115	[p7l1384t2572r1823b2673],
13	hematologic	JJ	O	hematologic	amod	14	SENT_115	[p7l1867t2572r2132b2651, p7l12t2700r305b2801],
14	measurements	NNS	O	measurement	prep_including	11	SENT_115	[p7l346t2717r999b2796],
15	,	,	O	,	_	0	SENT_115	[p7l346t2717r999b2796],
16	fasting	VBG	O	fast	amod	18	SENT_115	[p7l1046t2699r1347b2801],
17	lipid	NN	O	lipid	nn	18	SENT_115	[p7l1385t2700r1576b2800],
18	profile	NN	O	profile	appos	14	SENT_115	[p7l1617t2699r1928b2800],
19	,	,	O	,	_	0	SENT_115	[p7l1617t2699r1928b2800],
20	and	CC	O	and	_	0	SENT_115	[p7l1975t2700r2133b2779],
21	blood	NN	O	blood	nn	22	SENT_115	[p7l12t2827r697b2927],
22	—	NN	O	—	nsubjpass	32	SENT_115	[p7l12t2827r697b2927],
23	chemistry	NN	O	chemistry	nn	25	SENT_115	[p7l12t2827r697b2927],
24	profile	NN	O	profile	nn	25	SENT_115	[p7l719t2826r1018b2927],
25	)	NN	O	)	dep	22	SENT_115	[p7l719t2826r1018b2927],
26	were	VBD	O	be	auxpass	27	SENT_115	[p7l1047t2853r1244b2907],
27	assessed	VBN	O	assess	conj_and	11	SENT_115	[p7l1271t2827r1627b2906],
28	at	IN	O	at	_	0	SENT_115	[p7l1654t2844r1731b2905],
29	each	DT	O	each	det	30	SENT_115	[p7l1755t2827r1941b2905],
30	visit	NN	O	visit	prep_at	27	SENT_115	[p7l1965t2828r2138b2907],
31	and	CC	O	and	_	0	SENT_115	[p7l11t2956r168b3035],
32	graded	VBN	O	grade	conj_and	11	SENT_115	[p7l207t2956r501b3057],
33	according	VBG	O	accord	_	0	SENT_115	[p7l540t2956r967b3057],
34	to	TO	O	to	prepc_according_to	32	SENT_115	[p7l1003t2973r1084b3035],
35	the	DT	O	the	det	36	SENT_115	[p7l1124t2956r1257b3034],
36	criteria	NNS	O	criterion	pobj	32	SENT_115	[p7l1297t2957r1601b3035],
37	of	IN	O	of	_	0	SENT_115	[p7l1639t2955r1738b3035],
38	the	DT	O	the	det	39	SENT_115	[p7l1760t2956r1892b3035],
39	Division	NN	O	division	prep_of	36	SENT_115	[p7l1930t2957r2132b3035, p7l12t3084r185b3162],
40	of	IN	O	of	_	0	SENT_115	[p7l213t3082r312b3162],
41	the	DT	O	the	det	44	SENT_115	[p7l322t3083r452b3161],
42	Acquired	VBN	O	acquire	amod	44	SENT_115	[p7l476t3083r858b3183],
43	Immunodeficiency	NN	O	immunodeficiency	nn	44	SENT_115	[p7l885t3082r1685b3183],
44	Syndrome	NN	O	syndrome	prep_of	39	SENT_115	[p7l1711t3083r2133b3183],
45	at	IN	O	at	_	0	SENT_115	[p7l11t3229r89b3290],
46	the	DT	O	the	det	48	SENT_115	[p7l114t3212r246b3291],
47	National	NNP	ORGANIZATION	National	nn	48	SENT_115	[p7l274t3212r647b3291],
48	Institute	NNP	ORGANIZATION	Institute	prep_at	44	SENT_115	[p7l674t3213r1038b3291],
49	of	IN	ORGANIZATION	of	_	0	SENT_115	[p7l1068t3211r1168b3291],
50	Allergy	NNP	ORGANIZATION	Allergy	prep_of	48	SENT_115	[p7l1175t3212r1490b3313],
51	and	CC	O	and	_	0	SENT_115	[p7l1515t3212r1672b3291],
52	Infectious	JJ	O	infectious	amod	53	SENT_115	[p7l1699t3211r2131b3291],
53	Diseases	NNS	O	disease	prep_at	44	SENT_115	[p7l9t3341r379b3419],
54	of	IN	O	of	_	0	SENT_115	[p7l417t3339r517b3419],
55	the	DT	O	the	det	57	SENT_115	[p7l533t3340r665b3418],
56	National	NNP	ORGANIZATION	National	nn	57	SENT_115	[p7l698t3340r1071b3419],
57	Institutes	NNPS	ORGANIZATION	Institutes	prep_of	53	SENT_115	[p7l1104t3341r1511b3419],
58	of	IN	ORGANIZATION	of	_	0	SENT_115	[p7l1548t3339r1648b3419],
59	Health	NNP	ORGANIZATION	Health	prep_of	44	SENT_115	[p7l1664t3340r2053b3419],
60	.	.	O	.	_	0	SENT_115	[p7l1664t3340r2053b3419],

1	“	NN	O	“	_	0	SENT_116	[p7l1664t3340r2053b3419],

1	Viral	JJ	O	viral	amod	2	SENT_117	[p7l136t3468r343b3547],
2	genotype	NN	O	genotype	nsubjpass	4	SENT_117	[p7l381t3485r774b3569],
3	was	VBD	O	be	auxpass	4	SENT_117	[p7l809t3494r971b3547],
4	analyzed	VBN	O	analyze	_	0	SENT_117	[p7l1011t3468r1390b3568],
5	(	RB	O	(	advmod	4	SENT_117	[p7l1433t3474r1710b3566],
6	Quest	NNP	ORGANIZATION	Quest	nn	8	SENT_117	[p7l1433t3474r1710b3566],
7	Diagnostics	NNPS	ORGANIZATION	Diagnostics	nn	8	SENT_117	[p7l1742t3469r2132b3569, p7l12t3597r179b3687],
8	)	NN	O	)	dobj	4	SENT_117	[p7l1742t3469r2132b3569, p7l12t3597r179b3687],
9	at	IN	O	at	_	0	SENT_117	[p7l220t3613r298b3674],
10	the	DT	O	the	det	12	SENT_117	[p7l330t3596r460b3675],
11	screening	JJ	O	screening	amod	12	SENT_117	[p7l499t3597r907b3697],
12	visit	NN	O	visit	prep_at	4	SENT_117	[p7l937t3597r1131b3675],
13	.	.	O	.	_	0	SENT_117	[p7l937t3597r1131b3675],

1	Samples	NNS	O	sample	nsubjpass	6	SENT_118	[p7l1176t3596r1521b3696],
2	for	IN	O	for	_	0	SENT_118	[p7l1560t3595r1681b3675],
3	resistance	NN	O	resistance	nn	4	SENT_118	[p7l1715t3597r2133b3674],
4	testing	NN	O	testing	prep_for	1	SENT_118	[p8l12t21r309b121],
5	were	VBD	O	be	auxpass	6	SENT_118	[p8l335t46r536b99],
6	obtained	VBN	O	obtain	_	0	SENT_118	[p8l571t20r949b99],
7	at	IN	O	at	_	0	SENT_118	[p8l982t37r1061b98],
8	baseline	NN	O	baseline	prep_at	6	SENT_118	[p8l1090t20r1442b99],
9	and	CC	O	and	_	0	SENT_118	[p8l1475t20r1633b99],
10	at	IN	O	at	_	0	SENT_118	[p8l1666t37r1744b98],
11	the	DT	O	the	det	12	SENT_118	[p8l1774t20r1906b99],
12	time	NN	O	time	prep_at	6	SENT_118	[p8l1940t21r2133b98],
13	of	IN	O	of	_	0	SENT_118	[p8l12t147r112b227],
14	protocol	NN	O	protocol	prep_of	12	SENT_118	[p8l136t147r862b248],
15	—	RB	O	—	advmod	16	SENT_118	[p8l136t147r862b248],
16	defined	VBN	O	define	partmod	14	SENT_118	[p8l136t147r862b248],
17	Virologic	JJ	ORGANIZATION	virologic	amod	18	SENT_118	[p8l902t148r1279b249],
18	failure	NN	O	failure	dobj	16	SENT_118	[p8l1324t147r1600b227],
19	(	RB	O	(	advmod	20	SENT_118	[p8l1650t147r2002b239],
20	defined	VBN	O	define	partmod	18	SENT_118	[p8l1650t147r2002b239],
21	as	IN	O	as	_	0	SENT_118	[p8l2046t174r2131b226],
22	two	CD	NUMBER	two	num	26	SENT_118	[p8l12t293r171b355],
23	consecutive	JJ	O	consecutive	amod	26	SENT_118	[p8l227t277r735b355],
24	HIV-1	NN	O	hiv-1	nn	26	SENT_118	[p8l788t282r1038b355],
25	RNA	NN	O	rna	nn	26	SENT_118	[p8l1090t283r1302b359],
26	Values	NNS	O	value	prep_as	20	SENT_118	[p8l1347t276r1616b355],
27	of	IN	O	of	_	0	SENT_118	[p8l1672t275r1773b355],
28	at	IN	O	at	quantmod	30	SENT_118	[p8l1807t293r1887b354],
29	least	JJS	O	least	mwe	28	SENT_118	[p8l1934t276r2138b354],
30	50	CD	NUMBER	50	num	31	SENT_118	[p8l13t409r112b482],
31	copies	NNS	O	copy	prep_of	26	SENT_118	[p8l175t404r440b503],
32	per	IN	O	per	_	0	SENT_118	[p8l500t429r640b503],
33	milliliter	NN	O	milliliter	prep_per	31	SENT_118	[p8l696t403r1079b481],
34	on	IN	O	on	_	0	SENT_118	[p8l1136t429r1242b482],
35	or	CC	O	or	_	0	SENT_118	[p8l1302t429r1391b482],
36	after	IN	O	after	_	0	SENT_118	[p8l1446t402r1649b481],
37	week	NN	DURATION	week	nn	39	SENT_118	[p8l1700t403r1924b483],
38	24	CD	NUMBER	24	num	39	SENT_118	[p8l1978t409r2128b494],
39	)	NN	O	)	prep_after	20	SENT_118	[p8l1978t409r2128b494],
40	.	.	O	.	_	0	SENT_118	[p8l1978t409r2128b494],

1	Participants	NNS	O	participant	nsubjpass	3	SENT_119	[p8l10t532r524b631],
2	were	VBD	O	be	auxpass	3	SENT_119	[p8l558t557r759b611],
3	required	VBN	O	require	_	0	SENT_119	[p8l795t531r1157b631],
4	to	TO	O	to	aux	5	SENT_119	[p8l1193t548r1275b610],
5	withdraw	VB	O	withdraw	xcomp	3	SENT_119	[p8l1307t531r1722b611],
6	from	IN	O	from	_	0	SENT_119	[p8l1754t530r1964b610],
7	the	DT	O	the	det	8	SENT_119	[p8l2001t531r2133b609],
8	study	NN	O	study	prep_from	5	SENT_119	[p8l12t660r242b760],
9	if	IN	O	if	mark	16	SENT_119	[p8l297t659r375b738],
10	protocol	NN	O	protocol	nsubjpass	16	SENT_119	[p8l416t659r1141b760],
11	—	CD	NUMBER	—	num	10	SENT_119	[p8l416t659r1141b760],
12	def1ned	VBN	O	def1ne	partmod	10	SENT_119	[p8l416t659r1141b760],
13	virologic	JJ	O	virologic	amod	14	SENT_119	[p8l1197t660r1575b761],
14	failure	NN	O	failure	dobj	12	SENT_119	[p8l1635t659r1912b739],
15	was	VBD	O	be	auxpass	16	SENT_119	[p8l1969t686r2131b739],
16	confirmed	VBN	O	confirm	advcl	5	SENT_119	[p8l12t787r465b867],
17	before	IN	O	before	_	0	SENT_119	[p8l497t787r766b867],
18	week	NN	DURATION	week	prep_before	16	SENT_119	[p8l794t788r1017b867],
19	48	CD	NUMBER	48	num	18	SENT_119	[p8l1043t794r1169b867],
20	.	.	O	.	_	0	SENT_119	[p8l1043t794r1169b867],

1	Testing	VBG	O	test	csubj	10	SENT_120	[p8l1203t789r1524b889],
2	for	IN	O	for	_	0	SENT_120	[p8l1552t787r1676b867],
3	resistance	NN	O	resistance	prep_for	1	SENT_120	[p8l1704t789r2133b866],
4	in	IN	O	in	_	0	SENT_120	[p8l11t916r94b993],
5	all	DT	O	all	det	6	SENT_120	[p8l154t915r259b993],
6	participants	NNS	O	participant	prep_in	3	SENT_120	[p8l318t916r835b1015],
7	with	IN	O	with	_	0	SENT_120	[p8l893t915r1089b995],
8	protocol	NN	O	protocol	prep_with	1	SENT_120	[p8l1148t914r1875b1015],
9	—	RB	O	—	advmod	1	SENT_120	[p8l1148t914r1875b1015],
10	defined	VBD	O	define	_	0	SENT_120	[p8l1148t914r1875b1015],
11	virologic	JJ	O	virologic	amod	12	SENT_120	[p8l1931t916r2132b995, p8l10t1044r217b1145],
12	failure	NN	O	failure	nsubj	13	SENT_120	[p8l283t1043r560b1123],
13	included	VBD	O	include	ccomp	10	SENT_120	[p8l626t1044r993b1123],
14	determination	NN	O	determination	nsubj	31	SENT_120	[p8l1059t1044r1675b1123],
15	of	IN	O	of	_	0	SENT_120	[p8l1742t1043r1841b1123],
16	HIV-1	NN	O	hiv-1	nn	17	SENT_120	[p8l1889t1050r2133b1123],
17	reVerse	NN	O	reverse	prep_of	14	SENT_120	[p8l11t1173r888b1272],
18	—	CD	NUMBER	—	num	19	SENT_120	[p8l11t1173r888b1272],
19	transcriptase	NN	O	transcriptase	dep	17	SENT_120	[p8l11t1173r888b1272],
20	and	CC	O	and	_	0	SENT_120	[p8l928t1172r1084b1251],
21	integrase	NN	O	integrase	nn	22	SENT_120	[p8l1124t1173r1511b1273],
22	genotype	NN	O	genotype	prep_of	14	SENT_120	[p8l1551t1189r1938b1273],
23	and	CC	O	and	_	0	SENT_120	[p8l1978t1172r2134b1251],
24	phenotype	NN	O	phenotype	conj_and	22	SENT_120	[p8l9t1299r462b1399],
25	with	IN	O	with	_	0	SENT_120	[p8l516t1299r711b1379],
26	the	DT	O	the	det	27	SENT_120	[p8l770t1299r902b1377],
27	use	NN	O	use	prep_with	22	SENT_120	[p8l961t1325r1101b1378],
28	of	IN	O	of	_	0	SENT_120	[p8l1160t1298r1261b1378],
29	commercial	JJ	O	commercial	amod	30	SENT_120	[p8l1301t1299r1809b1378],
30	assays	NNS	O	assay	prep_of	27	SENT_120	[p8l1866t1325r2131b1399],
31	(	VBP	O	(	ccomp	13	SENT_120	[p8l16t1435r532b1529],
32	Monogram	NNP	ORGANIZATION	Monogram	nn	34	SENT_120	[p8l16t1435r532b1529],
33	Biosciences	NNP	ORGANIZATION	Biosciences	nn	34	SENT_120	[p8l607t1429r1163b1519],
34	)	NN	O	)	dobj	31	SENT_120	[p8l607t1429r1163b1519],
35	.	.	O	.	_	0	SENT_120	[p8l607t1429r1163b1519],

1	Participant	NN	O	participant	nn	2	SENT_121	[p8l1244t1428r2134b1528],
2	—	NN	O	—	nsubj	3	SENT_121	[p8l1244t1428r2134b1528],
3	reported	VBD	O	report	dep	9	SENT_121	[p8l1244t1428r2134b1528],
4	measures	NNS	O	measure	dobj	3	SENT_121	[p8l11t1582r419b1635],
5	of	IN	O	of	_	0	SENT_121	[p8l453t1555r553b1635],
6	health	NN	O	health	nn	7	SENT_121	[p8l566t1556r836b1635],
7	outcomes	NNS	O	outcome	prep_of	4	SENT_121	[p8l869t1573r1280b1635],
8	were	VBD	O	be	auxpass	9	SENT_121	[p8l1309t1582r1511b1635],
9	assessed	VBN	O	assess	_	0	SENT_121	[p8l1542t1556r1911b1635],
10	with	IN	O	with	_	0	SENT_121	[p8l1938t1556r2133b1635],
11	the	DT	O	the	det	12	SENT_121	[p8l12t1683r144b1761],
12	use	NN	O	use	prep_with	9	SENT_121	[p8l198t1709r338b1763],
13	of	IN	O	of	_	0	SENT_121	[p8l392t1682r492b1762],
14	the	DT	O	the	det	17	SENT_121	[p8l527t1683r659b1761],
15	20	CD	NUMBER	20	number	16	SENT_121	[p8l712t1684r1064b1779],
16	—	CD	NUMBER	—	num	17	SENT_121	[p8l712t1684r1064b1779],
17	item	NN	O	item	prep_of	12	SENT_121	[p8l712t1684r1064b1779],
18	,	,	O	,	_	0	SENT_121	[p8l712t1684r1064b1779],
19	self	NN	O	self	nn	20	SENT_121	[p8l1124t1682r1670b1783],
20	—	NN	O	—	nsubj	21	SENT_121	[p8l1124t1682r1670b1783],
21	reported	VBD	O	report	parataxis	9	SENT_121	[p8l1124t1682r1670b1783],
22	Symptom	NNP	O	Symptom	nn	24	SENT_121	[p8l1725t1689r2133b1783],
23	Distress	NNP	O	Distress	nn	24	SENT_121	[p8l9t1812r355b1889],
24	Module	NNP	O	Module	nsubj	29	SENT_121	[p8l397t1811r721b1890],
25	at	IN	O	at	_	0	SENT_121	[p8l763t1827r842b1888],
26	baseline	NN	O	baseline	prep_at	24	SENT_121	[p8l880t1811r1231b1889],
27	and	CC	O	and	_	0	SENT_121	[p8l1273t1811r1431b1889],
28	at	IN	O	at	_	0	SENT_121	[p8l1473t1828r1552b1888],
29	Weeks	NNS	DURATION	week	xcomp	21	SENT_121	[p8l1584t1811r1845b1890],
30	4	CD	NUMBER	4	num	29	SENT_121	[p8l1889t1817r1960b1906],
31	,	,	O	,	_	0	SENT_121	[p8l1889t1817r1960b1906],
32	24	CD	NUMBER	24	num	29	SENT_121	[p8l2008t1817r2128b1906],
33	,	,	O	,	_	0	SENT_121	[p8l2008t1817r2128b1906],
34	48	CD	NUMBER	48	num	29	SENT_121	[p8l9t1945r136b2034],
35	,	,	O	,	_	0	SENT_121	[p8l9t1945r136b2034],
36	and	CC	NUMBER	and	_	0	SENT_121	[p8l180t1939r338b2017],
37	96	CD	NUMBER	96	conj_and	29	SENT_121	[p8l377t1945r501b2034],
38	,	,	O	,	_	0	SENT_121	[p8l377t1945r501b2034],
39	as	IN	O	as	mark	40	SENT_121	[p8l546t1965r631b2017],
40	described	VBN	O	describe	advcl	9	SENT_121	[p8l674t1939r1085b2017],
41	preViously	RB	DATE	previously	advmod	40	SENT_121	[p8l1123t1939r1738b2038],
42	.17	CD	NUMBER	.17	num	43	SENT_121	[p8l1123t1939r1738b2038],
43	>	JJR	O	>	dobj	40	SENT_121	[p8l1123t1939r1738b2038],
44	18	CD	NUMBER	18	nsubjpass	9	SENT_121	[p8l1123t1939r1738b2038],

1	STATISTICAL	JJ	O	statistical	amod	2	SENT_122	[p8l11t2213r499b2263],
2	ANALYSIS	NN	O	analysis	nsubj	57	SENT_122	[p8l529t2213r904b2263],
3	According	VBG	O	accord	_	0	SENT_122	[p8l7t2312r454b2413],
4	to	TO	O	to	prepc_according_to	10	SENT_122	[p8l510t2329r591b2391],
5	the	DT	O	the	det	6	SENT_122	[p8l652t2312r784b2391],
6	protocol	NN	O	protocol	pobj	10	SENT_122	[p8l841t2312r1225b2412],
7	,	,	O	,	_	0	SENT_122	[p8l841t2312r1225b2412],
8	we	PRP	O	we	nsubj	10	SENT_122	[p8l1284t2338r1402b2391],
9	could	MD	O	could	aux	10	SENT_122	[p8l1462t2312r1696b2391],
10	conclude	VB	O	conclude	rcmod	2	SENT_122	[p8l1755t2312r2133b2391],
11	that	IN	O	that	complm	20	SENT_122	[p8l12t2440r187b2518],
12	treatment	NN	O	treatment	nsubj	20	SENT_122	[p8l227t2457r659b2518],
13	with	IN	O	with	_	0	SENT_122	[p8l694t2440r893b2519],
14	dolutegravir	NN	O	dolutegravir	prep_with	12	SENT_122	[p8l938t2440r1473b2541],
15	and	CC	O	and	_	0	SENT_122	[p8l1514t2440r1674b2519],
16	abacaVir	NN	O	abacavir	nn	18	SENT_122	[p8l1718t2440r2137b2519],
17	—	CD	NUMBER	—	num	18	SENT_122	[p8l1718t2440r2137b2519],
18	lamivudine	NN	O	lamivudine	conj_and	14	SENT_122	[p8l10t2568r497b2647],
19	was	VBD	O	be	cop	20	SENT_122	[p8l551t2594r713b2647],
20	noninferior	JJ	O	noninferior	ccomp	10	SENT_122	[p8l773t2567r1270b2647],
21	to	TO	O	to	_	0	SENT_122	[p8l1325t2585r1407b2647],
22	treatment	NN	O	treatment	prep_to	20	SENT_122	[p8l1466t2585r1890b2647],
23	with	IN	O	with	_	0	SENT_122	[p8l1938t2568r2133b2647],
24	efavirenz	NN	O	efavirenz	nn	27	SENT_122	[p8l12t2695r852b2775],
25	—	CD	NUMBER	—	num	27	SENT_122	[p8l12t2695r852b2775],
26	tenofovir	NN	O	tenofovir	nn	27	SENT_122	[p8l12t2695r852b2775],
27	DF	NN	O	df	prep_with	22	SENT_122	[p8l886t2696r1640b2775],
28	—	CD	NUMBER	—	num	29	SENT_122	[p8l886t2696r1640b2775],
29	emtricitabine	NN	O	emtricitabine	dep	38	SENT_122	[p8l886t2696r1640b2775],
30	if	IN	O	if	dep	38	SENT_122	[p8l1679t2695r1756b2774],
31	the	DT	O	the	det	33	SENT_122	[p8l1778t2696r1910b2775],
32	lower	JJR	O	lower	amod	33	SENT_122	[p8l1948t2696r2132b2775, p8l12t2849r92b2901],
33	boundary	NN	O	boundary	nsubj	38	SENT_122	[p8l136t2823r551b2923],
34	of	IN	O	of	_	0	SENT_122	[p8l592t2822r692b2902],
35	a	DT	O	a	det	36	SENT_122	[p8l718t2849r762b2901],
36	tWo	NN	NUMBER	two	prep_of	33	SENT_122	[p8l806t2823r1227b2903],
37	—	CD	NUMBER	—	num	36	SENT_122	[p8l806t2823r1227b2903],
38	sided	VBD	O	side	ccomp	20	SENT_122	[p8l806t2823r1227b2903],
39	95	CD	PERCENT	95	number	40	SENT_122	[p8l1272t2829r1456b2903],
40	%	NN	PERCENT	%	amod	42	SENT_122	[p8l1272t2829r1456b2903],
41	confidence	NN	O	confidence	nn	42	SENT_122	[p8l1502t2822r1973b2902],
42	interval	NN	O	interval	dobj	38	SENT_122	[p8l2018t2824r2132b2901, p8l12t2951r250b3030],
43	for	IN	O	for	_	0	SENT_122	[p8l282t2950r405b3030],
44	the	DT	O	the	det	45	SENT_122	[p8l435t2951r568b3029],
45	difference	NN	O	difference	prep_for	38	SENT_122	[p8l601t2950r1034b3030],
46	in	IN	O	in	_	0	SENT_122	[p8l1066t2952r1149b3029],
47	the	DT	O	the	det	50	SENT_122	[p8l1182t2951r1314b3029],
48	primary	JJ	O	primary	amod	50	SENT_122	[p8l1346t2952r1696b3051],
49	end	NN	O	end	nn	50	SENT_122	[p8l1725t2951r1877b3030],
50	point	NN	O	point	prep_in	45	SENT_122	[p8l1908t2952r2138b3051],
51	was	VBD	O	be	cop	57	SENT_122	[p8l7t3106r169b3159],
52	less	JJR	O	less	mwe	53	SENT_122	[p8l211t3080r366b3159],
53	than	IN	O	than	quantmod	54	SENT_122	[p8l409t3080r606b3158],
54	10	CD	PERCENT	10	num	56	SENT_122	[p8l649t3086r742b3159],
55	percentage	NN	PERCENT	percentage	nn	56	SENT_122	[p8l782t3097r1251b3181],
56	points	NNS	PERCENT	point	npadvmod	57	SENT_122	[p8l1291t3081r1560b3180],
57	lower	JJR	O	lower	_	0	SENT_122	[p8l1601t3080r1840b3159],
58	in	IN	O	in	_	0	SENT_122	[p8l1876t3081r1959b3158],
59	the	DT	O	the	det	60	SENT_122	[p8l2000t3080r2133b3158],
60	DTG	NN	O	dtg	prep_in	57	SENT_122	[p8l9t3214r687b3287],
61	.	.	O	.	_	0	SENT_122	[p8l9t3214r687b3287],

1	—	NN	O	—	_	0	SENT_123	[p8l9t3214r687b3287],
2	.	.	O	.	_	0	SENT_123	[p8l9t3214r687b3287],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_124	[p8l9t3214r687b3287],
2	.	.	O	.	_	0	SENT_124	[p8l9t3214r687b3287],

1	—	NN	O	—	_	0	SENT_125	[p8l9t3214r687b3287],
2	.	.	O	.	_	0	SENT_125	[p8l9t3214r687b3287],

1	3TC	NN	O	3tc	nn	2	SENT_126	[p8l9t3214r687b3287],
2	group	NN	O	group	_	0	SENT_126	[p8l719t3234r972b3309],
3	than	IN	O	than	dep	2	SENT_126	[p8l1004t3208r1200b3286],
4	in	IN	O	in	_	0	SENT_126	[p8l1230t3209r1313b3286],
5	the	DT	O	the	det	6	SENT_126	[p8l1343t3208r1476b3286],
6	EFV	NN	O	efv	prep_in	3	SENT_126	[p8l1505t3214r1778b3286],
7	.	.	O	.	_	0	SENT_126	[p8l1505t3214r1778b3286],

1	—	NN	O	—	_	0	SENT_127	[p8l1505t3214r1778b3286],
2	.	.	O	.	_	0	SENT_127	[p8l1505t3214r1778b3286],

1	T	NN	O	t	_	0	SENT_128	[p8l1505t3214r1778b3286],
2	DF	NN	O	df	dep	1	SENT_128	[p8l1779t3214r2071b3286],
3	.	.	O	.	_	0	SENT_128	[p8l1779t3214r2071b3286],

1	—	NN	O	—	_	0	SENT_129	[p8l1779t3214r2071b3286],
2	.	.	O	.	_	0	SENT_129	[p8l1779t3214r2071b3286],

1	FT	NNP	O	FT	nn	2	SENT_130	[p8l1779t3214r2071b3286],
2	C	NNP	O	C	_	0	SENT_130	[p8l2073t3214r2130b3287],
3	group	NN	O	group	dep	2	SENT_130	[p8l11t3362r286b3437],
4	.	.	O	.	_	0	SENT_130	[p8l11t3362r286b3437],

1	This	DT	O	this	det	2	SENT_131	[p8l344t3336r532b3414],
2	margin	NN	O	margin	nsubj	4	SENT_131	[p8l591t3337r906b3437],
3	is	VBZ	O	be	cop	4	SENT_131	[p8l963t3337r1029b3414],
4	consistent	JJ	O	consistent	_	0	SENT_131	[p8l1088t3337r1527b3415],
5	with	IN	O	with	_	0	SENT_131	[p8l1574t3336r1769b3415],
6	that	DT	O	that	prep_with	4	SENT_131	[p8l1827t3336r1999b3414],
7	in	IN	O	in	_	0	SENT_131	[p8l2050t3337r2133b3414],
8	other	JJ	O	other	amod	9	SENT_131	[p8l12t3464r239b3543],
9	trials	NNS	O	trial	prep_in	6	SENT_131	[p8l266t3464r485b3542],
10	in	IN	O	in	_	0	SENT_131	[p8l515t3465r599b3542],
11	this	DT	O	this	det	12	SENT_131	[p8l629t3464r788b3542],
12	population	NN	O	population	prep_in	9	SENT_131	[p8l818t3464r1386b3564],
13	.	.	O	.	_	0	SENT_131	[p8l818t3464r1386b3564],

1	”	NN	O	”	_	0	SENT_132	[p8l818t3464r1386b3564],
2	Assuming	VBG	O	assume	partmod	1	SENT_132	[p8l1411t3465r1853b3565],
3	a	DT	O	a	det	7	SENT_132	[p8l1878t3490r1923b3542],
4	75	CD	PERCENT	75	number	5	SENT_132	[p8l1951t3469r2134b3543],
5	%	NN	PERCENT	%	amod	7	SENT_132	[p8l1951t3469r2134b3543],
6	response	NN	O	response	nn	7	SENT_132	[p8l11t3618r392b3692],
7	rate	NN	O	rate	dobj	2	SENT_132	[p8l449t3609r609b3670],
8	in	IN	O	in	_	0	SENT_132	[p8l667t3593r750b3670],
9	the	DT	O	the	det	10	SENT_132	[p8l808t3592r940b3671],
10	EFV	NN	O	efv	prep_in	7	SENT_132	[p8l997t3598r1622b3671],
11	.	.	O	.	_	0	SENT_132	[p8l997t3598r1622b3671],

1	—	NN	O	—	_	0	SENT_133	[p8l997t3598r1622b3671],
2	.	.	O	.	_	0	SENT_133	[p8l997t3598r1622b3671],

1	TDF	NNP	O	TDF	_	0	SENT_134	[p8l997t3598r1622b3671],
2	.	.	O	.	_	0	SENT_134	[p8l997t3598r1622b3671],

1	—	NN	O	—	_	0	SENT_135	[p8l997t3598r1622b3671],
2	.	.	O	.	_	0	SENT_135	[p8l997t3598r1622b3671],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_136	[p8l997t3598r1622b3671],
2	group	NN	O	group	nsubj	44	SENT_136	[p8l1682t3618r1956b3693],
3	,	,	O	,	_	0	SENT_136	[p8l1682t3618r1956b3693],
4	we	PRP	O	we	nsubj	5	SENT_136	[p8l2015t3618r2133b3671],
5	calculated	VBD	O	calculate	parataxis	44	SENT_136	[p9l12t20r447b99],
6	that	IN	O	that	complm	14	SENT_136	[p9l503t20r675b98],
7	394	CD	NUMBER	394	num	8	SENT_136	[p9l728t26r879b99],
8	participants	NNS	O	participant	nsubj	14	SENT_136	[p9l934t21r1450b119],
9	who	WP	O	who	nsubjpass	12	SENT_136	[p9l1505t20r1688b99],
10	could	MD	O	could	aux	12	SENT_136	[p9l1746t20r1980b99],
11	be	VB	O	be	auxpass	12	SENT_136	[p9l2037t20r2133b98],
12	evaluated	VBN	O	evaluate	rcmod	8	SENT_136	[p9l12t149r414b228],
13	would	MD	O	would	aux	14	SENT_136	[p9l471t149r737b228],
14	need	VB	O	need	ccomp	5	SENT_136	[p9l799t149r1000b228],
15	to	TO	O	to	aux	17	SENT_136	[p9l1063t166r1145b228],
16	be	VB	O	be	auxpass	17	SENT_136	[p9l1209t149r1305b228],
17	included	VBN	O	include	xcomp	14	SENT_136	[p9l1367t149r1734b228],
18	in	IN	O	in	_	0	SENT_136	[p9l1796t150r1879b227],
19	each	DT	O	each	det	20	SENT_136	[p9l1942t149r2133b227],
20	group	NN	O	group	prep_in	17	SENT_136	[p9l11t303r263b378],
21	for	IN	O	for	_	0	SENT_136	[p9l301t276r425b356],
22	the	DT	O	the	det	23	SENT_136	[p9l459t277r591b355],
23	study	NN	O	study	prep_for	17	SENT_136	[p9l631t277r860b377],
24	to	TO	O	to	aux	25	SENT_136	[p9l893t294r975b356],
25	have	VB	O	have	xcomp	17	SENT_136	[p9l1013t277r1203b356],
26	90	CD	PERCENT	90	number	27	SENT_136	[p9l1240t282r1430b356],
27	%	NN	PERCENT	%	amod	28	SENT_136	[p9l1240t282r1430b356],
28	power	NN	O	power	dobj	25	SENT_136	[p9l1465t303r1732b377],
29	to	TO	O	to	aux	30	SENT_136	[p9l1766t294r1848b356],
30	determine	VB	O	determine	infmod	28	SENT_136	[p9l1887t277r2132b356, p9l11t406r228b484],
31	the	DT	O	the	det	32	SENT_136	[p9l267t405r400b483],
32	noninferiority	NN	O	noninferiority	dobj	30	SENT_136	[p9l439t404r1047b505],
33	of	IN	O	of	_	0	SENT_136	[p9l1081t404r1181b484],
34	dolutegravir	NN	O	dolutegravir	prep_of	32	SENT_136	[p9l1202t405r1725b506],
35	and	CC	O	and	_	0	SENT_136	[p9l1760t405r1917b484],
36	abacavir	NN	O	abacavir	nn	38	SENT_136	[p9l1955t405r2132b484, p9l12t533r779b629],
37	—	CD	NUMBER	—	num	38	SENT_136	[p9l1955t405r2132b484, p9l12t533r779b629],
38	lamivudine	NN	O	lamivudine	prep_of	32	SENT_136	[p9l1955t405r2132b484, p9l12t533r779b629],
39	,	,	O	,	_	0	SENT_136	[p9l1955t405r2132b484, p9l12t533r779b629],
40	at	IN	O	at	_	0	SENT_136	[p9l858t550r937b611],
41	a	DT	O	a	det	43	SENT_136	[p9l1004t559r1049b611],
42	one	CD	NUMBER	one	num	43	SENT_136	[p9l1121t533r1534b612],
43	—	NN	O	—	prep_at	17	SENT_136	[p9l1121t533r1534b612],
44	sided	VBD	O	side	_	0	SENT_136	[p9l1121t533r1534b612],
45	significance	NN	O	significance	nn	46	SENT_136	[p9l1609t532r2133b634],
46	level	NN	O	level	dobj	44	SENT_136	[p9l10t660r199b739],
47	of	IN	O	of	_	0	SENT_136	[p9l243t659r342b739],
48	2.5	CD	PERCENT	2.5	num	49	SENT_136	[p9l367t665r603b739],
49	%	NN	PERCENT	%	prep_of	46	SENT_136	[p9l367t665r603b739],
50	.	.	O	.	_	0	SENT_136	[p9l367t665r603b739],

1	Efficacy	NN	O	efficacy	nn	4	SENT_137	[p9l651t659r999b760],
2	and	CC	O	and	_	0	SENT_137	[p9l1037t660r1195b739],
3	safety	NN	O	safety	conj_and	1	SENT_137	[p9l1240t659r1493b760],
4	analyses	NNS	O	analysis	nsubjpass	6	SENT_137	[p9l1531t660r1890b760],
5	were	VBD	O	be	auxpass	6	SENT_137	[p9l1931t686r2133b740],
6	performed	VBN	O	perform	_	0	SENT_137	[p9l9t787r466b888],
7	in	IN	O	in	_	0	SENT_137	[p9l524t789r608b866],
8	the	DT	O	the	det	9	SENT_137	[p9l667t788r800b866],
9	intention	NN	O	intention	prep_in	6	SENT_137	[p9l859t789r1609b867],
10	—	CD	NUMBER	—	number	12	SENT_137	[p9l859t789r1609b867],
11	to	TO	O	to	dep	12	SENT_137	[p9l859t789r1609b867],
12	—	CD	NUMBER	—	num	14	SENT_137	[p9l859t789r1609b867],
13	treat	NN	O	treat	nn	14	SENT_137	[p9l859t789r1609b867],
14	population	NN	O	population	dep	9	SENT_137	[p9l1662t788r2133b888],
15	and	CC	O	and	_	0	SENT_137	[p9l11t916r168b995],
16	safety	NN	O	safety	nn	17	SENT_137	[p9l203t915r456b1016],
17	population	NN	O	population	dep	9	SENT_137	[p9l483t916r977b1016],
18	,	,	O	,	_	0	SENT_137	[p9l483t916r977b1016],
19	respectively	RB	O	respectively	advmod	9	SENT_137	[p9l1017t916r1536b1016],
20	;	:	O	;	_	0	SENT_137	[p9l1017t916r1536b1016],
21	both	CC	O	both	dep	6	SENT_137	[p9l1574t916r1772b995],
22	populations	NNS	O	population	nsubj	23	SENT_137	[p9l1804t916r2132b1016, p9l12t1046r222b1123],
23	included	VBD	O	include	conj	6	SENT_137	[p9l280t1045r647b1124],
24	all	DT	O	all	det	25	SENT_137	[p9l703t1045r807b1122],
25	participants	NNS	O	participant	dobj	23	SENT_137	[p9l862t1046r1379b1144],
26	who	WP	O	who	nsubj	30	SENT_137	[p9l1433t1045r1616b1124],
27	underwent	VBD	O	undergo	rcmod	25	SENT_137	[p9l1673t1045r2138b1124],
28	randomization	NN	O	randomization	dobj	27	SENT_137	[p9l11t1173r651b1252],
29	and	CC	O	and	_	0	SENT_137	[p9l692t1173r849b1252],
30	received	VBD	O	receive	rcmod	25	SENT_137	[p9l889t1173r1235b1252],
31	at	IN	O	at	quantmod	33	SENT_137	[p9l1275t1190r1354b1251],
32	least	JJS	O	least	mwe	31	SENT_137	[p9l1388t1173r1587b1252],
33	one	CD	NUMBER	one	num	34	SENT_137	[p9l1623t1199r1774b1252],
34	dose	NN	O	dose	dobj	30	SENT_137	[p9l1817t1173r2010b1252],
35	of	IN	O	of	_	0	SENT_137	[p9l2052t1172r2152b1252],
36	study	NN	O	study	nn	37	SENT_137	[p9l12t1301r242b1401],
37	drug	NN	O	drug	prep_of	34	SENT_137	[p9l283t1301r506b1402],
38	.	.	O	.	_	0	SENT_137	[p9l283t1301r506b1402],

1	The	DT	O	the	det	3	SENT_138	[p9l554t1301r714b1379],
2	two	CD	NUMBER	two	num	3	SENT_138	[p9l760t1318r917b1380],
3	populations	NNS	O	population	nsubj	5	SENT_138	[p9l962t1301r1475b1401],
4	were	VBD	O	be	cop	5	SENT_138	[p9l1518t1327r1719b1380],
5	identical	JJ	O	identical	_	0	SENT_138	[p9l1764t1301r2134b1380],
6	in	IN	O	in	_	0	SENT_138	[p9l11t1430r94b1506],
7	this	DT	O	this	det	8	SENT_138	[p9l128t1429r288b1507],
8	study	NN	O	study	prep_in	5	SENT_138	[p9l327t1429r569b1528],
9	.	.	O	.	_	0	SENT_138	[p9l327t1429r569b1528],

1	N	NN	O	n	nn	3	SENT_139	[p9l541t1597r555b1612],
2	ENGLJ	NN	O	englj	nn	3	SENT_139	[p9l570t1597r648b1619],
3	MED	NN	O	med	_	0	SENT_139	[p9l662t1597r714b1612],
4	369	CD	NUMBER	369	dep	3	SENT_139	[p9l724t1591r805b1619],
5	;	:	O	;	_	0	SENT_139	[p9l724t1591r805b1619],
6	19	CD	NUMBER	19	num	7	SENT_139	[p9l724t1591r805b1619],
7	NEjM.ORG	NN	O	nejm.org	dep	4	SENT_139	[p9l841t1597r965b1619],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	7	SENT_139	[p9l1002t1597r1137b1613],
9	7	CD	DATE	7	num	8	SENT_139	[p9l1147t1597r1166b1618],
10	,	,	DATE	,	_	0	SENT_139	[p9l1147t1597r1166b1618],
11	2013	CD	DATE	2013	num	8	SENT_139	[p9l1177t1597r1232b1619],
12	1809	CD	DATE	1809	dep	3	SENT_139	[p9l1940t1587r2016b1610],

1	The	DT	O	the	det	4	SENT_140	[p9l702t1630r753b1654],
2	New	NNP	O	New	nn	4	SENT_140	[p9l762t1631r824b1654],
3	England	NNP	O	England	nn	4	SENT_140	[p9l833t1630r944b1661],
4	Journal	NNP	O	Journal	_	0	SENT_140	[p9l952t1630r1050b1654],
5	of	IN	O	of	_	0	SENT_140	[p9l1059t1630r1088b1654],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_140	[p9l1095t1630r1220b1654],

1	The	DT	O	the	det	4	SENT_141	[p9l673t1818r719b1839],
2	NEW	NNP	O	NEW	nn	4	SENT_141	[p9l737t1820r822b1839],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_141	[p9l841t1820r1030b1839],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_141	[p9l1049t1820r1228b1846],
5	of	IN	O	of	_	0	SENT_141	[p9l1248t1818r1276b1845],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_141	[p9l1288t1820r1487b1839],

1	A	DT	O	a	det	3	SENT_142	[p9l657t1997r706b2049],
2	sensitivity	NN	O	sensitivity	nn	3	SENT_142	[p9l729t1993r1053b2066],
3	analysis	NN	O	analysis	nsubjpass	10	SENT_142	[p9l1073t1992r1327b2066],
4	of	IN	O	of	_	0	SENT_142	[p9l1353t1991r1428b2051],
5	the	DT	O	the	det	8	SENT_142	[p9l1438t1992r1537b2050],
6	primary	JJ	O	primary	amod	8	SENT_142	[p9l1560t1993r1822b2066],
7	end	NN	O	end	nn	8	SENT_142	[p9l1843t1992r1958b2051],
8	point	NN	O	point	prep_of	3	SENT_142	[p9l1980t1993r2152b2066],
9	was	VBD	O	be	auxpass	10	SENT_142	[p9l560t2106r681b2146],
10	performed	VBN	O	perform	_	0	SENT_142	[p9l721t2086r1062b2161],
11	in	IN	O	in	_	0	SENT_142	[p9l1101t2088r1163b2144],
12	the	DT	O	the	det	16	SENT_142	[p9l1203t2087r1302b2145],
13	per	FW	O	per	nn	16	SENT_142	[p9l1341t2087r1738b2161],
14	—	FW	O	—	nn	16	SENT_142	[p9l1341t2087r1738b2161],
15	protocol	NN	O	protocol	nn	16	SENT_142	[p9l1341t2087r1738b2161],
16	population	NN	O	population	prep_in	10	SENT_142	[p9l1775t2087r2144b2161],
17	,	,	O	,	_	0	SENT_142	[p9l1775t2087r2144b2161],
18	which	WDT	O	which	nsubj	19	SENT_142	[p9l560t2182r756b2241],
19	comprised	VBD	O	comprise	rcmod	16	SENT_142	[p9l796t2182r1131b2256],
20	the	DT	O	the	det	22	SENT_142	[p9l1170t2182r1270b2240],
21	intention-to-treat	JJ	O	intention-to-treat	amod	22	SENT_142	[p9l1308t2183r1869b2241],
22	population	NN	O	population	dobj	19	SENT_142	[p9l1902t2182r2147b2256, p9l564t2278r690b2336],
23	with	IN	O	with	_	0	SENT_142	[p9l729t2277r875b2336],
24	the	DT	O	the	det	25	SENT_142	[p9l918t2277r1017b2335],
25	exclusion	NN	O	exclusion	prep_with	19	SENT_142	[p9l1060t2277r1357b2336],
26	of	IN	O	of	_	0	SENT_142	[p9l1400t2276r1474b2336],
27	participants	NNS	O	participant	prep_of	25	SENT_142	[p9l1502t2278r1888b2351],
28	with	IN	O	with	_	0	SENT_142	[p9l1928t2277r2074b2336],
29	a	DT	O	a	det	31	SENT_142	[p9l2116t2296r2149b2335],
30	protocol	NN	O	protocol	nn	31	SENT_142	[p9l562t2372r832b2446],
31	deviation	NN	O	deviation	prep_with	19	SENT_142	[p9l863t2372r1158b2431],
32	that	WDT	O	that	nsubj	33	SENT_142	[p9l1190t2372r1318b2430],
33	met	VBD	O	meet	rcmod	31	SENT_142	[p9l1346t2384r1469b2430],
34	prespecified	JJ	O	prespecified	amod	35	SENT_142	[p9l1495t2371r1891b2446],
35	criteria	NNS	O	criterion	dobj	33	SENT_142	[p9l1923t2373r2149b2430],
36	(	RB	O	(	advmod	33	SENT_142	[p9l567t2467r760b2535],
37	Table	NNP	O	Table	nn	38	SENT_142	[p9l567t2467r760b2535],
38	S3	NN	O	s3	dep	33	SENT_142	[p9l789t2471r858b2526],
39	in	IN	O	in	_	0	SENT_142	[p9l886t2468r949b2524],
40	the	DT	O	the	det	43	SENT_142	[p9l976t2467r1075b2525],
41	Supplementary	NNP	O	Supplementary	nn	43	SENT_142	[p9l1104t2467r1587b2541],
42	Appendix	NNP	O	Appendix	nn	43	SENT_142	[p9l1608t2467r1956b2541],
43	)	NN	O	)	prep_in	33	SENT_142	[p9l1608t2467r1956b2541],
44	.	.	O	.	_	0	SENT_142	[p9l1608t2467r1956b2541],

1	Tests	NNS	O	test	nsubjpass	5	SENT_143	[p9l1984t2472r2147b2525],
2	of	IN	O	of	_	0	SENT_143	[p9l564t2561r639b2621],
3	homogeneity	NN	O	homogeneity	prep_of	1	SENT_143	[p9l656t2562r1076b2637],
4	were	VBD	O	be	auxpass	5	SENT_143	[p9l1101t2581r1252b2621],
5	assessed	VBN	O	assess	_	0	SENT_143	[p9l1283t2562r1558b2621],
6	at	IN	O	at	_	0	SENT_143	[p9l1589t2574r1648b2620],
7	10	CD	NUMBER	10	number	8	SENT_143	[p9l1678t2566r1813b2621],
8	°	CD	NUMBER	°	prep_at	5	SENT_143	[p9l1678t2566r1813b2621],
9	/	:	O	/	punct	10	SENT_143	[p9l1678t2566r1813b2621],
10	o	NN	O	o	dep	8	SENT_143	[p9l1678t2566r1813b2621],
11	to	TO	O	to	aux	12	SENT_143	[p9l1844t2574r1905b2621],
12	ensure	VB	O	ensure	xcomp	5	SENT_143	[p9l1937t2581r2148b2621],
13	that	IN	O	that	complm	18	SENT_143	[p9l564t2658r693b2716],
14	the	DT	O	the	det	16	SENT_143	[p9l736t2658r835b2717],
15	treatment	NN	O	treatment	nn	16	SENT_143	[p9l882t2670r1199b2717],
16	difference	NN	O	difference	nsubjpass	18	SENT_143	[p9l1242t2657r1565b2717],
17	was	VBD	O	be	auxpass	18	SENT_143	[p9l1609t2678r1730b2717],
18	maintained	VBN	O	maintain	ccomp	12	SENT_143	[p9l1778t2658r2148b2717],

1	1090	CD	NUMBER	1090	num	2	SENT_144	[p10l603t143r708b183],
2	Persons	NNS	O	person	nsubjpass	4	SENT_144	[p10l729t144r908b182],
3	were	VBD	O	be	auxpass	4	SENT_144	[p10l926t155r1033b183],
4	assessed	VBN	O	assess	_	0	SENT_144	[p10l1051t140r1254b182],
5	for	IN	O	for	_	0	SENT_144	[p10l1273t140r1337b182],
6	eligibility	NN	O	eligibility	prep_for	4	SENT_144	[p10l1353t140r1558b196],

1	246	CD	NUMBER	246	nsubjpass	3	SENT_145	[p10l1336t389r1416b428],
2	Were	VBD	O	be	auxpass	3	SENT_145	[p10l1433t390r1551b428],
3	excluded	VBN	O	exclude	_	0	SENT_145	[p10l1569t386r1767b428],
4	165	CD	NUMBER	165	dobj	3	SENT_145	[p10l1396t453r1470b492],
5	Did	VBD	O	do	aux	7	SENT_145	[p10l1494t450r1569b492],
6	not	RB	O	not	neg	7	SENT_145	[p10l1591t458r1664b492],
7	meet	VB	O	meet	rcmod	4	SENT_145	[p10l1683t458r1796b492],
8	inclusion	NN	O	inclusion	nn	9	SENT_145	[p10l1499t514r1703b556],
9	criteria	NNS	O	criterion	dobj	7	SENT_145	[p10l1723t518r1880b556],
10	or	CC	O	or	_	0	SENT_145	[p10l1899t529r1945b556],
11	met	VBD	O	meet	rcmod	4	SENT_145	[p10l1499t586r1585b621],
12	exclusion	NN	O	exclusion	nn	13	SENT_145	[p10l1602t578r1813b621],
13	criteria	NNS	O	criterion	dobj	11	SENT_145	[p10l1833t582r1989b621],
14	1	CD	NUMBER	1	nsubjpass	16	SENT_145	[p10l1452t646r1470b684],
15	Was	VBD	O	be	auxpass	16	SENT_145	[p10l1489t646r1586b685],
16	excluded	VBN	O	exclude	dep	11	SENT_145	[p10l1605t643r1803b685],
17	because	IN	O	because	mark	20	SENT_145	[p10l1499t707r1682b749],
18	study	NN	O	study	nsubjpass	22	SENT_145	[p10l1701t707r1824b762],
19	was	VBD	O	be	auxpass	20	SENT_145	[p10l1839t722r1925b749],
20	closed	VBN	O	close	advcl	16	SENT_145	[p10l1497t771r1641b813],
21	or	CC	O	or	_	0	SENT_145	[p10l1661t786r1708b813],
22	terminated	VBN	O	terminate	conj_or	20	SENT_145	[p10l1722t771r1973b813],

1	19	CD	NUMBER	19	nsubjpass	3	SENT_146	[p10l1424t839r1472b877],
2	Were	VBD	O	be	auxpass	3	SENT_146	[p10l1489t839r1607b877],
3	lost	VBN	O	lose	_	0	SENT_146	[p10l1627t835r1708b877],
4	to	TO	O	to	_	0	SENT_146	[p10l1723t843r1768b877],
5	follow-up	NN	O	follow-up	prep_to	3	SENT_146	[p10l1496t899r1709b954],

1	31	CD	NUMBER	31	nsubjpass	3	SENT_147	[p10l1421t967r1470b1006],
2	Were	VBD	O	be	auxpass	3	SENT_147	[p10l1489t968r1607b1006],
3	withdrawn	VBN	O	withdraw	_	0	SENT_147	[p10l1623t964r1861b1006],
4	by	IN	O	by	_	0	SENT_147	[p10l1499t1028r1546b1083],
5	investigator	NN	O	investigator	agent	3	SENT_147	[p10l1565t1032r1835b1083],

1	32	CD	NUMBER	32	num	3	SENT_148	[p10l1421t1096r1472b1134],
2	Withdrew	NN	O	withdrew	nn	3	SENT_148	[p10l1489t1092r1711b1135],
3	consent	NN	O	consent	nsubj	6	SENT_148	[p10l1728t1100r1910b1134],
4	5	CD	NUMBER	5	dep	3	SENT_148	[p10l1449t1160r1470b1198],
5	Were	VBD	O	be	cop	6	SENT_148	[p10l1489t1160r1607b1199],
6	eligible	JJ	O	eligible	_	0	SENT_148	[p10l1625t1156r1786b1212],
7	but	CC	O	but	cc	12	SENT_148	[p10l1807t1156r1879b1199],
8	enrollment	NN	O	enrollment	nn	9	SENT_148	[p10l1497t1220r1748b1263],
9	target	NN	O	target	nsubjpass	12	SENT_148	[p10l1764t1229r1898b1276],
10	had	VBD	O	have	aux	12	SENT_148	[p10l1917t1220r1996b1263],
11	been	VBN	O	be	auxpass	12	SENT_148	[p10l1499t1285r1603b1327],
12	reached	VBN	O	reach	ccomp	6	SENT_148	[p10l1626t1285r1801b1327],

1	844	CD	NUMBER	844	_	0	SENT_149	[p10l724t1520r804b1560],
2	Underwent	JJ	O	underwent	amod	3	SENT_149	[p10l825t1518r1076b1560],
3	randomization	NN	O	randomization	dep	1	SENT_149	[p10l1096t1518r1430b1560],

1	422	CD	NUMBER	422	nsubjpass	3	SENT_150	[p10l119t1975r199b2013],
2	Were	VBD	O	be	auxpass	3	SENT_150	[p10l216t1975r334b2014],
3	assigned	VBN	O	assign	_	0	SENT_150	[p10l353t1972r552b2027],
4	to	TO	O	to	_	0	SENT_150	[p10l571t1980r616b2014],
5	DTG	NNP	O	DTG	prep_to	3	SENT_150	[p10l638t1974r990b2014],
6	.	.	O	.	_	0	SENT_150	[p10l638t1974r990b2014],

1	—	NN	O	—	_	0	SENT_151	[p10l638t1974r990b2014],
2	.	.	O	.	_	0	SENT_151	[p10l638t1974r990b2014],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_152	[p10l638t1974r990b2014],
2	.	.	O	.	_	0	SENT_152	[p10l638t1974r990b2014],

1	—	NN	O	—	_	0	SENT_153	[p10l638t1974r990b2014],
2	.	.	O	.	_	0	SENT_153	[p10l638t1974r990b2014],

1	3TC	NN	O	3tc	_	0	SENT_154	[p10l638t1974r990b2014],

1	group	NN	O	group	_	0	SENT_155	[p10l232t2051r366b2092],

1	414	CD	NUMBER	414	nsubj	8	SENT_156	[p10l175t2104r256b2142],
2	Received	VBN	O	receive	partmod	1	SENT_156	[p10l278t2100r473b2143],
3	assigned	VBN	O	assign	dep	2	SENT_156	[p10l495t2100r694b2156],
4	intervention	NN	O	intervention	dobj	3	SENT_156	[p10l717t2104r989b2142],
5	8	CD	NUMBER	8	num	4	SENT_156	[p10l232t2167r255b2207],
6	Did	VBD	O	do	aux	8	SENT_156	[p10l278t2164r352b2206],
7	not	RB	O	not	neg	8	SENT_156	[p10l375t2172r447b2206],
8	receive	VB	O	receive	_	0	SENT_156	[p10l466t2168r622b2207],
9	assigned	VBN	O	assign	amod	10	SENT_156	[p10l641t2164r840b2220],
10	intervention	NN	O	intervention	dobj	8	SENT_156	[p10l863t2168r979b2206, p10l343t2232r512b2271],

1	4	LS	NUMBER	4	dep	2	SENT_157	[p10l287t2297r312b2334],
2	Withdrew	NN	O	withdrew	nsubjpass	11	SENT_157	[p10l328t2293r551b2335],
3	consent	NN	O	consent	prep	2	SENT_157	[p10l567t2301r749b2335],
4	2	CD	NUMBER	2	dep	3	SENT_157	[p10l288t2361r311b2398],
5	Were	VBD	O	be	auxpass	6	SENT_157	[p10l329t2361r446b2399],
6	withdrawn	VBN	O	withdraw	rcmod	2	SENT_157	[p10l463t2357r701b2399],
7	by	IN	O	by	_	0	SENT_157	[p10l724t2357r771b2412],
8	investigator	NN	O	investigator	agent	6	SENT_157	[p10l790t2361r951b2399, p10l329t2429r447b2477],
9	2	CD	NUMBER	2	num	8	SENT_157	[p10l288t2489r311b2527],
10	Were	VBD	O	be	auxpass	11	SENT_157	[p10l329t2489r446b2528],
11	lost	VBN	O	lose	_	0	SENT_157	[p10l467t2485r547b2528],
12	to	TO	O	to	_	0	SENT_157	[p10l563t2493r607b2528],
13	follow-up	NN	O	follow-up	prep_to	11	SENT_157	[p10l625t2485r838b2541],
14	or	CC	O	or	_	0	SENT_157	[p10l856t2500r903b2528],
15	had	VBD	O	have	conj_or	11	SENT_157	[p10l921t2485r1000b2528],
16	protocol	NN	O	protocol	nn	17	SENT_157	[p10l345t2550r531b2605],
17	deviation	NN	O	deviation	dobj	15	SENT_157	[p10l551t2550r759b2592],

1	51	CD	NUMBER	51	nsubjpass	3	SENT_158	[p10l145t2838r194b2877],
2	Were	VBD	O	be	auxpass	3	SENT_158	[p10l212t2838r330b2877],
3	withdrawn	VBN	O	withdraw	_	0	SENT_158	[p10l347t2835r585b2877],
4	from	IN	O	from	_	0	SENT_158	[p10l604t2834r711b2877],
5	study	NN	O	study	prep_from	3	SENT_158	[p10l733t2835r855b2890],
6	early	RB	O	early	advmod	5	SENT_158	[p10l872t2835r977b2890],

1	10	CD	NUMBER	10	nsubj	20	SENT_159	[p10l203t2902r253b2941],
2	Had	VBD	O	have	partmod	1	SENT_159	[p10l274t2899r364b2941],
3	adverse	JJ	O	adverse	amod	4	SENT_159	[p10l385t2899r560b2941],
4	event	NN	O	event	dobj	2	SENT_159	[p10l578t2907r700b2941],
5	14	CD	NUMBER	14	nsubj	11	SENT_159	[p10l203t2967r252b3005],
6	Had	VBD	O	have	partmod	5	SENT_159	[p10l274t2963r364b3005],
7	lack	NN	O	lack	dobj	6	SENT_159	[p10l387t2963r472b3005],
8	of	IN	O	of	_	0	SENT_159	[p10l489t2962r539b3005],
9	efﬁcacy	NN	O	efﬁcacy	prep_of	7	SENT_159	[p10l549t2962r718b3018],
10	7	CD	NUMBER	7	num	9	SENT_159	[p10l231t3031r252b3069],
11	Had	VBD	O	have	rcmod	4	SENT_159	[p10l274t3027r364b3069],
12	protocol	NN	O	protocol	nn	13	SENT_159	[p10l387t3027r573b3082],
13	deviation	NN	O	deviation	dobj	11	SENT_159	[p10l594t3027r802b3069],
14	14	CD	NUMBER	14	nsubjpass	16	SENT_159	[p10l203t3095r252b3133],
15	Were	VBD	O	be	auxpass	16	SENT_159	[p10l269t3095r387b3134],
16	lost	VBN	O	lose	rcmod	13	SENT_159	[p10l407t3091r487b3134],
17	to	TO	O	to	_	0	SENT_159	[p10l503t3100r547b3134],
18	follow-up	JJ	O	follow-up	amod	19	SENT_159	[p10l565t3091r778b3147],
19	5	CD	NUMBER	5	prep_to	16	SENT_159	[p10l229t3160r250b3198],
20	Withdrew	VBD	O	withdraw	_	0	SENT_159	[p10l269t3156r491b3198],
21	consent	NN	O	consent	nsubjpass	24	SENT_159	[p10l507t3164r689b3198],
22	1	CD	NUMBER	1	num	21	SENT_159	[p10l231t3224r250b3262],
23	Was	VBD	O	be	auxpass	24	SENT_159	[p10l269t3224r365b3262],
24	withdrawn	VBN	O	withdraw	ccomp	20	SENT_159	[p10l383t3220r621b3262],
25	by	IN	O	by	_	0	SENT_159	[p10l644t3220r692b3275],
26	investigator	NN	O	investigator	agent	24	SENT_159	[p10l710t3224r980b3276],

1	422	CD	NUMBER	422	nsubjpass	3	SENT_160	[p10l1171t1975r1251b2013],
2	Were	VBD	O	be	auxpass	3	SENT_160	[p10l1268t1976r1386b2014],
3	assigned	VBN	O	assign	_	0	SENT_160	[p10l1405t1972r1604b2027],
4	to	TO	O	to	_	0	SENT_160	[p10l1623t1980r1668b2014],
5	EFV	NN	O	efv	prep_to	3	SENT_160	[p10l1690t1975r2024b2014],
6	.	.	O	.	_	0	SENT_160	[p10l1690t1975r2024b2014],

1	—	NN	O	—	_	0	SENT_161	[p10l1690t1975r2024b2014],
2	.	.	O	.	_	0	SENT_161	[p10l1690t1975r2024b2014],

1	TDF	NNP	O	TDF	_	0	SENT_162	[p10l1690t1975r2024b2014],
2	.	.	O	.	_	0	SENT_162	[p10l1690t1975r2024b2014],

1	—	NN	O	—	_	0	SENT_163	[p10l1690t1975r2024b2014],
2	.	.	O	.	_	0	SENT_163	[p10l1690t1975r2024b2014],

1	FTC	NNP	O	FTC	_	0	SENT_164	[p10l1690t1975r2024b2014],

1	group	NN	O	group	_	0	SENT_165	[p10l1284t2051r1418b2092],

1	419	CD	NUMBER	419	nsubj	8	SENT_166	[p10l1227t2104r1307b2143],
2	Received	VBN	O	receive	partmod	1	SENT_166	[p10l1330t2100r1526b2142],
3	assigned	VBN	O	assign	dep	2	SENT_166	[p10l1547t2100r1746b2156],
4	intervention	NN	O	intervention	dobj	3	SENT_166	[p10l1769t2104r2041b2143],
5	3	CD	NUMBER	3	num	4	SENT_166	[p10l1285t2168r1305b2206],
6	Did	VBD	O	do	aux	8	SENT_166	[p10l1330t2165r1404b2207],
7	not	RB	O	not	neg	8	SENT_166	[p10l1427t2172r1499b2207],
8	receive	VB	O	receive	_	0	SENT_166	[p10l1519t2168r1674b2207],
9	assigned	VBN	O	assign	amod	10	SENT_166	[p10l1693t2165r1892b2220],
10	intervention	NN	O	intervention	dobj	8	SENT_166	[p10l1915t2168r2031b2207, p10l1331t2232r1500b2271],
11	owing	VBG	O	owe	amod	10	SENT_166	[p10l1520t2232r1658b2284],
12	to	TO	O	to	_	0	SENT_166	[p10l1673t2237r1718b2271],
13	withdrawal	NN	O	withdrawal	nn	14	SENT_166	[p10l1734t2228r1982b2271],
14	ofconsent	NN	O	ofconsent	prep_to	10	SENT_166	[p10l1332t2292r1574b2335],

1	84	CD	NUMBER	84	nsubjpass	3	SENT_167	[p10l1166t2837r1218b2877],
2	Were	VBD	O	be	auxpass	3	SENT_167	[p10l1234t2839r1352b2877],
3	withdrawn	VBN	O	withdraw	_	0	SENT_167	[p10l1368t2835r1607b2877],
4	from	IN	O	from	_	0	SENT_167	[p10l1626t2834r1733b2877],
5	study	NN	O	study	prep_from	3	SENT_167	[p10l1755t2835r1877b2890],
6	early	RB	O	early	advmod	5	SENT_167	[p10l1894t2835r1999b2890],

1	42	CD	NUMBER	42	nsubj	19	SENT_168	[p10l1221t2903r1273b2940],
2	Had	VBD	O	have	partmod	1	SENT_168	[p10l1296t2899r1386b2941],
3	adverse	JJ	O	adverse	amod	4	SENT_168	[p10l1407t2899r1582b2941],
4	event	NN	O	event	dobj	2	SENT_168	[p10l1600t2907r1722b2941],
5	13	CD	NUMBER	13	nsubj	6	SENT_168	[p10l1225t2966r1271b3005],
6	Had	VBD	O	have	rcmod	4	SENT_168	[p10l1296t2963r1386b3005],
7	lack	NN	O	lack	nn	8	SENT_168	[p10l1409t2963r1494b3005],
8	ofefficacy	NN	O	ofefficacy	dobj	6	SENT_168	[p10l1511t2962r1740b3018],
9	7	CD	NUMBER	7	nsubjpass	15	SENT_168	[p10l1252t3031r1274b3069],
10	Had	VBD	O	have	partmod	9	SENT_168	[p10l1296t3028r1386b3070],
11	protocol	NN	O	protocol	nn	12	SENT_168	[p10l1409t3028r1595b3082],
12	deviation	NN	O	deviation	dobj	10	SENT_168	[p10l1615t3027r1823b3070],
13	9	CD	NUMBER	9	num	12	SENT_168	[p10l1250t3095r1274b3134],
14	Were	VBD	O	be	auxpass	15	SENT_168	[p10l1291t3095r1408b3134],
15	lost	VBN	O	lose	rcmod	8	SENT_168	[p10l1428t3091r1509b3134],
16	to	TO	O	to	_	0	SENT_168	[p10l1525t3100r1569b3134],
17	follow-up	JJ	O	follow-up	amod	18	SENT_168	[p10l1586t3091r1800b3147],
18	11	CD	NUMBER	11	prep_to	15	SENT_168	[p10l1225t3160r1272b3197],
19	Withdrew	VBD	O	withdraw	_	0	SENT_168	[p10l1290t3156r1512b3198],
20	consent	NN	O	consent	nsubjpass	23	SENT_168	[p10l1529t3164r1711b3198],
21	2	CD	NUMBER	2	num	20	SENT_168	[p10l1250t3224r1273b3262],
22	Were	VBD	O	be	auxpass	23	SENT_168	[p10l1290t3224r1408b3262],
23	withdrawn	VBN	O	withdraw	ccomp	19	SENT_168	[p10l1425t3220r1663b3262],
24	by	IN	O	by	_	0	SENT_168	[p10l1686t3220r1733b3275],
25	investigator	NN	O	investigator	agent	23	SENT_168	[p10l1752t3224r2021b3276],

1	414	CD	NUMBER	414	nsubjpass	9	SENT_169	[p10l173t3579r254b3617],
2	Were	VBD	O	be	auxpass	3	SENT_169	[p10l271t3579r389b3617],
3	included	VBN	O	include	rcmod	1	SENT_169	[p10l409t3575r601b3617],
4	in	IN	O	in	_	0	SENT_169	[p10l623t3579r659b3617],
5	the	DT	O	the	det	6	SENT_169	[p10l678t3575r749b3617],
6	analysis	NN	O	analysis	prep_in	3	SENT_169	[p10l768t3575r946b3631],
7	419	CD	NUMBER	419	num	6	SENT_169	[p10l1205t3579r1285b3617],
8	Were	VBD	O	be	auxpass	9	SENT_169	[p10l1302t3579r1420b3617],
9	included	VBN	O	include	_	0	SENT_169	[p10l1440t3575r1632b3617],
10	in	IN	O	in	_	0	SENT_169	[p10l1655t3579r1691b3617],
11	the	DT	O	the	det	12	SENT_169	[p10l1710t3575r1781b3617],
12	analysis	NN	O	analysis	prep_in	9	SENT_169	[p10l1800t3575r1978b3631],

1	Fianna	NNP	O	Fianna	dep	4	SENT_170	[p10l64t3796r227b3834],
2	'	POS	O	'	_	0	SENT_170	[p10l250t3799r289b3834],
3	I	PRP	O	I	nsubj	4	SENT_170	[p10l250t3799r289b3834],
4	_	VBP	O	_	_	0	SENT_170	[p10l250t3799r289b3834],
5	Sfurlv	NNP	O	Sfurlv	nn	6	SENT_170	[p10l315t3795r464b3834],
6	Fnrnllmr-Inf	NNP	O	Fnrnllmr-Inf	dobj	4	SENT_170	[p10l487t3795r778b3834],
7	and	CC	O	and	_	0	SENT_170	[p10l798t3795r892b3834],
8	Rnnrlnminafinn	NNP	PERSON	Rnnrlnminafinn	dobj	4	SENT_170	[p10l919t3795r1331b3834],
9	.	.	O	.	_	0	SENT_170	[p10l919t3795r1331b3834],

1	.	.	O	.	_	0	SENT_171	[p11l64t6r73b14],

1	.5	CD	NUMBER	.5	num	2	SENT_172	[p11l96t6r226b30],
2	“	CD	NUMBER	“	_	0	SENT_172	[p11l96t6r226b30],
3	...	:	O	...	_	0	SENT_172	[p11l96t6r226b30],
4	....	CD	NUMBER	....	num	5	SENT_172	[p11l250t6r291b15],
5	.....	CD	NUMBER	.....	dep	2	SENT_172	[p11l313t6r456b30],
6	...	:	O	...	_	0	SENT_172	[p11l313t6r456b30],
7	I	PRP	O	I	nsubj	8	SENT_172	[p11l313t6r456b30],
8	_	VBP	O	_	dep	2	SENT_172	[p11l487t6r779b15],
9	...	:	O	...	_	0	SENT_172	[p11l487t6r779b15],
10	v.	CC	O	v.	prep	8	SENT_172	[p11l487t6r779b15],
11	.....	FW	O	.....	nn	12	SENT_172	[p11l487t6r779b15],
12	.....	FW	O	.....	dep	10	SENT_172	[p11l487t6r779b15],
13	.....	FW	O	.....	nn	14	SENT_172	[p11l798t6r892b15],
14	....	FW	O	....	advmod	8	SENT_172	[p11l798t6r892b15],
15	.	.	O	.	_	0	SENT_172	[p11l919t6r1333b15],

1	u.	NN	O	u.	_	0	SENT_173	[p11l919t6r1333b15],
2	.....	CD	NUMBER	.....	dep	1	SENT_173	[p11l919t6r1333b15],
3	.	.	O	.	_	0	SENT_173	[p11l919t6r1333b15],

1	.	.	O	.	_	0	SENT_174	[p11l919t6r1333b15],

1	v.	CC	O	v.	_	0	SENT_175	[p11l919t6r1333b15],
2	.....	CD	NUMBER	.....	dep	1	SENT_175	[p11l919t6r1333b15],
3	.....	CD	NUMBER	.....	dep	2	SENT_175	[p11l919t6r1333b15],
4	v.	CC	O	v.	cc	3	SENT_175	[p11l919t6r1333b15],
5	.	.	O	.	_	0	SENT_175	[p11l919t6r1333b15],

1	.	.	O	.	_	0	SENT_176	[p11l919t6r1333b15],

1	Participants	NNS	O	participant	nsubj	4	SENT_177	[p11l65t67r380b126],
2	may	MD	O	may	aux	4	SENT_177	[p11l406t80r512b127],
3	have	VB	O	have	aux	4	SENT_177	[p11l535t63r652b111],
4	had	VBD	O	have	_	0	SENT_177	[p11l676t63r768b111],
5	more	JJR	O	more	mwe	6	SENT_177	[p11l795t80r930b111],
6	than	IN	O	than	quantmod	7	SENT_177	[p11l951t63r1066b111],
7	one	CD	NUMBER	one	num	8	SENT_177	[p11l1091t80r1187b111],
8	reason	NN	O	reason	dobj	4	SENT_177	[p11l1212t80r1385b111],
9	for	IN	O	for	_	0	SENT_177	[p11l1408t63r1483b111],
10	exclusion	NN	O	exclusion	prep_for	8	SENT_177	[p11l1503t63r1765b111],
11	.	.	O	.	_	0	SENT_177	[p11l1503t63r1765b111],

1	DTG	NN	O	dtg	_	0	SENT_178	[p11l1793t66r2098b111],
2	.	.	O	.	_	0	SENT_178	[p11l1793t66r2098b111],

1	—	NN	O	—	_	0	SENT_179	[p11l1793t66r2098b111],
2	.	.	O	.	_	0	SENT_179	[p11l1793t66r2098b111],

1	ABC	NNP	ORGANIZATION	ABC	nn	2	SENT_180	[p11l1793t66r2098b111],
2	3TC	NN	O	3tc	nsubj	3	SENT_180	[p11l62t147r162b192],
3	denotes	VBZ	O	denote	_	0	SENT_180	[p11l183t143r394b192],
4	dolutegravir	NN	O	dolutegravir	dobj	3	SENT_180	[p11l418t143r741b207],
5	plus	CC	O	plus	prep	4	SENT_180	[p11l764t143r870b206],
6	abacavir	NN	O	abacavir	nn	9	SENT_180	[p11l894t143r1461b200],
7	—	CD	NUMBER	—	num	9	SENT_180	[p11l894t143r1461b200],
8	|	NN	O	|	nn	9	SENT_180	[p11l894t143r1461b200],
9	amivudine	NN	O	amivudine	dep	5	SENT_180	[p11l894t143r1461b200],
10	,	,	O	,	_	0	SENT_180	[p11l894t143r1461b200],
11	and	CC	O	and	_	0	SENT_180	[p11l1486t143r1579b192],
12	EFV	NN	O	efv	dobj	3	SENT_180	[p11l1608t147r1999b192],
13	.	.	O	.	_	0	SENT_180	[p11l1608t147r1999b192],

1	—	NN	O	—	_	0	SENT_181	[p11l1608t147r1999b192],
2	.	.	O	.	_	0	SENT_181	[p11l1608t147r1999b192],

1	TDF	NNP	O	TDF	_	0	SENT_182	[p11l1608t147r1999b192],
2	.	.	O	.	_	0	SENT_182	[p11l1608t147r1999b192],

1	—	NN	O	—	_	0	SENT_183	[p11l1608t147r1999b192],
2	.	.	O	.	_	0	SENT_183	[p11l1608t147r1999b192],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_184	[p11l1608t147r1999b192],
2	efavirenz	NN	O	efavirenz	_	0	SENT_184	[p11l61t223r579b272],
3	—	CD	NUMBER	—	num	6	SENT_184	[p11l61t223r579b272],
4	tenofovir	NN	O	tenofovir	nn	6	SENT_184	[p11l61t223r579b272],
5	disoproxil	NN	O	disoproxil	nn	6	SENT_184	[p11l599t224r856b286],
6	fumarate	NN	O	fumarate	dep	2	SENT_184	[p11l880t223r1534b272],
7	—	CD	NUMBER	—	num	8	SENT_184	[p11l880t223r1534b272],
8	emtricitabine	NN	O	emtricitabine	dep	6	SENT_184	[p11l880t223r1534b272],
9	.	.	O	.	_	0	SENT_184	[p11l880t223r1534b272],

1	across	IN	O	across	dep	21	SENT_185	[p11l11t590r272b643],
2	the	DT	O	the	det	4	SENT_185	[p11l319t564r449b642],
3	stratification	NN	O	stratification	nn	4	SENT_185	[p11l495t563r1041b643],
4	subgroups	NNS	O	subgroup	pobj	1	SENT_185	[p11l1087t564r1548b665],
5	:	:	O	:	_	0	SENT_185	[p11l1087t564r1548b665],
6	for	IN	O	for	_	0	SENT_185	[p11l1596t563r1717b643],
7	the	DT	O	the	det	13	SENT_185	[p11l1758t564r1889b642],
8	plasma	NN	O	plasma	nn	13	SENT_185	[p11l1932t564r2133b664, p11l12t717r144b768],
9	HIV	NN	MISC	hiv	nn	13	SENT_185	[p11l178t697r422b769],
10	—	NN	O	—	nn	13	SENT_185	[p11l178t697r422b769],
11	1	CD	NUMBER	1	num	13	SENT_185	[p11l178t697r422b769],
12	RNA	NN	O	rna	nn	13	SENT_185	[p11l461t697r669b774],
13	level	NN	O	level	prep_for	21	SENT_185	[p11l703t691r892b770],
14	at	IN	O	at	_	0	SENT_185	[p11l930t707r1008b768],
15	baseline	NN	O	baseline	prep_at	13	SENT_185	[p11l1043t691r1418b786],
16	,	,	O	,	_	0	SENT_185	[p11l1043t691r1418b786],
17	the	DT	O	the	det	19	SENT_185	[p11l1462t691r1595b769],
18	P	NN	O	p	nn	19	SENT_185	[p11l1632t697r1684b768],
19	value	NN	O	value	nsubj	21	SENT_185	[p11l1716t691r1936b770],
20	was	VBD	O	be	cop	21	SENT_185	[p11l1970t717r2132b770],
21	0.83	CD	NUMBER	0.83	_	0	SENT_185	[p11l12t824r188b897],
22	for	IN	O	for	_	0	SENT_185	[p11l230t817r353b897],
23	the	DT	O	the	det	24	SENT_185	[p11l390t818r523b896],
24	comparison	NN	O	comparison	prep_for	21	SENT_185	[p11l563t819r1072b918],
25	of	IN	O	of	_	0	SENT_185	[p11l1112t817r1212b897],
26	the	DT	O	the	det	28	SENT_185	[p11l1233t818r1366b896],
27	treatment	NN	O	treatment	nn	28	SENT_185	[p11l1405t835r1829b897],
28	difference	NN	O	difference	prep_of	24	SENT_185	[p11l1864t817r2133b897, p11l12t973r202b1026],
29	between	IN	O	between	_	0	SENT_185	[p11l240t947r598b1026],
30	participants	NNS	O	participant	prep_between	28	SENT_185	[p11l634t948r1150b1047],
31	With	IN	O	with	_	0	SENT_185	[p11l1186t947r1381b1026],
32	a	DT	O	a	det	35	SENT_185	[p11l1418t973r1462b1025],
33	high	JJ	O	high	amod	35	SENT_185	[p11l1498t947r1693b1048],
34	viral	JJ	O	viral	amod	35	SENT_185	[p11l1726t947r1917b1026],
35	load	NN	O	load	prep_with	30	SENT_185	[p11l1953t947r2134b1026],
36	and	CC	O	and	_	0	SENT_185	[p11l11t1074r169b1153],
37	those	DT	O	those	conj_and	30	SENT_185	[p11l230t1074r461b1153],
38	with	IN	O	with	_	0	SENT_185	[p11l518t1074r713b1154],
39	a	DT	O	a	det	42	SENT_185	[p11l773t1100r817b1152],
40	low	JJ	O	low	amod	42	SENT_185	[p11l875t1074r1030b1153],
41	Viral	JJ	O	viral	amod	42	SENT_185	[p11l1082t1074r1275b1153],
42	load	NN	O	load	prep_with	37	SENT_185	[p11l1333t1074r1537b1170],
43	,	,	O	,	_	0	SENT_185	[p11l1333t1074r1537b1170],
44	and	CC	O	and	_	0	SENT_185	[p11l1602t1074r1760b1153],
45	for	IN	O	for	_	0	SENT_185	[p11l1821t1073r1943b1153],
46	the	DT	O	the	det	47	SENT_185	[p11l2001t1074r2134b1152],
47	CD4	NN	O	cd4	prep_for	60	SENT_185	[p11l12t1208r258b1280],
48	+	CC	O	+	_	0	SENT_185	[p11l12t1208r258b1280],
49	T	NN	O	t	nn	52	SENT_185	[p11l304t1202r540b1279],
50	—	NN	O	—	nn	52	SENT_185	[p11l304t1202r540b1279],
51	cell	NN	O	cell	nn	52	SENT_185	[p11l304t1202r540b1279],
52	count	NN	O	count	conj_+	47	SENT_185	[p11l589t1218r833b1281],
53	at	IN	O	at	_	0	SENT_185	[p11l876t1218r955b1279],
54	baseline	NN	O	baseline	prep_at	52	SENT_185	[p11l1000t1202r1374b1297],
55	,	,	O	,	_	0	SENT_185	[p11l1000t1202r1374b1297],
56	the	DT	O	the	det	58	SENT_185	[p11l1430t1202r1563b1279],
57	P	NN	O	p	nn	58	SENT_185	[p11l1610t1208r1662b1279],
58	value	NN	O	value	nsubj	60	SENT_185	[p11l1705t1202r1925b1281],
59	was	VBD	O	be	cop	60	SENT_185	[p11l1969t1228r2132b1281],
60	0.41	CD	NUMBER	0.41	conj_and	21	SENT_185	[p11l12t1335r185b1408],
61	for	IN	O	for	_	0	SENT_185	[p11l235t1328r359b1408],
62	the	DT	O	the	det	63	SENT_185	[p11l407t1329r539b1407],
63	comparison	NN	O	comparison	prep_for	60	SENT_185	[p11l590t1330r1100b1429],
64	of	IN	O	of	_	0	SENT_185	[p11l1151t1328r1251b1408],
65	participants	NNS	O	participant	prep_of	63	SENT_185	[p11l1281t1330r1798b1429],
66	with	IN	O	with	_	0	SENT_185	[p11l1846t1329r2041b1409],
67	a	DT	O	a	det	69	SENT_185	[p11l2091t1355r2135b1407],
68	high	JJ	O	high	amod	69	SENT_185	[p11l12t1458r207b1559],
69	CD4	NN	O	cd4	prep_with	65	SENT_185	[p11l261t1464r508b1537],
70	+	CC	O	+	_	0	SENT_185	[p11l261t1464r508b1537],
71	T	NN	O	t	nn	74	SENT_185	[p11l559t1458r795b1536],
72	—	NN	O	—	nn	74	SENT_185	[p11l559t1458r795b1536],
73	cell	NN	O	cell	nn	74	SENT_185	[p11l559t1458r795b1536],
74	count	NN	O	count	conj_and	21	SENT_185	[p11l850t1475r1093b1537],
75	and	CC	O	and	_	0	SENT_185	[p11l1142t1458r1301b1537],
76	those	DT	O	those	conj_and	74	SENT_185	[p11l1355t1458r1587b1537],
77	with	IN	O	with	_	0	SENT_185	[p11l1637t1458r1832b1537],
78	a	DT	O	a	det	80	SENT_185	[p11l1886t1484r1930b1536],
79	low	JJ	O	low	amod	80	SENT_185	[p11l1983t1458r2138b1537],
80	CD4	NN	O	cd4	prep_with	60	SENT_185	[p11l12t1593r258b1666],
81	+	CC	O	+	_	0	SENT_185	[p11l12t1593r258b1666],
82	T	NN	O	t	nn	85	SENT_185	[p11l294t1587r530b1665],
83	—	NN	O	—	nn	85	SENT_185	[p11l294t1587r530b1665],
84	cell	NN	O	cell	nn	85	SENT_185	[p11l294t1587r530b1665],
85	count	NN	O	count	conj_+	80	SENT_185	[p11l570t1604r834b1666],
86	.	.	O	.	_	0	SENT_185	[p11l570t1604r834b1666],

1	In	IN	O	in	_	0	SENT_186	[p11l140t1723r228b1793],
2	the	DT	O	the	det	7	SENT_186	[p11l269t1715r401b1794],
3	Snapshot	NNP	O	Snapshot	nn	7	SENT_186	[p11l444t1715r839b1815],
4	algorithm	NN	O	algorithm	nn	7	SENT_186	[p11l873t1715r1302b1816],
5	(	CD	NUMBER	(	num	7	SENT_186	[p11l1347t1715r1605b1806],
6	Table	NNP	O	Table	nn	7	SENT_186	[p11l1347t1715r1605b1806],
7	S2	NN	O	s2	pobj	1	SENT_186	[p11l1647t1721r1742b1794],
8	and	CC	O	and	_	0	SENT_186	[p11l1782t1715r1940b1794],
9	Fig	NN	O	fig	pobj	1	SENT_186	[p11l1978t1716r2129b1816],
10	.	.	O	.	_	0	SENT_186	[p11l1978t1716r2129b1816],

1	S1	NN	O	s1	nsubjpass	74	SENT_187	[p11l14t1849r109b1921],
2	in	IN	O	in	_	0	SENT_187	[p11l145t1844r228b1920],
3	the	DT	O	the	det	6	SENT_187	[p11l265t1843r397b1921],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_187	[p11l435t1843r1082b1942],
5	Appendix	NNP	O	Appendix	nn	6	SENT_187	[p11l1110t1843r1575b1942],
6	)	NNP	O	)	prep_in	1	SENT_187	[p11l1110t1843r1575b1942],
7	,	,	O	,	_	0	SENT_187	[p11l1110t1843r1575b1942],
8	participants	NNS	O	participant	appos	6	SENT_187	[p11l1615t1844r2132b1942],
9	Whose	WP$	O	whose	poss	12	SENT_187	[p11l7t1971r282b2050],
10	last	JJ	O	last	amod	12	SENT_187	[p11l346t1971r500b2049],
11	available	JJ	O	available	amod	12	SENT_187	[p11l559t1971r930b2050],
12	HIV-1	NN	O	hiv-1	dep	37	SENT_187	[p11l994t1977r1238b2050],
13	RNA	NN	O	rna	nn	14	SENT_187	[p11l1302t1977r1511b2054],
14	value	NN	O	value	dep	20	SENT_187	[p11l1569t1971r1788b2050],
15	in	IN	O	in	_	0	SENT_187	[p11l1853t1972r1936b2048],
16	the	DT	O	the	det	17	SENT_187	[p11l2001t1971r2134b2049],
17	analysis	NN	O	analysis	prep_in	14	SENT_187	[p11l11t2099r351b2199],
18	window	NN	O	window	dep	20	SENT_187	[p11l413t2099r762b2178],
19	(	CD	NUMBER	(	num	18	SENT_187	[p11l827t2100r1000b2195],
20	i.e.	FW	O	i.e.	dep	33	SENT_187	[p11l827t2100r1000b2195],
21	,	,	O	,	_	0	SENT_187	[p11l827t2100r1000b2195],
22	from	IN	O	from	_	0	SENT_187	[p11l1070t2098r1280b2178],
23	week	NN	DURATION	week	prep_from	20	SENT_187	[p11l1340t2099r1564b2178],
24	42	CD	NUMBER	42	num	23	SENT_187	[p11l1622t2105r1720b2178],
25	through	IN	O	through	_	0	SENT_187	[p11l1786t2099r2134b2200],
26	Week	NN	DURATION	week	prep_through	23	SENT_187	[p11l7t2227r230b2306],
27	54	CD	NUMBER	54	num	28	SENT_187	[p11l275t2233r402b2317],
28	)	NN	O	)	nsubj	33	SENT_187	[p11l275t2233r402b2317],
29	was	VBD	O	be	cop	33	SENT_187	[p11l449t2253r612b2306],
30	less	JJR	O	less	mwe	31	SENT_187	[p11l661t2227r816b2305],
31	than	IN	O	than	quantmod	32	SENT_187	[p11l866t2227r1062b2305],
32	50	CD	NUMBER	50	num	33	SENT_187	[p11l1111t2233r1208b2305],
33	copies	NNS	O	copy	csubjpass	37	SENT_187	[p11l1257t2228r1523b2326],
34	per	IN	O	per	_	0	SENT_187	[p11l1570t2253r1710b2326],
35	milliliter	NN	O	milliliter	prep_per	33	SENT_187	[p11l1754t2227r2137b2305],
36	were	VBD	O	be	auxpass	37	SENT_187	[p11l7t2381r209b2434],
37	considered	VBN	O	consider	rcmod	8	SENT_187	[p11l254t2355r718b2434],
38	as	IN	O	as	_	0	SENT_187	[p11l760t2381r846b2433],
39	having	VBG	O	have	aux	40	SENT_187	[p11l892t2355r1183b2456],
40	had	VBD	O	have	prepc_as	37	SENT_187	[p11l1223t2355r1380b2434],
41	a	DT	O	a	det	42	SENT_187	[p11l1423t2381r1467b2433],
42	response	NN	O	response	dobj	40	SENT_187	[p11l1510t2381r1915b2455],
43	;	:	O	;	_	0	SENT_187	[p11l1510t2381r1915b2455],
44	participants	NNS	O	participant	dep	42	SENT_187	[p11l1961t2381r2133b2455, p11l12t2484r380b2582],
45	Whose	WP$	O	whose	poss	47	SENT_187	[p11l424t2483r698b2562],
46	HIV	NN	O	hiv	nn	47	SENT_187	[p11l743t2489r987b2561],
47	—	NN	O	—	nsubj	53	SENT_187	[p11l743t2489r987b2561],
48	1	CD	NUMBER	1	number	50	SENT_187	[p11l743t2489r987b2561],
49	RNA	NN	O	rna	dep	50	SENT_187	[p11l1031t2489r1240b2566],
50	level	NN	O	level	amod	47	SENT_187	[p11l1281t2483r1471b2562],
51	was	VBD	O	be	cop	53	SENT_187	[p11l1511t2509r1674b2562],
52	50	CD	NUMBER	50	num	53	SENT_187	[p11l1723t2489r1820b2561],
53	copies	NNS	O	copy	rcmod	44	SENT_187	[p11l1867t2484r2132b2582],
54	per	IN	O	per	_	0	SENT_187	[p11l11t2637r150b2711],
55	milliliter	NN	O	milliliter	prep_per	53	SENT_187	[p11l180t2611r563b2689],
56	or	CC	O	or	_	0	SENT_187	[p11l593t2637r682b2690],
57	higher	JJR	O	higher	conj_or	53	SENT_187	[p11l711t2611r991b2712],
58	in	IN	O	in	_	0	SENT_187	[p11l1020t2612r1103b2689],
59	the	DT	O	the	det	61	SENT_187	[p11l1137t2611r1269b2689],
60	analysis	NN	O	analysis	nn	61	SENT_187	[p11l1301t2611r1640b2711],
61	window	NN	O	window	prep_in	57	SENT_187	[p11l1671t2611r2019b2690],
62	or	CC	O	or	_	0	SENT_187	[p11l2049t2637r2138b2690],
63	who	WP	O	who	nsubj	66	SENT_187	[p11l7t2739r190b2818],
64	did	VBD	O	do	aux	66	SENT_187	[p11l239t2739r373b2817],
65	not	RB	O	not	neg	66	SENT_187	[p11l419t2756r562b2817],
66	have	VB	O	have	rcmod	8	SENT_187	[p11l603t2739r793b2818],
67	available	JJ	O	available	amod	68	SENT_187	[p11l839t2739r1210b2818],
68	data	NNS	O	datum	dobj	66	SENT_187	[p11l1257t2739r1440b2817],
69	in	IN	O	in	_	0	SENT_187	[p11l1484t2740r1568b2816],
70	the	DT	O	the	det	72	SENT_187	[p11l1614t2739r1747b2817],
71	analysis	NN	O	analysis	nn	72	SENT_187	[p11l1793t2739r2133b2838],
72	Window	NN	MISC	window	prep_in	68	SENT_187	[p11l7t2867r357b2946],
73	were	VBD	O	be	auxpass	74	SENT_187	[p11l407t2893r608b2946],
74	considered	VBN	O	consider	_	0	SENT_187	[p11l668t2867r1132b2946],
75	as	IN	O	as	_	0	SENT_187	[p11l1189t2893r1275b2945],
76	not	RB	O	not	neg	78	SENT_187	[p11l1335t2884r1478b2946],
77	having	VBG	O	have	aux	78	SENT_187	[p11l1531t2867r1822b2968],
78	had	VBD	O	have	prepc_as	74	SENT_187	[p11l1877t2867r2034b2946],
79	a	DT	O	a	det	80	SENT_187	[p11l2091t2893r2135b2945],
80	response	NN	O	response	dobj	78	SENT_187	[p11l12t3000r491b3095],
81	.	.	O	.	_	0	SENT_187	[p11l12t3000r491b3095],

1	”	NN	O	”	dep	7	SENT_188	[p11l12t3000r491b3095],
2	Since	IN	O	since	dep	7	SENT_188	[p11l546t2996r768b3074],
3	the	DT	O	the	det	5	SENT_188	[p11l819t2995r951b3073],
4	background	NN	O	background	nn	5	SENT_188	[p11l1003t2995r1517b3096],
5	regimen	NN	O	regimen	nsubj	7	SENT_188	[p11l1567t2996r1924b3096],
6	was	VBD	O	be	cop	7	SENT_188	[p11l1970t3021r2132b3074],
7	part	NN	O	part	advcl	19	SENT_188	[p11l11t3139r190b3222],
8	of	IN	O	of	_	0	SENT_188	[p11l241t3121r341b3201],
9	the	DT	O	the	det	12	SENT_188	[p11l378t3122r511b3200],
10	blinded	JJ	O	blinded	amod	12	SENT_188	[p11l568t3122r891b3201],
11	randomized	JJ	O	randomized	amod	12	SENT_188	[p11l946t3122r1467b3201],
12	treatment	NN	O	treatment	prep_of	7	SENT_188	[p11l1523t3139r1967b3218],
13	,	,	O	,	_	0	SENT_188	[p11l1523t3139r1967b3218],
14	no	DT	O	no	det	15	SENT_188	[p11l2028t3148r2133b3201],
15	changes	NNS	O	change	nsubjpass	19	SENT_188	[p11l12t3251r361b3352],
16	in	IN	O	in	_	0	SENT_188	[p11l399t3252r482b3329],
17	regimen	NNS	O	regimen	prep_in	15	SENT_188	[p11l519t3252r875b3352],
18	were	VBD	O	be	auxpass	19	SENT_188	[p11l908t3277r1110b3330],
19	permitted	VBN	O	permit	_	0	SENT_188	[p11l1146t3251r1572b3351],
20	in	IN	O	in	_	0	SENT_188	[p11l1609t3252r1692b3329],
21	this	DT	O	this	det	22	SENT_188	[p11l1729t3251r1889b3329],
22	trial	NN	O	trial	prep_in	19	SENT_188	[p11l1928t3251r2129b3330],
23	.	.	O	.	_	0	SENT_188	[p11l1928t3251r2129b3330],

1	The	DT	O	the	det	3	SENT_189	[p11l8t3378r169b3456],
2	adjusted	JJ	O	adjusted	amod	3	SENT_189	[p11l230t3378r586b3478],
3	difference	NN	O	difference	nsubj	12	SENT_189	[p11l648t3377r1079b3457],
4	in	IN	O	in	_	0	SENT_189	[p11l1141t3379r1223b3456],
5	the	DT	O	the	det	6	SENT_189	[p11l1285t3378r1418b3456],
6	proportions	NNS	O	proportion	prep_in	3	SENT_189	[p11l1478t3379r1988b3478],
7	of	IN	O	of	_	0	SENT_189	[p11l2053t3377r2152b3457],
8	participants	NNS	O	participant	prep_of	6	SENT_189	[p11l11t3508r527b3606],
9	with	IN	O	with	_	0	SENT_189	[p11l572t3507r767b3586],
10	a	DT	O	a	det	11	SENT_189	[p11l812t3533r857b3584],
11	response	NN	O	response	prep_with	8	SENT_189	[p11l902t3533r1283b3606],
12	(	VBD	O	(	_	0	SENT_189	[p11l1334t3507r1491b3597],
13	the	DT	O	the	det	14	SENT_189	[p11l1334t3507r1491b3597],
14	proportion	NN	O	proportion	dobj	12	SENT_189	[p11l1536t3508r2005b3606],
15	in	IN	O	in	_	0	SENT_189	[p11l2051t3508r2134b3584],
16	the	DT	O	the	det	17	SENT_189	[p11l12t3635r145b3713],
17	DTG	NN	O	dtg	prep_in	12	SENT_189	[p11l181t3641r858b3714],
18	.	.	O	.	_	0	SENT_189	[p11l181t3641r858b3714],

1	—	NN	O	—	_	0	SENT_190	[p11l181t3641r858b3714],
2	.	.	O	.	_	0	SENT_190	[p11l181t3641r858b3714],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_191	[p11l181t3641r858b3714],
2	.	.	O	.	_	0	SENT_191	[p11l181t3641r858b3714],

1	—	NN	O	—	_	0	SENT_192	[p11l181t3641r858b3714],
2	.	.	O	.	_	0	SENT_192	[p11l181t3641r858b3714],

1	3TC	NN	O	3tc	nn	2	SENT_193	[p11l181t3641r858b3714],
2	group	NN	O	group	_	0	SENT_193	[p11l898t3661r1150b3736],
3	minus	CC	O	minus	prep	2	SENT_193	[p11l1189t3636r1457b3714],
4	the	DT	O	the	det	5	SENT_193	[p11l1497t3635r1629b3714],
5	proportion	NN	O	proportion	dep	3	SENT_193	[p11l1665t3636r2134b3735],
6	in	IN	O	in	_	0	SENT_193	[p12l11t21r95b98],
7	the	DT	O	the	det	8	SENT_193	[p12l158t20r291b98],
8	EFV	NN	O	efv	prep_in	2	SENT_193	[p12l353t26r978b99],
9	.	.	O	.	_	0	SENT_193	[p12l353t26r978b99],

1	—	NN	O	—	_	0	SENT_194	[p12l353t26r978b99],
2	.	.	O	.	_	0	SENT_194	[p12l353t26r978b99],

1	TDF	NNP	O	TDF	_	0	SENT_195	[p12l353t26r978b99],
2	.	.	O	.	_	0	SENT_195	[p12l353t26r978b99],

1	—	NN	O	—	_	0	SENT_196	[p12l353t26r978b99],
2	.	.	O	.	_	0	SENT_196	[p12l353t26r978b99],

1	FTC	NNP	ORGANIZATION	FTC	nn	3	SENT_197	[p12l353t26r978b99],
2	group	NN	O	group	nn	3	SENT_197	[p12l1044t27r1322b121],
3	)	NN	O	)	nsubjpass	5	SENT_197	[p12l1044t27r1322b121],
4	was	VBD	O	be	auxpass	5	SENT_197	[p12l1386t46r1548b99],
5	based	VBN	O	base	_	0	SENT_197	[p12l1614t20r1859b99],
6	on	IN	O	on	_	0	SENT_197	[p12l1922t46r2028b99],
7	a	DT	O	a	det	9	SENT_197	[p12l2091t46r2135b98],
8	stratified	JJ	O	stratified	amod	9	SENT_197	[p12l13t146r407b226],
9	analysis	NN	O	analysis	prep_on	5	SENT_197	[p12l469t147r808b247],
10	that	IN	O	that	nsubj	11	SENT_197	[p12l873t147r1045b225],
11	used	VBN	O	use	rcmod	9	SENT_197	[p12l1102t147r1299b227],
12	Cochran	NNP	PERSON	Cochran	dobj	11	SENT_197	[p12l1361t147r2137b226],
13	.	.	O	.	_	0	SENT_197	[p12l1361t147r2137b226],

1	—	NN	O	—	_	0	SENT_198	[p12l1361t147r2137b226],
2	.	.	O	.	_	0	SENT_198	[p12l1361t147r2137b226],

1	Mantel	NNP	PERSON	Mantel	nn	2	SENT_199	[p12l1361t147r2137b226],
2	Haenszel	NNP	PERSON	Haenszel	_	0	SENT_199	[p12l11t276r404b355],
3	weights	NNS	O	weight	dep	2	SENT_199	[p12l449t276r782b377],
4	for	IN	O	for	_	0	SENT_199	[p12l835t275r959b355],
5	the	DT	O	the	det	8	SENT_199	[p12l1006t276r1139b354],
6	HIV-1	NN	MISC	hiv-1	nn	8	SENT_199	[p12l1189t282r1433b355],
7	RNA	NN	MISC	rna	nn	8	SENT_199	[p12l1483t283r1692b359],
8	level	NN	O	level	prep_for	3	SENT_199	[p12l1738t276r1928b355],
9	and	CC	O	and	_	0	SENT_199	[p12l1977t276r2134b355],
10	CD4	NN	O	cd4	prep_for	3	SENT_199	[p12l12t411r258b484],
11	+	CC	O	+	_	0	SENT_199	[p12l12t411r258b484],
12	T	NN	O	t	nn	15	SENT_199	[p12l294t405r530b483],
13	—	NN	O	—	nn	15	SENT_199	[p12l294t405r530b483],
14	cell	NN	O	cell	nn	15	SENT_199	[p12l294t405r530b483],
15	count	NN	O	count	conj_+	3	SENT_199	[p12l570t422r814b484],
16	at	IN	O	at	_	0	SENT_199	[p12l848t422r927b483],
17	baseline	NN	O	baseline	prep_at	15	SENT_199	[p12l961t405r1416b484],
18	?	.	O	?	_	0	SENT_199	[p12l961t405r1416b484],

1	“	NN	O	“	_	0	SENT_200	[p12l961t405r1416b484],

1	If	IN	O	if	mark	14	SENT_201	[p12l140t531r222b610],
2	both	DT	O	both	det	6	SENT_201	[p12l238t532r435b611],
3	the	DT	O	the	det	5	SENT_201	[p12l470t532r602b610],
4	per	FW	O	per	nn	5	SENT_201	[p12l634t532r1166b632],
5	—	FW	O	—	dep	6	SENT_201	[p12l634t532r1166b632],
6	protocol	NN	O	protocol	nsubj	14	SENT_201	[p12l634t532r1166b632],
7	and	CC	O	and	_	0	SENT_201	[p12l1198t532r1356b611],
8	intention	NN	O	intention	nsubj	14	SENT_201	[p12l1388t533r2139b611],
9	—	CD	NUMBER	—	num	8	SENT_201	[p12l1388t533r2139b611],
10	to	TO	O	to	_	0	SENT_201	[p12l1388t533r2139b611],
11	—	CD	NUMBER	—	num	13	SENT_201	[p12l1388t533r2139b611],
12	treat	NN	O	treat	nn	13	SENT_201	[p12l1388t533r2139b611],
13	analyses	NNS	O	analysis	prep_to	8	SENT_201	[p12l11t661r362b761],
14	showed	VBD	O	show	advcl	27	SENT_201	[p12l395t661r711b740],
15	the	DT	O	the	det	16	SENT_201	[p12l741t661r871b739],
16	noninferiority	NN	O	noninferiority	dobj	14	SENT_201	[p12l901t660r1492b761],
17	of	IN	O	of	_	0	SENT_201	[p12l1518t660r1617b740],
18	dolutegravir	NN	O	dolutegravir	prep_of	16	SENT_201	[p12l1629t661r2137b762],
19	and	CC	O	and	_	0	SENT_201	[p12l11t789r167b868],
20	abacaVir	NN	O	abacavir	nn	22	SENT_201	[p12l217t789r1115b885],
21	—	CD	NUMBER	—	num	22	SENT_201	[p12l217t789r1115b885],
22	lamivudine	NN	O	lamivudine	conj_and	18	SENT_201	[p12l217t789r1115b885],
23	,	,	O	,	_	0	SENT_201	[p12l217t789r1115b885],
24	testing	NN	O	testing	nsubj	27	SENT_201	[p12l1173t790r1463b890],
25	for	IN	O	for	_	0	SENT_201	[p12l1511t788r1632b868],
26	superiority	NN	O	superiority	prep_for	24	SENT_201	[p12l1682t790r2138b889],
27	was	VBD	O	be	_	0	SENT_201	[p12l7t942r168b995],
28	to	TO	O	to	aux	30	SENT_201	[p12l203t933r283b995],
29	be	VB	O	be	auxpass	30	SENT_201	[p12l318t916r412b995],
30	conducted	VBN	O	conduct	xcomp	27	SENT_201	[p12l446t916r901b995],
31	.	.	O	.	_	0	SENT_201	[p12l446t916r901b995],

1	In	IN	O	in	dep	104	SENT_202	[p12l938t924r1025b994],
2	addition	NN	O	addition	dep	104	SENT_202	[p12l1057t916r1428b1012],
3	,	,	O	,	_	0	SENT_202	[p12l1057t916r1428b1012],
4	if	IN	O	if	dep	104	SENT_202	[p12l1465t915r1541b994],
5	the	DT	O	the	dep	104	SENT_202	[p12l1556t916r1686b994],
6	intentionto	NN	O	intentionto	dep	104	SENT_202	[p12l1718t917r2133b995, p12l12t1061r321b1123],
7	—	RB	O	—	dep	104	SENT_202	[p12l1718t917r2133b995, p12l12t1061r321b1123],
8	treat	VB	O	treat	dep	104	SENT_202	[p12l1718t917r2133b995, p12l12t1061r321b1123],
9	analysis	NN	O	analysis	dep	104	SENT_202	[p12l346t1044r673b1144],
10	showed	VBD	O	show	dep	104	SENT_202	[p12l707t1044r1021b1124],
11	noninferiority	JJ	O	noninferiority	dep	104	SENT_202	[p12l1052t1043r1647b1144],
12	,	,	O	,	_	0	SENT_202	[p12l1052t1043r1647b1144],
13	the	DT	O	the	dep	104	SENT_202	[p12l1684t1044r1813b1122],
14	following	VBG	O	follow	dep	104	SENT_202	[p12l1844t1043r2133b1124, p12l11t1174r150b1274],
15	two	CD	NUMBER	two	dep	104	SENT_202	[p12l193t1190r350b1252],
16	superiority	NN	O	superiority	dep	104	SENT_202	[p12l399t1174r864b1273],
17	comparisons	NNS	O	comparison	dep	104	SENT_202	[p12l906t1174r1457b1273],
18	were	VBD	O	be	dep	104	SENT_202	[p12l1500t1199r1702b1252],
19	also	RB	O	also	dep	104	SENT_202	[p12l1747t1173r1918b1252],
20	prespecified	VBN	O	prespecify	dep	104	SENT_202	[p12l1963t1199r2133b1273, p12l13t1299r391b1400],
21	to	TO	O	to	dep	104	SENT_202	[p12l423t1317r504b1379],
22	be	VB	O	be	dep	104	SENT_202	[p12l537t1300r633b1379],
23	tested	VBN	O	test	dep	104	SENT_202	[p12l666t1300r936b1396],
24	,	,	O	,	_	0	SENT_202	[p12l666t1300r936b1396],
25	with	IN	O	with	dep	104	SENT_202	[p12l969t1300r1161b1380],
26	the	DT	O	the	dep	104	SENT_202	[p12l1193t1300r1324b1378],
27	use	NN	O	use	dep	104	SENT_202	[p12l1356t1326r1494b1380],
28	of	IN	O	of	dep	104	SENT_202	[p12l1527t1299r1626b1379],
29	the	DT	O	the	dep	104	SENT_202	[p12l1640t1300r1770b1378],
30	fallback	JJ	O	fallback	dep	104	SENT_202	[p12l1802t1299r2139b1380],
31	procedure21	NN	O	procedure21	dep	104	SENT_202	[p12l11t1428r614b1528],
32	»	CD	NUMBER	»	dep	104	SENT_202	[p12l11t1428r614b1528],
33	22	CD	NUMBER	22	dep	104	SENT_202	[p12l11t1428r614b1528],
34	to	TO	O	to	dep	104	SENT_202	[p12l671t1445r753b1507],
35	adjust	VB	O	adjust	dep	104	SENT_202	[p12l809t1428r1066b1528],
36	for	IN	O	for	dep	104	SENT_202	[p12l1117t1427r1240b1507],
37	the	DT	O	the	dep	104	SENT_202	[p12l1294t1428r1427b1506],
38	risk	NN	O	risk	dep	104	SENT_202	[p12l1484t1428r1648b1508],
39	of	IN	O	of	dep	104	SENT_202	[p12l1700t1427r1800b1507],
40	a	DT	O	a	dep	104	SENT_202	[p12l1837t1454r1881b1506],
41	false	JJ	O	false	dep	104	SENT_202	[p12l1936t1427r2134b1506],
42	positive	JJ	O	positive	dep	104	SENT_202	[p12l11t1558r341b1656],
43	result	NN	O	result	dep	104	SENT_202	[p12l381t1557r646b1652],
44	,	,	O	,	_	0	SENT_202	[p12l381t1557r646b1652],
45	at	IN	O	at	dep	104	SENT_202	[p12l690t1573r769b1635],
46	the	DT	O	the	dep	104	SENT_202	[p12l804t1557r937b1635],
47	1	CD	PERCENT	1	dep	104	SENT_202	[p12l981t1562r1105b1636],
48	%	NN	PERCENT	%	dep	104	SENT_202	[p12l981t1562r1105b1636],
49	and	CC	O	and	dep	104	SENT_202	[p12l1143t1557r1302b1635],
50	3	CD	PERCENT	3	dep	104	SENT_202	[p12l1342t1562r1474b1636],
51	%	NN	PERCENT	%	dep	104	SENT_202	[p12l1342t1562r1474b1636],
52	a	DT	O	a	dep	104	SENT_202	[p12l1513t1583r1558b1634],
53	priori	FW	O	priori	dep	104	SENT_202	[p12l1594t1558r1835b1656],
54	levels	NNS	O	level	dep	104	SENT_202	[p12l1873t1557r2129b1652],
55	,	,	O	,	_	0	SENT_202	[p12l1873t1557r2129b1652],
56	respectively	RB	O	respectively	dep	104	SENT_202	[p12l12t1685r531b1784],
57	:	:	O	:	_	0	SENT_202	[p12l12t1685r531b1784],
58	the	DT	O	the	dep	104	SENT_202	[p12l580t1685r713b1763],
59	time	NN	O	time	dep	104	SENT_202	[p12l758t1686r951b1763],
60	to	TO	O	to	dep	104	SENT_202	[p12l996t1702r1077b1763],
61	viral	JJ	O	viral	dep	104	SENT_202	[p12l1119t1685r1311b1764],
62	suppression	NN	O	suppression	dep	104	SENT_202	[p12l1356t1686r1867b1784],
63	(	NN	O	(	dep	104	SENT_202	[p12l1917t1685r2134b1775],
64	with	IN	O	with	dep	104	SENT_202	[p12l1917t1685r2134b1775],
65	the	DT	O	the	dep	104	SENT_202	[p12l12t1813r145b1891],
66	use	NN	O	use	dep	104	SENT_202	[p12l177t1839r317b1892],
67	of	IN	O	of	dep	104	SENT_202	[p12l350t1812r450b1892],
68	the	DT	O	the	dep	104	SENT_202	[p12l465t1813r597b1892],
69	generalized	VBN	O	generalize	dep	104	SENT_202	[p12l629t1813r1129b1914],
70	Wilcoxon	NNP	PERSON	Wilcoxon	dep	104	SENT_202	[p12l1157t1813r1565b1892],
71	test	NN	O	test	dep	104	SENT_202	[p12l1598t1820r1774b1904],
72	)	NN	O	)	dep	104	SENT_202	[p12l1598t1820r1774b1904],
73	and	CC	O	and	dep	104	SENT_202	[p12l1811t1813r1969b1892],
74	the	DT	O	the	dep	104	SENT_202	[p12l2001t1813r2134b1892],
75	change	NN	O	change	dep	104	SENT_202	[p12l12t1941r318b2042],
76	from	IN	O	from	dep	104	SENT_202	[p12l363t1940r574b2020],
77	baseline	NN	O	baseline	dep	104	SENT_202	[p12l620t1941r972b2020],
78	in	IN	O	in	dep	104	SENT_202	[p12l1017t1942r1101b2019],
79	the	DT	O	the	dep	104	SENT_202	[p12l1147t1941r1279b2019],
80	CD4	NN	O	cd4	dep	104	SENT_202	[p12l1325t1947r1571b2020],
81	+	CC	O	+	dep	104	SENT_202	[p12l1325t1947r1571b2020],
82	T	NN	O	t	dep	104	SENT_202	[p12l1613t1941r1849b2019],
83	—	NN	O	—	dep	104	SENT_202	[p12l1613t1941r1849b2019],
84	cell	NN	O	cell	dep	104	SENT_202	[p12l1613t1941r1849b2019],
85	count	NN	O	count	dep	104	SENT_202	[p12l1895t1958r2139b2020],
86	at	IN	O	at	dep	104	SENT_202	[p12l11t2085r90b2146],
87	week	NN	DURATION	week	dep	104	SENT_202	[p12l119t2068r341b2148],
88	48	CD	NUMBER	48	dep	104	SENT_202	[p12l373t2074r475b2147],
89	(	NN	O	(	dep	104	SENT_202	[p12l520t2068r737b2159],
90	with	IN	O	with	dep	104	SENT_202	[p12l520t2068r737b2159],
91	the	DT	O	the	dep	104	SENT_202	[p12l776t2068r909b2146],
92	use	NN	O	use	dep	104	SENT_202	[p12l947t2094r1087b2147],
93	of	IN	O	of	dep	104	SENT_202	[p12l1126t2067r1226b2147],
94	a	DT	O	a	dep	104	SENT_202	[p12l1245t2094r1289b2146],
95	repeated	VBN	O	repeat	dep	104	SENT_202	[p12l1325t2068r2132b2168],
96	—	NN	O	—	dep	104	SENT_202	[p12l1325t2068r2132b2168],
97	measures	NNS	O	measure	dep	104	SENT_202	[p12l1325t2068r2132b2168],
98	model	NN	O	model	dep	104	SENT_202	[p12l12t2196r279b2275],
99	with	IN	O	with	dep	104	SENT_202	[p12l306t2196r501b2276],
100	adjustment	NN	O	adjustment	dep	104	SENT_202	[p12l533t2196r1014b2296],
101	for	IN	O	for	dep	104	SENT_202	[p12l1041t2195r1164b2275],
102	stratification	NN	O	stratification	dep	104	SENT_202	[p12l1195t2195r1755b2275],
103	factors	NNS	O	factor	dep	104	SENT_202	[p12l1787t2195r2129b2287],
104	)	NN	O	)	_	0	SENT_202	[p12l1787t2195r2129b2287],
105	.	.	O	.	_	0	SENT_202	[p12l1787t2195r2129b2287],

1	RESULTS	NNS	O	result	_	0	SENT_203	[p12l836t2494r1311b2552],

1	PARTICIPANTS	NNS	O	participant	npadvmod	11	SENT_204	[p12l17t2727r576b2777],
2	Of	IN	O	of	_	0	SENT_204	[p12l12t2824r133b2904],
3	the	DT	O	the	det	5	SENT_204	[p12l149t2825r282b2903],
4	844	CD	NUMBER	844	num	5	SENT_204	[p12l316t2831r472b2904],
5	participants	NNS	O	participant	prep_of	11	SENT_204	[p12l505t2826r1021b2925],
6	who	WP	O	who	nsubj	7	SENT_204	[p12l1053t2825r1235b2905],
7	underwent	VBD	O	undergo	rcmod	5	SENT_204	[p12l1271t2825r1736b2905],
8	randomization	NN	O	randomization	dobj	7	SENT_204	[p12l1765t2825r2133b2904, p12l11t2954r331b3049],
9	,	,	O	,	_	0	SENT_204	[p12l1765t2825r2133b2904, p12l11t2954r331b3049],
10	833	CD	NUMBER	833	nsubj	11	SENT_204	[p12l385t2959r530b3032],
11	received	VBD	O	receive	_	0	SENT_204	[p12l581t2953r927b3033],
12	at	IN	O	at	quantmod	14	SENT_204	[p12l973t2970r1052b3031],
13	least	JJS	O	least	mwe	12	SENT_204	[p12l1094t2953r1293b3031],
14	one	CD	NUMBER	one	num	15	SENT_204	[p12l1336t2979r1487b3032],
15	dose	NN	O	dose	dobj	11	SENT_204	[p12l1535t2953r1730b3032],
16	of	IN	O	of	_	0	SENT_204	[p12l1778t2952r1878b3032],
17	study	NN	O	study	nn	18	SENT_204	[p12l1909t2953r2138b3053],
18	medication	NN	O	medication	prep_of	15	SENT_204	[p12l12t3082r495b3161],
19	(	CD	NUMBER	(	num	20	SENT_204	[p12l538t3083r717b3183],
20	Fig	NN	O	fig	dep	18	SENT_204	[p12l538t3083r717b3183],
21	.	.	O	.	_	0	SENT_204	[p12l538t3083r717b3183],

1	1	CD	NUMBER	1	_	0	SENT_205	[p12l765t3088r860b3173],
2	)	NN	O	)	dep	1	SENT_205	[p12l765t3088r860b3173],
3	.	.	O	.	_	0	SENT_205	[p12l765t3088r860b3173],

1	Adherence	NN	O	adherence	nsubj	5	SENT_206	[p12l900t3082r1355b3161],
2	to	TO	O	to	_	0	SENT_206	[p12l1395t3099r1476b3161],
3	treatment	NN	O	treatment	prep_to	1	SENT_206	[p12l1517t3099r1941b3161],
4	was	VBD	O	be	cop	5	SENT_206	[p12l1969t3108r2132b3161],
5	similar	JJ	O	similar	_	0	SENT_206	[p12l13t3210r326b3288],
6	in	IN	O	in	_	0	SENT_206	[p12l364t3211r448b3288],
7	the	DT	O	the	det	10	SENT_206	[p12l490t3210r625b3288],
8	two	CD	NUMBER	two	num	10	SENT_206	[p12l667t3227r827b3289],
9	study	NN	O	study	nn	10	SENT_206	[p12l872t3210r1106b3310],
10	groups	NNS	O	group	prep_in	5	SENT_206	[p12l1143t3236r1469b3311],
11	;	:	O	;	_	0	SENT_206	[p12l1143t3236r1469b3311],
12	3	CD	NUMBER	3	num	13	SENT_206	[p12l1516t3216r1560b3289],
13	participants	NNS	O	participant	nsubj	14	SENT_206	[p12l1604t3211r2132b3310],
14	(	VBP	O	(	parataxis	5	SENT_206	[p12l17t3344r92b3429],
15	2	CD	NUMBER	2	num	16	SENT_206	[p12l17t3344r92b3429],
16	participants	NNS	O	participant	dobj	14	SENT_206	[p12l131t3339r647b3438],
17	in	IN	O	in	_	0	SENT_206	[p12l685t3339r768b3416],
18	the	DT	O	the	det	19	SENT_206	[p12l804t3338r937b3416],
19	DTG	NN	O	dtg	prep_in	16	SENT_206	[p12l972t3344r1590b3417],
20	.	.	O	.	_	0	SENT_206	[p12l972t3344r1590b3417],

1	—	NN	O	—	_	0	SENT_207	[p12l972t3344r1590b3417],
2	.	.	O	.	_	0	SENT_207	[p12l972t3344r1590b3417],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_208	[p12l972t3344r1590b3417],
2	.	.	O	.	_	0	SENT_208	[p12l972t3344r1590b3417],

1	—	NN	O	—	_	0	SENT_209	[p12l972t3344r1590b3417],
2	.	.	O	.	_	0	SENT_209	[p12l972t3344r1590b3417],

1	3T	NN	O	3t	_	0	SENT_210	[p12l972t3344r1590b3417],
2	C	NN	O	c	nn	3	SENT_210	[p12l1592t3344r1649b3417],
3	group	NN	O	group	dep	1	SENT_210	[p12l1688t3364r1940b3439],
4	and	CC	O	and	_	0	SENT_210	[p12l1977t3338r2134b3417],
5	1	CD	NUMBER	1	dep	1	SENT_210	[p12l15t3472r59b3544],
6	in	IN	O	in	_	0	SENT_210	[p12l123t3467r206b3544],
7	the	DT	O	the	det	8	SENT_210	[p12l269t3466r402b3545],
8	EFV	NN	O	efv	prep_in	1	SENT_210	[p12l464t3472r1089b3545],
9	.	.	O	.	_	0	SENT_210	[p12l464t3472r1089b3545],

1	—	NN	O	—	_	0	SENT_211	[p12l464t3472r1089b3545],
2	.	.	O	.	_	0	SENT_211	[p12l464t3472r1089b3545],

1	TDF	NNP	O	TDF	_	0	SENT_212	[p12l464t3472r1089b3545],
2	.	.	O	.	_	0	SENT_212	[p12l464t3472r1089b3545],

1	—	NN	O	—	_	0	SENT_213	[p12l464t3472r1089b3545],
2	.	.	O	.	_	0	SENT_213	[p12l464t3472r1089b3545],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_214	[p12l464t3472r1089b3545],
2	group	NN	O	group	nsubjpass	5	SENT_214	[p12l1155t3472r1432b3567],
3	)	CD	NUMBER	)	num	2	SENT_214	[p12l1155t3472r1432b3567],
4	were	VBD	O	be	auxpass	5	SENT_214	[p12l1497t3492r1698b3545],
5	excluded	VBN	O	exclude	_	0	SENT_214	[p12l1762t3466r2134b3545],

1	1310	CD	DATE	1310	num	4	SENT_215	[p12l149t3625r225b3646],
2	N	NN	O	n	nn	4	SENT_215	[p12l933t3635r947b3650],
3	ENGLJ	NN	O	englj	nn	4	SENT_215	[p12l961t3635r1039b3657],
4	MED	NN	O	med	_	0	SENT_215	[p12l1054t3635r1106b3650],
5	36	CD	NUMBER	36	dep	4	SENT_215	[p12l1116t3629r1144b3657],
6	;	:	O	;	_	0	SENT_215	[p12l1164t3635r1178b3655],
7	1	CD	NUMBER	1	num	8	SENT_215	[p12l1164t3635r1178b3655],
8	NEjM.ORG	NN	O	nejm.org	dep	5	SENT_215	[p12l1233t3635r1357b3657],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	8	SENT_215	[p12l1394t3635r1529b3651],
10	7	CD	DATE	7	num	9	SENT_215	[p12l1539t3635r1558b3656],
11	,	,	DATE	,	_	0	SENT_215	[p12l1539t3635r1558b3656],
12	2013	CD	DATE	2013	num	9	SENT_215	[p12l1569t3635r1624b3657],

1	The	DT	O	the	det	4	SENT_216	[p12l935t3668r986b3692],
2	New	NNP	O	New	nn	4	SENT_216	[p12l995t3669r1057b3692],
3	Englan	NNP	O	Englan	nn	4	SENT_216	[p12l1066t3668r1160b3699],
4	ournal	NN	O	ournal	_	0	SENT_216	[p12l1199t3668r1283b3692],
5	of	IN	O	of	_	0	SENT_216	[p12l1293t3668r1322b3692],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_216	[p12l1329t3668r1454b3692],

1	Co	NNP	O	Co	_	0	SENT_217	[p12l728t3750r765b3774],
2	right	RB	O	right	advmod	4	SENT_217	[p12l799t3750r862b3781],
3	©	CD	NUMBER	©	pobj	2	SENT_217	[p12l871t3750r895b3774],
4	2013	CD	DATE	2013	dep	1	SENT_217	[p12l905t3750r969b3774],
5	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	7	SENT_217	[p12l979t3750r1170b3774],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_217	[p12l1180t3750r1288b3774],
7	Society	NNP	ORGANIZATION	Society	dep	4	SENT_217	[p12l1299t3750r1404b3781],
8	.	.	O	.	_	0	SENT_217	[p12l1299t3750r1404b3781],

1	All	DT	O	all	det	2	SENT_218	[p12l1415t3750r1456b3774],
2	rights	NNS	O	rights	nsubj	3	SENT_218	[p12l1465t3750r1540b3781],
3	reserved	VBN	O	reserve	_	0	SENT_218	[p12l1550t3750r1668b3774],
4	.	.	O	.	_	0	SENT_218	[p12l1550t3750r1668b3774],

1	DOLUTEGRAVI	NNP	O	DOLUTEGRAVI	_	0	SENT_219	[p12l507t3793r743b3812],
2	AND	CC	O	and	_	0	SENT_219	[p12l780t3793r852b3812],
3	ABACAVIR	NNP	O	ABACAVIR	conj_and	1	SENT_219	[p12l864t3793r1270b3812],
4	.	.	O	.	_	0	SENT_219	[p12l864t3793r1270b3812],

1	—	NN	O	—	_	0	SENT_220	[p12l864t3793r1270b3812],
2	.	.	O	.	_	0	SENT_220	[p12l864t3793r1270b3812],

1	LAMIVUDINE	NNP	O	LAMIVUDINE	_	0	SENT_221	[p12l864t3793r1270b3812],
2	FOR	IN	O	for	_	0	SENT_221	[p12l1284t3793r1348b3812],
3	HIV-1	NN	O	hiv-1	nn	4	SENT_221	[p12l1362t3793r1452b3812],
4	INFECTION	NN	O	infection	prep_for	1	SENT_221	[p12l1467t3793r1653b3812],

1	A	DT	O	a	det	2	SENT_222	[p13l265t102r287b127],
2	Proportion	NN	O	proportion	_	0	SENT_222	[p13l311t105r445b135],
3	of	IN	O	of	_	0	SENT_222	[p13l455t104r484b128],
4	Participants	NNS	O	participant	prep_of	2	SENT_222	[p13l490t105r641b135],
5	with	IN	O	with	_	0	SENT_222	[p13l650t104r704b128],
6	HIV-1	NN	O	hiv-1	nn	8	SENT_222	[p13l716t106r788b128],
7	RNA	NN	O	rna	nn	8	SENT_222	[p13l800t106r858b127],
8	Level	NN	O	level	prep_with	4	SENT_222	[p13l868t104r931b128],
9	<	JJR	O	<	dep	2	SENT_222	[p13l941t106r988b128],
10	50	CD	NUMBER	50	num	11	SENT_222	[p13l941t106r988b128],
11	Copies/ml	NN	O	copies/ml	dep	9	SENT_222	[p13l997t104r1129b135],

1	30	CD	NUMBER	30	number	2	SENT_223	[p13l386t484r413b505],
2	20	CD	NUMBER	20	num	3	SENT_223	[p13l386t531r413b552],
3	Difference	NN	O	difference	nsubj	13	SENT_223	[p13l594t519r715b541],
4	in	IN	O	in	_	0	SENT_223	[p13l725t521r744b541],
5	response	NN	O	response	prep_in	3	SENT_223	[p13l756t527r863b548],
6	at	IN	O	at	_	0	SENT_223	[p13l872t523r894b541],
7	wk	NN	DURATION	wk	prep_at	5	SENT_223	[p13l902t519r934b541],
8	48	CD	NUMBER	48	num	7	SENT_223	[p13l942t521r976b545],
9	,	,	O	,	_	0	SENT_223	[p13l942t521r976b545],
10	7	CD	PERCENT	7	num	12	SENT_223	[p13l988t521r999b541],
11	percentage	NN	PERCENT	percentage	nn	12	SENT_223	[p13l1011t523r1141b548],
12	points	NNS	PERCENT	point	appos	7	SENT_223	[p13l1151t521r1224b548],
13	(	VBP	PERCENT	(	_	0	SENT_223	[p13l1236t520r1297b548],
14	95	CD	PERCENT	95	number	15	SENT_223	[p13l1236t520r1297b548],
15	%	NN	PERCENT	%	amod	16	SENT_223	[p13l1236t520r1297b548],
16	CI	NN	O	ci	dobj	13	SENT_223	[p13l1306t521r1336b545],
17	,	,	O	,	_	0	SENT_223	[p13l1306t521r1336b545],
18	2-12	CD	NUMBER	2-12	num	19	SENT_223	[p13l1347t521r1414b548],
19	)	NN	O	)	appos	16	SENT_223	[p13l1347t521r1414b548],

1	P	NN	O	p	_	0	SENT_224	[p13l594t554r691b575],
2	=	JJ	O	=	amod	1	SENT_224	[p13l594t554r691b575],
3	0.003	CD	NUMBER	0.003	tmod	2	SENT_224	[p13l594t554r691b575],

1	DTG	NN	O	dtg	_	0	SENT_225	[p13l1560t168r1748b193],
2	.	.	O	.	_	0	SENT_225	[p13l1560t168r1748b193],

1	—	NN	O	—	_	0	SENT_226	[p13l1560t168r1748b193],
2	.	.	O	.	_	0	SENT_226	[p13l1560t168r1748b193],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_227	[p13l1560t168r1748b193],
2	.	.	O	.	_	0	SENT_227	[p13l1560t168r1748b193],

1	—	NN	O	—	_	0	SENT_228	[p13l1560t168r1748b193],
2	.	.	O	.	_	0	SENT_228	[p13l1560t168r1748b193],

1	3TC	NN	O	3tc	_	0	SENT_229	[p13l1560t168r1748b193],
2	,	,	O	,	_	0	SENT_229	[p13l1560t168r1748b193],
3	88	CD	PERCENT	88	num	4	SENT_229	[p13l1759t168r1811b190],
4	%	NN	PERCENT	%	dep	1	SENT_229	[p13l1759t168r1811b190],

1	EFV	NN	O	efv	_	0	SENT_230	[p13l1560t269r1739b293],
2	.	.	O	.	_	0	SENT_230	[p13l1560t269r1739b293],

1	—	NN	O	—	_	0	SENT_231	[p13l1560t269r1739b293],
2	.	.	O	.	_	0	SENT_231	[p13l1560t269r1739b293],

1	TDF	NNP	O	TDF	_	0	SENT_232	[p13l1560t269r1739b293],
2	.	.	O	.	_	0	SENT_232	[p13l1560t269r1739b293],

1	—	NN	O	—	_	0	SENT_233	[p13l1560t269r1739b293],
2	.	.	O	.	_	0	SENT_233	[p13l1560t269r1739b293],

1	FTC	NNP	ORGANIZATION	FTC	_	0	SENT_234	[p13l1560t269r1739b293],
2	,	,	O	,	_	0	SENT_234	[p13l1560t269r1739b293],
3	81	CD	PERCENT	81	num	4	SENT_234	[p13l1750t268r1802b290],
4	%	NN	PERCENT	%	dep	1	SENT_234	[p13l1750t268r1802b290],

1	Participants	NNS	O	participant	_	0	SENT_235	[p13l275t352r305b502],
2	(	CD	PERCENT	(	num	3	SENT_235	[p13l275t299r305b341],
3	%	NN	PERCENT	%	dep	1	SENT_235	[p13l275t299r305b341],
4	)	CD	NUMBER	)	dep	1	SENT_235	[p13l275t299r305b341],

1	B	NN	O	b	_	0	SENT_236	[p13l268t789r286b814],
2	Change	NNP	O	Change	dep	1	SENT_236	[p13l309t791r407b822],
3	in	IN	O	in	_	0	SENT_236	[p13l416t791r437b814],
4	CD4	NN	O	cd4	prep_in	2	SENT_236	[p13l448t793r520b815],
5	+	CC	O	+	_	0	SENT_236	[p13l448t793r520b815],
6	T-Cell	NN	O	t-cell	nn	8	SENT_236	[p13l529t791r601b815],
7	Count	NN	O	count	nn	8	SENT_236	[p13l611t793r690b815],
8	l	NN	O	l	conj_+	2	SENT_236	[p13l371t1000r383b1020],
9	\	CD	NUMBER	\	number	10	SENT_236	[p13l371t1000r383b1020],
10	)	CD	NUMBER	)	num	12	SENT_236	[p13l371t1000r383b1020],
11	O	NN	O	o	nn	12	SENT_236	[p13l385t1000r399b1020],
12	O	NN	O	o	dep	8	SENT_236	[p13l400t1000r413b1020],

1	A	DT	O	a	det	4	SENT_237	[p13l312t1012r341b1019],
2	M	NN	O	m	nn	4	SENT_237	[p13l309t1021r325b1030],
3	E	NN	O	e	nn	4	SENT_237	[p13l318t1033r333b1055],
4	E	NN	O	e	_	0	SENT_237	[p13l318t1059r333b1081],
5	\	CD	NUMBER	\	num	6	SENT_237	[p13l312t1083r340b1095],
6	L	NN	O	l	dep	4	SENT_237	[p13l309t1097r333b1116],
7	‘	CD	NUMBER	‘	num	10	SENT_237	[p13l309t1097r333b1116],
8	E	NN	O	e	nn	10	SENT_237	[p13l309t1119r333b1139],
9	u	NN	O	u	nn	10	SENT_237	[p13l317t1140r333b1153],
10	V	NN	O	v	dep	4	SENT_237	[p13l312t1154r341b1161],

1	I	PRP	O	I	nsubj	2	SENT_238	[p13l615t1217r617b1230],
2	ence	VBP	O	ence	_	0	SENT_238	[p13l660t1216r715b1231],
3	in	IN	O	in	_	0	SENT_238	[p13l725t1211r744b1230],
4	response	NN	O	response	prep_in	2	SENT_238	[p13l756t1216r863b1237],
5	at	IN	O	at	_	0	SENT_238	[p13l872t1213r894b1231],
6	wk	NN	DURATION	wk	nn	8	SENT_238	[p13l901t1209r934b1231],
7	48,59	CD	NUMBER	48,59	num	8	SENT_238	[p13l942t1210r1013b1235],
8	cells/mm3	NN	O	cells/mm3	prep_at	2	SENT_238	[p13l1023t1208r1145b1238],
9	(	CD	PERCENT	(	num	12	SENT_238	[p13l1158t1210r1218b1238],
10	95	CD	PERCENT	95	number	11	SENT_238	[p13l1158t1210r1218b1238],
11	%	NN	PERCENT	%	amod	12	SENT_238	[p13l1158t1210r1218b1238],
12	CI	NN	O	ci	dep	8	SENT_238	[p13l1227t1210r1258b1235],
13	,	,	O	,	_	0	SENT_238	[p13l1227t1210r1258b1235],
14	33-84	CD	NUMBER	33-84	num	15	SENT_238	[p13l1269t1210r1350b1238],
15	)	NN	O	)	appos	8	SENT_238	[p13l1269t1210r1350b1238],

1	cu	NN	O	cu	dep	9	SENT_239	[p13l282t846r298b860],
2	.5	CD	NUMBER	.5	num	1	SENT_239	[p13l275t862r297b884],
3	T	NN	O	t	dep	1	SENT_239	[p13l274t887r298b907],
4	)	CD	NUMBER	)	num	3	SENT_239	[p13l274t887r298b907],
5	III	CD	NUMBER	iii	num	6	SENT_239	[p13l282t908r298b921],
6	N	NN	O	n	dep	9	SENT_239	[p13l282t922r298b935],
7	no	DT	O	no	det	9	SENT_239	[p13l276t937r297b952],
8	§	NN	O	§	nn	9	SENT_239	[p13l282t964r298b1004],
9	¢	NN	O	¢	dep	13	SENT_239	[p13l274t1004r297b1024],
10	o	NN	O	o	dep	9	SENT_239	[p13l282t1032r298b1046],
11	no	DT	O	no	dep	10	SENT_239	[p13l282t1047r305b1062],
12	:	:	O	:	_	0	SENT_239	[p13l282t1064r297b1078],
13	N	NN	O	n	_	0	SENT_239	[p13l282t1080r298b1093],
14	.	.	O	.	_	0	SENT_239	[p13l274t1096r297b1110],

1	:	:	O	:	_	0	SENT_240	[p13l274t1096r297b1110],
2	U	NNP	O	U	nn	6	SENT_240	[p13l276t1112r298b1130],
3	C	NNP	O	C	nn	6	SENT_240	[p13l282t1140r297b1153],
4	N	NNP	O	N	nn	6	SENT_240	[p13l282t1156r298b1169],
5	o	NN	O	o	nn	6	SENT_240	[p13l282t1170r298b1184],
6	E	NN	O	e	_	0	SENT_240	[p13l276t1188r297b1210],
7	-	:	O	-	_	0	SENT_240	[p13l274t1222r298b1236],
8	u	NN	O	u	nn	9	SENT_240	[p13l274t1222r298b1236],
9	.3	NN	NUMBER	.3	dep	6	SENT_240	[p13l278t1237r298b1261],
10	VI	NNP	O	VI	prep	6	SENT_240	[p13l282t1262r298b1274],
11	.2	NN	NUMBER	.2	dep	10	SENT_240	[p13l275t1277r305b1300],
12	.	.	O	.	_	0	SENT_240	[p13l275t1277r305b1300],

1	‘	NN	O	‘	nn	2	SENT_241	[p13l274t1301r298b1316],
2	D	NN	O	d	_	0	SENT_241	[p13l274t1301r298b1316],
3	<	JJR	O	<	dep	2	SENT_241	[p13l276t1316r297b1335],

1	I	PRP	O	I	_	0	SENT_242	[p13l973t1326r976b1341],
2	I	PRP	O	I	dep	1	SENT_242	[p13l1147t1328r1149b1341],
3	I	PRP	O	I	dep	1	SENT_242	[p13l1320t1326r1323b1341],
4	24	CD	NUMBER	24	number	5	SENT_242	[p13l961t1348r988b1368],
5	32	CD	NUMBER	32	num	6	SENT_242	[p13l1135t1348r1161b1368],
6	40	CD	NUMBER	40	dep	3	SENT_242	[p13l1307t1348r1336b1369],

1	Figure	NN	O	figure	_	0	SENT_243	[p13l266t1474r350b1506],
2	2	CD	NUMBER	2	dep	1	SENT_243	[p13l361t1476r384b1498],
3	.	.	O	.	_	0	SENT_243	[p13l361t1476r384b1498],

1	Efficacy	NNP	O	Efficacy	nn	2	SENT_244	[p13l398t1473r506b1506],
2	Data	NNP	O	Data	_	0	SENT_244	[p13l518t1476r581b1499],
3	through	IN	O	through	_	0	SENT_244	[p13l591t1473r700b1506],
4	Week	NNP	DURATION	Week	prep_through	2	SENT_244	[p13l711t1473r787b1499],
5	48	CD	NUMBER	48	num	4	SENT_244	[p13l797t1475r839b1499],
6	.	.	O	.	_	0	SENT_244	[p13l797t1475r839b1499],

1	Panel	NN	O	panel	nn	2	SENT_245	[p13l266t1523r338b1549],
2	A	NN	O	a	nsubj	3	SENT_245	[p13l350t1525r369b1548],
3	shows	VBZ	O	show	_	0	SENT_245	[p13l380t1523r466b1549],
4	the	DT	O	the	det	5	SENT_245	[p13l477t1523r520b1549],
5	proportion	NN	O	proportion	dobj	3	SENT_245	[p13l533t1526r681b1556],
6	of	IN	O	of	_	0	SENT_245	[p13l694t1523r723b1549],
7	participants	NNS	O	participant	prep_of	5	SENT_245	[p13l731t1526r895b1556],
8	with	IN	O	with	_	0	SENT_245	[p13l906t1523r964b1549],
9	a	DT	O	a	det	13	SENT_245	[p13l977t1532r990b1549],
10	human	JJ	O	human	amod	13	SENT_245	[p13l1003t1523r1096b1549],
11	immunodeficiency	NN	O	immunodeficiency	nn	13	SENT_245	[p13l1111t1523r1370b1556],
12	virus	NN	O	virus	nn	13	SENT_245	[p13l1380t1526r1446b1549],
13	type	NN	O	type	prep_with	7	SENT_245	[p13l1457t1528r1516b1556],
14	1	CD	NUMBER	1	number	15	SENT_245	[p13l1530t1526r1541b1548],
15	(	CD	NUMBER	(	num	16	SENT_245	[p13l1556t1526r1627b1556],
16	HIV	NN	O	hiv	dep	13	SENT_245	[p13l1556t1526r1627b1556],
17	-	:	O	-	_	0	SENT_245	[p13l1556t1526r1627b1556],
18	NA	NN	O	na	nn	19	SENT_245	[p13l1687t1525r1729b1548],
19	level	NN	O	level	dep	13	SENT_245	[p13l1741t1523r1799b1549],
20	ofless	JJ	O	ofless	amod	19	SENT_245	[p13l1812t1523r1900b1549],
21	than	IN	O	than	_	0	SENT_245	[p13l263t1565r323b1590],
22	50	CD	NUMBER	50	num	23	SENT_245	[p13l337t1567r368b1590],
23	copies	NNS	O	copy	prep_than	20	SENT_245	[p13l379t1568r466b1598],
24	per	IN	O	per	_	0	SENT_245	[p13l480t1574r524b1598],
25	milliliter	NN	O	milliliter	nn	26	SENT_245	[p13l535t1565r648b1590],
26	accord	NN	O	accord	prep_per	23	SENT_245	[p13l659t1565r757b1590],
27	’	CD	NUMBER	’	num	30	SENT_245	[p13l659t1565r757b1590],
28	o	NN	O	o	nn	30	SENT_245	[p13l815t1574r830b1590],
29	study	NN	O	study	nn	30	SENT_245	[p13l843t1565r917b1598],
30	visit	NN	O	visit	dep	19	SENT_245	[p13l927t1568r990b1595],
31	,	,	O	,	_	0	SENT_245	[p13l927t1568r990b1595],
32	as	IN	O	as	mark	33	SENT_245	[p13l1003t1574r1031b1590],
33	calculated	VBN	O	calculate	advcl	3	SENT_245	[p13l1043t1565r1182b1590],
34	by	IN	O	by	_	0	SENT_245	[p13l1196t1565r1224b1598],
35	the	DT	O	the	det	39	SENT_245	[p13l1234t1565r1277b1590],
36	Snapshot	NNP	O	Snapshot	nn	39	SENT_245	[p13l1289t1565r1419b1598],
37	algorithm	NN	O	algorithm	nn	39	SENT_245	[p13l1430t1565r1563b1598],
38	oft	NN	O	oft	nn	39	SENT_245	[p13l1575t1565r1620b1590],
39	ood	NN	O	ood	prep_by	33	SENT_245	[p13l1683t1565r1734b1590],
40	and	CC	O	and	_	0	SENT_245	[p13l1747t1565r1796b1590],
41	Drug	NN	O	drug	nn	42	SENT_245	[p13l1811t1567r1878b1598],
42	Administration	NN	O	administration	prep_by	33	SENT_245	[p13l263t1607r480b1632],
43	.	.	O	.	_	0	SENT_245	[p13l263t1607r480b1632],

1	Panel	NN	O	panel	nn	2	SENT_246	[p13l495t1607r566b1632],
2	B	NN	O	b	nsubj	3	SENT_246	[p13l581t1609r596b1632],
3	shows	VBZ	O	show	_	0	SENT_246	[p13l608t1607r694b1632],
4	the	DT	O	the	det	6	SENT_246	[p13l705t1607r748b1632],
5	olute	JJ	O	olute	amod	6	SENT_246	[p13l809t1607r877b1632],
6	change	NN	O	change	dobj	3	SENT_246	[p13l889t1607r987b1640],
7	from	IN	O	from	_	0	SENT_246	[p13l997t1606r1062b1632],
8	baseline	NN	O	baseline	prep_from	3	SENT_246	[p13l1076t1607r1188b1632],
9	in	IN	O	in	_	0	SENT_246	[p13l1201t1609r1222b1632],
10	CD4	NN	O	cd4	prep_in	8	SENT_246	[p13l1235t1609r1313b1632],
11	+	CC	O	+	_	0	SENT_246	[p13l1235t1609r1313b1632],
12	T-cell	NN	O	t-cell	nn	13	SENT_246	[p13l1324t1607r1395b1632],
13	count	NN	O	count	conj_+	10	SENT_246	[p13l1408t1612r1494b1632],
14	.	.	O	.	_	0	SENT_246	[p13l1408t1612r1494b1632],

1	I	PRP	O	I	dep	2	SENT_247	[p13l1506t1610r1516b1632],
2	bars	NNS	O	bar	nsubj	3	SENT_247	[p13l1528t1607r1584b1632],
3	indicate	VBP	O	indicate	_	0	SENT_247	[p13l1597t1607r1705b1632],
4	95	CD	PERCENT	95	number	5	SENT_247	[p13l1716t1608r1775b1633],
5	%	NN	PERCENT	%	amod	7	SENT_247	[p13l1716t1608r1775b1633],
6	confidence	NN	O	confidence	nn	7	SENT_247	[p13l1787t1606r1865b1632, p13l264t1648r346b1674],
7	intervals	NNS	O	interval	dobj	3	SENT_247	[p13l358t1648r482b1674],
8	.	.	O	.	_	0	SENT_247	[p13l358t1648r482b1674],

1	Data	NNS	O	datum	nsubjpass	9	SENT_248	[p13l497t1651r559b1674],
2	on	IN	O	on	_	0	SENT_248	[p13l571t1657r604b1674],
3	the	DT	O	the	det	4	SENT_248	[p13l616t1648r659b1674],
4	CD4	NN	O	cd4	prep_on	1	SENT_248	[p13l670t1650r749b1674],
5	+	CC	O	+	_	0	SENT_248	[p13l670t1650r749b1674],
6	T-cell	NN	O	t-cell	nn	7	SENT_248	[p13l759t1648r831b1674],
7	counts	NNS	O	count	prep_on	1	SENT_248	[p13l843t1653r936b1674],
8	were	VBD	O	be	auxpass	9	SENT_248	[p13l947t1657r1012b1674],
9	analyzed	VBN	O	analyze	_	0	SENT_248	[p13l1024t1648r1143b1682],
10	with	IN	O	with	_	0	SENT_248	[p13l1154t1648r1211b1674],
11	the	DT	O	the	det	14	SENT_248	[p13l1223t1648r1267b1674],
12	use	NN	O	use	nn	14	SENT_248	[p13l1279t1657r1325b1674],
13	ofa	NN	O	ofa	nn	14	SENT_248	[p13l1336t1648r1386b1674],
14	repeated-measures	NNS	O	repeated-measure	prep_with	9	SENT_248	[p13l1399t1648r1665b1681],
15	mixed	JJ	O	mixed	amod	16	SENT_248	[p13l1678t1648r1758b1674],
16	model	NN	O	model	dobj	9	SENT_248	[p13l1772t1648r1857b1674],
17	that	WDT	O	that	nsubj	18	SENT_248	[p13l263t1690r317b1715],
18	included	VBD	O	include	rcmod	16	SENT_248	[p13l329t1690r446b1715],
19	the	DT	O	the	det	21	SENT_248	[p13l458t1690r501b1715],
20	following	VBG	O	follow	amod	21	SENT_248	[p13l512t1690r640b1723],
21	covariates	NNS	O	covariate	dobj	18	SENT_248	[p13l651t1693r797b1715],
22	:	:	O	:	_	0	SENT_248	[p13l651t1693r797b1715],
23	treatment	NN	O	treatment	nn	31	SENT_248	[p13l808t1695r953b1720],
24	,	,	O	,	_	0	SENT_248	[p13l808t1695r953b1720],
25	study	NN	O	study	dep	31	SENT_248	[p13l967t1690r1041b1723],
26	visit	NN	O	visit	nn	31	SENT_248	[p13l1051t1693r1114b1720],
27	,	,	O	,	_	0	SENT_248	[p13l1051t1693r1114b1720],
28	plasma	NN	O	plasma	dep	31	SENT_248	[p13l1128t1690r1226b1723],
29	HIV-1	NN	O	hiv-1	nn	31	SENT_248	[p13l1240t1692r1314b1716],
30	RNA	NN	O	rna	nn	31	SENT_248	[p13l1329t1692r1390b1715],
31	level	NN	O	level	conj_and	16	SENT_248	[p13l1402t1690r1461b1715],
32	at	IN	O	at	_	0	SENT_248	[p13l1474t1695r1498b1715],
33	baseline	NN	O	baseline	prep_at	31	SENT_248	[p13l1510t1690r1630b1720],
34	,	,	O	,	_	0	SENT_248	[p13l1510t1690r1630b1720],
35	CD4	NN	O	cd4	conj_and	16	SENT_248	[p13l1643t1692r1721b1715],
36	+	CC	O	+	_	0	SENT_248	[p13l1643t1692r1721b1715],
37	T-cell	NN	O	t-cell	nn	38	SENT_248	[p13l1731t1690r1803b1715],
38	count	NN	O	count	conj_+	35	SENT_248	[p13l1816t1695r1894b1715],
39	at	IN	O	at	_	0	SENT_248	[p13l264t1737r289b1757],
40	baseline	NN	O	baseline	prep_at	38	SENT_248	[p13l301t1732r421b1761],
41	,	,	O	,	_	0	SENT_248	[p13l301t1732r421b1761],
42	interaction	NN	O	interaction	conj_and	16	SENT_248	[p13l434t1734r582b1757],
43	between	IN	O	between	_	0	SENT_248	[p13l596t1732r711b1757],
44	treatment	NN	O	treatment	nn	47	SENT_248	[p13l723t1737r860b1757],
45	and	CC	O	and	_	0	SENT_248	[p13l872t1732r920b1757],
46	study	NN	O	study	nn	47	SENT_248	[p13l934t1732r1008b1765],
47	visit	NN	O	visit	prep_between	42	SENT_248	[p13l1018t1734r1081b1761],
48	,	,	O	,	_	0	SENT_248	[p13l1018t1734r1081b1761],
49	interaction	NN	O	interaction	dobj	9	SENT_248	[p13l1095t1734r1243b1757],
50	between	IN	O	between	_	0	SENT_248	[p13l1257t1732r1371b1757],
51	baseline	NN	O	baseline	nn	54	SENT_248	[p13l1386t1732r1498b1757],
52	HIV-1	NN	O	hiv-1	nn	54	SENT_248	[p13l1511t1734r1585b1757],
53	RNA	NN	O	rna	nn	54	SENT_248	[p13l1600t1733r1661b1757],
54	level	NN	O	level	prep_between	49	SENT_248	[p13l1673t1732r1732b1757],
55	and	CC	O	and	_	0	SENT_248	[p13l1745t1732r1794b1757],
56	study	NN	O	study	nn	57	SENT_248	[p13l1807t1732r1881b1765],
57	visit	NN	O	visit	prep_between	49	SENT_248	[p13l263t1776r325b1803],
58	,	,	O	,	_	0	SENT_248	[p13l263t1776r325b1803],
59	and	CC	O	and	_	0	SENT_248	[p13l337t1773r385b1799],
60	interaction	NN	O	interaction	conj_and	16	SENT_248	[p13l398t1776r543b1799],
61	between	IN	O	between	_	0	SENT_248	[p13l556t1773r669b1799],
62	baseline	NN	O	baseline	nn	63	SENT_248	[p13l682t1773r792b1799],
63	CD4	NN	O	cd4	prep_between	60	SENT_248	[p13l803t1775r880b1799],
64	+	CC	O	+	_	0	SENT_248	[p13l803t1775r880b1799],
65	T-cell	NN	O	t-cell	nn	66	SENT_248	[p13l890t1773r960b1799],
66	count	NN	O	count	conj_and	16	SENT_248	[p13l972t1778r1049b1799],
67	and	CC	O	and	_	0	SENT_248	[p13l1060t1773r1107b1799],
68	st	NN	O	st	nn	70	SENT_248	[p13l1120t1778r1143b1799],
69	d	NN	O	d	nn	70	SENT_248	[p13l1163t1773r1177b1799],
70	visit	NN	O	visit	conj_+	60	SENT_248	[p13l1202t1776r1264b1799],
71	.	.	O	.	_	0	SENT_248	[p13l1202t1776r1264b1799],

1	No	DT	O	no	det	2	SENT_249	[p13l1278t1776r1317b1799],
2	assumptions	NNS	O	assumption	nsubjpass	4	SENT_249	[p13l1328t1776r1502b1806],
3	were	VBD	O	be	auxpass	4	SENT_249	[p13l1513t1782r1576b1799],
4	made	VBN	O	make	ccomp	29	SENT_249	[p13l1588t1773r1663b1799],
5	about	IN	O	about	_	0	SENT_249	[p13l1674t1773r1751b1799],
6	the	DT	O	the	det	7	SENT_249	[p13l1761t1774r1803b1799],
7	correlations	NNS	O	correlation	poss	16	SENT_249	[p13l1814t1782r1892b1799, p13l265t1815r356b1840],
8	among	IN	O	among	_	0	SENT_249	[p13l368t1824r464b1848],
9	the	DT	O	the	det	13	SENT_249	[p13l474t1815r517b1840],
10	various	JJ	O	various	amod	13	SENT_249	[p13l528t1818r628b1840],
11	measurements	NNS	O	measurement	nn	13	SENT_249	[p13l642t1820r848b1840],
12	ofa	NN	O	ofa	nn	13	SENT_249	[p13l860t1815r909b1840],
13	participant	NN	O	participant	prep_among	7	SENT_249	[p13l923t1817r1095b1848],
14	's	POS	O	's	_	0	SENT_249	[p13l923t1817r1095b1848],
15	C	NN	O	c	nn	16	SENT_249	[p13l1107t1817r1125b1840],
16	T-cell	NN	O	t-cell	prep_about	4	SENT_249	[p13l1195t1815r1267b1840],
17	count	NN	O	count	dep	16	SENT_249	[p13l1280t1820r1358b1840],
18	(	CD	NUMBER	(	num	17	SENT_249	[p13l1372t1817r1428b1848],
19	i.e.	FW	O	i.e.	dep	17	SENT_249	[p13l1372t1817r1428b1848],
20	,	,	O	,	_	0	SENT_249	[p13l1372t1817r1428b1848],
21	the	DT	O	the	det	23	SENT_249	[p13l1440t1815r1483b1840],
22	correlation	NN	O	correlation	nn	23	SENT_249	[p13l1494t1815r1642b1840],
23	matrix	NN	O	matrix	nsubj	29	SENT_249	[p13l1657t1818r1743b1840],
24	for	IN	O	for	_	0	SENT_249	[p13l1753t1815r1791b1840],
25	withinparticipant	JJ	O	withinparticipant	amod	26	SENT_249	[p13l1801t1815r1896b1840, p13l265t1859r415b1890],
26	errors	NNS	O	error	prep_for	23	SENT_249	[p13l426t1866r507b1882],
27	is	VBZ	O	be	cop	29	SENT_249	[p13l520t1859r539b1882],
28	unstructured	JJ	O	unstructured	amod	29	SENT_249	[p13l553t1857r751b1890],
29	)	NN	O	)	_	0	SENT_249	[p13l553t1857r751b1890],
30	.	.	O	.	_	0	SENT_249	[p13l553t1857r751b1890],

1	CI	NN	O	ci	nsubj	2	SENT_250	[p13l764t1859r789b1882],
2	denotes	VBZ	O	denote	_	0	SENT_250	[p13l803t1857r913b1882],
3	confidence	NN	O	confidence	nn	4	SENT_250	[p13l925t1857r1077b1882],
4	interval	NN	O	interval	dobj	2	SENT_250	[p13l1090t1857r1199b1882],
5	.	.	O	.	_	0	SENT_250	[p13l1090t1857r1199b1882],

1	from	IN	O	from	_	0	SENT_251	[p13l8t2028r219b2108],
2	the	DT	O	the	det	6	SENT_251	[p13l250t2029r382b2107],
3	per	FW	O	per	nn	6	SENT_251	[p13l411t2029r944b2129],
4	—	FW	O	—	nn	6	SENT_251	[p13l411t2029r944b2129],
5	protocol	NN	O	protocol	nn	6	SENT_251	[p13l411t2029r944b2129],
6	population	NN	O	population	pobj	1	SENT_251	[p13l973t2029r1443b2129],
7	owing	VBG	O	owe	partmod	6	SENT_251	[p13l1475t2030r1744b2130],
8	to	TO	O	to	_	0	SENT_251	[p13l1771t2046r1853b2108],
9	an	DT	O	a	det	10	SENT_251	[p13l1884t2055r1987b2107],
10	interruption	NN	O	interruption	prep_to	7	SENT_251	[p13l2016t2030r2132b2107, p13l9t2158r448b2257],
11	of	IN	O	of	_	0	SENT_251	[p13l489t2156r589b2236],
12	the	DT	O	the	det	14	SENT_251	[p13l611t2157r743b2235],
13	study	NN	O	study	nn	14	SENT_251	[p13l785t2157r1016b2257],
14	drug	NN	O	drug	prep_of	10	SENT_251	[p13l1052t2157r1256b2258],
15	for	IN	O	for	_	0	SENT_251	[p13l1292t2156r1415b2236],
16	more	JJR	O	more	mwe	17	SENT_251	[p13l1452t2183r1672b2236],
17	than	IN	O	than	quantmod	18	SENT_251	[p13l1713t2157r1909b2235],
18	10	CD	PERCENT	10	num	19	SENT_251	[p13l1953t2163r2134b2236],
19	%	NN	PERCENT	%	prep_for	7	SENT_251	[p13l1953t2163r2134b2236],
20	of	IN	O	of	_	0	SENT_251	[p13l9t2284r109b2364],
21	the	DT	O	the	det	23	SENT_251	[p13l140t2285r273b2363],
22	total	JJ	O	total	amod	23	SENT_251	[p13l322t2285r519b2364],
23	time	NN	O	time	prep_of	19	SENT_251	[p13l568t2286r761b2363],
24	of	IN	O	of	_	0	SENT_251	[p13l811t2284r911b2364],
25	treatment	NN	O	treatment	nn	28	SENT_251	[p13l942t2302r1366b2363],
26	(	CD	NUMBER	(	num	28	SENT_251	[p13l1414t2285r1672b2376],
27	Table	NNP	O	Table	nn	28	SENT_251	[p13l1414t2285r1672b2376],
28	S3	NN	O	s3	prep_of	23	SENT_251	[p13l1724t2291r1816b2364],
29	in	IN	O	in	advmod	7	SENT_251	[p13l1868t2286r1951b2363],
30	the	DT	O	the	dep	29	SENT_251	[p13l2000t2285r2133b2363],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_252	[p13l11t2414r645b2514],
2	Appendix	NNP	O	Appendix	_	0	SENT_252	[p13l674t2414r1131b2514],
3	)	NN	O	)	dep	2	SENT_252	[p13l674t2414r1131b2514],
4	.	.	O	.	_	0	SENT_252	[p13l674t2414r1131b2514],

1	Demographic	JJ	MISC	demographic	_	0	SENT_253	[p13l1173t2414r1749b2515],
2	and	CC	O	and	_	0	SENT_253	[p13l1785t2414r1942b2493],
3	disease	NN	O	disease	conj_and	1	SENT_253	[p13l1979t2414r2132b2493, p13l9t2569r189b2621],

1	characteristics	NNS	O	characteristic	nsubj	6	SENT_254	[p13l251t2543r872b2621],
2	at	IN	O	at	_	0	SENT_254	[p13l934t2560r1013b2621],
3	baseline	NN	O	baseline	prep_at	1	SENT_254	[p13l1068t2543r1420b2622],
4	were	VBD	O	be	cop	6	SENT_254	[p13l1476t2569r1678b2622],
5	well	RB	O	well	advmod	6	SENT_254	[p13l1735t2543r1912b2622],
6	balanced	JJ	O	balanced	_	0	SENT_254	[p13l1972t2543r2132b2622, p13l8t2671r259b2750],

1	between	IN	O	between	_	0	SENT_255	[p13l294t2671r652b2750],
2	the	DT	O	the	det	4	SENT_255	[p13l687t2671r819b2749],
3	treatment	NN	O	treatment	nn	4	SENT_255	[p13l855t2688r1279b2749],
4	groups	NNS	O	group	pobj	1	SENT_255	[p13l1309t2697r1629b2772],
5	.	.	O	.	_	0	SENT_255	[p13l1309t2697r1629b2772],

1	The	DT	O	the	det	3	SENT_256	[p13l134t2799r295b2877],
2	median	JJ	O	median	amod	3	SENT_256	[p13l331t2799r654b2878],
3	age	NN	O	age	nsubj	10	SENT_256	[p13l690t2825r833b2900],
4	of	IN	O	of	_	0	SENT_256	[p13l870t2798r969b2878],
5	the	DT	O	the	det	7	SENT_256	[p13l987t2799r1120b2877],
6	study	NN	O	study	nn	7	SENT_256	[p13l1158t2799r1388b2899],
7	participants	NNS	O	participant	prep_of	3	SENT_256	[p13l1417t2800r1935b2899],
8	was	VBD	O	be	cop	10	SENT_256	[p13l1968t2825r2131b2878],
9	35	CD	DURATION	35	num	10	SENT_256	[p13l9t2932r102b3005],
10	years	NNS	NUMBER	year	_	0	SENT_256	[p13l148t2952r393b3026],
11	;	:	O	;	_	0	SENT_256	[p13l148t2952r393b3026],
12	16	CD	PERCENT	16	num	13	SENT_256	[p13l447t2931r626b3006],
13	%	NN	PERCENT	%	dep	10	SENT_256	[p13l447t2931r626b3006],
14	of	IN	O	of	_	0	SENT_256	[p13l673t2925r773b3005],
15	the	DT	O	the	det	16	SENT_256	[p13l802t2926r935b3004],
16	participants	NNS	O	participant	prep_of	13	SENT_256	[p13l981t2927r1498b3026],
17	were	VBD	O	be	cop	18	SENT_256	[p13l1544t2952r1745b3006],
18	Women	NNS	O	woman	rcmod	16	SENT_256	[p13l1788t2952r2128b3022],
19	,	,	O	,	_	0	SENT_256	[p13l1788t2952r2128b3022],

1	24	CD	PERCENT	24	num	2	SENT_257	[p13l8t3059r190b3133],
2	%	NN	PERCENT	%	nsubj	4	SENT_257	[p13l8t3059r190b3133],
3	were	VBD	O	be	cop	4	SENT_257	[p13l229t3080r431b3133],
4	black	JJ	O	black	_	0	SENT_257	[p13l476t3054r724b3150],
5	,	,	O	,	_	0	SENT_257	[p13l476t3054r724b3150],
6	and	CC	O	and	_	0	SENT_257	[p13l773t3054r931b3133],
7	4	CD	PERCENT	4	num	8	SENT_257	[p13l973t3060r1106b3133],
8	%	NN	PERCENT	%	nsubj	9	SENT_257	[p13l973t3060r1106b3133],
9	were	VBD	O	be	conj_and	4	SENT_257	[p13l1146t3080r1348b3133],
10	in	IN	O	in	_	0	SENT_257	[p13l1391t3055r1474b3132],
11	class	NN	O	class	nn	12	SENT_257	[p13l1519t3054r1723b3132],
12	C	NN	O	c	prep_in	9	SENT_257	[p13l1770t3060r1827b3133],
13	of	IN	O	of	_	0	SENT_257	[p13l1874t3053r1974b3133],
14	the	DT	O	the	prep_of	12	SENT_257	[p13l2001t3054r2133b3132],

1	Centers	NNPS	O	Centers	_	0	SENT_258	[p13l8t3189r331b3262],
2	for	IN	O	for	_	0	SENT_258	[p13l374t3182r497b3262],
3	Disease	NNP	O	Disease	nn	4	SENT_258	[p13l534t3184r861b3261],
4	Control	NNP	O	Control	prep_for	1	SENT_258	[p13l902t3183r1228b3262],
5	and	CC	O	and	_	0	SENT_258	[p13l1267t3183r1425b3262],
6	Prevention	NNP	O	Prevention	prep_for	1	SENT_258	[p13l1464t3184r1922b3262],
7	HIV	NN	O	hiv	dep	1	SENT_258	[p13l1962t3191r2137b3262],

1	classification	NN	O	classification	nn	2	SENT_259	[p13l9t3309r582b3389],
2	system	NN	O	system	nsubj	12	SENT_259	[p13l620t3327r912b3410],
3	(	CD	NUMBER	(	dep	2	SENT_259	[p13l955t3309r1307b3401],
4	defined	VBN	O	define	partmod	2	SENT_259	[p13l955t3309r1307b3401],
5	as	IN	O	as	_	0	SENT_259	[p13l1343t3336r1429b3388],
6	the	DT	O	the	det	7	SENT_259	[p13l1469t3310r1602b3388],
7	presence	NN	O	presence	prep_as	4	SENT_259	[p13l1638t3336r2014b3410],
8	of	IN	O	of	_	0	SENT_259	[p13l2052t3309r2152b3389],
9	specific	JJ	O	specific	amod	11	SENT_259	[p13l10t3437r340b3538],
10	opportunistic	JJ	O	opportunistic	amod	11	SENT_259	[p13l400t3439r987b3538],
11	infections	NNS	O	infection	prep_of	7	SENT_259	[p13l1046t3437r1501b3529],
12	)	VBP	O	)	_	0	SENT_259	[p13l1046t3437r1501b3529],
13	(	CD	NUMBER	(	num	15	SENT_259	[p13l1571t3438r1829b3529],
14	Table	NNP	O	Table	nn	15	SENT_259	[p13l1571t3438r1829b3529],
15	S4	NN	O	s4	dobj	12	SENT_259	[p13l1892t3444r1991b3517],
16	in	IN	O	in	_	0	SENT_259	[p13l2050t3439r2133b3516],
17	the	DT	O	the	det	20	SENT_259	[p13l9t3567r140b3645],
18	Supplementary	NNP	O	Supplementary	nn	20	SENT_259	[p13l180t3567r814b3666],
19	Appendix	NNP	O	Appendix	nn	20	SENT_259	[p13l844t3567r1301b3666],
20	)	NN	O	)	prep_in	15	SENT_259	[p13l844t3567r1301b3666],
21	.	.	O	.	_	0	SENT_259	[p13l844t3567r1301b3666],

1	The	DT	O	the	det	3	SENT_260	[p13l1341t3567r1499b3645],
2	median	JJ	O	median	amod	3	SENT_260	[p13l1537t3567r1855b3645],
3	HIV-1	NN	O	hiv-1	_	0	SENT_260	[p13l1892t3573r2133b3645],

1	RNA	NN	O	rna	nn	2	SENT_261	[p13l7t3702r216b3779],
2	level	NN	O	level	nsubj	8	SENT_261	[p13l257t3696r446b3775],
3	at	IN	O	at	_	0	SENT_261	[p13l490t3713r568b3774],
4	baseline	NN	O	baseline	prep_at	2	SENT_261	[p13l609t3696r960b3775],
5	was	VBD	O	be	cop	8	SENT_261	[p13l1001t3722r1164b3775],
6	4.68	CD	NUMBER	4.68	num	8	SENT_261	[p13l1209t3702r1389b3775],
7	loglo	JJ	O	loglo	amod	8	SENT_261	[p13l1434t3696r1640b3801],
8	copies	NNS	O	copy	_	0	SENT_261	[p13l1686t3697r1951b3796],
9	per	IN	O	per	_	0	SENT_261	[p13l1996t3722r2136b3796],
10	milliliter	NN	O	milliliter	prep_per	8	SENT_261	[p14l8t18r410b112],
11	,	,	O	,	_	0	SENT_261	[p14l8t18r410b112],
12	and	CC	O	and	_	0	SENT_261	[p14l447t18r605b97],
13	the	DT	O	the	det	15	SENT_261	[p14l637t18r770b96],
14	median	JJ	O	median	amod	15	SENT_261	[p14l802t18r1126b97],
15	CD4	NN	O	cd4	nsubj	22	SENT_261	[p14l1158t24r1404b97],
16	+	CC	O	+	_	0	SENT_261	[p14l1158t24r1404b97],
17	T	NN	O	t	nn	20	SENT_261	[p14l1434t18r1669b96],
18	—	NN	O	—	nn	20	SENT_261	[p14l1434t18r1669b96],
19	cell	NN	O	cell	nn	20	SENT_261	[p14l1434t18r1669b96],
20	count	NN	O	count	nsubj	22	SENT_261	[p14l1702t35r1946b97],
21	was	VBD	O	be	cop	22	SENT_261	[p14l1969t44r2131b97],
22	338	CD	NUMBER	338	conj_and	8	SENT_261	[p14l11t152r160b225],
23	per	IN	O	per	_	0	SENT_261	[p14l212t172r353b246],
24	cubic	JJ	O	cubic	amod	25	SENT_261	[p14l404t146r629b225],
25	millimeter	NN	O	millimeter	prep_per	22	SENT_261	[p14l681t146r1161b225],
26	.	.	O	.	_	0	SENT_261	[p14l681t146r1161b225],

1	More	RBR	O	more	amod	2	SENT_262	[p14l1216t154r1439b225],
2	participants	NNS	O	participant	_	0	SENT_262	[p14l1491t147r2011b246],
3	in	IN	O	in	_	0	SENT_262	[p14l2066t147r2150b224],
4	the	DT	O	the	det	5	SENT_262	[p14l11t275r144b353],
5	EFV	NN	O	efv	prep_in	2	SENT_262	[p14l176t281r806b354],
6	.	.	O	.	_	0	SENT_262	[p14l176t281r806b354],

1	—	NN	O	—	_	0	SENT_263	[p14l176t281r806b354],
2	.	.	O	.	_	0	SENT_263	[p14l176t281r806b354],

1	TDF	NNP	O	TDF	_	0	SENT_264	[p14l176t281r806b354],
2	.	.	O	.	_	0	SENT_264	[p14l176t281r806b354],

1	—	NN	O	—	_	0	SENT_265	[p14l176t281r806b354],
2	.	.	O	.	_	0	SENT_265	[p14l176t281r806b354],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_266	[p14l176t281r806b354],
2	group	NN	O	group	_	0	SENT_266	[p14l841t301r1095b376],
3	than	IN	O	than	prep	2	SENT_266	[p14l1129t275r1327b353],
4	in	IN	O	in	pcomp	3	SENT_266	[p14l1359t276r1443b353],
5	the	DT	O	the	det	6	SENT_266	[p14l1476t275r1610b353],
6	DTG	NN	O	dtg	pobj	4	SENT_266	[p14l1641t281r2153b354],
7	.	.	O	.	_	0	SENT_266	[p14l1641t281r2153b354],

1	—	NN	O	—	_	0	SENT_267	[p14l1641t281r2153b354],
2	.	.	O	.	_	0	SENT_267	[p14l1641t281r2153b354],

1	ABC	NNP	ORGANIZATION	ABC	nn	4	SENT_268	[p14l1641t281r2153b354],
2	3T	NN	O	3t	nn	4	SENT_268	[p14l11t410r122b483],
3	C	NN	O	c	nn	4	SENT_268	[p14l124t410r182b483],
4	group	NN	O	group	nsubj	5	SENT_268	[p14l226t429r480b505],
5	withdrew	VBD	O	withdraw	_	0	SENT_268	[p14l519t403r937b483],
6	from	IN	O	from	_	0	SENT_268	[p14l976t402r1188b483],
7	the	DT	O	the	det	8	SENT_268	[p14l1230t403r1364b482],
8	trial	NN	O	trial	prep_from	5	SENT_268	[p14l1406t403r1586b482],
9	prematurely	RB	O	prematurely	advmod	8	SENT_268	[p14l1626t403r2154b504],
10	(	CD	NUMBER	(	num	11	SENT_268	[p14l15t538r144b623],
11	84	CD	NUMBER	84	dobj	5	SENT_268	[p14l15t538r144b623],
12	and	CC	O	and	_	0	SENT_268	[p14l179t532r338b611],
13	51	CD	NUMBER	51	num	14	SENT_268	[p14l375t538r471b611],
14	participants	NNS	O	participant	conj_and	11	SENT_268	[p14l505t533r1051b632],
15	,	,	O	,	_	0	SENT_268	[p14l505t533r1051b632],
16	respectively	RB	O	respectively	advmod	17	SENT_268	[p14l1092t532r1644b632],
17	)	CD	NUMBER	)	rcmod	11	SENT_268	[p14l1092t532r1644b632],
18	,	,	O	,	_	0	SENT_268	[p14l1092t532r1644b632],
19	most	JJS	O	most	nsubj	25	SENT_268	[p14l1684t549r1903b611],
20	commonly	RB	O	commonly	advmod	19	SENT_268	[p14l1933t558r2148b611, p14l10t661r283b761],
21	owing	VBG	O	owe	_	0	SENT_268	[p14l319t662r591b762],
22	to	TO	O	to	_	0	SENT_268	[p14l627t678r710b740],
23	adverse	JJ	O	adverse	amod	24	SENT_268	[p14l751t661r1067b740],
24	events	NNS	O	event	prep_owing_to	19	SENT_268	[p14l1108t678r1374b740],
25	(	VBP	O	(	rcmod	11	SENT_268	[p14l1420t662r1601b762],
26	Fig	NN	O	fig	dobj	25	SENT_268	[p14l1420t662r1601b762],
27	.	.	O	.	_	0	SENT_268	[p14l1420t662r1601b762],

1	1	CD	NUMBER	1	_	0	SENT_269	[p14l1651t667r1746b752],
2	)	NN	O	)	dep	1	SENT_269	[p14l1651t667r1746b752],
3	.	.	O	.	_	0	SENT_269	[p14l1651t667r1746b752],

1	EFFICACY	NN	O	efficacy	nsubjpass	9	SENT_270	[p14l15t937r386b988],
2	A	NN	O	a	dep	3	SENT_270	[p14l6t1045r73b1115],
3	rapid	JJ	O	rapid	dep	1	SENT_270	[p14l102t1037r322b1137],
4	and	CC	O	and	_	0	SENT_270	[p14l353t1037r512b1116],
5	sustained	JJ	O	sustained	amod	7	SENT_270	[p14l546t1037r959b1116],
6	virologic	JJ	O	virologic	amod	7	SENT_270	[p14l986t1037r1367b1138],
7	response	NN	O	response	conj_and	3	SENT_270	[p14l1399t1063r1782b1137],
8	was	VBD	O	be	auxpass	9	SENT_270	[p14l1811t1063r1974b1116],
9	observed	VBN	O	observe	_	0	SENT_270	[p14l2009t1037r2148b1116, p14l11t1164r308b1260],
10	,	,	O	,	_	0	SENT_270	[p14l2009t1037r2148b1116, p14l11t1164r308b1260],
11	with	IN	O	with	_	0	SENT_270	[p14l339t1164r535b1244],
12	88	CD	PERCENT	88	num	13	SENT_270	[p14l566t1169r754b1243],
13	%	NN	PERCENT	%	prep_with	9	SENT_270	[p14l566t1169r754b1243],
14	of	IN	O	of	_	0	SENT_270	[p14l784t1163r885b1243],
15	the	DT	O	the	det	16	SENT_270	[p14l897t1164r1030b1242],
16	participants	NNS	O	participant	prep_of	13	SENT_270	[p14l1059t1165r1580b1264],
17	in	IN	O	in	_	0	SENT_270	[p14l1612t1165r1695b1242],
18	the	DT	O	the	det	23	SENT_270	[p14l1726t1164r1859b1242],
19	DTGABC	NNP	O	DTGABC	nn	23	SENT_270	[p14l1888t1170r2153b1243, p14l6t1300r367b1373],
20	—	CD	NUMBER	—	num	23	SENT_270	[p14l1888t1170r2153b1243, p14l6t1300r367b1373],
21	3T	NN	O	3t	nn	23	SENT_270	[p14l1888t1170r2153b1243, p14l6t1300r367b1373],
22	C	NN	O	c	nn	23	SENT_270	[p14l370t1300r427b1373],
23	group	NN	O	group	prep_in	16	SENT_270	[p14l463t1319r740b1395],
24	,	,	O	,	_	0	SENT_270	[p14l463t1319r740b1395],
25	as	IN	O	as	_	0	SENT_270	[p14l778t1320r863b1372],
26	compared	VBN	O	compare	prepc_as	9	SENT_270	[p14l899t1293r1330b1394],
27	with	IN	O	with	pcomp	26	SENT_270	[p14l1358t1293r1555b1373],
28	81	CD	PERCENT	81	num	29	SENT_270	[p14l1588t1299r1767b1373],
29	%	NN	PERCENT	%	pobj	27	SENT_270	[p14l1588t1299r1767b1373],
30	of	IN	O	of	_	0	SENT_270	[p14l1800t1292r1901b1373],
31	those	DT	O	those	prep_of	29	SENT_270	[p14l1916t1293r2149b1373],
32	in	IN	O	in	_	0	SENT_270	[p14l10t1423r93b1500],
33	the	DT	O	the	det	34	SENT_270	[p14l133t1422r267b1500],
34	EFV	NN	O	efv	prep_in	31	SENT_270	[p14l305t1428r936b1501],
35	.	.	O	.	_	0	SENT_270	[p14l305t1428r936b1501],

1	—	NN	O	—	_	0	SENT_271	[p14l305t1428r936b1501],
2	.	.	O	.	_	0	SENT_271	[p14l305t1428r936b1501],

1	TDF	NNP	O	TDF	_	0	SENT_272	[p14l305t1428r936b1501],
2	.	.	O	.	_	0	SENT_272	[p14l305t1428r936b1501],

1	—	NN	O	—	_	0	SENT_273	[p14l305t1428r936b1501],
2	.	.	O	.	_	0	SENT_273	[p14l305t1428r936b1501],

1	FTC	NNP	ORGANIZATION	FTC	nsubj	4	SENT_274	[p14l305t1428r936b1501],
2	group	NN	O	group	dep	1	SENT_274	[p14l977t1448r1254b1523],
3	,	,	O	,	_	0	SENT_274	[p14l977t1448r1254b1523],
4	having	VBG	O	have	_	0	SENT_274	[p14l1300t1422r1593b1523],
5	the	DT	O	the	det	8	SENT_274	[p14l1630t1422r1763b1500],
6	primary	JJ	O	primary	amod	8	SENT_274	[p14l1801t1423r2154b1522],
7	end	NN	O	end	nn	8	SENT_274	[p14l11t1549r165b1628],
8	point	NN	O	point	dobj	4	SENT_274	[p14l213t1550r444b1649],
9	of	IN	O	of	_	0	SENT_274	[p14l489t1548r590b1628],
10	a	DT	O	a	det	14	SENT_274	[p14l620t1575r664b1627],
11	plasma	NN	O	plasma	nn	14	SENT_274	[p14l710t1549r1023b1649],
12	HIV-1	NN	O	hiv-1	nn	14	SENT_274	[p14l1071t1555r1316b1628],
13	RNA	NN	O	rna	nn	14	SENT_274	[p14l1365t1556r1576b1633],
14	level	NN	O	level	prep_of	8	SENT_274	[p14l1621t1549r1811b1628],
15	of	IN	O	of	_	0	SENT_274	[p14l1860t1548r1961b1628],
16	less	JJR	O	less	mwe	17	SENT_274	[p14l1990t1549r2147b1627],
17	than	IN	O	than	quantmod	18	SENT_274	[p14l11t1678r209b1756],
18	50	CD	NUMBER	50	num	19	SENT_274	[p14l243t1684r341b1757],
19	copies	NNS	O	copy	prep_of	14	SENT_274	[p14l375t1679r642b1778],
20	per	IN	O	per	_	0	SENT_274	[p14l675t1704r816b1778],
21	milliliter	NN	O	milliliter	prep_per	19	SENT_274	[p14l846t1678r1232b1756],
22	at	IN	O	at	_	0	SENT_274	[p14l1262t1695r1341b1756],
23	week	NN	DURATION	week	prep_at	4	SENT_274	[p14l1364t1678r1589b1757],
24	48	CD	NUMBER	48	number	25	SENT_274	[p14l1615t1684r1717b1757],
25	(	CD	NUMBER	(	num	26	SENT_274	[p14l1757t1679r1938b1779],
26	Fig	NN	O	fig	dep	4	SENT_274	[p14l1757t1679r1938b1779],
27	.	.	O	.	_	0	SENT_274	[p14l1757t1679r1938b1779],

1	2A	NN	O	2a	_	0	SENT_275	[p14l1976t1684r2144b1769],
2	)	NN	O	)	dep	1	SENT_275	[p14l1976t1684r2144b1769],
3	.	.	O	.	_	0	SENT_275	[p14l1976t1684r2144b1769],

1	The	DT	O	the	det	4	SENT_276	[p14l7t1805r169b1883],
2	adjusted	JJ	O	adjusted	amod	4	SENT_276	[p14l222t1805r581b1905],
3	treatment	NN	O	treatment	nn	4	SENT_276	[p14l634t1822r1062b1883],
4	difference	NN	O	difference	nsubj	12	SENT_276	[p14l1111t1804r1546b1884],
5	between	IN	O	between	_	0	SENT_276	[p14l1601t1805r1961b1885],
6	the	DT	O	the	det	8	SENT_276	[p14l2016t1805r2149b1883],
7	two	CD	NUMBER	two	num	8	SENT_276	[p14l11t1951r169b2014],
8	groups	NNS	O	group	prep_between	4	SENT_276	[p14l206t1960r504b2036],
9	was	VBD	O	be	cop	12	SENT_276	[p14l538t1961r701b2014],
10	7	CD	PERCENT	7	num	12	SENT_276	[p14l740t1942r786b2014],
11	percentage	NN	PERCENT	percentage	nn	12	SENT_276	[p14l822t1951r1295b2036],
12	points	NNS	PERCENT	point	_	0	SENT_276	[p14l1329t1935r1601b2035],
13	(	VBP	PERCENT	(	rcmod	12	SENT_276	[p14l1644t1940r1857b2026],
14	95	CD	PERCENT	95	number	15	SENT_276	[p14l1644t1940r1857b2026],
15	%	NN	PERCENT	%	amod	16	SENT_276	[p14l1644t1940r1857b2026],
16	confiENGLJ	NN	O	confienglj	dobj	13	SENT_276	[p14l1893t1933r2148b2014, p14l570t2104r648b2126],

1	MED	NN	O	med	_	0	SENT_277	[p14l662t2104r714b2119],
2	;	:	O	;	_	0	SENT_277	[p14l772t2104r805b2125],
3	19	CD	NUMBER	19	num	5	SENT_277	[p14l772t2104r805b2125],
4	NEjM.ORG	NN	O	nejm.org	nn	5	SENT_277	[p14l841t2104r965b2126],
5	NOVEMBER	NNP	DATE	NOVEMBER	dep	1	SENT_277	[p14l1002t2104r1137b2120],
6	7,2013	CD	DATE	7,2013	number	7	SENT_277	[p14l1147t2104r1232b2126],
7	1811	CD	DATE	1811	dep	5	SENT_277	[p14l1940t2094r2016b2116],

1	T	NN	O	t	_	0	SENT_278	[p14l702t2138r721b2161],
2	e	SYM	O	e	dep	3	SENT_278	[p14l739t2145r753b2161],
3	ew	FW	O	ew	rcmod	1	SENT_278	[p14l786t2145r824b2161],
4	England	NNP	O	England	nn	5	SENT_278	[p14l833t2137r944b2168],
5	Journal	NNP	O	Journal	dep	1	SENT_278	[p14l952t2137r1050b2161],
6	of	IN	O	of	_	0	SENT_278	[p14l1059t2137r1088b2161],
7	Medicine	NNP	O	Medicine	prep_of	5	SENT_278	[p14l1095t2137r1220b2161],

1	Th	NN	O	th	npadvmod	19	SENT_279	[p14l673t2325r704b2346],
2	e	SYM	O	e	dep	11	SENT_279	[p14l710t2332r718b2346],
3	N	NN	O	n	nn	11	SENT_279	[p14l737t2327r760b2346],
4	E	NN	O	e	nn	11	SENT_279	[p14l769t2327r785b2346],
5	W	NN	O	w	nn	11	SENT_279	[p14l792t2327r822b2346],
6	E	NN	O	e	nn	11	SENT_279	[p14l841t2327r858b2346],
7	N	NN	O	n	nn	11	SENT_279	[p14l866t2327r889b2346],
8	G	NN	O	g	nn	11	SENT_279	[p14l896t2327r918b2346],
9	L	NN	O	l	nn	11	SENT_279	[p14l925t2327r941b2346],
10	A	NN	O	a	nn	11	SENT_279	[p14l948t2327r968b2346],
11	ND	NN	O	nd	dep	1	SENT_279	[p14l976t2327r1060b2353],
12	]	CD	NUMBER	]	num	13	SENT_279	[p14l976t2327r1060b2353],
13	O	NN	O	o	dep	11	SENT_279	[p14l1067t2327r1088b2346],
14	U	NNP	O	U	nn	18	SENT_279	[p14l1095t2327r1117b2346],
15	R	NNP	O	R	nn	18	SENT_279	[p14l1125t2327r1147b2346],
16	N	NNP	O	N	nn	18	SENT_279	[p14l1154t2327r1177b2346],
17	A	NNP	O	A	nn	18	SENT_279	[p14l1183t2327r1204b2346],
18	L	NN	O	l	dep	13	SENT_279	[p14l1211t2327r1228b2346],
19	of	IN	O	of	dep	23	SENT_279	[p14l1247t2325r1275b2352],
20	M	NN	O	m	nn	22	SENT_279	[p14l1287t2327r1314b2346],
21	E	NN	O	e	nn	22	SENT_279	[p14l1322t2327r1339b2346],
22	D	NN	O	d	pobj	19	SENT_279	[p14l1347t2327r1368b2346],
23	I	PRP	O	I	_	0	SENT_279	[p14l1376t2327r1386b2346],
24	C	NN	O	c	prep	23	SENT_279	[p14l1393t2327r1411b2346],
25	I	PRP	O	I	dep	26	SENT_279	[p14l1419t2327r1429b2346],
26	NE	NNS	O	ne	dep	24	SENT_279	[p14l1437t2327r1486b2346],

1	dence	NN	O	dence	nn	2	SENT_280	[p14l12t2547r256b2626],
2	interval	NN	O	interval	_	0	SENT_280	[p14l308t2547r634b2626],
3	[	CD	NUMBER	[	num	5	SENT_280	[p14l694t2553r869b2643],
4	CI	NN	O	ci	nn	5	SENT_280	[p14l694t2553r869b2643],
5	]	NN	O	]	dep	2	SENT_280	[p14l694t2553r869b2643],
6	,	,	O	,	_	0	SENT_280	[p14l694t2553r869b2643],
7	2	CD	NUMBER	2	number	9	SENT_280	[p14l926t2553r973b2625],
8	to	TO	O	to	dep	9	SENT_280	[p14l1027t2564r1108b2626],
9	12	CD	NUMBER	12	num	10	SENT_280	[p14l1164t2553r1314b2643],
10	)	CD	NUMBER	)	appos	2	SENT_280	[p14l1164t2553r1314b2643],
11	,	,	O	,	_	0	SENT_280	[p14l1164t2553r1314b2643],
12	with	IN	O	with	_	0	SENT_280	[p14l1366t2547r1562b2626],
13	dolutegravir	NN	O	dolutegravir	prep_with	2	SENT_280	[p14l1614t2547r2137b2648],
14	and	CC	O	and	_	0	SENT_280	[p14l11t2675r169b2754],
15	abacavir	NN	O	abacavir	nn	17	SENT_280	[p14l206t2675r1101b2754],
16	—	CD	NUMBER	—	num	17	SENT_280	[p14l206t2675r1101b2754],
17	lamivudine	NN	O	lamivudine	conj_and	13	SENT_280	[p14l206t2675r1101b2754],
18	meeting	VBG	O	meet	partmod	2	SENT_280	[p14l1139t2676r1494b2776],
19	the	DT	O	the	det	23	SENT_280	[p14l1529t2675r1661b2753],
20	noninferi	JJ	O	noninferi	amod	23	SENT_280	[p14l1699t2674r2133b2754],
21	—	NN	O	—	nn	23	SENT_280	[p14l1699t2674r2133b2754],
22	ority	NN	O	ority	nn	23	SENT_280	[p14l12t2804r212b2903],
23	criterion	NN	O	criterion	dobj	18	SENT_280	[p14l250t2804r638b2882],
24	.	.	O	.	_	0	SENT_280	[p14l250t2804r638b2882],

1	In	IN	O	in	_	0	SENT_281	[p14l684t2811r772b2881],
2	addition	NN	O	addition	prep_in	12	SENT_281	[p14l813t2803r1193b2899],
3	,	,	O	,	_	0	SENT_281	[p14l813t2803r1193b2899],
4	the	DT	O	the	det	5	SENT_281	[p14l1240t2803r1373b2881],
5	dolutegravir	NN	O	dolutegravir	nsubjpass	12	SENT_281	[p14l1415t2803r1939b2904],
6	and	CC	O	and	_	0	SENT_281	[p14l1977t2803r2134b2882],
7	abacavir	NN	O	abacavir	nn	10	SENT_281	[p14l11t2931r906b3010],
8	—	CD	NUMBER	—	num	10	SENT_281	[p14l11t2931r906b3010],
9	lamivudine	NN	O	lamivudine	nn	10	SENT_281	[p14l11t2931r906b3010],
10	regimen	NN	O	regimen	conj_and	5	SENT_281	[p14l956t2932r1313b3032],
11	was	VBD	O	be	auxpass	12	SENT_281	[p14l1357t2957r1520b3010],
12	shown	VBN	O	show	_	0	SENT_281	[p14l1573t2931r1855b3010],
13	to	TO	O	to	aux	16	SENT_281	[p14l1904t2948r1986b3010],
14	be	VB	O	be	cop	16	SENT_281	[p14l2038t2931r2134b3010],
15	statistically	RB	O	statistically	advmod	16	SENT_281	[p14l13t3058r506b3158],
16	superior	JJ	O	superior	xcomp	12	SENT_281	[p14l560t3059r914b3158],
17	to	TO	O	to	_	0	SENT_281	[p14l968t3075r1049b3137],
18	the	DT	O	the	det	22	SENT_281	[p14l1107t3058r1240b3136],
19	efavirenz	NN	O	efavirenz	nn	22	SENT_281	[p14l1297t3057r2137b3138],
20	—	CD	NUMBER	—	num	22	SENT_281	[p14l1297t3057r2137b3138],
21	tenofoVir	NN	O	tenofovir	nn	22	SENT_281	[p14l1297t3057r2137b3138],
22	DF	NN	O	df	prep_to	16	SENT_281	[p14l11t3187r749b3266],
23	—	CD	NUMBER	—	num	25	SENT_281	[p14l11t3187r749b3266],
24	emtricitabine	NN	O	emtricitabine	nn	25	SENT_281	[p14l11t3187r749b3266],
25	regimen	NN	O	regimen	dep	22	SENT_281	[p14l785t3188r1135b3288],
26	(	CD	NUMBER	(	num	27	SENT_281	[p14l1176t3193r1613b3278],
27	P	NN	O	p	dep	25	SENT_281	[p14l1176t3193r1613b3278],
28	=	JJ	O	=	advmod	16	SENT_281	[p14l1176t3193r1613b3278],
29	0.003	CD	NUMBER	0.003	num	30	SENT_281	[p14l1176t3193r1613b3278],
30	)	NN	O	)	dep	28	SENT_281	[p14l1176t3193r1613b3278],
31	.	.	O	.	_	0	SENT_281	[p14l1176t3193r1613b3278],

1	Overall	JJ	O	overall	amod	2	SENT_282	[p14l1654t3187r1956b3266],
2	differences	NNS	O	difference	nsubj	10	SENT_282	[p14l1992t3186r2133b3266, p14l12t3313r362b3392],
3	in	IN	O	in	_	0	SENT_282	[p14l403t3315r486b3392],
4	response	NN	O	response	nn	6	SENT_282	[p14l526t3340r906b3414],
5	(	CD	NUMBER	(	num	6	SENT_282	[p14l951t3315r1729b3405],
6	intention	NN	O	intention	prep_in	2	SENT_282	[p14l951t3315r1729b3405],
7	—	CD	NUMBER	—	number	9	SENT_282	[p14l951t3315r1729b3405],
8	to	TO	O	to	dep	9	SENT_282	[p14l951t3315r1729b3405],
9	—	CD	NUMBER	—	num	10	SENT_282	[p14l951t3315r1729b3405],
10	treat	NN	O	treat	_	0	SENT_282	[p14l951t3315r1729b3405],
11	analysis	NN	O	analysis	nsubj	14	SENT_282	[p14l1763t3314r2129b3414],
12	)	CD	NUMBER	)	num	11	SENT_282	[p14l1763t3314r2129b3414],
13	were	VBD	O	be	cop	14	SENT_282	[p14l7t3469r210b3522],
14	due	JJ	O	due	rcmod	10	SENT_282	[p14l256t3443r405b3522],
15	primarily	RB	O	primarily	advmod	14	SENT_282	[p14l449t3443r856b3542],
16	to	TO	O	to	_	0	SENT_282	[p14l897t3460r978b3521],
17	discontinuations	NNS	O	discontinuation	prep_to	14	SENT_282	[p14l1027t3443r1749b3522],
18	because	IN	O	because	mark	22	SENT_282	[p14l1798t3443r2134b3522],
19	of	IN	O	of	_	0	SENT_282	[p14l12t3569r113b3649],
20	adverse	JJ	O	adverse	amod	21	SENT_282	[p14l131t3570r446b3650],
21	events	NNS	O	event	prep_of	22	SENT_282	[p14l485t3587r748b3650],
22	(	VBP	O	(	dep	17	SENT_282	[p14l792t3576r915b3661],
23	10	CD	NUMBER	10	nsubj	27	SENT_282	[p14l792t3576r915b3661],
24	of	IN	O	of	_	0	SENT_282	[p14l955t3569r1054b3649],
25	414	CD	NUMBER	414	num	26	SENT_282	[p14l1072t3576r1217b3649],
26	participants	NNS	O	participant	prep_of	23	SENT_282	[p14l1254t3571r1770b3670],
27	[	VBP	O	[	ccomp	22	SENT_282	[p14l1819t3575r2004b3661],
28	2	CD	NUMBER	2	number	29	SENT_282	[p14l1819t3575r2004b3661],
29	°	CD	NUMBER	°	dobj	27	SENT_282	[p14l1819t3575r2004b3661],
30	/	:	O	/	punct	32	SENT_282	[p14l1819t3575r2004b3661],
31	o	NN	O	o	nn	32	SENT_282	[p14l1819t3575r2004b3661],
32	]	NN	O	]	dep	10	SENT_282	[p14l1819t3575r2004b3661],
33	in	IN	O	in	_	0	SENT_282	[p14l2050t3571r2134b3648],
34	the	DT	O	the	det	35	SENT_282	[p14l12t3699r145b3777],
35	DTG	NN	O	dtg	prep_in	32	SENT_282	[p14l173t3705r851b3778],
36	.	.	O	.	_	0	SENT_282	[p14l173t3705r851b3778],

1	—	NN	O	—	_	0	SENT_283	[p14l173t3705r851b3778],
2	.	.	O	.	_	0	SENT_283	[p14l173t3705r851b3778],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_284	[p14l173t3705r851b3778],
2	.	.	O	.	_	0	SENT_284	[p14l173t3705r851b3778],

1	—	NN	O	—	_	0	SENT_285	[p14l173t3705r851b3778],
2	.	.	O	.	_	0	SENT_285	[p14l173t3705r851b3778],

1	3TC	NN	O	3tc	nn	2	SENT_286	[p14l173t3705r851b3778],
2	group	NN	O	group	_	0	SENT_286	[p14l883t3725r1135b3800],
3	and	CC	O	and	_	0	SENT_286	[p14l1165t3699r1323b3778],
4	42	CD	NUMBER	42	conj_and	2	SENT_286	[p14l1351t3705r1449b3778],
5	of	IN	O	of	_	0	SENT_286	[p14l1481t3698r1581b3778],
6	419	CD	NUMBER	419	number	7	SENT_286	[p14l1591t3705r1739b3778],
7	[	CD	NUMBER	[	prep_of	2	SENT_286	[p14l1779t3704r2012b3790],
8	10	CD	NUMBER	10	num	9	SENT_286	[p14l1779t3704r2012b3790],
9	°	NN	O	°	dep	7	SENT_286	[p14l1779t3704r2012b3790],
10	/	:	O	/	punct	2	SENT_286	[p14l1779t3704r2012b3790],
11	o	NN	O	o	nn	12	SENT_286	[p14l1779t3704r2012b3790],
12	]	NN	O	]	dep	2	SENT_286	[p14l1779t3704r2012b3790],
13	in	IN	O	in	_	0	SENT_286	[p14l2050t3700r2134b3777],
14	the	DT	O	the	det	15	SENT_286	[p15l12t20r145b98],
15	EFV	NN	O	efv	prep_in	12	SENT_286	[p15l178t26r804b99],
16	.	.	O	.	_	0	SENT_286	[p15l178t26r804b99],

1	—	NN	O	—	_	0	SENT_287	[p15l178t26r804b99],
2	.	.	O	.	_	0	SENT_287	[p15l178t26r804b99],

1	TDF	NNP	O	TDF	_	0	SENT_288	[p15l178t26r804b99],
2	.	.	O	.	_	0	SENT_288	[p15l178t26r804b99],

1	—	NN	O	—	_	0	SENT_289	[p15l178t26r804b99],
2	.	.	O	.	_	0	SENT_289	[p15l178t26r804b99],

1	FTC	NNP	ORGANIZATION	FTC	_	0	SENT_290	[p15l178t26r804b99],
2	group	NN	O	group	dep	1	SENT_290	[p15l841t27r1119b121],
3	)	CD	NUMBER	)	number	4	SENT_290	[p15l841t27r1119b121],
4	(	CD	NUMBER	(	dep	2	SENT_290	[p15l1164t20r1421b111],
5	Table	NNP	O	Table	dep	1	SENT_290	[p15l1164t20r1421b111],
6	1	CD	NUMBER	1	number	7	SENT_290	[p15l1459t26r1554b111],
7	)	CD	NUMBER	)	dep	5	SENT_290	[p15l1459t26r1554b111],
8	.	.	O	.	_	0	SENT_290	[p15l1459t26r1554b111],

1	Similar	JJ	O	similar	amod	2	SENT_291	[p15l143t148r456b226],
2	results	NNS	O	result	nsubjpass	4	SENT_291	[p15l496t148r778b227],
3	were	VBD	O	be	auxpass	4	SENT_291	[p15l818t174r1020b227],
4	observed	VBN	O	observe	_	0	SENT_291	[p15l1062t148r1443b227],
5	in	IN	O	in	_	0	SENT_291	[p15l1484t149r1568b225],
6	the	DT	O	the	det	10	SENT_291	[p15l1610t148r1742b226],
7	per	FW	O	per	nn	10	SENT_291	[p15l1783t174r2133b247, p15l12t275r224b354],
8	—	FW	O	—	nn	10	SENT_291	[p15l1783t174r2133b247, p15l12t275r224b354],
9	protocol	NN	O	protocol	nn	10	SENT_291	[p15l1783t174r2133b247, p15l12t275r224b354],
10	population	NN	O	population	prep_in	4	SENT_291	[p15l262t275r757b375],
11	,	,	O	,	_	0	SENT_291	[p15l262t275r757b375],
12	from	IN	O	from	_	0	SENT_291	[p15l803t274r1013b354],
13	which	WDT	O	which	rel	15	SENT_291	[p15l1049t275r1311b355],
14	2	CD	NUMBER	2	num	15	SENT_291	[p15l1352t280r1487b354],
15	°	CD	NUMBER	°	rcmod	10	SENT_291	[p15l1352t280r1487b354],
16	/	:	O	/	punct	15	SENT_291	[p15l1352t280r1487b354],
17	o	NN	O	o	nsubjpass	22	SENT_291	[p15l1352t280r1487b354],
18	of	IN	O	of	_	0	SENT_291	[p15l1528t274r1627b354],
19	the	DT	O	the	det	20	SENT_291	[p15l1650t275r1782b353],
20	participants	NNS	O	participant	prep_of	17	SENT_291	[p15l1822t276r2133b375, p15l11t420r246b503],
21	were	VBD	O	be	auxpass	22	SENT_291	[p15l278t429r479b483],
22	excluded	VBN	O	exclude	dep	15	SENT_291	[p15l515t403r887b482],
23	(	RB	O	(	advmod	22	SENT_291	[p15l925t409r1051b494],
24	11	CD	NUMBER	11	dobj	22	SENT_291	[p15l925t409r1051b494],
25	of	IN	O	of	_	0	SENT_291	[p15l1087t402r1187b482],
26	414	CD	NUMBER	414	num	27	SENT_291	[p15l1201t409r1347b482],
27	participants	NNS	O	participant	prep_of	24	SENT_291	[p15l1379t404r1897b503],
28	[	CD	NUMBER	[	num	30	SENT_291	[p15l1942t409r2125b494],
29	30/o	CD	NUMBER	30/o	num	30	SENT_291	[p15l1942t409r2125b494],
30	]	NN	O	]	dep	27	SENT_291	[p15l1942t409r2125b494],
31	in	IN	O	in	_	0	SENT_291	[p15l11t533r95b610],
32	the	DT	O	the	det	33	SENT_291	[p15l141t532r274b610],
33	DTG	NN	O	dtg	prep_in	22	SENT_291	[p15l318t538r995b611],
34	.	.	O	.	_	0	SENT_291	[p15l318t538r995b611],

1	—	NN	O	—	_	0	SENT_292	[p15l318t538r995b611],
2	.	.	O	.	_	0	SENT_292	[p15l318t538r995b611],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_293	[p15l318t538r995b611],
2	.	.	O	.	_	0	SENT_293	[p15l318t538r995b611],

1	—	NN	O	—	_	0	SENT_294	[p15l318t538r995b611],
2	.	.	O	.	_	0	SENT_294	[p15l318t538r995b611],

1	3TC	NN	O	3tc	nn	2	SENT_295	[p15l318t538r995b611],
2	group	NN	O	group	nsubj	8	SENT_295	[p15l1044t558r1296b633],
3	and	CC	O	and	_	0	SENT_295	[p15l1343t532r1501b611],
4	7	CD	NUMBER	7	conj_and	2	SENT_295	[p15l1547t540r1593b611],
5	of	IN	O	of	_	0	SENT_295	[p15l1641t531r1741b611],
6	419	CD	NUMBER	419	num	7	SENT_295	[p15l1766t538r1915b611],
7	participants	NNS	O	participant	prep_of	4	SENT_295	[p15l1961t558r2133b632, p15l12t661r380b760],
8	[	VBP	O	[	_	0	SENT_295	[p15l432t665r616b751],
9	2	CD	NUMBER	2	number	10	SENT_295	[p15l432t665r616b751],
10	°	CD	NUMBER	°	dobj	8	SENT_295	[p15l432t665r616b751],
11	/	:	O	/	punct	13	SENT_295	[p15l432t665r616b751],
12	o	NN	O	o	nn	13	SENT_295	[p15l432t665r616b751],
13	]	NN	O	]	dep	10	SENT_295	[p15l432t665r616b751],
14	in	IN	O	in	_	0	SENT_295	[p15l666t661r749b738],
15	the	DT	O	the	det	16	SENT_295	[p15l790t660r922b739],
16	EFV	NN	O	efv	prep_in	10	SENT_295	[p15l961t666r1587b739],
17	.	.	O	.	_	0	SENT_295	[p15l961t666r1587b739],

1	—	NN	O	—	_	0	SENT_296	[p15l961t666r1587b739],
2	.	.	O	.	_	0	SENT_296	[p15l961t666r1587b739],

1	TDF	NNP	O	TDF	_	0	SENT_297	[p15l961t666r1587b739],
2	.	.	O	.	_	0	SENT_297	[p15l961t666r1587b739],

1	—	NN	O	—	_	0	SENT_298	[p15l961t666r1587b739],
2	.	.	O	.	_	0	SENT_298	[p15l961t666r1587b739],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_299	[p15l961t666r1587b739],
2	group	NN	O	group	nsubj	16	SENT_299	[p15l1629t667r1932b761],
3	)	CD	NUMBER	)	num	2	SENT_299	[p15l1629t667r1932b761],
4	,	,	O	,	_	0	SENT_299	[p15l1629t667r1932b761],
5	owing	VBG	O	owe	partmod	2	SENT_299	[p15l1979t686r2133b739, p15l11t789r150b889],
6	to	TO	O	to	_	0	SENT_299	[p15l184t805r265b867],
7	a	DT	O	a	det	8	SENT_299	[p15l302t814r346b866],
8	number	NN	O	number	prep_to	5	SENT_299	[p15l381t788r719b867],
9	of	IN	O	of	_	0	SENT_299	[p15l753t787r853b867],
10	reasons	NNS	O	reason	prep_of	8	SENT_299	[p15l870t814r1221b884],
11	,	,	O	,	_	0	SENT_299	[p15l870t814r1221b884],
12	including	VBG	O	include	_	0	SENT_299	[p15l1263t788r1673b889],
13	the	DT	O	the	det	14	SENT_299	[p15l1707t788r1839b866],
14	use	NN	O	use	prep_including	5	SENT_299	[p15l1876t814r2015b867],
15	of	IN	O	of	prep	14	SENT_299	[p15l2053t787r2152b867],
16	prohibited	VBN	O	prohibit	_	0	SENT_299	[p15l11t915r459b1015],
17	medication	NN	O	medication	nn	18	SENT_299	[p15l506t915r989b994],
18	(	NN	O	(	dobj	16	SENT_299	[p15l1042t916r1153b1006],
19	in	IN	O	in	prep	18	SENT_299	[p15l1042t916r1153b1006],
20	<	JJR	O	<	dep	19	SENT_299	[p15l1204t920r1384b995],
21	1	CD	NUMBER	1	num	22	SENT_299	[p15l1204t920r1384b995],
22	°	NN	O	°	dep	20	SENT_299	[p15l1204t920r1384b995],
23	/	:	O	/	punct	20	SENT_299	[p15l1204t920r1384b995],
24	o	NN	O	o	dep	20	SENT_299	[p15l1204t920r1384b995],
25	of	IN	O	of	_	0	SENT_299	[p15l1432t914r1532b994],
26	participants	NNS	O	participant	prep_of	24	SENT_299	[p15l1561t916r2129b1015],
27	)	CD	NUMBER	)	tmod	16	SENT_299	[p15l1561t916r2129b1015],
28	.	.	O	.	_	0	SENT_299	[p15l1561t916r2129b1015],

1	In	IN	O	in	dep	6	SENT_300	[p15l11t1051r99b1121],
2	this	DT	O	this	det	3	SENT_300	[p15l146t1043r305b1121],
3	analysis	NN	O	analysis	pobj	1	SENT_300	[p15l352t1043r717b1143],
4	,	,	O	,	_	0	SENT_300	[p15l352t1043r717b1143],
5	90	CD	PERCENT	90	num	6	SENT_300	[p15l768t1048r958b1122],
6	%	NN	PERCENT	%	_	0	SENT_300	[p15l768t1048r958b1122],
7	of	IN	O	of	_	0	SENT_300	[p15l1003t1042r1103b1122],
8	the	DT	O	the	det	9	SENT_300	[p15l1130t1043r1263b1121],
9	participants	NNS	O	participant	prep_of	6	SENT_300	[p15l1308t1044r1825b1143],
10	in	IN	O	in	_	0	SENT_300	[p15l1872t1044r1955b1121],
11	the	DT	O	the	det	12	SENT_300	[p15l2001t1043r2134b1121],
12	DTG	NN	O	dtg	prep_in	6	SENT_300	[p15l11t1178r693b1251],
13	.	.	O	.	_	0	SENT_300	[p15l11t1178r693b1251],

1	—	NN	O	—	_	0	SENT_301	[p15l11t1178r693b1251],
2	.	.	O	.	_	0	SENT_301	[p15l11t1178r693b1251],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_302	[p15l11t1178r693b1251],
2	.	.	O	.	_	0	SENT_302	[p15l11t1178r693b1251],

1	—	NN	O	—	_	0	SENT_303	[p15l11t1178r693b1251],
2	.	.	O	.	_	0	SENT_303	[p15l11t1178r693b1251],

1	3TC	NN	O	3tc	_	0	SENT_304	[p15l11t1178r693b1251],
2	group	NN	O	group	dep	1	SENT_304	[p15l726t1198r981b1273],
3	and	CC	O	and	_	0	SENT_304	[p15l1014t1172r1173b1251],
4	81	CD	PERCENT	81	num	5	SENT_304	[p15l1205t1177r1384b1251],
5	%	NN	PERCENT	%	dep	1	SENT_304	[p15l1205t1177r1384b1251],
6	in	IN	O	in	_	0	SENT_304	[p15l1415t1173r1499b1250],
7	the	DT	O	the	det	8	SENT_304	[p15l1532t1172r1665b1250],
8	EFV	NN	O	efv	prep_in	1	SENT_304	[p15l1697t1178r2151b1251, p15l11t1306r186b1380],
9	.	.	O	.	_	0	SENT_304	[p15l1697t1178r2151b1251, p15l11t1306r186b1380],

1	—	NN	O	—	_	0	SENT_305	[p15l1697t1178r2151b1251, p15l11t1306r186b1380],
2	.	.	O	.	_	0	SENT_305	[p15l1697t1178r2151b1251, p15l11t1306r186b1380],

1	TDFFTC	NN	O	tdfftc	nn	2	SENT_306	[p15l1697t1178r2151b1251, p15l11t1306r186b1380],
2	group	NN	O	group	nsubj	3	SENT_306	[p15l229t1326r482b1402],
3	had	VBD	O	have	_	0	SENT_306	[p15l525t1300r682b1380],
4	an	DT	O	a	det	7	SENT_306	[p15l722t1326r825b1379],
5	HIV-1	NN	O	hiv-1	nn	7	SENT_306	[p15l865t1306r1111b1379],
6	RNA	NN	O	rna	nn	7	SENT_306	[p15l1151t1307r1361b1384],
7	level	NN	O	level	dobj	3	SENT_306	[p15l1397t1300r1588b1380],
8	of	IN	O	of	_	0	SENT_306	[p15l1628t1299r1729b1380],
9	less	JJR	O	less	mwe	10	SENT_306	[p15l1750t1300r1907b1379],
10	than	IN	O	than	quantmod	11	SENT_306	[p15l1950t1300r2148b1379],
11	50	CD	NUMBER	50	num	12	SENT_306	[p15l14t1435r111b1508],
12	copies	NNS	O	copy	prep_of	7	SENT_306	[p15l176t1430r442b1529],
13	per	IN	O	per	_	0	SENT_306	[p15l505t1455r646b1529],
14	milliliter	NN	O	milliliter	nn	16	SENT_306	[p15l705t1429r1091b1507],
15	(	CD	NUMBER	(	num	16	SENT_306	[p15l1155t1430r1335b1530],
16	Fig	NN	O	fig	prep_per	12	SENT_306	[p15l1155t1430r1335b1530],
17	.	.	O	.	_	0	SENT_306	[p15l1155t1430r1335b1530],

1	3	CD	NUMBER	3	_	0	SENT_307	[p15l1404t1435r1502b1520],
2	)	NN	O	)	dep	1	SENT_307	[p15l1404t1435r1502b1520],
3	.	.	O	.	_	0	SENT_307	[p15l1404t1435r1502b1520],

1	The	DT	O	the	det	4	SENT_308	[p15l1566t1429r1728b1507],
2	adjusted	JJ	O	adjusted	amod	4	SENT_308	[p15l1790t1429r2148b1529],
3	treatment	NN	O	treatment	nn	4	SENT_308	[p15l12t1574r438b1636],
4	difference	NN	O	difference	nsubj	12	SENT_308	[p15l499t1556r934b1637],
5	between	IN	O	between	_	0	SENT_308	[p15l1000t1557r1360b1637],
6	the	DT	O	the	det	8	SENT_308	[p15l1425t1557r1559b1636],
7	two	CD	NUMBER	two	num	8	SENT_308	[p15l1624t1574r1782b1637],
8	groups	NNS	O	group	prep_between	4	SENT_308	[p15l1848t1583r2145b1659],
9	was	VBD	O	be	cop	12	SENT_308	[p15l7t1713r171b1766],
10	9	CD	PERCENT	9	num	12	SENT_308	[p15l209t1693r256b1766],
11	percentage	NN	PERCENT	percentage	nn	12	SENT_308	[p15l291t1703r763b1788],
12	points	NNS	PERCENT	point	dep	13	SENT_308	[p15l797t1688r1068b1787],
13	(	VBP	PERCENT	(	_	0	SENT_308	[p15l1111t1692r1324b1778],
14	95	CD	PERCENT	95	num	15	SENT_308	[p15l1111t1692r1324b1778],
15	%	NN	PERCENT	%	dobj	13	SENT_308	[p15l1111t1692r1324b1778],
16	CI	NN	O	ci	nsubj	13	SENT_308	[p15l1358t1693r1474b1783],
17	,	,	O	,	_	0	SENT_308	[p15l1358t1693r1474b1783],
18	4	CD	NUMBER	4	appos	16	SENT_308	[p15l1513t1693r1564b1766],
19	to	TO	O	to	_	0	SENT_308	[p15l1600t1703r1681b1766],
20	13	CD	NUMBER	13	num	21	SENT_308	[p15l1722t1693r1870b1783],
21	)	CD	NUMBER	)	prep_to	18	SENT_308	[p15l1722t1693r1870b1783],
22	,	,	O	,	_	0	SENT_308	[p15l1722t1693r1870b1783],
23	again	RB	O	again	advmod	24	SENT_308	[p15l1910t1688r2148b1788],
24	supporting	VBG	O	support	dep	13	SENT_308	[p15l13t1816r492b1917],
25	the	DT	O	the	det	26	SENT_308	[p15l553t1815r686b1894],
26	superiority	NN	O	superiority	dobj	24	SENT_308	[p15l752t1816r1220b1916],
27	of	IN	O	of	_	0	SENT_308	[p15l1280t1814r1381b1895],
28	the	DT	O	the	det	29	SENT_308	[p15l1426t1815r1560b1894],
29	dolutegravir	NN	O	dolutegravir	prep_of	26	SENT_308	[p15l1625t1815r2151b1917],
30	and	CC	O	and	_	0	SENT_308	[p15l11t1944r166b2024],
31	abacavir	NN	O	abacavir	nn	34	SENT_308	[p15l199t1944r1061b2024],
32	—	CD	NUMBER	—	num	34	SENT_308	[p15l199t1944r1061b2024],
33	lamivudine	NN	O	lamivudine	nn	34	SENT_308	[p15l199t1944r1061b2024],
34	regimen	NN	O	regimen	prep_of	26	SENT_308	[p15l1095t1945r1461b2046],
35	.	.	O	.	_	0	SENT_308	[p15l1095t1945r1461b2046],

1	If	IN	O	if	mark	12	SENT_309	[p15l1499t1943r1581b2022],
2	both	DT	O	both	preconj	4	SENT_309	[p15l1596t1944r1788b2024],
3	the	DT	O	the	det	4	SENT_309	[p15l1822t1944r1952b2023],
4	perprotocol	NN	O	perprotocol	nsubj	12	SENT_309	[p15l1984t1970r2147b2045, p15l11t2073r373b2173],
5	and	CC	O	and	_	0	SENT_309	[p15l417t2073r576b2152],
6	intention	NN	O	intention	nsubj	12	SENT_309	[p15l620t2074r1375b2152],
7	—	CD	NUMBER	—	number	9	SENT_309	[p15l620t2074r1375b2152],
8	to	TO	O	to	dep	9	SENT_309	[p15l620t2074r1375b2152],
9	—	CD	NUMBER	—	num	11	SENT_309	[p15l620t2074r1375b2152],
10	treat	NN	O	treat	nn	11	SENT_309	[p15l620t2074r1375b2152],
11	analyses	NNS	O	analysis	dep	6	SENT_309	[p15l1414t2073r1775b2173],
12	showed	VBD	O	show	csubj	19	SENT_309	[p15l1823t2073r2148b2152],
13	noninferiority	NN	O	noninferiority	dobj	12	SENT_309	[p15l12t2201r636b2303],
14	,	,	O	,	_	0	SENT_309	[p15l12t2201r636b2303],
15	then	RB	O	then	advmod	16	SENT_309	[p15l696t2202r888b2281],
16	testing	VBG	O	test	partmod	12	SENT_309	[p15l943t2203r1242b2304],
17	for	IN	O	for	_	0	SENT_309	[p15l1292t2201r1416b2282],
18	superiority	NN	O	superiority	prep_for	16	SENT_309	[p15l1469t2203r1937b2303],
19	was	VBD	O	be	_	0	SENT_309	[p15l1982t2228r2145b2282],
20	to	TO	O	to	aux	22	SENT_309	[p15l12t2349r94b2411],
21	be	VB	O	be	auxpass	22	SENT_309	[p15l134t2332r231b2411],
22	conducted	VBN	O	conduct	xcomp	19	SENT_309	[p15l269t2332r713b2411],
23	as	IN	O	as	mark	24	SENT_309	[p15l751t2358r837b2410],
24	described	VBN	O	describe	advcl	22	SENT_309	[p15l877t2332r1291b2411],
25	above	IN	O	above	prep	24	SENT_309	[p15l1327t2332r1595b2411],
26	.	.	O	.	_	0	SENT_309	[p15l1327t2332r1595b2411],

1	No	DT	O	no	det	3	SENT_310	[p15l1636t2340r1761b2411],
2	P	NN	O	p	nn	3	SENT_310	[p15l1798t2338r1851b2410],
3	Values	NNS	O	value	nsubjpass	5	SENT_310	[p15l1883t2332r2146b2411],
4	were	VBD	O	be	auxpass	5	SENT_310	[p15l7t2485r211b2539],
5	derived	VBN	O	derive	_	0	SENT_310	[p15l264t2459r574b2539],
6	for	IN	O	for	_	0	SENT_310	[p15l626t2458r750b2538],
7	the	DT	O	the	det	8	SENT_310	[p15l799t2459r933b2537],
8	test	NN	O	test	prep_for	5	SENT_310	[p15l986t2476r1141b2537],
9	of	IN	O	of	_	0	SENT_310	[p15l1189t2458r1290b2538],
10	superiority	NN	O	superiority	prep_of	8	SENT_310	[p15l1325t2460r1793b2559],
11	for	IN	O	for	_	0	SENT_310	[p15l1840t2458r1965b2538],
12	the	DT	O	the	det	16	SENT_310	[p15l2014t2459r2148b2537],
13	per	FW	O	per	nn	16	SENT_310	[p15l11t2587r546b2687],
14	—	FW	O	—	nn	16	SENT_310	[p15l11t2587r546b2687],
15	protocol	NN	O	protocol	nn	16	SENT_310	[p15l11t2587r546b2687],
16	population	NN	O	population	prep_for	5	SENT_310	[p15l585t2587r1083b2687],
17	;	:	O	;	_	0	SENT_310	[p15l585t2587r1083b2687],
18	the	DT	O	the	det	20	SENT_310	[p15l1129t2587r1263b2665],
19	confidence	NN	O	confidence	nn	20	SENT_310	[p15l1305t2586r1779b2666],
20	interval	NN	O	interval	nsubj	22	SENT_310	[p15l1820t2587r2148b2667],
21	was	VBD	O	be	cop	22	SENT_310	[p15l7t2741r171b2795],
22	sufficient	JJ	O	sufficient	dep	16	SENT_310	[p15l215t2714r629b2795],
23	to	TO	O	to	aux	24	SENT_310	[p15l664t2732r746b2794],
24	conclude	VB	O	conclude	xcomp	22	SENT_310	[p15l788t2715r1169b2795],
25	superiority	NN	O	superiority	dobj	24	SENT_310	[p15l1212t2716r1679b2815],
26	because	IN	O	because	mark	28	SENT_310	[p15l1716t2715r2054b2795],
27	it	PRP	O	it	nsubj	28	SENT_310	[p15l2093t2716r2153b2793],
28	excluded	VBD	O	exclude	advcl	24	SENT_310	[p15l12t2843r387b2923],
29	o.	NNP	O	o.	nn	30	SENT_310	[p15l434t2849r503b2922],
30	Data	NNP	O	Data	dobj	28	SENT_310	[p15l554t2850r756b2921],
31	from	IN	O	from	_	0	SENT_310	[p15l800t2842r1012b2922],
32	the	DT	O	the	det	36	SENT_310	[p15l1058t2843r1192b2921],
33	per	FW	O	per	nn	36	SENT_310	[p15l1237t2843r1772b2943],
34	—	FW	O	—	nn	36	SENT_310	[p15l1237t2843r1772b2943],
35	protocol	NN	O	protocol	nn	36	SENT_310	[p15l1237t2843r1772b2943],
36	population	NN	O	population	prep_from	30	SENT_310	[p15l1817t2843r2147b2943, p15l12t2973r182b3051],
37	are	VBP	O	be	auxpass	38	SENT_310	[p15l221t2998r351b3050],
38	presented	VBN	O	present	rcmod	36	SENT_310	[p15l390t2972r811b3072],
39	only	RB	O	only	advmod	38	SENT_310	[p15l851t2972r1036b3072],
40	to	TO	O	to	aux	41	SENT_310	[p15l1071t2989r1153b3051],
41	support	VB	O	support	xcomp	38	SENT_310	[p15l1196t2989r1530b3072],
42	the	DT	O	the	det	43	SENT_310	[p15l1565t2972r1699b3050],
43	results	NNS	O	result	dobj	41	SENT_310	[p15l1739t2972r2023b3051],
44	in	IN	O	in	_	0	SENT_310	[p15l2064t2973r2148b3050],
45	intention	NN	O	intention	prep_in	43	SENT_310	[p15l11t3102r767b3180],
46	—	CD	NUMBER	—	num	45	SENT_310	[p15l11t3102r767b3180],
47	to	TO	O	to	_	0	SENT_310	[p15l11t3102r767b3180],
48	—	CD	NUMBER	—	num	50	SENT_310	[p15l11t3102r767b3180],
49	treat	NN	O	treat	nn	50	SENT_310	[p15l11t3102r767b3180],
50	population	NN	O	population	prep_to	41	SENT_310	[p15l800t3101r1297b3201],
51	.	.	O	.	_	0	SENT_310	[p15l800t3101r1297b3201],

1	The	DT	O	the	det	2	SENT_311	[p15l138t3230r299b3309],
2	difference	NN	O	difference	dep	20	SENT_311	[p15l347t3229r781b3310],
3	of	IN	O	of	_	0	SENT_311	[p15l828t3229r929b3310],
4	7	CD	PERCENT	7	num	6	SENT_311	[p15l957t3238r1003b3309],
5	percentage	NN	PERCENT	percentage	nn	6	SENT_311	[p15l1049t3247r1521b3332],
6	points	NNS	PERCENT	point	prep_of	2	SENT_311	[p15l1566t3231r1836b3331],
7	in	IN	O	in	_	0	SENT_311	[p15l1884t3231r1968b3308],
8	the	DT	O	the	det	11	SENT_311	[p15l2014t3230r2148b3309],
9	treatment	NN	O	treatment	nn	11	SENT_311	[p15l12t3376r438b3437],
10	response	NN	O	response	nn	11	SENT_311	[p15l516t3385r899b3459],
11	(	NN	O	(	prep_in	6	SENT_311	[p15l987t3360r1099b3450],
12	in	IN	O	in	_	0	SENT_311	[p15l987t3360r1099b3450],
13	the	DT	O	the	det	14	SENT_311	[p15l1182t3359r1316b3437],
14	intention	NN	O	intention	prep_in	11	SENT_311	[p15l1397t3360r2153b3438],
15	—	CD	NUMBER	—	number	17	SENT_311	[p15l1397t3360r2153b3438],
16	to	TO	O	to	dep	17	SENT_311	[p15l1397t3360r2153b3438],
17	—	CD	NUMBER	—	num	14	SENT_311	[p15l1397t3360r2153b3438],
18	treat	NN	O	treat	nn	19	SENT_311	[p15l1397t3360r2153b3438],
19	analysis	NN	O	analysis	dep	20	SENT_311	[p16l11t22r380b123],
20	)	CD	NUMBER	)	_	0	SENT_311	[p16l11t22r380b123],
21	in	IN	O	in	_	0	SENT_311	[p16l433t23r517b100],
22	favor	NN	O	favor	prep_in	20	SENT_311	[p16l566t21r781b102],
23	of	IN	O	of	_	0	SENT_311	[p16l828t21r929b102],
24	dolutegravir	NN	O	dolutegravir	nn	27	SENT_311	[p16l960t22r1486b124],
25	and	CC	O	and	_	0	SENT_311	[p16l1531t22r1690b102],
26	abacavir	NN	O	abacavir	nn	27	SENT_311	[p16l1738t22r2151b102],
27	—	NN	O	—	prep_of	22	SENT_311	[p16l1738t22r2151b102],

1	Dolutegravir	NNP	O	Dolutegravir	nn	4	SENT_312	[p16l1423t243r1593b276],
2	and	CC	O	and	_	0	SENT_312	[p16l1602t243r1651b268],
3	Efavirenz-Tenofovir	NNP	O	Efavirenz-Tenofovir	nn	4	SENT_312	[p16l1763t243r2035b268],
4	Abacavir	NNP	O	Abacavir	_	0	SENT_312	[p16l1389t281r1685b306],
5	.	.	O	.	_	0	SENT_312	[p16l1389t281r1685b306],

1	—	NN	O	—	_	0	SENT_313	[p16l1389t281r1685b306],
2	.	.	O	.	_	0	SENT_313	[p16l1389t281r1685b306],

1	Lamivudine	NN	O	lamivudine	_	0	SENT_314	[p16l1389t281r1685b306],
2	DF	NN	O	df	dep	1	SENT_314	[p16l1779t281r2018b306],
3	.	.	O	.	_	0	SENT_314	[p16l1779t281r2018b306],

1	—	NN	O	—	_	0	SENT_315	[p16l1779t281r2018b306],
2	.	.	O	.	_	0	SENT_315	[p16l1779t281r2018b306],

1	Emtricitabine	NNP	O	Emtricitabine	_	0	SENT_316	[p16l1779t281r2018b306],

1	(	NN	O	(	nn	2	SENT_317	[p16l1478t321r1508b351],
2	N	NN	O	n	_	0	SENT_317	[p16l1478t321r1508b351],
3	=	JJ	O	=	dep	2	SENT_317	[p16l1516t321r1596b351],
4	414	CD	NUMBER	414	number	5	SENT_317	[p16l1516t321r1596b351],
5	)	CD	NUMBER	)	num	10	SENT_317	[p16l1516t321r1596b351],
6	(	NN	O	(	nn	10	SENT_317	[p16l1839t320r1956b351],
7	N	NN	O	n	nn	10	SENT_317	[p16l1839t320r1956b351],
8	=	JJ	O	=	amod	10	SENT_317	[p16l1839t320r1956b351],
9	419	CD	NUMBER	419	num	10	SENT_317	[p16l1839t320r1956b351],
10	)	NN	O	)	dep	3	SENT_317	[p16l1839t320r1956b351],

1	no.	NN	O	no.	_	0	SENT_318	[p16l1556t385r1593b401],
2	of	IN	O	of	_	0	SENT_318	[p16l1605t376r1635b409],
3	participants	NNS	O	participant	prep_of	1	SENT_318	[p16l1636t377r1790b409],
4	(	CD	PERCENT	(	num	5	SENT_318	[p16l1802t377r1847b409],
5	%	NN	PERCENT	%	dep	1	SENT_318	[p16l1802t377r1847b409],
6	)	CD	NUMBER	)	dep	5	SENT_318	[p16l1802t377r1847b409],

1	Adverse	JJ	O	adverse	amod	2	SENT_319	[p16l405t434r514b459],
2	event	NN	O	event	_	0	SENT_319	[p16l524t439r597b459],
3	leading	VBG	O	lead	dep	2	SENT_319	[p16l607t434r705b467],
4	to	TO	O	to	_	0	SENT_319	[p16l714t439r740b459],
5	discontinuation	NN	O	discontinuation	prep_to	3	SENT_319	[p16l750t434r964b459],
6	of	IN	O	of	_	0	SENT_319	[p16l975t433r1005b459],
7	study	NN	O	study	nn	8	SENT_319	[p16l1011t434r1083b467],
8	drug	NN	O	drug	prep_of	5	SENT_319	[p16l1092t434r1173b467],
9	'	''	O	'	_	0	SENT_319	[p16l1092t434r1173b467],
10	i	FW	O	i	nn	11	SENT_319	[p16l1092t434r1173b467],
11	‘	FW	O	‘	dobj	3	SENT_319	[p16l1092t434r1173b467],
12	42	CD	NUMBER	42	number	13	SENT_319	[p16l1853t436r1884b459],
13	(	CD	NUMBER	(	num	15	SENT_319	[p16l1897t435r1947b467],
14	10	CD	NUMBER	10	number	15	SENT_319	[p16l1897t435r1947b467],
15	)	CD	NUMBER	)	npadvmod	16	SENT_319	[p16l1897t435r1947b467],
16	Psychiatric	JJ	O	psychiatric	amod	17	SENT_319	[p16l458t491r602b524],
17	disorder	NN	O	disorder	dep	11	SENT_319	[p16l612t491r726b517],
18	15	CD	NUMBER	15	num	19	SENT_319	[p16l1855t494r1883b517],
19	(	NN	O	(	dep	32	SENT_319	[p16l1897t493r1930b524],
20	4	CD	NUMBER	4	number	21	SENT_319	[p16l1897t493r1930b524],
21	)	CD	NUMBER	)	dep	19	SENT_319	[p16l1897t493r1930b524],
22	Nervous	JJ	O	nervous	amod	25	SENT_319	[p16l458t551r571b574],
23	system	NN	O	system	nn	25	SENT_319	[p16l582t554r675b582],
24	disorder	NN	O	disorder	nn	25	SENT_319	[p16l687t549r800b574],
25	Skin	NN	O	skin	dep	21	SENT_319	[p16l456t607r512b632],
26	and	CC	O	and	_	0	SENT_319	[p16l523t607r571b632],
27	subcutaneous-tissue	JJ	O	subcutaneous-tissue	amod	28	SENT_319	[p16l583t607r866b632],
28	disorder	NN	O	disorder	conj_and	25	SENT_319	[p16l876t607r989b632],
29	Gastrointestinal	JJ	O	gastrointestinal	amod	30	SENT_319	[p16l456t664r674b689],
30	disorder	NN	O	disorder	dep	32	SENT_319	[p16l685t664r799b689],
31	General	NNP	O	General	nn	32	SENT_319	[p16l456t722r560b747],
32	disorder	NNP	O	disorder	dep	11	SENT_319	[p16l572t722r685b747],
33	or	CC	O	or	_	0	SENT_319	[p16l695t731r722b747],
34	administration-site	JJ	O	administration-site	amod	35	SENT_319	[p16l732t722r991b747],
35	condition	NN	O	condition	dep	11	SENT_319	[p16l1001t722r1128b747],

1	Adverse	JJ	O	adverse	amod	3	SENT_320	[p16l405t780r514b805],
2	event	NN	O	event	nn	3	SENT_320	[p16l524t784r597b805],
3	ofgrade	NN	O	ofgrade	_	0	SENT_320	[p16l606t779r717b813],
4	2-4	CD	NUMBER	2-4	dep	3	SENT_320	[p16l727t782r774b804],

1	Bronchitis	NN	O	bronchitis	_	0	SENT_321	[p16l458t837r594b862],

1	N	NN	O	n	_	0	SENT_322	[p16l1491t897r1505b920],
2	U-lI	NN	O	u-li	nn	3	SENT_322	[p16l1508t839r1522b1323],
3	\	NN	O	\	dep	1	SENT_322	[p16l1508t839r1522b1323],
4	.	.	O	.	_	0	SENT_322	[p16l1508t839r1522b1323],

1	|	NN	O	|	_	0	SENT_323	[p16l1508t839r1522b1323],
2	l	NN	O	l	dep	1	SENT_323	[p16l1508t839r1522b1323],
3	\	CD	NUMBER	\	number	4	SENT_323	[p16l1508t839r1522b1323],
4	3	CD	NUMBER	3	num	5	SENT_323	[p16l1508t839r1522b1323],
5	\	NN	O	\	dobj	2	SENT_323	[p16l1508t839r1522b1323],
6	l	NN	O	l	tmod	5	SENT_323	[p16l1508t839r1522b1323],
7	\	SYM	O	\	dep	5	SENT_323	[p16l1508t839r1522b1323],
8	-	:	O	-	_	0	SENT_323	[p16l1508t839r1522b1323],
9	D	NN	O	d	dep	1	SENT_323	[p16l1508t839r1522b1323],
10	\	CD	NUMBER	\	num	11	SENT_323	[p16l1508t839r1522b1323],
11	l	NN	O	l	tmod	9	SENT_323	[p16l1508t839r1522b1323],
12	\	NN	O	\	nn	14	SENT_323	[p16l1508t839r1522b1323],
13	l	NN	O	l	nn	14	SENT_323	[p16l1508t839r1522b1323],
14	|	NN	O	|	dep	9	SENT_323	[p16l1508t839r1522b1323],
15	.	.	O	.	_	0	SENT_323	[p16l1508t839r1522b1323],

1	—	NN	O	—	_	0	SENT_324	[p16l1508t839r1522b1323],
2	.	.	O	.	_	0	SENT_324	[p16l1508t839r1522b1323],
3	'	''	O	'	_	0	SENT_324	[p16l1508t839r1522b1323],

1	OO	NN	O	oo	nsubj	2	SENT_325	[p16l1508t839r1522b1323],
2	z-xzxzxz-xzxzxzxzxz-x	NN	O	z-xzxzxz-xzxzxzxzxz-x	_	0	SENT_325	[p16l1535t839r1542b1331],
3	I	PRP	O	I	nsubj	4	SENT_325	[p16l1544t1070r1558b1092],
4	\	VBP	O	\	ccomp	2	SENT_325	[p16l1544t1070r1558b1092],
5	)	CD	NUMBER	)	dobj	4	SENT_325	[p16l1544t1070r1558b1092],
6	I	PRP	O	I	nsubj	7	SENT_325	[p16l1544t839r1558b862],
7	\	VBP	O	\	rcmod	5	SENT_325	[p16l1544t839r1558b862],
8	)	CD	NUMBER	)	dobj	7	SENT_325	[p16l1544t839r1558b862],
9	xx	NN	O	xx	dep	8	SENT_325	[p16l1560t1070r1568b1101],
10	\	NN	O	\	dep	7	SENT_325	[p16l1560t839r1568b870],
11	/	:	O	/	punct	10	SENT_325	[p16l1560t839r1568b870],

1	Diarrhea	NNP	O	Diarrhea	_	0	SENT_326	[p16l458t895r573b920],

1	I	PRP	O	I	nsubj	2	SENT_327	[p16l1544t897r1558b977],
2	\	VBP	O	\	_	0	SENT_327	[p16l1544t897r1558b977],
3	)	CD	NUMBER	)	num	5	SENT_327	[p16l1544t897r1558b977],
4	U1	NN	O	u1	nn	5	SENT_327	[p16l1544t897r1558b977],
5	xaxa	NN	O	xaxa	dobj	2	SENT_327	[p16l1560t897r1568b985],

1	Nausea	NN	O	nausea	_	0	SENT_328	[p16l458t955r559b978],

1	Insomnia	NNP	O	Insomnia	_	0	SENT_329	[p16l458t1012r584b1035],

1	-	:	O	-	_	0	SENT_330	[p16l1543t1012r1558b1035],
2	I	PRP	O	I	_	0	SENT_330	[p16l1543t1012r1558b1035],
3	>	JJR	O	>	amod	4	SENT_330	[p16l1543t1012r1558b1035],
4	xz	NN	O	xz	dep	2	SENT_330	[p16l1560t1012r1568b1043],

1	Anxiety	NN	O	anxiety	_	0	SENT_331	[p16l455t1069r554b1101],
2	Depression	NN	O	depression	nn	3	SENT_331	[p16l458t1128r611b1158],
3	Headache	NN	O	headache	dep	1	SENT_331	[p16l458t1183r593b1208],

1	IUJI	NNP	ORGANIZATION	IUJI	nsubj	2	SENT_332	[p16l1493t1185r1504b1208, p16l1544t1128r1558b1208],
2	\	VBD	O	\	_	0	SENT_332	[p16l1493t1185r1504b1208, p16l1544t1128r1558b1208],
3	1	CD	NUMBER	1	number	4	SENT_332	[p16l1493t1185r1504b1208, p16l1544t1128r1558b1208],
4	\	CD	NUMBER	\	dobj	2	SENT_332	[p16l1560t1127r1568b1216],
5	/	:	O	/	punct	6	SENT_332	[p16l1560t1127r1568b1216],
6	\	CD	NUMBER	\	dep	4	SENT_332	[p16l1560t1127r1568b1216],
7	z	SYM	O	z	dep	4	SENT_332	[p16l1560t1127r1568b1216],

1	Dizziness	NN	O	dizziness	_	0	SENT_333	[p16l458t1243r587b1266],

1	Rash	NNP	O	Rash	_	0	SENT_334	[p16l458t1298r520b1323],

1	.	.	O	.	_	0	SENT_335	[p16l1546t1301r1557b1323],

1	_	NN	O	_	_	0	SENT_336	[p16l1546t1301r1557b1323],
2	.	.	O	.	_	0	SENT_336	[p16l1546t1301r1557b1323],

1	~	NN	O	~	_	0	SENT_337	[p16l1560t1300r1568b1331],
2	.	.	O	.	_	0	SENT_337	[p16l1560t1300r1568b1331],

1	a	DT	O	a	_	0	SENT_338	[p16l1560t1300r1568b1331],

1	Liver	NN	O	liver	nn	8	SENT_339	[p16l408t1358r471b1381],
2	aminotransferase	NN	O	aminotransferase	nn	8	SENT_339	[p16l481t1356r719b1381],
3	abnormality	NN	O	abnormality	nn	8	SENT_339	[p16l730t1356r893b1389],
4	ofgrade	NN	O	ofgrade	nn	8	SENT_339	[p16l902t1356r1012b1389],
5	2-4	CD	NUMBER	2-4	num	8	SENT_339	[p16l1022t1358r1070b1381],
6	Elevated	JJ	O	elevated	amod	8	SENT_339	[p16l458t1413r569b1439],
7	level	NN	O	level	nn	8	SENT_339	[p16l581t1413r638b1439],
8	ofalanine	NN	O	ofalanine	_	0	SENT_339	[p16l650t1413r782b1439],
9	aminotransferase	NN	O	aminotransferase	dep	8	SENT_339	[p16l793t1413r1032b1439],
10	Elevated	JJ	O	elevated	amod	13	SENT_339	[p16l458t1471r568b1496],
11	level	NN	O	level	nn	13	SENT_339	[p16l581t1471r638b1496],
12	ofaspartate	NN	O	ofaspartate	nn	13	SENT_339	[p16l650t1471r811b1504],
13	aminotransferase	NN	O	aminotransferase	dep	8	SENT_339	[p16l821t1471r1060b1496],

1	*	NN	O	*	nn	4	SENT_340	[p16l379t1558r394b1573],
2	Speciﬁc	NN	O	speciﬁc	nn	4	SENT_340	[p16l405t1556r507b1589],
3	adverse	JJ	O	adverse	amod	4	SENT_340	[p16l518t1556r620b1581],
4	events	NNS	O	event	nsubjpass	12	SENT_340	[p16l630t1561r715b1581],
5	leading	VBG	O	lead	partmod	4	SENT_340	[p16l728t1556r824b1589],
6	to	TO	O	to	_	0	SENT_340	[p16l833t1561r859b1581],
7	discontinuation	NN	O	discontinuation	nn	10	SENT_340	[p16l870t1556r1079b1581],
8	ofthe	NN	O	ofthe	nn	10	SENT_340	[p16l1091t1556r1167b1581],
9	study	NN	O	study	nn	10	SENT_340	[p16l1178t1556r1250b1589],
10	drug	NN	O	drug	prep_to	5	SENT_340	[p16l1260t1556r1321b1589],
11	are	VBP	O	be	auxpass	12	SENT_340	[p16l1332t1565r1371b1581],
12	reported	VBN	O	report	_	0	SENT_340	[p16l1383t1556r1494b1589],
13	here	RB	O	here	advmod	12	SENT_340	[p16l1507t1556r1563b1581],
14	if	IN	O	if	mark	16	SENT_340	[p16l1575t1556r1593b1581],
15	they	PRP	O	they	nsubj	16	SENT_340	[p16l1599t1556r1654b1589],
16	occurred	VBD	O	occur	advcl	12	SENT_340	[p16l1664t1556r1780b1581],
17	in	IN	O	in	_	0	SENT_340	[p16l1793t1558r1814b1581],
18	at	IN	O	at	quantmod	20	SENT_340	[p16l1827t1561r1851b1581],
19	least	JJS	O	least	mwe	18	SENT_340	[p16l1862t1556r1922b1581],
20	2	CD	PERCENT	2	dep	21	SENT_340	[p16l1933t1557r1975b1582],
21	%	NN	PERCENT	%	dep	23	SENT_340	[p16l1933t1557r1975b1582],
22	ofthe	NN	O	ofthe	nn	23	SENT_340	[p16l1986t1556r2063b1581],
23	participants	NNS	O	participant	prep_in	16	SENT_340	[p16l406t1595r565b1626],
24	in	IN	O	in	_	0	SENT_340	[p16l579t1595r600b1618],
25	either	DT	O	either	det	26	SENT_340	[p16l613t1593r691b1618],
26	group	NN	O	group	prep_in	16	SENT_340	[p16l702t1602r788b1626],
27	;	:	O	;	_	0	SENT_340	[p16l702t1602r788b1626],
28	overall	JJ	O	overall	amod	29	SENT_340	[p16l801t1593r888b1618],
29	numbers	NNS	O	number	nsubjpass	31	SENT_340	[p16l903t1593r1022b1618],
30	are	VBP	O	be	auxpass	31	SENT_340	[p16l1035t1602r1075b1618],
31	presented	VBN	O	present	parataxis	12	SENT_340	[p16l1088t1593r1220b1626],
32	for	IN	O	for	_	0	SENT_340	[p16l1232t1593r1270b1618],
33	all	DT	O	all	det	34	SENT_340	[p16l1281t1593r1309b1618],
34	participants	NNS	O	participant	prep_for	31	SENT_340	[p16l1323t1595r1490b1626],
35	,	,	O	,	_	0	SENT_340	[p16l1323t1595r1490b1626],
36	regardless	RB	O	regardless	advmod	31	SENT_340	[p16l1505t1593r1642b1626],
37	ofincidence	NN	O	ofincidence	pobj	36	SENT_340	[p16l1655t1593r1828b1618],
38	.	.	O	.	_	0	SENT_340	[p16l1655t1593r1828b1618],

1	Adverse	JJ	O	adverse	amod	2	SENT_341	[p16l1839t1593r1948b1618],
2	events	NNS	O	event	nsubj	33	SENT_341	[p16l1959t1598r2044b1618],
3	of	IN	O	of	_	0	SENT_341	[p16l404t1630r434b1655],
4	grade	NN	O	grade	prep_of	2	SENT_341	[p16l441t1630r516b1663],
5	2	CD	NUMBER	2	dep	4	SENT_341	[p16l528t1632r549b1660],
6	,	,	O	,	_	0	SENT_341	[p16l528t1632r549b1660],
7	3	CD	NUMBER	3	num	5	SENT_341	[p16l562t1632r583b1660],
8	,	,	O	,	_	0	SENT_341	[p16l562t1632r583b1660],
9	or	CC	O	or	_	0	SENT_341	[p16l596t1639r624b1655],
10	4	CD	NUMBER	4	dep	4	SENT_341	[p16l634t1632r648b1655],
11	and	CC	O	and	_	0	SENT_341	[p16l660t1630r708b1655],
12	abnormalities	NNS	O	abnormality	conj_and	4	SENT_341	[p16l722t1630r908b1655],
13	of	IN	O	of	_	0	SENT_341	[p16l920t1630r950b1655],
14	grade	NN	O	grade	prep_of	12	SENT_341	[p16l957t1630r1032b1663],
15	2	CD	NUMBER	2	nsubjpass	31	SENT_341	[p16l1044t1632r1065b1660],
16	,	,	O	,	_	0	SENT_341	[p16l1044t1632r1065b1660],
17	3	CD	NUMBER	3	num	15	SENT_341	[p16l1078t1632r1099b1660],
18	,	,	O	,	_	0	SENT_341	[p16l1078t1632r1099b1660],
19	or	CC	O	or	_	0	SENT_341	[p16l1112t1639r1140b1655],
20	4	CD	NUMBER	4	conj_or	15	SENT_341	[p16l1149t1632r1164b1655],
21	in	IN	O	in	_	0	SENT_341	[p16l1177t1632r1199b1655],
22	the	DT	O	the	det	25	SENT_341	[p16l1210t1630r1253b1655],
23	liver	NN	O	liver	nn	25	SENT_341	[p16l1266t1630r1321b1655],
24	aminotransferase	NN	O	aminotransferase	nn	25	SENT_341	[p16l1332t1630r1571b1655],
25	levels	NNS	O	level	prep_in	15	SENT_341	[p16l1583t1630r1656b1655],
26	that	WDT	O	that	nsubj	27	SENT_341	[p16l1667t1630r1721b1655],
27	developed	VBD	O	develop	rcmod	25	SENT_341	[p16l1732t1630r1870b1663],
28	during	IN	O	during	_	0	SENT_341	[p16l1883t1630r1971b1663],
29	treatment	NN	O	treatment	prep_during	27	SENT_341	[p16l1981t1635r2052b1655, p16l406t1672r475b1692],
30	are	VBP	O	be	auxpass	31	SENT_341	[p16l486t1676r526b1692],
31	reported	VBN	O	report	rcmod	2	SENT_341	[p16l539t1667r652b1700],
32	ifthey	NN	O	ifthey	dobj	31	SENT_341	[p16l666t1667r747b1700],
33	occurred	VBD	O	occur	_	0	SENT_341	[p16l758t1667r876b1692],
34	in	IN	O	in	_	0	SENT_341	[p16l890t1669r911b1692],
35	at	IN	O	at	quantmod	37	SENT_341	[p16l925t1672r949b1692],
36	least	JJS	O	least	mwe	35	SENT_341	[p16l961t1667r1023b1692],
37	3	CD	PERCENT	3	dep	38	SENT_341	[p16l1034t1668r1076b1693],
38	%	NN	PERCENT	%	dep	40	SENT_341	[p16l1034t1668r1076b1693],
39	ofthe	NN	O	ofthe	nn	40	SENT_341	[p16l1088t1667r1166b1692],
40	participants	NNS	O	participant	prep_in	33	SENT_341	[p16l1178t1669r1338b1700],
41	in	IN	O	in	_	0	SENT_341	[p16l1351t1669r1373b1692],
42	either	DT	O	either	det	43	SENT_341	[p16l1386t1667r1463b1692],
43	group	NN	O	group	prep_in	33	SENT_341	[p16l1474t1676r1561b1700],
44	.	.	O	.	_	0	SENT_341	[p16l1474t1676r1561b1700],

1	DF	NN	O	df	nsubj	2	SENT_342	[p16l1576t1669r1612b1692],
2	denotes	VBZ	O	denote	_	0	SENT_342	[p16l1624t1667r1731b1692],
3	disoproxil	NN	O	disoproxil	nn	4	SENT_342	[p16l1743t1667r1875b1700],
4	fumarate	NN	O	fumarate	dobj	2	SENT_342	[p16l1887t1667r2018b1692],
5	.	.	O	.	_	0	SENT_342	[p16l1887t1667r2018b1692],

1	1	CD	NUMBER	1	number	2	SENT_343	[p16l380t1706r396b1737],
2	‘	CD	NUMBER	‘	num	3	SENT_343	[p16l380t1706r396b1737],
3	Participants	NNS	O	participant	nsubj	5	SENT_343	[p16l407t1706r566b1737],
4	could	MD	O	could	aux	5	SENT_343	[p16l578t1704r651b1729],
5	have	VB	O	have	_	0	SENT_343	[p16l665t1704r726b1729],
6	more	JJR	O	more	mwe	7	SENT_343	[p16l739t1713r808b1729],
7	than	IN	O	than	quantmod	8	SENT_343	[p16l818t1704r878b1729],
8	one	CD	NUMBER	one	num	10	SENT_343	[p16l891t1713r940b1729],
9	adverse	JJ	O	adverse	amod	10	SENT_343	[p16l952t1704r1055b1729],
10	event	NN	O	event	dobj	5	SENT_343	[p16l1067t1709r1140b1729],
11	as	IN	O	as	_	0	SENT_343	[p16l1151t1713r1178b1729],
12	a	DT	O	a	det	13	SENT_343	[p16l1191t1713r1203b1729],
13	reason	NN	O	reason	prep_as	10	SENT_343	[p16l1217t1713r1305b1729],
14	for	IN	O	for	_	0	SENT_343	[p16l1318t1704r1355b1729],
15	withdrawing	VBG	O	withdraw	prepc_for	13	SENT_343	[p16l1365t1704r1540b1737],
16	.	.	O	.	_	0	SENT_343	[p16l1365t1704r1540b1737],

1	1312	CD	DATE	1312	num	3	SENT_344	[p16l93t1840r169b1861],
2	NENGLJ	NNP	O	NENGLJ	nn	3	SENT_344	[p16l877t1850r983b1872],
3	MED369	NN	O	med369	_	0	SENT_344	[p16l998t1844r1141b1872],
4	;	:	O	;	_	0	SENT_344	[p16l998t1844r1141b1872],
5	19	CD	NUMBER	19	num	6	SENT_344	[p16l998t1844r1141b1872],
6	NEjM	NNP	O	NEjM	dep	3	SENT_344	[p16l1177t1850r1301b1872],
7	,	,	O	,	_	0	SENT_344	[p16l1177t1850r1301b1872],
8	ORG	NNP	O	ORG	nn	9	SENT_344	[p16l1177t1850r1301b1872],
9	NovEMBER7	NNP	O	NovEMBER7	appos	6	SENT_344	[p16l1338t1850r1568b1872],
10	,2	CD	NUMBER	,2	num	11	SENT_344	[p16l1338t1850r1568b1872],
11	o13	NN	O	o13	dep	9	SENT_344	[p16l1338t1850r1568b1872],

1	The	DT	O	the	det	4	SENT_345	[p16l879t1907r930b1931],
2	New	NNP	O	New	nn	4	SENT_345	[p16l939t1908r1001b1931],
3	England	NNP	O	England	nn	4	SENT_345	[p16l1010t1907r1121b1938],
4	Joumal	NNP	O	Joumal	_	0	SENT_345	[p16l1130t1907r1227b1931],
5	of	IN	O	of	_	0	SENT_345	[p16l1237t1907r1266b1931],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_345	[p16l1273t1907r1398b1931],

1	DOLUTEGRAVIR	NN	O	dolutegravir	_	0	SENT_346	[p16l363t2032r625b2051],
2	AND	CC	O	and	cc	3	SENT_346	[p16l636t2032r708b2051],
3	ABACAVIR	NN	O	abacavir	dep	1	SENT_346	[p16l720t2032r1126b2051],
4	.	.	O	.	_	0	SENT_346	[p16l720t2032r1126b2051],

1	—	NN	O	—	_	0	SENT_347	[p16l720t2032r1126b2051],
2	.	.	O	.	_	0	SENT_347	[p16l720t2032r1126b2051],

1	LAMIVUDINE	NNP	O	LAMIVUDINE	_	0	SENT_348	[p16l720t2032r1126b2051],
2	FOR	IN	O	for	_	0	SENT_348	[p16l1140t2032r1205b2051],
3	HIV-1	NN	O	hiv-1	nn	4	SENT_348	[p16l1218t2032r1308b2051],
4	INFECTION	NN	O	infection	prep_for	1	SENT_348	[p16l1323t2032r1509b2051],

1	Participants	NNS	O	participant	nsubj	5	SENT_349	[p17l571t45r721b75],
2	with	IN	O	with	_	0	SENT_349	[p17l730t45r785b69],
3	HIV-1	NN	O	hiv-1	nn	4	SENT_349	[p17l797t47r868b69],
4	RNA	NN	O	rna	prep_with	1	SENT_349	[p17l881t47r939b68],
5	Level	NN	O	level	_	0	SENT_349	[p17l949t45r1012b69],
6	<	JJR	O	<	dep	5	SENT_349	[p17l1022t46r1069b69],
7	50	CD	NUMBER	50	num	8	SENT_349	[p17l1022t46r1069b69],
8	Copies/ml	NN	O	copies/ml	dep	6	SENT_349	[p17l1078t45r1210b76],
9	I	PRP	O	I	nsubj	10	SENT_349	[p17l608t105r633b130],
10	DTG	VBP	O	dtg	rcmod	8	SENT_349	[p17l647t106r830b127],
11	.	.	O	.	_	0	SENT_349	[p17l647t106r830b127],

1	—	NN	O	—	_	0	SENT_350	[p17l647t106r830b127],
2	.	.	O	.	_	0	SENT_350	[p17l647t106r830b127],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_351	[p17l647t106r830b127],
2	.	.	O	.	_	0	SENT_351	[p17l647t106r830b127],

1	—	NN	O	—	_	0	SENT_352	[p17l647t106r830b127],
2	.	.	O	.	_	0	SENT_352	[p17l647t106r830b127],

1	3TC	NN	O	3tc	_	0	SENT_353	[p17l647t106r830b127],

1	Subgroup	NN	O	subgroup	_	0	SENT_354	[p17l161t140r286b171],

1	Intention-to-Treat	NNP	O	Intention-to-Treat	nn	2	SENT_355	[p17l204t225r414b247],
2	Population	NNP	O	Population	_	0	SENT_355	[p17l424t224r551b253],

1	Per-Protocol	NNP	O	Per-Protocol	nn	2	SENT_356	[p17l269t337r413b359],
2	Population	NNP	O	Population	_	0	SENT_356	[p17l424t337r551b366],

1	Baseline	NN	O	baseline	nn	3	SENT_357	[p17l304t437r403b459],
2	HIV-1	NN	O	hiv-1	nn	3	SENT_357	[p17l413t439r480b459],
3	RNA	NN	O	rna	_	0	SENT_357	[p17l491t439r545b459],
4	$	$	MONEY	$	dep	3	SENT_357	[p17l310t472r420b497],
5	100,000	CD	MONEY	100,000	num	4	SENT_357	[p17l310t472r420b497],
6	Copies/ml	NN	O	copies/ml	dep	3	SENT_357	[p17l427t470r551b499],

1	Baseline	NN	O	baseline	nn	3	SENT_358	[p17l311t549r410b572],
2	HIV-1	NN	O	hiv-1	nn	3	SENT_358	[p17l420t551r487b572],
3	RNA	NN	O	rna	_	0	SENT_358	[p17l498t551r552b571],
4	>	JJR	O	>	dep	3	SENT_358	[p17l310t584r420b609],
5	100,000	CD	NUMBER	100,000	num	6	SENT_358	[p17l310t584r420b609],
6	Copies	NNPS	O	Copies	dep	4	SENT_358	[p17l427t583r521b612],
7	]	CD	NUMBER	]	num	8	SENT_358	[p17l427t583r521b612],
8	ml	NN	O	ml	dep	3	SENT_358	[p17l523t583r551b605],

1	Baseline	NN	O	baseline	nn	2	SENT_359	[p17l229t662r328b684],
2	CD4	NN	O	cd4	_	0	SENT_359	[p17l336t664r404b684],
3	+	CC	O	+	_	0	SENT_359	[p17l336t664r404b684],
4	T-cell	NN	O	t-cell	nn	5	SENT_359	[p17l412t662r475b684],
5	count	NN	O	count	conj_+	2	SENT_359	[p17l484t666r553b684],
6	>	JJR	O	>	dep	2	SENT_359	[p17l359t697r418b718],
7	200	CD	NUMBER	200	num	9	SENT_359	[p17l359t697r418b718],
8	Cells/mm	NN	O	cells/mm	nn	9	SENT_359	[p17l426t695r551b724],
9	’	NN	O	’	dep	6	SENT_359	[p17l426t695r551b724],

1	Baseline	NN	O	baseline	nn	2	SENT_360	[p17l229t774r328b797],
2	CD4	NN	O	cd4	_	0	SENT_360	[p17l336t776r404b797],
3	+	CC	O	+	_	0	SENT_360	[p17l336t776r404b797],
4	T-cell	NN	O	t-cell	nn	5	SENT_360	[p17l412t774r475b797],
5	count	NN	O	count	conj_+	2	SENT_360	[p17l484t778r553b797],
6	5200	CD	NUMBER	5200	num	7	SENT_360	[p17l359t809r418b830],
7	Cells/mm	NNP	O	Cells/mm	dep	2	SENT_360	[p17l426t808r551b837],
8	’	CD	NUMBER	’	num	7	SENT_360	[p17l426t808r551b837],

1	Women	NNS	O	woman	_	0	SENT_361	[p17l452t900r551b922],

1	Age	NN	O	age	_	0	SENT_362	[p17l412t1125r460b1154],
2	<	JJR	O	<	dep	1	SENT_362	[p17l469t1125r517b1147],
3	50	CD	DURATION	50	num	4	SENT_362	[p17l469t1125r517b1147],
4	Yr	NN	DURATION	yr	dep	1	SENT_362	[p17l525t1125r553b1147],

1	Age	NNP	O	Age	_	0	SENT_363	[p17l412t1238r460b1267],
2	:50	CD	NUMBER	:50	num	3	SENT_363	[p17l469t1237r517b1259],
3	Yr	NN	DURATION	yr	dep	1	SENT_363	[p17l525t1238r553b1259],

1	White	NNP	O	White	_	0	SENT_364	[p17l476t1348r552b1372],

1	Participants	NNS	O	participant	_	0	SENT_365	[p17l788t1634r939b1664],
2	(	CD	PERCENT	(	num	3	SENT_365	[p17l950t1635r991b1664],
3	%	NN	PERCENT	%	dep	1	SENT_365	[p17l950t1635r991b1664],
4	)	CD	NUMBER	)	dep	1	SENT_365	[p17l950t1635r991b1664],

1	I	PRP	O	I	_	0	SENT_366	[p17l964t105r989b130],
2	E	NN	O	e	nn	3	SENT_366	[p17l1003t106r1015b126],
3	FV	NN	O	fv	dep	1	SENT_366	[p17l1019t106r1098b127],
4	.	.	O	.	_	0	SENT_366	[p17l1019t106r1098b127],

1	—	NN	O	—	_	0	SENT_367	[p17l1019t106r1098b127],
2	.	.	O	.	_	0	SENT_367	[p17l1019t106r1098b127],

1	TD	NN	O	td	_	0	SENT_368	[p17l1019t106r1098b127],
2	F	NN	O	f	dep	1	SENT_368	[p17l1102t106r1177b127],
3	.	.	O	.	_	0	SENT_368	[p17l1102t106r1177b127],

1	—	NN	O	—	_	0	SENT_369	[p17l1102t106r1177b127],
2	.	.	O	.	_	0	SENT_369	[p17l1102t106r1177b127],

1	FTC	NNP	O	FTC	_	0	SENT_370	[p17l1102t106r1177b127],

1	no.	RB	O	no.	_	0	SENT_371	[p17l1204t149r1237b164],
2	/	:	O	/	punct	3	SENT_371	[p17l1239t141r1305b170],
3	total	JJ	O	total	dep	1	SENT_371	[p17l1239t141r1305b170],
4	no.	NN	O	no.	dep	3	SENT_371	[p17l1313t149r1346b164],
5	.	.	O	.	_	0	SENT_371	[p17l1313t149r1346b164],

1	Percent	NN	O	percent	nn	2	SENT_372	[p17l1430t47r1525b69],
2	Difference	NN	O	difference	dep	5	SENT_372	[p17l1535t44r1666b69],
3	between	IN	O	between	_	0	SENT_372	[p17l1676t45r1781b69],
4	Groups	NNS	O	group	prep_between	2	SENT_372	[p17l1791t47r1886b75],
5	(	VBP	O	(	_	0	SENT_372	[p17l1905t46r1969b76],
6	95	CD	PERCENT	95	number	7	SENT_372	[p17l1905t46r1969b76],
7	%	NN	PERCENT	%	amod	8	SENT_372	[p17l1905t46r1969b76],
8	Cl	NN	O	cl	dobj	5	SENT_372	[p17l1979t47r2014b76],
9	)	CD	NUMBER	)	nsubj	5	SENT_372	[p17l1979t47r2014b76],

1	Figure	NNP	O	Figure	_	0	SENT_373	[p17l122t1724r206b1757],
2	3	CD	NUMBER	3	dep	1	SENT_373	[p17l217t1726r239b1749],
3	.	.	O	.	_	0	SENT_373	[p17l217t1726r239b1749],

1	Efficacy	NNP	O	Efficacy	nn	2	SENT_374	[p17l253t1723r361b1757],
2	Data	NNP	O	Data	_	0	SENT_374	[p17l373t1726r436b1749],
3	at	IN	O	at	_	0	SENT_374	[p17l447t1728r472b1749],
4	Week	NNP	DURATION	Week	prep_at	2	SENT_374	[p17l481t1724r557b1749],
5	48	CD	NUMBER	48	num	4	SENT_374	[p17l567t1725r609b1754],
6	,	,	O	,	_	0	SENT_374	[p17l567t1725r609b1754],
7	According	VBG	O	accord	_	0	SENT_374	[p17l619t1724r760b1757],
8	to	TO	O	to	prepc_according_to	2	SENT_374	[p17l768t1728r796b1749],
9	Strata	NNP	O	Strata	pobj	2	SENT_374	[p17l806t1726r887b1749],
10	and	CC	O	and	_	0	SENT_374	[p17l899t1724r948b1749],
11	Subgroups	NNP	O	Subgroups	conj_and	9	SENT_374	[p17l959t1724r1117b1757],
12	.	.	O	.	_	0	SENT_374	[p17l959t1724r1117b1757],

1	The	DT	O	the	det	5	SENT_375	[p17l119t1774r170b1799],
2	left	JJ	O	left	amod	5	SENT_375	[p17l183t1773r226b1799],
3	side	NN	O	side	nn	5	SENT_375	[p17l238t1774r292b1799],
4	ofthe	NN	O	ofthe	nn	5	SENT_375	[p17l304t1773r382b1799],
5	figure	NN	O	figure	nsubj	6	SENT_375	[p17l393t1773r474b1807],
6	shows	VBZ	O	show	_	0	SENT_375	[p17l486t1774r571b1799],
7	the	DT	O	the	det	8	SENT_375	[p17l582t1774r626b1799],
8	proportion	NN	O	proportion	nn	27	SENT_375	[p17l638t1776r786b1807],
9	and	CC	O	and	_	0	SENT_375	[p17l799t1774r848b1799],
10	number	NN	O	number	nn	27	SENT_375	[p17l862t1774r970b1799],
11	of	IN	O	of	_	0	SENT_375	[p17l980t1773r1010b1799],
12	participants	NNS	O	participant	prep_of	8	SENT_375	[p17l1018t1776r1182b1807],
13	with	IN	O	with	_	0	SENT_375	[p17l1193t1774r1251b1799],
14	an	DT	O	a	det	17	SENT_375	[p17l1264t1783r1294b1799],
15	HIV-1	NN	O	hiv-1	nn	17	SENT_375	[p17l1309t1776r1383b1799],
16	RNA	NN	O	rna	nn	17	SENT_375	[p17l1398t1775r1459b1799],
17	level	NN	O	level	prep_with	12	SENT_375	[p17l1471t1774r1530b1799],
18	ofless	JJ	O	ofless	amod	27	SENT_375	[p17l1542t1773r1630b1799],
19	than	IN	O	than	_	0	SENT_375	[p17l1641t1774r1701b1799],
20	50	CD	NUMBER	50	num	21	SENT_375	[p17l1715t1775r1746b1799],
21	copies	NNS	O	copy	prep_than	18	SENT_375	[p17l1757t1776r1845b1807],
22	per	IN	O	per	_	0	SENT_375	[p17l1858t1783r1902b1807],
23	milliliter	NN	O	milliliter	prep_per	21	SENT_375	[p17l1913t1774r2026b1799],
24	at	IN	O	at	_	0	SENT_375	[p17l120t1820r145b1841],
25	week	NN	DURATION	week	prep_at	23	SENT_375	[p17l155t1815r225b1841],
26	48	CD	NUMBER	48	num	25	SENT_375	[p17l235t1817r267b1841],
27	(	NN	O	(	dobj	6	SENT_375	[p17l281t1815r425b1849],
28	according	VBG	O	accord	_	0	SENT_375	[p17l281t1815r425b1849],
29	to	TO	O	to	prepc_according_to	6	SENT_375	[p17l435t1820r462b1841],
30	the	DT	O	the	det	33	SENT_375	[p17l472t1815r516b1841],
31	Snapshot	NNP	O	Snapshot	nn	33	SENT_375	[p17l527t1815r657b1848],
32	algorithm	NN	O	algorithm	nn	33	SENT_375	[p17l668t1815r820b1849],
33	)	NN	O	)	pobj	6	SENT_375	[p17l668t1815r820b1849],
34	.	.	O	.	_	0	SENT_375	[p17l668t1815r820b1849],

1	Data	NNS	O	datum	nsubj	6	SENT_376	[p17l835t1818r897b1841],
2	for	IN	O	for	_	0	SENT_376	[p17l908t1815r947b1841],
3	strata	NN	O	stratum	prep_for	1	SENT_376	[p17l958t1820r1035b1841],
4	and	CC	O	and	_	0	SENT_376	[p17l1047t1815r1096b1841],
5	subgroups	NNS	O	subgroup	prep_for	1	SENT_376	[p17l1109t1815r1255b1849],
6	are	VBP	O	be	_	0	SENT_376	[p17l1267t1824r1308b1841],
7	from	IN	O	from	_	0	SENT_376	[p17l1318t1815r1383b1841],
8	the	DT	O	the	det	10	SENT_376	[p17l1395t1815r1438b1841],
9	intention-to-treat	JJ	O	intention-to-treat	amod	10	SENT_376	[p17l1451t1818r1689b1841],
10	population	NN	O	population	prep_from	6	SENT_376	[p17l1701t1815r1859b1848],
11	.	.	O	.	_	0	SENT_376	[p17l1701t1815r1859b1848],

1	On	IN	O	on	_	0	SENT_377	[p17l1871t1817r1911b1841],
2	the	DT	O	the	det	6	SENT_377	[p17l1923t1815r1967b1841],
3	right	JJ	O	right	amod	6	SENT_377	[p17l1979t1815r2042b1849],
4	side	NN	O	side	nn	6	SENT_377	[p17l121t1857r175b1882],
5	ofthe	NN	O	ofthe	nn	6	SENT_377	[p17l187t1857r266b1882],
6	figure	NN	O	figure	prep_on	14	SENT_377	[p17l276t1857r364b1890],
7	,	,	O	,	_	0	SENT_377	[p17l276t1857r364b1890],
8	the	DT	O	the	det	9	SENT_377	[p17l376t1857r420b1882],
9	differences	NNS	O	difference	nsubjpass	14	SENT_377	[p17l431t1857r583b1882],
10	between	IN	O	between	_	0	SENT_377	[p17l597t1857r712b1882],
11	the	DT	O	the	det	12	SENT_377	[p17l723t1857r767b1882],
12	groups	NNS	O	group	prep_between	9	SENT_377	[p17l778t1866r873b1890],
13	are	VBP	O	be	auxpass	14	SENT_377	[p17l886t1866r926b1882],
14	presented	VBN	O	present	_	0	SENT_377	[p17l939t1857r1083b1890],
15	;	:	O	;	_	0	SENT_377	[p17l939t1857r1083b1890],
16	all	DT	O	all	det	17	SENT_377	[p17l1096t1857r1124b1882],
17	comparisons	NNS	O	comparison	nsubjpass	19	SENT_377	[p17l1137t1860r1316b1890],
18	are	VBP	O	be	auxpass	19	SENT_377	[p17l1328t1866r1369b1882],
19	represented	VBN	O	represent	parataxis	14	SENT_377	[p17l1381t1857r1544b1890],
20	as	IN	O	as	_	0	SENT_377	[p17l1557t1866r1585b1882],
21	unadjusted	JJ	O	unadjusted	amod	22	SENT_377	[p17l1598t1857r1751b1890],
22	differences	NNS	O	difference	prep_as	19	SENT_377	[p17l1764t1857r1916b1882],
23	in	IN	O	in	_	0	SENT_377	[p17l1930t1859r1951b1882],
24	proportion	NN	O	proportion	nn	26	SENT_377	[p17l1965t1866r2020b1890, p17l121t1901r221b1932],
25	(	CD	NUMBER	(	num	26	SENT_377	[p17l237t1900r461b1932],
26	DTG	NN	O	dtg	prep_in	22	SENT_377	[p17l237t1900r461b1932],
27	.	.	O	.	_	0	SENT_377	[p17l237t1900r461b1932],

1	—	NN	O	—	_	0	SENT_378	[p17l237t1900r461b1932],
2	.	.	O	.	_	0	SENT_378	[p17l237t1900r461b1932],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_379	[p17l237t1900r461b1932],
2	.	.	O	.	_	0	SENT_379	[p17l237t1900r461b1932],

1	—	NN	O	—	_	0	SENT_380	[p17l237t1900r461b1932],
2	.	.	O	.	_	0	SENT_380	[p17l237t1900r461b1932],

1	3TC	NN	O	3tc	nn	2	SENT_381	[p17l237t1900r461b1932],
2	group	NN	O	group	_	0	SENT_381	[p17l472t1908r552b1932],
3	minus	CC	O	minus	prep	2	SENT_381	[p17l565t1901r649b1924],
4	EFV	NN	O	efv	dep	3	SENT_381	[p17l663t1901r866b1924],
5	.	.	O	.	_	0	SENT_381	[p17l663t1901r866b1924],

1	—	NN	O	—	_	0	SENT_382	[p17l663t1901r866b1924],
2	.	.	O	.	_	0	SENT_382	[p17l663t1901r866b1924],

1	TDF	NNP	O	TDF	_	0	SENT_383	[p17l663t1901r866b1924],
2	.	.	O	.	_	0	SENT_383	[p17l663t1901r866b1924],

1	—	NN	O	—	_	0	SENT_384	[p17l663t1901r866b1924],
2	.	.	O	.	_	0	SENT_384	[p17l663t1901r866b1924],

1	FTC	NNP	ORGANIZATION	FTC	nn	3	SENT_385	[p17l663t1901r866b1924],
2	group	NN	O	group	nn	3	SENT_385	[p17l878t1901r967b1932],
3	)	NN	O	)	nsubj	23	SENT_385	[p17l878t1901r967b1932],
4	and	CC	O	and	_	0	SENT_385	[p17l981t1899r1030b1924],
5	95	CD	PERCENT	95	number	6	SENT_385	[p17l1043t1900r1102b1925],
6	%	NN	PERCENT	%	amod	8	SENT_385	[p17l1043t1900r1102b1925],
7	confidence	NN	O	confidence	nn	8	SENT_385	[p17l1113t1898r1266b1924],
8	intervals	NNS	O	interval	conj_and	3	SENT_385	[p17l1279t1899r1403b1929],
9	,	,	O	,	_	0	SENT_385	[p17l1279t1899r1403b1929],
10	except	IN	O	except	_	0	SENT_385	[p17l1416t1904r1504b1932],
11	for	IN	O	for	prepc_except_for	23	SENT_385	[p17l1514t1898r1553b1924],
12	the	DT	O	the	det	14	SENT_385	[p17l1562t1899r1606b1924],
13	overall	JJ	O	overall	amod	14	SENT_385	[p17l1617t1899r1706b1924],
14	results	NNS	O	result	pobj	23	SENT_385	[p17l1720t1899r1810b1924],
15	in	IN	O	in	_	0	SENT_385	[p17l1824t1901r1845b1924],
16	the	DT	O	the	det	17	SENT_385	[p17l1857t1899r1901b1924],
17	intentionto-treat	NN	O	intentionto-treat	prep_in	14	SENT_385	[p17l1913t1901r2047b1924, p17l119t1945r222b1966],
18	and	CC	O	and	_	0	SENT_385	[p17l233t1940r282b1966],
19	per-protocol	JJ	O	per-protocol	amod	20	SENT_385	[p17l296t1940r464b1973],
20	populations	NNS	O	population	prep_in	14	SENT_385	[p17l478t1940r650b1973],
21	,	,	O	,	_	0	SENT_385	[p17l478t1940r650b1973],
22	which	WDT	O	which	nsubj	23	SENT_385	[p17l661t1940r741b1966],
23	show	VBP	O	show	_	0	SENT_385	[p17l755t1940r827b1966],
24	the	DT	O	the	det	26	SENT_385	[p17l836t1940r879b1966],
25	adjusted	JJ	O	adjusted	amod	26	SENT_385	[p17l891t1940r1008b1974],
26	difference	NN	O	difference	dobj	23	SENT_385	[p17l1021t1940r1159b1966],
27	and	CC	O	and	_	0	SENT_385	[p17l1171t1940r1219b1966],
28	the	DT	O	the	det	32	SENT_385	[p17l1231t1940r1274b1966],
29	95	CD	PERCENT	95	number	30	SENT_385	[p17l1286t1942r1345b1967],
30	%	NN	PERCENT	%	amod	32	SENT_385	[p17l1286t1942r1345b1967],
31	confidence	NN	O	confidence	nn	32	SENT_385	[p17l1356t1940r1509b1966],
32	interval	NN	O	interval	dobj	23	SENT_385	[p17l1521t1940r1631b1966],
33	.	.	O	.	_	0	SENT_385	[p17l1521t1940r1631b1966],

1	P	NN	O	p	nsubj	2	SENT_386	[p17l1645t1942r1762b1966],
2	=	JJ	O	=	_	0	SENT_386	[p17l1645t1942r1762b1966],
3	0.003	CD	NUMBER	0.003	dobj	2	SENT_386	[p17l1645t1942r1762b1966],
4	for	IN	O	for	_	0	SENT_386	[p17l1775t1940r1813b1966],
5	the	DT	O	the	det	7	SENT_386	[p17l1823t1940r1866b1966],
6	overall	JJ	O	overall	amod	7	SENT_386	[p17l1877t1940r1967b1966],
7	comparison	NN	O	comparison	prep_for	3	SENT_386	[p17l1979t1949r2048b1966, p17l121t1984r222b2015],
8	in	IN	O	in	_	0	SENT_386	[p17l236t1984r258b2007],
9	the	DT	O	the	det	11	SENT_386	[p17l269t1982r313b2007],
10	intention-to-treat	JJ	O	intention-to-treat	amod	11	SENT_386	[p17l325t1984r564b2007],
11	population	NN	O	population	prep_in	2	SENT_386	[p17l576t1982r733b2015],
12	.	.	O	.	_	0	SENT_386	[p17l576t1982r733b2015],

1	C	NN	O	c	nn	2	SENT_387	[p17l1404t1610r1426b1622],
2	EFV-TDF	NN	O	efv-tdf	_	0	SENT_387	[p17l1405t1635r1592b1657],
3	—	CD	NUMBER	—	num	4	SENT_387	[p17l1405t1635r1592b1657],
4	l	NN	O	l	tmod	2	SENT_387	[p17l1405t1635r1592b1657],
5	-	:	O	-	_	0	SENT_387	[p17l1405t1635r1592b1657],
6	'	''	O	'	_	0	SENT_387	[p17l1405t1635r1592b1657],
7	|	NN	O	|	nn	9	SENT_387	[p17l1405t1635r1592b1657],
8	'	''	O	'	_	0	SENT_387	[p17l1405t1635r1592b1657],
9	C	NN	O	c	dep	2	SENT_387	[p17l1405t1635r1592b1657],
10	Better	RBR	O	better	amod	11	SENT_387	[p17l1603t1635r1679b1657],
11	DTG	NN	O	dtg	dep	9	SENT_387	[p17l1706t1635r1908b1657],
12	.	.	O	.	_	0	SENT_387	[p17l1706t1635r1908b1657],

1	—	NN	O	—	_	0	SENT_388	[p17l1706t1635r1908b1657],
2	.	.	O	.	_	0	SENT_388	[p17l1706t1635r1908b1657],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_389	[p17l1706t1635r1908b1657],
2	.	.	O	.	_	0	SENT_389	[p17l1706t1635r1908b1657],

1	—	NN	O	—	_	0	SENT_390	[p17l1706t1635r1908b1657],
2	.	.	O	.	_	0	SENT_390	[p17l1706t1635r1908b1657],

1	3TC	CD	NUMBER	3tc	_	0	SENT_391	[p17l1706t1635r1908b1657],
2	Better	NNP	O	Better	dep	1	SENT_391	[p17l1918t1635r1994b1657],
3	>	JJR	O	>	dep	1	SENT_391	[p17l2016t1610r2039b1622],

1	lamivudine	NN	O	lamivudine	nsubjpass	3	SENT_392	[p17l93t2132r281b2163],
2	was	VBD	O	be	auxpass	3	SENT_392	[p17l307t2142r370b2163],
3	observed	VBN	O	observe	_	0	SENT_392	[p17l399t2132r546b2163],
4	among	IN	O	among	_	0	SENT_392	[p17l573t2142r690b2171],
5	participants	NNS	O	participant	prep_among	3	SENT_392	[p17l715t2132r916b2171],
6	with	IN	O	with	_	0	SENT_392	[p17l92t2181r168b2212],
7	a	DT	O	a	det	12	SENT_392	[p17l183t2191r201b2211],
8	high	JJ	O	high	amod	12	SENT_392	[p17l216t2181r292b2220],
9	baseline	NN	O	baseline	nn	12	SENT_392	[p17l308t2181r444b2211],
10	HIV-1	NN	O	hiv-1	nn	12	SENT_392	[p17l460t2183r555b2211],
11	RNA	NN	O	rna	nn	12	SENT_392	[p17l571t2183r652b2213],
12	level	NN	O	level	conj_and	12	SENT_392	[p17l666t2181r740b2212],
13	(	CD	NUMBER	(	num	16	SENT_392	[p17l757t2183r916b2218],
14	>	JJR	O	>	amod	16	SENT_392	[p17l757t2183r916b2218],
15	100,000	CD	NUMBER	100,000	num	16	SENT_392	[p17l757t2183r916b2218],
16	copies	NNS	O	copy	npadvmod	12	SENT_392	[p17l94t2230r197b2269],
17	per	IN	O	per	_	0	SENT_392	[p17l218t2240r273b2269],
18	milliliter	NN	O	milliliter	nn	19	SENT_392	[p17l293t2230r451b2265],
19	)	NN	O	)	prep_per	12	SENT_392	[p17l293t2230r451b2265],
20	and	CC	O	and	_	0	SENT_392	[p17l474t2230r535b2261],
21	among	IN	O	among	_	0	SENT_392	[p17l556t2240r673b2269],
22	those	DT	O	those	prep_among	12	SENT_392	[p17l693t2230r783b2260],
23	with	IN	O	with	_	0	SENT_392	[p17l803t2230r879b2261],
24	a	DT	O	a	det	29	SENT_392	[p17l900t2240r917b2260],
25	low	JJ	O	low	amod	29	SENT_392	[p17l93t2279r154b2310],
26	baseline	NN	O	baseline	nn	29	SENT_392	[p17l171t2279r307b2310],
27	HIV-1	NN	O	hiv-1	nn	29	SENT_392	[p17l326t2282r420b2310],
28	RNA	NN	O	rna	nn	29	SENT_392	[p17l439t2282r520b2312],
29	level	NN	O	level	prep_with	22	SENT_392	[p17l537t2279r610b2310],
30	(	CD	NUMBER	(	num	33	SENT_392	[p17l630t2282r794b2317],
31	$	$	MONEY	$	amod	33	SENT_392	[p17l630t2282r794b2317],
32	100,000	CD	MONEY	100,000	number	31	SENT_392	[p17l630t2282r794b2317],
33	copies	NNS	O	copy	dep	12	SENT_392	[p17l813t2280r916b2318],
34	per	IN	O	per	_	0	SENT_392	[p17l93t2339r147b2368],
35	milliliter	NN	O	milliliter	nn	36	SENT_392	[p17l168t2328r336b2366],
36	)	NN	O	)	prep_per	12	SENT_392	[p17l168t2328r336b2366],
37	;	:	O	;	_	0	SENT_392	[p17l168t2328r336b2366],
38	treatment	NN	O	treatment	nn	39	SENT_392	[p17l359t2335r524b2359],
39	differences	NNS	O	difference	nsubjpass	42	SENT_392	[p17l544t2328r728b2359],
40	were	VBD	O	be	auxpass	42	SENT_392	[p17l749t2339r828b2360],
41	also	RB	O	also	advmod	42	SENT_392	[p17l849t2328r916b2359],
42	maintained	VBN	O	maintain	parataxis	3	SENT_392	[p17l94t2378r286b2409],
43	across	IN	O	across	_	0	SENT_392	[p17l302t2388r406b2409],
44	key	JJ	O	key	amod	46	SENT_392	[p17l423t2378r479b2418],
45	demographic	JJ	O	demographic	amod	46	SENT_392	[p17l495t2378r714b2418],
46	subgroups	NNS	O	subgroup	prep_across	42	SENT_392	[p17l732t2378r914b2418],
47	,	,	O	,	_	0	SENT_392	[p17l732t2378r914b2418],
48	including	VBG	O	include	_	0	SENT_392	[p17l93t2428r253b2468],
49	subgroups	NNS	O	subgroup	prep_including	42	SENT_392	[p17l270t2428r443b2468],
50	defined	VBN	O	define	partmod	49	SENT_392	[p17l462t2428r589b2459],
51	according	VBG	O	accord	_	0	SENT_392	[p17l606t2428r772b2468],
52	to	TO	O	to	prepc_according_to	50	SENT_392	[p17l788t2435r820b2459],
53	race	NN	O	race	pobj	50	SENT_392	[p17l839t2439r914b2466],
54	,	,	O	,	_	0	SENT_392	[p17l839t2439r914b2466],
55	sex	NN	O	sex	conj_and	53	SENT_392	[p17l94t2488r155b2515],
56	,	,	O	,	_	0	SENT_392	[p17l94t2488r155b2515],
57	and	CC	O	and	_	0	SENT_392	[p17l175t2478r236b2508],
58	age	NN	O	age	nn	60	SENT_392	[p17l254t2488r309b2517],
59	(	CD	NUMBER	(	num	60	SENT_392	[p17l329t2478r399b2517],
60	Fig	NN	O	fig	conj_and	53	SENT_392	[p17l329t2478r399b2517],
61	.	.	O	.	_	0	SENT_392	[p17l329t2478r399b2517],

1	3	CD	NUMBER	3	_	0	SENT_393	[p17l419t2480r457b2513],
2	)	NN	O	)	dep	1	SENT_393	[p17l419t2480r457b2513],
3	.	.	O	.	_	0	SENT_393	[p17l419t2480r457b2513],

1	The	DT	O	the	det	3	SENT_394	[p17l476t2478r539b2508],
2	median	JJ	O	median	amod	3	SENT_394	[p17l557t2478r682b2508],
3	time	NN	O	time	dep	20	SENT_394	[p17l700t2478r775b2508],
4	to	TO	O	to	_	0	SENT_394	[p17l793t2484r825b2508],
5	Viral	JJ	O	viral	amod	6	SENT_394	[p17l842t2478r917b2509],
6	suppression	NN	O	suppression	prep_to	20	SENT_394	[p17l94t2528r292b2566],
7	(	CD	NUMBER	(	num	10	SENT_394	[p17l310t2530r417b2563],
8	HIV-1	NN	O	hiv-1	nn	10	SENT_394	[p17l310t2530r417b2563],
9	RNA	NN	O	rna	nn	10	SENT_394	[p17l433t2530r514b2560],
10	level	NN	O	level	dep	6	SENT_394	[p17l529t2527r602b2558],
11	of	IN	O	of	_	0	SENT_394	[p17l618t2527r657b2558],
12	<	JJR	O	<	prep_of	10	SENT_394	[p17l667t2530r727b2558],
13	50	CD	NUMBER	50	num	14	SENT_394	[p17l667t2530r727b2558],
14	copies	NNS	O	copy	dep	12	SENT_394	[p17l744t2528r847b2566],
15	per	IN	O	per	_	0	SENT_394	[p17l863t2537r918b2566],
16	milliliter	NN	O	milliliter	nn	17	SENT_394	[p17l956t2132r1114b2167],
17	)	NN	O	)	prep_per	14	SENT_394	[p17l956t2132r1114b2167],
18	was	VBD	O	be	cop	20	SENT_394	[p17l1136t2142r1199b2163],
19	28	CD	DURATION	28	num	20	SENT_394	[p17l1221t2134r1260b2162],
20	days	NNS	NUMBER	day	_	0	SENT_394	[p17l1282t2132r1354b2171],
21	among	IN	O	among	attr	20	SENT_394	[p17l1376t2142r1492b2171],
22	participants	NNS	O	participant	pobj	21	SENT_394	[p17l1512t2132r1712b2171],
23	receiving	VBG	O	receive	partmod	22	SENT_394	[p17l1735t2142r1779b2162, p17l956t2181r1075b2220],
24	dolutegravir	NN	O	dolutegravir	nn	28	SENT_394	[p17l1086t2181r1289b2220],
25	and	CC	O	and	_	0	SENT_394	[p17l1300t2181r1362b2211],
26	abacavir	NN	O	abacavir	nn	28	SENT_394	[p17l1374t2181r1731b2218],
27	—	CD	NUMBER	—	num	28	SENT_394	[p17l1374t2181r1731b2218],
28	lamivudine	NN	O	lamivudine	dobj	23	SENT_394	[p17l1374t2181r1731b2218],
29	,	,	O	,	_	0	SENT_394	[p17l1374t2181r1731b2218],
30	as	IN	O	as	advmod	23	SENT_394	[p17l1745t2191r1778b2211],
31	compared	VBN	O	compare	_	0	SENT_394	[p17l956t2230r1122b2269],
32	with	IN	O	with	prepc_compared_with	23	SENT_394	[p17l1139t2230r1215b2261],
33	84	CD	DURATION	84	num	34	SENT_394	[p17l1235t2232r1274b2261],
34	days	NNS	NUMBER	day	pobj	23	SENT_394	[p17l1294t2230r1365b2269],
35	among	IN	O	among	_	0	SENT_394	[p17l1385t2240r1502b2269],
36	those	DT	O	those	prep_among	34	SENT_394	[p17l1520t2230r1610b2260],
37	receiving	VBG	O	receive	partmod	36	SENT_394	[p17l1629t2230r1781b2269],
38	efavirenz	NN	O	efavirenz	nn	41	SENT_394	[p17l956t2279r1282b2310],
39	—	CD	NUMBER	—	num	41	SENT_394	[p17l956t2279r1282b2310],
40	tenofovir	NN	O	tenofovir	nn	41	SENT_394	[p17l956t2279r1282b2310],
41	DF	NN	O	df	nsubj	47	SENT_394	[p17l1307t2279r1600b2310],
42	—	CD	NUMBER	—	num	43	SENT_394	[p17l1307t2279r1600b2310],
43	emtricitabine	NN	O	emtricitabine	dep	41	SENT_394	[p17l1307t2279r1600b2310],
44	(	CD	NUMBER	(	num	46	SENT_394	[p17l1628t2280r1780b2315],
45	nominal	JJ	O	nominal	amod	46	SENT_394	[p17l1628t2280r1780b2315],
46	P	NN	O	p	dep	41	SENT_394	[p17l956t2331r1097b2364],
47	<	JJR	O	<	xcomp	37	SENT_394	[p17l956t2331r1097b2364],
48	0.001	CD	NUMBER	0.001	num	51	SENT_394	[p17l956t2331r1097b2364],
49	)	NN	O	)	nn	51	SENT_394	[p17l956t2331r1097b2364],
50	(	CD	NUMBER	(	num	51	SENT_394	[p17l1120t2329r1190b2368],
51	Fig	NN	O	fig	nsubj	20	SENT_394	[p17l1120t2329r1190b2368],
52	.	.	O	.	_	0	SENT_394	[p17l1120t2329r1190b2368],

1	S2	NN	O	s2	_	0	SENT_395	[p17l1212t2331r1249b2359],
2	in	IN	O	in	_	0	SENT_395	[p17l1268t2329r1301b2359],
3	the	DT	O	the	det	6	SENT_395	[p17l1320t2328r1372b2359],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_395	[p17l1392t2328r1642b2368],
5	Appendix	NNP	O	Appendix	nn	6	SENT_395	[p17l1658t2331r1779b2368, p17l956t2378r1027b2414],
6	)	NN	O	)	prep_in	1	SENT_395	[p17l1658t2331r1779b2368, p17l956t2378r1027b2414],
7	.	.	O	.	_	0	SENT_395	[p17l1658t2331r1779b2368, p17l956t2378r1027b2414],

1	The	DT	O	the	det	4	SENT_396	[p17l1041t2378r1104b2409],
2	adjusted	JJ	O	adjusted	amod	4	SENT_396	[p17l1117t2378r1255b2418],
3	mean	JJ	O	mean	amod	4	SENT_396	[p17l1268t2388r1360b2409],
4	change	NN	O	change	dep	19	SENT_396	[p17l1374t2378r1492b2418],
5	from	IN	O	from	_	0	SENT_396	[p17l1506t2378r1587b2409],
6	baseline	NN	O	baseline	prep_from	19	SENT_396	[p17l1601t2378r1737b2409],
7	at	IN	O	at	_	0	SENT_396	[p17l1750t2385r1781b2409],
8	Week	NN	DURATION	week	prep_at	6	SENT_396	[p17l955t2428r1041b2460],
9	48	CD	NUMBER	48	num	8	SENT_396	[p17l1058t2431r1098b2459],
10	in	IN	O	in	_	0	SENT_396	[p17l1118t2429r1151b2459],
11	the	DT	O	the	det	12	SENT_396	[p17l1171t2428r1222b2459],
12	CD4	NN	O	cd4	prep_in	8	SENT_396	[p17l1242t2431r1338b2459],
13	+	CC	O	+	_	0	SENT_396	[p17l1242t2431r1338b2459],
14	T	NN	O	t	nn	17	SENT_396	[p17l1356t2428r1448b2459],
15	—	NN	O	—	nn	17	SENT_396	[p17l1356t2428r1448b2459],
16	cell	NN	O	cell	nn	17	SENT_396	[p17l1356t2428r1448b2459],
17	count	NN	O	count	conj_+	12	SENT_396	[p17l1468t2435r1562b2460],
18	Was	VBD	O	be	cop	19	SENT_396	[p17l1578t2439r1642b2460],
19	greater	JJR	O	greater	_	0	SENT_396	[p17l1662t2435r1780b2468],
20	with	IN	O	with	_	0	SENT_396	[p17l954t2478r1030b2509],
21	dolutegravir	NN	O	dolutegravir	prep_with	19	SENT_396	[p17l1046t2478r1249b2517],
22	and	CC	O	and	_	0	SENT_396	[p17l1263t2478r1325b2508],
23	abacavir	NN	O	abacavir	conj_and	21	SENT_396	[p17l1340t2478r1687b2509],
24	—	CD	NUMBER	—	num	25	SENT_396	[p17l1340t2478r1687b2509],
25	lamivudine	NN	O	lamivudine	npadvmod	26	SENT_396	[p17l1340t2478r1687b2509],
26	than	IN	O	than	advmod	19	SENT_396	[p17l1703t2478r1779b2508],
27	with	IN	O	with	_	0	SENT_396	[p17l954t2527r1028b2558],
28	efavirenz	NN	O	efavirenz	nn	31	SENT_396	[p17l1039t2527r1349b2558],
29	—	CD	NUMBER	—	num	31	SENT_396	[p17l1039t2527r1349b2558],
30	tenofovir	NN	O	tenofovir	nn	31	SENT_396	[p17l1039t2527r1349b2558],
31	DF	NN	O	df	prep_with	19	SENT_396	[p17l1358t2527r1638b2558],
32	—	CD	NUMBER	—	num	34	SENT_396	[p17l1358t2527r1638b2558],
33	emtricitabine	NN	O	emtricitabine	nn	34	SENT_396	[p17l1358t2527r1638b2558],
34	(	NN	O	(	nsubj	19	SENT_396	[p17l1651t2530r1717b2563],
35	267	CD	NUMBER	267	npadvmod	36	SENT_396	[p17l1651t2530r1717b2563],
36	per	IN	O	per	advmod	34	SENT_396	[p17l1728t2537r1780b2566],

1	NENGLJMED369	NN	O	nengljmed369	_	0	SENT_397	[p17l591t2645r855b2673],
2	;	:	O	;	_	0	SENT_397	[p17l591t2645r855b2673],
3	19	CD	NUMBER	19	num	5	SENT_397	[p17l591t2645r855b2673],
4	NEJM.ORG	NN	O	nejm.org	nn	5	SENT_397	[p17l891t2651r1015b2673],
5	NOVEMBER7	NN	O	november7	dep	1	SENT_397	[p17l1052t2651r1283b2673],
6	,2013	CD	NUMBER	,2013	dep	5	SENT_397	[p17l1052t2651r1283b2673],
7	The	DT	O	the	det	10	SENT_397	[p17l752t2708r803b2732],
8	New	NNP	O	New	nn	10	SENT_397	[p17l812t2709r874b2732],
9	England	NNP	O	England	nn	10	SENT_397	[p17l883t2708r994b2739],
10	Journal	NNP	O	Journal	dep	5	SENT_397	[p17l1002t2708r1100b2732],
11	of	IN	O	of	_	0	SENT_397	[p17l1110t2708r1139b2732],
12	Medicine	NNP	O	Medicine	prep_of	10	SENT_397	[p17l1145t2708r1270b2732],

1	The	DT	O	the	det	4	SENT_398	[p17l816t2832r862b2853],
2	NEW	NNP	O	NEW	nn	4	SENT_398	[p17l880t2834r965b2853],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_398	[p17l984t2834r1173b2853],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_398	[p17l1192t2834r1371b2860],
5	of	IN	O	of	_	0	SENT_398	[p17l1391t2832r1419b2859],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_398	[p17l1431t2834r1630b2853],

1	A	DT	O	a	det	3	SENT_399	[p18l108t34r130b59],
2	Adverse	JJ	O	adverse	amod	3	SENT_399	[p18l151t36r254b60],
3	Events	NNS	O	event	_	0	SENT_399	[p18l265t38r348b60],

1	A	DT	O	a	det	2	SENT_400	[p18l749t106r767b120],
2	DTG	NN	O	dtg	_	0	SENT_400	[p18l780t101r963b122],
3	.	.	O	.	_	0	SENT_400	[p18l780t101r963b122],

1	—	NN	O	—	_	0	SENT_401	[p18l780t101r963b122],
2	.	.	O	.	_	0	SENT_401	[p18l780t101r963b122],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_402	[p18l780t101r963b122],
2	.	.	O	.	_	0	SENT_402	[p18l780t101r963b122],

1	—	NN	O	—	_	0	SENT_403	[p18l780t101r963b122],
2	.	.	O	.	_	0	SENT_403	[p18l780t101r963b122],

1	3TC	NN	O	3tc	_	0	SENT_404	[p18l780t101r963b122],
2	I	CD	NUMBER	i	num	3	SENT_404	[p18l1000t103r1019b122],
3	EFV	NN	O	efv	dep	1	SENT_404	[p18l1032t101r1205b122],
4	.	.	O	.	_	0	SENT_404	[p18l1032t101r1205b122],

1	—	NN	O	—	_	0	SENT_405	[p18l1032t101r1205b122],
2	.	.	O	.	_	0	SENT_405	[p18l1032t101r1205b122],

1	TDF	NNP	O	TDF	_	0	SENT_406	[p18l1032t101r1205b122],
2	.	.	O	.	_	0	SENT_406	[p18l1032t101r1205b122],

1	—	NN	O	—	_	0	SENT_407	[p18l1032t101r1205b122],
2	.	.	O	.	_	0	SENT_407	[p18l1032t101r1205b122],

1	FTC	NNP	O	FTC	_	0	SENT_408	[p18l1032t101r1205b122],

1	Dizziness	NN	O	dizziness	_	0	SENT_409	[p18l433t174r553b197],
2	I	CD	NUMBER	i	num	4	SENT_409	[p18l1789t201r1792b212],
3	Diarrhea	NNP	MISC	Diarrhea	nn	4	SENT_409	[p18l444t215r554b239],
4	|	NN	O	|	dep	1	SENT_409	[p18l1738t218r1830b245],
5	.	.	O	.	_	0	SENT_409	[p18l1738t218r1830b245],

1	—	NN	O	—	_	0	SENT_410	[p18l1738t218r1830b245],
2	.	.	O	.	_	0	SENT_410	[p18l1738t218r1830b245],

1	Q	NNP	O	Q	_	0	SENT_411	[p18l1738t218r1830b245],
2	.	.	O	.	_	0	SENT_411	[p18l1738t218r1830b245],

1	—	NN	O	—	_	0	SENT_412	[p18l1738t218r1830b245],
2	.	.	O	.	_	0	SENT_412	[p18l1738t218r1830b245],

1	|	NN	O	|	nn	2	SENT_413	[p18l1738t218r1830b245],
2	Nasopharyngitis	NN	O	nasopharyngitis	_	0	SENT_413	[p18l344t257r554b288],
3	I	PRP	O	I	nsubj	4	SENT_413	[p18l1744t251r1846b295],
4	—	VBP	O	—	rcmod	2	SENT_413	[p18l1744t251r1846b295],
5	:	:	O	:	_	0	SENT_413	[p18l1744t251r1846b295],
6	O	NN	O	o	nn	9	SENT_413	[p18l1744t251r1846b295],
7	—	CD	NUMBER	—	num	9	SENT_413	[p18l1744t251r1846b295],
8	l	NN	O	l	nn	9	SENT_413	[p18l1744t251r1846b295],
9	Nausea	NN	MISC	nausea	dep	2	SENT_413	[p18l458t301r554b322],
10	I	PRP	O	I	dep	9	SENT_413	[p18l1744t301r1848b329],
11	.	.	O	.	_	0	SENT_413	[p18l1744t301r1848b329],

1	—	NN	O	—	_	0	SENT_414	[p18l1744t301r1848b329],
2	.	.	O	.	_	0	SENT_414	[p18l1744t301r1848b329],

1	b	NN	O	b	_	0	SENT_415	[p18l1744t301r1848b329],
2	.	.	O	.	_	0	SENT_415	[p18l1744t301r1848b329],

1	—	NN	O	—	_	0	SENT_416	[p18l1744t301r1848b329],
2	.	.	O	.	_	0	SENT_416	[p18l1744t301r1848b329],

1	I	PRP	O	I	nsubj	2	SENT_417	[p18l1744t301r1848b329],
2	Headache	VBP	O	headache	_	0	SENT_417	[p18l426t340r554b364],
3	I	PRP	O	I	nsubj	4	SENT_417	[p18l1733t334r1842b379],
4	—	VBP	O	—	ccomp	2	SENT_417	[p18l1733t334r1842b379],
5	‘	CD	NUMBER	‘	dobj	4	SENT_417	[p18l1733t334r1842b379],
6	I	PRP	O	I	nsubj	7	SENT_417	[p18l1733t334r1842b379],
7	—	VBP	O	—	rcmod	5	SENT_417	[p18l1733t334r1842b379],
8	|	CD	NUMBER	|	dobj	7	SENT_417	[p18l1733t334r1842b379],
9	Insomnia	NNP	O	Insomnia	nn	10	SENT_417	[p18l435t382r554b405],
10	lI	NNP	O	lI	dep	8	SENT_417	[p18l1789t384r1905b412],
11	.	.	O	.	_	0	SENT_417	[p18l1789t384r1905b412],

1	—	NN	O	—	_	0	SENT_418	[p18l1789t384r1905b412],
2	.	.	O	.	_	0	SENT_418	[p18l1789t384r1905b412],

1	O	NN	O	o	_	0	SENT_419	[p18l1789t384r1905b412],
2	.	.	O	.	_	0	SENT_419	[p18l1789t384r1905b412],

1	—	NN	O	—	_	0	SENT_420	[p18l1789t384r1905b412],
2	.	.	O	.	_	0	SENT_420	[p18l1789t384r1905b412],

1	|	NNP	O	|	nn	2	SENT_421	[p18l1789t384r1905b412],
2	Fatigue	NNP	O	Fatigue	_	0	SENT_421	[p18l461t424r554b454],
3	I	PRP	O	I	dep	2	SENT_421	[p18l1747t418r1856b462],
4	.	.	O	.	_	0	SENT_421	[p18l1747t418r1856b462],

1	—	NN	O	—	_	0	SENT_422	[p18l1747t418r1856b462],
2	.	.	O	.	_	0	SENT_422	[p18l1747t418r1856b462],

1	EO	NN	O	eo	_	0	SENT_423	[p18l1747t418r1856b462],
2	.	.	O	.	_	0	SENT_423	[p18l1747t418r1856b462],

1	—	NN	O	—	_	0	SENT_424	[p18l1747t418r1856b462],
2	.	.	O	.	_	0	SENT_424	[p18l1747t418r1856b462],

1	I	PRP	O	I	_	0	SENT_425	[p18l1747t418r1856b462],

1	Abnormal	JJ	O	abnormal	amod	2	SENT_426	[p18l318t465r443b489],
2	Dreams	NNS	O	dream	nsubj	3	SENT_426	[p18l455t467r553b489],
3	|	VBP	O	|	_	0	SENT_426	[p18l1597t470r1723b492],
4	.	.	O	.	_	0	SENT_426	[p18l1597t470r1723b492],

1	—	NN	O	—	_	0	SENT_427	[p18l1597t470r1723b492],
2	.	.	O	.	_	0	SENT_427	[p18l1597t470r1723b492],

1	Q	NNP	O	Q	_	0	SENT_428	[p18l1597t470r1723b492],
2	.	.	O	.	_	0	SENT_428	[p18l1597t470r1723b492],

1	—	NN	O	—	_	0	SENT_429	[p18l1597t470r1723b492],
2	.	.	O	.	_	0	SENT_429	[p18l1597t470r1723b492],

1	|	NN	O	|	_	0	SENT_430	[p18l1597t470r1723b492],
2	:	:	O	:	_	0	SENT_430	[p18l1789t468r1792b495],
3	Upper	NNP	O	Upper	nn	6	SENT_430	[p18l126t509r205b537],
4	Respiratory	NNP	O	Respiratory	nn	6	SENT_430	[p18l215t507r359b538],
5	Trad	NNP	O	Trad	nn	6	SENT_430	[p18l367t509r432b530],
6	Infection	NN	O	infection	dep	7	SENT_430	[p18l443t506r553b530],
7	I	PRP	O	I	dep	1	SENT_430	[p18l1701t501r1829b545],
8	.	.	O	.	_	0	SENT_430	[p18l1701t501r1829b545],

1	—	NN	O	—	_	0	SENT_431	[p18l1701t501r1829b545],
2	.	.	O	.	_	0	SENT_431	[p18l1701t501r1829b545],

1	O-5	NN	O	o-5	_	0	SENT_432	[p18l1701t501r1829b545],
2	-	:	O	-	_	0	SENT_432	[p18l1701t501r1829b545],
3	!	.	O	!	_	0	SENT_432	[p18l1701t501r1829b545],

1	Rash	NNP	O	Rash	_	0	SENT_433	[p18l493t548r553b572],
2	I	PRP	O	I	dep	1	SENT_433	[p18l1491t553r1665b576],
3	?	.	O	?	_	0	SENT_433	[p18l1491t553r1665b576],

1	O	NN	O	o	_	0	SENT_434	[p18l1491t553r1665b576],
2	:	:	O	:	_	0	SENT_434	[p18l1491t553r1665b576],
3	I	PRP	O	I	dep	1	SENT_434	[p18l1491t553r1665b576],
4	I	PRP	O	I	nsubj	5	SENT_434	[p18l1789t551r1792b579],
5	Cough	VBP	O	cough	rcmod	3	SENT_434	[p18l470t590r553b621],
6	|	NNS	O	|	dobj	5	SENT_434	[p18l1683t584r1843b629],
7	:	:	O	:	_	0	SENT_434	[p18l1683t584r1843b629],
8	O-l	NN	O	o-l	nn	11	SENT_434	[p18l1683t584r1843b629],
9	—	CD	NUMBER	—	num	11	SENT_434	[p18l1683t584r1843b629],
10	|	NN	O	|	nn	11	SENT_434	[p18l1683t584r1843b629],
11	Depression	NN	O	depression	dep	1	SENT_434	[p18l409t632r553b662],
12	l	NN	O	l	tmod	11	SENT_434	[p18l1689t634r1854b662],
13	.	.	O	.	_	0	SENT_434	[p18l1689t634r1854b662],

1	—	NN	O	—	_	0	SENT_435	[p18l1689t634r1854b662],
2	.	.	O	.	_	0	SENT_435	[p18l1689t634r1854b662],

1	OI	NN	O	ous	_	0	SENT_436	[p18l1689t634r1854b662],
2	.	.	O	.	_	0	SENT_436	[p18l1689t634r1854b662],

1	—	NN	O	—	_	0	SENT_437	[p18l1689t634r1854b662],
2	.	.	O	.	_	0	SENT_437	[p18l1689t634r1854b662],

1	l	NN	O	l	nn	3	SENT_438	[p18l1689t634r1854b662],
2	Pyrexia	NN	PERSON	pyrexia	nn	3	SENT_438	[p18l464t674r554b704],
3	l	NN	O	l	_	0	SENT_438	[p18l1711t678r1883b701],
4	:	:	O	:	_	0	SENT_438	[p18l1711t678r1883b701],
5	O	NN	O	o	dep	3	SENT_438	[p18l1711t678r1883b701],
6	.	.	O	.	_	0	SENT_438	[p18l1711t678r1883b701],

1	—	NN	O	—	_	0	SENT_439	[p18l1711t678r1883b701],
2	.	.	O	.	_	0	SENT_439	[p18l1711t678r1883b701],

1	I	PRP	O	I	nsubj	2	SENT_440	[p18l1711t678r1883b701],
2	Anxiety	NN	O	anxiety	_	0	SENT_440	[p18l459t716r554b746],
3	|	NN	O	|	dobj	2	SENT_440	[p18l1597t718r1792b745],
4	.	.	O	.	_	0	SENT_440	[p18l1597t718r1792b745],

1	—	NN	O	—	_	0	SENT_441	[p18l1597t718r1792b745],
2	.	.	O	.	_	0	SENT_441	[p18l1597t718r1792b745],

1	Q	NNP	O	Q	_	0	SENT_442	[p18l1597t718r1792b745],
2	.	.	O	.	_	0	SENT_442	[p18l1597t718r1792b745],

1	—	NN	O	—	_	0	SENT_443	[p18l1597t718r1792b745],
2	.	.	O	.	_	0	SENT_443	[p18l1597t718r1792b745],

1	(	NN	O	(	_	0	SENT_444	[p18l1597t718r1792b745],
2	Back	RB	O	back	prep	1	SENT_444	[p18l430t757r490b780],
3	Pain	NN	O	pain	nn	4	SENT_444	[p18l500t757r553b780],
4	|	NN	O	|	pobj	2	SENT_444	[p18l1741t751r1928b795],
5	.	.	O	.	_	0	SENT_444	[p18l1741t751r1928b795],

1	—	NN	O	—	_	0	SENT_445	[p18l1741t751r1928b795],
2	.	.	O	.	_	0	SENT_445	[p18l1741t751r1928b795],

1	E	NN	O	e	_	0	SENT_446	[p18l1741t751r1928b795],
2	.	.	O	.	_	0	SENT_446	[p18l1741t751r1928b795],

1	—	NN	O	—	_	0	SENT_447	[p18l1741t751r1928b795],
2	.	.	O	.	_	0	SENT_447	[p18l1741t751r1928b795],

1	Oj	NNP	O	Oj	nn	6	SENT_448	[p18l1741t751r1928b795],
2	|	NNP	O	|	nn	6	SENT_448	[p18l1741t751r1928b795],
3	Vomiting	NNP	O	Vomiting	nn	6	SENT_448	[p18l436t799r555b829],
4	Ifbjl	NNP	O	Ifbjl	nn	6	SENT_448	[p18l1705t801r1890b845],
5	Bronchitis	NNP	O	Bronchitis	nn	6	SENT_448	[p18l425t840r554b864],
6	|	NNP	O	|	_	0	SENT_448	[p18l1733t845r1932b879],
7	:	:	O	:	_	0	SENT_448	[p18l1733t845r1932b879],
8	(	CD	NUMBER	(	dep	6	SENT_448	[p18l1733t845r1932b879],
9	.	.	O	.	_	0	SENT_448	[p18l1733t845r1932b879],

1	—	NN	O	—	_	0	SENT_449	[p18l1733t845r1932b879],
2	.	.	O	.	_	0	SENT_449	[p18l1733t845r1932b879],

1	Qj	NN	O	qj	_	0	SENT_450	[p18l1733t845r1932b879],
2	|	SYM	O	|	dep	3	SENT_450	[p18l1733t845r1932b879],
3	Oropharyngeal	NNP	O	Oropharyngeal	dep	6	SENT_450	[p18l297t882r488b913],
4	Pain	NN	O	pain	dep	3	SENT_450	[p18l500t882r553b905],
5	I	PRP	O	I	nsubj	6	SENT_450	[p18l1741t884r1946b912],
6	—	VBP	O	—	dep	1	SENT_450	[p18l1741t884r1946b912],
7	:	:	O	:	_	0	SENT_450	[p18l1741t884r1946b912],
8	Qj	NN	O	qj	nn	9	SENT_450	[p18l1741t884r1946b912],
9	|	NN	O	|	dobj	6	SENT_450	[p18l1741t884r1946b912],

1	Somnolence	NN	O	somnolence	_	0	SENT_451	[p18l395t923r554b947],
2	I	PRP	O	I	nsubj	3	SENT_451	[p18l1537t928r1764b951],
3	}	VBP	O	}	rcmod	1	SENT_451	[p18l1537t928r1764b951],
4	l	NN	O	l	tmod	3	SENT_451	[p18l1789t918r1792b945],

1	T	NN	O	t	nn	3	SENT_452	[p18l1477t951r2024b974],
2	|	CD	NUMBER	|	num	3	SENT_452	[p18l1477t951r2024b974],
3	Tl	NN	O	tl	dep	15	SENT_452	[p18l1477t951r2024b974],
4	—	CD	NUMBER	—	number	5	SENT_452	[p18l1477t951r2024b974],
5	15	CD	NUMBER	15	num	7	SENT_452	[p18l864t982r888b1002],
6	20	CD	NUMBER	20	number	7	SENT_452	[p18l966t982r993b1002],
7	25	CD	NUMBER	25	dep	3	SENT_452	[p18l1069t982r1095b1002],
8	30	CD	NUMBER	30	number	9	SENT_452	[p18l1172t982r1199b1002],
9	35	CD	NUMBER	35	num	7	SENT_452	[p18l1275t982r1301b1002],
10	40	CD	NUMBER	40	number	11	SENT_452	[p18l1377t982r1405b1002],
11	0.25	CD	NUMBER	0.25	amod	7	SENT_452	[p18l1557t982r1605b1002],
12	1.00	CD	NUMBER	1.00	dep	15	SENT_452	[p18l1768t982r1815b1002],
13	2.00	CD	NUMBER	2.00	number	14	SENT_452	[p18l1869t982r1918b1002],
14	4.00	CD	NUMBER	4.00	num	15	SENT_452	[p18l1969t982r2019b1002],
15	Incidence	NN	O	incidence	dep	19	SENT_452	[p18l835t1031r957b1054],
16	of	IN	O	of	_	0	SENT_452	[p18l966t1030r995b1054],
17	Event	NN	O	event	prep_of	15	SENT_452	[p18l1000t1033r1071b1054],
18	(	CD	PERCENT	(	num	19	SENT_452	[p18l1081t1032r1122b1062],
19	%	NN	PERCENT	%	dep	26	SENT_452	[p18l1081t1032r1122b1062],
20	)	CD	NUMBER	)	num	22	SENT_452	[p18l1081t1032r1122b1062],
21	Relative	JJ	O	relative	amod	22	SENT_452	[p18l1611t1031r1710b1054],
22	Risk	NN	O	risk	dep	19	SENT_452	[p18l1720t1031r1772b1054],
23	(	CD	PERCENT	(	number	24	SENT_452	[p18l1782t1032r1846b1062],
24	95	CD	PERCENT	95	num	25	SENT_452	[p18l1782t1032r1846b1062],
25	%	NN	PERCENT	%	dep	22	SENT_452	[p18l1782t1032r1846b1062],
26	Cl	NN	O	cl	_	0	SENT_452	[p18l1856t1032r1891b1062],
27	)	CD	NUMBER	)	num	26	SENT_452	[p18l1856t1032r1891b1062],

1	9	CD	NUMBER	9	_	0	SENT_453	[p18l908t1179r927b1198],
2	DTG	NN	O	dtg	dep	1	SENT_453	[p18l944t1177r1127b1198],
3	.	.	O	.	_	0	SENT_453	[p18l944t1177r1127b1198],

1	—	NN	O	—	_	0	SENT_454	[p18l944t1177r1127b1198],
2	.	.	O	.	_	0	SENT_454	[p18l944t1177r1127b1198],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_455	[p18l944t1177r1127b1198],
2	.	.	O	.	_	0	SENT_455	[p18l944t1177r1127b1198],

1	—	NN	O	—	_	0	SENT_456	[p18l944t1177r1127b1198],
2	.	.	O	.	_	0	SENT_456	[p18l944t1177r1127b1198],

1	3TC	NN	O	3tc	_	0	SENT_457	[p18l944t1177r1127b1198],
2	I	CD	NUMBER	i	num	3	SENT_457	[p18l1164t1180r1181b1198],
3	EFV	NN	O	efv	dep	1	SENT_457	[p18l1193t1177r1367b1198],
4	.	.	O	.	_	0	SENT_457	[p18l1193t1177r1367b1198],

1	—	NN	O	—	_	0	SENT_458	[p18l1193t1177r1367b1198],
2	.	.	O	.	_	0	SENT_458	[p18l1193t1177r1367b1198],

1	TDF	NNP	O	TDF	_	0	SENT_459	[p18l1193t1177r1367b1198],
2	.	.	O	.	_	0	SENT_459	[p18l1193t1177r1367b1198],

1	—	NN	O	—	_	0	SENT_460	[p18l1193t1177r1367b1198],
2	.	.	O	.	_	0	SENT_460	[p18l1193t1177r1367b1198],

1	FTC	NNP	O	FTC	_	0	SENT_461	[p18l1193t1177r1367b1198],

1	Mean	NN	O	mean	_	0	SENT_462	[p18l303t1569r325b1639],
2	Change	NNP	O	Change	dep	1	SENT_462	[p18l301t1461r332b1559],
3	from	IN	O	from	_	0	SENT_462	[p18l301t1394r325b1453],
4	Baseline	NNP	O	Baseline	prep_from	2	SENT_462	[p18l301t1275r325b1382],
5	(	CD	NUMBER	(	num	4	SENT_462	[p18l337t1387r368b1530],
6	ymol/liter	NN	O	ymol/liter	nn	7	SENT_462	[p18l337t1387r368b1530],
7	)	NN	O	)	dep	1	SENT_462	[p18l337t1387r368b1530],

1	Figure	NNP	O	Figure	_	0	SENT_463	[p18l122t1833r206b1865],
2	4	CD	NUMBER	4	dep	1	SENT_463	[p18l216t1835r240b1858],
3	.	.	O	.	_	0	SENT_463	[p18l216t1835r240b1858],

1	Safety	NNP	O	Safety	nn	2	SENT_464	[p18l251t1832r336b1866],
2	Proﬁle	NNP	O	Proﬁle	_	0	SENT_464	[p18l348t1832r437b1858],
3	over	IN	O	over	_	0	SENT_464	[p18l447t1841r506b1858],
4	48	CD	DURATION	48	num	5	SENT_464	[p18l516t1834r549b1858],
5	Weeks	NNS	DURATION	week	prep_over	2	SENT_464	[p18l558t1833r658b1858],
6	.	.	O	.	_	0	SENT_464	[p18l558t1833r658b1858],

1	Panel	NN	O	panel	nn	2	SENT_465	[p18l122t1883r194b1908],
2	A	NN	O	a	nsubj	3	SENT_465	[p18l206t1884r225b1907],
3	shows	VBZ	O	show	_	0	SENT_465	[p18l236t1883r321b1908],
4	the	DT	O	the	det	9	SENT_465	[p18l333t1883r376b1908],
5	most	RBS	O	most	advmod	6	SENT_465	[p18l389t1887r458b1908],
6	common	JJ	O	common	amod	9	SENT_465	[p18l469t1891r591b1908],
7	clinical	JJ	O	clinical	amod	9	SENT_465	[p18l604t1883r698b1908],
8	adverse	JJ	O	adverse	amod	9	SENT_465	[p18l711t1883r817b1908],
9	events	NNS	O	event	dobj	3	SENT_465	[p18l828t1887r917b1908],
10	(	VBP	O	(	rcmod	9	SENT_465	[p18l932t1883r1059b1916],
11	reported	VBN	O	report	dep	10	SENT_465	[p18l932t1883r1059b1916],
12	in	IN	O	in	_	0	SENT_465	[p18l1073t1885r1094b1907],
13	25	CD	PERCENT	25	num	14	SENT_465	[p18l1107t1884r1168b1909],
14	%	NN	PERCENT	%	prep_in	11	SENT_465	[p18l1107t1884r1168b1909],
15	of	IN	O	of	_	0	SENT_465	[p18l1180t1882r1210b1908],
16	participants	NNS	O	participant	prep_of	14	SENT_465	[p18l1218t1885r1382b1915],
17	in	IN	O	in	_	0	SENT_465	[p18l1395t1885r1417b1907],
18	either	DT	O	either	det	20	SENT_465	[p18l1429t1883r1509b1908],
19	group	NN	O	group	nn	20	SENT_465	[p18l1520t1885r1609b1916],
20	)	NN	O	)	prep_in	16	SENT_465	[p18l1520t1885r1609b1916],
21	and	CC	O	and	_	0	SENT_465	[p18l1623t1883r1672b1908],
22	relative	JJ	O	relative	amod	23	SENT_465	[p18l1686t1883r1784b1908],
23	risks	NNS	O	risk	prep_in	16	SENT_465	[p18l1797t1883r1866b1908],
24	.	.	O	.	_	0	SENT_465	[p18l1797t1883r1866b1908],

1	Adverse	JJ	O	adverse	amod	2	SENT_466	[p18l1878t1883r1989b1908],
2	events	NNS	O	event	nsubj	10	SENT_466	[p18l120t1929r208b1950],
3	with	IN	O	with	_	0	SENT_466	[p18l220t1924r277b1950],
4	a	DT	O	a	det	6	SENT_466	[p18l290t1933r303b1950],
5	relative-risk	JJ	O	relative-risk	amod	6	SENT_466	[p18l316t1924r476b1950],
6	value	NN	O	value	prep_with	2	SENT_466	[p18l486t1924r558b1950],
7	ofless	JJ	O	ofless	amod	6	SENT_466	[p18l569t1924r656b1950],
8	than	IN	O	than	_	0	SENT_466	[p18l668t1924r728b1950],
9	1.0	CD	NUMBER	1.0	prep_than	7	SENT_466	[p18l743t1926r781b1950],
10	occurred	VBD	O	occur	_	0	SENT_466	[p18l792t1924r912b1950],
11	less	RBR	O	less	advmod	12	SENT_466	[p18l926t1924r976b1950],
12	frequently	RB	O	frequently	advmod	10	SENT_466	[p18l987t1924r1127b1957],
13	with	IN	O	with	_	0	SENT_466	[p18l1137t1924r1194b1950],
14	dolutegravir	NN	O	dolutegravir	prep_with	12	SENT_466	[p18l1207t1924r1375b1958],
15	and	CC	O	and	_	0	SENT_466	[p18l1385t1924r1434b1950],
16	abacavir	NN	O	abacavir	conj_and	14	SENT_466	[p18l1447t1924r1734b1950],
17	—	CD	NUMBER	—	num	19	SENT_466	[p18l1447t1924r1734b1950],
18	|	NN	O	|	nn	19	SENT_466	[p18l1447t1924r1734b1950],
19	amivudine	NN	O	amivudine	npadvmod	20	SENT_466	[p18l1447t1924r1734b1950],
20	than	IN	O	than	advmod	12	SENT_466	[p18l1744t1924r1804b1950],
21	with	IN	O	with	_	0	SENT_466	[p18l1816t1924r1873b1950],
22	efavirenz	NN	O	efavirenz	nn	25	SENT_466	[p18l1886t1924r2029b1950],
23	—	CD	NUMBER	—	num	25	SENT_466	[p18l1886t1924r2029b1950],
24	tenofovir	NN	O	tenofovir	nn	25	SENT_466	[p18l119t1966r244b1991],
25	DF	NN	O	df	prep_with	10	SENT_466	[p18l257t1966r507b1996],
26	—	CD	NUMBER	—	num	27	SENT_466	[p18l257t1966r507b1996],
27	emtricitabine	NN	O	emtricitabine	dep	25	SENT_466	[p18l257t1966r507b1996],
28	,	,	O	,	_	0	SENT_466	[p18l257t1966r507b1996],
29	whereas	IN	O	whereas	mark	39	SENT_466	[p18l519t1966r632b1991],
30	those	DT	O	those	nsubj	39	SENT_466	[p18l643t1966r720b1991],
31	with	IN	O	with	_	0	SENT_466	[p18l730t1966r787b1991],
32	a	DT	O	a	det	34	SENT_466	[p18l800t1975r813b1991],
33	relative-risk	JJ	O	relative-risk	amod	34	SENT_466	[p18l827t1966r986b1991],
34	value	NN	O	value	prep_with	30	SENT_466	[p18l996t1966r1068b1991],
35	of	IN	O	of	_	0	SENT_466	[p18l1079t1966r1109b1991],
36	more	JJR	O	more	mwe	37	SENT_466	[p18l1117t1975r1187b1991],
37	than	IN	O	than	quantmod	38	SENT_466	[p18l1198t1966r1258b1991],
38	1.0	CD	NUMBER	1.0	prep_of	34	SENT_466	[p18l1273t1968r1311b1991],
39	occurred	VBD	O	occur	advcl	10	SENT_466	[p18l1322t1966r1442b1991],
40	more	RBR	O	more	advmod	41	SENT_466	[p18l1456t1975r1527b1991],
41	frequently	RB	O	frequently	advmod	39	SENT_466	[p18l1537t1966r1677b1999],
42	with	IN	O	with	_	0	SENT_466	[p18l1687t1966r1744b1991],
43	dolutegravir	NN	O	dolutegravir	prep_with	39	SENT_466	[p18l1757t1966r1925b1999],
44	and	CC	O	and	_	0	SENT_466	[p18l1936t1966r1984b1991],
45	abacavir	NN	O	abacavir	nn	48	SENT_466	[p18l120t2008r414b2037],
46	—	CD	NUMBER	—	num	48	SENT_466	[p18l120t2008r414b2037],
47	|	NN	O	|	nn	48	SENT_466	[p18l120t2008r414b2037],
48	amivudine	NN	O	amivudine	conj_and	43	SENT_466	[p18l120t2008r414b2037],
49	;	:	O	;	_	0	SENT_466	[p18l120t2008r414b2037],
50	a	DT	O	a	det	52	SENT_466	[p18l427t2016r440b2033],
51	relative-risk	JJ	O	relative-risk	amod	52	SENT_466	[p18l453t2008r613b2033],
52	value	NN	O	value	nsubj	55	SENT_466	[p18l623t2008r695b2033],
53	of	IN	O	of	_	0	SENT_466	[p18l706t2007r736b2033],
54	1.0	CD	NUMBER	1.0	prep_of	52	SENT_466	[p18l745t2009r783b2033],
55	indicates	VBZ	O	indicate	parataxis	10	SENT_466	[p18l795t2008r917b2033],
56	that	IN	O	that	complm	61	SENT_466	[p18l928t2008r983b2033],
57	the	DT	O	the	det	58	SENT_466	[p18l992t2008r1036b2033],
58	risk	NN	O	risk	nsubj	61	SENT_466	[p18l1049t2008r1096b2033],
59	was	VBD	O	be	cop	61	SENT_466	[p18l1105t2016r1157b2033],
60	the	DT	O	the	det	61	SENT_466	[p18l1168t2008r1211b2033],
61	same	JJ	O	same	ccomp	55	SENT_466	[p18l1223t2016r1296b2033],
62	in	IN	O	in	_	0	SENT_466	[p18l1308t2010r1330b2032],
63	the	DT	O	the	det	65	SENT_466	[p18l1342t2008r1385b2033],
64	two	CD	NUMBER	two	num	65	SENT_466	[p18l1396t2012r1446b2033],
65	groups	NNS	O	group	prep_in	61	SENT_466	[p18l1458t2016r1561b2041],
66	.	.	O	.	_	0	SENT_466	[p18l1458t2016r1561b2041],

1	Confidence	NN	O	confidence	nn	2	SENT_467	[p18l1574t2007r1732b2033],
2	intervals	NNS	O	interval	nsubj	3	SENT_467	[p18l1744t2008r1860b2033],
3	(	VBP	O	(	_	0	SENT_467	[p18l1875t2008r2024b2041],
4	horizontal	JJ	O	horizontal	amod	5	SENT_467	[p18l1875t2008r2024b2041],
5	bars	NNS	O	bar	nsubj	9	SENT_467	[p18l121t2049r186b2082],
6	)	RB	O	)	advmod	7	SENT_467	[p18l121t2049r186b2082],
7	excluding	VBG	O	exclude	partmod	5	SENT_467	[p18l201t2049r332b2083],
8	1.0	CD	NUMBER	1.0	dobj	7	SENT_467	[p18l345t2051r383b2075],
9	indicate	VBP	O	indicate	ccomp	3	SENT_467	[p18l395t2049r503b2075],
10	a	DT	O	a	det	12	SENT_467	[p18l515t2058r527b2074],
11	significant	JJ	O	significant	amod	12	SENT_467	[p18l540t2049r685b2083],
12	difference	NN	O	difference	dobj	9	SENT_467	[p18l696t2049r833b2075],
13	between	IN	O	between	_	0	SENT_467	[p18l846t2049r961b2075],
14	the	DT	O	the	det	16	SENT_467	[p18l973t2049r1016b2075],
15	two	CD	NUMBER	two	num	16	SENT_467	[p18l1026t2054r1077b2075],
16	groups	NNS	O	group	prep_between	12	SENT_467	[p18l1089t2058r1192b2083],
17	.	.	O	.	_	0	SENT_467	[p18l1089t2058r1192b2083],

1	Panel	NN	O	panel	nn	2	SENT_468	[p18l1207t2049r1278b2075],
2	B	NN	O	b	nsubj	3	SENT_468	[p18l1293t2052r1308b2074],
3	shows	VBZ	O	show	_	0	SENT_468	[p18l1321t2049r1406b2075],
4	the	DT	O	the	det	6	SENT_468	[p18l1417t2049r1460b2075],
5	mean	JJ	O	mean	amod	6	SENT_468	[p18l1473t2058r1547b2075],
6	change	NN	O	change	dobj	3	SENT_468	[p18l1560t2049r1658b2083],
7	from	IN	O	from	_	0	SENT_468	[p18l1669t2049r1733b2075],
8	baseline	NN	O	baseline	prep_from	3	SENT_468	[p18l1747t2049r1860b2075],
9	in	IN	O	in	_	0	SENT_468	[p18l1872t2052r1894b2074],
10	serum	NN	O	serum	nn	12	SENT_468	[p18l1907t2058r1992b2075],
11	creatinine	NN	O	creatinine	nn	12	SENT_468	[p18l120t2093r256b2116],
12	levels	NNS	O	level	prep_in	8	SENT_468	[p18l269t2091r351b2116],
13	.	.	O	.	_	0	SENT_468	[p18l269t2091r351b2116],

1	I	PRP	O	I	dep	2	SENT_469	[p18l363t2094r373b2116],
2	bars	NNS	O	bar	nsubj	3	SENT_469	[p18l385t2091r441b2116],
3	indicate	VBP	O	indicate	_	0	SENT_469	[p18l454t2091r562b2116],
4	1	CD	NUMBER	1	num	6	SENT_469	[p18l575t2093r586b2116],
5	standard	JJ	O	standard	amod	6	SENT_469	[p18l600t2091r720b2116],
6	deviation	NN	O	deviation	dobj	3	SENT_469	[p18l733t2091r867b2116],
7	.	.	O	.	_	0	SENT_469	[p18l733t2091r867b2116],

1	To	TO	O	to	aux	2	SENT_470	[p18l879t2093r911b2116],
2	convert	VB	O	convert	_	0	SENT_470	[p18l923t2096r1026b2116],
3	the	DT	O	the	det	4	SENT_470	[p18l1036t2091r1080b2116],
4	values	NNS	O	value	dobj	2	SENT_470	[p18l1090t2091r1177b2116],
5	for	IN	O	for	_	0	SENT_470	[p18l1188t2091r1227b2116],
6	creatinine	NN	O	creatinine	prep_for	4	SENT_470	[p18l1237t2093r1373b2116],
7	to	TO	O	to	_	0	SENT_470	[p18l1384t2096r1410b2116],
8	milligrams	NNS	O	milligram	prep_to	2	SENT_470	[p18l1423t2091r1568b2124],
9	per	IN	O	per	_	0	SENT_470	[p18l1582t2100r1625b2124],
10	deciliter	NN	O	deciliter	prep_per	8	SENT_470	[p18l1635t2091r1752b2121],
11	,	,	O	,	_	0	SENT_470	[p18l1635t2091r1752b2121],
12	divide	NN	O	divide	appos	10	SENT_470	[p18l1764t2091r1847b2116],
13	by	IN	O	by	_	0	SENT_470	[p18l1859t2091r1888b2124],
14	88.4	CD	NUMBER	88.4	prep_by	2	SENT_470	[p18l1899t2093r1963b2116],
15	.	.	O	.	_	0	SENT_470	[p18l1899t2093r1963b2116],

1	cubic	JJ	O	cubic	amod	2	SENT_471	[p18l381t2241r468b2272],
2	millimeter	NN	O	millimeter	_	0	SENT_471	[p18l489t2241r667b2272],
3	vs.	CC	O	vs.	prep	2	SENT_471	[p18l686t2252r728b2272],
4	208	CD	NUMBER	208	dep	3	SENT_471	[p18l752t2244r811b2272],
5	per	IN	O	per	_	0	SENT_471	[p18l833t2251r887b2280],
6	cubic	JJ	O	cubic	amod	7	SENT_471	[p18l908t2241r995b2272],
7	millimeter	NN	O	millimeter	prep_per	4	SENT_471	[p18l1016t2241r1202b2278],
8	;	:	O	;	_	0	SENT_471	[p18l1016t2241r1202b2278],
9	compared	VBN	O	compare	_	0	SENT_471	[p18l1244t2241r1409b2280],
10	with	IN	O	with	prepc_compared_with	4	SENT_471	[p18l1426t2241r1502b2272],
11	that	DT	O	that	dep	17	SENT_471	[p18l1521t2241r1588b2272],
12	of	IN	O	of	_	0	SENT_471	[p18l1605t2241r1644b2272],
13	efavirenz	NN	O	efavirenz	prep_of	11	SENT_471	[p18l1656t2241r1981b2272],
14	—	CD	NUMBER	—	num	15	SENT_471	[p18l1656t2241r1981b2272],
15	tenofovir	NN	O	tenofovir	dep	17	SENT_471	[p18l1656t2241r1981b2272],
16	DFnominal	JJ	O	dfnominal	amod	17	SENT_471	[p18l1999t2244r2067b2272, p18l381t2291r524b2321],
17	P	NN	O	p	dep	20	SENT_471	[p18l540t2293r684b2326],
18	<	JJR	O	<	dep	17	SENT_471	[p18l540t2293r684b2326],
19	0.001	CD	NUMBER	0.001	num	20	SENT_471	[p18l540t2293r684b2326],
20	)	NN	O	)	dep	22	SENT_471	[p18l540t2293r684b2326],
21	(	CD	NUMBER	(	num	22	SENT_471	[p18l705t2291r776b2330],
22	Fig	NN	O	fig	dep	4	SENT_471	[p18l705t2291r776b2330],
23	.	.	O	.	_	0	SENT_471	[p18l705t2291r776b2330],

1	2B	NN	O	2b	_	0	SENT_472	[p18l795t2293r859b2326],
2	)	NN	O	)	dep	1	SENT_472	[p18l795t2293r859b2326],
3	.	.	O	.	_	0	SENT_472	[p18l795t2293r859b2326],

1	There	EX	O	there	expl	2	SENT_473	[p18l876t2291r973b2321],
2	were	VBD	O	be	_	0	SENT_473	[p18l988t2301r1068b2322],
3	no	DT	O	no	det	4	SENT_473	[p18l1084t2301r1126b2321],
4	sig	NN	O	sig	nsubj	2	SENT_473	[p18l1144t2291r1203b2330],
5	-	:	O	-	_	0	SENT_473	[p18l1144t2291r1203b2330],
6	emtricitabine	NN	O	emtricitabine	nn	8	SENT_473	[p18l1244t2291r1471b2321],
7	(	CD	NUMBER	(	num	8	SENT_473	[p18l1491t2291r1562b2330],
8	Fig	NN	O	fig	dep	4	SENT_473	[p18l1491t2291r1562b2330],
9	.	.	O	.	_	0	SENT_473	[p18l1491t2291r1562b2330],

1	4	CD	NUMBER	4	_	0	SENT_474	[p18l1581t2293r1609b2328],
2	,	,	O	,	_	0	SENT_474	[p18l1581t2293r1609b2328],
3	and	CC	O	and	dep	1	SENT_474	[p18l1628t2291r1691b2321],
4	Table	NNP	O	Table	nn	5	SENT_474	[p18l1706t2291r1798b2321],
5	S5	NNP	O	S5	dep	1	SENT_474	[p18l1816t2293r1852b2321],
6	in	IN	O	in	_	0	SENT_474	[p18l1870t2291r1903b2321],
7	the	DT	O	the	det	9	SENT_474	[p18l1920t2291r1973b2321],
8	Supnificant	JJ	MISC	supnificant	amod	9	SENT_474	[p18l1991t2293r2066b2330, p18l381t2340r516b2371],
9	changes	NNS	O	change	prep_in	5	SENT_474	[p18l533t2341r668b2380],
10	from	IN	O	from	dep	5	SENT_474	[p18l688t2340r769b2371],
11	baseline	NN	O	baseline	pobj	10	SENT_474	[p18l788t2340r925b2371],
12	in	IN	O	in	dep	5	SENT_474	[p18l944t2341r976b2371],
13	measures	NNS	O	measure	pobj	12	SENT_474	[p18l995t2351r1152b2372],
14	of	IN	O	of	_	0	SENT_474	[p18l1172t2340r1211b2371],
15	plementary	JJ	O	plementary	amod	17	SENT_474	[p18l1243t2340r1437b2380],
16	Appendix	NN	O	appendix	nn	17	SENT_474	[p18l1467t2340r1652b2380],
17	)	NN	O	)	prep_of	13	SENT_474	[p18l1467t2340r1652b2380],
18	.	.	O	.	_	0	SENT_474	[p18l1467t2340r1652b2380],

1	During	IN	O	during	_	0	SENT_475	[p18l1686t2341r1809b2380],
2	the	DT	O	the	det	5	SENT_475	[p18l1841t2340r1893b2371],
3	48-week	JJ	DURATION	48-week	amod	5	SENT_475	[p18l1925t2340r2068b2372],
4	health	NN	O	health	nn	5	SENT_475	[p18l381t2390r486b2421],
5	outcomes	NNS	O	outcome	pobj	1	SENT_475	[p18l501t2397r661b2422],
6	in	IN	O	in	_	0	SENT_475	[p18l676t2391r709b2421],
7	either	CC	O	either	advmod	9	SENT_475	[p18l724t2391r820b2421],
8	treatment	NN	O	treatment	nn	9	SENT_475	[p18l834t2397r998b2421],
9	group	NN	O	group	prep_in	5	SENT_475	[p18l1012t2400r1118b2430],
10	.	.	O	.	_	0	SENT_475	[p18l1012t2400r1118b2430],

1	observation	NN	O	observation	nn	2	SENT_476	[p18l1244t2391r1443b2421],
2	period	NN	O	period	nsubj	18	SENT_476	[p18l1460t2390r1571b2430],
3	of	IN	O	of	_	0	SENT_476	[p18l1589t2390r1628b2421],
4	this	DT	O	this	det	13	SENT_476	[p18l1639t2390r1703b2421],
5	study	NN	O	study	nn	13	SENT_476	[p18l1722t2390r1819b2430],
6	,	,	O	,	_	0	SENT_476	[p18l1722t2390r1819b2430],
7	diarrhea	NN	O	diarrhea	dep	13	SENT_476	[p18l1840t2390r1993b2428],
8	,	,	O	,	_	0	SENT_476	[p18l1840t2390r1993b2428],
9	nasopharyngitis	NN	O	nasopharyngitis	dep	13	SENT_476	[p18l2013t2400r2066b2421, p18l1244t2440r1488b2480],
10	,	,	O	,	_	0	SENT_476	[p18l2013t2400r2066b2421, p18l1244t2440r1488b2480],
11	nausea	NN	O	nausea	dep	13	SENT_476	[p18l1515t2450r1641b2478],
12	,	,	O	,	_	0	SENT_476	[p18l1515t2450r1641b2478],
13	headache	NN	O	headache	prep_of	2	SENT_476	[p18l1668t2440r1835b2478],
14	,	,	O	,	_	0	SENT_476	[p18l1668t2440r1835b2478],
15	and	CC	O	and	_	0	SENT_476	[p18l1861t2440r1924b2471],
16	fatigue	NN	O	fatigue	nn	17	SENT_476	[p18l1948t2440r2066b2480],
17	SAFETY	NN	O	safety	prep_of	2	SENT_476	[p18l381t2497r491b2516],
18	were	VBD	O	be	_	0	SENT_476	[p18l1242t2500r1321b2521],
19	among	IN	O	among	_	0	SENT_476	[p18l1334t2500r1453b2529],
20	the	DT	O	the	det	24	SENT_476	[p18l1464t2490r1517b2520],
21	most	RBS	O	most	advmod	23	SENT_476	[p18l1530t2496r1615b2520],
22	commonly	RB	O	commonly	advmod	23	SENT_476	[p18l1627t2490r1808b2529],
23	reported	VBN	O	report	amod	24	SENT_476	[p18l1819t2490r1965b2529],
24	cliniThe	NN	O	clinithe	prep_among	18	SENT_476	[p18l1978t2490r2066b2520, p18l379t2539r443b2570],
25	48-week	JJ	DURATION	48-week	amod	27	SENT_476	[p18l460t2539r602b2571],
26	safety	NN	O	safety	nn	27	SENT_476	[p18l619t2539r719b2579],
27	profile	NN	O	profile	nsubj	45	SENT_476	[p18l735t2539r849b2579],
28	of	IN	O	of	_	0	SENT_476	[p18l867t2539r907b2570],
29	dolutegravir	NN	O	dolutegravir	prep_of	27	SENT_476	[p18l917t2539r1125b2579],
30	and	CC	O	and	_	0	SENT_476	[p18l1141t2539r1204b2570],
31	cal	JJ	O	cal	amod	33	SENT_476	[p18l1244t2540r1291b2570],
32	adverse	JJ	O	adverse	amod	33	SENT_476	[p18l1307t2539r1432b2570],
33	events	NNS	O	event	nsubj	45	SENT_476	[p18l1448t2546r1553b2571],
34	(	JJ	O	(	amod	42	SENT_476	[p18l1571t2539r1701b2579],
35	mainly	RB	O	mainly	advmod	36	SENT_476	[p18l1571t2539r1701b2579],
36	mild	JJ	O	mild	amod	42	SENT_476	[p18l1715t2539r1793b2570],
37	to	TO	O	to	_	0	SENT_476	[p18l1809t2546r1841b2570],
38	moderate	JJ	O	moderate	prep_to	36	SENT_476	[p18l1858t2539r2017b2570],
39	in	IN	O	in	_	0	SENT_476	[p18l2033t2540r2066b2570],
40	abacavir	NN	O	abacavir	prep_in	38	SENT_476	[p18l381t2589r737b2621],
41	—	CD	NUMBER	—	num	40	SENT_476	[p18l381t2589r737b2621],
42	lamivudine	NN	O	lamivudine	dep	33	SENT_476	[p18l381t2589r737b2621],
43	was	VBD	O	be	cop	45	SENT_476	[p18l747t2600r811b2621],
44	generally	RB	O	generally	advmod	45	SENT_476	[p18l824t2589r981b2629],
45	favorable	JJ	O	favorable	rcmod	24	SENT_476	[p18l991t2589r1155b2627],
46	,	,	O	,	_	0	SENT_476	[p18l991t2589r1155b2627],
47	as	IN	O	as	_	0	SENT_476	[p18l1169t2600r1203b2620],
48	severity	NN	O	severity	nn	49	SENT_476	[p18l1244t2590r1393b2629],
49	)	NN	O	)	prep_as	45	SENT_476	[p18l1244t2590r1393b2629],
50	.	.	O	.	_	0	SENT_476	[p18l1244t2590r1393b2629],

1	Overall	RB	O	overall	_	0	SENT_477	[p18l1408t2589r1540b2627],
2	,	,	O	,	_	0	SENT_477	[p18l1408t2589r1540b2627],
3	adverse	JJ	O	adverse	amod	4	SENT_477	[p18l1555t2589r1680b2621],
4	events	NNS	O	event	dep	5	SENT_477	[p18l1694t2596r1799b2621],
5	of	IN	O	of	dep	1	SENT_477	[p18l1814t2589r1853b2620],
6	grade	NN	O	grade	pobj	5	SENT_477	[p18l1859t2589r1954b2629],
7	3	CD	NUMBER	3	num	6	SENT_477	[p18l1968t2592r1985b2621],
8	or	CC	O	or	_	0	SENT_477	[p18l2000t2599r2035b2620],
9	4	CD	NUMBER	4	num	6	SENT_477	[p18l2047t2592r2066b2620],

1	1814	CD	DATE	1814	num	4	SENT_478	[p18l94t2687r171b2709],
2	N	NN	O	n	nn	4	SENT_478	[p18l879t2697r892b2712],
3	ENGLJ	NN	O	englj	nn	4	SENT_478	[p18l907t2697r985b2719],
4	MED	NN	O	med	_	0	SENT_478	[p18l1000t2697r1052b2712],
5	369	CD	NUMBER	369	dep	4	SENT_478	[p18l1062t2691r1143b2719],
6	;	:	O	;	_	0	SENT_478	[p18l1062t2691r1143b2719],
7	19	CD	NUMBER	19	num	8	SENT_478	[p18l1062t2691r1143b2719],
8	NEJM.ORG	NN	O	nejm.org	dep	5	SENT_478	[p18l1178t2697r1302b2719],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	8	SENT_478	[p18l1339t2697r1474b2713],
10	7	CD	DATE	7	num	9	SENT_478	[p18l1484t2697r1503b2718],
11	,	,	DATE	,	_	0	SENT_478	[p18l1484t2697r1503b2718],
12	2013	CD	DATE	2013	num	9	SENT_478	[p18l1515t2697r1570b2719],

1	The	DT	O	the	det	4	SENT_479	[p18l881t2754r932b2778],
2	New	NNP	O	New	nn	4	SENT_479	[p18l941t2755r1003b2778],
3	England	NNP	O	England	nn	4	SENT_479	[p18l1012t2754r1123b2785],
4	Journal	NNP	O	Journal	_	0	SENT_479	[p18l1131t2754r1229b2778],
5	of	IN	O	of	_	0	SENT_479	[p18l1238t2754r1267b2778],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_479	[p18l1274t2754r1399b2778],

1	DOLUTEGRAVIR	NN	O	dolutegravir	_	0	SENT_480	[p18l507t2942r769b2961],
2	AND	CC	O	and	cc	3	SENT_480	[p18l780t2942r852b2961],
3	ABACAVIR	NN	O	abacavir	dep	1	SENT_480	[p18l864t2942r1270b2961],
4	.	.	O	.	_	0	SENT_480	[p18l864t2942r1270b2961],

1	—	NN	O	—	_	0	SENT_481	[p18l864t2942r1270b2961],
2	.	.	O	.	_	0	SENT_481	[p18l864t2942r1270b2961],

1	LAMIVUDINE	NNP	O	LAMIVUDINE	_	0	SENT_482	[p18l864t2942r1270b2961],
2	FOR	IN	O	for	_	0	SENT_482	[p18l1284t2942r1348b2961],
3	I-IIV-1	NN	O	i-iiv-1	nn	4	SENT_482	[p18l1362t2942r1452b2961],
4	INFECTION	NN	O	infection	prep_for	1	SENT_482	[p18l1467t2942r1653b2961],

1	were	VBD	O	be	auxpass	2	SENT_483	[p18l6t3183r209b3237],
2	reported	VBN	O	report	_	0	SENT_483	[p18l253t3157r621b3257],
3	in	IN	O	in	_	0	SENT_483	[p18l664t3158r748b3235],
4	10	CD	PERCENT	10	num	5	SENT_483	[p18l795t3163r977b3236],
5	%	NN	PERCENT	%	prep_in	2	SENT_483	[p18l795t3163r977b3236],
6	of	IN	O	of	_	0	SENT_483	[p18l1020t3156r1121b3236],
7	the	DT	O	the	det	8	SENT_483	[p18l1146t3157r1280b3235],
8	participants	NNS	O	participant	prep_of	5	SENT_483	[p18l1322t3158r1843b3257],
9	in	IN	O	in	_	0	SENT_483	[p18l1888t3158r1972b3235],
10	the	DT	O	the	det	11	SENT_483	[p18l2016t3157r2149b3235],
11	DTG	NN	O	dtg	prep_in	8	SENT_483	[p18l8t3292r691b3366],
12	.	.	O	.	_	0	SENT_483	[p18l8t3292r691b3366],

1	—	NN	O	—	_	0	SENT_484	[p18l8t3292r691b3366],
2	.	.	O	.	_	0	SENT_484	[p18l8t3292r691b3366],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_485	[p18l8t3292r691b3366],
2	.	.	O	.	_	0	SENT_485	[p18l8t3292r691b3366],

1	—	NN	O	—	_	0	SENT_486	[p18l8t3292r691b3366],
2	.	.	O	.	_	0	SENT_486	[p18l8t3292r691b3366],

1	3TC	NN	O	3tc	nn	2	SENT_487	[p18l8t3292r691b3366],
2	group	NN	O	group	nsubj	4	SENT_487	[p18l724t3312r978b3388],
3	and	CC	O	and	dep	4	SENT_487	[p18l1009t3286r1168b3366],
4	in	IN	O	in	_	0	SENT_487	[p18l1197t3287r1282b3364],
5	16	CD	PERCENT	16	num	6	SENT_487	[p18l1315t3292r1494b3366],
6	%	NN	PERCENT	%	pobj	4	SENT_487	[p18l1315t3292r1494b3366],
7	of	IN	O	of	_	0	SENT_487	[p18l1525t3285r1625b3366],
8	those	DT	O	those	prep_of	6	SENT_487	[p18l1638t3286r1871b3366],
9	in	IN	O	in	_	0	SENT_487	[p18l1900t3287r1985b3364],
10	the	DT	O	the	det	11	SENT_487	[p18l2015t3286r2149b3365],
11	EFV	NN	O	efv	prep_in	4	SENT_487	[p18l8t3421r639b3494],
12	.	.	O	.	_	0	SENT_487	[p18l8t3421r639b3494],

1	—	NN	O	—	_	0	SENT_488	[p18l8t3421r639b3494],
2	.	.	O	.	_	0	SENT_488	[p18l8t3421r639b3494],

1	TDF	NNP	O	TDF	_	0	SENT_489	[p18l8t3421r639b3494],
2	.	.	O	.	_	0	SENT_489	[p18l8t3421r639b3494],

1	—	NN	O	—	_	0	SENT_490	[p18l8t3421r639b3494],
2	.	.	O	.	_	0	SENT_490	[p18l8t3421r639b3494],

1	FTC	NNP	ORGANIZATION	FTC	_	0	SENT_491	[p18l8t3421r639b3494],
2	group	NN	O	group	dep	1	SENT_491	[p18l673t3441r950b3516],
3	.	.	O	.	_	0	SENT_491	[p18l673t3441r950b3516],

1	Rash	NNP	O	Rash	nsubj	20	SENT_492	[p18l986t3415r1202b3498],
2	and	CC	O	and	_	0	SENT_492	[p18l1233t3415r1392b3494],
3	neuropsychiatric	JJ	O	neuropsychiatric	amod	4	SENT_492	[p18l1424t3415r2150b3515],
4	events	NNS	O	event	conj_and	1	SENT_492	[p18l11t3560r276b3622],
5	(	JJ	O	(	amod	1	SENT_492	[p18l315t3543r756b3644],
6	including	VBG	O	include	_	0	SENT_492	[p18l315t3543r756b3644],
7	abnormal	JJ	O	abnormal	amod	12	SENT_492	[p18l784t3543r1204b3622],
8	dreams	NNS	O	dream	nn	12	SENT_492	[p18l1236t3543r1579b3639],
9	,	,	O	,	_	0	SENT_492	[p18l1236t3543r1579b3639],
10	anxiety	NN	O	anxiety	dep	12	SENT_492	[p18l1616t3544r1946b3643],
11	,	,	O	,	_	0	SENT_492	[p18l1616t3544r1946b3643],
12	dizziness	NN	O	dizziness	prep_including	1	SENT_492	[p18l1985t3543r2148b3622, p18l10t3672r300b3768],
13	,	,	O	,	_	0	SENT_492	[p18l1985t3543r2148b3622, p18l10t3672r300b3768],
14	and	CC	O	and	_	0	SENT_492	[p18l339t3671r498b3751],
15	somnolence	NN	O	somnolence	nn	16	SENT_492	[p18l534t3671r1076b3763],
16	)	NN	O	)	prep_including	1	SENT_492	[p18l534t3671r1076b3763],
17	were	VBD	O	be	cop	20	SENT_492	[p18l1111t3697r1314b3751],
18	significantly	RB	O	significantly	advmod	20	SENT_492	[p18l1351t3670r1898b3773],
19	more	RBR	O	more	advmod	20	SENT_492	[p18l1929t3697r2149b3751],
20	common	JJ	O	common	_	0	SENT_492	[p19l11t47r390b101],
21	with	IN	O	with	_	0	SENT_492	[p19l437t21r630b101],
22	efavirenz	NN	O	efavirenz	nn	25	SENT_492	[p19l683t20r1510b101],
23	—	CD	NUMBER	—	num	25	SENT_492	[p19l683t20r1510b101],
24	tenofovir	NN	O	tenofovir	nn	25	SENT_492	[p19l683t20r1510b101],
25	DF	NN	O	df	prep_with	20	SENT_492	[p19l1557t22r2148b100, p19l11t149r217b245],
26	—	CD	NUMBER	—	num	27	SENT_492	[p19l1557t22r2148b100, p19l11t149r217b245],
27	emtricitabine	NN	O	emtricitabine	dep	25	SENT_492	[p19l1557t22r2148b100, p19l11t149r217b245],
28	,	,	O	,	_	0	SENT_492	[p19l1557t22r2148b100, p19l11t149r217b245],

1	whereas	IN	O	whereas	_	0	SENT_493	[p19l262t149r616b229],
2	insomnia	NN	O	insomnia	prep_whereas	4	SENT_493	[p19l661t150r1074b228],
3	was	VBD	O	be	auxpass	4	SENT_493	[p19l1111t175r1275b229],
4	reported	VBN	O	report	_	0	SENT_493	[p19l1320t149r1690b249],
5	more	RBR	O	more	advmod	6	SENT_493	[p19l1733t175r1954b228],
6	frequently	RB	O	frequently	advmod	4	SENT_493	[p19l1998t148r2148b227, p19l11t278r331b378],
7	with	IN	O	with	_	0	SENT_493	[p19l373t278r569b357],
8	dolutegravir	NN	O	dolutegravir	prep_with	4	SENT_493	[p19l621t278r1149b379],
9	and	CC	O	and	_	0	SENT_493	[p19l1196t278r1355b357],
10	abacavir	NN	O	abacavir	prep_with	4	SENT_493	[p19l1405t278r2148b357, p19l11t406r197b485],
11	—	CD	NUMBER	—	num	14	SENT_493	[p19l1405t278r2148b357, p19l11t406r197b485],
12	lamivudine	NN	O	lamivudine	nn	14	SENT_493	[p19l1405t278r2148b357, p19l11t406r197b485],
13	(	CD	NUMBER	(	num	14	SENT_493	[p19l259t407r440b507],
14	Fig	NN	O	fig	nsubjpass	4	SENT_493	[p19l259t407r440b507],
15	.	.	O	.	_	0	SENT_493	[p19l259t407r440b507],

1	4A	NN	O	4a	_	0	SENT_494	[p19l502t412r668b497],
2	)	NN	O	)	dep	1	SENT_494	[p19l502t412r668b497],
3	.	.	O	.	_	0	SENT_494	[p19l502t412r668b497],

1	Insomnia	NNP	O	Insomnia	nn	2	SENT_495	[p19l729t407r1147b485],
2	events	NNS	O	event	nsubj	9	SENT_495	[p19l1204t423r1469b485],
3	were	VBD	O	be	cop	5	SENT_495	[p19l1525t432r1728b485],
4	typically	RB	O	typically	advmod	5	SENT_495	[p19l1786t406r2154b506],
5	mild	JJ	O	mild	_	0	SENT_495	[p19l10t534r209b613],
6	in	IN	O	in	_	0	SENT_495	[p19l251t535r335b612],
7	intensity	NN	O	intensity	prep_in	5	SENT_495	[p19l376t535r754b634],
8	and	CC	O	and	_	0	SENT_495	[p19l791t534r950b613],
9	led	VBD	O	lead	conj_and	9	SENT_495	[p19l991t534r1118b613],
10	to	TO	O	to	_	0	SENT_495	[p19l1160t551r1242b613],
11	the	DT	O	the	det	12	SENT_495	[p19l1287t534r1420b612],
12	discontinuation	NN	O	discontinuation	prep_to	9	SENT_495	[p19l1463t534r2149b613],
13	of	IN	O	of	_	0	SENT_495	[p19l11t662r111b743],
14	the	DT	O	the	det	16	SENT_495	[p19l127t663r261b742],
15	study	NN	O	study	nn	16	SENT_495	[p19l296t663r528b764],
16	drug	NN	O	drug	prep_of	12	SENT_495	[p19l557t663r763b765],
17	in	IN	O	in	_	0	SENT_495	[p19l792t664r876b741],
18	one	CD	NUMBER	one	num	19	SENT_495	[p19l911t689r1063b743],
19	participant	NN	O	participant	prep_in	16	SENT_495	[p19l1095t664r1577b764],
20	in	IN	O	in	_	0	SENT_495	[p19l1604t664r1688b741],
21	the	DT	O	the	det	22	SENT_495	[p19l1722t663r1855b742],
22	DTG	NN	O	dtg	prep_in	19	SENT_495	[p19l1887t669r2153b743],
23	—	CD	NUMBER	—	num	24	SENT_495	[p19l1887t669r2153b743],
24	ABC	NNP	ORGANIZATION	ABC	dep	22	SENT_495	[p19l6t798r428b871],
25	—	CD	NUMBER	—	num	24	SENT_495	[p19l6t798r428b871],
26	3TC	NN	O	3tc	nn	27	SENT_495	[p19l6t798r428b871],
27	group	NN	O	group	dep	24	SENT_495	[p19l460t818r715b893],
28	and	CC	O	and	_	0	SENT_495	[p19l746t792r905b871],
29	in	IN	O	in	_	0	SENT_495	[p19l934t793r1018b870],
30	two	CD	NUMBER	two	prep_in	9	SENT_495	[p19l1049t809r1208b871],
31	in	IN	O	in	_	0	SENT_495	[p19l1239t793r1323b870],
32	the	DT	O	the	det	33	SENT_495	[p19l1353t792r1487b870],
33	EFV	NN	O	efv	prep_in	9	SENT_495	[p19l1517t798r2147b871],
34	.	.	O	.	_	0	SENT_495	[p19l1517t798r2147b871],

1	—	NN	O	—	_	0	SENT_496	[p19l1517t798r2147b871],
2	.	.	O	.	_	0	SENT_496	[p19l1517t798r2147b871],

1	TDF	NNP	O	TDF	_	0	SENT_497	[p19l1517t798r2147b871],
2	.	.	O	.	_	0	SENT_497	[p19l1517t798r2147b871],

1	—	NN	O	—	_	0	SENT_498	[p19l1517t798r2147b871],
2	.	.	O	.	_	0	SENT_498	[p19l1517t798r2147b871],

1	FTC	NNP	ORGANIZATION	FTC	_	0	SENT_499	[p19l1517t798r2147b871],
2	group	NN	O	group	dep	1	SENT_499	[p19l10t946r281b1022],
3	.	.	O	.	_	0	SENT_499	[p19l10t946r281b1022],

1	No	DT	O	no	det	2	SENT_500	[p19l318t928r442b1000],
2	cases	NNS	O	case	nsubjpass	12	SENT_500	[p19l478t947r697b999],
3	of	IN	O	of	_	0	SENT_500	[p19l733t919r833b1000],
4	myocardial	JJ	O	myocardial	amod	5	SENT_500	[p19l847t920r1322b1021],
5	infarction	NN	O	infarction	prep_of	2	SENT_500	[p19l1353t919r1775b1000],
6	or	CC	O	or	_	0	SENT_500	[p19l1809t946r1897b1000],
7	other	JJ	O	other	amod	10	SENT_500	[p19l1928t920r2153b1000],
8	ischemic	JJ	O	ischemic	amod	10	SENT_500	[p19l10t1049r391b1127],
9	coronary	JJ	O	coronary	amod	10	SENT_500	[p19l429t1075r816b1149],
10	events	NNS	O	event	prep_of	2	SENT_500	[p19l850t1066r1115b1128],
11	were	VBD	O	be	auxpass	12	SENT_500	[p19l1150t1075r1354b1128],
12	reported	VBN	O	report	_	0	SENT_500	[p19l1392t1049r1760b1149],
13	through	IN	O	through	_	0	SENT_500	[p19l1799t1049r2149b1150],
14	week	NN	DURATION	week	prep_through	12	SENT_500	[p19l6t1178r231b1257],
15	48	CD	NUMBER	48	num	14	SENT_500	[p19l259t1184r387b1257],
16	.	.	O	.	_	0	SENT_500	[p19l259t1184r387b1257],

1	Drug	NN	O	drug	nn	2	SENT_501	[p19l138t1306r689b1407],
2	—	NN	O	—	nsubj	3	SENT_501	[p19l138t1306r689b1407],
3	related	JJ	O	related	_	0	SENT_501	[p19l138t1306r689b1407],
4	adverse	JJ	O	adverse	amod	5	SENT_501	[p19l747t1306r1064b1385],
5	events	NNS	O	event	nsubj	6	SENT_501	[p19l1124t1323r1389b1385],
6	(	RB	O	(	xcomp	3	SENT_501	[p19l1454t1312r1565b1397],
7	as	IN	O	as	mark	14	SENT_501	[p19l1454t1312r1565b1397],
8	assessed	VBN	O	assess	csubjpass	14	SENT_501	[p19l1626t1306r1997b1385],
9	by	IN	O	by	_	0	SENT_501	[p19l2056t1306r2154b1406],
10	the	DT	O	the	det	12	SENT_501	[p19l11t1434r144b1513],
11	investigator	NN	O	investigator	nn	12	SENT_501	[p19l191t1435r726b1536],
12	)	NN	O	)	prep_by	8	SENT_501	[p19l191t1435r726b1536],
13	were	VBD	O	be	auxpass	14	SENT_501	[p19l775t1460r978b1514],
14	reported	VBN	O	report	ccomp	6	SENT_501	[p19l1025t1434r1395b1535],
15	more	RBR	O	more	advmod	16	SENT_501	[p19l1443t1460r1664b1514],
16	frequently	RB	O	frequently	advmod	14	SENT_501	[p19l1711t1433r2154b1535],
17	among	IN	O	among	_	0	SENT_501	[p19l10t1589r308b1665],
18	participants	NNS	O	participant	prep_among	14	SENT_501	[p19l342t1564r850b1664],
19	who	WP	O	who	nsubj	20	SENT_501	[p19l886t1563r1069b1643],
20	received	VBD	O	receive	rcmod	18	SENT_501	[p19l1108t1563r1449b1643],
21	efavirenz	NN	O	efavirenz	nn	24	SENT_501	[p19l1488t1562r2148b1643, p19l10t1691r211b1772],
22	—	CD	NUMBER	—	num	24	SENT_501	[p19l1488t1562r2148b1643, p19l10t1691r211b1772],
23	tenofovir	NN	O	tenofovir	nn	24	SENT_501	[p19l1488t1562r2148b1643, p19l10t1691r211b1772],
24	DF	NN	O	df	dobj	20	SENT_501	[p19l261t1692r1022b1772],
25	—	CD	NUMBER	—	num	26	SENT_501	[p19l261t1692r1022b1772],
26	emtricitabine	NN	O	emtricitabine	npadvmod	27	SENT_501	[p19l261t1692r1022b1772],
27	than	IN	O	than	advmod	24	SENT_501	[p19l1076t1692r1274b1771],
28	among	IN	O	among	_	0	SENT_501	[p19l1327t1718r1629b1794],
29	those	DT	O	those	prep_among	24	SENT_501	[p19l1681t1692r1914b1772],
30	who	WP	O	who	nsubj	31	SENT_501	[p19l1964t1692r2148b1772],
31	received	VBD	O	receive	rcmod	29	SENT_501	[p19l10t1821r358b1900],
32	dolutegravir	NN	O	dolutegravir	nn	36	SENT_501	[p19l427t1821r954b1922],
33	and	CC	O	and	_	0	SENT_501	[p19l1020t1821r1179b1900],
34	abacavir	NN	O	abacavir	conj_and	32	SENT_501	[p19l1246t1821r2149b1900],
35	—	CD	NUMBER	—	num	36	SENT_501	[p19l1246t1821r2149b1900],
36	lamivudine	NN	O	lamivudine	iobj	31	SENT_501	[p19l1246t1821r2149b1900],
37	(	CD	PERCENT	(	num	39	SENT_501	[p19l15t1954r227b2040],
38	66	CD	PERCENT	66	num	39	SENT_501	[p19l15t1954r227b2040],
39	%	NN	PERCENT	%	dobj	31	SENT_501	[p19l15t1954r227b2040],
40	vs.	CC	O	vs.	prep	39	SENT_501	[p19l260t1975r370b2028],
41	43	CD	PERCENT	43	num	42	SENT_501	[p19l411t1954r645b2045],
42	%	NN	PERCENT	%	dep	40	SENT_501	[p19l411t1954r645b2045],
43	)	CD	NUMBER	)	tmod	42	SENT_501	[p19l411t1954r645b2045],
44	,	,	O	,	_	0	SENT_501	[p19l411t1954r645b2045],
45	as	IN	O	as	mark	48	SENT_501	[p19l687t1975r774b2027],
46	were	VBD	O	be	cop	48	SENT_501	[p19l809t1975r1012b2028],
47	adverse	JJ	O	adverse	amod	48	SENT_501	[p19l1050t1949r1367b2028],
48	events	NNS	O	event	dep	43	SENT_501	[p19l1405t1966r1671b2028],
49	leading	VBG	O	lead	partmod	48	SENT_501	[p19l1709t1949r2032b2050],
50	to	TO	O	to	_	0	SENT_501	[p19l2067t1966r2149b2028],
51	discontinuation	NN	O	discontinuation	prep_to	49	SENT_501	[p19l11t2077r697b2157],
52	of	IN	O	of	_	0	SENT_501	[p19l765t2076r866b2157],
53	the	DT	O	the	det	55	SENT_501	[p19l915t2077r1049b2156],
54	study	NN	O	study	nn	55	SENT_501	[p19l1118t2077r1349b2178],
55	drug	NN	O	drug	prep_of	51	SENT_501	[p19l1413t2077r1638b2179],
56	.	.	O	.	_	0	SENT_501	[p19l1413t2077r1638b2179],

1	The	DT	O	the	det	5	SENT_502	[p19l1707t2077r1869b2156],
2	most	RBS	O	most	advmod	3	SENT_502	[p19l1937t2094r2154b2157],
3	frequent	JJ	O	frequent	amod	5	SENT_502	[p19l10t2205r377b2307],
4	adverse	JJ	O	adverse	amod	5	SENT_502	[p19l428t2206r746b2286],
5	events	NNS	O	event	_	0	SENT_502	[p19l803t2223r1068b2286],
6	leading	VBG	O	lead	partmod	5	SENT_502	[p19l1125t2206r1448b2308],
7	to	TO	O	to	_	0	SENT_502	[p19l1501t2223r1583b2286],
8	the	DT	O	the	det	9	SENT_502	[p19l1642t2206r1775b2285],
9	discontinuation	NN	O	discontinuation	prep_to	6	SENT_502	[p19l1833t2206r2148b2286, p19l11t2337r400b2416],
10	of	IN	O	of	_	0	SENT_502	[p19l434t2335r533b2416],
11	efavirenz	NN	O	efavirenz	nn	14	SENT_502	[p19l549t2335r1376b2416],
12	—	CD	NUMBER	—	num	14	SENT_502	[p19l549t2335r1376b2416],
13	tenofovir	NN	O	tenofovir	nn	14	SENT_502	[p19l549t2335r1376b2416],
14	DF	NN	O	df	prep_of	9	SENT_502	[p19l1405t2336r2149b2416],
15	—	CD	NUMBER	—	num	16	SENT_502	[p19l1405t2336r2149b2416],
16	emtricitabine	NN	O	emtricitabine	dep	14	SENT_502	[p19l1405t2336r2149b2416],

1	(	NN	O	(	_	0	SENT_503	[p19l15t2465r189b2560],
2	i.e.	FW	O	i.e.	dep	1	SENT_503	[p19l15t2465r189b2560],
3	,	,	O	,	_	0	SENT_503	[p19l15t2465r189b2560],
4	those	DT	O	those	appos	1	SENT_503	[p19l241t2464r475b2543],
5	that	WDT	O	that	nsubj	6	SENT_503	[p19l522t2464r695b2542],
6	occurred	VBD	O	occur	rcmod	4	SENT_503	[p19l737t2464r1119b2544],
7	in	IN	O	in	_	0	SENT_503	[p19l1164t2465r1248b2542],
8	>	JJR	O	>	prep_in	6	SENT_503	[p19l1300t2469r1482b2543],
9	2	CD	NUMBER	2	num	10	SENT_503	[p19l1300t2469r1482b2543],
10	°	NN	O	°	dep	8	SENT_503	[p19l1300t2469r1482b2543],
11	/	:	O	/	punct	1	SENT_503	[p19l1300t2469r1482b2543],
12	o	NN	O	o	nsubj	18	SENT_503	[p19l1300t2469r1482b2543],
13	of	IN	O	of	_	0	SENT_503	[p19l1528t2463r1629b2543],
14	the	DT	O	the	det	16	SENT_503	[p19l1656t2464r1790b2542],
15	participants	NNS	O	participant	nn	16	SENT_503	[p19l1835t2465r2148b2564, p19l8t2600r271b2693],
16	)	NN	O	)	prep_of	12	SENT_503	[p19l1835t2465r2148b2564, p19l8t2600r271b2693],
17	were	VBD	O	be	cop	18	SENT_503	[p19l314t2619r518b2672],
18	psychiatric	JJ	O	psychiatric	dep	1	SENT_503	[p19l558t2593r1031b2693],
19	and	CC	O	and	_	0	SENT_503	[p19l1072t2593r1231b2672],
20	nervous	JJ	O	nervous	amod	22	SENT_503	[p19l1272t2619r1609b2672],
21	system	NN	O	system	nn	22	SENT_503	[p19l1654t2610r1949b2693],
22	disorders	NNS	O	disorder	conj_and	18	SENT_503	[p19l1991t2593r2148b2672, p19l11t2722r305b2817],
23	;	:	O	;	_	0	SENT_503	[p19l1991t2593r2148b2672, p19l11t2722r305b2817],
24	in	IN	O	in	_	0	SENT_503	[p19l376t2723r460b2800],
25	the	DT	O	the	det	26	SENT_503	[p19l529t2722r663b2801],
26	DTG	NN	O	dtg	prep_in	18	SENT_503	[p19l729t2728r1412b2801],
27	.	.	O	.	_	0	SENT_503	[p19l729t2728r1412b2801],

1	—	NN	O	—	_	0	SENT_504	[p19l729t2728r1412b2801],
2	.	.	O	.	_	0	SENT_504	[p19l729t2728r1412b2801],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_505	[p19l729t2728r1412b2801],
2	.	.	O	.	_	0	SENT_505	[p19l729t2728r1412b2801],

1	—	NN	O	—	_	0	SENT_506	[p19l729t2728r1412b2801],
2	.	.	O	.	_	0	SENT_506	[p19l729t2728r1412b2801],

1	3TC	NN	O	3tc	nn	2	SENT_507	[p19l729t2728r1412b2801],
2	group	NN	O	group	nsubj	12	SENT_507	[p19l1482t2748r1759b2823],
3	,	,	O	,	_	0	SENT_507	[p19l1482t2748r1759b2823],
4	adverse	JJ	O	adverse	amod	5	SENT_507	[p19l1832t2722r2149b2801],
5	events	NNS	O	event	appos	2	SENT_507	[p19l11t2867r276b2930],
6	leading	VBG	O	lead	partmod	5	SENT_507	[p19l312t2850r634b2952],
7	to	TO	O	to	_	0	SENT_507	[p19l665t2867r747b2930],
8	discontinuation	NN	O	discontinuation	prep_to	6	SENT_507	[p19l784t2850r1470b2930],
9	of	IN	O	of	_	0	SENT_507	[p19l1505t2849r1606b2930],
10	the	DT	O	the	det	11	SENT_507	[p19l1622t2850r1756b2929],
11	regimen	NN	O	regimen	prep_of	8	SENT_507	[p19l1790t2851r2150b2952],
12	occurred	VBD	O	occur	_	0	SENT_507	[p19l11t2978r392b3058],
13	in	IN	O	in	mark	18	SENT_507	[p19l441t2979r525b3056],
14	two	CD	NUMBER	two	nn	17	SENT_507	[p19l574t2995r733b3057],
15	or	CC	O	or	_	0	SENT_507	[p19l785t3004r874b3057],
16	fewer	JJR	O	fewer	conj_or	14	SENT_507	[p19l920t2977r1158b3058],
17	participants	NNS	O	participant	nsubj	18	SENT_507	[p19l1203t2979r1724b3078],
18	(	VBP	O	(	advcl	12	SENT_507	[p19l1781t2983r2011b3069],
19	<	JJR	O	<	dobj	18	SENT_507	[p19l1781t2983r2011b3069],
20	1	CD	NUMBER	1	num	21	SENT_507	[p19l1781t2983r2011b3069],
21	°	NN	O	°	dep	19	SENT_507	[p19l1781t2983r2011b3069],
22	/	:	O	/	punct	21	SENT_507	[p19l1781t2983r2011b3069],
23	o	NN	O	o	nn	24	SENT_507	[p19l1781t2983r2011b3069],
24	)	NN	O	)	nsubj	31	SENT_507	[p19l1781t2983r2011b3069],
25	in	IN	O	in	_	0	SENT_507	[p19l2065t2979r2149b3056],
26	each	DT	O	each	prep_in	24	SENT_507	[p19l11t3107r204b3186],
27	of	IN	O	of	_	0	SENT_507	[p19l245t3106r345b3187],
28	the	DT	O	the	det	30	SENT_507	[p19l367t3107r500b3186],
29	various	JJ	O	various	amod	30	SENT_507	[p19l536t3108r849b3187],
30	categories	NNS	O	category	prep_of	26	SENT_507	[p19l891t3108r1327b3209],
31	(	VBP	O	(	dep	21	SENT_507	[p19l1374t3107r1634b3199],
32	Table	NNP	O	Table	nsubj	34	SENT_507	[p19l1374t3107r1634b3199],
33	1	CD	NUMBER	1	num	34	SENT_507	[p19l1677t3113r1773b3199],
34	)	CD	NUMBER	)	xcomp	31	SENT_507	[p19l1677t3113r1773b3199],
35	.	.	O	.	_	0	SENT_507	[p19l1677t3113r1773b3199],

1	Overall	RB	O	overall	advmod	6	SENT_508	[p19l140t3236r473b3332],
2	,	,	O	,	_	0	SENT_508	[p19l140t3236r473b3332],
3	nine	CD	NUMBER	nine	num	4	SENT_508	[p19l518t3237r707b3314],
4	participants	NNS	O	participant	nsubjpass	6	SENT_508	[p19l746t3237r1267b3336],
5	were	VBD	O	be	auxpass	6	SENT_508	[p19l1305t3262r1508b3315],
6	considered	VBN	O	consider	_	0	SENT_508	[p19l1548t3236r2016b3315],
7	by	IN	O	by	_	0	SENT_508	[p19l2056t3236r2154b3336],
8	the	DT	O	the	det	9	SENT_508	[p19l11t3365r144b3443],
9	investigator	NN	O	investigator	agent	6	SENT_508	[p19l201t3366r712b3466],
10	to	TO	O	to	aux	12	SENT_508	[p19l767t3382r849b3444],
11	have	VB	O	have	aux	12	SENT_508	[p19l907t3365r1098b3444],
12	had	VBD	O	have	xcomp	6	SENT_508	[p19l1155t3365r1313b3444],
13	a	DT	O	a	det	16	SENT_508	[p19l1369t3391r1413b3443],
14	serious	JJ	O	serious	amod	16	SENT_508	[p19l1470t3366r1774b3444],
15	adverse	JJ	O	adverse	amod	16	SENT_508	[p19l1832t3365r2149b3444],
16	event	NN	O	event	dobj	12	SENT_508	[p19l11t3510r236b3572],
17	that	WDT	O	that	nsubjpass	19	SENT_508	[p19l290t3493r464b3571],
18	was	VBD	O	be	auxpass	19	SENT_508	[p19l512t3519r676b3572],
19	related	VBN	O	relate	rcmod	16	SENT_508	[p19l735t3493r1030b3572],
20	to	TO	O	to	_	0	SENT_508	[p19l1088t3510r1170b3572],
21	the	DT	O	the	det	23	SENT_508	[p19l1230t3493r1364b3571],
22	study	NN	O	study	nn	23	SENT_508	[p19l1423t3493r1655b3593],
23	drug	NN	O	drug	prep_to	19	SENT_508	[p19l1709t3493r1934b3594],
24	:	:	O	:	_	0	SENT_508	[p19l1709t3493r1934b3594],
25	one	CD	NUMBER	one	num	27	SENT_508	[p19l1997t3519r2149b3572],
26	participant	NN	O	participant	nn	27	SENT_508	[p19l9t3622r490b3721],
27	(	NN	O	(	dep	28	SENT_508	[p19l543t3626r774b3712],
28	<	JJR	O	<	dep	23	SENT_508	[p19l543t3626r774b3712],
29	10/o	CD	NUMBER	10/o	num	30	SENT_508	[p19l543t3626r774b3712],
30	)	NN	O	)	dep	28	SENT_508	[p19l543t3626r774b3712],
31	in	IN	O	in	_	0	SENT_508	[p19l832t3622r916b3699],
32	the	DT	O	the	det	33	SENT_508	[p19l969t3621r1104b3699],
33	DTG	NN	O	dtg	prep_in	19	SENT_508	[p19l1155t3627r1838b3700],
34	.	.	O	.	_	0	SENT_508	[p19l1155t3627r1838b3700],

1	—	NN	O	—	_	0	SENT_509	[p19l1155t3627r1838b3700],
2	.	.	O	.	_	0	SENT_509	[p19l1155t3627r1838b3700],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_510	[p19l1155t3627r1838b3700],
2	.	.	O	.	_	0	SENT_510	[p19l1155t3627r1838b3700],

1	—	NN	O	—	_	0	SENT_511	[p19l1155t3627r1838b3700],
2	.	.	O	.	_	0	SENT_511	[p19l1155t3627r1838b3700],

1	3TC	NN	O	3tc	nn	2	SENT_512	[p19l1155t3627r1838b3700],
2	group	NN	O	group	_	0	SENT_512	[p19l1894t3647r2148b3722],

1	(	NN	O	(	_	0	SENT_513	[p20l15t20r234b111],
2	with	IN	O	with	_	0	SENT_513	[p20l15t20r234b111],
3	suspected	VBN	O	suspect	amod	6	SENT_513	[p20l276t20r699b120],
4	drug	NN	O	drug	nn	6	SENT_513	[p20l741t20r946b121],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_513	[p20l984t20r1691b120],
6	)	NN	O	)	prep_with	1	SENT_513	[p20l984t20r1691b120],
7	and	CC	O	and	_	0	SENT_513	[p20l1736t20r1895b99],
8	eight	CD	NUMBER	eight	num	9	SENT_513	[p20l1937t20r2154b121],
9	(	NN	O	(	prep_with	1	SENT_513	[p20l15t154r202b240],
10	2	CD	PERCENT	2	number	11	SENT_513	[p20l15t154r202b240],
11	%	NN	PERCENT	%	amod	9	SENT_513	[p20l15t154r202b240],
12	)	CD	NUMBER	)	dep	9	SENT_513	[p20l15t154r202b240],
13	in	IN	O	in	_	0	SENT_513	[p20l259t149r343b226],
14	the	DT	O	the	det	15	SENT_513	[p20l396t148r530b227],
15	EFV	NN	O	efv	prep_in	1	SENT_513	[p20l581t154r1212b228],
16	.	.	O	.	_	0	SENT_513	[p20l581t154r1212b228],

1	—	NN	O	—	_	0	SENT_514	[p20l581t154r1212b228],
2	.	.	O	.	_	0	SENT_514	[p20l581t154r1212b228],

1	TDF	NNP	O	TDF	_	0	SENT_515	[p20l581t154r1212b228],
2	.	.	O	.	_	0	SENT_515	[p20l581t154r1212b228],

1	—	NN	O	—	_	0	SENT_516	[p20l581t154r1212b228],
2	.	.	O	.	_	0	SENT_516	[p20l581t154r1212b228],

1	FTC	NNP	ORGANIZATION	FTC	nsubj	2	SENT_517	[p20l581t154r1212b228],
2	group	NN	O	group	_	0	SENT_517	[p20l1266t174r1521b250],
3	(	CD	NUMBER	(	number	4	SENT_517	[p20l1579t147r1786b240],
4	four	CD	NUMBER	four	num	5	SENT_517	[p20l1579t147r1786b240],
5	participants	NNS	O	participant	dobj	2	SENT_517	[p20l1835t149r2148b249, p20l9t294r245b377],
6	with	IN	O	with	_	0	SENT_517	[p20l308t277r504b356],
7	psychiatric	JJ	O	psychiatric	amod	8	SENT_517	[p20l567t277r1040b377],
8	events	NNS	O	event	prep_with	5	SENT_517	[p20l1105t294r1395b373],
9	,	,	O	,	_	0	SENT_517	[p20l1105t294r1395b373],
10	two	CD	NUMBER	two	dobj	2	SENT_517	[p20l1466t294r1624b356],
11	with	IN	O	with	_	0	SENT_517	[p20l1686t277r1882b356],
12	drug	NN	O	drug	nn	13	SENT_517	[p20l1947t277r2153b378],
13	hypersensitivity	NN	O	hypersensitivity	prep_with	10	SENT_517	[p20l10t405r708b505],
14	,	,	O	,	_	0	SENT_517	[p20l10t405r708b505],
15	one	CD	NUMBER	one	conj_and	5	SENT_517	[p20l764t431r917b484],
16	with	IN	O	with	_	0	SENT_517	[p20l962t405r1158b485],
17	a	DT	O	a	det	19	SENT_517	[p20l1207t431r1252b483],
18	cerebrovascular	JJ	O	cerebrovascular	amod	19	SENT_517	[p20l1301t405r1981b484],
19	accident	NN	O	accident	prep_with	15	SENT_517	[p20l2028t431r2148b483, p20l11t535r295b632],
20	,	,	O	,	_	0	SENT_517	[p20l2028t431r2148b483, p20l11t535r295b632],
21	and	CC	O	and	_	0	SENT_517	[p20l332t535r491b615],
22	one	CD	NUMBER	one	dobj	2	SENT_517	[p20l523t561r676b615],
23	with	IN	O	with	_	0	SENT_517	[p20l704t535r901b615],
24	renal	JJ	O	renal	amod	26	SENT_517	[p20l933t535r1151b614],
25	failure	NN	O	failure	nn	26	SENT_517	[p20l1183t534r1513b627],
26	)	NN	O	)	prep_with	2	SENT_517	[p20l1183t534r1513b627],
27	.	.	O	.	_	0	SENT_517	[p20l1183t534r1513b627],

1	The	DT	O	the	det	2	SENT_518	[p20l1547t535r1709b614],
2	incidence	NN	O	incidence	nsubj	8	SENT_518	[p20l1740t535r2149b615],
3	of	IN	O	of	_	0	SENT_518	[p20l11t664r111b745],
4	serious	JJ	O	serious	amod	6	SENT_518	[p20l134t666r438b745],
5	adverse	JJ	O	adverse	amod	6	SENT_518	[p20l479t665r797b745],
6	events	NNS	O	event	prep_of	2	SENT_518	[p20l837t682r1102b745],
7	was	VBD	O	be	cop	8	SENT_518	[p20l1140t692r1304b745],
8	similar	JJ	O	similar	_	0	SENT_518	[p20l1348t665r1656b744],
9	in	IN	O	in	_	0	SENT_518	[p20l1692t666r1776b744],
10	the	DT	O	the	det	15	SENT_518	[p20l1816t665r1950b745],
11	two	CD	NUMBER	two	num	12	SENT_518	[p20l1990t682r2149b745],
12	groups	NNS	O	group	dep	13	SENT_518	[p20l10t820r308b895],
13	(	RB	O	(	amod	15	SENT_518	[p20l364t794r624b885],
14	Table	NNP	O	Table	nn	15	SENT_518	[p20l364t794r624b885],
15	S6	NN	O	s6	prep_in	8	SENT_518	[p20l677t800r773b873],
16	in	IN	O	in	_	0	SENT_518	[p20l823t795r907b872],
17	the	DT	O	the	det	20	SENT_518	[p20l957t794r1091b872],
18	Supplementary	NNP	O	Supplementary	nn	20	SENT_518	[p20l1143t794r1794b894],
19	Appendix	NNP	O	Appendix	nn	20	SENT_518	[p20l1836t802r2148b894, p20l11t922r195b1013],
20	)	NN	O	)	prep_in	15	SENT_518	[p20l1836t802r2148b894, p20l11t922r195b1013],
21	.	.	O	.	_	0	SENT_518	[p20l1836t802r2148b894, p20l11t922r195b1013],

1	Through	IN	O	through	dep	6	SENT_519	[p20l230t922r609b1023],
2	week	NN	DURATION	week	pobj	1	SENT_519	[p20l638t922r863b1001],
3	48	CD	NUMBER	48	num	2	SENT_519	[p20l890t928r1018b1018],
4	,	,	O	,	_	0	SENT_519	[p20l890t928r1018b1018],
5	two	CD	NUMBER	two	num	6	SENT_519	[p20l1057t939r1215b1001],
6	participants	NNS	O	participant	_	0	SENT_519	[p20l1249t923r1794b1022],
7	,	,	O	,	_	0	SENT_519	[p20l1249t923r1794b1022],
8	both	CC	O	both	advmod	6	SENT_519	[p20l1834t922r2033b1001],
9	in	IN	O	in	_	0	SENT_519	[p20l2065t923r2149b1000],
10	the	DT	O	the	det	11	SENT_519	[p20l11t1050r143b1128],
11	EFV	NN	O	efv	prep_in	6	SENT_519	[p20l176t1056r796b1129],
12	.	.	O	.	_	0	SENT_519	[p20l176t1056r796b1129],

1	—	NN	O	—	_	0	SENT_520	[p20l176t1056r796b1129],
2	.	.	O	.	_	0	SENT_520	[p20l176t1056r796b1129],

1	TDF	NNP	O	TDF	_	0	SENT_521	[p20l176t1056r796b1129],
2	.	.	O	.	_	0	SENT_521	[p20l176t1056r796b1129],

1	—	NN	O	—	_	0	SENT_522	[p20l176t1056r796b1129],
2	.	.	O	.	_	0	SENT_522	[p20l176t1056r796b1129],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_523	[p20l176t1056r796b1129],
2	group	NN	O	group	nsubjpass	9	SENT_523	[p20l833t1076r1104b1151],
3	,	,	O	,	_	0	SENT_523	[p20l833t1076r1104b1151],
4	died	VBD	O	die	partmod	2	SENT_523	[p20l1144t1050r1347b1146],
5	;	:	O	;	_	0	SENT_523	[p20l1144t1050r1347b1146],
6	these	DT	O	these	det	7	SENT_523	[p20l1385t1050r1607b1128],
7	deaths	NNS	O	death	nsubjpass	9	SENT_523	[p20l1642t1050r1918b1129],
8	were	VBD	O	be	auxpass	9	SENT_523	[p20l1950t1076r2149b1129],
9	considered	VBN	O	consider	_	0	SENT_523	[p20l11t1178r478b1257],
10	to	TO	O	to	aux	12	SENT_523	[p20l540t1195r621b1257],
11	be	VB	O	be	cop	12	SENT_523	[p20l685t1178r782b1257],
12	unrelated	JJ	O	unrelated	xcomp	9	SENT_523	[p20l843t1178r1255b1257],
13	to	TO	O	to	_	0	SENT_523	[p20l1316t1195r1399b1257],
14	the	DT	O	the	det	18	SENT_523	[p20l1462t1178r1595b1256],
15	study	NN	O	study	nn	18	SENT_523	[p20l1658t1178r1890b1278],
16	drug	NN	O	drug	nn	18	SENT_523	[p20l1947t1178r2153b1279],
17	(	CD	NUMBER	(	num	18	SENT_523	[p20l15t1306r296b1405],
18	sepsis	NN	O	sepsis	prep_to	12	SENT_523	[p20l15t1306r296b1405],
19	with	IN	O	with	_	0	SENT_523	[p20l336t1305r533b1385],
20	renal	JJ	O	renal	amod	21	SENT_523	[p20l574t1305r793b1383],
21	failure	NN	O	failure	prep_with	12	SENT_523	[p20l834t1304r1114b1385],
22	in	IN	O	in	_	0	SENT_523	[p20l1154t1306r1239b1383],
23	one	CD	NUMBER	one	num	24	SENT_523	[p20l1281t1331r1433b1384],
24	participant	NN	O	participant	prep_in	21	SENT_523	[p20l1473t1306r1955b1405],
25	and	CC	O	and	_	0	SENT_523	[p20l1990t1305r2149b1384],
26	pneumonia	NN	O	pneumonia	conj_and	21	SENT_523	[p20l9t1435r504b1534],
27	in	IN	O	in	_	0	SENT_523	[p20l543t1435r627b1512],
28	one	CD	NUMBER	one	num	29	SENT_523	[p20l668t1441r871b1530],
29	)	NN	O	)	prep_in	26	SENT_523	[p20l668t1441r871b1530],
30	,	,	O	,	_	0	SENT_523	[p20l668t1441r871b1530],
31	although	IN	O	although	mark	43	SENT_523	[p20l916t1434r1306b1535],
32	the	DT	O	the	det	35	SENT_523	[p20l1347t1434r1481b1512],
33	accompanying	VBG	O	accompany	amod	35	SENT_523	[p20l1522t1435r2153b1535],
34	renal	JJ	O	renal	amod	35	SENT_523	[p20l10t1561r229b1639],
35	failure	NN	O	failure	nsubjpass	43	SENT_523	[p20l278t1560r557b1641],
36	in	IN	O	in	_	0	SENT_523	[p20l606t1562r690b1639],
37	the	DT	O	the	det	39	SENT_523	[p20l739t1561r873b1639],
38	one	CD	NUMBER	one	num	39	SENT_523	[p20l924t1587r1076b1640],
39	participant	NN	O	participant	prep_in	35	SENT_523	[p20l1124t1562r1605b1661],
40	with	IN	O	with	_	0	SENT_523	[p20l1644t1561r1841b1641],
41	sepsis	NN	O	sepsis	prep_with	35	SENT_523	[p20l1892t1562r2147b1661],
42	was	VBD	O	be	auxpass	43	SENT_523	[p20l6t1716r170b1769],
43	considered	VBN	O	consider	advcl	12	SENT_523	[p20l239t1690r706b1769],
44	to	TO	O	to	aux	47	SENT_523	[p20l773t1707r855b1769],
45	be	VB	O	be	cop	47	SENT_523	[p20l924t1690r1021b1769],
46	possibly	RB	O	possibly	advmod	47	SENT_523	[p20l1086t1690r1443b1790],
47	related	JJ	O	related	xcomp	43	SENT_523	[p20l1504t1690r1798b1769],
48	to	TO	O	to	_	0	SENT_523	[p20l1865t1707r1947b1769],
49	the	DT	O	the	det	51	SENT_523	[p20l2016t1690r2149b1768],
50	study	NN	O	study	nn	51	SENT_523	[p20l11t1819r243b1919],
51	medication	NN	O	medication	prep_to	47	SENT_523	[p20l279t1819r788b1898],
52	.	.	O	.	_	0	SENT_523	[p20l279t1819r788b1898],

1	Participants	NNS	O	participant	nsubj	2	SENT_524	[p20l139t1949r658b2048],
2	receiving	VBG	O	receive	_	0	SENT_524	[p20l695t1949r1089b2049],
3	dolutegravir	NN	O	dolutegravir	nn	7	SENT_524	[p20l1122t1948r1648b2049],
4	and	CC	O	and	_	0	SENT_524	[p20l1681t1948r1840b2027],
5	abaca	NN	O	abaca	nn	7	SENT_524	[p20l1874t1948r2148b2027],
6	—	NN	O	—	nn	7	SENT_524	[p20l1874t1948r2148b2027],
7	vir	NN	O	vir	dobj	2	SENT_524	[p20l6t2077r665b2156],
8	—	CD	NUMBER	—	num	9	SENT_524	[p20l6t2077r665b2156],
9	lamivudine	NN	O	lamivudine	nsubj	10	SENT_524	[p20l6t2077r665b2156],
10	had	VBD	O	have	rcmod	7	SENT_524	[p20l704t2077r862b2156],
11	small	JJ	O	small	amod	13	SENT_524	[p20l902t2077r1139b2155],
12	mean	JJ	O	mean	amod	13	SENT_524	[p20l1177t2103r1416b2156],
13	increases	NNS	O	increase	dobj	10	SENT_524	[p20l1454t2078r1851b2155],
14	in	IN	O	in	_	0	SENT_524	[p20l1892t2078r1976b2155],
15	the	DT	O	the	det	18	SENT_524	[p20l2016t2077r2149b2156],
16	serum	NN	O	serum	nn	18	SENT_524	[p20l12t2231r282b2285],
17	creatinine	NN	O	creatinine	nn	18	SENT_524	[p20l319t2206r753b2284],
18	level	NN	O	level	prep_in	13	SENT_524	[p20l789t2205r1002b2302],
19	,	,	O	,	_	0	SENT_524	[p20l789t2205r1002b2302],
20	a	DT	O	a	det	21	SENT_524	[p20l1043t2232r1088b2284],
21	finding	NN	O	finding	ccomp	2	SENT_524	[p20l1123t2204r1449b2307],
22	consistent	JJ	O	consistent	amod	21	SENT_524	[p20l1483t2206r1926b2285],
23	with	IN	O	with	_	0	SENT_524	[p20l1952t2205r2149b2285],
24	that	DT	O	that	prep_with	22	SENT_524	[p20l11t2334r184b2413],
25	in	IN	O	in	_	0	SENT_524	[p20l232t2335r316b2412],
26	previous	JJ	O	previous	amod	27	SENT_524	[p20l368t2335r733b2435],
27	studies	NNS	O	study	prep_in	24	SENT_524	[p20l790t2334r1092b2414],
28	of	IN	O	of	_	0	SENT_524	[p20l1149t2333r1249b2414],
29	dolutegravir	NN	O	dolutegravir	prep_of	27	SENT_524	[p20l1285t2334r2006b2436],
30	.12	CD	NUMBER	.12	number	31	SENT_524	[p20l1285t2334r2006b2436],
31	’23	CD	NUMBER	’23	num	29	SENT_524	[p20l1285t2334r2006b2436],
32	In	IN	O	in	dep	21	SENT_524	[p20l2060t2342r2150b2412],
33	our	PRP$	O	we	poss	34	SENT_524	[p20l11t2489r158b2542],
34	study	NN	O	study	pobj	32	SENT_524	[p20l220t2463r465b2563],
35	,	,	O	,	_	0	SENT_524	[p20l220t2463r465b2563],
36	the	DT	O	the	det	38	SENT_524	[p20l535t2463r668b2541],
37	mean	JJ	O	mean	amod	38	SENT_524	[p20l732t2489r971b2541],
38	increases	NNS	O	increase	nsubj	60	SENT_524	[p20l1034t2464r1457b2559],
39	,	,	O	,	_	0	SENT_524	[p20l1034t2464r1457b2559],
40	which	WDT	O	which	nsubj	41	SENT_524	[p20l1522t2463r1786b2542],
41	ranged	VBD	O	range	rcmod	38	SENT_524	[p20l1851t2463r2150b2564],
42	from	IN	O	from	_	0	SENT_524	[p20l10t2590r222b2671],
43	10.2	CD	NUMBER	10.2	number	45	SENT_524	[p20l258t2597r432b2671],
44	to	TO	NUMBER	to	dep	45	SENT_524	[p20l467t2608r548b2671],
45	13.4	CD	NUMBER	13.4	prep_from	41	SENT_524	[p20l587t2597r764b2671],
46	,	,	O	,	_	0	SENT_524	[p20l796t2591r1033b2692],
47	umol	NN	O	umol	appos	45	SENT_524	[p20l796t2591r1033b2692],
48	per	IN	O	per	_	0	SENT_524	[p20l1064t2617r1205b2692],
49	liter	NN	O	liter	prep_per	47	SENT_524	[p20l1235t2591r1409b2670],
50	(	CD	NUMBER	(	num	49	SENT_524	[p20l1444t2597r1650b2683],
51	0.12	CD	NUMBER	0.12	dep	49	SENT_524	[p20l1444t2597r1650b2683],
52	to	TO	O	to	_	0	SENT_524	[p20l1684t2608r1767b2671],
53	0.15	CD	NUMBER	0.15	num	54	SENT_524	[p20l1802t2597r1977b2671],
54	mg	NN	O	mg	prep_to	41	SENT_524	[p20l2013t2617r2153b2693],
55	per	IN	O	per	_	0	SENT_524	[p20l8t2746r149b2820],
56	deciliter	NN	O	deciliter	nn	57	SENT_524	[p20l184t2720r585b2816],
57	)	NN	O	)	prep_per	54	SENT_524	[p20l184t2720r585b2816],
58	,	,	O	,	_	0	SENT_524	[p20l184t2720r585b2816],
59	were	VBD	O	be	cop	60	SENT_524	[p20l623t2746r826b2800],
60	evident	JJ	O	evident	ccomp	2	SENT_524	[p20l864t2720r1176b2800],
61	by	IN	O	by	_	0	SENT_524	[p20l1210t2720r1307b2820],
62	week	NN	DURATION	week	prep_by	60	SENT_524	[p20l1335t2720r1560b2800],
63	2	CD	NUMBER	2	num	62	SENT_524	[p20l1593t2726r1641b2798],
64	and	CC	O	and	_	0	SENT_524	[p20l1678t2720r1837b2799],
65	subsequently	RB	O	subsequently	advmod	72	SENT_524	[p20l1876t2720r2148b2799, p20l11t2849r331b2949],
66	remained	VBD	O	remain	cop	72	SENT_524	[p20l376t2849r787b2928],
67	stable	JJ	O	stable	amod	72	SENT_524	[p20l838t2849r1088b2928],
68	through	IN	O	through	_	0	SENT_524	[p20l1138t2849r1490b2950],
69	week	NN	DURATION	week	prep_through	67	SENT_524	[p20l1535t2849r1760b2928],
70	48	CD	NUMBER	48	num	69	SENT_524	[p20l1804t2855r1906b2928],
71	(	CD	NUMBER	(	tmod	67	SENT_524	[p20l1963t2850r2144b2950],
72	Fig	NN	O	fig	conj_and	60	SENT_524	[p20l1963t2850r2144b2950],
73	.	.	O	.	_	0	SENT_524	[p20l1963t2850r2144b2950],

1	4B	NN	O	4b	_	0	SENT_525	[p20l8t2984r169b3069],
2	)	NN	O	)	dep	1	SENT_525	[p20l8t2984r169b3069],
3	.	.	O	.	_	0	SENT_525	[p20l8t2984r169b3069],

1	No	DT	O	no	det	3	SENT_526	[p20l229t2985r355b3057],
2	significant	JJ	O	significant	amod	3	SENT_526	[p20l415t2976r887b3079],
3	change	NN	O	change	nsubjpass	7	SENT_526	[p20l941t2977r1248b3079],
4	from	IN	O	from	_	0	SENT_526	[p20l1305t2976r1517b3057],
5	baseline	NN	O	baseline	prep_from	3	SENT_526	[p20l1575t2977r1930b3057],
6	was	VBD	O	be	auxpass	7	SENT_526	[p20l1983t3004r2147b3057],
7	observed	VBN	O	observe	_	0	SENT_526	[p20l11t3106r395b3185],
8	in	IN	O	in	_	0	SENT_526	[p20l458t3107r542b3184],
9	the	DT	O	the	det	11	SENT_526	[p20l607t3106r741b3184],
10	urinary	JJ	O	urinary	amod	11	SENT_526	[p20l805t3107r1128b3206],
11	albumin	NN	O	albumin	prep_in	7	SENT_526	[p20l1188t3106r2149b3185],
12	—	CD	NUMBER	—	number	14	SENT_526	[p20l1188t3106r2149b3185],
13	to	TO	O	to	dep	14	SENT_526	[p20l1188t3106r2149b3185],
14	—	CD	NUMBER	—	num	11	SENT_526	[p20l1188t3106r2149b3185],
15	creatinine	NN	O	creatinine	nn	17	SENT_526	[p20l1188t3106r2149b3185],
16	ratio	NN	O	ratio	nn	17	SENT_526	[p20l10t3236r209b3314],
17	(	NN	O	(	dobj	7	SENT_526	[p20l263t3235r482b3326],
18	with	IN	O	with	_	0	SENT_526	[p20l263t3235r482b3326],
19	urinary	JJ	O	urinary	amod	20	SENT_526	[p20l530t3236r854b3335],
20	albumin	NN	O	albumin	prep_with	17	SENT_526	[p20l896t3235r1262b3314],
21	measured	VBN	O	measure	partmod	20	SENT_526	[p20l1310t3235r1732b3314],
22	in	IN	O	in	_	0	SENT_526	[p20l1779t3236r1863b3313],
23	milligrams	NNS	O	milligram	prep_in	21	SENT_526	[p20l1911t3235r2148b3313, p20l10t3390r282b3465],
24	per	IN	O	per	_	0	SENT_526	[p20l316t3390r457b3464],
25	liter	NN	O	liter	prep_per	23	SENT_526	[p20l487t3364r661b3443],
26	and	CC	O	and	_	0	SENT_526	[p20l691t3364r850b3443],
27	creatinine	NN	O	creatinine	conj_and	25	SENT_526	[p20l884t3365r1318b3442],
28	in	IN	O	in	_	0	SENT_526	[p20l1350t3365r1435b3442],
29	micromoles	NNS	O	micromole	prep_in	21	SENT_526	[p20l1468t3364r1977b3443],
30	per	IN	O	per	_	0	SENT_526	[p20l2012t3390r2153b3464],
31	liter	NN	O	liter	prep_per	29	SENT_526	[p20l9t3492r205b3588],
32	;	:	O	;	_	0	SENT_526	[p20l9t3492r205b3588],
33	the	DT	O	the	det	35	SENT_526	[p20l259t3492r392b3570],
34	ratio	NN	O	ratio	nn	35	SENT_526	[p20l443t3493r641b3571],
35	value	NN	O	value	nsubjpass	37	SENT_526	[p20l687t3492r908b3571],
36	was	VBD	O	be	auxpass	37	SENT_526	[p20l954t3518r1117b3571],
37	multiplied	VBN	O	multiply	parataxis	7	SENT_526	[p20l1168t3492r1616b3592],
38	by	IN	O	by	_	0	SENT_526	[p20l1665t3492r1763b3592],
39	1000	CD	DATE	1000	agent	37	SENT_526	[p20l1811t3498r2015b3571],
40	to	TO	O	to	aux	41	SENT_526	[p20l2067t3509r2148b3571],
41	achieve	VB	O	achieve	xcomp	37	SENT_526	[p20l10t3621r323b3701],
42	a	DT	O	a	det	43	SENT_526	[p20l383t3648r427b3700],
43	ratio	NN	O	ratio	dobj	41	SENT_526	[p20l486t3622r684b3701],
44	of	IN	O	of	_	0	SENT_526	[p20l746t3620r846b3701],
45	milligrams	NNS	O	milligram	prep_of	43	SENT_526	[p20l887t3621r1369b3723],
46	per	IN	O	per	_	0	SENT_526	[p20l1429t3647r1570b3722],
47	millimoles	NNS	O	millimole	prep_per	45	SENT_526	[p20l1627t3621r2144b3713],
48	)	CD	NUMBER	)	dep	47	SENT_526	[p20l1627t3621r2144b3713],
49	.	.	O	.	_	0	SENT_526	[p20l1627t3621r2144b3713],

1	The	DT	O	the	det	3	SENT_527	[p21l6t21r168b99],
2	median	JJ	O	median	amod	3	SENT_527	[p21l224t21r550b100],
3	ratio	NN	O	ratio	nsubjpass	5	SENT_527	[p21l605t22r803b100],
4	was	VBD	O	be	auxpass	5	SENT_527	[p21l856t47r1019b100],
5	o.	VBN	O	o.	_	0	SENT_527	[p21l1077t27r1258b100],
6	oo	NN	O	oo	dobj	5	SENT_527	[p21l1077t27r1258b100],
7	in	IN	O	in	_	0	SENT_527	[p21l1314t22r1398b99],
8	the	DT	O	the	det	9	SENT_527	[p21l1453t21r1587b99],
9	DTG	NN	O	dtg	prep_in	6	SENT_527	[p21l1642t27r2153b100],
10	.	.	O	.	_	0	SENT_527	[p21l1642t27r2153b100],

1	—	NN	O	—	_	0	SENT_528	[p21l1642t27r2153b100],
2	.	.	O	.	_	0	SENT_528	[p21l1642t27r2153b100],

1	ABC	NNP	ORGANIZATION	ABC	nn	3	SENT_529	[p21l1642t27r2153b100],
2	3TC	NN	O	3tc	nn	3	SENT_529	[p21l11t155r182b228],
3	group	NN	O	group	_	0	SENT_529	[p21l238t175r492b250],
4	(	CD	NUMBER	(	num	6	SENT_529	[p21l552t149r1124b249],
5	interquartile	NN	O	interquartile	nn	6	SENT_529	[p21l552t149r1124b249],
6	range	NN	O	range	dep	3	SENT_529	[p21l1179t175r1444b250],
7	,	,	O	,	_	0	SENT_529	[p21l1179t175r1444b250],
8	-0.30	CD	NUMBER	-0.30	num	10	SENT_529	[p21l1503t155r1745b228],
9	to	TO	O	to	dep	10	SENT_529	[p21l1800t166r1882b228],
10	0.30	CD	NUMBER	0.30	appos	6	SENT_529	[p21l1938t155r2144b240],
11	)	CD	NUMBER	)	dep	3	SENT_529	[p21l1938t155r2144b240],
12	and	CC	O	and	_	0	SENT_529	[p21l10t277r169b356],
13	0.05	CD	NUMBER	0.05	dep	3	SENT_529	[p21l207t283r382b356],
14	in	IN	O	in	_	0	SENT_529	[p21l423t278r507b355],
15	the	DT	O	the	det	16	SENT_529	[p21l546t277r680b355],
16	EFV	NN	O	efv	prep_in	11	SENT_529	[p21l717t283r1348b356],
17	.	.	O	.	_	0	SENT_529	[p21l717t283r1348b356],

1	—	NN	O	—	_	0	SENT_530	[p21l717t283r1348b356],
2	.	.	O	.	_	0	SENT_530	[p21l717t283r1348b356],

1	TDF	NNP	O	TDF	_	0	SENT_531	[p21l717t283r1348b356],
2	.	.	O	.	_	0	SENT_531	[p21l717t283r1348b356],

1	—	NN	O	—	_	0	SENT_532	[p21l717t283r1348b356],
2	.	.	O	.	_	0	SENT_532	[p21l717t283r1348b356],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_533	[p21l717t283r1348b356],
2	group	NN	O	group	_	0	SENT_533	[p21l1388t303r1642b378],
3	(	CD	NUMBER	(	num	2	SENT_533	[p21l1687t278r2148b377],
4	interquar	NN	O	interquar	nn	7	SENT_533	[p21l1687t278r2148b377],
5	—	CD	NUMBER	—	num	7	SENT_533	[p21l1687t278r2148b377],
6	tile	NN	O	tile	nn	7	SENT_533	[p21l11t405r145b483],
7	range	NN	O	range	dep	2	SENT_533	[p21l185t431r451b506],
8	,	,	O	,	_	0	SENT_533	[p21l185t431r451b506],
9	-0.20	CD	NUMBER	-0.20	appos	7	SENT_533	[p21l495t411r738b484],
10	to	TO	O	to	_	0	SENT_533	[p21l779t422r862b484],
11	0.30	CD	NUMBER	0.30	num	12	SENT_533	[p21l903t411r1135b496],
12	)	CD	NUMBER	)	prep_to	9	SENT_533	[p21l903t411r1135b496],
13	.	.	O	.	_	0	SENT_533	[p21l903t411r1135b496],

1	The	DT	O	the	det	2	SENT_534	[p21l137t533r299b612],
2	distribution	NN	O	distribution	nsubj	6	SENT_534	[p21l339t533r853b613],
3	and	CC	O	and	_	0	SENT_534	[p21l892t533r1050b613],
4	number	NN	O	number	conj_and	2	SENT_534	[p21l1090t533r1430b613],
5	of	IN	O	of	prep	2	SENT_534	[p21l1468t532r1569b613],
6	graded	VBN	O	grade	_	0	SENT_534	[p21l1589t533r1887b635],
7	clinical	JJ	O	clinical	amod	11	SENT_534	[p21l1927t533r2148b612, p21l11t662r130b740],
8	biochemical	JJ	O	biochemical	amod	11	SENT_534	[p21l174t662r690b741],
9	and	CC	O	and	_	0	SENT_534	[p21l733t662r890b741],
10	hematologic	JJ	O	hematologic	amod	11	SENT_534	[p21l933t662r1460b763],
11	events	NNS	O	event	dobj	6	SENT_534	[p21l1504t679r1764b741],
12	that	WDT	O	that	nsubj	13	SENT_534	[p21l1811t662r1981b740],
13	developed	VBD	O	develop	rcmod	11	SENT_534	[p21l2020t662r2148b741, p21l6t790r330b890],
14	While	IN	O	while	mark	18	SENT_534	[p21l400t790r633b869],
15	the	DT	O	the	det	16	SENT_534	[p21l708t790r840b868],
16	participants	NNS	O	participant	nsubj	18	SENT_534	[p21l912t791r1422b890],
17	were	VBD	O	be	aux	18	SENT_534	[p21l1493t816r1694b869],
18	receiving	VBG	O	receive	csubj	21	SENT_534	[p21l1768t791r2153b891],
19	treatment	NN	O	treatment	dobj	18	SENT_534	[p21l11t935r438b997],
20	were	VBD	O	be	cop	21	SENT_534	[p21l465t944r668b997],
21	similar	JJ	O	similar	ccomp	13	SENT_534	[p21l707t918r1015b996],
22	in	IN	O	in	_	0	SENT_534	[p21l1049t919r1132b996],
23	the	DT	O	the	det	25	SENT_534	[p21l1170t918r1303b996],
24	two	CD	NUMBER	two	num	25	SENT_534	[p21l1341t935r1500b997],
25	groups	NNS	O	group	prep_in	21	SENT_534	[p21l1538t944r1860b1019],
26	.	.	O	.	_	0	SENT_534	[p21l1538t944r1860b1019],

1	Elevations	NNS	O	elevation	nsubj	42	SENT_535	[p21l1901t918r2148b997, p21l11t1046r219b1124],
2	in	IN	O	in	_	0	SENT_535	[p21l254t1046r338b1123],
3	alanine	NN	O	alanine	nn	4	SENT_535	[p21l371t1045r685b1123],
4	aminotransferase	NN	O	aminotransferase	prep_in	1	SENT_535	[p21l719t1044r1488b1141],
5	,	,	O	,	_	0	SENT_535	[p21l719t1044r1488b1141],
6	aspartate	NN	O	aspartate	nn	7	SENT_535	[p21l1528t1062r1918b1145],
7	aminotransferase	NN	O	aminotransferase	prep_in	1	SENT_535	[p21l1952t1046r2148b1123, p21l10t1172r625b1269],
8	,	,	O	,	_	0	SENT_535	[p21l1952t1046r2148b1123, p21l10t1172r625b1269],
9	bilirubin	NN	O	bilirubin	conj_and	4	SENT_535	[p21l683t1173r1085b1269],
10	,	,	O	,	_	0	SENT_535	[p21l683t1173r1085b1269],
11	and	CC	O	and	_	0	SENT_535	[p21l1141t1173r1300b1252],
12	alkaline	NN	O	alkaline	nn	14	SENT_535	[p21l1350t1173r1697b1253],
13	phosphatase	NN	O	phosphatase	nn	14	SENT_535	[p21l1746t1173r2148b1273, p21l11t1319r180b1381],
14	levels	NNS	O	level	conj_and	4	SENT_535	[p21l237t1302r469b1382],
15	of	IN	O	of	_	0	SENT_535	[p21l531t1301r632b1382],
16	grade	NN	O	grade	prep_of	14	SENT_535	[p21l671t1302r911b1404],
17	2	CD	NUMBER	2	dep	14	SENT_535	[p21l970t1308r1041b1399],
18	,	,	O	,	_	0	SENT_535	[p21l970t1308r1041b1399],
19	3	CD	NUMBER	3	num	17	SENT_535	[p21l1106t1308r1176b1399],
20	,	,	O	,	_	0	SENT_535	[p21l1106t1308r1176b1399],
21	or	CC	O	or	_	0	SENT_535	[p21l1240t1328r1330b1382],
22	4	CD	NUMBER	4	conj_or	17	SENT_535	[p21l1383t1309r1434b1382],
23	that	WDT	O	that	nsubj	24	SENT_535	[p21l1492t1302r1666b1381],
24	developed	VBD	O	develop	rcmod	1	SENT_535	[p21l1720t1302r2150b1403],
25	While	IN	O	while	mark	29	SENT_535	[p21l6t1431r243b1510],
26	the	DT	O	the	det	27	SENT_535	[p21l292t1431r426b1510],
27	participants	NNS	O	participant	nsubj	29	SENT_535	[p21l472t1432r993b1531],
28	were	VBD	O	be	aux	29	SENT_535	[p21l1038t1457r1241b1510],
29	receiving	VBG	O	receive	csubj	31	SENT_535	[p21l1289t1432r1682b1532],
30	treatment	NN	O	treatment	dobj	29	SENT_535	[p21l1727t1448r2154b1509],
31	occurred	VBD	O	occur	ccomp	24	SENT_535	[p21l11t1559r385b1638],
32	in	IN	O	in	_	0	SENT_535	[p21l414t1560r497b1637],
33	similar	JJ	O	similar	amod	34	SENT_535	[p21l529t1559r830b1637],
34	proportions	NNS	O	proportion	prep_in	31	SENT_535	[p21l856t1560r1360b1659],
35	in	IN	O	in	_	0	SENT_535	[p21l1392t1560r1474b1637],
36	the	DT	O	the	det	38	SENT_535	[p21l1505t1559r1636b1637],
37	two	CD	NUMBER	two	num	38	SENT_535	[p21l1667t1576r1824b1638],
38	groups	NNS	O	group	prep_in	31	SENT_535	[p21l1855t1585r2147b1660],
39	(	RB	O	(	advmod	31	SENT_535	[p21l15t1686r275b1777],
40	Table	NNP	O	Table	dep	42	SENT_535	[p21l15t1686r275b1777],
41	1	CD	NUMBER	1	num	42	SENT_535	[p21l324t1692r420b1777],
42	)	CD	NUMBER	)	_	0	SENT_535	[p21l324t1692r420b1777],
43	.	.	O	.	_	0	SENT_535	[p21l324t1692r420b1777],

1	None	NN	O	none	nsubj	5	SENT_536	[p21l469t1694r698b1765],
2	of	IN	O	of	_	0	SENT_536	[p21l744t1685r845b1765],
3	the	DT	O	the	det	4	SENT_536	[p21l873t1686r1006b1764],
4	participants	NNS	O	participant	prep_of	1	SENT_536	[p21l1050t1687r1572b1786],
5	had	VBD	O	have	_	0	SENT_536	[p21l1619t1686r1777b1765],
6	concurrent	JJ	O	concurrent	amod	7	SENT_536	[p21l1822t1712r2148b1766, p21l10t1833r183b1895],
7	increases	NNS	O	increase	dobj	5	SENT_536	[p21l227t1817r625b1896],
8	in	IN	O	in	_	0	SENT_536	[p21l676t1817r760b1895],
9	alanine	NN	O	alanine	nn	10	SENT_536	[p21l808t1816r1129b1895],
10	aminotransferase	NN	O	aminotransferase	prep_in	7	SENT_536	[p21l1178t1815r1942b1896],
11	and	CC	O	and	_	0	SENT_536	[p21l1991t1816r2150b1896],
12	bilirubin	NN	O	bilirubin	nn	13	SENT_536	[p21l11t1946r391b2025],
13	levels	NNS	O	level	conj_and	10	SENT_536	[p21l430t1946r686b2025],
14	.	.	O	.	_	0	SENT_536	[p21l430t1946r686b2025],

1	VIROLOGY	NNP	O	VIROLOGY	dep	17	SENT_537	[p21l8t2220r424b2271],
2	Through	IN	O	through	_	0	SENT_537	[p21l7t2320r386b2422],
3	Week	NNP	DURATION	Week	prep_through	17	SENT_537	[p21l429t2320r654b2400],
4	48	CD	NUMBER	48	num	3	SENT_537	[p21l696t2326r823b2417],
5	,	,	O	,	_	0	SENT_537	[p21l696t2326r823b2417],
6	a	DT	O	a	det	7	SENT_537	[p21l876t2347r920b2399],
7	total	NN	O	total	nsubj	17	SENT_537	[p21l967t2320r1166b2400],
8	of	IN	O	of	_	0	SENT_537	[p21l1214t2319r1314b2400],
9	4	CD	PERCENT	4	num	10	SENT_537	[p21l1341t2325r1477b2400],
10	%	NN	PERCENT	%	prep_of	7	SENT_537	[p21l1341t2325r1477b2400],
11	of	IN	O	of	_	0	SENT_537	[p21l1524t2319r1625b2400],
12	the	DT	O	the	det	13	SENT_537	[p21l1655t2320r1788b2399],
13	participants	NNS	O	participant	prep_of	10	SENT_537	[p21l1834t2321r2148b2421, p21l9t2466r245b2550],
14	in	IN	O	in	_	0	SENT_537	[p21l279t2450r362b2527],
15	each	DT	O	each	det	16	SENT_537	[p21l395t2449r588b2528],
16	group	NN	O	group	prep_in	13	SENT_537	[p21l620t2475r873b2551],
17	met	VBD	O	meet	_	0	SENT_537	[p21l907t2466r1072b2528],
18	the	DT	O	the	det	19	SENT_537	[p21l1099t2449r1233b2528],
19	criteria	NNS	O	criterion	dobj	17	SENT_537	[p21l1266t2450r1572b2528],
20	for	IN	O	for	mark	28	SENT_537	[p21l1602t2448r1726b2529],
21	protocoldefined	VBN	O	protocoldefine	csubj	28	SENT_537	[p21l1753t2449r2148b2550, p21l11t2577r340b2658],
22	virologic	JJ	O	virologic	amod	23	SENT_537	[p21l373t2578r754b2680],
23	failure	NN	O	failure	dobj	21	SENT_537	[p21l790t2577r1070b2658],
24	and	CC	O	and	_	0	SENT_537	[p21l1107t2578r1266b2658],
25	had	VBD	O	have	conj_and	21	SENT_537	[p21l1303t2578r1461b2658],
26	resistance	NN	O	resistance	nn	27	SENT_537	[p21l1498t2579r1930b2657],
27	testing	NN	O	testing	dobj	25	SENT_537	[p21l1968t2595r2148b2657, p21l10t2708r150b2809],
28	performed	VBD	O	perform	advcl	17	SENT_537	[p21l197t2706r658b2808],
29	(	CD	NUMBER	(	num	31	SENT_537	[p21l714t2707r975b2799],
30	Table	NNP	O	Table	nn	31	SENT_537	[p21l714t2707r975b2799],
31	S7	NN	O	s7	dobj	28	SENT_537	[p21l1029t2714r1125b2787],
32	in	IN	O	in	_	0	SENT_537	[p21l1177t2708r1261b2785],
33	the	DT	O	the	det	36	SENT_537	[p21l1314t2707r1448b2786],
34	Supplementary	NNP	O	Supplementary	nn	36	SENT_537	[p21l1502t2707r2154b2808],
35	Appendix	NNP	O	Appendix	nn	36	SENT_537	[p21l6t2835r476b2935],
36	)	NN	O	)	prep_in	28	SENT_537	[p21l6t2835r476b2935],
37	.	.	O	.	_	0	SENT_537	[p21l6t2835r476b2935],

1	The	DT	O	the	det	2	SENT_538	[p21l542t2835r704b2913],
2	majority	NN	O	majority	nsubj	6	SENT_538	[p21l768t2836r1132b2935],
3	of	IN	O	of	_	0	SENT_538	[p21l1192t2834r1292b2914],
4	these	DT	O	these	det	5	SENT_538	[p21l1339t2835r1564b2913],
5	participants	NNS	O	participant	prep_of	2	SENT_538	[p21l1626t2836r2148b2935],
6	had	VBD	O	have	_	0	SENT_538	[p21l10t2963r167b3042],
7	lovv	JJ	O	lovv	amod	10	SENT_538	[p21l203t2963r582b3043],
8	—	NN	O	—	nn	10	SENT_538	[p21l203t2963r582b3043],
9	level	NN	O	level	nn	10	SENT_538	[p21l203t2963r582b3043],
10	viremia	NN	O	viremia	dobj	6	SENT_538	[p21l613t2964r965b3059],
11	,	,	O	,	_	0	SENT_538	[p21l613t2964r965b3059],
12	with	IN	O	with	_	0	SENT_538	[p21l1003t2963r1200b3043],
13	16	CD	TIME	16	prep_with	6	SENT_538	[p21l1240t2969r1334b3042],
14	of	IN	TIME	of	_	0	SENT_538	[p21l1372t2962r1473b3042],
15	18	CD	TIME	18	num	16	SENT_538	[p21l1494t2969r1589b3042],
16	participants	NNS	O	participant	prep_of	13	SENT_538	[p21l1626t2964r2147b3063],
17	who	WP	O	who	nsubj	18	SENT_538	[p21l6t3092r190b3171],
18	received	VBD	O	receive	rcmod	16	SENT_538	[p21l237t3092r585b3171],
19	dolutegravir	NN	O	dolutegravir	nn	23	SENT_538	[p21l631t3092r1158b3193],
20	and	CC	O	and	_	0	SENT_538	[p21l1201t3092r1360b3171],
21	abacavir	NN	O	abacavir	nn	23	SENT_538	[p21l1405t3092r2148b3171],
22	—	NN	O	—	nn	23	SENT_538	[p21l1405t3092r2148b3171],
23	lamivu	NN	O	lamivu	dobj	18	SENT_538	[p21l1405t3092r2148b3171],
24	—	CD	NUMBER	—	num	25	SENT_538	[p21l1405t3092r2148b3171],
25	dine	NN	O	dine	dep	23	SENT_538	[p21l11t3221r197b3301],
26	and	CC	O	and	_	0	SENT_538	[p21l227t3221r386b3301],
27	11	CD	TIME	11	conj_and	23	SENT_538	[p21l421t3228r517b3300],
28	of	IN	TIME	of	_	0	SENT_538	[p21l549t3220r650b3301],
29	17	CD	TIME	17	prep_of	27	SENT_538	[p21l666t3227r760b3301],
30	who	WP	O	who	nsubj	31	SENT_538	[p21l788t3221r972b3301],
31	received	VBD	O	receive	rcmod	27	SENT_538	[p21l1004t3221r1353b3301],
32	efavirenz	NN	O	efavirenz	nn	37	SENT_538	[p21l1384t3220r2148b3301],
33	—	NN	O	—	nn	37	SENT_538	[p21l1384t3220r2148b3301],
34	tenofo	NN	O	tenofo	nn	37	SENT_538	[p21l1384t3220r2148b3301],
35	—	CD	NUMBER	—	num	37	SENT_538	[p21l1384t3220r2148b3301],
36	vir	NN	O	vir	nn	37	SENT_538	[p21l6t3351r122b3429],
37	DF	NN	O	df	nsubj	40	SENT_538	[p21l157t3350r917b3429],
38	—	CD	NUMBER	—	num	39	SENT_538	[p21l157t3350r917b3429],
39	emtricitabine	NN	O	emtricitabine	dep	37	SENT_538	[p21l157t3350r917b3429],
40	having	VBG	O	have	dep	31	SENT_538	[p21l957t3350r1250b3451],
41	an	DT	O	a	det	44	SENT_538	[p21l1286t3376r1390b3428],
42	HIV-1	NN	O	hiv-1	nn	44	SENT_538	[p21l1428t3356r1674b3429],
43	RNA	NN	O	rna	nn	44	SENT_538	[p21l1713t3356r1924b3433],
44	level	NN	O	level	dobj	40	SENT_538	[p21l1959t3350r2150b3429],
45	of	IN	O	of	_	0	SENT_538	[p21l11t3476r111b3556],
46	less	JJR	O	less	mwe	47	SENT_538	[p21l131t3477r287b3555],
47	than	IN	O	than	quantmod	48	SENT_538	[p21l330t3477r527b3555],
48	200	CD	NUMBER	200	num	49	SENT_538	[p21l566t3483r721b3556],
49	copies	NNS	O	copy	prep_of	44	SENT_538	[p21l763t3478r1029b3577],
50	per	IN	O	per	_	0	SENT_538	[p21l1069t3503r1210b3577],
51	milliliter	NN	O	milliliter	prep_per	49	SENT_538	[p21l1246t3477r1633b3555],
52	at	IN	O	at	_	0	SENT_538	[p21l1668t3494r1747b3555],
53	the	DT	O	the	det	54	SENT_538	[p21l1782t3477r1915b3555],
54	time	NN	O	time	prep_at	40	SENT_538	[p21l1955t3478r2149b3555],
55	of	IN	O	of	_	0	SENT_538	[p21l11t3605r111b3686],
56	virologic	JJ	O	virologic	amod	57	SENT_538	[p21l141t3606r522b3708],
57	failure	NN	O	failure	prep_of	54	SENT_538	[p21l574t3605r877b3686],
58	.	.	O	.	_	0	SENT_538	[p21l574t3605r877b3686],

1	Among	IN	O	among	_	0	SENT_539	[p21l932t3614r1255b3708],
2	the	DT	O	the	det	3	SENT_539	[p21l1305t3606r1439b3685],
3	participants	NNS	O	participant	pobj	1	SENT_539	[p21l1490t3607r2011b3707],
4	in	IN	O	in	_	0	SENT_539	[p21l2065t3607r2150b3684],
5	the	DT	O	the	det	6	SENT_539	[p22l11t20r144b99],
6	DTG	NN	O	dtg	prep_in	3	SENT_539	[p22l179t26r861b99],
7	.	.	O	.	_	0	SENT_539	[p22l179t26r861b99],

1	—	NN	O	—	_	0	SENT_540	[p22l179t26r861b99],
2	.	.	O	.	_	0	SENT_540	[p22l179t26r861b99],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_541	[p22l179t26r861b99],
2	.	.	O	.	_	0	SENT_541	[p22l179t26r861b99],

1	—	NN	O	—	_	0	SENT_542	[p22l179t26r861b99],
2	.	.	O	.	_	0	SENT_542	[p22l179t26r861b99],

1	3TC	NN	O	3tc	nn	2	SENT_543	[p22l179t26r861b99],
2	group	NN	O	group	nsubjpass	14	SENT_543	[p22l899t46r1175b121],
3	,	,	O	,	_	0	SENT_543	[p22l899t46r1175b121],
4	no	DT	O	no	det	6	SENT_543	[p22l1216t46r1322b99],
5	major	JJ	O	major	amod	6	SENT_543	[p22l1359t21r1611b120],
6	NRTI	NN	ORGANIZATION	nrtus	appos	2	SENT_543	[p22l1641t26r1876b103],
7	or	CC	O	or	_	0	SENT_543	[p22l1912t46r2001b99],
8	integrase	NN	O	integrase	nn	9	SENT_543	[p22l2033t21r2148b98, p22l11t148r744b249],
9	—	NN	O	—	appos	2	SENT_543	[p22l2033t21r2148b98, p22l11t148r744b249],
10	inhibitor	NN	O	inhibitor	nn	12	SENT_543	[p22l2033t21r2148b98, p22l11t148r744b249],
11	resistance	NN	O	resistance	nn	12	SENT_543	[p22l792t149r1223b226],
12	mutations	NNS	O	mutation	dep	6	SENT_543	[p22l1275t149r1713b227],
13	were	VBD	O	be	auxpass	14	SENT_543	[p22l1762t174r1965b227],
14	detected	VBN	O	detect	_	0	SENT_543	[p22l2017t148r2148b227, p22l11t276r269b356],
15	with	IN	O	with	_	0	SENT_543	[p22l298t276r495b356],
16	the	DT	O	the	det	17	SENT_543	[p22l529t276r663b355],
17	use	NN	O	use	prep_with	14	SENT_543	[p22l697t303r838b356],
18	of	IN	O	of	_	0	SENT_543	[p22l873t275r974b356],
19	commercial	JJ	O	commercial	amod	20	SENT_543	[p22l990t276r1501b356],
20	testing	NN	O	testing	prep_of	17	SENT_543	[p22l1535t277r1854b378],
21	.	.	O	.	_	0	SENT_543	[p22l1535t277r1854b378],

1	In	IN	O	in	_	0	SENT_544	[p22l1892t284r1981b354],
2	the	DT	O	the	det	3	SENT_544	[p22l2016t276r2149b355],
3	EFV	NN	O	efv	pobj	1	SENT_544	[p22l8t411r639b484],
4	.	.	O	.	_	0	SENT_544	[p22l8t411r639b484],

1	—	NN	O	—	_	0	SENT_545	[p22l8t411r639b484],
2	.	.	O	.	_	0	SENT_545	[p22l8t411r639b484],

1	TDF	NNP	O	TDF	_	0	SENT_546	[p22l8t411r639b484],
2	.	.	O	.	_	0	SENT_546	[p22l8t411r639b484],

1	—	NN	O	—	_	0	SENT_547	[p22l8t411r639b484],
2	.	.	O	.	_	0	SENT_547	[p22l8t411r639b484],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_548	[p22l8t411r639b484],
2	group	NN	O	group	nsubj	6	SENT_548	[p22l673t431r949b506],
3	,	,	O	,	_	0	SENT_548	[p22l673t431r949b506],
4	1	CD	NUMBER	1	num	5	SENT_548	[p22l989t411r1034b483],
5	participant	NN	O	participant	appos	2	SENT_548	[p22l1064t406r1546b505],
6	had	VBD	O	have	_	0	SENT_548	[p22l1571t405r1729b484],
7	the	DT	O	the	det	10	SENT_548	[p22l1761t405r1894b483],
8	tenofovir	NN	O	tenofovir	nn	10	SENT_548	[p22l1926t422r2148b484, p22l10t533r211b614],
9	DF	NN	O	df	nn	10	SENT_548	[p22l238t534r868b614],
10	—	NN	O	—	dobj	6	SENT_548	[p22l238t534r868b614],
11	associated	VBN	O	associate	partmod	10	SENT_548	[p22l238t534r868b614],
12	resistance	NN	O	resistance	nn	14	SENT_548	[p22l899t535r1331b613],
13	mutation	NN	O	mutation	nn	14	SENT_548	[p22l1363t535r1759b614],
14	K65K/R	NN	O	k65k/r	dobj	11	SENT_548	[p22l1790t540r2144b631],
15	,	,	O	,	_	0	SENT_548	[p22l1790t540r2144b631],
16	and	CC	O	and	_	0	SENT_548	[p22l10t663r169b742],
17	4	CD	NUMBER	4	nsubj	18	SENT_548	[p22l199t669r249b742],
18	had	VBD	O	have	conj_and	6	SENT_548	[p22l282t663r439b742],
19	N	NN	O	n	nn	21	SENT_548	[p22l470t671r546b743],
20	N	NN	O	n	nn	21	SENT_548	[p22l549t671r624b742],
21	RTI	NN	ORGANIZATION	rtus	dobj	18	SENT_548	[p22l628t669r784b747],
22	resistance	NN	O	resistance	nn	23	SENT_548	[p22l816t664r1247b741],
23	mutations	NNS	O	mutation	nsubj	24	SENT_548	[p22l1280t664r1718b743],
24	(	VBP	O	(	rcmod	21	SENT_548	[p22l1757t663r2018b754],
25	Table	NNP	O	Table	nn	26	SENT_548	[p22l1757t663r2018b754],
26	S7	NNP	O	S7	dobj	24	SENT_548	[p22l2053t669r2149b742],
27	in	IN	O	in	_	0	SENT_548	[p22l10t793r93b870],
28	the	DT	O	the	det	31	SENT_548	[p22l128t792r262b870],
29	Supplementary	NNP	O	Supplementary	nn	31	SENT_548	[p22l300t792r951b892],
30	Appendix	NNP	O	Appendix	nn	31	SENT_548	[p22l978t792r1448b892],
31	)	NN	O	)	prep_in	26	SENT_548	[p22l978t792r1448b892],
32	.	.	O	.	_	0	SENT_548	[p22l978t792r1448b892],

1	DISCUSSION	NN	O	discussion	_	0	SENT_549	[p22l738t1090r1421b1150],

1	The	DT	O	the	det	2	SENT_550	[p22l7t1351r169b1430],
2	efficacy	NN	O	efficacy	nsubj	12	SENT_550	[p22l214t1350r552b1452],
3	of	IN	O	of	_	0	SENT_550	[p22l592t1350r693b1431],
4	dolutegravir	NN	O	dolutegravir	prep_of	2	SENT_550	[p22l719t1351r1246b1453],
5	plus	CC	O	plus	prep	4	SENT_550	[p22l1286t1351r1462b1452],
6	abacavir	NN	O	abacavir	nn	10	SENT_550	[p22l1508t1351r2148b1431],
7	—	CD	NUMBER	—	num	10	SENT_550	[p22l1508t1351r2148b1431],
8	lami	NN	O	lamus	nn	10	SENT_550	[p22l1508t1351r2148b1431],
9	—	NN	O	—	nn	10	SENT_550	[p22l1508t1351r2148b1431],
10	vudine	NN	O	vudine	dep	5	SENT_550	[p22l6t1478r299b1558],
11	was	VBD	O	be	cop	12	SENT_550	[p22l339t1504r503b1558],
12	superior	JJ	O	superior	_	0	SENT_550	[p22l551t1479r908b1578],
13	to	TO	O	to	_	0	SENT_550	[p22l950t1495r1032b1557],
14	that	DT	O	that	prep_to	12	SENT_550	[p22l1079t1478r1252b1556],
15	of	IN	O	of	_	0	SENT_550	[p22l1293t1477r1393b1557],
16	the	DT	O	the	det	18	SENT_550	[p22l1419t1478r1553b1556],
17	combination	NN	O	combination	nn	18	SENT_550	[p22l1599t1478r2149b1557],
18	therapy	NN	O	therapy	prep_of	14	SENT_550	[p22l11t1605r335b1705],
19	of	IN	O	of	_	0	SENT_550	[p22l366t1604r466b1684],
20	efaVirenz	NNP	O	efaVirenz	nn	22	SENT_550	[p22l483t1604r1330b1685],
21	—	CD	NUMBER	—	num	22	SENT_550	[p22l483t1604r1330b1685],
22	tenofovir	NN	O	tenofovir	prep_of	18	SENT_550	[p22l483t1604r1330b1685],
23	DF	NN	O	df	nn	25	SENT_550	[p22l1360t1605r2144b1701],
24	—	CD	NUMBER	—	num	25	SENT_550	[p22l1360t1605r2144b1701],
25	emtricitabine	NN	O	emtricitabine	tmod	12	SENT_550	[p22l1360t1605r2144b1701],
26	,	,	O	,	_	0	SENT_550	[p22l1360t1605r2144b1701],
27	which	WDT	O	which	nsubj	31	SENT_550	[p22l6t1733r270b1812],
28	is	VBZ	O	be	cop	31	SENT_550	[p22l319t1734r385b1811],
29	a	DT	O	a	det	31	SENT_550	[p22l436t1759r481b1811],
30	recommended	VBN	O	recommend	amod	31	SENT_550	[p22l528t1733r1149b1812],
31	therapy	NN	O	therapy	rcmod	25	SENT_550	[p22l1198t1733r1522b1833],
32	in	IN	O	in	_	0	SENT_550	[p22l1566t1734r1650b1811],
33	guidelines	NNS	O	guideline	prep_in	31	SENT_550	[p22l1699t1733r2147b1834],

1	N	NN	O	n	nn	3	SENT_551	[p22l541t1902r555b1917],
2	ENGLJ	NN	O	englj	nn	3	SENT_551	[p22l570t1902r648b1924],
3	MED369	NN	O	med369	_	0	SENT_551	[p22l662t1896r776b1924],
4	;	:	O	;	_	0	SENT_551	[p22l662t1896r776b1924],
5	9	CD	NUMBER	9	num	6	SENT_551	[p22l793t1902r805b1923],
6	J	NN	O	j	dep	3	SENT_551	[p22l870t1902r879b1924],
7	.	.	O	.	_	0	SENT_551	[p22l907t1914r911b1918],

1	NOVEMBER	NNP	DATE	NOVEMBER	_	0	SENT_552	[p22l1002t1902r1137b1918],
2	7	CD	DATE	7	num	1	SENT_552	[p22l1147t1902r1166b1923],
3	,	,	DATE	,	_	0	SENT_552	[p22l1147t1902r1166b1923],
4	2013	CD	DATE	2013	num	1	SENT_552	[p22l1177t1902r1233b1924],
5	1315	CD	DATE	1315	dep	1	SENT_552	[p22l1940t1892r2015b1915],

1	The	DT	O	the	det	4	SENT_553	[p22l702t1935r753b1959],
2	New	NNP	O	New	nn	4	SENT_553	[p22l762t1936r824b1959],
3	England	NNP	O	England	nn	4	SENT_553	[p22l833t1935r944b1966],
4	Journal	NNP	O	Journal	_	0	SENT_553	[p22l953t1935r1050b1959],
5	of	IN	O	of	_	0	SENT_553	[p22l1060t1935r1089b1959],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_553	[p22l1095t1935r1220b1959],

1	The	DT	O	the	det	4	SENT_554	[p22l673t2123r719b2144],
2	NEW	NNP	O	NEW	nn	4	SENT_554	[p22l737t2125r822b2144],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_554	[p22l841t2125r1030b2144],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_554	[p22l1049t2125r1228b2151],
5	of	IN	O	of	_	0	SENT_554	[p22l1248t2123r1276b2150],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_554	[p22l1288t2125r1487b2144],

1	for	IN	O	for	_	0	SENT_555	[p22l11t2345r134b2425],
2	persons	NNS	O	person	prep_for	13	SENT_555	[p22l177t2372r513b2446],
3	with	IN	O	with	_	0	SENT_555	[p22l558t2346r754b2426],
4	HIV	NN	MISC	hiv	nn	6	SENT_555	[p22l802t2354r976b2425],
5	infection	NN	O	infection	nn	6	SENT_555	[p22l1020t2345r1526b2425],
6	.1	NN	NUMBER	.1	prep_with	2	SENT_555	[p22l1020t2345r1526b2425],
7	'	''	O	'	_	0	SENT_555	[p22l1020t2345r1526b2425],
8	3	CD	NUMBER	3	dep	2	SENT_555	[p22l1020t2345r1526b2425],
9	The	DT	O	the	det	11	SENT_555	[p22l1572t2346r1733b2424],
10	superior	JJ	O	superior	amod	11	SENT_555	[p22l1782t2347r2137b2446],
11	responses	NNS	O	response	nsubjpass	13	SENT_555	[p22l11t2501r434b2574],
12	were	VBD	O	be	auxpass	13	SENT_555	[p22l476t2501r677b2554],
13	driven	VBN	O	drive	_	0	SENT_555	[p22l722t2475r987b2554],
14	primarily	RB	O	primarily	advmod	13	SENT_555	[p22l1029t2475r1436b2574],
15	by	IN	O	by	_	0	SENT_555	[p22l1474t2475r1571b2574],
16	a	DT	O	a	det	18	SENT_555	[p22l1610t2501r1655b2552],
17	lower	JJR	O	lower	amod	18	SENT_555	[p22l1695t2475r1933b2554],
18	rate	NN	O	rate	agent	13	SENT_555	[p22l1973t2492r2134b2553],
19	of	IN	O	of	_	0	SENT_555	[p22l11t2602r112b2682],
20	discontinuation	NN	O	discontinuation	prep_of	18	SENT_555	[p22l141t2603r822b2682],
21	due	JJ	O	due	_	0	SENT_555	[p22l869t2603r1018b2682],
22	to	TO	O	to	_	0	SENT_555	[p22l1066t2620r1148b2682],
23	adverse	JJ	O	adverse	amod	24	SENT_555	[p22l1195t2603r1510b2682],
24	events	NNS	O	event	prep_due_to	13	SENT_555	[p22l1558t2620r1822b2682],
25	in	IN	O	in	_	0	SENT_555	[p22l1870t2604r1953b2681],
26	the	DT	O	the	det	27	SENT_555	[p22l2001t2603r2134b2681],
27	DTG	NN	O	dtg	prep_in	24	SENT_555	[p22l10t2737r687b2810],
28	.	.	O	.	_	0	SENT_555	[p22l10t2737r687b2810],

1	—	NN	O	—	_	0	SENT_556	[p22l10t2737r687b2810],
2	.	.	O	.	_	0	SENT_556	[p22l10t2737r687b2810],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_557	[p22l10t2737r687b2810],
2	.	.	O	.	_	0	SENT_557	[p22l10t2737r687b2810],

1	—	NN	O	—	_	0	SENT_558	[p22l10t2737r687b2810],
2	.	.	O	.	_	0	SENT_558	[p22l10t2737r687b2810],

1	3TC	NN	O	3tc	nn	2	SENT_559	[p22l10t2737r687b2810],
2	group	NN	O	group	_	0	SENT_559	[p22l719t2757r971b2832],
3	than	IN	O	than	dep	2	SENT_559	[p22l1004t2731r1200b2809],
4	in	IN	O	in	_	0	SENT_559	[p22l1230t2732r1313b2809],
5	the	DT	O	the	det	6	SENT_559	[p22l1344t2731r1476b2810],
6	EFV	NN	O	efv	prep_in	3	SENT_559	[p22l1505t2737r2131b2810],
7	.	.	O	.	_	0	SENT_559	[p22l1505t2737r2131b2810],

1	—	NN	O	—	_	0	SENT_560	[p22l1505t2737r2131b2810],
2	.	.	O	.	_	0	SENT_560	[p22l1505t2737r2131b2810],

1	TDF	NNP	O	TDF	_	0	SENT_561	[p22l1505t2737r2131b2810],
2	.	.	O	.	_	0	SENT_561	[p22l1505t2737r2131b2810],

1	—	NN	O	—	_	0	SENT_562	[p22l1505t2737r2131b2810],
2	.	.	O	.	_	0	SENT_562	[p22l1505t2737r2131b2810],

1	FTC	NNP	ORGANIZATION	FTC	_	0	SENT_563	[p22l1505t2737r2131b2810],
2	group	NN	O	group	dep	1	SENT_563	[p22l11t2885r285b2960],
3	.	.	O	.	_	0	SENT_563	[p22l11t2885r285b2960],

1	The	DT	O	the	det	3	SENT_564	[p22l346t2859r507b2938],
2	treatment	NN	O	treatment	nn	3	SENT_564	[p22l567t2876r991b2938],
3	differences	NNS	O	difference	nsubj	46	SENT_564	[p22l1045t2858r1520b2938],
4	favoring	VBG	O	favor	partmod	3	SENT_564	[p22l1581t2858r1938b2960],
5	dolutegravir	NN	O	dolutegravir	dobj	4	SENT_564	[p22l1994t2859r2133b2938, p22l10t2987r426b3088],
6	plus	CC	O	plus	prep	5	SENT_564	[p22l456t2987r631b3087],
7	abacavir	NN	O	abacavir	nn	9	SENT_564	[p22l667t2987r1563b3066],
8	—	CD	NUMBER	—	num	9	SENT_564	[p22l667t2987r1563b3066],
9	lamivudine	NN	O	lamivudine	dep	6	SENT_564	[p22l667t2987r1563b3066],
10	were	VBD	O	be	cop	11	SENT_564	[p22l1593t3013r1795b3066],
11	similar	JJ	O	similar	_	0	SENT_564	[p22l1831t2987r2137b3065],
12	in	IN	O	in	_	0	SENT_564	[p22l10t3115r94b3192],
13	participants	NNS	O	participant	prep_in	11	SENT_564	[p22l140t3115r657b3214],
14	with	IN	O	with	_	0	SENT_564	[p22l702t3114r897b3194],
15	HIV-1	NN	O	hiv-1	nn	17	SENT_564	[p22l944t3120r1188b3192],
16	RNA	NN	O	rna	nn	17	SENT_564	[p22l1235t3121r1445b3198],
17	levels	NNS	O	level	prep_with	13	SENT_564	[p22l1488t3114r1718b3194],
18	of	IN	O	of	_	0	SENT_564	[p22l1769t3113r1869b3193],
19	up	RB	O	up	dep	31	SENT_564	[p22l1898t3140r2002b3214],
20	to	TO	O	to	_	0	SENT_564	[p22l2051t3131r2133b3193],
21	100,000	CD	NUMBER	100,000	num	22	SENT_564	[p22l14t3249r348b3338],
22	copies	NNS	O	copy	prep_to	19	SENT_564	[p22l398t3244r663b3342],
23	per	IN	O	per	_	0	SENT_564	[p22l713t3269r853b3342],
24	milliliter	NN	O	milliliter	prep_per	22	SENT_564	[p22l898t3243r1281b3321],
25	and	CC	O	and	_	0	SENT_564	[p22l1326t3243r1484b3321],
26	in	IN	O	in	dep	31	SENT_564	[p22l1531t3244r1614b3320],
27	those	DT	O	those	pobj	26	SENT_564	[p22l1664t3243r1895b3321],
28	with	IN	O	with	_	0	SENT_564	[p22l1939t3243r2134b3322],
29	HIV-1	NN	O	hiv-1	nn	30	SENT_564	[p22l10t3377r254b3449],
30	RNA	NN	O	rna	prep_with	27	SENT_564	[p22l294t3377r503b3454],
31	levels	NNS	O	level	prep_of	17	SENT_564	[p22l540t3371r770b3450],
32	above	IN	O	above	_	0	SENT_564	[p22l812t3371r1054b3450],
33	100,000	CD	NUMBER	100,000	num	34	SENT_564	[p22l1099t3377r1433b3466],
34	copies	NNS	O	copy	prep_above	11	SENT_564	[p22l1475t3372r1740b3470],
35	per	IN	O	per	_	0	SENT_564	[p22l1781t3397r1921b3470],
36	milliliter	NN	O	milliliter	prep_per	34	SENT_564	[p22l1958t3371r2133b3448, p22l10t3499r244b3577],
37	and	CC	O	and	_	0	SENT_564	[p22l287t3499r446b3577],
38	were	VBD	O	be	auxpass	40	SENT_564	[p22l488t3525r690b3578],
39	also	RB	O	also	advmod	40	SENT_564	[p22l737t3499r908b3577],
40	maintained	VBN	O	maintain	conj_and	11	SENT_564	[p22l957t3499r1454b3577],
41	across	IN	O	across	_	0	SENT_564	[p22l1500t3525r1766b3577],
42	key	JJ	O	key	amod	44	SENT_564	[p22l1815t3499r1960b3598],
43	demographic	JJ	O	demographic	amod	44	SENT_564	[p22l2003t3499r2133b3577, p22l11t3627r477b3728],
44	subgroups	NNS	O	subgroup	prep_across	40	SENT_564	[p22l526t3627r997b3728],
45	,	,	O	,	_	0	SENT_564	[p22l526t3627r997b3728],
46	including	VBG	O	include	conj_and	11	SENT_564	[p22l1050t3627r1460b3728],
47	subgroups	NNS	O	subgroup	pobj	46	SENT_564	[p22l1506t3627r1952b3728],
48	deﬁned	VBN	O	deﬁned	partmod	47	SENT_564	[p22l2003t3627r2132b3706, p23l11t20r236b100],

1	according	VBG	O	accord	_	0	SENT_565	[p23l291t21r718b122],
2	to	TO	O	to	pcomp	1	SENT_565	[p23l771t38r852b100],
3	race	NN	O	race	pobj	2	SENT_565	[p23l909t47r1104b117],
4	,	,	O	,	_	0	SENT_565	[p23l909t47r1104b117],
5	sex	NN	O	sex	pobj	2	SENT_565	[p23l1167t47r1323b117],
6	,	,	O	,	_	0	SENT_565	[p23l1167t47r1323b117],
7	and	CC	O	and	_	0	SENT_565	[p23l1384t21r1541b100],
8	age	NN	O	age	conj_and	3	SENT_565	[p23l1596t47r1762b122],
9	.	.	O	.	_	0	SENT_565	[p23l1596t47r1762b122],

1	Finally	RB	O	finally	advmod	16	SENT_566	[p23l1823t21r2129b121],
2	,	,	O	,	_	0	SENT_566	[p23l1823t21r2129b121],
3	statistically	RB	O	statistically	advmod	4	SENT_566	[p23l12t148r506b248],
4	superior	JJ	O	superior	amod	5	SENT_566	[p23l546t149r900b248],
5	responses	NNS	O	response	nsubjpass	16	SENT_566	[p23l941t174r1365b248],
6	in	IN	O	in	_	0	SENT_566	[p23l1410t149r1493b226],
7	favor	NN	O	favor	prep_in	5	SENT_566	[p23l1536t147r1749b228],
8	of	IN	O	of	_	0	SENT_566	[p23l1791t147r1891b227],
9	dolutegravir	NN	O	dolutegravir	prep_of	7	SENT_566	[p23l1917t148r2133b228, p23l11t278r345b378],
10	plus	CC	O	plus	prep	9	SENT_566	[p23l383t277r558b377],
11	abacavir	NN	O	abacavir	nn	13	SENT_566	[p23l602t277r1498b356],
12	—	CD	NUMBER	—	num	13	SENT_566	[p23l602t277r1498b356],
13	lamivudine	NN	O	lamivudine	dep	10	SENT_566	[p23l602t277r1498b356],
14	were	VBD	O	be	auxpass	16	SENT_566	[p23l1536t303r1738b356],
15	also	RB	O	also	advmod	16	SENT_566	[p23l1780t277r1951b356],
16	observed	VBN	O	observe	_	0	SENT_566	[p23l1995t277r2132b356, p23l12t405r283b484],
17	with	IN	O	with	_	0	SENT_566	[p23l317t405r512b484],
18	respect	NN	O	respect	prep_with	16	SENT_566	[p23l551t422r859b505],
19	to	TO	O	to	_	0	SENT_566	[p23l894t422r975b484],
20	the	DT	O	the	det	21	SENT_566	[p23l1016t405r1148b483],
21	change	NN	O	change	prep_to	16	SENT_566	[p23l1188t405r1493b506],
22	from	IN	O	from	_	0	SENT_566	[p23l1532t404r1743b484],
23	baseline	NN	O	baseline	prep_from	16	SENT_566	[p23l1781t405r2134b484],
24	in	IN	O	in	_	0	SENT_566	[p23l10t535r94b612],
25	CD4	NN	O	cd4	prep_in	23	SENT_566	[p23l128t540r374b613],
26	+	CC	O	+	_	0	SENT_566	[p23l128t540r374b613],
27	T	NN	O	t	nn	30	SENT_566	[p23l406t534r642b613],
28	—	JJ	O	—	amod	30	SENT_566	[p23l406t534r642b613],
29	cell	NN	O	cell	nn	30	SENT_566	[p23l406t534r642b613],
30	counts	NNS	O	count	conj_+	16	SENT_566	[p23l677t551r960b613],
31	at	IN	O	at	_	0	SENT_566	[p23l997t551r1075b612],
32	week	NN	DURATION	week	prep_at	30	SENT_566	[p23l1100t534r1323b613],
33	48	CD	NUMBER	48	num	32	SENT_566	[p23l1352t540r1478b613],
34	.	.	O	.	_	0	SENT_566	[p23l1352t540r1478b613],

1	The	DT	O	the	dep	199	SENT_567	[p23l136t662r297b740],
2	response	NN	O	response	dep	199	SENT_567	[p23l330t688r711b761],
3	rates	NNS	O	rate	dep	199	SENT_567	[p23l744t679r947b740],
4	at	IN	O	at	dep	199	SENT_567	[p23l981t679r1059b740],
5	week	NN	DURATION	week	dep	199	SENT_567	[p23l1083t662r1306b741],
6	48	CD	NUMBER	48	dep	199	SENT_567	[p23l1332t668r1434b740],
7	were	VBD	O	be	dep	199	SENT_567	[p23l1464t688r1667b741],
8	consistent	JJ	O	consistent	dep	199	SENT_567	[p23l1700t663r2139b740],
9	with	IN	O	with	dep	199	SENT_567	[p23l6t790r201b869],
10	rates	NNS	O	rate	dep	199	SENT_567	[p23l250t807r453b868],
11	reported	VBN	O	report	dep	199	SENT_567	[p23l503t790r869b890],
12	in	IN	O	in	dep	199	SENT_567	[p23l917t791r1000b868],
13	several	JJ	O	several	dep	199	SENT_567	[p23l1050t790r1342b869],
14	studies	NNS	O	study	dep	199	SENT_567	[p23l1391t790r1691b869],
15	involving	VBG	O	involve	dep	199	SENT_567	[p23l1740t790r2137b891],
16	participants	NNS	O	participant	dep	199	SENT_567	[p23l10t919r515b1017],
17	who	WP	O	who	dep	199	SENT_567	[p23l547t918r727b997],
18	had	VBD	O	have	dep	199	SENT_567	[p23l763t918r917b996],
19	not	RB	O	not	dep	199	SENT_567	[p23l951t935r1092b996],
20	previously	RB	DATE	previously	dep	199	SENT_567	[p23l1119t918r1549b1017],
21	received	VBN	O	receive	dep	199	SENT_567	[p23l1579t918r1917b997],
22	ART	NN	O	art	dep	199	SENT_567	[p23l1948t924r2137b1001],
23	in	IN	O	in	dep	199	SENT_567	[p23l10t1047r94b1124],
24	which	WDT	O	which	dep	199	SENT_567	[p23l127t1046r389b1125],
25	integrase	NN	O	integrase	dep	199	SENT_567	[p23l426t1046r1242b1147],
26	—	NN	O	—	dep	199	SENT_567	[p23l426t1046r1242b1147],
27	inhibitor	NN	O	inhibitor	dep	199	SENT_567	[p23l426t1046r1242b1147],
28	regimens	NNS	O	regimen	dep	199	SENT_567	[p23l1277t1047r1699b1147],
29	,	,	O	,	_	0	SENT_567	[p23l1277t1047r1699b1147],
30	efavirenz	NN	O	efavirenz	dep	199	SENT_567	[p23l1743t1045r2134b1125],
31	regimens	NNS	O	regimen	dep	199	SENT_567	[p23l11t1175r433b1275],
32	,	,	O	,	_	0	SENT_567	[p23l11t1175r433b1275],
33	or	CC	O	or	dep	199	SENT_567	[p23l503t1200r592b1253],
34	both	DT	O	both	dep	199	SENT_567	[p23l652t1174r850b1253],
35	were	VBD	O	be	dep	199	SENT_567	[p23l909t1200r1111b1253],
36	used	VBN	O	use	dep	199	SENT_567	[p23l1173t1174r1665b1270],
37	,12	CD	NUMBER	,12	dep	199	SENT_567	[p23l1173t1174r1665b1270],
38	>	JJR	O	>	dep	199	SENT_567	[p23l1173t1174r1665b1270],
39	13	CD	NUMBER	13	dep	199	SENT_567	[p23l1173t1174r1665b1270],
40	»	NN	O	»	dep	199	SENT_567	[p23l1173t1174r1665b1270],
41	24	CD	NUMBER	24	dep	199	SENT_567	[p23l1173t1174r1665b1270],
42	including	VBG	O	include	dep	199	SENT_567	[p23l1726t1174r2137b1275],
43	one	CD	NUMBER	one	dep	199	SENT_567	[p23l11t1328r162b1381],
44	study	NN	O	study	dep	199	SENT_567	[p23l205t1302r435b1402],
45	showing	VBG	O	show	dep	199	SENT_567	[p23l473t1302r840b1403],
46	that	IN	O	that	dep	199	SENT_567	[p23l878t1302r1050b1380],
47	dolutegravir	NN	O	dolutegravir	dep	199	SENT_567	[p23l1086t1302r1609b1403],
48	was	VBD	O	be	dep	199	SENT_567	[p23l1642t1328r1805b1381],
49	nonin	JJ	O	nonin	dep	199	SENT_567	[p23l1847t1303r2132b1381],
50	—	NN	O	—	dep	199	SENT_567	[p23l1847t1303r2132b1381],
51	ferior	NN	O	ferior	dep	199	SENT_567	[p23l11t1429r247b1509],
52	to	TO	O	to	dep	199	SENT_567	[p23l313t1447r395b1509],
53	raltegravir	NN	O	raltegravir	dep	199	SENT_567	[p23l464t1430r914b1531],
54	with	IN	O	with	dep	199	SENT_567	[p23l975t1430r1170b1509],
55	respect	NN	O	respect	dep	199	SENT_567	[p23l1238t1447r1547b1530],
56	to	TO	O	to	dep	199	SENT_567	[p23l1611t1447r1691b1509],
57	virologic	JJ	O	virologic	dep	199	SENT_567	[p23l1757t1430r2135b1531],
58	success	NN	O	success	dep	199	SENT_567	[p23l12t1583r327b1637],
59	(	NN	O	(	dep	199	SENT_567	[p23l369t1563r584b1648],
60	88	CD	PERCENT	88	dep	199	SENT_567	[p23l369t1563r584b1648],
61	%	NN	PERCENT	%	dep	199	SENT_567	[p23l369t1563r584b1648],
62	and	CC	O	and	dep	199	SENT_567	[p23l617t1557r775b1636],
63	85	CD	PERCENT	85	dep	199	SENT_567	[p23l811t1562r993b1636],
64	%	NN	PERCENT	%	dep	199	SENT_567	[p23l811t1562r993b1636],
65	of	IN	O	of	dep	199	SENT_567	[p23l1028t1556r1128b1636],
66	the	DT	O	the	dep	199	SENT_567	[p23l1145t1557r1278b1635],
67	participants	NNS	O	participant	dep	199	SENT_567	[p23l1312t1558r1829b1657],
68	with	IN	O	with	dep	199	SENT_567	[p23l1861t1557r2056b1637],
69	a	DT	O	a	dep	199	SENT_567	[p23l2091t1583r2135b1635],
70	response	NN	O	response	dep	199	SENT_567	[p23l11t1712r384b1785],
71	to	TO	O	to	dep	199	SENT_567	[p23l417t1703r498b1764],
72	treatment	NN	O	treatment	dep	199	SENT_567	[p23l532t1703r948b1764],
73	[	CD	NUMBER	[	dep	199	SENT_567	[p23l984t1692r1252b1776],
74	HIV-1	NN	O	hiv-1	dep	199	SENT_567	[p23l984t1692r1252b1776],
75	RNA	NN	MISC	rna	dep	199	SENT_567	[p23l1283t1692r1491b1769],
76	level	NN	O	level	dep	199	SENT_567	[p23l1519t1686r1725b1781],
77	,	,	O	,	_	0	SENT_567	[p23l1519t1686r1725b1781],
78	<	JJR	O	<	dep	199	SENT_567	[p23l1766t1692r1917b1764],
79	50	CD	NUMBER	50	dep	199	SENT_567	[p23l1766t1692r1917b1764],
80	copies	NNS	O	copy	dep	199	SENT_567	[p23l1952t1712r2132b1785, p23l10t1815r120b1892],
81	per	IN	O	per	dep	199	SENT_567	[p23l153t1840r294b1913],
82	millimeter	NN	O	millimeter	dep	199	SENT_567	[p23l325t1814r833b1909],
83	]	NN	O	]	dep	199	SENT_567	[p23l325t1814r833b1909],
84	,	,	O	,	_	0	SENT_567	[p23l325t1814r833b1909],
85	respectively	RB	O	respectively	dep	199	SENT_567	[p23l873t1814r1500b1913],
86	)	CD	NUMBER	)	dep	199	SENT_567	[p23l873t1814r1500b1913],
87	.12	CD	NUMBER	.12	dep	199	SENT_567	[p23l873t1814r1500b1913],
88	In	IN	O	in	dep	199	SENT_567	[p23l1533t1821r1622b1891],
89	the	DT	O	the	dep	199	SENT_567	[p23l1657t1814r1789b1892],
90	current	JJ	DATE	current	dep	199	SENT_567	[p23l1825t1831r2139b1893],
91	study	NN	O	study	dep	199	SENT_567	[p23l12t1941r262b2041],
92	,	,	O	,	_	0	SENT_567	[p23l12t1941r262b2041],
93	the	DT	O	the	dep	199	SENT_567	[p23l325t1941r460b2019],
94	81	CD	PERCENT	81	dep	199	SENT_567	[p23l518t1947r699b2020],
95	%	NN	PERCENT	%	dep	199	SENT_567	[p23l518t1947r699b2020],
96	response	NN	O	response	dep	199	SENT_567	[p23l756t1967r1146b2041],
97	rate	NN	O	rate	dep	199	SENT_567	[p23l1203t1958r1367b2019],
98	with	IN	O	with	dep	199	SENT_567	[p23l1420t1941r1619b2021],
99	efavirenz	NN	O	efavirenz	dep	199	SENT_567	[p23l1678t1940r2136b2021],
100	—	CD	NUMBER	—	dep	199	SENT_567	[p23l1678t1940r2136b2021],
101	tenofovir	NN	O	tenofovir	dep	199	SENT_567	[p23l11t2069r404b2149],
102	DF	NN	O	df	dep	199	SENT_567	[p23l459t2070r1214b2149],
103	—	CD	NUMBER	—	dep	199	SENT_567	[p23l459t2070r1214b2149],
104	emtricitabine	NN	O	emtricitabine	dep	199	SENT_567	[p23l459t2070r1214b2149],
105	was	VBD	O	be	dep	199	SENT_567	[p23l1269t2096r1432b2149],
106	similar	JJ	O	similar	dep	199	SENT_567	[p23l1495t2070r1801b2148],
107	to	TO	O	to	dep	199	SENT_567	[p23l1858t2087r1939b2149],
108	the	DT	O	the	dep	199	SENT_567	[p23l2001t2070r2134b2148],
109	rate	NN	O	rate	dep	199	SENT_567	[p23l11t2214r171b2276],
110	seen	VBN	O	see	dep	199	SENT_567	[p23l224t2224r412b2276],
111	in	IN	O	in	dep	199	SENT_567	[p23l463t2199r547b2275],
112	two	CD	NUMBER	two	dep	199	SENT_567	[p23l598t2214r756b2277],
113	pivotal	JJ	O	pivotal	dep	199	SENT_567	[p23l807t2198r1098b2297],
114	studies	NNS	O	study	dep	199	SENT_567	[p23l1151t2198r1451b2277],
115	that	WDT	O	that	dep	199	SENT_567	[p23l1505t2198r1677b2276],
116	used	VBD	O	use	dep	199	SENT_567	[p23l1723t2198r1921b2277],
117	this	DT	O	this	dep	199	SENT_567	[p23l1972t2198r2132b2276],
118	regimen	NN	O	regimen	dep	199	SENT_567	[p23l11t2327r367b2427],
119	as	IN	O	as	dep	199	SENT_567	[p23l420t2352r506b2404],
120	the	DT	O	the	dep	199	SENT_567	[p23l562t2326r695b2404],
121	comparator	NN	O	comparator	dep	199	SENT_567	[p23l750t2331r1442b2426],
122	.13	CD	NUMBER	.13	dep	199	SENT_567	[p23l750t2331r1442b2426],
123	>	JJR	O	>	dep	199	SENT_567	[p23l750t2331r1442b2426],
124	24	CD	NUMBER	24	dep	199	SENT_567	[p23l750t2331r1442b2426],
125	In	IN	O	in	dep	199	SENT_567	[p23l1494t2334r1583b2404],
126	the	DT	O	the	dep	199	SENT_567	[p23l1637t2326r1770b2404],
127	current	JJ	DATE	current	dep	199	SENT_567	[p23l1825t2343r2139b2405],
128	study	NN	O	study	dep	199	SENT_567	[p23l12t2454r255b2554],
129	,	,	O	,	_	0	SENT_567	[p23l12t2454r255b2554],
130	the	DT	O	the	dep	199	SENT_567	[p23l318t2454r450b2532],
131	percentage	NN	O	percentage	dep	199	SENT_567	[p23l507t2471r975b2555],
132	of	IN	O	of	dep	199	SENT_567	[p23l1034t2453r1134b2533],
133	participants	NNS	O	participant	dep	199	SENT_567	[p23l1171t2455r1687b2554],
134	receiving	VBG	O	receive	dep	199	SENT_567	[p23l1747t2455r2137b2555],
135	efavirenz	NN	O	efavirenz	dep	199	SENT_567	[p23l11t2581r851b2661],
136	—	CD	NUMBER	—	dep	199	SENT_567	[p23l11t2581r851b2661],
137	tenofovir	NN	O	tenofovir	dep	199	SENT_567	[p23l11t2581r851b2661],
138	DF	NN	O	df	dep	199	SENT_567	[p23l913t2582r1667b2661],
139	—	CD	NUMBER	—	dep	199	SENT_567	[p23l913t2582r1667b2661],
140	emtricitabine	NN	O	emtricitabine	dep	199	SENT_567	[p23l913t2582r1667b2661],
141	who	WP	O	who	dep	199	SENT_567	[p23l1728t2582r1911b2661],
142	had	VBD	O	have	dep	199	SENT_567	[p23l1977t2582r2134b2661],
143	adverse	JJ	O	adverse	dep	199	SENT_567	[p23l10t2710r325b2789],
144	events	NNS	O	event	dep	199	SENT_567	[p23l359t2727r622b2789],
145	leading	VBG	O	lead	dep	199	SENT_567	[p23l656t2710r975b2811],
146	to	TO	O	to	dep	199	SENT_567	[p23l1005t2727r1086b2789],
147	withdrawal	NN	O	withdrawal	dep	199	SENT_567	[p23l1116t2710r1606b2789],
148	(	CD	PERCENT	(	dep	199	SENT_567	[p23l1643t2715r1854b2801],
149	10	CD	PERCENT	10	dep	199	SENT_567	[p23l1643t2715r1854b2801],
150	%	NN	PERCENT	%	dep	199	SENT_567	[p23l1643t2715r1854b2801],
151	of	IN	O	of	dep	199	SENT_567	[p23l1886t2709r1986b2789],
152	the	DT	O	the	dep	199	SENT_567	[p23l2001t2710r2133b2788],
153	participants	NNS	O	participant	dep	199	SENT_567	[p23l10t2839r526b2938],
154	in	IN	O	in	dep	199	SENT_567	[p23l588t2839r672b2916],
155	the	DT	O	the	dep	199	SENT_567	[p23l733t2838r866b2917],
156	group	NN	O	group	dep	199	SENT_567	[p23l926t2845r1204b2939],
157	)	NN	O	)	dep	199	SENT_567	[p23l926t2845r1204b2939],
158	was	VBD	O	be	dep	199	SENT_567	[p23l1266t2864r1428b2917],
159	less	JJR	O	less	dep	199	SENT_567	[p23l1490t2838r1646b2916],
160	than	IN	O	than	dep	199	SENT_567	[p23l1709t2838r1905b2916],
161	that	DT	O	that	dep	199	SENT_567	[p23l1966t2838r2139b2916],
162	observed	VBN	O	observe	dep	199	SENT_567	[p23l11t2965r392b3045],
163	in	IN	O	in	dep	199	SENT_567	[p23l425t2966r509b3043],
164	a	DT	O	a	dep	199	SENT_567	[p23l543t2991r587b3043],
165	recent	JJ	O	recent	dep	199	SENT_567	[p23l620t2982r884b3043],
166	cohort	NN	O	cohort	dep	199	SENT_567	[p23l914t2965r1196b3044],
167	study	NN	O	study	dep	199	SENT_567	[p23l1226t2965r1468b3065],
168	,	,	O	,	_	0	SENT_567	[p23l1226t2965r1468b3065],
169	in	IN	O	in	dep	199	SENT_567	[p23l1508t2966r1591b3043],
170	which	WDT	O	which	dep	199	SENT_567	[p23l1621t2965r1884b3045],
171	89	CD	NUMBER	89	dep	199	SENT_567	[p23l1918t2971r2016b3044],
172	of	IN	O	of	dep	199	SENT_567	[p23l2053t2964r2153b3044],
173	472	CD	NUMBER	472	dep	199	SENT_567	[p23l9t3099r158b3172],
174	participants	NNS	O	participant	dep	199	SENT_567	[p23l210t3094r726b3193],
175	(	VBP	O	(	dep	199	SENT_567	[p23l785t3098r1021b3184],
176	19	CD	PERCENT	19	dep	199	SENT_567	[p23l785t3098r1021b3184],
177	%	NN	PERCENT	%	dep	199	SENT_567	[p23l785t3098r1021b3184],
178	)	CD	NUMBER	)	dep	199	SENT_567	[p23l785t3098r1021b3184],
179	discontinued	VBN	O	discontinue	dep	199	SENT_567	[p23l1078t3093r1637b3173],
180	efavirenz	NN	O	efavirenz	dep	199	SENT_567	[p23l1690t3092r2137b3173],
181	—	CD	NUMBER	—	dep	199	SENT_567	[p23l1690t3092r2137b3173],
182	tenofovir	NN	O	tenofovir	dep	199	SENT_567	[p23l11t3221r401b3301],
183	DF	NN	O	df	dep	199	SENT_567	[p23l439t3222r1193b3301],
184	—	CD	NUMBER	—	dep	199	SENT_567	[p23l439t3222r1193b3301],
185	emtricitabine	NN	O	emtricitabine	dep	199	SENT_567	[p23l439t3222r1193b3301],
186	during	IN	O	during	dep	199	SENT_567	[p23l1237t3222r1526b3323],
187	the	DT	DURATION	the	dep	199	SENT_567	[p23l1565t3222r1698b3300],
188	first	JJ	DURATION	first	dep	199	SENT_567	[p23l1740t3221r1924b3300],
189	year	NN	DURATION	year	dep	199	SENT_567	[p23l1957t3248r2137b3322],
190	of	IN	O	of	dep	199	SENT_567	[p23l11t3349r112b3429],
191	therapy	NN	O	therapy	dep	199	SENT_567	[p23l140t3350r474b3450],
192	,	,	O	,	_	0	SENT_567	[p23l140t3350r474b3450],
193	owing	VBG	O	owe	dep	199	SENT_567	[p23l527t3351r796b3451],
194	primarily	RB	O	primarily	dep	199	SENT_567	[p23l837t3350r1243b3450],
195	to	TO	O	to	dep	199	SENT_567	[p23l1286t3367r1366b3429],
196	neuropsychiatric	JJ	O	neuropsychiatric	dep	199	SENT_567	[p23l1414t3350r2134b3450],
197	toxic	JJ	O	toxic	dep	199	SENT_567	[p23l11t3479r217b3556],
198	events	NNS	O	event	dep	199	SENT_567	[p23l257t3483r621b3556],
199	.25	CD	NUMBER	.25	_	0	SENT_567	[p23l257t3483r621b3556],

1	In	IN	O	in	_	0	SENT_568	[p23l139t3613r227b3683],
2	this	DT	O	this	det	3	SENT_568	[p23l270t3605r429b3683],
3	HLA	NN	O	hlum	pobj	1	SENT_568	[p23l473t3605r1418b3706],
4	.	.	O	.	_	0	SENT_568	[p23l473t3605r1418b3706],

1	—	NN	O	—	_	0	SENT_569	[p23l473t3605r1418b3706],
2	.	.	O	.	_	0	SENT_569	[p23l473t3605r1418b3706],

1	B	NN	O	b	_	0	SENT_570	[p23l473t3605r1418b3706],
2	*	CD	NUMBER	*	number	3	SENT_570	[p23l473t3605r1418b3706],
3	5701	CD	NUMBER	5701	num	1	SENT_570	[p23l473t3605r1418b3706],
4	.	.	O	.	_	0	SENT_570	[p23l473t3605r1418b3706],

1	—	NN	O	—	_	0	SENT_571	[p23l473t3605r1418b3706],
2	.	.	O	.	_	0	SENT_571	[p23l473t3605r1418b3706],

1	negative	JJ	O	negative	amod	2	SENT_572	[p23l473t3605r1418b3706],
2	population	NN	O	population	nsubj	17	SENT_572	[p23l1459t3605r1953b3705],
3	,	,	O	,	_	0	SENT_572	[p23l1459t3605r1953b3705],
4	the	DT	O	the	det	6	SENT_572	[p23l2001t3605r2134b3683],
5	safety	NN	O	safety	nn	6	SENT_572	[p24l12t20r266b121],
6	proﬁle	NN	O	proﬁle	appos	2	SENT_572	[p24l294t20r582b121],
7	of	IN	O	of	_	0	SENT_572	[p24l617t20r717b100],
8	dolutegravir	NN	O	dolutegravir	prep_of	6	SENT_572	[p24l734t21r1256b122],
9	plus	CC	O	plus	prep	8	SENT_572	[p24l1286t21r1462b121],
10	abacavir	NN	O	abacavir	nn	14	SENT_572	[p24l1497t21r2133b100],
11	—	CD	NUMBER	—	num	14	SENT_572	[p24l1497t21r2133b100],
12	lami	NN	O	lamus	nn	14	SENT_572	[p24l1497t21r2133b100],
13	—	NN	O	—	nn	14	SENT_572	[p24l1497t21r2133b100],
14	vudine	NN	O	vudine	dep	9	SENT_572	[p24l6t149r303b228],
15	Was	VBD	O	be	cop	17	SENT_572	[p24l363t175r527b228],
16	generally	RB	O	generally	advmod	17	SENT_572	[p24l594t149r997b250],
17	favorable	JJ	O	favorable	_	0	SENT_572	[p24l1057t148r1477b245],
18	,	,	O	,	_	0	SENT_572	[p24l1057t148r1477b245],
19	as	IN	O	as	_	0	SENT_572	[p24l1546t175r1633b227],
20	compared	VBN	O	compare	prepc_as	17	SENT_572	[p24l1700t149r2134b249],
21	with	IN	O	with	pcomp	20	SENT_572	[p24l6t276r205b356],
22	the	DT	O	the	det	24	SENT_572	[p24l266t276r401b354],
23	safety	NN	O	safety	nn	24	SENT_572	[p24l464t275r722b376],
24	profile	NN	O	profile	pobj	21	SENT_572	[p24l777t275r1072b376],
25	of	IN	O	of	_	0	SENT_572	[p24l1133t275r1234b355],
26	efavirenz	NN	O	efavirenz	nn	29	SENT_572	[p24l1277t275r2137b356],
27	—	CD	NUMBER	—	num	29	SENT_572	[p24l1277t275r2137b356],
28	tenofovir	NN	O	tenofovir	nn	29	SENT_572	[p24l1277t275r2137b356],
29	DF	NN	O	df	prep_of	24	SENT_572	[p24l10t405r791b484],
30	—	CD	NUMBER	—	num	31	SENT_572	[p24l10t405r791b484],
31	emtricitabine	NN	O	emtricitabine	dep	29	SENT_572	[p24l10t405r791b484],
32	.	.	O	.	_	0	SENT_572	[p24l10t405r791b484],

1	Dolutegravir	NNP	O	Dolutegravir	nsubjpass	3	SENT_573	[p24l860t405r1403b506],
2	was	VBD	O	be	auxpass	3	SENT_573	[p24l1460t431r1623b484],
3	associated	VBN	O	associate	dep	7	SENT_573	[p24l1689t405r2134b484],
4	With	IN	O	with	_	0	SENT_573	[p24l6t533r201b612],
5	significantly	RB	O	significantly	advmod	6	SENT_573	[p24l240t532r784b634],
6	lower	JJR	O	lower	prep_with	3	SENT_573	[p24l815t533r1053b612],
7	reported	VBD	O	report	_	0	SENT_573	[p24l1086t533r1453b633],
8	rates	NNS	O	rate	dobj	7	SENT_573	[p24l1490t550r1692b612],
9	of	IN	O	of	_	0	SENT_573	[p24l1732t532r1832b612],
10	neuropsychiatric	JJ	O	neuropsychiatric	amod	13	SENT_573	[p24l1850t559r2133b612, p24l10t661r479b760],
11	and	CC	O	and	_	0	SENT_573	[p24l525t661r682b739],
12	rash	JJ	O	rash	conj_and	10	SENT_573	[p24l730t661r912b739],
13	events	NNS	O	event	prep_of	8	SENT_573	[p24l959t678r1223b740],
14	than	IN	O	than	mark	17	SENT_573	[p24l1273t661r1469b739],
15	have	VBP	O	have	aux	17	SENT_573	[p24l1517t661r1706b740],
16	been	VBN	O	be	auxpass	17	SENT_573	[p24l1754t661r1956b739],
17	described	VBN	O	describe	advcl	7	SENT_573	[p24l2003t661r2133b739, p24l12t788r315b867],
18	previously	RB	DATE	previously	advmod	17	SENT_573	[p24l342t788r773b888],
19	With	IN	O	with	_	0	SENT_573	[p24l793t788r985b868],
20	efavirenz	NN	O	efavirenz	prep_with	17	SENT_573	[p24l1015t787r1589b868],
21	.25	CD	NUMBER	.25	num	20	SENT_573	[p24l1015t787r1589b868],
22	»	CD	NUMBER	»	number	23	SENT_573	[p24l1015t787r1589b868],
23	26	CD	NUMBER	26	num	25	SENT_573	[p24l1015t787r1589b868],
24	No	DT	O	no	det	25	SENT_573	[p24l1617t796r1740b867],
25	episodes	NNS	O	episode	dep	20	SENT_573	[p24l1772t788r2131b888],
26	of	IN	O	of	_	0	SENT_573	[p24l11t916r112b996],
27	serious	JJ	O	serious	amod	29	SENT_573	[p24l146t918r448b996],
28	rash	NN	O	rash	nn	29	SENT_573	[p24l503t917r685b995],
29	(	NN	O	(	prep_of	25	SENT_573	[p24l741t924r936b1018],
30	e.g.	FW	O	e.g.	nsubj	7	SENT_573	[p24l741t924r936b1018],
31	,	,	O	,	_	0	SENT_573	[p24l741t924r936b1018],
32	the	DT	O	the	det	33	SENT_573	[p24l994t917r1126b995],
33	Stevens	NNP	PERSON	Stevens	appos	30	SENT_573	[p24l1181t917r1905b1008],
34	.	.	O	.	_	0	SENT_573	[p24l1181t917r1905b1008],

1	—	NN	O	—	_	0	SENT_574	[p24l1181t917r1905b1008],
2	.	.	O	.	_	0	SENT_574	[p24l1181t917r1905b1008],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_575	[p24l1181t917r1905b1008],
2	syndrome	NN	O	syndrome	nsubjpass	13	SENT_575	[p24l1959t943r2133b1017, p24l11t1045r311b1140],
3	,	,	O	,	_	0	SENT_575	[p24l1959t943r2133b1017, p24l11t1045r311b1140],
4	toxic	JJ	O	toxic	amod	6	SENT_575	[p24l350t1046r556b1123],
5	epidermal	JJ	O	epidermal	amod	6	SENT_575	[p24l589t1045r1021b1144],
6	necrolysis	NN	O	necrolysis	nsubjpass	13	SENT_575	[p24l1054t1045r1499b1144],
7	,	,	O	,	_	0	SENT_575	[p24l1054t1045r1499b1144],
8	and	CC	O	and	_	0	SENT_575	[p24l1538t1045r1695b1123],
9	erythema	NN	O	erythema	nn	11	SENT_575	[p24l1730t1045r2135b1144],
10	multiforme	JJ	O	multiforme	amod	11	SENT_575	[p24l11t1171r527b1263],
11	)	NN	O	)	nsubjpass	13	SENT_575	[p24l11t1171r527b1263],
12	were	VBD	O	be	auxpass	13	SENT_575	[p24l586t1198r788b1252],
13	reported	VBN	O	report	_	0	SENT_575	[p24l846t1172r1213b1272],
14	in	IN	O	in	_	0	SENT_575	[p24l1270t1173r1353b1250],
15	either	CC	O	either	advmod	17	SENT_575	[p24l1412t1172r1659b1250],
16	treatment	NN	O	treatment	nn	17	SENT_575	[p24l1715t1189r2139b1250],
17	group	NN	O	group	prep_in	13	SENT_575	[p24l11t1327r286b1402],
18	.	.	O	.	_	0	SENT_575	[p24l11t1327r286b1402],

1	The	DT	O	the	det	2	SENT_576	[p24l338t1301r499b1379],
2	rate	NN	O	rate	nsubj	9	SENT_576	[p24l549t1318r709b1379],
3	of	IN	O	of	_	0	SENT_576	[p24l761t1300r860b1380],
4	insomnia	NN	O	insomnia	prep_of	2	SENT_576	[p24l892t1302r1300b1380],
5	(	CD	PERCENT	(	number	6	SENT_576	[p24l1354t1306r1589b1392],
6	15	CD	PERCENT	15	num	7	SENT_576	[p24l1354t1306r1589b1392],
7	%	NN	PERCENT	%	dep	4	SENT_576	[p24l1354t1306r1589b1392],
8	)	CD	NUMBER	)	dep	7	SENT_576	[p24l1354t1306r1589b1392],
9	was	VBD	O	be	_	0	SENT_576	[p24l1641t1327r1803b1380],
10	higher	JJR	O	higher	dep	11	SENT_576	[p24l1856t1301r2137b1402],
11	than	IN	O	than	advmod	9	SENT_576	[p24l11t1429r208b1507],
12	in	IN	O	in	_	0	SENT_576	[p24l254t1430r337b1507],
13	previous	JJ	O	previous	amod	14	SENT_576	[p24l383t1430r744b1529],
14	studies	NNS	O	study	prep_in	9	SENT_576	[p24l795t1429r1095b1508],
15	of	IN	O	of	_	0	SENT_576	[p24l1144t1428r1245b1508],
16	dolutegravir	FW	O	dolutegravir	nn	17	SENT_576	[p24l1273t1429r1797b1530],
17	(	FW	O	(	prep_of	14	SENT_576	[p24l1845t1434r2006b1520],
18	5	CD	PERCENT	5	num	19	SENT_576	[p24l1845t1434r2006b1520],
19	%	NN	PERCENT	%	dep	32	SENT_576	[p24l1845t1434r2006b1520],
20	of	IN	O	of	_	0	SENT_576	[p24l2053t1428r2153b1508],
21	the	DT	O	the	det	22	SENT_576	[p24l12t1557r146b1635],
22	participants	NNS	O	participant	prep_of	19	SENT_576	[p24l196t1558r716b1657],
23	in	IN	O	in	_	0	SENT_576	[p24l769t1558r852b1635],
24	two	CD	NUMBER	two	num	26	SENT_576	[p24l904t1574r1062b1637],
25	other	JJ	O	other	amod	26	SENT_576	[p24l1116t1557r1344b1636],
26	phase	NN	O	phase	prep_in	22	SENT_576	[p24l1391t1557r1642b1657],
27	3	CD	NUMBER	3	num	28	SENT_576	[p24l1693t1563r1738b1636],
28	trials9	NN	O	trials9	dep	32	SENT_576	[p24l1792t1557r2148b1635],
29	’12	CD	NUMBER	’12	num	32	SENT_576	[p24l1792t1557r2148b1635],
30	and	CC	O	and	_	0	SENT_576	[p24l11t1685r170b1764],
31	2	CD	PERCENT	2	num	32	SENT_576	[p24l208t1690r343b1764],
32	%	NN	PERCENT	%	dep	14	SENT_576	[p24l208t1690r343b1764],
33	of	IN	O	of	_	0	SENT_576	[p24l382t1684r482b1764],
34	those	DT	O	those	prep_of	32	SENT_576	[p24l503t1685r735b1764],
35	in	IN	O	in	_	0	SENT_576	[p24l773t1686r857b1763],
36	a	DT	O	a	det	40	SENT_576	[p24l895t1711r939b1763],
37	phase	NN	O	phase	nn	40	SENT_576	[p24l974t1685r1225b1785],
38	2b	JJ	O	2b	amod	40	SENT_576	[p24l1263t1685r1365b1764],
39	trial7v23	NN	O	trial7v23	nn	40	SENT_576	[p24l1405t1685r1761b1776],
40	)	NN	O	)	prep_in	34	SENT_576	[p24l1405t1685r1761b1776],
41	.	.	O	.	_	0	SENT_576	[p24l1405t1685r1761b1776],

1	SINGLE	NN	O	single	nsubj	6	SENT_577	[p24l1807t1691r2145b1764],
2	was	VBD	O	be	cop	6	SENT_577	[p24l7t1840r171b1894],
3	the	DT	O	the	det	6	SENT_577	[p24l224t1814r358b1893],
4	only	JJ	O	only	amod	6	SENT_577	[p24l408t1814r594b1915],
5	randomized	JJ	O	randomized	amod	6	SENT_577	[p24l639t1814r1164b1894],
6	study	NN	O	study	_	0	SENT_577	[p24l1215t1814r1446b1915],
7	of	IN	O	of	_	0	SENT_577	[p24l1492t1813r1593b1894],
8	dolutegravir	NN	O	dolutegravir	prep_of	6	SENT_577	[p24l1625t1814r2151b1916],
9	that	WDT	O	that	nsubj	10	SENT_577	[p24l12t1943r186b2021],
10	included	VBD	O	include	rcmod	6	SENT_577	[p24l213t1943r582b2022],
11	a	DT	O	a	det	13	SENT_577	[p24l613t1969r658b2021],
12	targeted	VBN	O	target	amod	13	SENT_577	[p24l690t1943r1047b2044],
13	questionnaire	NN	O	questionnaire	dobj	10	SENT_577	[p24l1081t1944r1700b2043],
14	,	,	O	,	_	0	SENT_577	[p24l1081t1944r1700b2043],
15	including	VBG	O	include	_	0	SENT_577	[p24l1739t1943r2152b2044],
16	specific	JJ	O	specific	amod	17	SENT_577	[p24l13t2069r345b2170],
17	questions	NNS	O	question	prep_including	6	SENT_577	[p24l377t2071r790b2170],
18	on	IN	O	on	_	0	SENT_577	[p24l825t2096r931b2149],
19	insomnia	NN	O	insomnia	prep_on	17	SENT_577	[p24l962t2071r1396b2149],
20	.	.	O	.	_	0	SENT_577	[p24l962t2071r1396b2149],

1	Insomnia	NNP	O	Insomnia	nn	2	SENT_578	[p24l1432t2071r1849b2149],
2	events	NNS	O	event	nsubj	5	SENT_578	[p24l1880t2087r2145b2150],
3	were	VBD	O	be	cop	5	SENT_578	[p24l7t2225r210b2278],
4	generally	RB	O	generally	advmod	5	SENT_578	[p24l259t2199r656b2300],
5	mild	JJ	O	mild	_	0	SENT_578	[p24l700t2199r899b2278],
6	and	CC	O	and	_	0	SENT_578	[p24l948t2199r1107b2278],
7	led	VBD	O	lead	conj_and	5	SENT_578	[p24l1154t2199r1281b2278],
8	to	TO	O	to	_	0	SENT_578	[p24l1330t2216r1412b2278],
9	discontinuation	NN	O	discontinuation	prep_to	7	SENT_578	[p24l1463t2199r2148b2278],
10	of	IN	O	of	_	0	SENT_578	[p24l12t2326r113b2407],
11	the	DT	O	the	det	13	SENT_578	[p24l137t2327r271b2406],
12	study	NN	O	study	nn	13	SENT_578	[p24l315t2327r546b2428],
13	drug	NN	O	drug	prep_of	9	SENT_578	[p24l585t2327r790b2429],
14	in	IN	O	in	_	0	SENT_578	[p24l827t2328r912b2405],
15	only	RB	O	only	advmod	17	SENT_578	[p24l955t2327r1139b2428],
16	one	CD	NUMBER	one	num	17	SENT_578	[p24l1178t2353r1330b2407],
17	participant	NN	O	participant	prep_in	7	SENT_578	[p24l1371t2328r1852b2428],
18	in	IN	O	in	_	0	SENT_578	[p24l1888t2328r1972b2405],
19	the	DT	O	the	det	20	SENT_578	[p24l2014t2327r2148b2406],
20	DTG	NN	O	dtg	prep_in	17	SENT_578	[p24l11t2463r693b2536],
21	.	.	O	.	_	0	SENT_578	[p24l11t2463r693b2536],

1	—	NN	O	—	_	0	SENT_579	[p24l11t2463r693b2536],
2	.	.	O	.	_	0	SENT_579	[p24l11t2463r693b2536],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_580	[p24l11t2463r693b2536],
2	.	.	O	.	_	0	SENT_580	[p24l11t2463r693b2536],

1	—	NN	O	—	_	0	SENT_581	[p24l11t2463r693b2536],
2	.	.	O	.	_	0	SENT_581	[p24l11t2463r693b2536],

1	3TC	NN	O	3tc	_	0	SENT_582	[p24l11t2463r693b2536],
2	group	NN	O	group	dep	1	SENT_582	[p24l734t2482r1011b2558],
3	.	.	O	.	_	0	SENT_582	[p24l734t2482r1011b2558],

1	Mild	JJ	O	mild	dep	130	SENT_583	[p24l139t2585r363b2681],
2	,	,	O	,	_	0	SENT_583	[p24l139t2585r363b2681],
3	nonprogressive	JJ	O	nonprogressive	dep	130	SENT_583	[p24l415t2586r1074b2686],
4	increases	NNS	O	increase	dep	130	SENT_583	[p24l1120t2586r1517b2664],
5	in	IN	O	in	dep	130	SENT_583	[p24l1565t2586r1649b2663],
6	the	DT	O	the	dep	130	SENT_583	[p24l1696t2585r1830b2663],
7	serum	NN	O	serum	dep	130	SENT_583	[p24l1878t2611r2148b2664],
8	creatinine	NN	O	creatinine	dep	130	SENT_583	[p24l12t2714r446b2791],
9	level	NN	O	level	dep	130	SENT_583	[p24l482t2713r673b2792],
10	were	VBD	O	be	dep	130	SENT_583	[p24l705t2739r908b2792],
11	observed	VBN	O	observe	dep	130	SENT_583	[p24l947t2713r1330b2792],
12	with	IN	O	with	dep	130	SENT_583	[p24l1363t2713r1560b2792],
13	dolutegravir	NN	O	dolutegravir	dep	130	SENT_583	[p24l1598t2713r2142b2814],
14	,	,	O	,	_	0	SENT_583	[p24l1598t2713r2142b2814],
15	as	IN	O	as	dep	130	SENT_583	[p24l11t2867r97b2919],
16	have	VBP	O	have	dep	130	SENT_583	[p24l135t2841r325b2920],
17	been	VBN	O	be	dep	130	SENT_583	[p24l362t2841r564b2920],
18	described	VBN	O	describe	dep	130	SENT_583	[p24l600t2841r1014b2920],
19	in	IN	O	in	dep	130	SENT_583	[p24l1048t2842r1132b2919],
20	previous	JJ	O	previous	dep	130	SENT_583	[p24l1166t2842r1530b2941],
21	phase	NN	O	phase	dep	130	SENT_583	[p24l1566t2841r1817b2941],
22	2b	NN	O	2b	dep	130	SENT_583	[p24l1852t2841r1953b2920],
23	and	CC	O	and	dep	130	SENT_583	[p24l1990t2841r2148b2920],
24	3	CD	NUMBER	3	dep	130	SENT_583	[p24l13t2976r57b3049],
25	studies	NNS	O	study	dep	130	SENT_583	[p24l102t2970r707b3049],
26	.7	CD	NUMBER	.7	dep	130	SENT_583	[p24l102t2970r707b3049],
27	’	CD	NUMBER	’	dep	130	SENT_583	[p24l102t2970r707b3049],
28	9	CD	NUMBER	9	dep	130	SENT_583	[p24l102t2970r707b3049],
29	»	NN	O	»	dep	130	SENT_583	[p24l102t2970r707b3049],
30	12	CD	NUMBER	12	dep	130	SENT_583	[p24l102t2970r707b3049],
31	’23	CD	NUMBER	’23	dep	130	SENT_583	[p24l102t2970r707b3049],
32	In	FW	O	in	dep	130	SENT_583	[p24l747t2978r837b3048],
33	vitro	FW	O	vitro	dep	130	SENT_583	[p24l873t2971r1072b3049],
34	work	NN	O	work	dep	130	SENT_583	[p24l1109t2970r1331b3049],
35	has	VBZ	O	have	dep	130	SENT_583	[p24l1367t2970r1512b3048],
36	identified	VBN	O	identify	dep	130	SENT_583	[p24l1554t2969r1974b3049],
37	the	DT	O	the	dep	130	SENT_583	[p24l2014t2970r2148b3048],
38	likely	JJ	O	likely	dep	130	SENT_583	[p24l11t3097r245b3197],
39	mechanism	NN	O	mechanism	dep	130	SENT_583	[p24l287t3097r791b3175],
40	as	IN	O	as	dep	130	SENT_583	[p24l838t3123r924b3175],
41	the	DT	O	the	dep	130	SENT_583	[p24l973t3097r1107b3175],
42	blockade	NN	O	blockade	dep	130	SENT_583	[p24l1155t3097r1537b3177],
43	of	IN	O	of	dep	130	SENT_583	[p24l1585t3096r1685b3176],
44	creatinine	NN	O	creatinine	dep	130	SENT_583	[p24l1714t3098r2148b3175],
45	secretion	NN	O	secretion	dep	130	SENT_583	[p24l13t3226r404b3304],
46	by	IN	O	by	dep	130	SENT_583	[p24l465t3225r563b3325],
47	means	NNS	O	means	dep	130	SENT_583	[p24l618t3251r899b3303],
48	of	IN	O	of	dep	130	SENT_583	[p24l961t3224r1062b3304],
49	inhibition	NN	O	inhibition	dep	130	SENT_583	[p24l1103t3225r1534b3304],
50	of	IN	O	of	dep	130	SENT_583	[p24l1595t3224r1695b3304],
51	the	DT	O	the	dep	130	SENT_583	[p24l1736t3225r1870b3303],
52	renal	JJ	O	renal	dep	130	SENT_583	[p24l1930t3225r2148b3303],
53	transporter	NN	O	transporter	dep	130	SENT_583	[p24l12t3371r496b3454],
54	organic	JJ	O	organic	dep	130	SENT_583	[p24l531t3355r851b3455],
55	cation	NN	O	cation	dep	130	SENT_583	[p24l888t3355r1148b3433],
56	transporter	NN	O	transporter	dep	130	SENT_583	[p24l1186t3371r1668b3454],
57	2	CD	NUMBER	2	dep	130	SENT_583	[p24l1702t3360r1773b3450],
58	,	,	O	,	_	0	SENT_583	[p24l1702t3360r1773b3450],
59	with	IN	O	with	dep	130	SENT_583	[p24l1811t3354r2005b3433],
60	no	DT	O	no	dep	130	SENT_583	[p24l2042t3380r2147b3433],
61	effect	NN	O	effect	dep	130	SENT_583	[p24l12t3481r256b3561],
62	on	IN	O	on	dep	130	SENT_583	[p24l291t3508r397b3562],
63	the	DT	O	the	dep	130	SENT_583	[p24l437t3482r570b3561],
64	actual	JJ	O	actual	dep	130	SENT_583	[p24l608t3482r869b3562],
65	glomerular	JJ	O	glomerular	dep	130	SENT_583	[p24l908t3482r1394b3584],
66	filtration	NN	O	filtration	dep	130	SENT_583	[p24l1430t3481r1822b3562],
67	rate	NN	O	rate	dep	130	SENT_583	[p24l1861t3499r2022b3561],
68	as	IN	O	as	dep	130	SENT_583	[p24l2060t3509r2146b3561],
69	measured	VBN	O	measure	dep	130	SENT_583	[p24l12t3610r425b3690],
70	by	IN	O	by	dep	130	SENT_583	[p24l462t3610r559b3710],
71	the	DT	O	the	dep	130	SENT_583	[p24l591t3610r723b3688],
72	clearance	NN	O	clearance	dep	130	SENT_583	[p24l760t3610r1156b3688],
73	of	IN	O	of	dep	130	SENT_583	[p24l1194t3609r1294b3689],
74	lOl1	NN	O	lol1	dep	130	SENT_583	[p24l1311t3610r1715b3689],
75	€	CD	NUMBER	€	dep	130	SENT_583	[p24l1311t3610r1715b3689],
76	XOl	NNP	O	XOl	dep	130	SENT_583	[p24l1311t3610r1715b3689],
77	.27	CD	NUMBER	.27	dep	130	SENT_583	[p24l1311t3610r1715b3689],
78	A	DT	O	a	dep	130	SENT_583	[p24l1748t3618r1814b3688],
79	similar	JJ	O	similar	dep	130	SENT_583	[p24l1849t3610r2151b3688],
80	effect	NN	O	effect	dep	130	SENT_583	[p25l12t20r256b99],
81	has	VBZ	O	have	dep	130	SENT_583	[p25l300t21r445b99],
82	been	VBN	O	be	dep	130	SENT_583	[p25l497t21r699b100],
83	reported	VBN	O	report	dep	130	SENT_583	[p25l749t21r1117b121],
84	with	IN	O	with	dep	130	SENT_583	[p25l1162t21r1358b101],
85	use	NN	O	use	dep	130	SENT_583	[p25l1408t47r1548b101],
86	of	IN	O	of	dep	130	SENT_583	[p25l1599t20r1699b100],
87	trimetho	NN	O	trimetho	dep	130	SENT_583	[p25l1731t21r2147b100],
88	—	CD	NUMBER	—	dep	130	SENT_583	[p25l1731t21r2147b100],
89	prim	JJ	O	prim	dep	130	SENT_583	[p25l11t151r323b250],
90	,28	CD	NUMBER	,28	dep	130	SENT_583	[p25l11t151r323b250],
91	cobicistat	NN	O	cobicistat	dep	130	SENT_583	[p25l373t150r1072b246],
92	,13	CD	NUMBER	,13	dep	130	SENT_583	[p25l373t150r1072b246],
93	’	CD	NUMBER	’	dep	130	SENT_583	[p25l373t150r1072b246],
94	27	CD	NUMBER	27	dep	130	SENT_583	[p25l373t150r1072b246],
95	’29	CD	NUMBER	’29	dep	130	SENT_583	[p25l373t150r1072b246],
96	and	CC	O	and	dep	130	SENT_583	[p25l1120t150r1278b229],
97	the	DT	O	the	dep	130	SENT_583	[p25l1327t150r1460b229],
98	NNRTI	NNP	O	NNRTI	dep	130	SENT_583	[p25l1506t156r1820b234],
99	rilpivi	NN	O	rilpivus	dep	130	SENT_583	[p25l1867t150r2147b250],
100	—	CD	NUMBER	—	dep	130	SENT_583	[p25l1867t150r2147b250],
101	rine	NN	O	rine	dep	130	SENT_583	[p25l12t280r368b359],
102	.3	NN	NUMBER	.3	dep	130	SENT_583	[p25l12t280r368b359],
103	°	CD	NUMBER	°	dep	130	SENT_583	[p25l12t280r368b359],
104	»	CD	NUMBER	»	dep	130	SENT_583	[p25l12t280r368b359],
105	31	CD	NUMBER	31	dep	130	SENT_583	[p25l12t280r368b359],
106	The	DT	O	the	dep	130	SENT_583	[p25l406t279r565b358],
107	effect	NN	O	effect	dep	130	SENT_583	[p25l608t278r846b358],
108	of	IN	O	of	dep	130	SENT_583	[p25l882t278r981b359],
109	dolutegravir	NN	O	dolutegravir	dep	130	SENT_583	[p25l1004t279r1519b381],
110	on	IN	O	on	dep	130	SENT_583	[p25l1557t305r1663b359],
111	the	DT	O	the	dep	130	SENT_583	[p25l1704t279r1835b358],
112	serum	NN	O	serum	dep	130	SENT_583	[p25l1878t305r2148b359],
113	creatinine	NN	O	creatinine	dep	130	SENT_583	[p25l12t409r446b486],
114	level	NN	O	level	dep	130	SENT_583	[p25l479t408r669b487],
115	occurs	VBZ	O	occur	dep	130	SENT_583	[p25l703t434r984b487],
116	early	JJ	O	early	dep	130	SENT_583	[p25l1021t408r1227b508],
117	and	CC	O	and	dep	130	SENT_583	[p25l1256t408r1415b487],
118	plateaus	NN	O	plateau	dep	130	SENT_583	[p25l1447t408r1803b508],
119	quickly	RB	O	quickly	dep	130	SENT_583	[p25l1839t408r2153b508],
120	(	VBD	O	(	dep	130	SENT_583	[p25l17t536r325b627],
121	Within	IN	O	within	dep	130	SENT_583	[p25l17t536r325b627],
122	approximately	RB	O	approximately	dep	130	SENT_583	[p25l376t536r996b636],
123	2	CD	DURATION	2	dep	130	SENT_583	[p25l1043t542r1090b614],
124	Weeks	NNS	DURATION	week	dep	130	SENT_583	[p25l1138t536r1400b616],
125	after	IN	O	after	dep	130	SENT_583	[p25l1453t535r1656b614],
126	the	DT	O	the	dep	130	SENT_583	[p25l1705t536r1838b614],
127	initiation	NN	O	initiation	dep	130	SENT_583	[p25l1888t537r2147b614, p25l12t666r183b745],
128	of	IN	O	of	dep	130	SENT_583	[p25l224t664r324b745],
129	therapy	NN	O	therapy	dep	130	SENT_583	[p25l346t665r717b766],
130	)	NN	O	)	_	0	SENT_583	[p25l346t665r717b766],
131	.	.	O	.	_	0	SENT_583	[p25l346t665r717b766],

1	Given	VBN	O	give	prep	17	SENT_584	[p25l763t666r1008b745],
2	the	DT	O	the	det	3	SENT_584	[p25l1048t665r1182b744],
3	effect	NN	O	effect	dep	1	SENT_584	[p25l1223t664r1466b744],
4	of	IN	O	of	_	0	SENT_584	[p25l1502t664r1603b745],
5	dolutegravir	NN	O	dolutegravir	prep_of	3	SENT_584	[p25l1625t665r2151b767],
6	on	IN	O	on	_	0	SENT_584	[p25l12t820r119b873],
7	creatinine	NN	O	creatinine	nn	8	SENT_584	[p25l168t795r602b873],
8	secretion	NN	O	secretion	prep_on	5	SENT_584	[p25l651t795r1065b890],
9	,	,	O	,	_	0	SENT_584	[p25l651t795r1065b890],
10	a	DT	O	a	det	12	SENT_584	[p25l1118t820r1163b872],
11	small	JJ	O	small	amod	12	SENT_584	[p25l1211t794r1447b872],
12	increase	NN	O	increase	nsubjpass	17	SENT_584	[p25l1494t795r1848b872],
13	in	IN	O	in	_	0	SENT_584	[p25l1896t795r1979b872],
14	serum	NN	O	serum	nn	15	SENT_584	[p25l2029t820r2147b873, p25l12t949r190b1002],
15	creatinine	NN	O	creatinine	prep_in	12	SENT_584	[p25l221t924r641b1001],
16	is	VBZ	O	be	auxpass	17	SENT_584	[p25l672t924r737b1001],
17	anticipated	VBN	O	anticipate	_	0	SENT_584	[p25l769t923r1233b1023],
18	when	WRB	O	when	advmod	24	SENT_584	[p25l1259t923r1490b1002],
19	treatment	NN	O	treatment	nsubjpass	24	SENT_584	[p25l1521t940r1935b1001],
20	with	IN	O	with	_	0	SENT_584	[p25l1957t923r2148b1002],
21	the	DT	O	the	det	22	SENT_584	[p25l12t1052r146b1130],
22	drug	NN	O	drug	prep_with	19	SENT_584	[p25l202t1052r407b1153],
23	is	VBZ	O	be	auxpass	24	SENT_584	[p25l459t1053r525b1130],
24	initiated	VBN	O	initiate	advcl	17	SENT_584	[p25l582t1052r968b1148],
25	;	:	O	;	_	0	SENT_584	[p25l582t1052r968b1148],
26	this	DT	O	this	det	27	SENT_584	[p25l1028t1052r1189b1130],
27	change	NN	O	change	nsubj	31	SENT_584	[p25l1247t1052r1553b1153],
28	is	VBZ	O	be	cop	31	SENT_584	[p25l1609t1053r1674b1130],
29	not	RB	O	not	neg	31	SENT_584	[p25l1732t1069r1875b1131],
30	clini	JJ	O	clini	amod	31	SENT_584	[p25l1926t1052r2147b1130],
31	—	NN	O	—	parataxis	17	SENT_584	[p25l1926t1052r2147b1130],
32	cally	RB	O	cally	advmod	33	SENT_584	[p25l12t1180r212b1281],
33	meaningful	JJ	O	meaningful	amod	31	SENT_584	[p25l274t1179r806b1282],
34	,	,	O	,	_	0	SENT_584	[p25l274t1179r806b1282],
35	because	IN	O	because	mark	39	SENT_584	[p25l878t1180r1217b1260],
36	it	PRP	O	it	nsubj	39	SENT_584	[p25l1283t1181r1343b1259],
37	does	VBZ	O	do	aux	39	SENT_584	[p25l1405t1180r1599b1260],
38	not	RB	O	not	neg	39	SENT_584	[p25l1667t1197r1812b1260],
39	reflect	VB	O	reflect	advcl	31	SENT_584	[p25l1872t1179r2153b1259],
40	changes	NNS	O	change	dobj	39	SENT_584	[p25l12t1309r363b1411],
41	in	IN	O	in	_	0	SENT_584	[p25l404t1310r488b1387],
42	the	DT	O	the	det	46	SENT_584	[p25l529t1309r663b1388],
43	actual	JJ	O	actual	amod	46	SENT_584	[p25l702t1309r963b1389],
44	glomerular	JJ	O	glomerular	amod	46	SENT_584	[p25l1003t1309r1490b1411],
45	filtration	NN	O	filtration	nn	46	SENT_584	[p25l1527t1308r1918b1389],
46	rate	NN	O	rate	prep_in	39	SENT_584	[p25l1958t1326r2143b1389],
47	.	.	O	.	_	0	SENT_584	[p25l1958t1326r2143b1389],

1	Progressive	JJ	O	progressive	amod	2	SENT_585	[p25l11t1439r502b1539],
2	changes	NNS	O	change	nsubj	22	SENT_585	[p25l549t1438r899b1539],
3	in	IN	O	in	_	0	SENT_585	[p25l947t1439r1030b1516],
4	the	DT	O	the	det	6	SENT_585	[p25l1077t1438r1210b1516],
5	creatinine	NN	O	creatinine	nn	6	SENT_585	[p25l1257t1439r1691b1517],
6	level	NN	O	level	prep_in	2	SENT_585	[p25l1736t1438r1926b1517],
7	over	IN	O	over	_	0	SENT_585	[p25l1972t1464r2151b1517],
8	time	NN	O	time	prep_over	6	SENT_585	[p25l12t1567r206b1645],
9	(	CD	NUMBER	(	num	8	SENT_585	[p25l279t1573r394b1658],
10	or	CC	O	or	_	0	SENT_585	[p25l279t1573r394b1658],
11	changes	NNS	O	change	prep_in	2	SENT_585	[p25l460t1566r809b1668],
12	that	WDT	O	that	nsubj	13	SENT_585	[p25l880t1566r1054b1645],
13	emerge	VBP	O	emerge	rcmod	11	SENT_585	[p25l1117t1592r1431b1668],
14	after	IN	O	after	_	0	SENT_585	[p25l1498t1565r1701b1645],
15	the	DT	DURATION	the	det	17	SENT_585	[p25l1766t1566r1900b1645],
16	first	JJ	DURATION	first	amod	17	SENT_585	[p25l1968t1565r2153b1645],
17	month	NN	DURATION	month	prep_after	13	SENT_585	[p25l12t1694r299b1773],
18	of	IN	O	of	_	0	SENT_585	[p25l361t1693r461b1773],
19	therapy	NN	O	therapy	nn	20	SENT_585	[p25l504t1694r850b1794],
20	)	NN	O	)	prep_of	17	SENT_585	[p25l504t1694r850b1794],
21	are	VBP	O	be	cop	22	SENT_585	[p25l917t1720r1046b1772],
22	likely	JJ	O	likely	_	0	SENT_585	[p25l1106t1694r1340b1794],
23	to	TO	O	to	aux	25	SENT_585	[p25l1397t1711r1479b1773],
24	be	VB	O	be	auxpass	25	SENT_585	[p25l1543t1694r1639b1773],
25	associated	VBN	O	associate	xcomp	22	SENT_585	[p25l1700t1694r2148b1773],
26	with	IN	O	with	_	0	SENT_585	[p25l7t1823r204b1902],
27	other	JJ	O	other	amod	28	SENT_585	[p25l238t1823r467b1902],
28	causes	NNS	O	cause	prep_with	25	SENT_585	[p25l497t1849r774b1902],
29	that	WDT	O	that	nsubj	30	SENT_585	[p25l810t1823r983b1901],
30	require	VBP	O	require	rcmod	28	SENT_585	[p25l1011t1824r1318b1923],
31	investigation	NN	O	investigation	dobj	30	SENT_585	[p25l1351t1824r1909b1924],
32	(	CD	NUMBER	(	num	31	SENT_585	[p25l1947t1829r2142b1924],
33	e.g.	FW	O	e.g.	dep	31	SENT_585	[p25l1947t1829r2142b1924],
34	,	,	O	,	_	0	SENT_585	[p25l1947t1829r2142b1924],
35	nephrotoxic	JJ	O	nephrotoxic	amod	36	SENT_585	[p25l12t1951r532b2051],
36	drugs	NNS	O	drug	dobj	30	SENT_585	[p25l571t1951r841b2052],
37	,	,	O	,	_	0	SENT_585	[p25l571t1951r841b2052],
38	HIV	NN	O	hiv	nn	39	SENT_585	[p25l886t1951r1539b2030],
39	—	NN	O	—	appos	36	SENT_585	[p25l886t1951r1539b2030],
40	associated	VBN	O	associate	partmod	39	SENT_585	[p25l886t1951r1539b2030],
41	nephropathy	NN	O	nephropathy	dobj	40	SENT_585	[p25l1578t1951r2143b2051],
42	,	,	O	,	_	0	SENT_585	[p25l1578t1951r2143b2051],
43	or	CC	O	or	_	0	SENT_585	[p25l12t2105r102b2158],
44	obstruction	NN	O	obstruction	nn	45	SENT_585	[p25l139t2079r691b2170],
45	)	NN	O	)	dobj	30	SENT_585	[p25l139t2079r691b2170],
46	.	.	O	.	_	0	SENT_585	[p25l139t2079r691b2170],

1	Resistance	NN	O	resistance	nsubj	4	SENT_586	[p25l140t2209r601b2291],
2	did	VBD	O	do	aux	4	SENT_586	[p25l649t2208r785b2287],
3	not	RB	O	not	neg	4	SENT_586	[p25l831t2225r975b2287],
4	develop	VB	O	develop	_	0	SENT_586	[p25l1018t2208r1343b2308],
5	during	IN	O	during	_	0	SENT_586	[p25l1392t2208r1682b2309],
6	treatment	NN	O	treatment	prep_during	4	SENT_586	[p25l1727t2225r2153b2286],
7	to	TO	O	to	_	0	SENT_586	[p25l12t2353r94b2416],
8	any	DT	O	any	prep_to	4	SENT_586	[p25l134t2362r285b2437],
9	of	IN	O	of	_	0	SENT_586	[p25l321t2335r421b2416],
10	the	DT	O	the	det	12	SENT_586	[p25l443t2336r576b2415],
11	regimen	NN	O	regimen	nn	12	SENT_586	[p25l615t2337r974b2438],
12	components	NNS	O	component	prep_of	8	SENT_586	[p25l1014t2353r1543b2437],
13	in	IN	O	in	_	0	SENT_586	[p25l1584t2337r1668b2414],
14	any	DT	O	any	prep_in	12	SENT_586	[p25l1706t2362r1857b2437],
15	of	IN	O	of	_	0	SENT_586	[p25l1893t2335r1993b2416],
16	the	DT	O	the	det	17	SENT_586	[p25l2015t2336r2148b2415],
17	participants	NNS	O	participant	prep_of	14	SENT_586	[p25l11t2466r530b2565],
18	in	IN	O	in	_	0	SENT_586	[p25l585t2466r669b2543],
19	the	DT	O	the	det	20	SENT_586	[p25l722t2465r856b2544],
20	DTG	NN	O	dtg	prep_in	17	SENT_586	[p25l908t2471r1590b2544],
21	.	.	O	.	_	0	SENT_586	[p25l908t2471r1590b2544],

1	—	NN	O	—	_	0	SENT_587	[p25l908t2471r1590b2544],
2	.	.	O	.	_	0	SENT_587	[p25l908t2471r1590b2544],

1	ABC	NNP	ORGANIZATION	ABC	_	0	SENT_588	[p25l908t2471r1590b2544],
2	.	.	O	.	_	0	SENT_588	[p25l908t2471r1590b2544],

1	—	NN	O	—	_	0	SENT_589	[p25l908t2471r1590b2544],
2	.	.	O	.	_	0	SENT_589	[p25l908t2471r1590b2544],

1	3TC	NN	O	3tc	nn	2	SENT_590	[p25l908t2471r1590b2544],
2	group	NN	O	group	_	0	SENT_590	[p25l1644t2491r1898b2566],
3	—	CD	NUMBER	—	dep	2	SENT_590	[p25l1949t2510r2057b2518],
4	a	DT	O	a	det	5	SENT_590	[p25l2105t2491r2150b2543],
5	finding	NN	O	finding	dep	3	SENT_590	[p25l12t2592r338b2695],
6	similar	JJ	O	similar	amod	5	SENT_590	[p25l372t2593r679b2672],
7	to	TO	O	to	_	0	SENT_590	[p25l711t2610r793b2673],
8	that	DT	O	that	prep_to	6	SENT_590	[p25l830t2593r1003b2672],
9	in	IN	O	in	_	0	SENT_590	[p25l1031t2594r1116b2671],
10	a	DT	O	a	det	12	SENT_590	[p25l1149t2620r1194b2672],
11	pivotal	JJ	O	pivotal	amod	12	SENT_590	[p25l1226t2593r1518b2694],
12	phase	NN	O	phase	prep_in	8	SENT_590	[p25l1552t2593r1802b2694],
13	3	CD	NUMBER	3	num	14	SENT_590	[p25l1838t2600r1882b2673],
14	study	NN	O	study	dep	2	SENT_590	[p25l1922t2593r2153b2694],
15	of	IN	O	of	_	0	SENT_590	[p25l12t2721r113b2802],
16	dolutegravir	NN	O	dolutegravir	prep_of	14	SENT_590	[p25l142t2722r668b2824],
17	versus	CC	O	versus	prep	16	SENT_590	[p25l708t2748r976b2802],
18	raltegravir	NN	O	raltegravir	dep	17	SENT_590	[p25l1024t2722r1574b2824],
19	.	.	O	.	_	0	SENT_590	[p25l1024t2722r1574b2824],

1	”	NN	O	”	nsubj	33	SENT_591	[p25l1024t2722r1574b2824],
2	By	IN	O	by	_	0	SENT_591	[p25l1619t2729r1724b2823],
3	contrast	NN	O	contrast	prep_by	13	SENT_591	[p25l1767t2739r2142b2819],
4	,	,	O	,	_	0	SENT_591	[p25l1767t2739r2142b2819],
5	in	IN	O	in	rcmod	1	SENT_591	[p25l11t2852r95b2929],
6	the	DT	O	the	det	8	SENT_591	[p25l135t2851r269b2929],
7	latter	JJ	O	latter	amod	8	SENT_591	[p25l308t2851r537b2929],
8	study	NN	O	study	pobj	5	SENT_591	[p25l576t2851r820b2951],
9	,	,	O	,	_	0	SENT_591	[p25l576t2851r820b2951],
10	resistance	NN	O	resistance	nsubj	13	SENT_591	[p25l865t2852r1296b2929],
11	to	TO	O	to	_	0	SENT_591	[p25l1337t2868r1420b2930],
12	integrase	NN	O	integrase	prep_to	10	SENT_591	[p25l1460t2852r1858b2952],
13	developed	VBD	O	develop	rcmod	1	SENT_591	[p25l1900t2851r2147b2930, p25l12t2978r221b3078],
14	in	IN	O	in	_	0	SENT_591	[p25l282t2979r366b3056],
15	5	CD	PERCENT	5	num	16	SENT_591	[p25l430t2984r562b3058],
16	%	NN	PERCENT	%	prep_in	13	SENT_591	[p25l430t2984r562b3058],
17	of	IN	O	of	_	0	SENT_591	[p25l624t2977r725b3057],
18	participants	NNS	O	participant	prep_of	16	SENT_591	[p25l766t2979r1286b3078],
19	and	CC	O	and	_	0	SENT_591	[p25l1350t2978r1509b3057],
20	resistance	NN	O	resistance	nsubj	23	SENT_591	[p25l1570t2979r2001b3056],
21	to	TO	O	to	_	0	SENT_591	[p25l2065t2995r2147b3057],
22	NRTI	NN	ORGANIZATION	nrtus	prep_to	20	SENT_591	[p25l10t3112r245b3190],
23	developed	VBD	O	develop	rcmod	1	SENT_591	[p25l283t3106r713b3206],
24	in	IN	O	in	_	0	SENT_591	[p25l751t3107r835b3184],
25	20	CD	PERCENT	20	num	26	SENT_591	[p25l874t3111r1063b3186],
26	%	NN	PERCENT	%	prep_in	23	SENT_591	[p25l874t3111r1063b3186],
27	of	IN	O	of	_	0	SENT_591	[p25l1102t3105r1203b3185],
28	the	DT	O	the	det	29	SENT_591	[p25l1223t3106r1357b3184],
29	participants	NNS	O	participant	prep_of	26	SENT_591	[p25l1395t3107r1915b3206],
30	with	IN	O	with	_	0	SENT_591	[p25l1952t3106r2148b3186],
31	protocol	NN	O	protocol	prep_with	23	SENT_591	[p25l11t3234r741b3336],
32	—	RB	O	—	advmod	33	SENT_591	[p25l11t3234r741b3336],
33	defined	VBD	O	define	_	0	SENT_591	[p25l11t3234r741b3336],
34	virologic	JJ	O	virologic	amod	35	SENT_591	[p25l792t3235r1173b3337],
35	failure	NN	O	failure	dobj	33	SENT_591	[p25l1227t3234r1507b3315],
36	who	WP	O	who	nsubj	37	SENT_591	[p25l1559t3235r1743b3315],
37	received	VBD	O	receive	rcmod	35	SENT_591	[p25l1801t3235r2148b3315],
38	the	DT	O	the	det	40	SENT_591	[p25l12t3364r148b3443],
39	raltegravir	NN	O	raltegravir	nn	40	SENT_591	[p25l210t3364r1195b3465],
40	—	NN	O	—	dobj	37	SENT_591	[p25l210t3364r1195b3465],
41	containing	VBG	O	contain	xcomp	37	SENT_591	[p25l210t3364r1195b3465],
42	regimen	NN	O	regimen	dobj	41	SENT_591	[p25l1253t3365r1723b3465],
43	.	.	O	.	_	0	SENT_591	[p25l1253t3365r1723b3465],

1	”	NN	O	”	_	0	SENT_592	[p25l1253t3365r1723b3465],
2	Furthermore	RB	O	furthermore	advmod	1	SENT_592	[p25l1783t3364r2147b3443, p25l12t3517r260b3587],
3	,	,	O	,	_	0	SENT_592	[p25l1783t3364r2147b3443, p25l12t3517r260b3587],
4	in	IN	O	in	_	0	SENT_592	[p25l321t3492r405b3569],
5	SINGLE	NNP	O	SINGLE	prep_in	1	SENT_592	[p25l464t3497r828b3587],
6	,	,	O	,	_	0	SENT_592	[p25l464t3497r828b3587],
7	four	CD	NUMBER	four	num	8	SENT_592	[p25l890t3490r1071b3571],
8	participants	NNS	O	participant	appos	1	SENT_592	[p25l1122t3492r1643b3591],
9	with	IN	O	with	_	0	SENT_592	[p25l1696t3491r1892b3571],
10	Virologic	JJ	ORGANIZATION	virologic	amod	11	SENT_592	[p25l1944t3492r2147b3571, p25l11t3620r220b3722],
11	failure	NN	O	failure	prep_with	8	SENT_592	[p25l284t3619r563b3700],
12	in	IN	O	in	_	0	SENT_592	[p25l627t3621r712b3698],
13	the	DT	O	the	det	14	SENT_592	[p25l777t3620r910b3699],
14	EFV	NN	O	efv	prep_in	11	SENT_592	[p25l974t3626r1604b3700],
15	.	.	O	.	_	0	SENT_592	[p25l974t3626r1604b3700],

1	—	NN	O	—	_	0	SENT_593	[p25l974t3626r1604b3700],
2	.	.	O	.	_	0	SENT_593	[p25l974t3626r1604b3700],

1	TDF	NNP	O	TDF	_	0	SENT_594	[p25l974t3626r1604b3700],
2	.	.	O	.	_	0	SENT_594	[p25l974t3626r1604b3700],

1	—	NN	O	—	_	0	SENT_595	[p25l974t3626r1604b3700],
2	.	.	O	.	_	0	SENT_595	[p25l974t3626r1604b3700],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_596	[p25l974t3626r1604b3700],
2	group	NN	O	group	nsubj	3	SENT_596	[p25l1670t3646r1925b3722],
3	had	VBD	O	have	_	0	SENT_596	[p25l1991t3620r2148b3700],

1	NNRTI	NNP	ORGANIZATION	NNRTI	nn	3	SENT_597	[p26l10t26r323b104],
2	resistance	NN	O	resistance	nn	3	SENT_597	[p26l358t21r789b98],
3	mutations	NNS	O	mutation	_	0	SENT_597	[p26l825t21r1262b99],
4	that	WDT	O	that	nsubj	5	SENT_597	[p26l1300t20r1474b98],
5	developed	VBD	O	develop	rcmod	3	SENT_597	[p26l1505t20r1935b120],
6	during	IN	O	during	_	0	SENT_597	[p26l1971t20r2147b99, p26l11t150r151b250],
7	treatment	NN	O	treatment	prep_during	5	SENT_597	[p26l189t166r636b245],
8	,	,	O	,	_	0	SENT_597	[p26l189t166r636b245],
9	and	CC	O	and	_	0	SENT_597	[p26l681t149r839b228],
10	one	CD	NUMBER	one	num	12	SENT_597	[p26l880t175r1032b228],
11	additional	JJ	O	additional	amod	12	SENT_597	[p26l1071t149r1512b228],
12	participant	NN	O	participant	conj_and	3	SENT_597	[p26l1549t150r2030b249],
13	in	IN	O	in	_	0	SENT_597	[p26l2064t150r2148b227],
14	the	DT	O	the	det	15	SENT_597	[p26l12t277r148b356],
15	EFV	NN	O	efv	prep_in	12	SENT_597	[p26l200t283r842b357],
16	.	.	O	.	_	0	SENT_597	[p26l200t283r842b357],

1	—	NN	O	—	_	0	SENT_598	[p26l200t283r842b357],
2	.	.	O	.	_	0	SENT_598	[p26l200t283r842b357],

1	TDF	NNP	O	TDF	_	0	SENT_599	[p26l200t283r842b357],
2	.	.	O	.	_	0	SENT_599	[p26l200t283r842b357],

1	—	NN	O	—	_	0	SENT_600	[p26l200t283r842b357],
2	.	.	O	.	_	0	SENT_600	[p26l200t283r842b357],

1	FTC	NNP	ORGANIZATION	FTC	nn	2	SENT_601	[p26l200t283r842b357],
2	group	NN	O	group	nsubj	3	SENT_601	[p26l897t303r1156b379],
3	had	VBD	O	have	_	0	SENT_601	[p26l1211t277r1370b357],
4	a	DT	O	a	det	7	SENT_601	[p26l1423t304r1468b356],
5	tenofovir	NN	O	tenofovir	nn	7	SENT_601	[p26l1521t276r1922b357],
6	DF	NN	O	df	nn	7	SENT_601	[p26l1971t284r2152b356],
7	—	NN	O	—	dobj	3	SENT_601	[p26l1971t284r2152b356],
8	associated	VBN	O	associate	partmod	7	SENT_601	[p26l11t407r461b486],
9	resistance	NN	O	resistance	nn	10	SENT_601	[p26l511t408r942b485],
10	mutation	NN	O	mutation	dobj	8	SENT_601	[p26l992t408r1410b486],
11	.	.	O	.	_	0	SENT_601	[p26l992t408r1410b486],

1	The	DT	O	the	_	0	SENT_602	[p26l1461t407r1623b485],
2	accumulating	VBG	O	accumulate	partmod	1	SENT_602	[p26l1673t407r2147b486, p26l11t536r151b637],
3	clinical	JJ	O	clinical	amod	4	SENT_602	[p26l216t535r532b614],
4	data	NNS	O	datum	dobj	2	SENT_602	[p26l599t535r782b615],
5	from	IN	O	from	_	0	SENT_602	[p26l848t534r1059b615],
6	this	DT	O	this	det	7	SENT_602	[p26l1127t535r1287b614],
7	study	NN	O	study	prep_from	2	SENT_602	[p26l1358t535r1589b636],
8	and	CC	O	and	_	0	SENT_602	[p26l1650t535r1809b615],
9	others	NNS	O	other	prep_from	2	SENT_602	[p26l1877t535r2145b615],
10	(	RB	O	(	advmod	2	SENT_602	[p26l17t664r284b765],
11	along	IN	O	along	_	0	SENT_602	[p26l17t664r284b765],
12	with	IN	O	with	prepc_along_with	2	SENT_602	[p26l313t664r510b743],
13	in	FW	O	in	nn	14	SENT_602	[p26l547t665r630b742],
14	vitro	FW	O	vitro	dep	15	SENT_602	[p26l664t665r863b743],
15	tests	NNS	O	test	dep	2	SENT_602	[p26l903t681r1098b743],
16	including	VBG	O	include	_	0	SENT_602	[p26l1136t664r1550b765],
17	viral	JJ	O	viral	amod	18	SENT_602	[p26l1579t664r1773b743],
18	passage	NN	O	passage	prep_including	15	SENT_602	[p26l1809t690r2148b765],

1	1316	CD	DATE	1316	num	4	SENT_603	[p26l149t840r225b862],
2	N	NN	O	n	nn	4	SENT_603	[p26l933t851r947b866],
3	ENGLJ	NN	O	englj	nn	4	SENT_603	[p26l961t851r1039b873],
4	MED	NN	O	med	_	0	SENT_603	[p26l1054t851r1106b866],
5	36	CD	NUMBER	36	dep	4	SENT_603	[p26l1116t845r1144b873],
6	;	:	O	;	_	0	SENT_603	[p26l1164t851r1178b871],
7	1	CD	NUMBER	1	num	8	SENT_603	[p26l1164t851r1178b871],
8	NEjM.ORG	NN	O	nejm.org	dep	5	SENT_603	[p26l1233t851r1357b873],
9	NOVEMBER	NNP	DATE	NOVEMBER	dep	8	SENT_603	[p26l1394t851r1529b867],
10	7	CD	DATE	7	num	9	SENT_603	[p26l1539t851r1558b872],
11	,	,	DATE	,	_	0	SENT_603	[p26l1539t851r1558b872],
12	2013	CD	DATE	2013	num	9	SENT_603	[p26l1569t851r1624b873],

1	The	DT	O	the	det	4	SENT_604	[p26l935t884r986b908],
2	New	NNP	O	New	nn	4	SENT_604	[p26l995t885r1057b908],
3	Englan	NNP	O	Englan	nn	4	SENT_604	[p26l1066t884r1160b915],
4	ournal	NN	O	ournal	_	0	SENT_604	[p26l1199t884r1283b908],
5	of	IN	O	of	_	0	SENT_604	[p26l1293t884r1322b908],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_604	[p26l1329t884r1454b908],

1	DOLUTEGRAVIR	NN	O	dolutegravir	_	0	SENT_605	[p26l507t1072r769b1091],
2	AND	CC	O	and	cc	3	SENT_605	[p26l780t1072r852b1091],
3	ABACAVIR	NN	O	abacavir	dep	1	SENT_605	[p26l864t1072r1270b1091],
4	.	.	O	.	_	0	SENT_605	[p26l864t1072r1270b1091],

1	—	NN	O	—	_	0	SENT_606	[p26l864t1072r1270b1091],
2	.	.	O	.	_	0	SENT_606	[p26l864t1072r1270b1091],

1	LAMIVUDINE	NNP	O	LAMIVUDINE	_	0	SENT_607	[p26l864t1072r1270b1091],
2	FOR	IN	O	for	_	0	SENT_607	[p26l1284t1072r1348b1091],
3	HIV-1	NN	O	hiv-1	nn	4	SENT_607	[p26l1362t1072r1452b1091],
4	INFECTION	NN	O	infection	prep_for	1	SENT_607	[p26l1467t1072r1653b1091],

1	and	CC	O	and	dep	2	SENT_608	[p26l11t1286r172b1365],
2	integrase	NN	O	integrase	_	0	SENT_608	[p26l253t1287r662b1387],
3	binding	NN	O	binding	nn	4	SENT_608	[p26l745t1286r1091b1387],
4	assays	NNS	O	assay	nsubj	6	SENT_608	[p26l1170t1293r1471b1386],
5	)	RB	O	)	advmod	6	SENT_608	[p26l1170t1293r1471b1386],
6	suggest	VBP	O	suggest	rcmod	2	SENT_608	[p26l1560t1303r1897b1387],
7	that	IN	O	that	complm	13	SENT_608	[p26l1975t1286r2152b1364],
8	there	EX	O	there	expl	13	SENT_608	[p26l12t1414r234b1492],
9	may	MD	O	may	aux	13	SENT_608	[p26l270t1440r453b1514],
10	be	VB	O	be	cop	13	SENT_608	[p26l484t1414r582b1493],
11	a	DT	O	a	det	13	SENT_608	[p26l617t1440r662b1492],
12	higher	JJR	O	higher	amod	13	SENT_608	[p26l695t1414r985b1515],
13	barrier	NN	O	barrier	ccomp	6	SENT_608	[p26l1017t1414r1321b1493],
14	to	TO	O	to	_	0	SENT_608	[p26l1353t1431r1436b1493],
15	resistance	NN	O	resistance	prep_to	13	SENT_608	[p26l1473t1415r1916b1493],
16	with	IN	O	with	_	0	SENT_608	[p26l1947t1414r2147b1493],
17	dolutegravir	NN	O	dolutegravir	prep_with	15	SENT_608	[p26l12t1542r552b1643],
18	than	IN	O	than	dep	13	SENT_608	[p26l603t1542r804b1620],
19	with	IN	O	with	_	0	SENT_608	[p26l852t1542r1052b1621],
20	other	JJ	O	other	amod	22	SENT_608	[p26l1106t1542r1340b1621],
21	integrase	NN	O	integrase	nn	22	SENT_608	[p26l1389t1543r1797b1643],
22	inhibitOrS_s	NN	O	inhibitors_s	prep_with	13	SENT_608	[p26l1850t1542r2145b1621, p26l12t1695r624b1769],
23	,12	CD	NUMBER	,12	number	24	SENT_608	[p26l1850t1542r2145b1621, p26l12t1695r624b1769],
24	—	CD	NUMBER	—	dep	22	SENT_608	[p26l1850t1542r2145b1621, p26l12t1695r624b1769],
25	14,32,33	CD	NUMBER	14,32,33	dep	24	SENT_608	[p26l1850t1542r2145b1621, p26l12t1695r624b1769],

1	This	DT	O	this	det	2	SENT_609	[p26l137t1796r326b1874],
2	study	NN	O	study	nsubj	3	SENT_609	[p26l381t1796r612b1896],
3	has	VBZ	O	have	_	0	SENT_609	[p26l660t1796r804b1874],
4	some	DT	O	some	det	5	SENT_609	[p26l860t1822r1085b1875],
5	limitations	NNS	O	limitation	dobj	3	SENT_609	[p26l1135t1796r1635b1875],
6	.	.	O	.	_	0	SENT_609	[p26l1135t1796r1635b1875],

1	First	RB	ORDINAL	first	advmod	10	SENT_610	[p26l1691t1797r1909b1892],
2	,	,	O	,	_	0	SENT_610	[p26l1691t1797r1909b1892],
3	only	RB	O	only	quantmod	4	SENT_610	[p26l1966t1796r2152b1896],
4	16	CD	PERCENT	16	num	5	SENT_610	[p26l15t1930r194b2004],
5	%	NN	PERCENT	%	nsubj	10	SENT_610	[p26l15t1930r194b2004],
6	of	IN	O	of	_	0	SENT_610	[p26l237t1923r337b2003],
7	the	DT	O	the	det	8	SENT_610	[p26l362t1924r495b2002],
8	participants	NNS	O	participant	prep_of	5	SENT_610	[p26l537t1925r1057b2024],
9	were	VBD	O	be	cop	10	SENT_610	[p26l1098t1950r1301b2004],
10	women	NNS	O	woman	_	0	SENT_610	[p26l1340t1950r1681b2020],
11	,	,	O	,	_	0	SENT_610	[p26l1340t1950r1681b2020],
12	which	WDT	O	which	nsubj	13	SENT_610	[p26l1725t1924r1990b2004],
13	reflects	VBZ	O	reflect	rcmod	10	SENT_610	[p26l2032t1950r2145b2002, p26l11t2052r246b2132],
14	the	DT	O	the	det	15	SENT_610	[p26l312t2053r446b2132],
15	difficulties	NNS	O	difficulty	dobj	13	SENT_610	[p26l510t2052r983b2133],
16	in	IN	O	in	_	0	SENT_610	[p26l1048t2054r1131b2131],
17	recruiting	VBG	O	recruit	prepc_in	13	SENT_610	[p26l1195t2054r1627b2155],
18	women	NNS	O	woman	dobj	17	SENT_610	[p26l1683t2079r2001b2133],
19	in	IN	O	in	_	0	SENT_610	[p26l2063t2054r2147b2131],
20	long	JJ	O	long	amod	23	SENT_610	[p26l10t2182r429b2283],
21	—	JJ	O	—	amod	23	SENT_610	[p26l10t2182r429b2283],
22	term	NN	O	term	nn	23	SENT_610	[p26l10t2182r429b2283],
23	studies	NNS	O	study	prep_in	18	SENT_610	[p26l463t2182r755b2261],
24	with	IN	O	with	_	0	SENT_610	[p26l785t2182r977b2261],
25	strict	JJ	O	strict	amod	26	SENT_610	[p26l1010t2183r1225b2260],
26	requirements	NNS	O	requirement	prep_with	17	SENT_610	[p26l1252t2183r1810b2282],
27	regarding	VBG	O	regard	_	0	SENT_610	[p26l1844t2182r2145b2283, p26l11t2311r151b2412],
28	birth	NN	O	birth	nn	29	SENT_610	[p26l192t2310r406b2390],
29	control	NN	O	control	prep_regarding	26	SENT_610	[p26l451t2310r759b2390],
30	and	CC	O	and	_	0	SENT_610	[p26l802t2310r961b2390],
31	the	DT	O	the	det	32	SENT_610	[p26l1006t2310r1139b2389],
32	exclusion	NN	O	exclusion	prep_regarding	26	SENT_610	[p26l1185t2310r1585b2390],
33	of	IN	O	of	_	0	SENT_610	[p26l1630t2309r1731b2390],
34	pregnant	JJ	O	pregnant	amod	35	SENT_610	[p26l1755t2327r2153b2412],
35	Women	NNS	O	woman	prep_of	32	SENT_610	[p26l7t2464r348b2518],
36	.	.	O	.	_	0	SENT_610	[p26l7t2464r348b2518],

1	Second	RB	ORDINAL	second	advmod	24	SENT_611	[p26l405t2438r734b2534],
2	,	,	O	,	_	0	SENT_611	[p26l405t2438r734b2534],
3	the	DT	O	the	det	4	SENT_611	[p26l791t2438r924b2517],
4	proportion	NN	O	proportion	nsubj	24	SENT_611	[p26l973t2439r1444b2538],
5	of	IN	O	of	_	0	SENT_611	[p26l1495t2437r1595b2517],
6	participants	NNS	O	participant	prep_of	4	SENT_611	[p26l1625t2439r2145b2538],
7	with	IN	O	with	_	0	SENT_611	[p26l7t2566r203b2646],
8	a	DT	O	a	det	9	SENT_611	[p26l252t2592r297b2644],
9	CD4	NN	O	cd4	prep_with	6	SENT_611	[p26l345t2572r593b2645],
10	+	CC	O	+	_	0	SENT_611	[p26l345t2572r593b2645],
11	T	NN	O	t	nn	14	SENT_611	[p26l639t2566r877b2644],
12	—	NN	O	—	nn	14	SENT_611	[p26l639t2566r877b2644],
13	cell	NN	O	cell	nn	14	SENT_611	[p26l639t2566r877b2644],
14	count	NN	O	count	prep_with	6	SENT_611	[p26l927t2583r1173b2646],
15	of	IN	O	of	_	0	SENT_611	[p26l1218t2565r1318b2645],
16	less	JJR	O	less	mwe	17	SENT_611	[p26l1348t2566r1505b2644],
17	than	IN	O	than	quantmod	18	SENT_611	[p26l1557t2566r1755b2644],
18	200	CD	NUMBER	200	prep_of	14	SENT_611	[p26l1805t2572r1960b2645],
19	per	IN	O	per	_	0	SENT_611	[p26l2009t2592r2150b2666],
20	cubic	JJ	O	cubic	amod	21	SENT_611	[p26l12t2694r236b2774],
21	millimeter	NN	O	millimeter	prep_per	18	SENT_611	[p26l287t2694r748b2772],
22	was	VBD	O	be	cop	24	SENT_611	[p26l792t2720r956b2774],
23	relatively	RB	O	relatively	advmod	24	SENT_611	[p26l1010t2694r1397b2794],
24	low	JJ	O	low	_	0	SENT_611	[p26l1443t2694r1600b2774],
25	(	NN	O	(	dep	24	SENT_611	[p26l1652t2694r1823b2785],
26	but	CC	O	but	_	0	SENT_611	[p26l1652t2694r1823b2785],
27	reflective	JJ	O	reflective	conj_but	24	SENT_611	[p26l1870t2693r2145b2772, p26l12t2824r159b2903],
28	of	IN	O	of	_	0	SENT_611	[p26l203t2822r304b2903],
29	evolving	VBG	O	evolve	prepc_of	24	SENT_611	[p26l329t2823r688b2925],
30	guidelines	NNS	O	guideline	dobj	29	SENT_611	[p26l727t2823r1175b2925],
31	for	IN	O	for	_	0	SENT_611	[p26l1220t2822r1344b2903],
32	starting	VBG	O	start	prepc_for	29	SENT_611	[p26l1386t2824r1730b2925],
33	therapy	NN	O	therapy	nn	34	SENT_611	[p26l1770t2823r2141b2924],
34	)	NN	O	)	dobj	32	SENT_611	[p26l1770t2823r2141b2924],
35	.	.	O	.	_	0	SENT_611	[p26l1770t2823r2141b2924],

1	Two	CD	NUMBER	two	num	2	SENT_612	[p26l7t2958r185b3031],
2	studies	NNS	O	study	nsubjpass	13	SENT_612	[p26l226t2952r528b3031],
3	involving	VBG	O	involve	_	0	SENT_612	[p26l568t2952r967b3053],
4	participants	NNS	O	participant	prep_involving	2	SENT_612	[p26l1000t2953r1521b3052],
5	who	WP	O	who	nsubj	8	SENT_612	[p26l1557t2952r1741b3031],
6	had	VBD	O	have	aux	8	SENT_612	[p26l1781t2952r1938b3031],
7	previously	RB	DATE	previously	advmod	8	SENT_612	[p26l1975t2978r2145b3052, p26l7t3080r300b3180],
8	received	VBN	O	receive	rcmod	4	SENT_612	[p26l326t3080r664b3159],
9	treatment	NN	O	treatment	dobj	8	SENT_612	[p26l695t3097r1109b3159],
10	are	VBP	O	be	aux	13	SENT_612	[p26l1135t3106r1261b3158],
11	currently	RB	DATE	currently	advmod	13	SENT_612	[p26l1294t3080r1674b3180],
12	being	VBG	O	be	auxpass	13	SENT_612	[p26l1701t3080r1937b3181],
13	conducted	VBN	O	conduct	_	0	SENT_612	[p26l1966t3106r2145b3159, p26l12t3208r290b3288],
14	(	CD	NUMBER	(	num	15	SENT_612	[p26l344t3214r821b3299],
15	SAILING33	NN	O	sailing33	dobj	13	SENT_612	[p26l344t3214r821b3299],
16	and	CC	O	and	_	0	SENT_612	[p26l872t3208r1028b3287],
17	VIKING	NN	O	viking	conj_and	15	SENT_612	[p26l1073t3214r1499b3289],
18	—	CD	NUMBER	—	number	19	SENT_612	[p26l1073t3214r1499b3289],
19	3	CD	NUMBER	3	num	21	SENT_612	[p26l1073t3214r1499b3289],
20	[	NN	O	[	nn	21	SENT_612	[p26l1560t3208r2145b3299],
21	ClinicalTrials	NNS	O	clinicaltrial	dep	17	SENT_612	[p26l1560t3208r2145b3299],
22	.	.	O	.	_	0	SENT_612	[p26l15t3363r190b3438],

1	gov	NN	O	gov	nn	2	SENT_613	[p26l15t3363r190b3438],
2	number	NN	O	number	nsubj	16	SENT_613	[p26l230t3337r581b3433],
3	,	,	O	,	_	0	SENT_613	[p26l230t3337r581b3433],
4	NCTO1328O41	NN	O	ncto1328o41	appos	2	SENT_613	[p26l628t3342r1386b3433],
5	]	CD	NUMBER	]	number	6	SENT_613	[p26l628t3342r1386b3433],
6	34	CD	NUMBER	34	num	7	SENT_613	[p26l628t3342r1386b3433],
7	)	NN	O	)	dep	4	SENT_613	[p26l628t3342r1386b3433],
8	;	:	O	;	_	0	SENT_613	[p26l628t3342r1386b3433],
9	these	DT	O	these	det	14	SENT_613	[p26l1434t3337r1655b3416],
10	two	CD	NUMBER	two	num	14	SENT_613	[p26l1699t3354r1855b3416],
11	ongo	JJ	O	ongo	amod	14	SENT_613	[p26l1901t3363r2145b3438],
12	—	NN	O	—	nn	14	SENT_613	[p26l1901t3363r2145b3438],
13	ing	NN	O	ing	nn	14	SENT_613	[p26l11t3466r149b3567],
14	studies	NNS	O	study	dep	4	SENT_613	[p26l181t3465r483b3545],
15	will	MD	O	will	aux	16	SENT_613	[p26l517t3465r682b3545],
16	provide	VB	O	provide	_	0	SENT_613	[p26l716t3465r1036b3566],
17	data	NNS	O	datum	dobj	16	SENT_613	[p26l1073t3465r1257b3545],
18	on	IN	O	on	_	0	SENT_613	[p26l1292t3491r1398b3545],
19	the	DT	O	the	det	20	SENT_613	[p26l1435t3465r1568b3544],
20	effectiveness	NN	O	effectiveness	prep_on	16	SENT_613	[p26l1605t3464r2144b3545],
21	of	IN	O	of	_	0	SENT_613	[p26l12t3593r114b3674],
22	dolutegravir	NN	O	dolutegravir	prep_of	20	SENT_613	[p26l135t3594r673b3696],
23	in	IN	O	in	_	0	SENT_613	[p26l708t3595r794b3672],
24	persons	NNS	O	person	prep_in	16	SENT_613	[p26l831t3620r1176b3695],
25	with	IN	O	with	_	0	SENT_613	[p26l1213t3594r1412b3674],
26	baseline	NN	O	baseline	nn	27	SENT_613	[p26l1452t3594r1814b3674],
27	immunodeficiency	NN	O	immunodeficiency	prep_with	24	SENT_613	[p26l1853t3595r2145b3674, p27l11t19r565b120],

1	that	DT	O	that	nsubj	4	SENT_614	[p27l597t20r770b98],
2	is	VBZ	O	be	cop	4	SENT_614	[p27l800t21r866b98],
3	more	RBR	O	more	advmod	4	SENT_614	[p27l904t46r1125b99],
4	severe	JJ	O	severe	_	0	SENT_614	[p27l1162t46r1421b100],
5	than	IN	O	than	_	0	SENT_614	[p27l1457t20r1655b98],
6	that	DT	O	that	prep_than	4	SENT_614	[p27l1691t20r1864b98],
7	in	IN	O	in	_	0	SENT_614	[p27l1894t21r1978b98],
8	the	DT	O	the	det	9	SENT_614	[p27l2014t20r2147b98],
9	participants	NNS	O	participant	prep_in	6	SENT_614	[p27l10t150r530b250],
10	in	IN	O	in	_	0	SENT_614	[p27l585t150r669b227],
11	our	PRP$	O	we	poss	12	SENT_614	[p27l723t175r869b229],
12	study	NN	O	study	prep_in	9	SENT_614	[p27l922t149r1165b250],
13	.	.	O	.	_	0	SENT_614	[p27l922t149r1165b250],

1	Long	JJ	O	long	amod	3	SENT_615	[p27l1223t157r1682b251],
2	—	NN	O	—	nn	3	SENT_615	[p27l1223t157r1682b251],
3	term	NN	O	term	nsubj	9	SENT_615	[p27l1223t157r1682b251],
4	follow	VBP	O	follow	rcmod	3	SENT_615	[p27l1735t148r2146b250],
5	—	RB	O	—	advmod	4	SENT_615	[p27l1735t148r2146b250],
6	up	RB	O	up	advmod	9	SENT_615	[p27l1735t148r2146b250],
7	will	MD	O	will	aux	9	SENT_615	[p27l7t277r172b357],
8	be	VB	O	be	cop	9	SENT_615	[p27l218t277r315b356],
9	useful	JJ	O	useful	_	0	SENT_615	[p27l361t276r628b357],
10	to	TO	O	to	aux	12	SENT_615	[p27l673t294r755b356],
11	further	RB	O	further	advmod	12	SENT_615	[p27l803t276r1113b357],
12	define	VB	O	define	xcomp	9	SENT_615	[p27l1157t276r1429b356],
13	any	DT	O	any	det	14	SENT_615	[p27l1474t303r1625b377],
14	differences	NNS	O	difference	dobj	12	SENT_615	[p27l1667t276r2145b356],
15	between	IN	O	between	_	0	SENT_615	[p27l12t406r378b485],
16	treatments	NNS	O	treatment	prep_between	14	SENT_615	[p27l430t423r907b484],
17	with	IN	O	with	_	0	SENT_615	[p27l956t406r1156b485],
18	respect	NN	O	respect	prep_with	12	SENT_615	[p27l1208t423r1525b506],
19	to	TO	O	to	_	0	SENT_615	[p27l1571t423r1655b485],
20	the	DT	O	the	det	21	SENT_615	[p27l1709t406r1844b484],
21	emergence	NN	O	emergence	prep_to	12	SENT_615	[p27l1897t432r2145b484, p27l15t561r263b636],
22	of	IN	O	of	_	0	SENT_615	[p27l315t534r414b614],
23	resistance	NN	O	resistance	prep_of	21	SENT_615	[p27l445t536r872b614],
24	as	RB	O	as	_	0	SENT_615	[p27l921t561r1007b613],
25	well	RB	O	well	_	0	SENT_615	[p27l1053t535r1230b614],
26	as	IN	O	as	_	0	SENT_615	[p27l1278t561r1363b613],
27	the	DT	O	the	det	28	SENT_615	[p27l1415t535r1547b614],
28	efficacy	NN	O	efficacy	conj_and	21	SENT_615	[p27l1597t534r1933b635],
29	and	CC	O	and	_	0	SENT_615	[p27l1977t535r2134b614],
30	safety	NN	O	safety	nn	31	SENT_615	[p27l16t661r269b761],
31	profiles	NNS	O	profile	conj_and	21	SENT_615	[p27l302t661r657b761],
32	.	.	O	.	_	0	SENT_615	[p27l302t661r657b761],

1	We	PRP	O	we	nsubj	3	SENT_616	[p27l140t798r273b868],
2	are	VBP	O	be	aux	3	SENT_616	[p27l324t816r453b868],
3	continuing	VBG	O	continue	_	0	SENT_616	[p27l506t791r979b891],
4	to	TO	O	to	aux	5	SENT_616	[p27l1028t807r1109b869],
5	follow	VB	O	follow	xcomp	3	SENT_616	[p27l1162t789r1435b869],
6	participants	NNS	O	participant	dobj	5	SENT_616	[p27l1482t791r1997b890],
7	in	IN	O	in	_	0	SENT_616	[p27l2051t791r2134b868],
8	the	DT	O	the	det	11	SENT_616	[p27l16t918r148b997],
9	two	CD	NUMBER	two	num	11	SENT_616	[p27l187t935r345b997],
10	treatment	NN	O	treatment	nn	11	SENT_616	[p27l385t935r808b996],
11	groups	NNS	O	group	prep_in	6	SENT_616	[p27l842t944r1137b1019],
12	through	IN	O	through	_	0	SENT_616	[p27l1179t918r1526b1019],
13	144	CD	DURATION	144	num	14	SENT_616	[p27l1569t924r1716b997],
14	weeks	NNS	NUMBER	week	prep_through	5	SENT_616	[p27l1751t918r2011b997],
15	of	IN	O	of	_	0	SENT_616	[p27l2053t917r2153b997],
16	therapy	NN	O	therapy	prep_of	14	SENT_616	[p27l16t1046r349b1145],
17	.	.	O	.	_	0	SENT_616	[p27l16t1046r349b1145],

1	In	IN	O	in	_	0	SENT_617	[p27l402t1053r491b1123],
2	the	DT	O	the	det	6	SENT_617	[p27l541t1046r673b1124],
3	SPRING	NNP	DATE	SPRING	nn	6	SENT_617	[p27l724t1052r1150b1129],
4	—	NN	O	—	nn	6	SENT_617	[p27l724t1052r1150b1129],
5	2	CD	NUMBER	2	num	6	SENT_617	[p27l724t1052r1150b1129],
6	study	NN	O	study	prep_in	13	SENT_617	[p27l1201t1046r1443b1145],
7	,	,	O	,	_	0	SENT_617	[p27l1201t1046r1443b1145],
8	the	DT	O	the	det	9	SENT_617	[p27l1499t1046r1631b1124],
9	data	NNS	O	datum	nsubj	13	SENT_617	[p27l1681t1046r1863b1124],
10	at	IN	O	at	_	0	SENT_617	[p27l1910t1063r1989b1124],
11	96	CD	DURATION	96	num	12	SENT_617	[p27l2033t1052r2133b1124],
12	weeks	NNS	NUMBER	week	prep_at	9	SENT_617	[p27l11t1173r271b1252],
13	showed	VBD	O	show	_	0	SENT_617	[p27l326t1173r648b1252],
14	continued	VBN	O	continue	amod	15	SENT_617	[p27l700t1173r1128b1252],
15	efficacy	NN	O	efficacy	dobj	13	SENT_617	[p27l1180t1172r1516b1272],
16	with	IN	O	with	_	0	SENT_617	[p27l1558t1173r1752b1252],
17	no	DT	O	no	det	19	SENT_617	[p27l1804t1199r1908b1251],
18	new	JJ	O	new	amod	19	SENT_617	[p27l1961t1199r2138b1252],
19	issues	NNS	O	issue	prep_with	15	SENT_617	[p27l14t1302r268b1380],
20	regarding	VBG	O	regard	_	0	SENT_617	[p27l317t1301r740b1402],
21	safety	NN	O	safety	amod	24	SENT_617	[p27l786t1300r1038b1401],
22	or	CC	O	or	_	0	SENT_617	[p27l1082t1327r1170b1380],
23	toxic	JJ	O	toxic	conj_or	21	SENT_617	[p27l1215t1302r1420b1380],
24	events	NNS	O	event	prep_regarding	19	SENT_617	[p27l1468t1307r1829b1380],
25	.35	CD	NUMBER	.35	num	26	SENT_617	[p27l1468t1307r1829b1380],
26	Monitoring	NN	O	monitoring	nsubj	44	SENT_617	[p27l1876t1302r2133b1380, p27l16t1430r280b1530],
27	of	IN	O	of	_	0	SENT_617	[p27l344t1428r444b1508],
28	efficacy	NN	O	efficacy	prep_of	26	SENT_617	[p27l494t1428r829b1529],
29	and	CC	O	and	_	0	SENT_617	[p27l891t1429r1048b1508],
30	safety	NN	O	safety	conj_and	28	SENT_617	[p27l1117t1428r1369b1529],
31	in	IN	O	in	_	0	SENT_617	[p27l1431t1430r1514b1507],
32	the	DT	O	the	det	35	SENT_617	[p27l1581t1429r1714b1508],
33	ongoing	JJ	O	ongoing	amod	35	SENT_617	[p27l1782t1430r2138b1530],
34	SINGLE	JJ	O	single	amod	35	SENT_617	[p27l17t1562r354b1634],
35	trial	NN	O	trial	prep_in	28	SENT_617	[p27l396t1556r596b1651],
36	,	,	O	,	_	0	SENT_617	[p27l396t1556r596b1651],
37	through	IN	O	through	_	0	SENT_617	[p27l641t1556r989b1656],
38	more	JJR	DURATION	more	mwe	39	SENT_617	[p27l1028t1581r1247b1634],
39	than	IN	DURATION	than	quantmod	40	SENT_617	[p27l1287t1556r1483b1633],
40	96	CD	DURATION	96	num	41	SENT_617	[p27l1523t1562r1622b1634],
41	weeks	NNS	NUMBER	week	prep_through	44	SENT_617	[p27l1658t1556r1943b1651],
42	,	,	O	,	_	0	SENT_617	[p27l1658t1556r1943b1651],
43	has	VBZ	O	have	aux	44	SENT_617	[p27l1988t1556r2132b1633],
44	shown	VBN	O	show	rcmod	24	SENT_617	[p27l16t1683r298b1762],
45	similar	JJ	O	similar	amod	46	SENT_617	[p27l362t1683r668b1761],
46	persistence	NN	O	persistence	dobj	44	SENT_617	[p27l726t1684r1206b1782],
47	of	IN	O	of	_	0	SENT_617	[p27l1270t1682r1370b1761],
48	efficacy	NN	O	efficacy	prep_of	46	SENT_617	[p27l1415t1682r1750b1782],
49	and	CC	O	and	_	0	SENT_617	[p27l1808t1683r1965b1761],
50	no	DT	O	no	det	53	SENT_617	[p27l2028t1709r2133b1761],
51	new	JJ	O	new	amod	53	SENT_617	[p27l15t1837r193b1890],
52	safety	NN	O	safety	nn	53	SENT_617	[p27l252t1810r504b1911],
53	signals	NNS	O	signal	conj_and	48	SENT_617	[p27l563t1811r887b1912],
54	.	.	O	.	_	0	SENT_617	[p27l563t1811r887b1912],

1	The	DT	O	the	det	3	SENT_618	[p27l950t1811r1111b1889],
2	primary	JJ	O	primary	amod	3	SENT_618	[p27l1171t1812r1521b1911],
3	results	NNS	O	result	nsubj	7	SENT_618	[p27l1578t1811r1861b1890],
4	from	IN	O	from	_	0	SENT_618	[p27l1925t1810r2135b1890],
5	these	DT	O	these	det	6	SENT_618	[p27l16t1938r239b2015],
6	studies	NNS	O	study	prep_from	3	SENT_618	[p27l279t1938r578b2016],
7	suggest	VBP	O	suggest	_	0	SENT_618	[p27l620t1954r946b2038],
8	that	IN	O	that	complm	11	SENT_618	[p27l981t1938r1152b2015],
9	dolutegravir	NN	O	dolutegravir	nsubj	11	SENT_618	[p27l1187t1938r1709b2038],
10	may	MD	O	may	aux	11	SENT_618	[p27l1743t1964r1923b2037],
11	provide	VB	O	provide	ccomp	7	SENT_618	[p27l1955t1963r2133b2037, p27l11t2066r183b2145],
12	people	NNS	O	people	dobj	11	SENT_618	[p27l238t2066r520b2166],
13	living	VBG	O	live	partmod	12	SENT_618	[p27l575t2066r819b2167],
14	with	IN	O	with	_	0	SENT_618	[p27l867t2066r1062b2145],
15	HIV	NN	MISC	hiv	nn	16	SENT_618	[p27l1117t2074r1292b2145],
16	infection	NN	O	infection	prep_with	13	SENT_618	[p27l1344t2065r1729b2145],
17	with	IN	O	with	_	0	SENT_618	[p27l1782t2066r1976b2145],
18	an	DT	O	a	det	22	SENT_618	[p27l2032t2092r2134b2144],
19	additional	JJ	O	additional	amod	22	SENT_618	[p27l14t2194r450b2272],
20	initial	JJ	O	initial	amod	22	SENT_618	[p27l489t2194r745b2272],
21	treatment	NN	O	treatment	nn	22	SENT_618	[p27l785t2211r1208b2272],
22	option	NN	O	option	prep_with	13	SENT_618	[p27l1242t2195r1544b2293],
23	.	.	O	.	_	0	SENT_618	[p27l1242t2195r1544b2293],

1	Presented	VBN	O	present	_	0	SENT_619	[p27l98t2487r426b2546],
2	in	IN	O	in	_	0	SENT_619	[p27l465t2488r530b2545],
3	part	NN	O	part	prep_in	1	SENT_619	[p27l569t2500r708b2562],
4	at	IN	O	at	_	0	SENT_619	[p27l744t2499r805b2545],
5	the	DT	O	the	det	8	SENT_619	[p27l842t2487r945b2546],
6	52nd	JJ	ORDINAL	52nd	amod	8	SENT_619	[p27l987t2487r1148b2546],
7	Interscience	NNP	O	Interscience	nn	8	SENT_619	[p27l1187t2488r1593b2546],
8	Conference	NN	O	conference	prep_at	1	SENT_619	[p27l1634t2486r2013b2546],
9	on	IN	O	on	_	0	SENT_619	[p27l2054t2506r2135b2546],
10	Antimicrobial	NNP	O	Antimicrobial	nn	11	SENT_619	[p27l11t2583r476b2642],
11	Agents	NNPS	O	Agents	prep_on	8	SENT_619	[p27l510t2588r736b2658],
12	and	CC	O	and	_	0	SENT_619	[p27l775t2583r895b2642],
13	Chemotherapy	NNP	O	Chemotherapy	prep_at	1	SENT_619	[p27l933t2583r1424b2658],
14	,	,	O	,	_	0	SENT_619	[p27l933t2583r1424b2658],
15	San	NNP	LOCATION	San	nn	16	SENT_619	[p27l1468t2587r1584b2642],
16	Francisco	NNP	LOCATION	Francisco	appos	13	SENT_619	[p27l1620t2584r1952b2654],
17	,	,	O	,	_	0	SENT_619	[p27l1620t2584r1952b2654],
18	Sep	NNP	DATE	Sep	appos	13	SENT_619	[p27l1996t2587r2134b2658],
19	—	CD	NUMBER	—	num	18	SENT_619	[p27l1996t2587r2134b2658],
20	tember	NN	O	tember	dep	18	SENT_619	[p27l15t2679r247b2737],
21	9-12	CD	NUMBER	9-12	num	20	SENT_619	[p27l270t2683r443b2750],
22	,	,	O	,	_	0	SENT_619	[p27l270t2683r443b2750],
23	2012	CD	DATE	2012	appos	13	SENT_619	[p27l473t2683r647b2738],
24	.	.	O	.	_	0	SENT_619	[p27l473t2683r647b2738],

1	Supported	VBN	O	support	_	0	SENT_620	[p27l102t2775r438b2850],
2	by	IN	O	by	_	0	SENT_620	[p27l483t2775r557b2850],
3	ViiV	NNP	O	ViiV	nn	4	SENT_620	[p27l597t2775r735b2833],
4	Healthcare	NNP	O	Healthcare	prep_by	1	SENT_620	[p27l777t2775r1155b2834],
5	.	.	O	.	_	0	SENT_620	[p27l777t2775r1155b2834],

1	ViiV	NNP	O	ViiV	nn	2	SENT_621	[p27l1202t2775r1340b2833],
2	Healthcare	NNP	O	Healthcare	nsubj	3	SENT_621	[p27l1383t2775r1742b2833],
3	contracted	VBD	O	contract	_	0	SENT_621	[p27l1788t2775r2135b2834],
4	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	nsubj	6	SENT_621	[p27l14t2871r584b2932],
5	to	TO	O	to	aux	6	SENT_621	[p27l607t2884r669b2930],
6	conduct	VB	O	conduct	xcomp	3	SENT_621	[p27l693t2871r955b2931],
7	the	DT	O	the	det	9	SENT_621	[p27l974t2871r1075b2929],
8	clinical	JJ	O	clinical	amod	9	SENT_621	[p27l1098t2871r1339b2929],
9	trials	NNS	O	trial	dobj	6	SENT_621	[p27l1361t2871r1529b2929],
10	of	IN	O	of	_	0	SENT_621	[p27l1554t2870r1629b2930],
11	the	DT	O	the	det	12	SENT_621	[p27l1638t2871r1739b2930],
12	compound	NN	O	compound	prep_of	9	SENT_621	[p27l1762t2871r2131b2946],
13	.	.	O	.	_	0	SENT_621	[p27l1762t2871r2131b2946],

1	Disclosure	NN	O	disclosure	nsubj	2	SENT_622	[p27l98t2967r445b3027],
2	forms	VBZ	O	form	_	0	SENT_622	[p27l478t2966r671b3026],
3	provided	VBN	O	provide	csubj	8	SENT_622	[p27l704t2967r990b3042],
4	by	IN	O	by	_	0	SENT_622	[p27l1023t2967r1097b3042],
5	the	DT	O	the	det	6	SENT_622	[p27l1127t2967r1228b3025],
6	authors	NNS	O	author	prep_by	3	SENT_622	[p27l1260t2967r1507b3027],
7	are	VBP	O	be	cop	8	SENT_622	[p27l1541t2986r1639b3025],
8	available	JJ	O	available	ccomp	2	SENT_622	[p27l1671t2967r1956b3027],
9	with	IN	O	with	_	0	SENT_622	[p27l1986t2967r2135b3027],
10	the	DT	O	the	det	12	SENT_622	[p27l15t3063r115b3121],
11	full	JJ	O	full	amod	12	SENT_622	[p27l141t3062r255b3123],
12	text	NN	O	text	prep_with	8	SENT_622	[p27l280t3075r403b3122],
13	of	IN	O	of	_	0	SENT_622	[p27l425t3062r501b3122],
14	this	DT	O	this	det	15	SENT_622	[p27l512t3063r634b3121],
15	article	NN	O	article	prep_of	12	SENT_622	[p27l661t3063r866b3121],
16	at	IN	O	at	_	0	SENT_622	[p27l892t3076r951b3121],
17	NEJM.org	NN	O	nejm.org	prep_at	15	SENT_622	[p27l971t3068r1310b3138],
18	.	.	O	.	_	0	SENT_622	[p27l971t3068r1310b3138],

1	We	PRP	O	we	nsubj	2	SENT_623	[p27l97t3164r198b3218],
2	thank	VBP	O	thank	_	0	SENT_623	[p27l221t3159r417b3219],
3	the	DT	O	the	det	5	SENT_623	[p27l436t3159r538b3217],
4	study	NN	O	study	nn	5	SENT_623	[p27l562t3159r738b3234],
5	staff	NN	O	staff	dobj	2	SENT_623	[p27l758t3158r919b3217],
6	and	CC	O	and	_	0	SENT_623	[p27l928t3159r1048b3218],
7	G.	NNP	PERSON	G.	nn	8	SENT_623	[p27l1071t3163r1142b3218],
8	Uhlenbrauck	NNP	PERSON	Uhlenbrauck	dobj	2	SENT_623	[p27l1168t3159r1607b3230],
9	,	,	O	,	_	0	SENT_623	[p27l1168t3159r1607b3230],
10	P.A.	NNP	PERSON	P.A.	nn	11	SENT_623	[p27l1633t3164r1756b3218],
11	Zipfel	NNP	PERSON	Zipfel	conj_and	5	SENT_623	[p27l1782t3158r1988b3234],
12	,	,	O	,	_	0	SENT_623	[p27l1782t3158r1988b3234],
13	and	CC	O	and	_	0	SENT_623	[p27l2015t3159r2135b3218],
14	J.L.	NNP	PERSON	J.L.	nn	15	SENT_623	[p27l7t3260r114b3324],
15	Martin	NNP	PERSON	Martin	conj_and	5	SENT_623	[p27l152t3256r740b3330],
16	.	.	O	.	_	0	SENT_623	[p27l152t3256r740b3330],

1	—	NN	O	—	_	0	SENT_624	[p27l152t3256r740b3330],
2	.	.	O	.	_	0	SENT_624	[p27l152t3256r740b3330],

1	Carpenter	NNP	PERSON	Carpenter	nsubj	14	SENT_625	[p27l152t3256r740b3330],
2	for	IN	O	for	_	0	SENT_625	[p27l774t3254r868b3314],
3	providing	VBG	O	provide	prepc_for	1	SENT_625	[p27l901t3255r1222b3330],
4	editorial	NN	O	editorial	nn	5	SENT_625	[p27l1256t3255r1534b3314],
5	assistance	NN	O	assistance	dobj	3	SENT_625	[p27l1569t3256r1903b3314],
6	on	IN	O	on	_	0	SENT_625	[p27l1941t3274r2021b3314],
7	an	DT	O	a	det	9	SENT_625	[p27l2057t3274r2135b3313],
8	earlier	JJR	O	earlier	amod	9	SENT_625	[p27l15t3351r225b3409],
9	version	NN	O	version	prep_on	3	SENT_625	[p27l244t3352r481b3410],
10	of	IN	O	of	_	0	SENT_625	[p27l507t3350r583b3410],
11	the	DT	O	the	det	13	SENT_625	[p27l594t3351r695b3409],
12	article	NN	O	article	nn	13	SENT_625	[p27l720t3351r926b3409],
13	(	NN	O	(	prep_of	9	SENT_625	[p27l955t3350r1206b3419],
14	funded	VBN	O	fund	_	0	SENT_625	[p27l955t3350r1206b3419],
15	by	IN	O	by	_	0	SENT_625	[p27l1233t3351r1307b3426],
16	ViiV	NNP	O	ViiV	nn	18	SENT_625	[p27l1326t3352r1464b3410],
17	Healthcare	NNP	O	Healthcare	nn	18	SENT_625	[p27l1487t3351r1885b3419],
18	)	NN	O	)	prep_by	14	SENT_625	[p27l1487t3351r1885b3419],
19	.	.	O	.	_	0	SENT_625	[p27l1487t3351r1885b3419],

1	REFERENCES	NNS	O	reference	_	0	SENT_626	[p27l16t3521r339b3552],

1	1	LS	NUMBER	1	_	0	SENT_627	[p28l14t29r51b68],
2	.	.	O	.	_	0	SENT_627	[p28l14t29r51b68],

1	Guidelines	NNS	O	guideline	_	0	SENT_628	[p28l109t24r377b68],
2	for	IN	O	for	_	0	SENT_628	[p28l408t23r479b68],
3	the	DT	O	the	det	4	SENT_628	[p28l507t24r584b68],
4	use	NN	O	use	prep_for	1	SENT_628	[p28l613t38r695b68],
5	of	IN	O	of	_	0	SENT_628	[p28l724t23r781b68],
6	antiretroviral	JJ	O	antiretroviral	amod	7	SENT_628	[p28l800t24r1042b68, p28l10t95r121b139],
7	agents	NNS	O	agent	prep_of	4	SENT_628	[p28l145t104r303b151],
8	in	IN	O	in	_	0	SENT_628	[p28l328t95r376b138],
9	HIV	NN	MISC	hiv	nn	10	SENT_628	[p28l400t94r756b139],
10	—	NN	O	—	prep_in	7	SENT_628	[p28l400t94r756b139],
11	1	CD	NUMBER	1	num	14	SENT_628	[p28l400t94r756b139],
12	—	RB	O	—	advmod	13	SENT_628	[p28l400t94r756b139],
13	infected	JJ	O	infected	amod	14	SENT_628	[p28l400t94r756b139],
14	adults	NNS	O	adult	dep	1	SENT_628	[p28l781t95r928b139],
15	and	CC	O	and	_	0	SENT_628	[p28l953t95r1043b139],
16	adolescents	NNS	O	adolescent	dep	1	SENT_628	[p28l12t166r317b210],
17	.	.	O	.	_	0	SENT_628	[p28l12t166r317b210],

1	Washington	NNP	LOCATION	Washington	_	0	SENT_629	[p28l358t166r679b222],
2	,	,	O	,	_	0	SENT_629	[p28l358t166r679b222],
3	DC	NNP	O	DC	appos	1	SENT_629	[p28l722t169r812b210],
4	:	:	O	:	_	0	SENT_629	[p28l722t169r812b210],
5	Department	NNP	ORGANIZATION	Department	dep	1	SENT_629	[p28l854t169r1042b222, p28l12t246r140b281],
6	of	IN	ORGANIZATION	of	_	0	SENT_629	[p28l176t236r233b281],
7	Health	NNP	ORGANIZATION	Health	nn	10	SENT_629	[p28l262t237r430b281],
8	and	CC	ORGANIZATION	and	_	0	SENT_629	[p28l469t237r560b281],
9	Human	NNP	ORGANIZATION	Human	nn	10	SENT_629	[p28l598t241r785b281],
10	Services	NNPS	ORGANIZATION	Services	prep_of	5	SENT_629	[p28l825t237r1040b290],
11	,	,	O	,	_	0	SENT_629	[p28l825t237r1040b290],
12	Panel	NN	O	panel	nsubj	20	SENT_629	[p28l12t308r147b352],
13	on	IN	O	on	_	0	SENT_629	[p28l184t322r245b352],
14	Antiretroviral	JJ	O	antiretroviral	amod	15	SENT_629	[p28l280t308r628b352],
15	Guidelines	NNS	O	guideline	prep_on	12	SENT_629	[p28l665t308r935b352],
16	for	IN	O	for	_	0	SENT_629	[p28l973t307r1045b352],
17	Adults	NNS	O	adult	prep_for	15	SENT_629	[p28l10t379r172b423],
18	and	CC	O	and	_	0	SENT_629	[p28l206t379r297b423],
19	Adolescents	NNS	O	adolescent	conj_and	17	SENT_629	[p28l328t379r629b423],
20	(	VBP	O	(	dep	1	SENT_629	[p28l666t378r1042b435],
21	http://aidsinfo	NN	O	http://aidsinfo	dobj	20	SENT_629	[p28l666t378r1042b435],
22	.	.	O	.	_	0	SENT_629	[p28l14t449r878b506],

1	nih	NN	O	nih	_	0	SENT_630	[p28l14t449r878b506],
2	.	.	O	.	_	0	SENT_630	[p28l14t449r878b506],

1	gov/contentfiles/lvguidelines	NNS	O	gov/contentfiles/lvguidelines	_	0	SENT_631	[p28l14t449r878b506],
2	/	:	O	/	punct	1	SENT_631	[p28l14t449r878b506],
3	adultandadolescentgl	NN	O	adultandadolescentgl	dep	1	SENT_631	[p28l12t520r693b577],
4	.	.	O	.	_	0	SENT_631	[p28l12t520r693b577],

1	pdf	NN	O	pdf	_	0	SENT_632	[p28l12t520r693b577],
2	)	NN	O	)	dep	1	SENT_632	[p28l12t520r693b577],
3	.	.	O	.	_	0	SENT_632	[p28l12t520r693b577],

1	2	LS	NUMBER	2	_	0	SENT_633	[p28l12t597r51b636],
2	.	.	O	.	_	0	SENT_633	[p28l12t597r51b636],

1	Thompson	NNP	PERSON	Thompson	nn	2	SENT_634	[p28l107t592r368b648],
2	MA	NNP	PERSON	MA	_	0	SENT_634	[p28l383t596r481b645],
3	,	,	O	,	_	0	SENT_634	[p28l383t596r481b645],
4	Aberg	NNP	PERSON	Aberg	nn	5	SENT_634	[p28l499t592r646b648],
5	IA	NNP	O	IA	appos	2	SENT_634	[p28l655t596r723b645],
6	,	,	O	,	_	0	SENT_634	[p28l655t596r723b645],
7	Hoy	NNP	O	Hoy	nn	8	SENT_634	[p28l743t596r840b648],
8	JF	NNP	O	JF	appos	2	SENT_634	[p28l849t596r909b645],
9	,	,	O	,	_	0	SENT_634	[p28l849t596r909b645],
10	et	FW	O	et	nn	11	SENT_634	[p28l929t601r972b636],
11	al.	FW	O	al.	appos	2	SENT_634	[p28l985t592r1040b636],
12	.	.	O	.	_	0	SENT_634	[p28l985t592r1040b636],

1	Antiretroviral	JJ	O	antiretroviral	amod	2	SENT_635	[p28l10t663r342b707],
2	treatment	NN	O	treatment	_	0	SENT_635	[p28l370t672r607b707],
3	of	IN	O	of	_	0	SENT_635	[p28l633t662r689b707],
4	adult	JJ	O	adult	amod	6	SENT_635	[p28l707t663r829b707],
5	HIV	NN	O	hiv	nn	6	SENT_635	[p28l854t667r952b706],
6	infection	NN	O	infection	prep_of	2	SENT_635	[p28l978t663r1042b706, p28l12t733r192b778],
7	:	:	O	:	_	0	SENT_635	[p28l978t663r1042b706, p28l12t733r192b778],
8	2012	CD	DATE	2012	num	9	SENT_635	[p28l216t737r330b778],
9	recommendations	NNS	O	recommendation	dep	2	SENT_635	[p28l352t734r788b778],
10	of	IN	O	of	_	0	SENT_635	[p28l812t733r868b778],
11	the	DT	O	the	det	14	SENT_635	[p28l879t734r954b778],
12	International	NNP	ORGANIZATION	International	nn	14	SENT_635	[p28l975t738r1042b777, p28l13t805r278b849],
13	Antiviral	NNP	ORGANIZATION	Antiviral	nn	14	SENT_635	[p28l315t805r528b849],
14	Society	NNP	ORGANIZATION	Society	prep_of	9	SENT_635	[p28l568t805r859b861],
15	.	.	O	.	_	0	SENT_635	[p28l568t805r859b861],

1	—	NN	O	—	_	0	SENT_636	[p28l568t805r859b861],
2	.	.	O	.	_	0	SENT_636	[p28l568t805r859b861],

1	USA	NNP	LOCATION	USA	_	0	SENT_637	[p28l568t805r859b861],
2	panel	NN	O	panel	dep	1	SENT_637	[p28l896t805r1040b861],
3	.	.	O	.	_	0	SENT_637	[p28l896t805r1040b861],

1	JAMA	NNP	O	JAMA	_	0	SENT_638	[p28l7t880r153b927],
2	2012	CD	DATE	2012	num	1	SENT_638	[p28l170t879r617b929],
3	;	:	O	;	_	0	SENT_638	[p28l170t879r617b929],
4	308:387	CD	NUMBER	308:387	num	5	SENT_638	[p28l170t879r617b929],
5	—	NN	O	—	dep	1	SENT_638	[p28l170t879r617b929],
6	402	CD	NUMBER	402	dep	5	SENT_638	[p28l170t879r617b929],
7	.	.	O	.	_	0	SENT_638	[p28l170t879r617b929],

1	3	LS	NUMBER	3	_	0	SENT_639	[p28l12t952r49b991],
2	.	.	O	.	_	0	SENT_639	[p28l12t952r49b991],

1	European	JJ	MISC	european	amod	2	SENT_640	[p28l108t951r339b1003],
2	AIDS	NNP	MISC	AIDS	_	0	SENT_640	[p28l355t950r479b991],
3	Clinical	JJ	MISC	clinical	amod	5	SENT_640	[p28l499t947r685b991],
4	Society	NNP	MISC	Society	nn	5	SENT_640	[p28l704t947r874b1003],
5	guidelines	NNS	O	guideline	dep	2	SENT_640	[p28l890t947r1042b1003, p28l12t1018r138b1071],
6	,	,	O	,	_	0	SENT_640	[p28l890t947r1042b1003, p28l12t1018r138b1071],
7	version	NN	O	version	appos	5	SENT_640	[p28l165t1018r337b1062],
8	7.0	CD	NUMBER	7.0	num	9	SENT_640	[p28l364t1021r428b1062],
9	—	CD	NUMBER	—	dep	2	SENT_640	[p28l452t1043r513b1047],
10	October	NNP	DATE	October	tmod	9	SENT_640	[p28l537t1018r730b1062],
11	2013	CD	DATE	2013	num	10	SENT_640	[p28l755t1021r881b1062],
12	.	.	O	.	_	0	SENT_640	[p28l755t1021r881b1062],

1	Paris	NNP	LOCATION	Paris	nsubj	14	SENT_641	[p28l910t1018r1041b1062],
2	:	:	O	:	_	0	SENT_641	[p28l910t1018r1041b1062],
3	European	JJ	MISC	european	amod	4	SENT_641	[p28l12t1093r252b1145],
4	AIDS	NNP	MISC	AIDS	dep	1	SENT_641	[p28l280t1092r408b1133],
5	Clinical	JJ	MISC	clinical	dep	4	SENT_641	[p28l439t1089r634b1133],
6	Society	NNP	MISC	Society	dep	4	SENT_641	[p28l665t1089r843b1145],
7	(	CD	NUMBER	(	num	8	SENT_641	[p28l873t1089r1042b1145],
8	http	NN	O	http	dep	6	SENT_641	[p28l873t1089r1042b1145],
9	:	:	O	:	_	0	SENT_641	[p28l873t1089r1042b1145],
10	/	:	O	/	punct	4	SENT_641	[p28l873t1089r1042b1145],
11	/	:	O	/	punct	13	SENT_641	[p28l873t1089r1042b1145],
12	www.eacsociety.orgl	NN	O	www.eacsociety.orgl	nn	13	SENT_641	[p28l10t1160r1038b1216],
13	Portals/o/Guidelines	NNS	O	portals/o/guidelines	dep	1	SENT_641	[p28l10t1160r1038b1216],
14	_	VBP	O	_	_	0	SENT_641	[p28l10t1230r561b1287],
15	Online_131014	NN	O	online_131014	dobj	14	SENT_641	[p28l10t1230r561b1287],
16	.	.	O	.	_	0	SENT_641	[p28l10t1230r561b1287],

1	pdf	NN	O	pdf	_	0	SENT_642	[p28l10t1230r561b1287],
2	)	NN	O	)	dep	1	SENT_642	[p28l10t1230r561b1287],
3	.	.	O	.	_	0	SENT_642	[p28l10t1230r561b1287],

1	4	LS	NUMBER	4	_	0	SENT_643	[p28l11t1307r51b1346],
2	.	.	O	.	_	0	SENT_643	[p28l11t1307r51b1346],

1	Rozenbaum	NNP	PERSON	Rozenbaum	nn	2	SENT_644	[p28l108t1302r401b1349],
2	W	NNP	O	W	_	0	SENT_644	[p28l421t1306r482b1355],
3	,	,	O	,	_	0	SENT_644	[p28l421t1306r482b1355],
4	Katlama	NNP	PERSON	Katlama	nn	5	SENT_644	[p28l508t1302r715b1347],
5	C	NNP	PERSON	C	appos	2	SENT_644	[p28l737t1305r784b1355],
6	,	,	O	,	_	0	SENT_644	[p28l737t1305r784b1355],
7	Massip	NNP	O	Massip	nn	8	SENT_644	[p28l808t1302r980b1358],
8	P	NN	O	p	appos	2	SENT_644	[p28l1002t1305r1040b1355],
9	,	,	O	,	_	0	SENT_644	[p28l1002t1305r1040b1355],
10	et	FW	O	et	nn	11	SENT_644	[p28l13t1382r56b1417],
11	al.	FW	O	al.	appos	2	SENT_644	[p28l70t1373r125b1417],
12	.	.	O	.	_	0	SENT_644	[p28l70t1373r125b1417],

1	Treatment	NN	O	treatment	nn	2	SENT_645	[p28l143t1376r400b1417],
2	intensification	NN	O	intensification	_	0	SENT_645	[p28l413t1372r774b1417],
3	with	IN	O	with	_	0	SENT_645	[p28l788t1373r899b1417],
4	abacavir	NN	O	abacavir	prep_with	2	SENT_645	[p28l915t1373r1042b1417, p28l12t1444r103b1488],
5	in	IN	O	in	_	0	SENT_645	[p28l121t1444r169b1487],
6	HIV-infected	JJ	MISC	hiv-infected	amod	7	SENT_645	[p28l189t1443r503b1488],
7	patients	NNS	O	patient	prep_in	2	SENT_645	[p28l523t1444r719b1500],
8	with	IN	O	with	_	0	SENT_645	[p28l738t1444r849b1488],
9	at	IN	DURATION	at	quantmod	11	SENT_645	[p28l870t1453r914b1488],
10	least	JJS	DURATION	least	mwe	9	SENT_645	[p28l932t1444r1046b1488],
11	12	CD	DURATION	12	num	12	SENT_645	[p28l14t1518r70b1558],
12	weeks	NNS	NUMBER	week	prep_with	2	SENT_645	[p28l86t1515r234b1559],
13	previous	JJ	O	previous	amod	15	SENT_645	[p28l252t1515r459b1571],
14	lamivudine/zidovudine	NN	O	lamivudine/zidovudine	nn	15	SENT_645	[p28l478t1515r1043b1565],
15	treatment	NN	O	treatment	dep	12	SENT_645	[p28l13t1595r267b1630],
16	.	.	O	.	_	0	SENT_645	[p28l13t1595r267b1630],

1	Antivir	NNP	O	Antivir	nn	2	SENT_646	[p28l287t1586r460b1630],
2	Ther	NNP	O	Ther	_	0	SENT_646	[p28l475t1586r590b1630],
3	2001	CD	DATE	2001	num	2	SENT_646	[p28l608t1589r967b1639],
4	;	:	O	;	_	0	SENT_646	[p28l608t1589r967b1639],
5	6:135	CD	NUMBER	6:135	number	6	SENT_646	[p28l608t1589r967b1639],
6	—	CD	NUMBER	—	dep	2	SENT_646	[p28l608t1589r967b1639],
7	42	CD	NUMBER	42	dep	6	SENT_646	[p28l608t1589r967b1639],
8	.	.	O	.	_	0	SENT_646	[p28l608t1589r967b1639],

1	5	CD	NUMBER	5	_	0	SENT_647	[p28l13t1662r50b1701],
2	.	.	O	.	_	0	SENT_647	[p28l13t1662r50b1701],

1	Katlama	NN	PERSON	katlama	nn	2	SENT_648	[p28l108t1657r316b1702],
2	C	NN	PERSON	c	_	0	SENT_648	[p28l331t1660r378b1710],
3	,	,	O	,	_	0	SENT_648	[p28l331t1660r378b1710],
4	Fenske	NNP	PERSON	Fenske	nn	5	SENT_648	[p28l397t1657r565b1701],
5	S	NNP	O	S	appos	2	SENT_648	[p28l582t1660r621b1710],
6	,	,	O	,	_	0	SENT_648	[p28l582t1660r621b1710],
7	Gazzard	NNP	PERSON	Gazzard	nn	8	SENT_648	[p28l640t1657r846b1701],
8	B	NNP	O	B	appos	2	SENT_648	[p28l862t1660r907b1710],
9	,	,	O	,	_	0	SENT_648	[p28l862t1660r907b1710],
10	et	FW	O	et	nn	11	SENT_648	[p28l927t1666r971b1701],
11	al.	FW	O	al.	appos	2	SENT_648	[p28l985t1657r1040b1701],
12	.	.	O	.	_	0	SENT_648	[p28l985t1657r1040b1701],

1	TRIZAL	NN	ORGANIZATION	trizal	nn	2	SENT_649	[p28l10t1731r206b1774],
2	study	NN	O	study	_	0	SENT_649	[p28l226t1728r368b1784],
3	:	:	O	:	_	0	SENT_649	[p28l226t1728r368b1784],
4	switching	NN	O	switching	dep	2	SENT_649	[p28l391t1728r633b1784],
5	from	IN	O	from	_	0	SENT_649	[p28l651t1727r771b1772],
6	successful	JJ	O	successful	amod	7	SENT_649	[p28l792t1727r1043b1772],
7	HAART	NN	O	haart	prep_from	4	SENT_649	[p28l12t1802r203b1846],
8	to	TO	O	to	_	0	SENT_649	[p28l235t1808r281b1843],
9	Trizivir	FW	O	trizivir	nn	12	SENT_649	[p28l313t1799r495b1843],
10	(	FW	O	(	nn	12	SENT_649	[p28l529t1799r1043b1850],
11	abacavir	FW	O	abacavir	nn	12	SENT_649	[p28l529t1799r1043b1850],
12	—	FW	O	—	prep_to	7	SENT_649	[p28l529t1799r1043b1850],
13	lamivudine	NN	O	lamivudine	nn	16	SENT_649	[p28l529t1799r1043b1850],
14	—	CD	NUMBER	—	num	16	SENT_649	[p28l13t1870r296b1914],
15	zidovudine	NN	O	zidovudine	nn	16	SENT_649	[p28l13t1870r296b1914],
16	combination	NN	O	combination	dep	12	SENT_649	[p28l315t1870r621b1914],
17	tablet	NN	O	tablet	dep	16	SENT_649	[p28l639t1870r802b1921],
18	)	CD	NUMBER	)	num	17	SENT_649	[p28l639t1870r802b1921],
19	:	:	O	:	_	0	SENT_649	[p28l639t1870r802b1921],
20	48	CD	DURATION	48	num	21	SENT_649	[p28l822t1873r879b1914],
21	weeks	NNS	NUMBER	week	dep	2	SENT_649	[p28l896t1870r1042b1914],
22	efficacy	NN	O	efficacy	nn	27	SENT_649	[p28l13t1940r213b1997],
23	,	,	O	,	_	0	SENT_649	[p28l13t1940r213b1997],
24	safety	NN	O	safety	nn	27	SENT_649	[p28l259t1940r403b1997],
25	and	CC	O	and	_	0	SENT_649	[p28l442t1941r531b1985],
26	adherence	NN	O	adherence	nn	27	SENT_649	[p28l573t1941r822b1985],
27	results	NNS	O	result	dep	21	SENT_649	[p28l863t1941r1040b1985],
28	.	.	O	.	_	0	SENT_649	[p28l863t1941r1040b1985],

1	HIV	NN	O	hiv	nsubj	2	SENT_650	[p28l12t2017r111b2056],
2	Med	VBD	O	med	_	0	SENT_650	[p28l126t2013r232b2057],
3	2003	CD	DATE	2003	dobj	2	SENT_650	[p28l251t2016r580b2066],
4	;	:	O	;	_	0	SENT_650	[p28l251t2016r580b2066],
5	4:79	CD	NUMBER	4:79	num	6	SENT_650	[p28l251t2016r580b2066],
6	-86	CD	NUMBER	-86	dep	3	SENT_650	[p28l251t2016r580b2066],
7	.	.	O	.	_	0	SENT_650	[p28l251t2016r580b2066],

1	6	CD	NUMBER	6	_	0	SENT_651	[p28l12t2088r51b2127],
2	.	.	O	.	_	0	SENT_651	[p28l12t2088r51b2127],

1	Min	NN	DURATION	min	nn	2	SENT_652	[p28l107t2083r204b2126],
2	S	NN	O	s	_	0	SENT_652	[p28l221t2086r259b2136],
3	,	,	O	,	_	0	SENT_652	[p28l221t2086r259b2136],
4	Song	NN	O	song	nn	5	SENT_652	[p28l279t2086r398b2139],
5	I	NN	O	i	appos	2	SENT_652	[p28l411t2087r440b2136],
6	,	,	O	,	_	0	SENT_652	[p28l411t2087r440b2136],
7	Borland	NNP	ORGANIZATION	Borland	nn	8	SENT_652	[p28l458t2083r649b2127],
8	J	NNP	O	J	appos	2	SENT_652	[p28l659t2087r691b2136],
9	,	,	O	,	_	0	SENT_652	[p28l659t2087r691b2136],
10	et	FW	O	et	nn	11	SENT_652	[p28l710t2092r753b2127],
11	al.	FW	O	al.	appos	2	SENT_652	[p28l766t2083r820b2127],
12	.	.	O	.	_	0	SENT_652	[p28l766t2083r820b2127],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_653	[p28l838t2083r1042b2127, p28l13t2154r261b2198],
2	and	CC	O	and	_	0	SENT_653	[p28l283t2154r372b2198],
3	safety	NN	O	safety	conj_and	1	SENT_653	[p28l393t2153r538b2210],
4	of	IN	O	of	_	0	SENT_653	[p28l556t2153r613b2198],
5	S/GSK1349572	NN	O	s/gsk1349572	prep_of	1	SENT_653	[p28l624t2157r996b2207],
6	,	,	O	,	_	0	SENT_653	[p28l624t2157r996b2207],
7	a	DT	O	a	det	11	SENT_653	[p28l1019t2168r1044b2198],
8	next-generation	JJ	O	next-generation	amod	11	SENT_653	[p28l12t2225r398b2281],
9	HIV	NN	MISC	hiv	nn	11	SENT_653	[p28l428t2229r527b2268],
10	integrase	NN	O	integrase	nn	11	SENT_653	[p28l554t2225r780b2281],
11	inhibitor	NN	O	inhibitor	appos	5	SENT_653	[p28l810t2225r1040b2278],
12	,	,	O	,	_	0	SENT_653	[p28l810t2225r1040b2278],
13	in	IN	O	in	_	0	SENT_653	[p28l12t2296r59b2339],
14	healthy	JJ	O	healthy	amod	15	SENT_653	[p28l81t2296r262b2352],
15	volunteers	NNS	O	volunteer	prep_in	1	SENT_653	[p28l279t2296r547b2340],
16	.	.	O	.	_	0	SENT_653	[p28l279t2296r547b2340],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_654	[p28l570t2296r853b2340],
2	Agents	NNPS	O	Agents	nn	3	SENT_654	[p28l873t2300r1042b2352],
3	Chemother	NNP	O	Chemother	_	0	SENT_654	[p28l12t2367r287b2411],
4	2010	CD	DATE	2010	dep	3	SENT_654	[p28l304t2370r665b2420],
5	;	:	O	;	_	0	SENT_654	[p28l304t2370r665b2420],
6	54:254	CD	NUMBER	54:254	number	7	SENT_654	[p28l304t2370r665b2420],
7	—	CD	NUMBER	—	dep	3	SENT_654	[p28l304t2370r665b2420],
8	8	CD	NUMBER	8	dep	7	SENT_654	[p28l304t2370r665b2420],
9	.	.	O	.	_	0	SENT_654	[p28l304t2370r665b2420],

1	7	CD	NUMBER	7	_	0	SENT_655	[p28l13t2443r47b2482],
2	.	.	O	.	_	0	SENT_655	[p28l13t2443r47b2482],

1	van	NNP	PERSON	van	nn	3	SENT_656	[p28l106t2452r192b2482],
2	Lunzen	NNP	PERSON	Lunzen	nn	3	SENT_656	[p28l226t2442r411b2482],
3	J	NNP	PERSON	J	_	0	SENT_656	[p28l440t2442r473b2491],
4	,	,	O	,	_	0	SENT_656	[p28l440t2442r473b2491],
5	Maggiolo	NNP	O	Maggiolo	nn	6	SENT_656	[p28l509t2438r747b2494],
6	F	NN	O	f	appos	3	SENT_656	[p28l781t2442r820b2491],
7	,	,	O	,	_	0	SENT_656	[p28l781t2442r820b2491],
8	Arribas	NNP	PERSON	Arribas	nn	9	SENT_656	[p28l856t2438r1042b2482],
9	JR	NNP	O	JR	appos	3	SENT_656	[p28l7t2512r81b2562],
10	,	,	O	,	_	0	SENT_656	[p28l7t2512r81b2562],
11	et	FW	O	et	nn	12	SENT_656	[p28l125t2518r170b2553],
12	al.	FW	O	al.	appos	3	SENT_656	[p28l208t2509r265b2553],
13	.	.	O	.	_	0	SENT_656	[p28l208t2509r265b2553],

1	Once	RB	DATE	once	dep	3	SENT_657	[p28l309t2512r434b2553],
2	daily	JJ	SET	daily	amod	3	SENT_657	[p28l476t2509r597b2565],
3	dolutegravir	NN	O	dolutegravir	dep	7	SENT_657	[p28l636t2509r942b2565],
4	(	CD	NUMBER	(	num	7	SENT_657	[p28l984t2512r1042b2560],
5	SI	NNP	O	SI	nn	7	SENT_657	[p28l984t2512r1042b2560],
6	GSK1349572	NNP	O	GSK1349572	nn	7	SENT_657	[p28l1118t27r1455b75],
7	)	NN	O	)	dep	15	SENT_657	[p28l1118t27r1455b75],
8	in	IN	O	in	_	0	SENT_657	[p28l1480t24r1528b67],
9	combination	NN	O	combination	nn	10	SENT_657	[p28l1552t24r1870b68],
10	therapy	NN	O	therapy	prep_in	7	SENT_657	[p28l1893t24r2082b80],
11	in	IN	O	in	_	0	SENT_657	[p28l2101t24r2149b67],
12	antiretroviral	JJ	O	antiretroviral	amod	13	SENT_657	[p28l1118t95r1607b139],
13	—	NN	O	—	prep_in	10	SENT_657	[p28l1118t95r1607b139],
14	naive	JJ	O	naive	amod	15	SENT_657	[p28l1118t95r1607b139],
15	adults	NNS	O	adult	dep	19	SENT_657	[p28l1663t95r1813b139],
16	with	IN	O	with	_	0	SENT_657	[p28l1868t95r1981b139],
17	HIV	NN	MISC	hiv	prep_with	15	SENT_657	[p28l2037t99r2147b139],
18	:	:	O	:	_	0	SENT_657	[p28l2037t99r2147b139],
19	planned	VBN	O	plan	_	0	SENT_657	[p28l1118t166r1321b222],
20	interim	JJ	O	interim	amod	22	SENT_657	[p28l1355t166r1541b210],
21	48	CD	DURATION	48	num	22	SENT_657	[p28l1574t169r1633b210],
22	week	NN	NUMBER	week	nsubj	23	SENT_657	[p28l1665t166r1794b210],
23	results	VBZ	O	result	ccomp	19	SENT_657	[p28l1826t166r1992b210],
24	from	IN	O	from	_	0	SENT_657	[p28l2028t165r2149b210],
25	SPRING	VBG	O	spring	prepc_from	23	SENT_657	[p28l1120t240r1382b290],
26	—	CD	NUMBER	—	number	27	SENT_657	[p28l1120t240r1382b290],
27	1	CD	NUMBER	1	dobj	25	SENT_657	[p28l1120t240r1382b290],
28	,	,	O	,	_	0	SENT_657	[p28l1120t240r1382b290],
29	a	DT	O	a	det	31	SENT_657	[p28l1409t251r1434b281],
30	dose	NN	O	dose	nn	31	SENT_657	[p28l1458t237r1805b293],
31	—	NN	O	—	appos	27	SENT_657	[p28l1458t237r1805b293],
32	ranging	VBG	O	range	partmod	31	SENT_657	[p28l1458t237r1805b293],
33	,	,	O	,	_	0	SENT_657	[p28l1458t237r1805b293],
34	randomised	VBN	O	randomise	dep	19	SENT_657	[p28l1832t237r2146b290],
35	,	,	O	,	_	0	SENT_657	[p28l1832t237r2146b290],
36	phase	NN	O	phase	nn	38	SENT_657	[p28l1118t308r1262b364],
37	2b	JJ	O	2b	amod	38	SENT_657	[p28l1293t308r1350b352],
38	trial	NN	O	trial	dobj	19	SENT_657	[p28l1382t308r1500b352],
39	.	.	O	.	_	0	SENT_657	[p28l1382t308r1500b352],

1	Lancet	NNP	O	Lancet	nn	3	SENT_658	[p28l1533t312r1700b352],
2	Infect	NNP	O	Infect	nn	3	SENT_658	[p28l1727t307r1875b352],
3	Dis	NNP	O	Dis	_	0	SENT_658	[p28l1902t308r1982b352],
4	2012	CD	DATE	2012	num	3	SENT_658	[p28l2014t311r2147b361],
5	;	:	O	;	_	0	SENT_658	[p28l2014t311r2147b361],
6	12:111	CD	NUMBER	12:111	number	7	SENT_658	[p28l1120t382r1340b423],
7	—	CD	NUMBER	—	dep	3	SENT_658	[p28l1120t382r1340b423],
8	8	CD	NUMBER	8	dep	7	SENT_658	[p28l1120t382r1340b423],
9	.	.	O	.	_	0	SENT_658	[p28l1120t382r1340b423],

1	8	CD	NUMBER	8	_	0	SENT_659	[p28l1118t454r1158b494],
2	.	.	O	.	_	0	SENT_659	[p28l1118t454r1158b494],

1	Hightower	NNP	PERSON	Hightower	nn	2	SENT_660	[p28l1214t450r1483b506],
2	KE	NNP	PERSON	KE	_	0	SENT_660	[p28l1512t454r1597b503],
3	,	,	O	,	_	0	SENT_660	[p28l1512t454r1597b503],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_660	[p28l1630t454r1774b506],
5	R	NNP	PERSON	R	appos	2	SENT_660	[p28l1803t453r1853b503],
6	,	,	O	,	_	0	SENT_660	[p28l1803t453r1853b503],
7	Deanda	NNP	PERSON	Deanda	nn	8	SENT_660	[p28l1886t450r2078b494],
8	F	NN	O	f	appos	2	SENT_660	[p28l2107t454r2146b503],
9	,	,	O	,	_	0	SENT_660	[p28l2107t454r2146b503],
10	et	FW	O	et	nn	11	SENT_660	[p28l1119t530r1163b565],
11	al.	FW	O	al.	appos	2	SENT_660	[p28l1181t521r1234b565],
12	.	.	O	.	_	0	SENT_660	[p28l1181t521r1234b565],

1	Dolutegravir	NNP	O	Dolutegravir	nsubj	5	SENT_661	[p28l1254t521r1551b577],
2	(	CD	NUMBER	(	num	4	SENT_661	[p28l1569t524r1943b572],
3	S/GSK1349572	NN	O	s/gsk1349572	nn	4	SENT_661	[p28l1569t524r1943b572],
4	)	NN	O	)	dep	1	SENT_661	[p28l1569t524r1943b572],
5	exhibits	VBZ	O	exhibit	_	0	SENT_661	[p28l1964t521r2148b565],
6	significantly	RB	O	significantly	advmod	7	SENT_661	[p28l1119t591r1438b648],
7	slower	JJR	O	slower	amod	8	SENT_661	[p28l1481t592r1642b636],
8	dissociation	NN	O	dissociation	dobj	5	SENT_661	[p28l1686t592r1991b636],
9	than	IN	O	than	_	0	SENT_661	[p28l2036t592r2149b636],
10	raltegravir	NN	O	raltegravir	prep_than	8	SENT_661	[p28l1119t663r1370b719],
11	and	CC	O	and	_	0	SENT_661	[p28l1389t663r1477b707],
12	elvitegravir	NN	O	elvitegravir	conj_and	10	SENT_661	[p28l1498t663r1767b719],
13	from	IN	O	from	_	0	SENT_661	[p28l1786t662r1904b707],
14	wild	JJ	O	wild	amod	16	SENT_661	[p28l1922t663r2149b719],
15	—	NN	O	—	nn	16	SENT_661	[p28l1922t663r2149b719],
16	type	NN	O	type	nn	23	SENT_661	[p28l1922t663r2149b719],
17	and	CC	O	and	_	0	SENT_661	[p28l1118t734r1209b778],
18	integrase	NN	O	integrase	nn	20	SENT_661	[p28l1245t734r1476b790],
19	inhibitor	NN	O	inhibitor	nn	20	SENT_661	[p28l1512t734r1974b778],
20	—	NN	O	—	nn	23	SENT_661	[p28l1512t734r1974b778],
21	resistant	JJ	O	resistant	amod	23	SENT_661	[p28l1512t734r1974b778],
22	HIV-1	NN	MISC	hiv-1	nn	23	SENT_661	[p28l2007t737r2149b777],
23	integrase	NN	O	integrase	prep_from	5	SENT_661	[p28l1118t805r1491b861],
24	.	.	O	.	_	0	SENT_661	[p28l1118t805r1491b861],

1	—	NN	O	—	_	0	SENT_662	[p28l1118t805r1491b861],
2	.	.	O	.	_	0	SENT_662	[p28l1118t805r1491b861],

1	DNA	NN	O	dna	nn	2	SENT_663	[p28l1118t805r1491b861],
2	complexes	NNS	O	complex	_	0	SENT_663	[p28l1537t805r1811b861],
3	.	.	O	.	_	0	SENT_663	[p28l1537t805r1811b861],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_664	[p28l1860t805r2148b849],
2	Agents	NNPS	O	Agents	nn	3	SENT_664	[p28l1117t880r1285b932],
3	Chemother	NNP	O	Chemother	_	0	SENT_664	[p28l1305t876r1580b920],
4	2011	CD	DATE	2011	dep	3	SENT_664	[p28l1598t879r1975b929],
5	;	:	O	;	_	0	SENT_664	[p28l1598t879r1975b929],
6	55:4552	CD	NUMBER	55:4552	number	7	SENT_664	[p28l1598t879r1975b929],
7	—	CD	NUMBER	—	dep	3	SENT_664	[p28l1598t879r1975b929],
8	9	CD	NUMBER	9	dep	7	SENT_664	[p28l1598t879r1975b929],
9	.	.	O	.	_	0	SENT_664	[p28l1598t879r1975b929],

1	9	CD	NUMBER	9	_	0	SENT_665	[p28l1118t952r1156b991],
2	.	.	O	.	_	0	SENT_665	[p28l1118t952r1156b991],

1	Eron	NNP	PERSON	Eron	nn	2	SENT_666	[p28l1214t951r1329b991],
2	H	NNP	PERSON	H	_	0	SENT_666	[p28l1340t951r1391b1000],
3	,	,	O	,	_	0	SENT_666	[p28l1340t951r1391b1000],
4	Clotet	NNP	PERSON	Clotet	nn	5	SENT_666	[p28l1411t947r1558b991],
5	B	NNP	PERSON	B	appos	2	SENT_666	[p28l1570t950r1616b1000],
6	,	,	O	,	_	0	SENT_666	[p28l1570t950r1616b1000],
7	Durant	NNP	PERSON	Durant	appos	2	SENT_666	[p28l1635t950r1810b991],
8	I	PRP	O	I	dep	7	SENT_666	[p28l1818t951r1850b1000],
9	,	,	O	,	_	0	SENT_666	[p28l1818t951r1850b1000],
10	et	FW	O	et	nn	11	SENT_666	[p28l1870t956r1914b991],
11	al.	FW	O	al.	appos	2	SENT_666	[p28l1927t947r1982b991],
12	.	.	O	.	_	0	SENT_666	[p28l1927t947r1982b991],

1	Safety	NN	O	safety	_	0	SENT_667	[p28l2003t946r2152b1003],
2	and	CC	O	and	_	0	SENT_667	[p28l1118t1018r1208b1062],
3	efficacy	NN	O	efficacy	conj_and	1	SENT_667	[p28l1228t1017r1421b1074],
4	of	IN	O	of	_	0	SENT_667	[p28l1439t1017r1496b1062],
5	dolutegravir	NN	O	dolutegravir	prep_of	1	SENT_667	[p28l1506t1018r1806b1074],
6	in	IN	O	in	_	0	SENT_667	[p28l1824t1018r1872b1061],
7	treatmentexperienced	JJ	O	treatmentexperienced	amod	8	SENT_667	[p28l1892t1027r2148b1062, p28l1119t1089r1417b1145],
8	subjects	NNS	O	subject	prep_in	5	SENT_667	[p28l1465t1089r1663b1145],
9	with	IN	O	with	_	0	SENT_667	[p28l1708t1089r1821b1133],
10	raltegravirresistant	JJ	O	raltegravirresistant	amod	14	SENT_667	[p28l1867t1089r2148b1145, p28l1119t1160r1333b1204],
11	HIV	NN	MISC	hiv	nn	14	SENT_667	[p28l1361t1164r1460b1203],
12	type	NN	O	type	nn	14	SENT_667	[p28l1489t1169r1592b1216],
13	1	CD	NUMBER	1	num	14	SENT_667	[p28l1625t1163r1649b1203],
14	infection	NN	O	infection	prep_with	8	SENT_667	[p28l1680t1159r1915b1204],
15	:	:	O	:	_	0	SENT_667	[p28l1680t1159r1915b1204],
16	24-week	JJ	DURATION	24-week	amod	17	SENT_667	[p28l1948t1160r2152b1204],
17	results	NNS	O	result	dep	1	SENT_667	[p28l1119t1231r1281b1275],
18	of	IN	O	of	_	0	SENT_667	[p28l1305t1230r1362b1275],
19	the	DT	O	the	det	21	SENT_667	[p28l1376t1231r1451b1275],
20	VIKING	NNP	O	VIKING	nn	21	SENT_667	[p28l1473t1234r1672b1276],
21	Study	NNP	O	Study	prep_of	17	SENT_667	[p28l1698t1231r1841b1287],
22	.	.	O	.	_	0	SENT_667	[p28l1698t1231r1841b1287],

1	J	NNP	O	J	nn	3	SENT_668	[p28l1862t1235r1883b1282],
2	Infect	NNP	O	Infect	nn	3	SENT_668	[p28l1905t1230r2049b1275],
3	Dis	NNP	O	Dis	_	0	SENT_668	[p28l2069t1231r2148b1275],
4	2013	CD	DATE	2013	num	3	SENT_668	[p28l1119t1305r1500b1355],
5	;	:	O	;	_	0	SENT_668	[p28l1119t1305r1500b1355],
6	207:740	CD	NUMBER	207:740	number	7	SENT_668	[p28l1119t1305r1500b1355],
7	—	CD	NUMBER	—	dep	3	SENT_668	[p28l1119t1305r1500b1355],
8	8	CD	NUMBER	8	dep	7	SENT_668	[p28l1119t1305r1500b1355],
9	.	.	O	.	_	0	SENT_668	[p28l1119t1305r1500b1355],

1	10	CD	NUMBER	10	_	0	SENT_669	[p28l1120t1377r1181b1417],
2	.	.	O	.	_	0	SENT_669	[p28l1120t1377r1181b1417],

1	Declaration	NN	O	declaration	_	0	SENT_670	[p28l1214t1373r1489b1417],
2	of	IN	O	of	_	0	SENT_670	[p28l1511t1372r1566b1417],
3	Helsinki	NNP	LOCATION	Helsinki	prep_of	1	SENT_670	[p28l1578t1373r1790b1417],
4	:	:	O	:	_	0	SENT_670	[p28l1578t1373r1790b1417],
5	ethical	JJ	O	ethical	amod	6	SENT_670	[p28l1814t1373r1972b1417],
6	principles	NNS	O	principle	dep	1	SENT_670	[p28l1993t1373r2148b1429, p28l1118t1444r1210b1500],
7	for	IN	O	for	_	0	SENT_670	[p28l1232t1443r1300b1488],
8	medical	JJ	O	medical	amod	9	SENT_670	[p28l1319t1444r1506b1488],
9	research	NN	O	research	prep_for	6	SENT_670	[p28l1526t1444r1725b1488],
10	involving	VBG	O	involve	partmod	9	SENT_670	[p28l1745t1444r1963b1500],
11	human	JJ	O	human	amod	12	SENT_670	[p28l1982t1444r2149b1488],
12	subjects	NNS	O	subject	dobj	10	SENT_670	[p28l1119t1515r1333b1571],
13	.	.	O	.	_	0	SENT_670	[p28l1119t1515r1333b1571],

1	Ferney	NNP	PERSON	Ferney	_	0	SENT_671	[p28l1364t1515r1757b1571],
2	.	.	O	.	_	0	SENT_671	[p28l1364t1515r1757b1571],

1	—	NN	O	—	_	0	SENT_672	[p28l1364t1515r1757b1571],
2	.	.	O	.	_	0	SENT_672	[p28l1364t1515r1757b1571],

1	Voltaire	NNP	PERSON	Voltaire	nn	3	SENT_673	[p28l1364t1515r1757b1571],
2	,	,	O	,	_	0	SENT_673	[p28l1364t1515r1757b1571],
3	France	NNP	LOCATION	France	_	0	SENT_673	[p28l1788t1519r1968b1559],
4	:	:	O	:	_	0	SENT_673	[p28l1788t1519r1968b1559],
5	World	NNP	ORGANIZATION	World	nn	7	SENT_673	[p28l1998t1515r2149b1559],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_673	[p28l1117t1586r1316b1630],
7	Association	NNP	ORGANIZATION	Association	dep	3	SENT_673	[p28l1346t1586r1656b1639],
8	,	,	O	,	_	0	SENT_673	[p28l1346t1586r1656b1639],
9	2008	CD	DATE	2008	num	11	SENT_673	[p28l1691t1589r1810b1630],
10	(	CD	NUMBER	(	num	11	SENT_673	[p28l1846t1586r2151b1642],
11	http	NN	O	http	appos	7	SENT_673	[p28l1846t1586r2151b1642],
12	:	:	O	:	_	0	SENT_673	[p28l1846t1586r2151b1642],
13	l/www	NN	O	l/www	dep	7	SENT_673	[p28l1846t1586r2151b1642],
14	.	.	O	.	_	0	SENT_673	[p28l1121t1657r2110b1713],

1	wma.net/enl30publicationsl10policies/	NN	O	wma.net/enl30publicationsl10policies/	_	0	SENT_674	[p28l1121t1657r2110b1713],
2	b3/17c	NN	O	b3/17c	dep	1	SENT_674	[p28l1119t1727r1415b1784],
3	.	.	O	.	_	0	SENT_674	[p28l1119t1727r1415b1784],

1	pdﬂ	NN	O	pdﬂ	_	0	SENT_675	[p28l1119t1727r1415b1784],
2	.	.	O	.	_	0	SENT_675	[p28l1119t1727r1415b1784],

1	11	CD	NUMBER	11	_	0	SENT_676	[p28l1120t1804r1183b1843],
2	.	.	O	.	_	0	SENT_676	[p28l1120t1804r1183b1843],

1	Mallal	JJ	O	mallal	amod	2	SENT_677	[p28l1213t1799r1369b1843],
2	S	NN	O	s	_	0	SENT_677	[p28l1398t1802r1437b1852],
3	,	,	O	,	_	0	SENT_677	[p28l1398t1802r1437b1852],
4	Phillips	NNP	PERSON	Phillips	nn	5	SENT_677	[p28l1467t1799r1652b1855],
5	E	NNP	O	E	appos	2	SENT_677	[p28l1681t1803r1724b1852],
6	,	,	O	,	_	0	SENT_677	[p28l1681t1803r1724b1852],
7	Carosi	NNP	PERSON	Carosi	nn	8	SENT_677	[p28l1755t1799r1912b1843],
8	G	NNP	PERSON	G	appos	2	SENT_677	[p28l1939t1802r1991b1852],
9	,	,	O	,	_	0	SENT_677	[p28l1939t1802r1991b1852],
10	et	FW	O	et	nn	11	SENT_677	[p28l2022t1808r2066b1843],
11	al.	FW	O	al.	appos	2	SENT_677	[p28l2091t1799r2146b1843],
12	.	.	O	.	_	0	SENT_677	[p28l2091t1799r2146b1843],

1	HLA-B	NN	O	hla-b	_	0	SENT_678	[p28l1118t1870r1419b1914],
2	*	CD	NUMBER	*	number	3	SENT_678	[p28l1118t1870r1419b1914],
3	5701	CD	NUMBER	5701	num	4	SENT_678	[p28l1118t1870r1419b1914],
4	screening	NN	O	screening	dep	1	SENT_678	[p28l1437t1870r1671b1926],
5	for	IN	O	for	_	0	SENT_678	[p28l1686t1869r1756b1914],
6	hypersensitivity	NN	O	hypersensitivity	prep_for	4	SENT_678	[p28l1771t1870r2152b1926],
7	to	TO	O	to	_	0	SENT_678	[p28l1119t1950r1164b1985],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_678	[p28l1181t1941r1391b1985],
9	.	.	O	.	_	0	SENT_678	[p28l1181t1941r1391b1985],

1	N	NN	O	n	nn	2	SENT_679	[p28l1410t1945r1452b1985],
2	EnglJ	NN	O	englj	nsubj	3	SENT_679	[p28l1467t1941r1608b1997],
3	Med	VBD	O	med	_	0	SENT_679	[p28l1622t1941r1726b1985],
4	2008	CD	DATE	2008	dobj	3	SENT_679	[p28l1743t1944r2146b1994],
5	;	:	O	;	_	0	SENT_679	[p28l1743t1944r2146b1994],
6	358:568	CD	NUMBER	358:568	number	7	SENT_679	[p28l1743t1944r2146b1994],
7	—	CD	NUMBER	—	dep	4	SENT_679	[p28l1743t1944r2146b1994],
8	79	CD	NUMBER	79	dep	7	SENT_679	[p28l1743t1944r2146b1994],
9	.	.	O	.	_	0	SENT_679	[p28l1743t1944r2146b1994],

1	12	CD	NUMBER	12	_	0	SENT_680	[p28l1120t2018r1185b2057],
2	.	.	O	.	_	0	SENT_680	[p28l1120t2018r1185b2057],

1	Raffi	NNP	PERSON	Raffi	nn	2	SENT_681	[p28l1214t2012r1340b2059],
2	F	NN	PERSON	f	_	0	SENT_681	[p28l1356t2017r1394b2066],
3	,	,	O	,	_	0	SENT_681	[p28l1356t2017r1394b2066],
4	Rachlis	NNP	PERSON	Rachlis	nn	5	SENT_681	[p28l1414t2013r1595b2059],
5	A	NNP	O	A	appos	2	SENT_681	[p28l1612t2017r1661b2066],
6	,	,	O	,	_	0	SENT_681	[p28l1612t2017r1661b2066],
7	Stellbrink	NNP	O	Stellbrink	nn	9	SENT_681	[p28l1683t2013r1926b2057],
8	H	NNP	O	H	nn	9	SENT_681	[p28l1940t2017r2012b2066],
9	]	NN	O	]	appos	2	SENT_681	[p28l1940t2017r2012b2066],
10	,	,	O	,	_	0	SENT_681	[p28l1940t2017r2012b2066],
11	et	FW	O	et	nn	12	SENT_681	[p28l2033t2022r2077b2057],
12	al.	FW	O	al.	appos	2	SENT_681	[p28l2090t2013r2146b2057],
13	.	.	O	.	_	0	SENT_681	[p28l2090t2013r2146b2057],

1	Once	RB	DATE	once	advmod	18	SENT_682	[p28l1119t2083r1385b2139],
2	—	CD	NUMBER	—	num	4	SENT_682	[p28l1119t2083r1385b2139],
3	daily	JJ	SET	daily	amod	4	SENT_682	[p28l1119t2083r1385b2139],
4	dolutegravir	NN	O	dolutegravir	pobj	1	SENT_682	[p28l1404t2083r1703b2139],
5	versus	CC	O	versus	prep	4	SENT_682	[p28l1719t2097r1871b2127],
6	raltegravir	NN	O	raltegravir	dep	5	SENT_682	[p28l1893t2083r2151b2139],
7	in	IN	O	in	_	0	SENT_682	[p28l1118t2154r1165b2197],
8	antiretroviral	JJ	O	antiretroviral	amod	11	SENT_682	[p28l1193t2154r1668b2198],
9	—	NN	O	—	npadvmod	10	SENT_682	[p28l1193t2154r1668b2198],
10	naive	JJ	O	naive	amod	11	SENT_682	[p28l1193t2154r1668b2198],
11	adults	NNS	O	adult	prep_in	1	SENT_682	[p28l1697t2154r1843b2198],
12	with	IN	O	with	_	0	SENT_682	[p28l1870t2154r1982b2198],
13	HIV-1	NN	O	hiv-1	nn	14	SENT_682	[p28l2010t2157r2149b2197],
14	infection	NN	O	infection	prep_with	1	SENT_682	[p28l1118t2224r1353b2269],
15	:	:	O	:	_	0	SENT_682	[p28l1118t2224r1353b2269],
16	48	CD	DURATION	48	num	17	SENT_682	[p28l1381t2228r1438b2269],
17	week	NN	NUMBER	week	dep	14	SENT_682	[p28l1463t2225r1590b2269],
18	results	VBZ	O	result	_	0	SENT_682	[p28l1613t2225r1775b2269],
19	from	IN	O	from	_	0	SENT_682	[p28l1803t2224r1922b2269],
20	the	DT	O	the	prep_from	18	SENT_682	[p28l1948t2225r2024b2269],
21	randomised	VBN	O	randomise	partmod	20	SENT_682	[p28l2050t2239r2148b2269, p28l1119t2296r1346b2349],
22	,	,	O	,	_	0	SENT_682	[p28l2050t2239r2148b2269, p28l1119t2296r1346b2349],
23	double	JJ	O	double	amod	31	SENT_682	[p28l1396t2296r1730b2349],
24	—	RB	O	—	advmod	27	SENT_682	[p28l1396t2296r1730b2349],
25	blind	JJ	O	blind	amod	27	SENT_682	[p28l1396t2296r1730b2349],
26	,	,	O	,	_	0	SENT_682	[p28l1396t2296r1730b2349],
27	non	JJ	O	non	amod	31	SENT_682	[p28l1779t2295r2152b2352],
28	—	NN	O	—	nn	31	SENT_682	[p28l1779t2295r2152b2352],
29	inferiority	NN	O	inferiority	nn	31	SENT_682	[p28l1779t2295r2152b2352],
30	SPRING	NN	DATE	spring	nn	31	SENT_682	[p28l1120t2370r1363b2414],
31	—	NN	O	—	appos	20	SENT_682	[p28l1120t2370r1363b2414],
32	2	CD	NUMBER	2	num	33	SENT_682	[p28l1120t2370r1363b2414],
33	study	NN	O	study	nsubj	18	SENT_682	[p28l1383t2367r1522b2423],
34	.	.	O	.	_	0	SENT_682	[p28l1383t2367r1522b2423],

1	Lancet	NNP	O	Lancet	_	0	SENT_683	[p28l1544t2371r1708b2411],
2	2013	CD	DATE	2013	num	1	SENT_683	[p28l1725t2370r2138b2420],
3	;	:	O	;	_	0	SENT_683	[p28l1725t2370r2138b2420],
4	381:735	CD	NUMBER	381:735	number	5	SENT_683	[p28l1725t2370r2138b2420],
5	—	CD	NUMBER	—	dep	1	SENT_683	[p28l1725t2370r2138b2420],
6	43	CD	NUMBER	43	dep	5	SENT_683	[p28l1725t2370r2138b2420],
7	.	.	O	.	_	0	SENT_683	[p28l1725t2370r2138b2420],

1	13	CD	NUMBER	13	_	0	SENT_684	[p28l1120t2443r1183b2482],
2	.	.	O	.	_	0	SENT_684	[p28l1120t2443r1183b2482],

1	Sax	NNP	O	Sax	nn	2	SENT_685	[p28l1216t2441r1299b2482],
2	PE	NNP	O	PE	_	0	SENT_685	[p28l1319t2441r1393b2491],
3	,	,	O	,	_	0	SENT_685	[p28l1319t2441r1393b2491],
4	DeJesus	NNP	PERSON	DeJesus	nn	5	SENT_685	[p28l1418t2441r1606b2489],
5	E	NNP	O	E	appos	2	SENT_685	[p28l1630t2442r1673b2491],
6	,	,	O	,	_	0	SENT_685	[p28l1630t2442r1673b2491],
7	Mills	NNP	PERSON	Mills	nn	8	SENT_685	[p28l1698t2438r1821b2482],
8	A	NNP	O	A	appos	2	SENT_685	[p28l1843t2442r1893b2491],
9	,	,	O	,	_	0	SENT_685	[p28l1843t2442r1893b2491],
10	et	FW	O	et	nn	11	SENT_685	[p28l1919t2447r1963b2482],
11	al.	FW	O	al.	appos	2	SENT_685	[p28l1983t2438r2038b2482],
12	.	.	O	.	_	0	SENT_685	[p28l1983t2438r2038b2482],

1	Coformulated	VBN	O	coformulate	_	0	SENT_686	[p28l2064t2441r2148b2482, p28l1119t2508r1386b2553],
2	elvitegravir	NN	O	elvitegravir	nn	7	SENT_686	[p28l1402t2509r1681b2565],
3	,	,	O	,	_	0	SENT_686	[p28l1402t2509r1681b2565],
4	cobicistat	NN	O	cobicistat	dep	7	SENT_686	[p28l1700t2509r1942b2562],
5	,	,	O	,	_	0	SENT_686	[p28l1700t2509r1942b2562],
6	emtrici	NN	O	emtricus	dep	7	SENT_686	[p28l1961t2509r2148b2553],
7	—	NN	O	—	dobj	1	SENT_686	[p28l1961t2509r2148b2553],

1	tabine	NN	O	tabine	_	0	SENT_687	[p28l12t2866r339b2976],
2	,	,	O	,	_	0	SENT_687	[p28l12t2866r339b2976],
3	and	CC	O	and	_	0	SENT_687	[p28l391t2866r572b2956],
4	tenofovir	NN	O	tenofovir	conj_and	1	SENT_687	[p28l620t2864r1061b2958],
5	versus	CC	O	versus	prep	4	SENT_687	[p28l1100t2896r1404b2958],
6	co-formulated	JJ	O	co-formulated	amod	7	SENT_687	[p28l1453t2864r2147b2958],
7	efavirenz	NN	O	efavirenz	dep	5	SENT_687	[p28l12t3014r503b3126],
8	,	,	O	,	_	0	SENT_687	[p28l12t3014r503b3126],
9	emtricitabine	NN	O	emtricitabine	appos	7	SENT_687	[p28l544t3016r1252b3126],
10	,	,	O	,	_	0	SENT_687	[p28l544t3016r1252b3126],
11	and	CC	O	and	_	0	SENT_687	[p28l1292t3016r1477b3106],
12	tenofovir	NN	O	tenofovir	conj_and	1	SENT_687	[p28l1513t3014r1974b3108],
13	for	IN	O	for	_	0	SENT_687	[p28l2005t3014r2151b3106],
14	initial	JJ	O	initial	amod	15	SENT_687	[p28l10t3166r315b3256],
15	treatment	NN	O	treatment	prep_for	12	SENT_687	[p28l349t3184r851b3256],
16	of	IN	O	of	dep	1	SENT_687	[p28l879t3164r997b3256],
17	HIV-1	NN	O	hiv-1	nn	18	SENT_687	[p28l1009t3172r1298b3256],
18	infection	NN	O	infection	pobj	16	SENT_687	[p28l1332t3164r1820b3256],
19	:	:	O	:	_	0	SENT_687	[p28l1332t3164r1820b3256],
20	a	DT	O	a	dep	18	SENT_687	[p28l1858t3196r1910b3256],
21	randomised	VBN	O	randomise	partmod	20	SENT_687	[p28l1941t3196r2145b3256, p28l12t3316r483b3426],
22	,	,	O	,	_	0	SENT_687	[p28l1941t3196r2145b3256, p28l12t3316r483b3426],

1	double	RB	O	double	advmod	3	SENT_688	[p28l578t3316r1270b3426],
2	—	RB	O	—	advmod	3	SENT_688	[p28l578t3316r1270b3426],
3	blind	JJ	O	blind	_	0	SENT_688	[p28l578t3316r1270b3426],
4	,	,	O	,	_	0	SENT_688	[p28l578t3316r1270b3426],
5	phase	NN	O	phase	dep	3	SENT_688	[p28l1363t3316r1661b3432],
6	3	CD	NUMBER	3	num	7	SENT_688	[p28l1752t3322r1802b3406],
7	trial	NN	O	trial	dep	5	SENT_688	[p28l1896t3316r2141b3426],
8	,	,	O	,	_	0	SENT_688	[p28l1896t3316r2141b3426],

1	analysis	NN	O	analysis	_	0	SENT_689	[p28l10t3466r413b3582],
2	of	IN	O	of	_	0	SENT_689	[p28l465t3464r582b3556],
3	results	NNS	O	result	prep_of	1	SENT_689	[p28l610t3466r945b3558],
4	after	IN	O	after	_	0	SENT_689	[p28l995t3464r1234b3556],
5	48	CD	DURATION	48	num	6	SENT_689	[p28l1278t3472r1398b3556],
6	weeks	NNS	NUMBER	week	prep_after	1	SENT_689	[p28l1443t3466r1772b3558],
7	.	.	O	.	_	0	SENT_689	[p28l1443t3466r1772b3558],

1	Lancet	NNP	O	Lancet	_	0	SENT_690	[p28l1822t3474r2153b3556],

1	2012	CD	DATE	2012	_	0	SENT_691	[p28l10t3622r917b3726],
2	;	:	O	;	_	0	SENT_691	[p28l10t3622r917b3726],
3	379:2439	CD	NUMBER	379:2439	number	4	SENT_691	[p28l10t3622r917b3726],
4	—	CD	NUMBER	—	dep	1	SENT_691	[p28l10t3622r917b3726],
5	48	CD	NUMBER	48	dep	4	SENT_691	[p28l10t3622r917b3726],
6	.	.	O	.	_	0	SENT_691	[p28l10t3622r917b3726],

1	[	NN	O	[	nn	2	SENT_692	[p28l979t3624r1454b3726],
2	Erratum	NN	O	erratum	_	0	SENT_692	[p28l979t3624r1454b3726],
3	,	,	O	,	_	0	SENT_692	[p28l979t3624r1454b3726],
4	Lancet	NNP	O	Lancet	appos	2	SENT_692	[p28l1505t3624r1838b3706],
5	2012	CD	DATE	2012	num	4	SENT_692	[p28l1878t3622r2143b3726],
6	;	:	O	;	_	0	SENT_692	[p28l1878t3622r2143b3726],

1	380:730	CD	NUMBER	380:730	nsubj	3	SENT_693	[p29l12t29r469b127],
2	.	.	O	.	_	0	SENT_693	[p29l12t29r469b127],
3	]	SYM	O	]	_	0	SENT_693	[p29l12t29r469b127],

1	14	CD	NUMBER	14	_	0	SENT_694	[p29l16t185r148b265],
2	.	.	O	.	_	0	SENT_694	[p29l16t185r148b265],

1	DeJesus	NNP	PERSON	DeJesus	nn	2	SENT_695	[p29l209t183r606b279],
2	E	NNP	O	E	_	0	SENT_695	[p29l675t183r768b285],
3	,	,	O	,	_	0	SENT_695	[p29l675t183r768b285],
4	Rockstroh	NNP	ORGANIZATION	Rockstroh	nn	5	SENT_695	[p29l839t175r1376b271],
5	JK	NNP	ORGANIZATION	JK	appos	2	SENT_695	[p29l1431t183r1585b285],
6	,	,	O	,	_	0	SENT_695	[p29l1431t183r1585b285],
7	Henry	NNP	PERSON	Henry	nn	8	SENT_695	[p29l1656t183r1977b291],
8	K	NNP	PERSON	K	appos	2	SENT_695	[p29l2037t183r2141b285],
9	,	,	O	,	_	0	SENT_695	[p29l2037t183r2141b285],
10	et	FW	O	et	nn	11	SENT_695	[p29l12t343r102b415],
11	al.	FW	O	al.	appos	2	SENT_695	[p29l126t325r239b415],
12	.	.	O	.	_	0	SENT_695	[p29l126t325r239b415],

1	Co	NNP	O	Co	nsubj	3	SENT_696	[p29l277t323r1003b417],
2	—	RB	O	—	advmod	3	SENT_696	[p29l277t323r1003b417],
3	formulated	VBD	O	formulate	_	0	SENT_696	[p29l277t323r1003b417],
4	elvitegravir	NN	O	elvitegravir	dobj	3	SENT_696	[p29l1033t325r1605b441],
5	,	,	O	,	_	0	SENT_696	[p29l1033t325r1605b441],
6	cobicistat	NN	O	cobicistat	dobj	3	SENT_696	[p29l1644t325r2141b435],
7	,	,	O	,	_	0	SENT_696	[p29l1644t325r2141b435],
8	emtricitabine	NN	O	emtricitabine	conj_and	4	SENT_696	[p29l12t475r718b585],
9	,	,	O	,	_	0	SENT_696	[p29l12t475r718b585],
10	and	CC	O	and	_	0	SENT_696	[p29l811t475r997b565],
11	tenofovir	NN	O	tenofovir	conj_and	4	SENT_696	[p29l1086t473r1547b565],
12	disoproxil	NN	O	disoproxil	nn	13	SENT_696	[p29l1633t475r2147b591],
13	fumarate	NN	O	fumarate	nsubj	17	SENT_696	[p29l10t623r463b717],
14	versus	CC	O	versus	prep	13	SENT_696	[p29l492t655r798b717],
15	ritonavir	NN	O	ritonavir	nn	16	SENT_696	[p29l833t625r1691b715],
16	—	NN	O	—	dep	14	SENT_696	[p29l833t625r1691b715],
17	boosted	VBD	O	boost	rcmod	4	SENT_696	[p29l833t625r1691b715],
18	atazana	NN	O	atazana	nn	19	SENT_696	[p29l1724t643r2145b715],
19	—	NN	O	—	dobj	17	SENT_696	[p29l1724t643r2145b715],

1	vir	NN	O	vir	_	0	SENT_697	[p29l6t775r142b867],
2	plus	CC	O	plus	prep	1	SENT_697	[p29l189t775r397b891],
3	co	NN	O	co	nn	4	SENT_697	[p29l453t773r1176b867],
4	—	NN	O	—	dep	2	SENT_697	[p29l453t773r1176b867],
5	formulated	VBN	O	formulate	partmod	4	SENT_697	[p29l453t773r1176b867],
6	emtricitabine	NN	O	emtricitabine	nn	10	SENT_697	[p29l1230t775r1910b865],
7	and	CC	O	and	_	0	SENT_697	[p29l1961t775r2147b865],
8	tenofovir	NN	O	tenofovir	nn	10	SENT_697	[p29l12t923r473b1015],
9	disoproxil	NN	O	disoproxil	nn	10	SENT_697	[p29l534t925r1049b1041],
10	fumarate	NN	O	fumarate	dobj	5	SENT_697	[p29l1111t923r1575b1017],
11	for	IN	O	for	_	0	SENT_697	[p29l1638t923r1784b1015],
12	initial	JJ	O	initial	amod	13	SENT_697	[p29l1844t925r2147b1015],
13	treatment	NN	O	treatment	prep_for	10	SENT_697	[p29l12t1093r496b1165],
14	of	IN	O	of	_	0	SENT_697	[p29l518t1073r634b1165],
15	HIV-1	NN	O	hiv-1	nn	16	SENT_697	[p29l640t1081r921b1165],
16	infection	NN	O	infection	prep_of	13	SENT_697	[p29l949t1073r1417b1165],
17	:	:	O	:	_	0	SENT_697	[p29l949t1073r1417b1165],
18	a	DT	O	a	det	19	SENT_697	[p29l1449t1105r1501b1165],
19	randomised	JJ	O	randomised	dep	10	SENT_697	[p29l1527t1075r2141b1185],
20	,	,	O	,	_	0	SENT_697	[p29l1527t1075r2141b1185],
21	double	JJ	O	double	advmod	19	SENT_697	[p29l12t1225r688b1335],
22	—	RB	O	—	advmod	23	SENT_697	[p29l12t1225r688b1335],
23	blind	JJ	O	blind	amod	1	SENT_697	[p29l12t1225r688b1335],
24	,	,	O	,	_	0	SENT_697	[p29l12t1225r688b1335],
25	phase	NN	O	phase	appos	1	SENT_697	[p29l734t1225r1029b1341],
26	3	CD	NUMBER	3	num	25	SENT_697	[p29l1070t1231r1152b1335],
27	,	,	O	,	_	0	SENT_697	[p29l1070t1231r1152b1335],
28	non	JJ	O	non	amod	31	SENT_697	[p29l1200t1223r1956b1341],
29	—	NN	O	—	nn	31	SENT_697	[p29l1200t1223r1956b1341],
30	inferiority	NN	O	inferiority	nn	31	SENT_697	[p29l1200t1223r1956b1341],
31	trial	NN	O	trial	appos	1	SENT_697	[p29l1993t1225r2145b1315, p29l10t1375r126b1465],
32	.	.	O	.	_	0	SENT_697	[p29l1993t1225r2145b1315, p29l10t1375r126b1465],

1	Lancet	NNP	O	Lancet	_	0	SENT_698	[p29l169t1383r510b1465],
2	2012	CD	DATE	2012	num	1	SENT_698	[p29l544t1381r1464b1485],
3	;	:	O	;	_	0	SENT_698	[p29l544t1381r1464b1485],
4	379:2429	CD	NUMBER	379:2429	number	5	SENT_698	[p29l544t1381r1464b1485],
5	—	CD	NUMBER	—	dep	1	SENT_698	[p29l544t1381r1464b1485],
6	38	CD	NUMBER	38	dep	5	SENT_698	[p29l544t1381r1464b1485],
7	.	.	O	.	_	0	SENT_698	[p29l544t1381r1464b1485],

1	15	CD	NUMBER	15	_	0	SENT_699	[p29l16t1535r146b1615],
2	.	.	O	.	_	0	SENT_699	[p29l16t1535r146b1615],

1	Smith	NNP	PERSON	Smith	nn	2	SENT_700	[p29l213t1525r511b1615],
2	F	NN	O	f	_	0	SENT_700	[p29l550t1533r630b1635],
3	,	,	O	,	_	0	SENT_700	[p29l550t1533r630b1635],
4	Hammerstrom	NNP	ORGANIZATION	Hammerstrom	nn	5	SENT_700	[p29l678t1533r1435b1615],
5	T	NN	ORGANIZATION	t	appos	2	SENT_700	[p29l1473t1531r1563b1635],
6	,	,	O	,	_	0	SENT_700	[p29l1473t1531r1563b1635],
7	Soon	RB	O	soon	advmod	8	SENT_700	[p29l1613t1531r1862b1615],
8	G	NN	O	g	appos	2	SENT_700	[p29l1904t1531r2014b1635],
9	,	,	O	,	_	0	SENT_700	[p29l1904t1531r2014b1635],
10	et	FW	O	et	nn	11	SENT_700	[p29l2063t1543r2153b1615],
11	al.	FW	O	al.	appos	8	SENT_700	[p29l10t1675r126b1765],
12	.	.	O	.	_	0	SENT_700	[p29l10t1675r126b1765],

1	A	DT	O	a	det	2	SENT_701	[p29l205t1683r281b1763],
2	meta-analysis	NN	O	meta-analysis	nsubj	4	SENT_701	[p29l357t1675r1053b1791],
3	to	TO	O	to	aux	4	SENT_701	[p29l1132t1693r1228b1765],
4	assess	VB	O	assess	_	0	SENT_701	[p29l1308t1705r1621b1765],
5	the	DT	O	the	det	7	SENT_701	[p29l1700t1675r1856b1765],
6	FDA	NNP	ORGANIZATION	FDA	nn	7	SENT_701	[p29l1933t1681r2151b1765],
7	DAVP	NN	O	davp	poss	10	SENT_701	[p29l10t1831r369b1915],
8	’s	POS	O	’s	_	0	SENT_701	[p29l10t1831r369b1915],
9	TLOVR	NN	O	tlovr	nn	10	SENT_701	[p29l408t1831r787b1921],
10	algorithm	NN	O	algorithm	dobj	4	SENT_701	[p29l815t1825r1322b1941],
11	in	IN	O	in	_	0	SENT_701	[p29l1363t1825r1461b1913],
12	HIV	NN	MISC	hiv	nn	13	SENT_701	[p29l1501t1833r1705b1915],
13	submissions	NNS	O	submission	prep_in	4	SENT_701	[p29l1744t1825r2145b1917, p29l12t1975r299b2065],
14	.	.	O	.	_	0	SENT_701	[p29l1744t1825r2145b1917, p29l12t1975r299b2065],

1	Drug	NN	O	drug	nn	2	SENT_702	[p29l345t1983r606b2091],
2	lnfJ	NN	O	lnfj	_	0	SENT_702	[p29l640t1973r858b2079],
3	2011	CD	DATE	2011	dep	2	SENT_702	[p29l895t1981r1748b2085],
4	;	:	O	;	_	0	SENT_702	[p29l895t1981r1748b2085],
5	45:291	CD	NUMBER	45:291	num	6	SENT_702	[p29l895t1981r1748b2085],
6	-300	CD	NUMBER	-300	dep	2	SENT_702	[p29l895t1981r1748b2085],
7	.	.	O	.	_	0	SENT_702	[p29l895t1981r1748b2085],

1	16	CD	NUMBER	16	_	0	SENT_703	[p29l16t2135r146b2215],
2	.	.	O	.	_	0	SENT_703	[p29l16t2135r146b2215],

1	Division	NN	O	division	_	0	SENT_704	[p29l209t2125r626b2217],
2	of	IN	O	of	_	0	SENT_704	[p29l666t2123r782b2215],
3	AIDS	NNP	MISC	AIDS	nn	4	SENT_704	[p29l793t2131r1055b2215],
4	table	NN	O	table	prep_of	1	SENT_704	[p29l1096t2125r1340b2215],
5	for	IN	O	for	_	0	SENT_704	[p29l1377t2123r1523b2215],
6	grading	VBG	O	grade	prepc_for	4	SENT_704	[p29l1557t2125r1958b2241],
7	the	DT	O	the	det	8	SENT_704	[p29l1991t2125r2147b2215],
8	severity	NN	O	severity	dobj	6	SENT_704	[p29l12t2275r399b2391],
9	of	IN	O	of	_	0	SENT_704	[p29l474t2273r590b2365],
10	adult	JJ	O	adult	amod	14	SENT_704	[p29l648t2275r905b2367],
11	and	CC	O	and	_	0	SENT_704	[p29l979t2275r1164b2365],
12	pediatric	JJ	O	pediatric	conj_and	10	SENT_704	[p29l1242t2275r1696b2391],
13	adverse	JJ	O	adverse	amod	14	SENT_704	[p29l1774t2275r2147b2367],
14	events	NNS	O	event	prep_of	8	SENT_704	[p29l12t2443r343b2517],
15	:	:	O	:	_	0	SENT_704	[p29l12t2443r343b2517],
16	version	NN	O	version	dep	1	SENT_704	[p29l375t2425r731b2515],
17	1.0	CD	NUMBER	1.0	num	16	SENT_704	[p29l767t2431r935b2535],
18	,	,	O	,	_	0	SENT_704	[p29l767t2431r935b2535],
19	December	NNP	DATE	December	appos	16	SENT_704	[p29l973t2425r1477b2515],
20	2004	CD	DATE	2004	num	19	SENT_704	[p29l1507t2431r1776b2535],
21	;	:	O	;	_	0	SENT_704	[p29l1507t2431r1776b2535],
22	clarification	NN	O	clarification	dep	1	SENT_704	[p29l1814t2423r2145b2515, p29l12t2575r315b2665],
23	August	NNP	DATE	August	tmod	22	SENT_704	[p29l369t2583r724b2691],
24	2009	CD	DATE	2009	num	23	SENT_704	[p29l777t2581r1039b2665],
25	.	.	O	.	_	0	SENT_704	[p29l777t2581r1039b2665],

1	Bethesda	NNP	LOCATION	Bethesda	nn	3	SENT_705	[p29l1102t2575r1579b2685],
2	,	,	O	,	_	0	SENT_705	[p29l1102t2575r1579b2685],
3	MD	NNP	O	MD	_	0	SENT_705	[p29l1641t2581r1852b2665],
4	:	:	O	:	_	0	SENT_705	[p29l1641t2581r1852b2665],
5	Division	NNP	O	Division	dep	3	SENT_705	[p29l1913t2575r2145b2665, p29l12t2725r215b2815],
6	of	IN	O	of	_	0	SENT_705	[p29l247t2723r363b2815],
7	AIDS	NNP	MISC	AIDS	prep_of	5	SENT_705	[p29l369t2731r654b2835],
8	,	,	O	,	_	0	SENT_705	[p29l369t2731r654b2835],
9	2009	CD	DATE	2009	num	11	SENT_705	[p29l692t2731r931b2815],
10	(	CD	NUMBER	(	num	11	SENT_705	[p29l971t2725r2145b2841],
11	http	NN	O	http	appos	7	SENT_705	[p29l971t2725r2145b2841],
12	:	:	O	:	_	0	SENT_705	[p29l971t2725r2145b2841],
13	l/rsc	NN	O	l/rsc	dep	11	SENT_705	[p29l971t2725r2145b2841],
14	.	.	O	.	_	0	SENT_705	[p29l971t2725r2145b2841],

1	tech—res.com	NNP	O	tech—res.com	_	0	SENT_706	[p29l971t2725r2145b2841],
2	/	:	O	/	punct	3	SENT_706	[p29l971t2725r2145b2841],
3	Document/safetyandpharmacovigilance	NNP	O	Document/safetyandpharmacovigilance	dep	1	SENT_706	[p29l10t2873r2125b2991],
4	]	CD	NUMBER	]	num	7	SENT_706	[p29l10t2873r2125b2991],
5	Table_for_Grading_Severity_of_Adult	NNP	O	Table_for_Grading_Severity_of_Adult	nn	7	SENT_706	[p29l8t3023r2067b3141],
6	_	CD	NUMBER	_	num	7	SENT_706	[p29l8t3023r2067b3141],
7	Pediatric_Adverse_Events	NNS	O	pediatric_adverse_events	dep	3	SENT_706	[p29l10t3173r1607b3291],
8	.	.	O	.	_	0	SENT_706	[p29l10t3173r1607b3291],

1	pdf	NN	O	pdf	_	0	SENT_707	[p29l10t3173r1607b3291],
2	)	NN	O	)	dep	1	SENT_707	[p29l10t3173r1607b3291],
3	.	.	O	.	_	0	SENT_707	[p29l10t3173r1607b3291],

1	17	CD	NUMBER	17	_	0	SENT_708	[p29l16t3335r138b3415],
2	.	.	O	.	_	0	SENT_708	[p29l16t3335r138b3415],

1	Justice	NNP	O	Justice	nn	2	SENT_709	[p29l199t3325r546b3429],
2	AC	NN	O	ac	_	0	SENT_709	[p29l610t3331r786b3435],
3	,	,	O	,	_	0	SENT_709	[p29l610t3331r786b3435],
4	Holmes	NNP	PERSON	Holmes	nn	5	SENT_709	[p29l859t3325r1256b3415],
5	W	NNP	PERSON	W	appos	2	SENT_709	[p29l1321t3333r1448b3435],
6	,	,	O	,	_	0	SENT_709	[p29l1321t3333r1448b3435],
7	Gifford	NNP	ORGANIZATION	Gifford	nn	8	SENT_709	[p29l1523t3323r1906b3415],
8	AL	NNP	ORGANIZATION	AL	appos	2	SENT_709	[p29l1967t3333r2141b3435],
9	,	,	O	,	_	0	SENT_709	[p29l1967t3333r2141b3435],
10	et	FW	O	et	nn	11	SENT_709	[p29l12t3493r104b3565],
11	al.	FW	O	al.	appos	2	SENT_709	[p29l170t3475r287b3565],
12	.	.	O	.	_	0	SENT_709	[p29l170t3475r287b3565],

1	Development	NNP	O	Development	nsubj	8	SENT_710	[p29l365t3475r1039b3591],
2	and	CC	O	and	_	0	SENT_710	[p29l1102t3475r1288b3565],
3	validation	NN	O	validation	conj_and	1	SENT_710	[p29l1352t3475r1860b3565],
4	of	IN	O	of	_	0	SENT_710	[p29l1932t3473r2049b3565],
5	a	DT	O	a	det	7	SENT_710	[p29l2097t3505r2149b3565],
6	self	NN	O	self	nn	7	SENT_710	[p29l12t3623r758b3741],
7	—	NN	O	—	prep_of	3	SENT_710	[p29l12t3623r758b3741],
8	completed	VBD	O	complete	_	0	SENT_710	[p29l12t3623r758b3741],
9	HIV	NN	MISC	hiv	nn	11	SENT_710	[p29l791t3633r995b3715],
10	symptom	NN	O	symptom	nn	11	SENT_710	[p29l1027t3643r1499b3741],
11	index	NN	O	index	dobj	8	SENT_710	[p29l1533t3625r1836b3715],
12	.	.	O	.	_	0	SENT_710	[p29l1533t3625r1836b3715],

1	J	NNP	O	J	nn	2	SENT_711	[p29l1864t3633r1908b3729],
2	Clin	NNP	O	Clin	_	0	SENT_711	[p29l1938t3625r2147b3715],

1	Epidemiol	NNP	O	Epidemiol	_	0	SENT_712	[p30l10t24r525b140],
2	2001	CD	DATE	2001	num	1	SENT_712	[p30l564t24r1284b140],
3	;	:	O	;	_	0	SENT_712	[p30l564t24r1284b140],
4	54	CD	NUMBER	54	dep	1	SENT_712	[p30l564t24r1284b140],
5	:	:	O	:	_	0	SENT_712	[p30l564t24r1284b140],
6	Suppl	NN	O	suppl	dep	1	SENT_712	[p30l564t24r1284b140],
7	1	CD	NUMBER	1	num	6	SENT_712	[p30l1327t30r1840b114],
8	:	:	O	:	_	0	SENT_712	[p30l1327t30r1840b114],
9	S77	CD	NUMBER	s77	dep	6	SENT_712	[p30l1327t30r1840b114],
10	.	.	O	.	_	0	SENT_712	[p30l1327t30r1840b114],

1	—	NN	O	—	_	0	SENT_713	[p30l1327t30r1840b114],
2	.	.	O	.	_	0	SENT_713	[p30l1327t30r1840b114],

1	S90	NN	O	s90	_	0	SENT_714	[p30l1327t30r1840b114],
2	.	.	O	.	_	0	SENT_714	[p30l1327t30r1840b114],

1	18	CD	NUMBER	18	_	0	SENT_715	[p30l16t182r150b266],
2	.	.	O	.	_	0	SENT_715	[p30l16t182r150b266],

1	Marc	NNP	PERSON	Marc	nn	2	SENT_716	[p30l207t182r469b264],
2	LG	NNP	PERSON	LG	_	0	SENT_716	[p30l514t180r690b284],
3	,	,	O	,	_	0	SENT_716	[p30l514t180r690b284],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_716	[p30l739t182r1039b290],
5	MM	NN	O	mm	appos	2	SENT_716	[p30l1079t182r1312b284],
6	,	,	O	,	_	0	SENT_716	[p30l1079t182r1312b284],
7	Testa	NNP	PERSON	Testa	nn	8	SENT_716	[p30l1363t180r1637b264],
8	MA	NNP	O	MA	appos	5	SENT_716	[p30l1678t182r1888b264],
9	.	.	O	.	_	0	SENT_716	[p30l1678t182r1888b264],

1	Psychometric	JJ	MISC	psychometric	amod	2	SENT_717	[p30l1940t182r2145b290, p30l12t324r526b414],
2	evaluation	NN	O	evaluation	_	0	SENT_717	[p30l560t324r1083b416],
3	of	IN	O	of	_	0	SENT_717	[p30l1118t322r1236b414],
4	the	DT	O	the	det	8	SENT_717	[p30l1248t324r1405b414],
5	HIV	NN	MISC	hiv	nn	8	SENT_717	[p30l1439t332r1643b414],
6	symptom	NN	O	symptom	nn	8	SENT_717	[p30l1675t342r2147b440],
7	distress	NN	O	distress	nn	8	SENT_717	[p30l12t474r393b564],
8	scale	NN	O	scale	prep_of	2	SENT_717	[p30l435t474r704b564],
9	.	.	O	.	_	0	SENT_717	[p30l435t474r704b564],

1	AIDS	NNP	MISC	AIDS	nn	2	SENT_718	[p30l743t480r1001b564],
2	Care	NNP	O	Care	_	0	SENT_718	[p30l1041t480r1266b564],
3	2012	CD	DATE	2012	num	2	SENT_718	[p30l1303t480r2131b584],
4	;	:	O	;	_	0	SENT_718	[p30l1303t480r2131b584],
5	24:1432	CD	NUMBER	24:1432	number	6	SENT_718	[p30l1303t480r2131b584],
6	—	CD	NUMBER	—	dep	2	SENT_718	[p30l1303t480r2131b584],
7	41	CD	NUMBER	41	dep	6	SENT_718	[p30l1303t480r2131b584],
8	.	.	O	.	_	0	SENT_718	[p30l1303t480r2131b584],

1	19	CD	NUMBER	19	_	0	SENT_719	[p30l16t634r144b714],
2	.	.	O	.	_	0	SENT_719	[p30l16t634r144b714],

1	Hill	NNP	O	Hill	nn	2	SENT_720	[p30l209t624r403b712],
2	A	NNP	O	A	_	0	SENT_720	[p30l444t632r546b734],
3	,	,	O	,	_	0	SENT_720	[p30l444t632r546b734],
4	Sabin	NNP	PERSON	Sabin	nn	6	SENT_720	[p30l602t624r879b714],
5	C.	NNP	PERSON	C.	nn	6	SENT_720	[p30l923t630r1023b714],
6	Designing	NNP	PERSON	Designing	appos	2	SENT_720	[p30l1072t624r1601b740],
7	and	CC	O	and	_	0	SENT_720	[p30l1641t624r1826b714],
8	interIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	NNP	O	interIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	appos	2	SENT_720	[p30l1872t624r2145b714, p30l507t1046r1602b1065],

1	ON	IN	O	on	_	0	SENT_721	[p30l1606t1046r1653b1065],

1	preting	VBG	O	prete	amod	4	SENT_722	[p30l8t1359r373b1472],
2	HIV	NN	MISC	hiv	nn	4	SENT_722	[p30l414t1365r612b1445],
3	noninferiority	NN	O	noninferiority	nn	4	SENT_722	[p30l653t1357r1356b1470],
4	trials	NNS	O	trial	_	0	SENT_722	[p30l1397t1357r1650b1445],
5	in	IN	O	in	_	0	SENT_722	[p30l1696t1359r1792b1445],
6	naive	JJ	O	naive	amod	9	SENT_722	[p30l1838t1359r2093b1447],
7	and	CC	O	and	_	0	SENT_722	[p30l10t1503r191b1593],
8	experienced	JJ	O	experienced	amod	9	SENT_722	[p30l241t1503r832b1616],
9	patients	NNS	O	patient	prep_in	4	SENT_722	[p30l882t1505r1306b1616],
10	.	.	O	.	_	0	SENT_722	[p30l882t1505r1306b1616],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_723	[p30l1358t1509r1613b1593],
2	2008	CD	DATE	2008	num	1	SENT_723	[p30l1667t1509r2087b1610],
3	;	:	O	;	_	0	SENT_723	[p30l1667t1509r2087b1610],
4	22	CD	NUMBER	22	num	6	SENT_723	[p30l1667t1509r2087b1610],
5	:	:	O	:	_	0	SENT_723	[p30l1667t1509r2087b1610],
6	913-21	CD	NUMBER	913-21	dep	1	SENT_723	[p30l10t1656r364b1740],
7	.	.	O	.	_	0	SENT_723	[p30l10t1656r364b1740],

1	20	CD	NUMBER	20	_	0	SENT_724	[p30l8t1805r144b1885],
2	.	.	O	.	_	0	SENT_724	[p30l8t1805r144b1885],

1	Sato	NNP	PERSON	Sato	nn	2	SENT_725	[p30l208t1802r412b1885],
2	T.	NNP	O	T.	_	0	SENT_725	[p30l455t1803r542b1885],
3	On	IN	O	on	dep	2	SENT_725	[p30l594t1802r738b1885],
4	the	DT	O	the	det	6	SENT_725	[p30l783t1796r935b1883],
5	Variance	NNP	O	Variance	nn	6	SENT_725	[p30l975t1798r1390b1885],
6	estimator	NN	O	estimator	pobj	3	SENT_725	[p30l1436t1798r1912b1885],
7	for	IN	O	for	_	0	SENT_725	[p30l1955t1796r2095b1885],
8	the	DT	O	the	det	9	SENT_725	[p30l10t1941r163b2028],
9	Mantel	NNP	O	Mantel	prep_for	6	SENT_725	[p30l204t1941r1044b2028],
10	.	.	O	.	_	0	SENT_725	[p30l204t1941r1044b2028],

1	—	NN	O	—	_	0	SENT_726	[p30l204t1941r1044b2028],
2	.	.	O	.	_	0	SENT_726	[p30l204t1941r1044b2028],

1	Haenszel	NNP	PERSON	Haenszel	nsubj	2	SENT_727	[p30l204t1941r1044b2028],
2	risk	NN	O	risk	_	0	SENT_727	[p30l1088t1941r1277b2030],
3	difference	NN	O	difference	dobj	2	SENT_727	[p30l1316t1941r1844b2030],
4	.	.	O	.	_	0	SENT_727	[p30l1316t1941r1844b2030],

1	Biometrics	NNS	O	biometric	_	0	SENT_728	[p30l1892t1943r2091b2030, p30l10t2088r377b2174],
2	1989	CD	DATE	1989	num	1	SENT_728	[p30l422t2092r1185b2193],
3	;	:	O	;	_	0	SENT_728	[p30l422t2092r1185b2193],
4	42:311	CD	NUMBER	42:311	number	5	SENT_728	[p30l422t2092r1185b2193],
5	—	CD	NUMBER	—	dep	1	SENT_728	[p30l422t2092r1185b2193],
6	23	CD	NUMBER	23	dep	5	SENT_728	[p30l422t2092r1185b2193],
7	.	.	O	.	_	0	SENT_728	[p30l422t2092r1185b2193],

1	21	CD	NUMBER	21	_	0	SENT_729	[p30l8t2243r142b2321],
2	.	.	O	.	_	0	SENT_729	[p30l8t2243r142b2321],

1	Wiens	NNP	ORGANIZATION	Wiens	nn	2	SENT_730	[p30l200t2234r506b2320],
2	BL	NN	ORGANIZATION	bl	_	0	SENT_730	[p30l542t2240r696b2341],
3	,	,	O	,	_	0	SENT_730	[p30l542t2240r696b2341],
4	Dmitrienko	NNP	O	Dmitrienko	nn	8	SENT_730	[p30l736t2232r1310b2322],
5	A.	NNP	O	A.	nn	8	SENT_730	[p30l1343t2240r1444b2321],
6	The	NNP	O	The	nn	8	SENT_730	[p30l1481t2232r1665b2320],
7	fallback	JJ	O	fallback	amod	8	SENT_730	[p30l1700t2232r2097b2322],
8	procedure	NN	O	procedure	appos	2	SENT_730	[p30l8t2378r507b2491],
9	for	IN	O	for	_	0	SENT_730	[p30l563t2378r706b2468],
10	evaluating	VBG	O	evaluate	prepc_for	8	SENT_730	[p30l760t2378r1275b2493],
11	a	DT	O	a	det	13	SENT_730	[p30l1327t2407r1376b2466],
12	single	JJ	O	single	amod	13	SENT_730	[p30l1434t2378r1724b2493],
13	family	NN	O	family	dobj	10	SENT_730	[p30l1780t2378r2097b2491],
14	of	IN	O	of	_	0	SENT_730	[p30l11t2524r125b2614],
15	hypotheses	NNS	O	hypothesis	prep_of	13	SENT_730	[p30l159t2524r744b2637],
16	.	.	O	.	_	0	SENT_730	[p30l159t2524r744b2637],

1	I	PRP	O	I	_	0	SENT_731	[p30l793t2532r836b2627],
2	Biopharm	NNP	O	Biopharm	nn	3	SENT_731	[p30l886t2524r1380b2637],
3	Stat	NN	O	stat	dep	1	SENT_731	[p30l1438t2530r1625b2614],
4	2005	CD	DATE	2005	num	3	SENT_731	[p30l1675t2530r2087b2631],
5	;	:	O	;	_	0	SENT_731	[p30l1675t2530r2087b2631],
6	15	CD	NUMBER	15	num	8	SENT_731	[p30l1675t2530r2087b2631],
7	:	:	O	:	_	0	SENT_731	[p30l1675t2530r2087b2631],
8	929-42	CD	NUMBER	929-42	dep	1	SENT_731	[p30l10t2677r372b2761],
9	.	.	O	.	_	0	SENT_731	[p30l10t2677r372b2761],

1	22	CD	NUMBER	22	_	0	SENT_732	[p30l8t2828r144b2905],
2	.	.	O	.	_	0	SENT_732	[p30l8t2828r144b2905],

1	Dmitrienko	NNP	MISC	Dmitrienko	nn	2	SENT_733	[p30l202t2817r762b2907],
2	A	NNP	MISC	A	_	0	SENT_733	[p30l791t2825r890b2926],
3	,	,	O	,	_	0	SENT_733	[p30l791t2825r890b2926],
4	Tamhane	NNP	O	Tamhane	nn	5	SENT_733	[p30l923t2817r1378b2905],
5	AC	NN	O	ac	appos	2	SENT_733	[p30l1405t2823r1572b2924],
6	,	,	O	,	_	0	SENT_733	[p30l1405t2823r1572b2924],
7	Wiens	NNP	PERSON	Wiens	nn	8	SENT_733	[p30l1605t2819r1903b2905],
8	BL	NN	O	bl	appos	5	SENT_733	[p30l1935t2825r2085b2906],
9	.	.	O	.	_	0	SENT_733	[p30l1935t2825r2085b2906],

1	General	NNP	O	General	_	0	SENT_734	[p30l10t2963r400b3053],
2	multistage	JJ	O	multistage	amod	4	SENT_734	[p30l484t2963r1011b3078],
3	gatekeeping	NN	O	gatekeeping	nn	4	SENT_734	[p30l1096t2963r1699b3078],
4	procedures	NNS	O	procedure	dep	1	SENT_734	[p30l1778t2992r2091b3076, p30l11t3109r307b3199],
5	.	.	O	.	_	0	SENT_734	[p30l1778t2992r2091b3076, p30l11t3109r307b3199],

1	Bioml	NNP	O	Bioml	_	0	SENT_735	[p30l350t3111r679b3212],
2	2008	CD	DATE	2008	num	1	SENT_735	[p30l715t3115r1481b3216],
3	;	:	O	;	_	0	SENT_735	[p30l715t3115r1481b3216],
4	50:667	CD	NUMBER	50:667	number	5	SENT_735	[p30l715t3115r1481b3216],
5	—	CD	NUMBER	—	dep	1	SENT_735	[p30l715t3115r1481b3216],
6	77	CD	NUMBER	77	dep	5	SENT_735	[p30l715t3115r1481b3216],
7	.	.	O	.	_	0	SENT_735	[p30l715t3115r1481b3216],

1	23	CD	NUMBER	23	_	0	SENT_736	[p30l8t3266r142b3343],
2	.	.	O	.	_	0	SENT_736	[p30l8t3266r142b3343],

1	Stellbrink	NNP	O	Stellbrink	nn	2	SENT_737	[p30l208t3255r696b3345],
2	H-1	NNP	O	H-1	_	0	SENT_737	[p30l746t3263r925b3364],
3	,	,	O	,	_	0	SENT_737	[p30l746t3263r925b3364],
4	Reynes	NNP	PERSON	Reynes	nn	5	SENT_737	[p30l983t3263r1331b3368],
5	J	NNP	PERSON	J	appos	2	SENT_737	[p30l1378t3263r1442b3364],
6	,	,	O	,	_	0	SENT_737	[p30l1378t3263r1442b3364],
7	Lazzarin	NNP	O	Lazzarin	nn	8	SENT_737	[p30l1502t3257r1936b3343],
8	A	NNP	O	A	appos	2	SENT_737	[p30l1986t3263r2085b3364],
9	,	,	O	,	_	0	SENT_737	[p30l1986t3263r2085b3364],
10	et	FW	O	et	nn	11	SENT_737	[p30l11t3420r99b3489],
11	al.	FW	O	al.	appos	2	SENT_737	[p30l144t3401r257b3491],
12	.	.	O	.	_	0	SENT_737	[p30l144t3401r257b3491],

1	Dolutegravir	NNP	O	Dolutegravir	_	0	SENT_738	[p30l313t3401r939b3516],
2	in	IN	O	in	_	0	SENT_738	[p30l987t3403r1082b3489],
3	antiretroViral	JJ	O	antiretroviral	amod	6	SENT_738	[p30l1133t3401r2091b3491],
4	—	NN	O	—	nn	6	SENT_738	[p30l1133t3401r2091b3491],
5	naiVe	NN	O	naive	nn	6	SENT_738	[p30l1133t3401r2091b3491],
6	adults	NNS	O	adult	prep_in	1	SENT_738	[p30l10t3547r311b3636],
7	with	IN	O	with	_	0	SENT_738	[p30l357t3547r585b3636],
8	HIV-1	NN	O	hiv-1	prep_with	6	SENT_738	[p30l631t3553r947b3636],
9	:	:	O	:	_	0	SENT_738	[p30l631t3553r947b3636],
10	96-week	JJ	DURATION	96-week	amod	11	SENT_738	[p30l999t3547r1421b3636],
11	results	NNS	O	result	dep	1	SENT_738	[p30l1463t3547r1798b3636],
12	from	IN	O	from	_	0	SENT_738	[p30l1848t3547r2093b3636],
13	a	DT	O	a	prep_from	11	SENT_738	[p30l10t3721r60b3780],
14	randomized	VBN	O	randomize	partmod	13	SENT_738	[p30l109t3692r719b3782],
15	dose-ranging	JJ	O	dose-ranging	amod	16	SENT_738	[p30l769t3692r1444b3807],
16	study	NN	O	study	dobj	14	SENT_738	[p30l1492t3692r1778b3805],
17	.	.	O	.	_	0	SENT_738	[p30l1492t3692r1778b3805],

1	AIDS	NN	MISC	aid	_	0	SENT_739	[p30l1830t3698r2089b3782],

1	24	CD	NUMBER	24	_	0	SENT_740	[p31l8t181r142b258],
2	.	.	O	.	_	0	SENT_740	[p31l8t181r142b258],

1	Lennox	NNP	PERSON	Lennox	nn	2	SENT_741	[p31l202t178r562b259],
2	JL	NNP	O	JL	_	0	SENT_741	[p31l579t178r709b277],
3	,	,	O	,	_	0	SENT_741	[p31l579t178r709b277],
4	DeJesus	NNP	PERSON	DeJesus	nn	5	SENT_741	[p31l744t178r1119b273],
5	E	NNP	O	E	appos	2	SENT_741	[p31l1150t178r1238b279],
6	,	,	O	,	_	0	SENT_741	[p31l1150t178r1238b279],
7	Lazzarin	NNP	O	Lazzarin	nn	8	SENT_741	[p31l1275t172r1700b258],
8	A	NNP	O	A	appos	2	SENT_741	[p31l1727t178r1825b277],
9	,	,	O	,	_	0	SENT_741	[p31l1727t178r1825b277],
10	et	FW	O	et	nn	11	SENT_741	[p31l1863t189r1951b258],
11	al.	FW	O	al.	appos	2	SENT_741	[p31l1976t170r2085b259],
12	.	.	O	.	_	0	SENT_741	[p31l1976t170r2085b259],

1	Safety	NN	O	safety	_	0	SENT_742	[p31l12t316r313b429],
2	and	CC	O	and	_	0	SENT_742	[p31l377t316r558b406],
3	efficacy	NN	O	efficacy	conj_and	1	SENT_742	[p31l630t316r1018b429],
4	of	IN	O	of	_	0	SENT_742	[p31l1086t316r1199b406],
5	raltegravir-based	JJ	O	raltegravir-based	amod	9	SENT_742	[p31l1249t316r2093b431],
6	Versus	NNP	O	Versus	nn	9	SENT_742	[p31l6t491r313b551],
7	efavirenz-based	JJ	O	efavirenz-based	amod	9	SENT_742	[p31l360t462r1137b551],
8	combination	NN	O	combination	nn	9	SENT_742	[p31l1183t462r1813b551],
9	therapy	NN	O	therapy	prep_of	1	SENT_742	[p31l1857t462r2091b549, p31l10t636r175b720],

1	in	IN	O	in	_	0	SENT_743	[p31l206t609r301b695],
2	treatment-naive	JJ	O	treatment-naive	amod	3	SENT_743	[p31l338t609r1100b697],
3	patients	NNS	O	patient	pobj	1	SENT_743	[p31l1136t609r1522b720],
4	with	IN	O	with	_	0	SENT_743	[p31l1558t607r1778b697],
5	HIV-1	NN	MISC	hiv-1	nn	6	SENT_743	[p31l1815t613r2091b695],
6	infection	NN	O	infection	prep_with	3	SENT_743	[p31l10t753r474b842],
7	:	:	O	:	_	0	SENT_743	[p31l10t753r474b842],
8	a	DT	O	a	det	11	SENT_743	[p31l517t782r567b841],
9	multicentre	JJ	O	multicentre	amod	11	SENT_743	[p31l604t753r1191b862],
10	,	,	O	,	_	0	SENT_743	[p31l604t753r1191b862],
11	double-blind	JJ	O	double-blind	dep	3	SENT_743	[p31l1238t753r1856b843],
12	randomised	VBN	O	randomise	partmod	11	SENT_743	[p31l1895t782r2091b841, p31l11t899r434b988],

1	controlled	JJ	O	controlled	amod	2	SENT_744	[p31l464t899r968b988],
2	trial	NN	O	trial	_	0	SENT_744	[p31l999t899r1230b988],
3	.	.	O	.	_	0	SENT_744	[p31l999t899r1230b988],

1	Lancet	NNP	O	Lancet	_	0	SENT_745	[p31l1265t907r1595b987],
2	2009	CD	DATE	2009	num	1	SENT_745	[p31l1619t905r2087b1006],
3	;	:	O	;	_	0	SENT_745	[p31l1619t905r2087b1006],
4	374	CD	NUMBER	374	dep	1	SENT_745	[p31l1619t905r2087b1006],
5	:	:	O	:	_	0	SENT_745	[p31l1619t905r2087b1006],

1	796-806	CD	NUMBER	796-806	_	0	SENT_746	[p31l12t1051r439b1134],
2	.	.	O	.	_	0	SENT_746	[p31l12t1051r439b1134],

1	[	NN	O	[	nn	2	SENT_747	[p31l542t1053r906b1152],
2	Errata	NNP	O	Errata	_	0	SENT_747	[p31l542t1053r906b1152],
3	,	,	O	,	_	0	SENT_747	[p31l542t1053r906b1152],
4	Lancet	NNP	O	Lancet	dep	2	SENT_747	[p31l997t1053r1328b1133],
5	2009	CD	DATE	2009	num	4	SENT_747	[p31l1410t1051r2085b1152],
6	;	:	O	;	_	0	SENT_747	[p31l1410t1051r2085b1152],
7	374:786	CD	NUMBER	374:786	dep	4	SENT_747	[p31l1410t1051r2085b1152],
8	,	,	O	,	_	0	SENT_747	[p31l1410t1051r2085b1152],

1	25	CD	NUMBER	25	_	0	SENT_748	[p31l8t1347r142b1424],
2	.	.	O	.	_	0	SENT_748	[p31l8t1347r142b1424],

1	Scourfield	NNP	MISC	Scourfield	nn	2	SENT_749	[p31l208t1336r715b1426],
2	A	NNP	MISC	A	_	0	SENT_749	[p31l750t1344r850b1445],
3	,	,	O	,	_	0	SENT_749	[p31l750t1344r850b1445],
4	Zheng	NNP	PERSON	Zheng	nn	5	SENT_749	[p31l894t1336r1205b1451],
5	J	NNP	PERSON	J	appos	2	SENT_749	[p31l1230t1344r1296b1444],
6	,	,	O	,	_	0	SENT_749	[p31l1230t1344r1296b1444],
7	Chinthapalli	NNP	PERSON	Chinthapalli	nn	8	SENT_749	[p31l1341t1336r1967b1449],
8	S	NNP	O	S	appos	2	SENT_749	[p31l2009t1342r2085b1444],
9	,	,	O	,	_	0	SENT_749	[p31l2009t1342r2085b1444],
10	et	FW	O	et	nn	11	SENT_749	[p31l11t1501r99b1570],
11	al.	FW	O	al.	appos	2	SENT_749	[p31l144t1482r255b1572],
12	.	.	O	.	_	0	SENT_749	[p31l144t1482r255b1572],

1	Discontinuation	NN	O	discontinuation	_	0	SENT_750	[p31l311t1484r1116b1572],
2	of	IN	O	of	_	0	SENT_750	[p31l1168t1482r1281b1572],
3	Atripla	NNP	O	Atripla	prep_of	1	SENT_750	[p31l1307t1482r1652b1595],
4	as	IN	O	as	_	0	SENT_750	[p31l1698t1511r1797b1570],
5	firstline	NN	O	firstline	nn	6	SENT_750	[p31l1850t1482r2091b1570, p31l8t1628r193b1716],
6	therapy	NN	O	therapy	prep_as	1	SENT_750	[p31l228t1628r599b1741],
7	in	IN	O	in	_	0	SENT_750	[p31l628t1630r723b1716],
8	HIV-1	NN	O	hiv-1	nn	10	SENT_750	[p31l758t1634r1040b1716],
9	infected	JJ	O	infected	amod	10	SENT_750	[p31l1074t1628r1475b1718],
10	individuals	NNS	O	individual	prep_in	1	SENT_750	[p31l1510t1628r2085b1718],
11	.	.	O	.	_	0	SENT_750	[p31l1510t1628r2085b1718],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_751	[p31l6t1780r261b1863],
2	2012	CD	DATE	2012	num	1	SENT_751	[p31l303t1780r1213b1881],
3	;	:	O	;	_	0	SENT_751	[p31l303t1780r1213b1881],
4	26:1399	CD	NUMBER	26:1399	number	5	SENT_751	[p31l303t1780r1213b1881],
5	-401	CD	NUMBER	-401	dep	1	SENT_751	[p31l303t1780r1213b1881],
6	.	.	O	.	_	0	SENT_751	[p31l303t1780r1213b1881],

1	26	CD	NUMBER	26	_	0	SENT_752	[p31l8t1930r146b2010],
2	.	.	O	.	_	0	SENT_752	[p31l8t1930r146b2010],

1	Atripla	NNP	O	Atripla	_	0	SENT_753	[p31l200t1920r571b2033],
2	.	.	O	.	_	0	SENT_753	[p31l200t1920r571b2033],

1	Princeton	NNP	ORGANIZATION	Princeton	nn	3	SENT_754	[p31l641t1922r1148b2027],
2	,	,	O	,	_	0	SENT_754	[p31l641t1922r1148b2027],
3	NJ	NNP	O	NJ	_	0	SENT_754	[p31l1218t1928r1364b2023],
4	:	:	O	:	_	0	SENT_754	[p31l1218t1928r1364b2023],
5	Bristol-Myers	NNP	O	Bristol-Myers	nn	6	SENT_754	[p31l1434t1920r2089b2033],
6	Squibb	NNP	O	Squibb	dep	3	SENT_754	[p31l12t2066r377b2179],
7	,	,	O	,	_	0	SENT_754	[p31l12t2066r377b2179],
8	2012	CD	DATE	2012	num	9	SENT_754	[p31l422t2072r657b2156],
9	(	CD	NUMBER	(	appos	6	SENT_754	[p31l702t2066r1133b2181],
10	package	NN	O	package	nn	12	SENT_754	[p31l702t2066r1133b2181],
11	insert	NN	O	insert	nn	12	SENT_754	[p31l1172t2068r1518b2169],
12	)	NN	O	)	dep	9	SENT_754	[p31l1172t2068r1518b2169],
13	.	.	O	.	_	0	SENT_754	[p31l1172t2068r1518b2169],

1	27	CD	NUMBER	27	_	0	SENT_755	[p31l51t2623r113b2661],
2	.	.	O	.	_	0	SENT_755	[p31l51t2623r113b2661],

1	Koteff	NNP	PERSON	Koteff	nn	2	SENT_756	[p31l145t2618r308b2663],
2	J	NNP	PERSON	J	_	0	SENT_756	[p31l327t2622r359b2670],
3	,	,	O	,	_	0	SENT_756	[p31l327t2622r359b2670],
4	Borland	NNP	ORGANIZATION	Borland	nn	5	SENT_756	[p31l396t2618r590b2661],
5	J	NNP	O	J	appos	2	SENT_756	[p31l620t2622r652b2671],
6	,	,	O	,	_	0	SENT_756	[p31l620t2622r652b2671],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_756	[p31l690t2618r814b2661],
8	S	NNP	O	S	appos	2	SENT_756	[p31l850t2621r888b2671],
9	,	,	O	,	_	0	SENT_756	[p31l850t2621r888b2671],
10	et	FW	O	et	nn	11	SENT_756	[p31l926t2627r970b2661],
11	al.	FW	O	al.	appos	2	SENT_756	[p31l1002t2618r1057b2661],
12	.	.	O	.	_	0	SENT_756	[p31l1002t2618r1057b2661],

1	A	DT	O	a	det	4	SENT_757	[p31l49t2692r85b2730],
2	phase	NN	O	phase	nn	4	SENT_757	[p31l108t2688r247b2742],
3	1	CD	NUMBER	1	num	4	SENT_757	[p31l273t2691r297b2730],
4	study	NN	O	study	nsubj	6	SENT_757	[p31l322t2688r450b2742],
5	to	TO	O	to	aux	6	SENT_757	[p31l472t2697r517b2731],
6	evaluate	VB	O	evaluate	_	0	SENT_757	[p31l542t2688r736b2731],
7	the	DT	O	the	det	8	SENT_757	[p31l760t2688r834b2730],
8	effect	NN	O	effect	dobj	6	SENT_757	[p31l858t2688r994b2730],
9	of	IN	O	of	_	0	SENT_757	[p31l1015t2688r1070b2731],
10	dolutegravir	NN	O	dolutegravir	prep_of	8	SENT_757	[p31l52t2757r345b2813],
11	on	IN	O	on	_	0	SENT_757	[p31l374t2771r432b2800],
12	renal	JJ	O	renal	amod	15	SENT_757	[p31l462t2757r584b2800],
13	function	NN	O	function	nn	15	SENT_757	[p31l613t2757r818b2801],
14	Via	NNP	O	Via	nn	15	SENT_757	[p31l846t2758r915b2801],
15	measurement	NN	O	measurement	prep_on	6	SENT_757	[p31l944t2771r1060b2800, p31l52t2836r277b2871],
16	of	IN	O	of	_	0	SENT_757	[p31l300t2827r356b2870],
17	iohexol	NN	O	iohexol	prep_of	15	SENT_757	[p31l370t2827r544b2870],
18	and	CC	O	and	_	0	SENT_757	[p31l569t2827r657b2870],
19	para	NN	O	para	nn	22	SENT_757	[p31l681t2827r1060b2882],
20	—	CD	NUMBER	—	num	22	SENT_757	[p31l681t2827r1060b2882],
21	aminohip	NN	O	aminohip	nn	22	SENT_757	[p31l681t2827r1060b2882],
22	—	NN	O	—	conj_and	15	SENT_757	[p31l681t2827r1060b2882],
23	purate	JJ	O	purate	amod	24	SENT_757	[p31l50t2906r204b2952],
24	clearance	NN	O	clearance	dep	22	SENT_757	[p31l227t2897r452b2940],
25	in	IN	O	in	_	0	SENT_757	[p31l475t2898r521b2940],
26	healthy	JJ	O	healthy	amod	27	SENT_757	[p31l544t2897r721b2952],
27	subjects	NNS	O	subject	prep_in	6	SENT_757	[p31l742t2897r947b2952],
28	.	.	O	.	_	0	SENT_757	[p31l742t2897r947b2952],

1	Br	NN	O	br	nn	4	SENT_758	[p31l972t2901r1062b2947],
2	]	CD	NUMBER	]	num	4	SENT_758	[p31l972t2901r1062b2947],
3	Clin	NNP	O	Clin	nn	4	SENT_758	[p31l51t2967r150b3011],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_758	[p31l168t2967r426b3010],
5	2013	CD	DATE	2013	dep	4	SENT_758	[p31l444t2970r797b3019],
6	;	:	O	;	_	0	SENT_758	[p31l444t2970r797b3019],
7	75:990	CD	NUMBER	75:990	num	8	SENT_758	[p31l444t2970r797b3019],
8	-6	CD	NUMBER	-6	dep	4	SENT_758	[p31l444t2970r797b3019],
9	.	.	O	.	_	0	SENT_758	[p31l444t2970r797b3019],

1	28	CD	NUMBER	28	_	0	SENT_759	[p31l51t3041r116b3081],
2	.	.	O	.	_	0	SENT_759	[p31l51t3041r116b3081],

1	Andreev	NNP	PERSON	Andreev	nn	2	SENT_760	[p31l143t3037r341b3081],
2	E	NNP	O	E	_	0	SENT_760	[p31l352t3041r395b3090],
3	,	,	O	,	_	0	SENT_760	[p31l352t3041r395b3090],
4	Koopman	NNP	PERSON	Koopman	nn	5	SENT_760	[p31l412t3041r644b3092],
5	M	NNP	O	M	appos	2	SENT_760	[p31l657t3041r716b3090],
6	,	,	O	,	_	0	SENT_760	[p31l657t3041r716b3090],
7	Arisz	NNP	O	Arisz	nn	10	SENT_760	[p31l732t3038r855b3080],
8	L.	NNP	O	L.	nn	10	SENT_760	[p31l869t3041r910b3080],
9	A	NNP	O	A	nn	10	SENT_760	[p31l926t3041r962b3080],
10	rise	NN	O	rise	appos	2	SENT_760	[p31l975t3038r1060b3080],
11	in	IN	O	in	_	0	SENT_760	[p31l51t3108r97b3150],
12	plasma	NN	O	plasma	nn	13	SENT_760	[p31l118t3107r291b3162],
13	creatinine	NN	O	creatinine	prep_in	10	SENT_760	[p31l312t3108r553b3150],
14	that	WDT	O	that	nsubj	18	SENT_760	[p31l576t3107r672b3150],
15	is	VBZ	O	be	cop	18	SENT_760	[p31l690t3108r727b3150],
16	not	RB	O	not	neg	18	SENT_760	[p31l750t3116r829b3151],
17	a	DT	O	a	det	18	SENT_760	[p31l848t3121r872b3150],
18	sign	NN	O	sign	rcmod	13	SENT_760	[p31l894t3108r993b3163],
19	of	IN	O	of	_	0	SENT_760	[p31l1015t3107r1070b3150],
20	renal	JJ	O	renal	amod	21	SENT_760	[p31l51t3177r173b3220],
21	failure	NN	O	failure	prep_of	18	SENT_760	[p31l192t3177r361b3221],
22	:	:	O	:	_	0	SENT_760	[p31l192t3177r361b3221],
23	which	WDT	O	which	dobj	27	SENT_760	[p31l380t3177r527b3221],
24	drugs	NNS	O	drug	nsubj	27	SENT_760	[p31l547t3177r682b3233],
25	can	MD	O	can	aux	27	SENT_760	[p31l704t3191r787b3220],
26	be	VB	O	be	cop	27	SENT_760	[p31l806t3177r860b3220],
27	responsible	JJ	O	responsible	rcmod	10	SENT_760	[p31l879t3191r1060b3232, p31l52t3246r215b3297],
28	?	.	O	?	_	0	SENT_760	[p31l879t3191r1060b3232, p31l52t3246r215b3297],

1	J	NNP	O	J	nn	3	SENT_761	[p31l879t3191r1060b3232, p31l52t3246r215b3297],
2	Intern	NNP	O	Intern	nn	3	SENT_761	[p31l232t3251r380b3290],
3	Med	NNP	O	Med	_	0	SENT_761	[p31l398t3247r501b3290],
4	1999	CD	DATE	1999	num	3	SENT_761	[p31l522t3250r922b3299],
5	;	:	O	;	_	0	SENT_761	[p31l522t3250r922b3299],
6	246:247	CD	NUMBER	246:247	number	7	SENT_761	[p31l522t3250r922b3299],
7	-52	CD	NUMBER	-52	dep	3	SENT_761	[p31l522t3250r922b3299],
8	.	.	O	.	_	0	SENT_761	[p31l522t3250r922b3299],

1	29	CD	NUMBER	29	_	0	SENT_762	[p31l51t3322r115b3360],
2	.	.	O	.	_	0	SENT_762	[p31l51t3322r115b3360],

1	Lepist	NNP	O	Lepist	nn	2	SENT_763	[p31l145t3318r291b3372],
2	E1	NN	O	e1	_	0	SENT_763	[p31l311t3321r372b3370],
3	,	,	O	,	_	0	SENT_763	[p31l311t3321r372b3370],
4	Murray	NNP	ORGANIZATION	Murray	nn	5	SENT_763	[p31l397t3321r572b3372],
5	BP	NNP	ORGANIZATION	BP	appos	2	SENT_763	[p31l593t3321r662b3370],
6	,	,	O	,	_	0	SENT_763	[p31l593t3321r662b3370],
7	Tong	NNP	PERSON	Tong	nn	8	SENT_763	[p31l687t3321r809b3373],
8	L	NNP	PERSON	L	appos	5	SENT_763	[p31l830t3321r872b3370],
9	,	,	O	,	_	0	SENT_763	[p31l830t3321r872b3370],
10	Roy	NNP	PERSON	Roy	nn	11	SENT_763	[p31l898t3321r990b3372],
11	A	NNP	O	A	appos	5	SENT_763	[p31l1009t3321r1057b3370],
12	,	,	O	,	_	0	SENT_763	[p31l1009t3321r1057b3370],
13	Bannister	NNP	PERSON	Bannister	nn	14	SENT_763	[p31l50t3388r285b3430],
14	R	NNP	O	R	appos	5	SENT_763	[p31l307t3391r355b3440],
15	,	,	O	,	_	0	SENT_763	[p31l307t3391r355b3440],
16	Ray	NNP	PERSON	Ray	nn	17	SENT_763	[p31l383t3391r472b3442],
17	AS	NNP	O	AS	appos	5	SENT_763	[p31l492t3390r569b3430],
18	.	.	O	.	_	0	SENT_763	[p31l492t3390r569b3430],

1	Effect	NN	O	effect	_	0	SENT_764	[p31l597t3387r739b3430],
2	of	IN	O	of	_	0	SENT_764	[p31l761t3387r817b3430],
3	cobicistat	NN	O	cobicistat	prep_of	1	SENT_764	[p31l832t3387r1063b3431],
4	and	CC	O	and	_	0	SENT_764	[p31l51t3457r139b3500],
5	ritonavir	NN	O	ritonavir	prep_of	1	SENT_764	[p31l167t3458r375b3501],
6	on	IN	O	on	_	0	SENT_764	[p31l402t3471r461b3500],
7	proximal	JJ	O	proximal	amod	11	SENT_764	[p31l489t3457r708b3512],
8	renal	JJ	O	renal	amod	11	SENT_764	[p31l736t3457r857b3500],
9	tubular	JJ	O	tubular	amod	11	SENT_764	[p31l885t3457r1062b3501],
10	cell	NN	O	cell	nn	11	SENT_764	[p31l52t3527r133b3570],
11	uptake	NN	O	uptake	prep_on	1	SENT_764	[p31l158t3527r320b3582],
12	and	CC	O	and	_	0	SENT_764	[p31l345t3527r433b3570],
13	efflux	NN	O	efflux	nn	14	SENT_764	[p31l459t3527r602b3571],
14	transporters	NNS	O	transporter	conj_and	11	SENT_764	[p31l626t3536r937b3582],
15	.	.	O	.	_	0	SENT_764	[p31l626t3536r937b3582],

1	Presented	VBN	O	present	_	0	SENT_765	[p31l965t3531r1060b3570, p31l52t3597r207b3641],
2	at	IN	O	at	_	0	SENT_765	[p31l222t3606r266b3640],
3	the	DT	O	the	det	6	SENT_765	[p31l280t3597r354b3640],
4	51st	JJ	ORDINAL	51st	amod	6	SENT_765	[p31l371t3600r469b3641],
5	Interscience	NNP	O	Interscience	nn	6	SENT_765	[p31l482t3598r772b3640],
6	Conference	NN	O	conference	prep_at	1	SENT_765	[p31l789t3597r1061b3641],
7	on	IN	O	on	_	0	SENT_765	[p31l52t3681r111b3711],
8	Antimicrobial	NNP	O	Antimicrobial	nn	9	SENT_765	[p31l127t3667r466b3711],
9	Agents	NNPS	O	Agents	prep_on	6	SENT_765	[p31l483t3671r648b3723],
10	and	CC	O	and	_	0	SENT_765	[p31l668t3667r756b3710],
11	Chemotherapy	NNP	O	Chemotherapy	conj_and	6	SENT_765	[p31l775t3667r1060b3711, p31l51t3751r140b3792],
12	,	,	O	,	_	0	SENT_765	[p31l775t3667r1060b3711, p31l51t3751r140b3792],
13	Chicago	NNP	LOCATION	Chicago	nn	15	SENT_765	[p31l162t3737r370b3793],
14	,	,	O	,	_	0	SENT_765	[p31l162t3737r370b3793],
15	September	NNP	DATE	September	appos	11	SENT_765	[p31l393t3737r648b3792],
16	17-20	CD	DATE	17-20	num	15	SENT_765	[p31l668t3740r815b3790],
17	,	,	DATE	,	_	0	SENT_765	[p31l668t3740r815b3790],
18	2011	CD	DATE	2011	num	15	SENT_765	[p31l838t3740r964b3781],
19	.	.	O	.	_	0	SENT_765	[p31l838t3740r964b3781],

1	abet	IN	O	abet	_	0	SENT_766	[p31l986t3737r1060b3781, p31l1135t2627r1178b2661],

1	al.	FW	O	al.	_	0	SENT_767	[p31l1199t2618r1255b2661],
2	.	.	O	.	_	0	SENT_767	[p31l1199t2618r1255b2661],

1	In	FW	O	in	nn	2	SENT_768	[p31l1281t2622r1330b2661],
2	vitro	FW	O	vitro	amod	4	SENT_768	[p31l1351t2619r1462b2662],
3	antiretroviral	JJ	O	antiretroviral	amod	4	SENT_768	[p31l1485t2618r1806b2662],
4	properties	NNS	O	property	_	0	SENT_768	[p31l1828t2619r2073b2673],
5	of	IN	O	of	_	0	SENT_768	[p31l2098t2618r2153b2661],
6	SIGSK1349572	NN	O	sigsk1349572	prep_of	4	SENT_768	[p31l1136t2691r1506b2740],
7	,	,	O	,	_	0	SENT_768	[p31l1136t2691r1506b2740],
8	a	DT	O	a	det	12	SENT_768	[p31l1552t2702r1577b2730],
9	next-generation	JJ	O	next-generation	amod	12	SENT_768	[p31l1619t2689r2005b2743],
10	HIV	NN	MISC	hiv	nn	12	SENT_768	[p31l2047t2692r2145b2730],
11	integrase	NN	O	integrase	nn	12	SENT_768	[p31l1134t2758r1360b2813],
12	inhibitor	NN	O	inhibitor	appos	4	SENT_768	[p31l1394t2757r1624b2801],
13	.	.	O	.	_	0	SENT_768	[p31l1394t2757r1624b2801],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_769	[p31l1659t2757r1941b2801],
2	Agents	NNPS	O	Agents	nn	3	SENT_769	[p31l1974t2761r2142b2813],
3	Chemother	NNP	O	Chemother	_	0	SENT_769	[p31l1134t2827r1403b2870],
4	2011	CD	DATE	2011	dep	3	SENT_769	[p31l1420t2830r1794b2879],
5	;	:	O	;	_	0	SENT_769	[p31l1420t2830r1794b2879],
6	55:813	CD	NUMBER	55:813	num	7	SENT_769	[p31l1420t2830r1794b2879],
7	-21	CD	NUMBER	-21	dep	3	SENT_769	[p31l1420t2830r1794b2879],
8	.	.	O	.	_	0	SENT_769	[p31l1420t2830r1794b2879],

1	33	CD	NUMBER	33	_	0	SENT_770	[p31l1134t2902r1197b2940],
2	.	.	O	.	_	0	SENT_770	[p31l1134t2902r1197b2940],

1	Cahn	NNP	PERSON	Cahn	nn	2	SENT_771	[p31l1228t2897r1354b2941],
2	P	NN	O	p	_	0	SENT_771	[p31l1378t2901r1414b2950],
3	,	,	O	,	_	0	SENT_771	[p31l1378t2901r1414b2950],
4	Pozniak	NNP	PERSON	Pozniak	nn	5	SENT_771	[p31l1441t2897r1636b2941],
5	AL	NNP	PERSON	AL	appos	2	SENT_771	[p31l1656t2901r1736b2950],
6	,	,	O	,	_	0	SENT_771	[p31l1656t2901r1736b2950],
7	Mingrone	NNP	O	Mingrone	nn	8	SENT_771	[p31l1762t2898r1998b2953],
8	H	NNP	O	H	appos	2	SENT_771	[p31l2022t2901r2075b2950],
9	,	,	O	,	_	0	SENT_771	[p31l2022t2901r2075b2950],
10	et	FW	O	et	nn	11	SENT_771	[p31l2103t2906r2146b2940],
11	al.	FW	O	al.	appos	2	SENT_771	[p31l1134t2967r1188b3010],
12	.	.	O	.	_	0	SENT_771	[p31l1134t2967r1188b3010],

1	Dolutegravir	NNP	O	Dolutegravir	nsubj	14	SENT_772	[p31l1210t2967r1515b3023],
2	versus	CC	O	versus	prep	1	SENT_772	[p31l1530t2981r1679b3011],
3	raltegravir	NN	O	raltegravir	dep	2	SENT_772	[p31l1700t2967r1953b3023],
4	in	IN	O	in	_	0	SENT_772	[p31l1970t2968r2017b3010],
5	antiretroviral-experienced	JJ	O	antiretroviral-experienced	amod	8	SENT_772	[p31l2036t2968r2143b3010, p31l1134t3037r1659b3092],
6	,	,	O	,	_	0	SENT_772	[p31l2036t2968r2143b3010, p31l1134t3037r1659b3092],
7	integraseinhibitornaive	JJ	O	integraseinhibitornaive	amod	8	SENT_772	[p31l1684t3037r2143b3093, p31l1134t3108r1258b3151],
8	adults	NNS	O	adult	prep_in	3	SENT_772	[p31l1289t3107r1433b3151],
9	with	IN	O	with	_	0	SENT_772	[p31l1464t3107r1573b3151],
10	HIV	NN	O	hiv	prep_with	8	SENT_772	[p31l1604t3111r1710b3150],
11	:	:	O	:	_	0	SENT_772	[p31l1604t3111r1710b3150],
12	week	NN	DURATION	week	dep	8	SENT_772	[p31l1741t3107r1866b3151],
13	48	CD	NUMBER	48	num	14	SENT_772	[p31l1894t3110r1951b3151],
14	results	NNS	O	result	_	0	SENT_772	[p31l1983t3107r2142b3151],
15	from	IN	O	from	_	0	SENT_772	[p31l1134t3177r1251b3221],
16	the	DT	O	the	prep_from	14	SENT_772	[p31l1271t3177r1346b3220],
17	randomised	VBN	O	randomise	partmod	16	SENT_772	[p31l1366t3177r1666b3230],
18	,	,	O	,	_	0	SENT_772	[p31l1366t3177r1666b3230],
19	double-blind	JJ	O	double-blind	amod	21	SENT_772	[p31l1690t3177r2009b3230],
20	,	,	O	,	_	0	SENT_772	[p31l1690t3177r2009b3230],
21	noninferiority	JJ	O	noninferiority	amod	23	SENT_772	[p31l2032t3191r2143b3220, p31l1134t3246r1386b3302],
22	SAILING	NN	O	sailing	nn	23	SENT_772	[p31l1411t3250r1629b3290],
23	study	NN	O	study	dobj	14	SENT_772	[p31l1658t3247r1797b3302],
24	.	.	O	.	_	0	SENT_772	[p31l1658t3247r1797b3302],

1	Lancet	NNP	O	Lancet	_	0	SENT_773	[p31l1827t3251r1990b3290],
2	2013	CD	DATE	2013	num	1	SENT_773	[p31l2014t3250r2141b3299],
3	;	:	O	;	_	0	SENT_773	[p31l2014t3250r2141b3299],
4	382:700	CD	NUMBER	382:700	number	5	SENT_773	[p31l1135t3320r1383b3361],
5	-8	CD	NUMBER	-8	dep	1	SENT_773	[p31l1135t3320r1383b3361],
6	.	.	O	.	_	0	SENT_773	[p31l1135t3320r1383b3361],

1	34	CD	NUMBER	34	_	0	SENT_774	[p31l1134t3392r1200b3430],
2	.	.	O	.	_	0	SENT_774	[p31l1134t3392r1200b3430],

1	Nichols	NNP	PERSON	Nichols	nn	2	SENT_775	[p31l1227t3387r1413b3431],
2	G	NNP	PERSON	G	_	0	SENT_775	[p31l1442t3390r1494b3440],
3	,	,	O	,	_	0	SENT_775	[p31l1442t3390r1494b3440],
4	Lazzarin	NNP	O	Lazzarin	nn	5	SENT_775	[p31l1524t3388r1739b3430],
5	A	NNP	O	A	appos	2	SENT_775	[p31l1764t3391r1813b3440],
6	,	,	O	,	_	0	SENT_775	[p31l1764t3391r1813b3440],
7	Maggiolo	NNP	O	Maggiolo	nn	8	SENT_775	[p31l1843t3387r2074b3443],
8	F	NN	O	f	appos	2	SENT_775	[p31l2102t3391r2140b3440],
9	,	,	O	,	_	0	SENT_775	[p31l2102t3391r2140b3440],
10	et	FW	O	et	nn	11	SENT_775	[p31l1135t3466r1178b3500],
11	al.	FW	O	al.	appos	2	SENT_775	[p31l1199t3457r1255b3500],
12	.	.	O	.	_	0	SENT_775	[p31l1199t3457r1255b3500],

1	Phase	NN	O	phase	_	0	SENT_776	[p31l1280t3457r1417b3500],
2	3	CD	NUMBER	3	num	3	SENT_776	[p31l1441t3460r1465b3501],
3	assessment	NN	O	assessment	dep	1	SENT_776	[p31l1489t3466r1763b3500],
4	of	IN	O	of	_	0	SENT_776	[p31l1784t3457r1839b3501],
5	dolutegravir	FW	O	dolutegravir	nn	7	SENT_776	[p31l1852t3457r2145b3513],
6	(	FW	O	(	nn	7	SENT_776	[p31l1137t3530r1281b3577],
7	DTG	NN	O	dtg	prep_of	3	SENT_776	[p31l1137t3530r1281b3577],
8	)	CD	NUMBER	)	number	9	SENT_776	[p31l1137t3530r1281b3577],
9	50	CD	NUMBER	50	num	10	SENT_776	[p31l1301t3530r1355b3571],
10	mg	NN	O	mg	dep	7	SENT_776	[p31l1371t3541r1447b3583],
11	twice	RB	O	twice	advmod	7	SENT_776	[p31l1461t3528r1588b3571],
12	daily	RB	SET	daily	advmod	7	SENT_776	[p31l1604t3527r1720b3582],
13	in	IN	O	in	amod	7	SENT_776	[p31l1733t3528r1779b3570],
14	HIV-1-infected	JJ	O	hiv-1-infected	amod	15	SENT_776	[p31l1794t3527r2143b3570],
15	subjects	NNS	O	subject	dep	7	SENT_776	[p31l1135t3597r1325b3652],
16	with	IN	O	with	_	0	SENT_776	[p31l1346t3597r1454b3641],
17	raltegravir	NN	O	raltegravir	prep_with	15	SENT_776	[p31l1476t3597r1729b3653],
18	(	CD	NUMBER	(	num	17	SENT_776	[p31l1751t3601r1885b3647],
19	RAL	NN	O	ral	nn	22	SENT_776	[p31l1751t3601r1885b3647],
20	)	CD	NUMBER	)	num	22	SENT_776	[p31l1751t3601r1885b3647],
21	and/or	NN	O	and/or	nn	22	SENT_776	[p31l1910t3597r2066b3647],
22	elvitegravir	NN	O	elvitegravir	dep	1	SENT_776	[p31l2086t3597r2143b3640, p31l1132t3668r1362b3723],
23	(	CD	NUMBER	(	num	24	SENT_776	[p31l1388t3670r1522b3717],
24	EVG	NN	O	evg	dep	22	SENT_776	[p31l1388t3670r1522b3717],
25	)	CD	NUMBER	)	num	26	SENT_776	[p31l1388t3670r1522b3717],
26	resistance	NN	O	resistance	dep	1	SENT_776	[p31l1550t3668r1791b3710],
27	in	IN	O	in	_	0	SENT_776	[p31l1815t3668r1862b3710],
28	VIKING	NNP	O	VIKING	prep_in	26	SENT_776	[p31l1885t3670r2141b3712],
29	—	CD	NUMBER	—	number	30	SENT_776	[p31l1885t3670r2141b3712],
30	3	CD	NUMBER	3	dep	1	SENT_776	[p31l1885t3670r2141b3712],
31	:	:	O	:	_	0	SENT_776	[p31l1885t3670r2141b3712],
32	Week	NN	DURATION	week	dep	30	SENT_776	[p31l1132t3737r1256b3781],
33	24	CD	NUMBER	24	num	34	SENT_776	[p31l1285t3740r1340b3780],
34	results	NNS	O	result	dep	32	SENT_776	[p31l1371t3737r1530b3781],
35	of	IN	O	of	_	0	SENT_776	[p31l1564t3737r1619b3781],
36	all	DT	O	all	prep_of	34	SENT_776	[p31l1641t3737r1699b3780],
37	183	CD	NUMBER	183	num	38	SENT_776	[p31l1733t3740r1813b3781],
38	patients	NNS	O	patient	npadvmod	39	SENT_776	[p31l1845t3738r2037b3792],
39	enstract	JJ	O	enstract	amod	36	SENT_776	[p31l2070t3751r2143b3780, p32l52t23r198b57],
40	.	.	O	.	_	0	SENT_776	[p31l2070t3751r2143b3780, p32l52t23r198b57],

1	30	CD	NUMBER	30	_	0	SENT_777	[p32l51t87r116b126],
2	.	.	O	.	_	0	SENT_777	[p32l51t87r116b126],

1	Cohen	NNP	PERSON	Cohen	nn	3	SENT_778	[p32l145t83r298b126],
2	C	NNP	O	C	nn	3	SENT_778	[p32l323t86r385b136],
3	]	NN	O	]	_	0	SENT_778	[p32l323t86r385b136],
4	,	,	O	,	_	0	SENT_778	[p32l323t86r385b136],
5	Andrade	NNP	PERSON	Andrade	appos	3	SENT_778	[p32l410t83r885b127],
6	.	.	O	.	_	0	SENT_778	[p32l410t83r885b127],

1	—	NN	O	—	_	0	SENT_779	[p32l410t83r885b127],
2	.	.	O	.	_	0	SENT_779	[p32l410t83r885b127],

1	Villanueva	NNP	PERSON	Villanueva	nn	2	SENT_780	[p32l410t83r885b127],
2	J	NNP	PERSON	J	_	0	SENT_780	[p32l903t87r935b136],
3	,	,	O	,	_	0	SENT_780	[p32l903t87r935b136],
4	Clotet	NNP	O	Clotet	nn	5	SENT_780	[p32l962t83r1060b126, p32l51t162r114b196],
5	B	NNP	O	B	appos	2	SENT_780	[p32l141t157r185b206],
6	,	,	O	,	_	0	SENT_780	[p32l141t157r185b206],
7	et	FW	O	et	nn	8	SENT_780	[p32l220t162r263b196],
8	al.	FW	O	al.	appos	5	SENT_780	[p32l290t153r345b196],
9	.	.	O	.	_	0	SENT_780	[p32l290t153r345b196],

1	Rilpivirine	NN	PERSON	rilpivirine	_	0	SENT_781	[p32l378t153r632b208],
2	versus	CC	O	versus	prep	1	SENT_781	[p32l661t167r809b197],
3	efavirenz	NN	O	efavirenz	dep	2	SENT_781	[p32l842t153r1060b197],
4	with	IN	O	with	_	0	SENT_781	[p32l49t223r158b267],
5	two	CD	NUMBER	two	num	7	SENT_781	[p32l174t232r261b267],
6	background	NN	O	background	nn	7	SENT_781	[p32l278t223r566b279],
7	nucleoside	NN	O	nucleoside	prep_with	3	SENT_781	[p32l582t223r835b267],
8	or	CC	O	or	_	0	SENT_781	[p32l851t237r901b266],
9	nucleotide	NN	O	nucleotide	conj_or	1	SENT_781	[p32l915t223r1060b267, p32l52t293r170b336],
10	reverse	JJ	O	reverse	amod	12	SENT_781	[p32l202t307r369b337],
11	transcriptase	NN	O	transcriptase	nn	12	SENT_781	[p32l400t294r715b348],
12	inhibitors	NNS	O	inhibitor	dep	9	SENT_781	[p32l746t293r982b336],
13	in	IN	O	in	dep	1	SENT_781	[p32l1014t294r1061b336],
14	treatment-naive	JJ	O	treatment-naive	amod	15	SENT_781	[p32l52t364r420b406],
15	adults	NNS	O	adult	pobj	13	SENT_781	[p32l438t363r578b406],
16	infected	VBN	O	infect	partmod	15	SENT_781	[p32l596t362r787b406],
17	with	IN	O	with	_	0	SENT_781	[p32l802t363r909b406],
18	HIV-1	NN	O	hiv-1	prep_with	16	SENT_781	[p32l926t366r1060b405],

1	(	RB	O	(	advmod	2	SENT_782	[p32l54t435r302b482],
2	THRIVE	VB	O	thrive	_	0	SENT_782	[p32l54t435r302b482],
3	)	CD	NUMBER	)	dobj	2	SENT_782	[p32l54t435r302b482],
4	:	:	O	:	_	0	SENT_782	[p32l54t435r302b482],
5	a	DT	O	a	det	6	SENT_782	[p32l332t446r356b475],
6	phase	NN	O	phase	dobj	2	SENT_782	[p32l382t432r521b487],
7	3	CD	NUMBER	3	dep	6	SENT_782	[p32l550t435r588b485],
8	,	,	O	,	_	0	SENT_782	[p32l550t435r588b485],
9	randomised	VBN	O	randomise	partmod	6	SENT_782	[p32l620t432r920b485],
10	,	,	O	,	_	0	SENT_782	[p32l620t432r920b485],
11	noninferiority	JJ	O	noninferiority	amod	12	SENT_782	[p32l951t446r1060b476, p32l51t501r303b556],
12	trial	NN	O	trial	dep	2	SENT_782	[p32l320t502r436b545],
13	.	.	O	.	_	0	SENT_782	[p32l320t502r436b545],

1	Lancet	NNP	O	Lancet	_	0	SENT_783	[p32l458t506r622b544],
2	2011	CD	DATE	2011	num	1	SENT_783	[p32l639t505r1048b553],
3	;	:	O	;	_	0	SENT_783	[p32l639t505r1048b553],
4	378:229	CD	NUMBER	378:229	number	5	SENT_783	[p32l639t505r1048b553],
5	-37	CD	NUMBER	-37	dep	1	SENT_783	[p32l639t505r1048b553],
6	.	.	O	.	_	0	SENT_783	[p32l639t505r1048b553],

1	31	CD	NUMBER	31	_	0	SENT_784	[p32l51t576r113b614],
2	.	.	O	.	_	0	SENT_784	[p32l51t576r113b614],

1	Molina	NNP	PERSON	Molina	nn	2	SENT_785	[p32l144t571r312b614],
2	JM	NN	O	jm	_	0	SENT_785	[p32l323t575r402b624],
3	,	,	O	,	_	0	SENT_785	[p32l323t575r402b624],
4	Cahn	NNP	PERSON	Cahn	nn	5	SENT_785	[p32l422t571r547b615],
5	P	NN	O	p	appos	2	SENT_785	[p32l563t575r599b624],
6	,	,	O	,	_	0	SENT_785	[p32l563t575r599b624],
7	Grinsztejn	NN	PERSON	grinsztejn	nn	8	SENT_785	[p32l620t572r866b626],
8	B	NN	PERSON	b	appos	2	SENT_785	[p32l883t575r927b624],
9	,	,	O	,	_	0	SENT_785	[p32l883t575r927b624],
10	et	FW	O	et	nn	11	SENT_785	[p32l948t580r990b614],
11	al.	FW	O	al.	appos	2	SENT_785	[p32l1004t571r1058b614],
12	.	.	O	.	_	0	SENT_785	[p32l1004t571r1058b614],

1	Rilpivirine	NN	PERSON	rilpivirine	_	0	SENT_786	[p32l50t641r305b696],
2	versus	CC	O	versus	prep	1	SENT_786	[p32l319t655r468b685],
3	efavirenz	NN	O	efavirenz	dep	2	SENT_786	[p32l486t641r704b685],
4	with	IN	O	with	_	0	SENT_786	[p32l719t641r827b685],
5	tenofovir	NN	O	tenofovir	prep_with	3	SENT_786	[p32l844t641r1062b685],
6	and	CC	O	and	_	0	SENT_786	[p32l51t711r140b754],
7	emtricitabine	NN	O	emtricitabine	conj_and	5	SENT_786	[p32l193t711r522b754],
8	in	IN	O	in	_	0	SENT_786	[p32l574t712r621b754],
9	treatment-naive	JJ	O	treatment-naive	amod	10	SENT_786	[p32l674t712r1061b755],
10	adults	NNS	O	adult	prep_in	1	SENT_786	[p32l51t781r198b825],
11	infected	VBN	O	infect	partmod	10	SENT_786	[p32l252t781r452b824],
12	with	IN	O	with	_	0	SENT_786	[p32l502t781r613b825],
13	HIV-1	NN	O	hiv-1	nn	15	SENT_786	[p32l665t784r804b824],
14	(	CD	NUMBER	(	num	15	SENT_786	[p32l860t784r1058b831],
15	ECHO	NN	O	echo	prep_with	11	SENT_786	[p32l860t784r1058b831],
16	)	CD	NUMBER	)	num	15	SENT_786	[p32l860t784r1058b831],
17	:	:	O	:	_	0	SENT_786	[p32l860t784r1058b831],
18	a	DT	O	a	det	19	SENT_786	[p32l51t865r75b894],
19	phase	NN	O	phase	dep	1	SENT_786	[p32l92t851r228b906],
20	3	CD	NUMBER	3	dep	19	SENT_786	[p32l247t854r271b895],
21	randomised	VBN	O	randomise	partmod	1	SENT_786	[p32l291t851r573b894],
22	double-blind	JJ	O	double-blind	amod	24	SENT_786	[p32l592t851r891b895],
23	activecontrolled	JJ	O	activecontrolled	amod	24	SENT_786	[p32l909t852r1060b895, p32l52t921r302b964],
24	trial	NN	O	trial	dobj	21	SENT_786	[p32l321t921r437b964],
25	.	.	O	.	_	0	SENT_786	[p32l321t921r437b964],

1	Lancet	NNP	O	Lancet	_	0	SENT_787	[p32l459t925r622b964],
2	2011	CD	DATE	2011	num	1	SENT_787	[p32l638t924r1057b973],
3	;	:	O	;	_	0	SENT_787	[p32l638t924r1057b973],
4	378:238	CD	NUMBER	378:238	number	5	SENT_787	[p32l638t924r1057b973],
5	-46	CD	NUMBER	-46	dep	1	SENT_787	[p32l638t924r1057b973],
6	.	.	O	.	_	0	SENT_787	[p32l638t924r1057b973],

1	32	CD	NUMBER	32	_	0	SENT_788	[p32l51t996r117b1034],
2	.	.	O	.	_	0	SENT_788	[p32l51t996r117b1034],

1	Kobayashi	NNP	LOCATION	Kobayashi	nn	2	SENT_789	[p32l145t991r397b1046],
2	M	NNP	O	M	nsubj	10	SENT_789	[p32l427t995r487b1044],
3	,	,	O	,	_	0	SENT_789	[p32l427t995r487b1044],
4	Yoshinaga	NNP	PERSON	Yoshinaga	nn	5	SENT_789	[p32l521t991r775b1047],
5	T	NN	PERSON	t	appos	2	SENT_789	[p32l804t995r847b1044],
6	,	,	O	,	_	0	SENT_789	[p32l804t995r847b1044],
7	Seki	NNP	PERSON	Seki	nn	8	SENT_789	[p32l884t991r984b1035],
8	T	NN	PERSON	t	appos	5	SENT_789	[p32l1014t994r1057b1044],
9	,	,	O	,	_	0	SENT_789	[p32l1014t994r1057b1044],
10	rolled	VBD	O	roll	_	0	SENT_789	[p32l1134t14r1286b57],
11	.	.	O	.	_	0	SENT_789	[p32l1134t14r1286b57],

1	Presented	VBN	O	present	_	0	SENT_790	[p32l1310t14r1545b57],
2	at	IN	O	at	_	0	SENT_790	[p32l1567t23r1611b56],
3	the	DT	O	the	det	5	SENT_790	[p32l1630t14r1704b57],
4	7th	NNP	ORDINAL	7th	nn	5	SENT_790	[p32l1727t14r1804b56],
5	International	NNP	MISC	International	prep_at	1	SENT_790	[p32l1825t14r2144b57],

1	AIDS	NNP	O	AIDS	nn	3	SENT_791	[p32l1132t86r1256b126],
2	Society	NNP	O	Society	nn	3	SENT_791	[p32l1286t84r1456b138],
3	Conference	NNP	O	Conference	_	0	SENT_791	[p32l1481t83r1752b126],
4	on	IN	O	on	_	0	SENT_791	[p32l1780t97r1839b126],
5	HIV	NN	O	hiv	nn	6	SENT_791	[p32l1866t87r1962b126],
6	Pathogenesis	NN	ORGANIZATION	pathogenesis	prep_on	3	SENT_791	[p32l1987t83r2143b126, p32l1134t154r1323b209],
7	,	,	O	,	_	0	SENT_791	[p32l1987t83r2143b126, p32l1134t154r1323b209],
8	Treatment	NN	O	treatment	prep_on	3	SENT_791	[p32l1346t156r1608b206],
9	,	,	O	,	_	0	SENT_791	[p32l1346t156r1608b206],
10	and	CC	O	and	_	0	SENT_791	[p32l1632t153r1720b196],
11	Prevention	NNP	O	Prevention	conj_and	6	SENT_791	[p32l1740t154r2009b206],
12	,	,	O	,	_	0	SENT_791	[p32l1740t154r2009b206],
13	Kuala	NNP	LOCATION	Kuala	nn	14	SENT_791	[p32l2033t157r2143b198, p32l1134t223r1175b266],
14	Lumpur	NNP	LOCATION	Lumpur	appos	3	SENT_791	[p32l1190t227r1393b278],
15	,	,	O	,	_	0	SENT_791	[p32l1190t227r1393b278],
16	Malaysia	NNP	LOCATION	Malaysia	appos	3	SENT_791	[p32l1411t223r1635b278],
17	,	,	O	,	_	0	SENT_791	[p32l1411t223r1635b278],
18	June	NNP	DATE	June	nn	19	SENT_791	[p32l1650t227r1758b273],
19	30-July	NNP	DATE	30-July	appos	3	SENT_791	[p32l1775t223r1940b278],
20	3	CD	DATE	3	num	19	SENT_791	[p32l1955t226r1994b276],
21	,	,	DATE	,	_	0	SENT_791	[p32l1955t226r1994b276],
22	2013	CD	DATE	2013	num	19	SENT_791	[p32l2014t226r2140b267],
23	.	.	O	.	_	0	SENT_791	[p32l2014t226r2140b267],

1	abstract	JJ	O	abstract	amod	2	SENT_792	[p32l1134t293r1327b336],
2	TULBPE19	NN	O	tulbpe19	_	0	SENT_792	[p32l1341t296r1607b337],
3	.	.	O	.	_	0	SENT_792	[p32l1341t296r1607b337],

1	35	CD	NUMBER	35	_	0	SENT_793	[p32l1134t368r1197b406],
2	.	.	O	.	_	0	SENT_793	[p32l1134t368r1197b406],

1	Raffi	NNP	PERSON	Raffi	nn	2	SENT_794	[p32l1227t362r1352b408],
2	F	NN	PERSON	f	_	0	SENT_794	[p32l1369t367r1407b415],
3	,	,	O	,	_	0	SENT_794	[p32l1369t367r1407b415],
4	Jaeger	NN	PERSON	jaeger	nn	5	SENT_794	[p32l1423t367r1573b418],
5	H	NN	O	h	appos	2	SENT_794	[p32l1590t367r1643b415],
6	,	,	O	,	_	0	SENT_794	[p32l1590t367r1643b415],
7	Quiros-Roldan	JJ	O	quiros-roldan	amod	8	SENT_794	[p32l1665t363r2020b416],
8	E	NN	O	e	appos	2	SENT_794	[p32l2038t367r2082b415],
9	,	,	O	,	_	0	SENT_794	[p32l2038t367r2082b415],
10	et	FW	O	et	nn	11	SENT_794	[p32l2104t372r2146b405],
11	al.	FW	O	al.	appos	2	SENT_794	[p32l1134t432r1187b475],
12	.	.	O	.	_	0	SENT_794	[p32l1134t432r1187b475],

1	Once-daily	JJ	O	once-daily	amod	2	SENT_795	[p32l1222t432r1477b487],
2	dolutegravir	NN	O	dolutegravir	dep	14	SENT_795	[p32l1507t432r1793b488],
3	versus	CC	O	versus	prep	2	SENT_795	[p32l1821t446r1967b476],
4	twicedaily	RB	O	twicedaily	advmod	5	SENT_795	[p32l1999t433r2143b476, p32l1135t502r1251b556],
5	raltegravir	NN	O	raltegravir	dep	3	SENT_795	[p32l1293t502r1545b557],
6	in	IN	O	in	_	0	SENT_795	[p32l1588t503r1634b544],
7	antiretroviral-naive	JJ	O	antiretroviral-naive	amod	8	SENT_795	[p32l1678t502r2143b545],
8	adults	NNS	O	adult	prep_in	5	SENT_795	[p32l1134t571r1277b615],
9	with	IN	O	with	_	0	SENT_795	[p32l1314t571r1422b615],
10	HIV-1	NN	O	hiv-1	prep_with	8	SENT_795	[p32l1459t574r1596b614],
11	infection	NN	O	infection	dep	14	SENT_795	[p32l1632t571r1849b614],
12	(	CD	NUMBER	(	num	11	SENT_795	[p32l1889t574r2143b621],
13	SPRING-2	NN	O	spring-2	nn	14	SENT_795	[p32l1889t574r2143b621],
14	study	NN	O	study	dep	18	SENT_795	[p32l1135t641r1292b696],
15	)	CD	NUMBER	)	dep	14	SENT_795	[p32l1135t641r1292b696],
16	:	:	O	:	_	0	SENT_795	[p32l1135t641r1292b696],
17	96	CD	DURATION	96	num	18	SENT_795	[p32l1322t644r1377b684],
18	week	NN	NUMBER	week	_	0	SENT_795	[p32l1403t641r1528b685],
19	results	VBZ	O	result	rcmod	18	SENT_795	[p32l1553t641r1712b685],
20	from	IN	O	from	_	0	SENT_795	[p32l1741t641r1858b684],
21	a	DT	O	a	prep_from	19	SENT_795	[p32l1886t655r1910b684],
22	randomised	VBN	O	randomise	partmod	21	SENT_795	[p32l1937t641r2143b684, p32l1134t711r1242b764],
23	,	,	O	,	_	0	SENT_795	[p32l1937t641r2143b684, p32l1134t711r1242b764],
24	double-blind	JJ	O	double-blind	amod	27	SENT_795	[p32l1281t711r1600b763],
25	,	,	O	,	_	0	SENT_795	[p32l1281t711r1600b763],
26	non-inferiority	JJ	O	non-inferiority	amod	27	SENT_795	[p32l1638t711r1995b766],
27	trial	NN	O	trial	appos	21	SENT_795	[p32l2028t711r2140b754],
28	.	.	O	.	_	0	SENT_795	[p32l2028t711r2140b754],

1	Lancet	NNP	O	Lancet	nn	3	SENT_796	[p32l1133t785r1294b824],
2	Infect	NNP	O	Infect	nn	3	SENT_796	[p32l1309t781r1451b824],
3	Dis	NNP	O	Dis	_	0	SENT_796	[p32l1467t782r1544b824],
4	2013	CD	DATE	2013	num	3	SENT_796	[p32l1564t784r1934b833],
5	;	:	O	;	_	0	SENT_796	[p32l1564t784r1934b833],
6	13:927	CD	NUMBER	13:927	number	7	SENT_796	[p32l1564t784r1934b833],
7	-35	CD	NUMBER	-35	dep	3	SENT_796	[p32l1564t784r1934b833],
8	.	.	O	.	_	0	SENT_796	[p32l1564t784r1934b833],

1	Copyright	NN	O	copyright	_	0	SENT_797	[p32l1136t858r1311b906],
2	©	CD	NUMBER	©	num	6	SENT_797	[p32l1329t862r1368b901],
3	2013	CD	DATE	2013	num	6	SENT_797	[p32l1387t861r1478b894],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_797	[p32l1496t858r1760b894],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_797	[p32l1777t858r1922b894],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_797	[p32l1936t860r2072b905],
7	.	.	O	.	_	0	SENT_797	[p32l1936t860r2072b905],

1	MY	NN	O	my	nn	2	SENT_798	[p32l879t1229r910b1244],
2	NE	NNS	O	ne	_	0	SENT_798	[p32l923t1229r979b1250],
3	}	CD	NUMBER	}	num	4	SENT_798	[p32l923t1229r979b1250],
4	M	NN	O	m	dep	2	SENT_798	[p32l923t1229r979b1250],
5	IN	IN	O	in	_	0	SENT_798	[p32l993t1229r1015b1245],
6	THEJOURNAL	NNP	O	THEJOURNAL	nn	7	SENT_798	[p32l1027t1229r1184b1250],
7	ONLINE	NNP	O	ONLINE	prep_in	4	SENT_798	[p32l1195t1229r1282b1245],

1	Individual	JJ	O	individual	amod	2	SENT_799	[p32l647t1264r774b1287],
2	subscribers	NNS	O	subscriber	nsubj	4	SENT_799	[p32l783t1264r926b1287],
3	can	MD	O	can	aux	4	SENT_799	[p32l935t1271r978b1287],
4	store	VB	O	store	_	0	SENT_799	[p32l987t1268r1048b1287],
5	articles	NNS	O	article	dobj	4	SENT_799	[p32l1057t1264r1146b1287],
6	and	CC	O	and	_	0	SENT_799	[p32l1155t1264r1201b1287],
7	searches	NNS	O	search	conj_and	5	SENT_799	[p32l1210t1264r1317b1287],
8	using	VBG	O	use	xcomp	4	SENT_799	[p32l1326t1264r1396b1293],
9	a	DT	O	a	det	10	SENT_799	[p32l1403t1271r1417b1287],
10	feature	NN	O	feature	dobj	8	SENT_799	[p32l1425t1263r1511b1287],
11	on	IN	O	on	_	0	SENT_799	[p32l732t1309r763b1324],
12	the	DT	O	the	det	13	SENT_799	[p32l772t1301r810b1324],
13	journal	NN	O	journal	poss	18	SENT_799	[p32l819t1301r925b1330],
14	’s	POS	O	’s	_	0	SENT_799	[p32l819t1301r925b1330],
15	website	NN	O	website	nn	18	SENT_799	[p32l933t1301r1029b1324],
16	(	CD	NUMBER	(	num	18	SENT_799	[p32l1039t1303r1181b1331],
17	NEJM.org	NN	O	nejm.org	nn	18	SENT_799	[p32l1039t1303r1181b1331],
18	)	NN	O	)	prep_on	8	SENT_799	[p32l1039t1303r1181b1331],
19	called	VBN	O	call	partmod	18	SENT_799	[p32l1192t1301r1264b1324],
20	“	CD	NUMBER	“	dobj	19	SENT_799	[p32l1274t1302r1325b1330],
21	My	PRP$	O	my	poss	22	SENT_799	[p32l1274t1302r1325b1330],
22	NEJM	NNP	O	NEJM	dep	20	SENT_799	[p32l1332t1303r1426b1328],
23	.	.	O	.	_	0	SENT_799	[p32l1332t1303r1426b1328],

1	”	NN	O	”	_	0	SENT_800	[p32l1332t1303r1426b1328],

1	Each	DT	O	each	det	2	SENT_801	[p32l658t1339r719b1362],
2	article	NN	O	article	nsubj	5	SENT_801	[p32l727t1339r804b1362],
3	and	CC	O	and	_	0	SENT_801	[p32l812t1339r858b1362],
4	search	NN	O	search	nsubj	5	SENT_801	[p32l867t1339r948b1362],
5	result	VBP	O	result	_	0	SENT_801	[p32l956t1339r1028b1362],
6	links	NNS	O	link	dobj	5	SENT_801	[p32l1035t1339r1096b1362],
7	to	TO	O	to	_	0	SENT_801	[p32l1105t1343r1128b1362],
8	this	DT	O	this	det	9	SENT_801	[p32l1138t1339r1183b1362],
9	feature	NN	O	feature	prep_to	5	SENT_801	[p32l1192t1338r1286b1362],
10	.	.	O	.	_	0	SENT_801	[p32l1192t1338r1286b1362],

1	Users	NNS	O	user	nsubj	3	SENT_802	[p32l1296t1341r1366b1362],
2	can	MD	O	can	aux	3	SENT_802	[p32l1375t1346r1418b1362],
3	create	VB	O	create	_	0	SENT_802	[p32l1427t1343r1500b1362],
4	personal	JJ	O	personal	amod	5	SENT_802	[p32l611t1376r720b1405],
5	folders	NNS	O	folder	dobj	3	SENT_802	[p32l729t1376r815b1399],
6	and	CC	O	and	_	0	SENT_802	[p32l824t1376r871b1399],
7	move	VB	O	move	conj_and	3	SENT_802	[p32l879t1384r946b1399],
8	articles	NNS	O	article	dobj	7	SENT_802	[p32l954t1376r1044b1399],
9	into	IN	O	into	_	0	SENT_802	[p32l1053t1376r1102b1399],
10	them	PRP	O	they	prep_into	7	SENT_802	[p32l1111t1376r1175b1399],
11	for	IN	O	for	_	0	SENT_802	[p32l1184t1376r1220b1399],
12	convenient	JJ	O	convenient	amod	13	SENT_802	[p32l1228t1376r1366b1399],
13	retrieval	NN	O	retrieval	prep_for	10	SENT_802	[p32l1374t1376r1475b1399],
14	later	RB	O	later	advmod	7	SENT_802	[p32l1483t1376r1545b1399],
15	.	.	O	.	_	0	SENT_802	[p32l1483t1376r1545b1399],

1	N	NN	O	n	nn	2	SENT_803	[p32l48t2167r85b2209],
2	ENGL	NN	ORGANIZATION	engl	_	0	SENT_803	[p32l126t2166r345b2227],
3	}	CD	NUMBER	}	num	4	SENT_803	[p32l126t2166r345b2227],
4	MED	NN	O	med	dep	2	SENT_803	[p32l387t2167r532b2208],
5	369	CD	NUMBER	369	num	7	SENT_803	[p32l561t2151r787b2226],
6	;	:	O	;	_	0	SENT_803	[p32l561t2151r787b2226],
7	19	CD	NUMBER	19	dep	2	SENT_803	[p32l561t2151r787b2226],

1	NEJM.ORG	NN	O	nejm.org	_	0	SENT_804	[p32l887t2166r1234b2227],

1	NOVEMBER	NNP	DATE	NOVEMBER	_	0	SENT_805	[p32l1338t2166r1716b2209],
2	7	CD	DATE	7	num	1	SENT_805	[p32l1745t2167r1797b2224],
3	,	,	DATE	,	_	0	SENT_805	[p32l1745t2167r1797b2224],
4	2013	CD	DATE	2013	appos	1	SENT_805	[p32l1829t2166r1984b2226],

1	The	DT	O	the	det	4	SENT_806	[p32l53t2259r195b2324],
2	New	NNP	O	New	nn	4	SENT_806	[p32l221t2261r394b2324],
3	England	NNP	O	England	nn	4	SENT_806	[p32l421t2259r731b2343],
4	Journal	NNP	O	Journal	_	0	SENT_806	[p32l756t2259r1029b2324],
5	of	IN	O	of	_	0	SENT_806	[p32l1056t2258r1136b2324],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_806	[p32l1155t2258r1506b2324],

